<SEC-DOCUMENT>0001213900-23-022437.txt : 20230323
<SEC-HEADER>0001213900-23-022437.hdr.sgml : 20230323
<ACCEPTANCE-DATETIME>20230323161554
ACCESSION NUMBER:		0001213900-23-022437
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230323
DATE AS OF CHANGE:		20230323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rail Vision Ltd.
		CENTRAL INDEX KEY:			0001743905
		STANDARD INDUSTRIAL CLASSIFICATION:	RAILROAD EQUIPMENT [3743]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41334
		FILM NUMBER:		23756410

	BUSINESS ADDRESS:	
		STREET 1:		15 HA?TIDHAR ST.
		STREET 2:		P.O.B 2155
		CITY:			RA?ANANA
		STATE:			L3
		ZIP:			4366517
		BUSINESS PHONE:		97299577706

	MAIL ADDRESS:	
		STREET 1:		15 HA?TIDHAR ST.
		STREET 2:		P.O.B 2155
		CITY:			RA?ANANA
		STATE:			L3
		ZIP:			4366517
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>f20f2022_railvisionltd.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:38 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:rvsn="http://www.RailVision.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
WASHINGTON, DC 20549</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType">20-F</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric>
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric>
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric>
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric>
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File No.: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-41334</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RAIL
VISION LTD.</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Exact
name of registrant as specified in its charter)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
of registrant&#8217;s name into English:</i> Not applicable</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Israel</b></span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">15
Ha&#8217;Tidhar St</ix:nonNumeric><br/>
<ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Ra&#8217;anana</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">4366517</ix:nonNumeric> <ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric><br/>
Tel: +972-9-957-7706</b></span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Jurisdiction of incorporation or organization)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address of principal executive offices)</i></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shahar
Hania</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15
Ha&#8217;Tidhar St</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown">Ra&#8217;anana</ix:nonNumeric>,
<ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode">4366517</ix:nonNumeric> <ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel:
<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode">+<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber">972-9-957-7706</ix:nonNumeric></ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Email:
<ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress">marketing@railvision.io</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(b) of the Act:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class to be registered</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which each<br/> class is to be registered</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares, par value NIS 0.01 per share</span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RVSN</span></ix:nonNumeric></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Stock Market LLC</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to purchase ordinary shares, par value NIS 0.01 per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RVSNW</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq Stock Market LLC</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(g) of the Act: None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
for which there is a reporting obligation pursuant to Section 15(d) of the Act: None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of December 31, 2022: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">16,091,488</ix:nonFraction> ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric> &#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Exchange Act of 1934. Yes &#9744; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric> &#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#9746; &#160;No &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months. <ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#9746; &#160;No &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric> &#9746;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityExTransitionPeriod">&#9746;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;The
term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board
to its Accounting Standards Codification after April 5, 2012.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Indicate by check mark whether any of those
error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-0">U.S. GAAP</span> &#9746;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International Financial Reporting<br/> Standards as issued by the International<br/> Accounting Standards Board &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#9744;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the
registrant has elected to follow. &#9744; Item 17&#160;&#160;&#160;&#160;&#9744; Item 18</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this is an annual report, indicate by check mark whether the registrant is a shell company. Yes &#9744; No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">INTRODUCTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">EMERGING GROWTH COMPANY STATUS</a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">MARKET, INDUSTRY, AND OTHER DATA</a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">PART I</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IDENTITY
    OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFFER
    STATISTICS AND EXPECTED TIMETABLE</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KEY
    INFORMATION</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization
    and Indebtedness</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons
    for the Offer and Use of Proceeds</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
    ON THE COMPANY</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">History
    and Development of the Company</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Overview</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
    Structure</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property,
    Plants and Equipment</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNRESOLVED
    STAFF COMMENTS</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING
    AND FINANCIAL REVIEW AND PROSPECTS</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Results</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
    and Capital Resources</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and Development, Patents and Licenses</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trend
    Information</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in"><a href="#b_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
    Accounting Estimates</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS,
    SENIOR MANAGEMENT AND EMPLOYEES</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Senior Management</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    Practices</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Ownership</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAJOR
    SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center">61</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
    Shareholders</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    Party Transactions</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests
    of Experts and Counsel</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
    INFORMATION</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
    and Other Financial Information</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    Changes</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_038"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    OFFER AND LISTING</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer
    and Listing Details</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
    of Distribution</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_041"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_042"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
    Shareholders</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_043"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#b_044"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
    of the Issue</span></a></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_045"><span style="font-size: 10pt">ADDITIONAL
    INFORMATION</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_046"><span style="font-size: 10pt">Share
    Capital</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_047"><span style="font-size: 10pt">Articles
    of Association</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_048"><span style="font-size: 10pt">Material
    Contracts</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_049"><span style="font-size: 10pt">Exchange
    Controls</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_050"><span style="font-size: 10pt">Taxation</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_051"><span style="font-size: 10pt">Dividends
    and Paying Agents</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_052"><span style="font-size: 10pt">Statement
    by Experts</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_053"><span style="font-size: 10pt">Documents
    on Display</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_054"><span style="font-size: 10pt">Subsidiary
    Information</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_055"><span style="font-size: 10pt">QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_056"><span style="font-size: 10pt">DESCRIPTION
    OF SECURITIES OTHER THAN EQUITY SECURITIES</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_057"><span style="font-size: 10pt">Debt
    Securities</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_058"><span style="font-size: 10pt">Warrants
    and rights</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_059"><span style="font-size: 10pt">Other
    Securities</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_060"><span style="font-size: 10pt">American
    Depositary Shares</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_061"><span style="font-size: 10pt">PART
    II</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_062"><span style="font-size: 10pt">DEFAULTS,
    DIVIDEND ARREARAGES AND DELINQUENCIES</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_063"><span style="font-size: 10pt">MATERIAL
    MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_064"><span style="font-size: 10pt">CONTROLS
    AND PROCEDURES</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_065"><span style="font-size: 10pt">[RESERVED]</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_066"><span style="font-size: 10pt">AUDIT
    COMMITTEE FINANCIAL EXPERT</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_067"><span style="font-size: 10pt">CODE
    OF ETHICS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_068"><span style="font-size: 10pt">PRINCIPAL
    ACCOUNTANT FEES AND SERVICES</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16D.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_069"><span style="font-size: 10pt">EXEMPTIONS
    FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16E.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_070"><span style="font-size: 10pt">PURCHASES
    OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16F.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_071"><span style="font-size: 10pt">CHANGE
    IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16G.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_072"><span style="font-size: 10pt">CORPORATE
    GOVERNANCE</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16H.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_073"><span style="font-size: 10pt">MINE
    SAFETY DISCLOSURE</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16I</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_074"><span style="font-size: 10pt">DISCLOSURE
    REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_075"><span style="font-size: 10pt">PART
    III</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    17.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_076"><span style="font-size: 10pt">FINANCIAL
    STATEMENTS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">82</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    18.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_077"><span style="font-size: 10pt">FINANCIAL
    STATEMENTS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    19.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_078"><span style="font-size: 10pt">EXHIBITS</span></a></span></td>
    <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#b_079"><span style="font-size: 10pt">SIGNATURES</span></a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">84</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Unless the context otherwise
requires, references in this Annual Report on Form 20-F to the &#8220;Company,&#8221; &#8220;Rail Vision,&#8221; &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our&#8221; and other similar designations refer to Rail Vision Ltd. All references to &#8220;shares&#8221; or &#8220;ordinary shares&#8221;
are to our ordinary shares, NIS 0.01 par value per share. All references to &#8220;Israel&#8221; are to the State of Israel. &#8220;U.S.
GAAP&#8221; means the generally accepted accounting principles of the United States. Unless otherwise stated, all of our financial information
presented in this Annual Report has been prepared in accordance with U.S. GAAP. Any discrepancies in any table between totals and sums
of the amounts listed are due to rounding. Unless otherwise indicated, or the context otherwise requires, references in this Annual Report
to financial and operational data for a particular year refer to the fiscal year of our company ended December 31 of that year.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
reporting currency and financial currency is the U.S. dollar. In this Annual Report, &#8220;NIS&#8221; means New Israeli Shekel, and
&#8220;$,&#8221; &#8220;US$&#8221; and &#8220;U.S. dollars&#8221; mean United States dollars.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EMERGING
GROWTH COMPANY STATUS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an &#8220;emerging growth company,&#8221; as defined in the U.S. Jumpstart Our Business Startups Act of 2012, or JOBS Act,
and we may take advantage of certain exemptions, including exemptions from various reporting requirements that are otherwise applicable
to public traded entities that do not qualify as emerging growth companies. These exemptions include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley
Act; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory
audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial
statements (i.e., an auditor discussion and analysis).</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section
13(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, for complying with new or revised accounting standards.
We have elected to irrevocably opt out of this extended transition period and, as a result, we are required to comply with new or revised
accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Under federal
securities laws, our decision to opt out of the extended transition period is irrevocable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earliest of: (i) the last day of the first fiscal year in which our annual gross revenues
exceed $1.07 billion; (ii) the last day of the fiscal year following the fifth anniversary of the date of our initial public offering
(i.e., December 31, 2027); (iii) the date that we become a &#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2&#160;under
the&#160;Exchange Act, which would occur if the aggregate worldwide market value of our ordinary shares, including ordinary shares represented
by warrants, held by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal
quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year period.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRADEMARKS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We own or have rights to trademarks,
service marks and trade names that we use in connection with the operation of our business, including our corporate name, logos and website
names. Other trademarks, service marks and trade names appearing in this Annual Report on Form 20-F are the property of their respective
owners. Solely for convenience, some of the trademarks, service marks and trade names referred to in this Annual Report on Form 20-F are
listed without the &#174; and &#8482; symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks,
service marks and trade names.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="b_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Certain information included
or incorporated by reference in this Annual Report may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of
the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often characterized by
the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221;
&#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;project&#8221;
or other similar words, but are not the only way these statements are identified.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that
contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating to the
research, development, completion and use of our products, and all statements (other than statements of historical facts) that address
activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Important
factors that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking
statements. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated
in forward-looking statements, including, but not limited to, the factors summarized below:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    lack of operating history;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    current and future capital requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to manufacture, market and sell our products and to generate revenues;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain our relationships with key partners and grow relationships with new partners;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain or protect the validity of our U.S. and other patents and other intellectual property;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to launch and penetrate markets in new locations and new market segments;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to retain key executive members and hire additional personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain and expand intellectual property rights;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interpretations
    of current laws and the passages of future laws;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to achieve greater regulatory compliance needed in existing and new markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    overall demand for passenger and freight transport;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to achieve key performance milestones in our planned operational testing;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to establish adequate sales, marketing and distribution channels;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
    of our business model by investors; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
    factors referred to in &#8220;Item 3.D. Risk Factors,&#8221; &#8220;Item 4. Information on the Company,&#8221; and &#8220;Item 5.
    Operating and Financial Review and Prospects,&#8221; as well as in this Annual Report on Form 20-F generally.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our
or our industry&#8217;s actual results, levels of activity, performance, or achievements to be materially different from those anticipated
by the forward-looking statements. We discuss many of these risks in this Annual Report on Form 20-F in greater detail under the heading
&#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 20-F. You should not rely upon forward-looking statements as predictions
of future events.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether as a result of new information, future events or otherwise, after the date of this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET,
INDUSTRY AND OTHER DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
data and certain industry data and forecasts used throughout this Annual Report on Form 20-F were obtained from sources we believe to
be reliable, including market research databases, publicly available information, reports of governmental agencies, and industry publications
and surveys. We have relied on certain data from third party sources, including industry forecasts and market research, which we believe
to be reliable based on our management&#8217;s knowledge of the industry. While we are not aware of any misstatements regarding the industry
data presented in this Annual Report on Form 20-F, our estimates involve risks and uncertainties and are subject to change based on various
factors, including those discussed under the heading &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
made in this Annual Report on Form 20-F concerning the contents of any agreement, contract or other document are summaries of such agreements,
contracts or documents and are not a complete description of all of their terms. If we filed any of these agreements, contracts or documents
as exhibits to this Report or to any previous filing with the Securities and Exchange Commission, or SEC, you may read the document itself
for a complete understanding of its terms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="b_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
I</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;1.
IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;2.
OFFER STATISTICS AND EXPECTED TIMETABLE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;3.
KEY INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
[Reserved]</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Capitalization and Indebtedness</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Reasons for the Offer and Use of Proceeds</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Risk Factors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully consider the risks described below, together with all of the other information in this Annual Report on Form 20-F. The
risks and uncertainties described below are those significant risk factors, currently known and specific to us, that we believe are relevant
to an investment in our securities. Additional risks and uncertainties not currently known to us or that we now deem immaterial may also
harm us. If any of these risks materialize our business, results of operations or financial condition could suffer, and the price of
our ordinary shares could decline substantially.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Risk Factors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to numerous risks and uncertainties, including those highlighted in the section titled &#8220;Risk Factors&#8221;
below. These risks include, among others, the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Financial Condition and Capital Requirements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are a development-stage company and have a limited operating history on which to assess the prospects for our business, have incurred
    significant losses since the date of our inception, and anticipate that we will continue to incur significant losses until we are
    able to successfully commercialize our products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have not generated significant revenue from the sale of our current products and may never be profitable.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    expect that we will need to invest significant time and raise substantial additional capital before we can expect to become profitable
    from sales of our products. This additional capital may not be available on acceptable terms, or at all. Failure to obtain this necessary
    capital when needed may force us to delay, limit or terminate our product development efforts or other operations. Raising additional
    capital would cause dilution to our existing shareholders, and may affect the rights of existing shareholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The report of our independent registered public accounting firm contains an
explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to Our Business and Industry</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    depend entirely on the success of our current products in development, we may not be able to successfully introduce these products
    and commercialize them, and we may not be able to successfully manage our planned growth, and our operating results and financial
    condition may fluctuate. Defects in products could give rise to product returns or product liability, warranty or other claims that
    could result in material expenses, diversion of management time and attention, and damage to our reputation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business may be adversely affected by changes in railway safety regulations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business may be subject to risks arising from the COVID-19 pandemic which has had an impact our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors
    from benefiting from the expertise of some of our former employees.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    markets in which we participate are competitive and our failure to compete successfully could cause any future revenues and the demand
    for our products not to materialize or to decline over time.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our relationships with suppliers for our products and services, especially with single source suppliers of components of our products,
    were to terminate or our manufacturing arrangements were to be disrupted, our business could be interrupted.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    planned international operations will expose us to additional market and operational risks, and failure to manage these risks may
    adversely affect our business and operating results.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
    disruptions of our information technology systems or breaches of our data security could adversely affect our business. Additionally,
    we are subject to data ownership and privacy regulations which may expose us to lawsuits and sanctions for violations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are exposed to fluctuations in currency exchange rates, which could negatively affect our financial condition and results of operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    events, developments, or social media posts and interactions may impact our reputation.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our business, operating results and growth rates may be adversely affected
by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated
liquidity risk.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Environmental, social and corporate governance (ESG) issues, including
those related to climate change and sustainability, may have an adverse effect on our business, financial condition and results of operations
and damage our reputation.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to Our Intellectual Property</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are unable to obtain and maintain effective patent rights for our products, we may not be able to compete effectively in our markets.
    If we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others
    to compete against us, affecting our ability to compete.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be involved in lawsuits to protect or enforce our intellectual property, which could be expensive, time consuming, and unsuccessful
    and we may be subject to claims challenging the inventorship of our intellectual property, and we may not be able to protect our
    intellectual property rights throughout the world.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to the Ownership of Our Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    principal shareholders, officers and directors beneficially own approximately 64.0% of our ordinary shares. They will therefore be
    able to exert significant control over matters submitted to our shareholders for approval, which could limit your ability to influence
    the outcome of key transactions, including a change of control, and which may result in conflicts with us or you in the future.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    of our directors have relationships with our principal shareholders, which may cause conflicts of interest with respect to our business.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a &#8220;foreign private issuer&#8221; we are permitted, and intend, to follow certain home country corporate governance practices
    instead of otherwise applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors under
    rules applicable to domestic U.S. issuers.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be a &#8220;passive foreign investment company,&#8221; or PFIC, for U.S. federal income tax purposes in the current taxable year
    or may be one in any subsequent taxable year. There generally would be negative tax consequences for U.S. taxpayers that are holders
    of our ordinary shares if we are or were to become a PFIC.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be subject to securities litigation, which is expensive and could divert management attention.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
Related to Israeli Law and Our Incorporation, Location and Operations in Israel</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
    of Israeli law and our articles of association may delay, prevent or otherwise impede a merger with, or an acquisition of, our company,
    even when the terms of such a transaction are favorable to us and our shareholders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
    rights and responsibilities as a holder of our securities are governed by Israeli law, which differs in some material respects from
    the rights and responsibilities of shareholders of U.S. companies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    may be difficult to enforce a judgment of a U.S. court against us and our officers and directors and the Israeli experts named in
    this Annual Report in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our officers
    and directors and these experts.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    headquarters, research and development and other significant operations are located in Israel, and, therefore, our results may be
    adversely affected by political, economic and military instability in Israel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    operations may be disrupted as a result of the obligation of management or key personnel to perform military service.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Financial Condition and Capital Requirements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are a development-stage company and have a limited operating history on which to assess the prospects for our business, have incurred
significant losses since the date of our inception, and anticipate that we will continue to incur significant losses until we are able
to successfully commercialize our products.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a development-stage company with a limited operating history. We have incurred net losses since our inception in 2016, including
net losses of approximately $10.5 million for the year ended December 31, 2022. As of December 31, 2022, we had an accumulated deficit
of approximately $54.8 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have devoted substantially all of our financial resources to develop our solutions. We have financed our operations primarily through
the issuance of equity securities. The amount of our future net losses will depend, in part, on completing the development of our products,
the rate of our future expenditures and our ability to obtain funding through the issuance of our securities, strategic collaborations
or grants. We expect to continue to incur significant losses until we are able to successfully commercialize our products. We anticipate
that our expenses will increase substantially if and as we:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue
    the development and testing of our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establish
    a sales, marketing, and distribution infrastructure to commercialize our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to identify, assess, acquire, license, and/or develop other products and subsequent generations of our current products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to maintain, protect, and expand our intellectual property portfolio;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">seek
    to attract and retain skilled personnel; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">create
    additional infrastructure to support our operations as a public company and our product development and planned future commercialization
    efforts.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have not generated significant revenue from the sale of our current products and may never be profitable.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not yet generated significant revenues since the date of our inception. Our first revenues were recorded in our unaudited interim
condensed financial statements for the period ended June 30, 2021. Our ability to generate revenue and achieve profitability depends
on our ability to successfully complete the development of, and to commercialize, our products. Our ability to generate future revenue
from product sales depends heavily on our success in many areas, including but not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">completing
    development and testing of our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    and maintaining supply and manufacturing relationships with third parties that can provide adequate (in amount and quality) products
    to support market demand for our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">launching
    and commercializing products, either directly or with a collaborator or distributor;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
    any competing technological and market developments;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying,
    assessing, acquiring and/or developing new products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiating
    favorable terms in any collaboration, licensing or other arrangements into which we may enter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintaining,
    protecting and expanding our portfolio of intellectual property rights, including patents, trade secrets and know-how; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attracting,
    hiring and retaining qualified personnel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
expect that we will need to invest significant time and raise substantial additional capital before we can expect to become profitable
from sales of our products. This additional capital may not be available on acceptable terms, or at all. Failure to obtain this necessary
capital when needed may force us to delay, limit or terminate our product development efforts or other operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will need to invest significant time and require substantial additional capital to commercialize our products. In addition,
our operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds
sooner than planned. Our future capital requirements will depend on many factors, including but not limited to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    scope, rate of progress, results and cost of product development, testing and other related activities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost of establishing commercial supplies of our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost and timing of establishing sales, marketing, and distribution capabilities; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms and timing of any collaborative, licensing, and other arrangements that we may establish.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to
develop and commercialize our products. In addition, we cannot guarantee that future financing will be available, when needed, in sufficient
amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights
of our shareholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may
cause the market price of our ordinary shares to decline. The incurrence of indebtedness could result in increased fixed payment obligations,
and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations
on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact
our ability to conduct our business. We could also be required to seek funds through arrangements with collaborative partners or otherwise
at an earlier stage than otherwise would be desirable, and we may be required to relinquish rights to some of our technologies or products
or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and
prospects. Even if we believe that we have sufficient funds for our current or future operating plans, we may seek additional capital
if market conditions are favorable or if we have specific strategic considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our
research or development programs or the commercialization of our products or be unable to expand our operations or otherwise capitalize
on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Raising
additional capital would cause dilution to our existing shareholders, and may affect the rights of existing shareholders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek additional capital through a combination of private and public equity offerings, debt financings and collaborations and strategic
and licensing arrangements. To the extent that we raise additional capital through the issuance of equity or convertible debt securities,
your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights
as a holder of our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b><i>The report of our independent registered
public accounting firm contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify; text-indent: 0.5in; background-color: white">The
report of our independent registered public accounting firm on our audited financial statements as of and for the year ended&#160;December&#160;31,&#160;2022
contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.&#160;Our financial statements
do not include any adjustments that might result from the outcome of the uncertainty regarding our ability to continue as a going concern.
This going concern opinion could materially limit our ability to raise additional funds through the issuance of equity or debt securities
or otherwise. Further reports on our financial statements may include an explanatory paragraph with respect to our ability to continue
as a going concern. If we cannot continue as a going concern, our investors may lose their entire investment in our ordinary shares.<b><i>&#160;</i></b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business and Industry</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend entirely on the success of our current products in development, and we may not be able to successfully introduce these products
and commercialize them.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have invested almost all of our efforts and financial resources in the research, development and testing of our products in development.
As a result, our business is entirely dependent on our ability to complete the development of, and to successfully commercialize, our
product candidates. The process of development and commercialization is long, complex, costly and uncertain of outcome. While we have
several ongoing tests with train operators through which we hope to demonstrate our technology, we cannot assure you that any of these
programs will result in subsequent sales of our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Defects
in products could give rise to product returns or product liability, warranty or other claims that could result in material expenses,
diversion of management time and attention, and damage to our reputation.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we are successful in introducing our products to the market, our products may contain undetected defects or errors that, despite testing,
are not discovered until after a product has been used. Specifically, our safety device is complex and could have, or could be alleged
to have, defects in design or manufacturing or other errors or failures. This could result in delayed market acceptance of those products,
claims from distributors, end-users or others, increased end-user service and support costs and warranty claims, damage to our reputation
and business, or significant costs to correct the defect or error. Furthermore, we face a risk of exposure to claims in the event that
our products are used in connection with autonomous train operations, and do not perform as expected or experience a malfunction that
results in personal injury or death.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
claim brought against us, regardless of its merit, could result in material expense, diversion of management time and attention, and
damage to our reputation, and could cause us to fail to retain or attract customers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently maintain a limited coverage of product liability insurance, which could materially affect our financial condition in the event
we have a product liability claim.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we maintain a limited coverage of product liability insurance in the amount of $3 million, which will be necessary prior to the commercialization
of our products. It is likely that our current and/or any future product liability insurance that we will have in the future will be
subject to significant deductibles and there is no guarantee that such insurance will be available or adequate to protect against all
such claims, or we may elect to self-insure with respect to certain matters. Costs or payments made in connection with warranty and product
liability claims and product recalls or other claims could materially affect our financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may be adversely affected by changes in railway safety regulations</i></b>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the autonomous train industry continues to develop, regulators, including the U.S. Department of Transportation&#8217;s Federal Railroad
Administration, or FRA, and the European Union Agency for Railways, or ERA, may adapt existing regulations and create new ones in order
to ensure the compatibility of autonomous trains and autonomous train technology with regulatory expectations, requirements relating
to safety and legal liability. On March 29, 2018, for instance, the FRA issued a formal Request For Information, or RFI, regarding the
&#8220;future of automation in the railroad industry,&#8221; which is part of a broader effort by the U.S. Department of Transportation
to advance the safe deployment of autonomous technologies. We cannot anticipate what regulations will materialize from the FRA&#8217;s
RFI, or from parallel inquiries underway in other countries in which we operate. Likewise, we cannot predict the limitations, restrictions
and controls nor the economic consequences flowing from such regulations. Should restrictive regulations apply, they could delay the
introduction of autonomous train technology, cause us to redesign aspects of our products, impose additional costs and adversely affect
our results of operations. We cannot assure you that we have been or will be at all times in complete compliance with such laws, regulations
and permits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business is subject to risks arising from the COVID-19 pandemic which has impacted and continues to impact our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
health epidemics or outbreaks could adversely impact our business. In late 2019, a novel strain of COVID-19, also known as
coronavirus, that started in Wuhan, China spread around the globe. Many countries
around the world, including Israel and the United States, implemented significant governmental measures to control the spread of the
virus, including temporary closure of businesses, severe restrictions on travel and the movement of people, and other material
limitations on the conduct of business. In response to the COVID-19 global pandemic, we implemented business continuity plans
designed to address and mitigate the impact of the COVID-19 pandemic on our employees and business. In particular, we implemented
remote working and workplace protocols for our employees. The implementation of measures to prevent the spread of COVID-19 resulted
in disruptions to our partnering efforts which depend, in part, on attendance at in-person meetings, industry conferences and other
events and during 2020 we engaged in cost-cutting measures that included temporary salary reductions, reduction of headcount and
placing employees on unpaid leave. Also, due to COVID-19 impacting the global supply chain, supplies and component shortages
negatively impacted our ability to plan and deliver upon orders received in a timely fashion. While we have resumed normal
operations at this point, it is not possible at this time to estimate the full impact that the COVID-19 pandemic could have on our
operations, as the impact will depend on future developments, which are highly uncertain and cannot be predicted with confidence.
Any actions we take to counteract future consequences of the COVID-19 pandemic may not be successful, and the ultimate impact of
COVID-19 on our operations is uncertain. Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts
to our business as a result of its global economic impact, including any recession that has occurred or may occur in the
future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
operating results and financial condition may fluctuate.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if we are successful in introducing our products to the market, the operating results and financial condition of our company may fluctuate
from quarter to quarter and year to year and are likely to continue to vary due to a number of factors, many of which will not be within
our control. If our operating results do not meet the guidance that we provide to the marketplace or the expectations of securities analysts
or investors, the market price of our ordinary shares will likely decline. Fluctuations in our operating results and financial condition
may be due to a number of factors, including those listed below:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    degree of market acceptance of our products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    mix of products and services that we sell during any period;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">long
    sale cycles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the amount that we spend to develop, acquire or license new products, technologies or businesses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the amounts that we spend to promote our products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the cost of satisfying our warranty obligations and servicing our installed base of systems;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    between our expenditures to develop and market new or enhanced systems and the generation of sales from those products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">development
    of new competitive products and services by others;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
    in predicting sales patterns and reorder rates;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
    or threats of litigation, including intellectual property claims by third parties;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in accounting rules and tax laws;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in regulations and standards;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    geographic distribution of our sales;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    responses to price competition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic and industry conditions that affect end-user demand and end-user levels of product design and manufacturing;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in interest rates that affect returns on our cash balances and short-term investments;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in dollar-NIS exchange rates that affect the value of our net assets, future revenues and expenditures from and/or relating to our
    activities carried out in those currencies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    level of research and development activities by our company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in end-use/end-user governmental regulation policy.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to all of the foregoing factors, and the other risks discussed herein, you should not rely on quarter to quarter and year to year comparisons
of our operating results as an indicator of our future performance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
markets in which we participate are competitive. Even if we are successful in completing the development of our products in development,
our failure to compete successfully could cause any future revenues and the demand for our products not to materialize or to decline
over time.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
aim to sell our products to train operators and/or rolling stock manufacturers. Many of our current and potential competitors have extensive
track records and relationships within the rail industry and/or the automotive industry. Many of our current and potential competitors
have longer operating histories and more extensive name recognition than we have and may also have greater financial, marketing, manufacturing,
distribution and other resources than we have. Current and future competitors may be able to respond more quickly to new or emerging
technologies and changes in customer demands and to devote greater resources to the development, promotion and sale of their products
than we can. Our current and potential competitors may develop and market new technologies that render our existing or future products
obsolete, unmarketable or less competitive (whether from a price perspective or otherwise). We cannot assure you that we will be able
to establish a competitive position or to compete successfully against current and future sources of competition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our relationships with suppliers for our products and services, especially with single source suppliers of components of our products,
were to terminate or our manufacturing arrangements were to be disrupted, our business could be interrupted.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
purchase component parts that are used in our products from third-party suppliers. While there are several potential suppliers of most
of these component parts that we use, we currently choose to use only one or a limited number of suppliers for several of these components.
Our reliance on a single or limited number of vendors involves a number of risks, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    shortages of some key components;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    performance shortfalls, if traceable to particular product components, since the supplier of the faulty component cannot readily
    be replaced;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discontinuation
    of a product on which we rely;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    delays of several months in the delivery of components in the event a replacement product is sought;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    insolvency of these vendors; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    control over delivery schedules, manufacturing capabilities, quality and costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we require any new supplier to become &#8220;qualified&#8221; pursuant to our internal procedures. The qualification process
involves evaluations of varying durations, which may cause production delays if we were required to qualify a new supplier unexpectedly.
We generally assemble our systems and parts based on our internal forecasts and the availability of assemblies, components and finished
goods that are supplied to us by third parties, which are subject to various lead times. If certain suppliers were to decide to discontinue
production of an assembly, or component that we use, the unanticipated change in the availability of supplies, or unanticipated supply
limitations, could cause delays in, or loss of, sales, increased production or related costs and consequently reduced margins, and damage
to our reputation. If we were unable to find a suitable supplier for a particular component or compound, we could be required to modify
our existing products or the end-parts that we offer to accommodate substitute components or compounds.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
in some of our agreements, customers require the ability to maintain systems for a period of at least ten years. During such a long period,
there is a risk that some of the system components of our products will become obsolete and will not be available from our suppliers.
Therefore, there is a risk that we will be obliged to hold an inventory of components that may become obsolete, or be forced to locate
or develop alternatives to such components.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Discontinuation
of operations at our and third-parties&#8217; manufacturing sites could prevent us from timely filling customer orders and could lead
to unforeseen costs for us.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to assemble and test the systems that we sell at single facilities in various locations that are specifically dedicated to separate
categories of systems. Because of our reliance on all of these production facilities, a disruption at any of those facilities could materially
damage our ability to supply our products to the marketplace in a timely manner. Depending on the cause of the disruption, we could also
incur significant costs to remedy the disruption and resume product shipments. Such disruptions may be caused by, among other factors,
earthquakes, fire, flood and other natural disasters. Accordingly, any such disruption could result in a material adverse effect on our
revenue, results of operations and earnings, and could also potentially damage our reputation. Additionally, we rely on third-party manufacturers
for components of our products, and we do not have control over the facilities of these third-party manufacturers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
planned international operations will expose us to additional market and operational risks, and failure to manage these risks may adversely
affect our business and operating results.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to derive a substantial percentage of our sales from international markets. Accordingly, we will face significant operational
risks from doing business internationally, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">having
    to ship and/or manufacture overseas;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cultural
    barriers sustained by conducting business activity in foreign countries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations
    in foreign currency exchange rates;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
    longer sales and payment cycles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
    greater difficulties in collecting accounts receivable;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
    adverse tax consequences;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    protection of intellectual property rights in certain countries, particularly in Asia and South America;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in staffing and managing foreign operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
    and business practices favoring local competition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    and difficulties of customizing products for foreign countries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with a wide variety of complex foreign laws, treaties and regulations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tariffs,
    trade barriers and other regulatory or contractual limitations on our ability to sell or develop our products in certain foreign
    markets; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    subject to the laws, regulations and the court systems of many jurisdictions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure to manage the market and operational risks associated with our international operations effectively could limit the future growth
of our business and adversely affect our operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business and operations might be adversely affected by security breaches, including any cybersecurity incidents.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on the efficient and uninterrupted operation of our computer and communications systems, and those of our consultants, contractors
and vendors, which we use for, among other things, sensitive company data, including our intellectual property, financial data and other
proprietary business information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
certain of our operations have business continuity and disaster recovery plans and other security measures intended to prevent and minimize
the impact of IT-related interruptions, our IT infrastructure and the IT infrastructure of our consultants, contractors and vendors are
vulnerable to damage from cyberattacks, computer viruses, unauthorized access, electrical failures and natural disasters or other catastrophic
events. We could experience failures in our information systems and computer servers, which could result in an interruption of our normal
business operations and require substantial expenditure of financial and administrative resources to remedy. System failures, accidents
or security breaches can cause interruptions in our operations and can result in a material disruption of our targeted phage therapies,
product candidates and other business operations. The loss of data from completed or future studies or clinical trials could result in
delays in our research, development or regulatory approval efforts and significantly increase our costs to recover or reproduce the data.
To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate
disclosure of confidential or proprietary information, we could incur regulatory investigations and redresses, penalties and liabilities
and the development of our product candidates could be delayed or otherwise adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though we believe we carry commercially reasonable business interruption and liability insurance, we might suffer losses as a result
of business interruptions that exceed the coverage available under our insurance policies or for which we do not have coverage. For example,
we are not insured against terrorist attacks or cyberattacks. Any natural disaster or catastrophic event could have a significant negative
impact on our operations and financial results. Moreover, any such event could delay the development of our product candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to data ownership and privacy regulations which may expose us to lawsuits and sanctions for violations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the General Data Protection Regulation (GDPR) of the European Union, there are general restrictions regarding the photographing of images
without the knowledge and permission of the person being photographed. In this context, the information collected by our system&#8217;s
detection units must be protected and encrypted. Failure to comply with these regulations under the GDPR may expose us to lawsuits and
sanctions for such violations. In addition, the ownership of the information collected through our system&#8217;s detection units is
determined in accordance with the local law under which the train operates and will usually remain the property of the customer, with
us receiving only limited permission to make use of the information for system improvement but not for other uses, and all subject to
the provisions of the said law. These limitations may impede the implementation of our plans to develop certain services through the
processing of information obtained by the systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to certain U.S. and foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations.
We can face serious consequences for violations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
other matters, U.S. and foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations,
which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal
counsel, accountants, consultants, contractors and other partners from authorizing, promising, offering, providing, soliciting or receiving,
directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector.
Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment,
tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect interactions
with officials and employees of government agencies or government-affiliated hospitals, universities and other organizations. We also
expect our non-U.S. activities to increase over time. We plan to engage third parties for clinical trials and/or to obtain necessary
permits, licenses, patent registrations and other regulatory approvals, and we can be held liable for the corrupt or other illegal activities
of our personnel, agents or partners, even if we do not explicitly authorize or have prior knowledge of such activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to taxation in several countries, including the United States and Israel; changes in tax laws or challenges to our tax positions
could adversely affect our business, results of operations, and financial condition. As such, we are subject to tax laws, regulations,
and policies of the U.S. federal, state, and local governments and of comparable taxing authorities in foreign jurisdictions. Changes
in tax laws, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates in the
future and otherwise adversely affect our tax positions and/or our tax liabilities. There can be no assurance that our effective tax
rates, tax payments, tax credits, or incentives will not be adversely affected by changes in tax laws in various jurisdictions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to successfully manage our planned growth and expansion.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to make investments in our products in development. We expect that our annual operating expenses will continue to
increase as we invest in business development, marketing, research and development, manufacturing and production infrastructure, and
develop customer service and support resources for future customers. Failure to expand operational and financial systems timely or efficiently
may result in operating inefficiencies, which could increase costs and expenses to a greater extent than we anticipate and may also prevent
us from successfully executing our business plan. We may not be able to offset the costs of operation expansion by leveraging the economies
of scale from our growth in negotiations with our suppliers and contract manufacturers. Additionally, if we increase our operating expenses
in anticipation of the growth of our business and this growth falls short of our expectations, our financial results will be negatively
impacted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our business grows, we will have to manage additional product design projects, materials procurement processes, and sales efforts and
marketing for an increasing number of products, as well as expand the number and scope of our relationships with suppliers, distributors
and end customers. If we fail to manage these additional responsibilities and relationships successfully, we may incur significant costs,
which may negatively impact our operating results. Additionally, in our efforts to develop new products with innovative functionality
and features, we may devote significant research and development resources to products and product features for which a market does not
develop quickly, or at all. If we are not able to predict market trends accurately, we may not benefit from such research and development
activities, and our results of operations may suffer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
future success depends in part on our ability to retain our executive officers and to attract, retain and motivate other qualified personnel.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the services of our executive officers, senior management and qualified employees. The loss of their services
without proper replacement may adversely impact the achievement of our objectives. Also, our performance is largely dependent on the
talents and efforts of highly skilled individuals, particularly our software engineers. Recruiting and retaining qualified employees,
consultants, and advisors for our business, including scientific and technical personnel, will also be critical to our success. There
is currently a shortage of skilled personnel in our industry, which is likely to continue. As a result, competition for skilled personnel
is intense and the turnover rate can be high. We may not be able to attract and retain personnel on acceptable terms given the competition
in the industry in which we operate. Moreover, certain of our competitors or other technology businesses may seek to hire our employees.
The inability to recruit and retain qualified personnel, or the loss of the services of our executive officers, without proper replacement,
may impede the progress of our development and commercialization objectives.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Under
applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors
from benefiting from the expertise of some of our former employees.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally enter into non-competition agreements with our employees. These agreements prohibit our employees from competing directly with
us or working for our competitors or clients for a limited period after they cease working for us. We may be unable to enforce these
agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors
from benefiting from the expertise that our former employees or consultants developed while working for us. For example, Israeli courts
have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities
of the former employee will harm one of a limited number of material interests of the employer that have been recognized by the courts,
such as the secrecy of a company&#8217;s confidential commercial information or the protection of its intellectual property. If we cannot
demonstrate that such interests will be harmed, we may be unable to prevent our competitors from benefiting from the expertise of our
former employees or consultants and our ability to remain competitive may be diminished.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
events, developments, or social media posts and interactions may impact our reputation.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Damage
to our reputation can be the result of the actual or perceived occurrence of any number of events, and could include any negative publicity,
whether true or not. The increased usage of social media and other web-based tools used to generate, publish and discuss user-generated
content and to connect with other users has made it increasingly easy for individuals and groups to communicate and share opinions and
views in regard to issuers and their activities, whether true or not. Negative posts or comments about us on any social network could
damage our reputation. In addition, employees or others might disclose non-public sensitive information related to our business through
external media channels. The continuing evolution of social media will present us with new challenges and risks. We do not ultimately
have direct control over how we are perceived by others. Reputation loss may result in decreased investor confidence, increased challenges
in developing and maintaining community relations and an impediment to our overall ability to advance our business strategy and realize
on our growth prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We previously identified material weaknesses
in our internal control over financial reporting, which have been remediated. If we identify additional material weaknesses in the future
or otherwise fail to maintain an effective system of internal controls, we may not be able to produce timely and accurate financial statements,
and we or our independent registered public accounting firm may conclude that our internal control over financial reporting is not effective,
which could adversely affect our investors&#8217; confidence and our stock price.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an emerging growth
company under the JOBS Act, our management is required to report upon the effectiveness of our internal control over financial reporting
under Section 404 of the Sarbanes-Oxley Act. Our independent registered public accounting firm is not required to formally attest to
the effectiveness of our internal control over financial reporting until the date we are no longer an emerging growth company and reach
accelerated filer status. Any failure to implement required new or improved controls, or difficulties encountered in their implementation,
could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404 of
the Sarbanes-Oxley Act may reveal deficiencies in our
internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes
to our financial statements or identify other areas for further attention or improvement. As previously disclosed, in connection
with our financial statement close process for 2021, we identified a material weakness in our entity level control components relating
to documenting our financial reporting process. While we have remediated such material weaknesses, we cannot assure you that we have
identified all material weaknesses or that there will not be additional material weaknesses or deficiencies that we will identify in
the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our business, operating results and growth rates
may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial
institutions and associated liquidity risk.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our business depends on the economic health of the
global economies. If the conditions in the global economies remain uncertain or continue to be volatile, or if they deteriorate, including
as a result of the impact of military conflict, such as the war between Russia and Ukraine, terrorism or other geopolitical events, our
business, operating results and financial condition may be materially adversely affected. Economic weakness, inflation and increases in
interest rates, limited availability of credit, liquidity shortages and constrained capital spending have at times in the past resulted,
and may in the future result, in challenging and delayed sales cycles, slower adoption of new technologies and increased price competition,
and could negatively affect our ability to forecast future periods, which could result in an inability to satisfy demand for our products
and a loss of market share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In addition, increases in inflation raise our costs
for commodities, labor, materials and services and other costs required to grow and operate our business, and failure to secure these
on reasonable terms may adversely impact our financial condition. Additionally, increases in inflation, along with the uncertainties surrounding
COVID-19, geopolitical developments and global supply chain disruptions, have caused, and may in the future cause, global economic uncertainty
and uncertainty about the interest rate environment, which may make it more difficult, costly or dilutive for us to secure additional
financing. A failure to adequately respond to these risks could have a material adverse impact on our financial condition, results of
operations or cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">More recently, the closures of
SVB and Signature Bank and their placement into receivership with the FDIC created bank-specific and broader financial institution liquidity
risk and concerns. Although the Department of the Treasury, the Federal Reserve and the FDIC jointly released a statement that depositors
at SVB and Signature Bank would have access to their funds, even those in excess of the standard FDIC insurance limits, under a systemic
risk exception, future adverse developments with respect to specific financial institutions or the broader financial services industry
may lead to market-wide liquidity shortages, impair the ability of companies to access near-term working capital needs, and create additional
market and economic uncertainty. There can be no assurance that future credit and financial market instability and a deterioration in
confidence in economic conditions will not occur. While we do not have any business relationships with SVB or Signature Bank, our general
business strategy may be adversely affected by any such economic downturn, liquidity shortages, volatile business environment or continued
unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, or if adverse developments are experienced
by financial institutions, it may cause short-term liquidity risk and also make any necessary debt or equity financing more difficult,
more costly, more onerous with respect to financial and operating covenants and more dilutive. Failure to secure any necessary financing
in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock
price and could require us to alter our operating plans. In addition, there is a risk that one or more of our service providers, financial
institutions, manufacturers, suppliers and other partners may be adversely affected by the foregoing risks, which could directly affect
our ability to attain our operating goals on schedule and on budget.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Environmental, social and corporate governance
(ESG) issues, including those related to climate change and sustainability, may have an adverse effect on our business, financial condition
and results of operations and damage our reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There is an increasing focus from
certain investors, customers, consumers, employees and other stakeholders concerning ESG matters. Additionally, public interest and legislative
pressure related to public companies&#8217; ESG practices continue to grow. If our ESG practices fail to meet regulatory requirements
or investor, customer, consumer, employee or other shareholders&#8217; evolving expectations and standards for responsible corporate citizenship
in areas including environmental stewardship, support for local communities, Board of Director and employee diversity, human capital management,
employee health and safety practices, product quality, supply chain management, corporate governance and transparency, our reputation,
brand and employee retention may be negatively impacted, and our customers and suppliers may be unwilling to continue to do business with
us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Customers, consumers, investors
and other shareholders are increasingly focusing on environmental issues, including climate change, energy and water use, plastic waste
and other sustainability concerns. Concern over climate change may result in new or increased legal and regulatory requirements to reduce
or mitigate impacts to the environment. Changing customer and consumer preferences or increased regulatory requirements may result in
increased demands or requirements regarding plastics and packaging materials, including single-use and non-recyclable plastic products
and packaging, other components of our products and their environmental impact on sustainability, or increased customer and consumer concerns
or perceptions (whether accurate or inaccurate) regarding the effects of substances present in certain of our products. Complying with
these demands or requirements could cause us to incur additional manufacturing, operating or product development costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">If we do not adapt to or comply
with new regulations, including the SEC&#8217;s published proposed rules that would require companies to provide significantly expanded
climate-related disclosures in their periodic reporting, which may require us to incur significant additional costs to comply and impose
increased oversight obligations on our management and board of directors, or fail to meet evolving investor, industry or stakeholder expectations
and concerns regarding ESG issues, investors may reconsider their capital investment in our Company, we may become subject to penalties,
and customers and consumers may choose to stop purchasing our products, if approved for commercialization, which could have a material
adverse effect on our reputation, business or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Intellectual Property</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to obtain and maintain effective patent rights for our products, we may not be able to compete effectively in our markets.
If we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others
to compete against us.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
we have relied on trade secret protection and confidentiality agreements to protect the intellectual property related to our technologies
and products. Since our incorporation, we have also sought patent protection for certain of our products. Our success depends in large
part on our ability to obtain and maintain patent and other intellectual property protection in the United States and in other countries
with respect to our proprietary technology and new products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have sought to protect our proprietary position by filing patent applications in the United States and in other countries with respect
to our novel technologies and products, which are important to our business. Patent prosecution is expensive and time consuming, and
we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It
is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain
patent protection.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a growing portfolio of six patents registered in the USA;&#160;two patent registered in China; one patent registered from the European
Patent Office (EPO) and being validated in Germany, Switzerland, Hungary, Austria, Denmark, France and Great Britain; two patent issued
in Japan; 24 pending patent applications, of which two are US provisional patent applications and 21 are national phase patent applications
filed in the USA, EPO, China, Japan and India under the provisions of the Patent Cooperation Treaty (PCT) through World Intellectual
Property Organization (WIPO); and one of which is a patent application in Hong Kong and requested based on the Chinese national phase
patent application. We cannot offer any assurances about which, if any, patent applications will be issued, the breadth of any such patent
once issued, or whether any issued patents will be found invalid or unenforceable or will be threatened by third parties. Any successful
opposition to these patents or any other patents owned by or licensed to us could deprive us of rights necessary for the successful commercialization
of any existing or new products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
there is no guarantee that the patent registration applications that were submitted by us with regards to our technologies will result
in patent registration. In the event of failure to complete patent registration, the Company&#8217;s developments will not be proprietary,
which might allow other entities to manufacture the Company&#8217;s products and compete with us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
there is no assurance that all potentially relevant prior art relating to our patent applications has been found, which can invalidate
a patent or prevent a patent from issuing from a pending patent application. Even if patents do successfully issue, and even if such
patents cover our products, third parties may challenge their validity, enforceability or scope, which may result in such patents being
narrowed, found unenforceable or invalidated. Furthermore, even if they are unchallenged, our patent applications and any future patents
may not adequately protect our intellectual property, provide exclusivity for our new products, or prevent others from designing around
our claims. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact
on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we cannot obtain and maintain effective patent rights for our products, we may not be able to compete effectively, and our business and
results of operations would be harmed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to maintain effective proprietary rights for our products, we may not be able to compete effectively in our markets.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the protection afforded by any patents that may be granted, we seek to protect our proprietary technology and processes,
in part, by entering into confidentiality agreements with our employees, consultants, scientific advisors, and contractors. We also seek
to preserve the integrity and confidentiality of our data, trade secrets and intellectual property by maintaining physical security of
our premises and physical and electronic security of our information technology systems. Agreements or security measures may be breached,
and we may not have adequate remedies for any breach. In addition, our trade secrets and intellectual property may otherwise become known
or be independently discovered by competitors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot provide any assurances that our trade secrets and other confidential proprietary information will not be disclosed in violation
of our confidentiality agreements or that competitors will not otherwise gain access to our trade secrets or independently develop substantially
equivalent information and techniques. Also, misappropriation or unauthorized and unavoidable disclosure of our trade secrets and intellectual
property could impair our competitive position and may have a material adverse effect on our business. Additionally, if the steps taken
to maintain our trade secrets and intellectual property are deemed inadequate, we may have insufficient recourse against third parties
for misappropriating any trade secret.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
property rights of third parties could adversely affect our ability to commercialize our products, and we might be required to litigate
or obtain licenses from third parties in order to develop or market our product candidates. Such litigation or licenses could be costly
or not available on commercially reasonable terms.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is inherently difficult to conclusively assess our freedom to operate without infringing on third party rights. Our competitive position
may be adversely affected if existing patents or patents resulting from patent applications issued to third parties or other third party
intellectual property rights are held to cover our products or elements thereof, or our manufacturing or uses relevant to our development
plans. In such cases, we may not be in a position to develop or commercialize products or our product candidates unless we successfully
pursue litigation to nullify or invalidate the third party intellectual property right concerned, or enter into a license agreement with
the intellectual property right holder, if available on commercially reasonable terms. There may also be pending patent applications
that if they result in issued patents, could be alleged to be infringed by our products. If such an infringement claim should be brought
and be successful, we may be required to pay substantial damages, be forced to abandon our products or seek a license from any patent
holders. No assurances can be given that a license will be available on commercially reasonable terms, if at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is also possible that we have failed to identify relevant third party patents or applications. For example, U.S. patent applications
filed before November 29, 2000 and certain U.S. patent applications filed after that date that will not be filed outside the United States
remain confidential until patents are issued. Patent applications in the United States and elsewhere are published approximately 18 months
after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date.
Therefore, patent applications covering our new products or platform technology could have been filed by others without our knowledge.
Additionally, pending patent applications which have been published can, subject to certain limitations, be later amended in a manner
that could cover our platform technologies, our products or the use of our products. Third party intellectual property right holders
may also actively bring infringement claims against us. We cannot guarantee that we will be able to successfully settle or otherwise
resolve such infringement claims. If we are unable to successfully settle future claims on terms acceptable to us, we may be required
to engage in or continue costly, unpredictable and time-consuming litigation and may be prevented from or experience substantial delays
in pursuing the development of and/or marketing our products. If we fail in any such dispute, in addition to being forced to pay damages,
we may be temporarily or permanently prohibited from commercializing our products that are held to be infringing. We might, if possible,
also be forced to redesign our new products so that we no longer infringe the third party intellectual property rights. Any of these
events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would
otherwise be able to devote to our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Patent
policy and rule changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement
or defense of any issued patents.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of any
patents that may issue from our patent applications, or narrow the scope of our patent protection. The laws of foreign countries may
not protect our rights to the same extent as the laws of the United States. Publications of discoveries in the scientific literature
often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published
until 18 months after filing, or in some cases not at all. We therefore cannot be certain that we were the first to file the invention
claimed in our owned and licensed patent or pending applications, or that we or our licensor were the first to file for patent protection
of such inventions. Assuming all other requirements for patentability are met, in the United States prior to March 15, 2013, the first
to make the claimed invention without undue delay in filing, is entitled to the patent, while outside the United States, the first to
file a patent application is entitled to the patent. After March 15, 2013, under the Leahy-Smith America Invents Act, or the Leahy-Smith
Act, enacted on September 16, 2011, the United States has moved to a first to file system. The Leahy-Smith Act also includes a number
of significant changes that affect the way patent applications will be prosecuted and may also affect patent litigation. In general,
the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications
and the enforcement or defense of any issued patents, all of which could have a material adverse effect on our business and financial
condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be involved in lawsuits to protect or enforce our intellectual property, which could be expensive, time consuming, and unsuccessful.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may infringe our intellectual property. If we were to initiate legal proceedings against a third party to enforce a patent covering one
of our products, the defendant could counterclaim that the patent covering our product candidate is invalid and/or unenforceable. In
patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds
for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness,
or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent
withheld relevant information from the United States Patent and Trademark Office, or the USPTO, or made a misleading statement, during
prosecution. Under the Leahy-Smith Act, the validity of U.S. patents may also be challenged in post-grant proceedings before the USPTO.
The outcome following legal assertions of invalidity and unenforceability is unpredictable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivation
proceedings initiated by third parties or brought by us may be necessary to determine the priority of inventions and/or their scope with
respect to our patent or patent applications or those of our licensors. An unfavorable outcome could require us to cease using the related
technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does
not offer us a license on commercially reasonable terms. Our defense of litigation or interference proceedings may fail and, even if
successful, may result in substantial costs and distract our management and other employees. In addition, the uncertainties associated
with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our research programs, license
necessary technology from third parties, or enter into development partnerships that would help us bring our products to market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some
of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements
of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these
results to be negative, it could have a material adverse effect on the price of our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims challenging the inventorship of our intellectual property.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to claims that former employees, collaborators or other third parties have an interest in, or right to compensation, with
respect to our current patent and patent applications, future patents or other intellectual property as an inventor or co-inventor. For
example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing
our products. Litigation may be necessary to defend against these and other claims challenging inventorship or claiming the right to
compensation. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property
rights, such as exclusive ownership of, or rights to use, valuable intellectual property. Such an outcome could have a material adverse
effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and
be a distraction to management and other employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee in the course and as a result
of or arising from his or her employment with a company are regarded as &#8220;service inventions,&#8221; which belong to the employer,
absent a specific agreement between the employee and employer giving the employee service invention rights. The Patent Law also provides
that if there is no such agreement between an employer and an employee, the Israeli Compensation and Royalties Committee, or the Committee,
a body constituted under the Patent Law, shall determine whether the employee is entitled to remuneration for his inventions. Recent
case law clarifies that the right to receive consideration for &#8220;service inventions&#8221; can be waived by the employee. The Committee
will examine, on a case-by-case basis, the general contractual framework between the parties, using interpretation rules of the general
Israeli contract laws. Further, the Committee has not yet determined one specific formula for calculating this remuneration (but rather
uses the criteria specified in the Patent Law). Although we generally enter into assignment-of-invention agreements with our employees
pursuant to which such individuals assign to us all rights to any inventions created in the scope of their employment or engagement with
us, we may face claims demanding remuneration in consideration of assigned inventions. As a consequence of such claims, we could be required
to pay additional remuneration or royalties to our current and former employees, or be forced to litigate such claims, which could negatively
affect our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to protect our intellectual property rights throughout the world.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing,
prosecuting, and defending patents on products, as well as monitoring their infringement in all countries throughout the world, would
be prohibitively expensive, and our intellectual property rights in some countries can be less extensive than those in the United States.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competitors
may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export
otherwise infringing products to territories where we have patent protection but enforcement is not as strong as that in the United States.
These products may compete with our products. Future patents or other intellectual property rights may not be effective or sufficient
to prevent such products from competing with our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets,
and other intellectual property protection, which could make it difficult for us to stop the marketing of competing products in violation
of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could
result in substantial costs and divert our efforts and attention from other aspects of our business, could put our future patents at
risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties
to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may
not be commercially meaningful. Accordingly, our efforts to monitor and enforce our intellectual property rights around the world may
be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to the Ownership of Our Securities</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
principal shareholders, officers and directors beneficially own approximately 64% of our outstanding ordinary shares. They will therefore
be able to exert significant control over matters submitted to our shareholders for approval, which could limit your ability to influence
the outcome of key transactions, including a change of control, and which may result in conflicts with us or you in the future.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal shareholders, officers and directors beneficially own approximately 64% of our ordinary shares. This significant concentration
of share ownership may adversely affect the trading price for our ordinary shares because investors often perceive disadvantages in owning
shares in companies with controlling shareholders. As a result, these shareholders, if they acted together, could significantly influence
or even unilaterally approve matters requiring approval by our shareholders, including the election of directors and the approval of
mergers or other business combination transactions. The interests of these shareholders may not always coincide with our interests or
the interests of other shareholders, and which may result in conflicts with us or you in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
of our directors have relationships with our principal shareholders, which may cause conflicts of interest with respect to our business.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
of our current directors were appointed by Knorr-Bremse and one director was nominated by Foresight, our largest shareholders. In addition,
pursuant to our amended and restated articles of association, shareholders are entitled to appoint a director to our board of directors
for each 10% of our outstanding share capital that they own and in such case the appointment will be for an undefined period. As a result,
these directors may face real or apparent conflicts of interest with respect to matters affecting both us and Knorr-Bremse or Foresight,
whose interests may be adverse to ours in certain circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
JOBS Act will allow us to postpone the date by which we must comply with some of the laws and regulations intended to protect investors
and to reduce the amount of information we provide in our reports filed with the SEC, which could undermine investor confidence in our
company and adversely affect the market price of our ordinary shares.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
so long as we remain an &#8220;emerging growth company&#8221; as defined in the JOBS Act, we intend to take advantage of certain exemptions
from various requirements that are applicable to public companies that are not &#8220;emerging growth companies&#8221; including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions of the Sarbanes-Oxley Act requiring that our independent registered public accounting firm provide an attestation report
    on the effectiveness of our internal control over financial reporting;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    rules that may be adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotation or a supplement
    to the auditor&#8217;s report on the financial statements; and,</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
    107 of the JOBS Act, which provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period
    provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised
    accounting standards. This means that an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards
    until those standards would otherwise apply to private companies. We have elected to delay such adoption of new or revised accounting
    standards. As a result of this adoption, our financial statements may not be comparable to companies that comply with the public
    company effective date.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to take advantage of these exemptions until we are no longer an &#8220;emerging growth company.&#8221; We will remain an emerging
growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of our first
sale of common equity securities pursuant to an effective registration statement under the Securities Act, (b) in which we have total
annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market
value of our ordinary shares that is held by non-affiliates exceeds $700 million as of the prior June 30, and (2) the date on which we
have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict if investors will find our ordinary shares less attractive because we may rely on these exemptions. If some investors
find our ordinary shares less attractive as a result, there may be a less active trading market for our ordinary shares, and our market
prices may be more volatile and may decline.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a &#8220;foreign private issuer&#8221; we are permitted, and intend, to follow certain home country corporate governance practices instead
of otherwise applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors under rules applicable
to domestic U.S. issuers.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
status as a &#8220;foreign private issuer&#8221; exempts us from compliance with certain SEC laws and regulations and certain regulations
of the Nasdaq Stock Market, including the proxy rules, the short-swing profits recapture rules, and certain governance requirements such
as independent director oversight of the nomination of directors and executive compensation. In addition, we will not be required under
the Exchange Act to file current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies
whose securities are registered under the Exchange Act and we will generally be exempt from filing quarterly reports with the SEC. Also,
although the Israeli Companies Law, or the Companies Law, will require us to disclose the annual compensation of our five most highly
compensated senior officers on an individual basis, this disclosure will not be as extensive as that required of a U.S. domestic issuer.
For example, the disclosure required under the Companies Law is limited to compensation paid in the immediately preceding year without
any requirement to disclose option exercises and vested stock options, pension benefits or potential payments upon termination or a change
of control. Furthermore, as a foreign private issuer, we are also not subject to the requirements of Regulation FD (Fair Disclosure)
promulgated under the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
exemptions and leniencies will reduce the frequency and scope of information and protections to which you are entitled as an investor.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be a &#8220;passive foreign investment company,&#8221; or PFIC, for U.S. federal income tax purposes in the current taxable year
or may become one in any subsequent taxable year. There generally would be negative tax consequences for U.S. taxpayers that are holders
of our ordinary shares if we are or were to become a PFIC.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the projected composition of our income and valuation of our assets, we may have been a PFIC during 2022, and although we have not
determined whether we will be a PFIC in 2023, or in any subsequent year, our operating results for any such years may cause us to be
a PFIC. The determination of whether we are a PFIC is made on an annual basis and will depend on the composition of our income and assets
from time to time. We will be treated as a PFIC for U.S. federal income tax purposes in any taxable year in which either (1) at least
75% of our gross income is &#8220;passive income&#8221; or (2) on average at least 50% of our assets by value produce passive income
or are held for the production of passive income. Passive income for this purpose generally includes, among other things, certain dividends,
interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of property that gives
rise to passive income. Passive income also includes amounts derived by reason of the temporary investment of funds, including those
raised in a public offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets
of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account. The tests for
determining PFIC status are applied annually, and it is difficult to make accurate projections of future income and assets which are
relevant to this determination. In addition, our PFIC status may depend in part on the market value of our ordinary shares. Accordingly,
there can be no assurance that we currently are not or will not become a PFIC in the future. If we are a PFIC in any taxable year during
which a U.S. taxpayer holds our ordinary shares, such U.S. taxpayer would be subject to certain adverse U.S. federal income tax rules.
In particular, if the U.S. taxpayer did not make an election to treat us as a &#8220;qualified electing fund,&#8221; or QEF, or make
a &#8220;mark-to-market&#8221; election, then &#8220;excess distributions&#8221; to the U.S. taxpayer, and any gain realized on the sale
or other disposition of our ordinary shares by the U.S. taxpayer: (1) would be allocated ratably over the U.S. taxpayer&#8217;s holding
period for the ordinary shares; (2) the amount allocated to the current taxable year and any period prior to the first day of the first
taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years
would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge
for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition,
if the U.S. Internal Revenue Service, or the IRS, determines that we are a PFIC for a year with respect to which we have determined that
we were not a PFIC, it may be too late for a U.S. taxpayer to make a timely QEF or mark-to-market election. U.S. taxpayers that have
held our ordinary shares during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC in
subsequent years, subject to exceptions for U.S. taxpayer who made a timely QEF or mark-to-market election. A U.S. taxpayer can make
a QEF election by completing the relevant portions of and filing IRS Form 8621 in accordance with the instructions thereto. We do not
intend to notify U.S. taxpayers that hold our ordinary shares if we believe we will be treated as a PFIC for any taxable year in order
to enable U.S. taxpayers to consider whether to make a QEF election. In addition, we do not intend to furnish such U.S. taxpayers annually
with information needed in order to complete IRS Form 8621 and to make and maintain a valid QEF election for any year in which we or
any of our, if any, are a PFIC. U.S. taxpayers that hold our ordinary shares are strongly urged to consult their tax advisors about the
PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them of making a QEF or mark-to-market
election with respect to our ordinary shares in the event that we are a PFIC. See &#8220;Taxation&#8212;U.S. Federal Income Tax Considerations&#8212;Passive
Foreign Investment Companies&#8221; for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
a United States person is treated as owning at least 10% of our ordinary shares, such holder may be subject to adverse U.S. federal income
tax consequences.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our
ordinary shares, such person may be treated as a &#8220;United States shareholder&#8221; with respect to each controlled foreign corporation,
or CFC. A United States shareholder of a CFC may be required to report annually and include in its U.S. taxable income its pro rata share
of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and investments in U.S. property by CFCs, regardless
of whether we make any distributions, and may be subject to tax reporting obligations. An individual that is a United States shareholder
with respect to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United
States shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder
to significant monetary penalties and may prevent the statute of limitations with respect to such shareholder&#8217;s U.S. federal income
tax return for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in
determining whether we are treated as CFC or whether any investor is treated as a United States shareholder with respect to CFC or furnish
to any United States shareholders information that may be necessary to comply with the aforementioned reporting and tax paying obligations.
The United States Internal Revenue Service has provided limited guidance on situations in which investors may rely on publicly available
information to comply with their reporting and tax paying obligations with respect to CFCs. A United States investor should consult its
advisors regarding the potential application of these rules to an investment in our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to securities litigation, which is expensive and could divert management attention.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, companies that have experienced volatility in the market price of their shares have been subject to securities class action
litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs
and diversion of management&#8217;s attention and resources, which could seriously hurt our business. Any adverse determination in litigation
could also subject us to significant liabilities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market price of our securities may be highly volatile, and you could lose all or part of your investment.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our ordinary shares and warrants is likely to be volatile. This volatility may prevent you from being able to sell your
ordinary shares or warrants at or above the price you paid for your securities. Our share price could be subject to wide fluctuations
in response to a variety of factors, which include:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    we achieve our anticipated corporate objectives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated fluctuations in our quarterly or annual operating results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our financial or operational estimates or projections;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to implement our operational plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">termination
    of the lock-up agreement or other restrictions on the ability of our shareholders to sell shares after the initial public offering;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the economic performance or market valuations of companies similar to ours; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic or political conditions in the United States or elsewhere.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our ordinary
shares, regardless of our actual operating performance, and we have little or no control over these factors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they
adversely change their recommendations or publish negative reports regarding our business or the ordinary shares, our share price and
trading volume could decline.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for the ordinary shares will be influenced by the research and reports that industry or securities analysts may publish
about us, our business, our market or our competitors. We do not have any control over these analysts and we cannot provide any assurance
that analysts will cover us or provide favorable coverage. If any of the analysts who may cover us adversely change their recommendation
regarding the ordinary shares, or provide more favorable relative recommendations about our competitors, the price of our ordinary shares
would likely decline. If any analyst who may cover us were to cease coverage of our company or fail to regularly publish reports on us,
we could lose visibility in the financial markets, which in turn could cause the price of our ordinary shares or trading volume to decline.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a &#8220;foreign private issuer,&#8221; we are permitted, and intend, to follow certain home country corporate governance practices instead
of otherwise applicable SEC and Nasdaq Capital Market requirements, which may result in less protection than is accorded to investors
under rules applicable to domestic U.S. issuers.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &#8220;foreign private issuer&#8221; and are not subject to the same requirements that are imposed upon U.S. domestic issuers by
the SEC. Under the Exchange Act, we will be subject to reporting obligations that, in certain respects, are less detailed and less frequent
than those of U.S. domestic reporting companies. For example, we will not be required to issue quarterly reports or proxy statements
that comply with the requirements applicable to U.S. domestic reporting companies. Furthermore, although under regulations promulgated
under the Companies Law, as an Israeli public company listed overseas we will be required to disclose the compensation of our five most
highly compensated office holders on an individual basis (rather than on an aggregate basis), this disclosure will not be as extensive
as that required of U.S. domestic reporting companies. We will also have four months after the end of each fiscal year to file our annual
reports with the SEC and will not be required to file current reports as frequently or promptly as U.S. domestic reporting companies.
Furthermore, our officers, directors and principal shareholders will be exempt from the requirements to report transactions and short-swing
profit recovery required by Section 16 of the Exchange Act. Also, as a &#8220;foreign private issuer,&#8221; we are not subject to the
requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. These exemptions and leniencies will reduce the frequency
and scope of information and protections available to investors in comparison to those applicable to a U.S. domestic reporting companies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as a &#8220;foreign private issuer,&#8221; we are permitted to follow certain home country corporate governance practices instead
of those otherwise required under the listing rules of the Nasdaq for domestic U.S. issuers. For instance, we follow home country practice
in Israel instead of the listing rules of the Nasdaq requiring that a majority of a listed company&#8217;s board of directors be comprised
of independent directors within a specified period after listing. In addition, we will follow our home country law instead of the listing
rules of the Nasdaq that require that we obtain shareholder approval for certain dilutive events, such as the establishment or amendment
of certain equity based compensation plans, an issuance that will result in a change of control of our company, certain transactions
other than a public offering involving issuances of a 20% or greater interest in the company, and certain acquisitions of the stock or
assets of another company. We may in the future elect to follow home country corporate governance practices in Israel with regard to
other matters. Following our home country corporate governance practices as opposed to the requirements that would otherwise apply to
a U.S. company listed on the Nasdaq may provide less protection to investors than what would otherwise be accorded to investors under
the listing rules of the Nasdaq applicable to domestic U.S. issuers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Israeli Law and Our Incorporation, Location and Operations in Israel</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are exposed to fluctuations in currency exchange rates, which could negatively affect our financial condition and results of operations.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional and reporting currency is the U.S. dollar. A material portion of our operating expenses is incurred outside the United States,
mainly in NIS, and is subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in NIS. Our foreign
currency-denominated expenses consist primarily of personnel, rent and other overhead costs. Since a significant portion of our expenses
is incurred in NIS, any appreciation of the NIS relative to the U.S. dollar would adversely impact our net loss or net income, as relevant.
We are therefore exposed to foreign currency risk due to fluctuations in exchange rates. This may result in gains or losses with respect
to movements in exchange rates which may be material and may also cause fluctuations in reported financial information that are not necessarily
related to its operating results. In relation to the effect of inflation, results for tax purposes are measured in terms of earnings
in NIS after certain adjustments for increases in the Israeli Consumer Price Index, or CPI. As the results in our financial statements
are measured in U.S. dollars, the difference between the annual change in the Israeli CPI and in the NIS/U.S. dollar exchange rate can
cause a difference between taxable income and the net loss shown in the financial statements. We expect that the majority of our revenues
will be generated in U.S. dollars with the balance in EURO for the foreseeable future, and that a significant portion of our expenses
will continue to be denominated in NIS and partially in U.S. dollars and EURO. To date, foreign currency transaction gains and losses
and exchange rate fluctuations have not been material to our financial statements, and we have not engaged in any foreign currency hedging
transactions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
of Israeli law and our articles of association may delay, prevent or otherwise impede a merger with, or an acquisition of, our company,
even when the terms of such a transaction are favorable to us and our shareholders.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company incorporated under the law of the State of Israel, we are subject to Israeli law. Israeli corporate law regulates mergers,
requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors,
officers or significant shareholders and regulates other matters that may be relevant to such types of transactions. For example, a merger
may not be consummated unless at least 50 days have passed from the date on which a merger proposal is filed by each merging company
with the Israel Registrar of Companies and at least 30 days have passed from the date on which the shareholders of both merging companies
have approved the merger. In addition, a majority of each class of securities of the target company must approve a merger. Moreover,
a tender offer for all of a company&#8217;s issued and outstanding shares can only be completed if the acquirer receives positive responses
from the holders of at least 95% of the issued share capital and a majority of the offerees that do not have a personal interest in the
tender offer approves the tender offer, unless, following consummation of the tender offer, the acquirer would hold at least 98% of the
company&#8217;s outstanding shares. Furthermore, the shareholders, including those who indicated their acceptance of the tender offer,
may, at any time within six months following the completion of the tender offer, claim that the consideration for the acquisition of
the shares does not reflect their fair market value, and petition an Israeli court to alter the consideration for the acquisition accordingly,
unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not seek such appraisal rights, and
the acquirer or the company published all required information with respect to the tender offer prior to the tender offer&#8217;s response
date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
tax considerations also may make potential transactions unappealing to us or to our shareholders whose country of residence does not
have a tax treaty with Israel exempting such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free
share exchanges to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances
but makes the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years
from the date of the transaction during which sales and dispositions of shares of the participating companies may be subject to certain
restrictions and additional terms. Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and
when such time expires, the tax becomes payable even if no disposition of the shares has occurred. See &#8220;Taxation&#8212;Israeli
Tax Considerations and Government Programs&#8221; for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Your
rights and responsibilities as a holder of our securities are governed by Israeli law, which differs in some material respects from the
rights and responsibilities of shareholders of U.S. companies.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under Israeli law. The rights and responsibilities of the holders of our ordinary shares are governed by our articles
of association and by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities
of shareholders in typical U.S.-based corporations. In particular, a shareholder of an Israeli company has certain duties to act in good
faith and in a customary manner in exercising its rights and performing its obligations towards the company and other shareholders and
to refrain from abusing its power in the company including, among other things, in voting at the general meeting of shareholders on certain
matters, such as an amendment to the company&#8217;s articles of association, an increase of the company&#8217;s authorized share capital,
a merger of the company, and approval of related party transactions that require shareholder approval. In addition, a controlling shareholder
or a shareholder who knows that it possesses the power to determine the outcome of a shareholder vote or to appoint or prevent the appointment
of an officer of the company has a duty to act in fairness towards the company with regard to such vote or appointment. However, Israeli
law does not define the substance of this duty of fairness. There is limited case law available to assist us in understanding the nature
of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations on holders
of our ordinary shares that are not typically imposed on shareholders of U.S. corporations. See &#8220;Directors, Senior Management and
Employees&#8212;Board Practices&#8212;Duties of Shareholders&#8221; for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>It
may be difficult to enforce a judgment of a U.S. court against us and our officers and directors and the Israeli experts named in this
Annual Report in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our officers and
directors and these experts.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated in Israel and our corporate headquarters are located in Israel. All of our executive officers and directors and the
Israeli experts named in this Annual Report are located outside of the U.S. All of our assets and most of the assets of these persons
are located in Israel. Therefore, a judgment obtained against us, or any of these persons, including a judgment based on the civil liability
provisions of the U.S. federal securities laws, may not be collectible in the United States and may not necessarily be enforced by an
Israeli court. It also may be difficult to affect service of process on these persons in the United States or to assert U.S. securities
law claims in original actions instituted in Israel. Additionally, it may be difficult for an investor, or any other person or entity,
to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may refuse to hear a claim based on an alleged violation
of U.S. securities laws reasoning that Israel is not the most appropriate forum in which to bring such a claim. In addition, even if
an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is
found to be applicable, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time consuming
and costly process. Certain matters of procedure will also be governed by Israeli law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated with enforcing
a judgment against us in Israel, you may not be able to collect any damages awarded by either a U.S. or foreign court.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
headquarters, research and development and other significant operations are located in Israel, and, therefore, our results may be adversely
affected by political, economic and military instability in Israel.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive offices, corporate headquarters and research and development facilities&#160;are located in Israel. In addition, all of our
officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding
region may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken
place between Israel and its neighboring Arab countries, the Hamas (an Islamist militia and political group that controls the Gaza strip)
and the Hezbollah (an Islamist militia and political group based in Lebanon). Any hostilities involving Israel or the interruption or
curtailment of trade between Israel and its trading partners could negatively affect business conditions in Israel in general and our
business in particular, and adversely affect our operations and results of operations. Ongoing and revived hostilities or other Israeli
political or economic factors, such as, an interruption of operations at the Ben Gurion International Airport, could prevent or delay
our regular operation, product development and delivery of products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, political uprisings, social unrest and violence in various countries in the Middle East and North Africa, including Israel&#8217;s
neighbor Syria, is affecting the political stability and may lead to deterioration in the political and trade relationships that exist
between the State of Israel and certain other countries. Any armed conflicts, terrorist activities or political instability in the region
could adversely affect business conditions, could harm our results of operations and the market price of our securities, and could make
it more difficult for us to raise capital. Parties with whom we do business may sometimes decline to travel to Israel during periods
of heightened unrest or tension, forcing us to make alternative arrangements when necessary in order to meet our business partners face
to face. Several countries, principally in the Middle East, still restrict doing business with Israel and Israeli companies, and additional
countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in Israel or political instability
in the region continues or increases. Similarly, Israeli companies are limited in conducting business with entities from several countries.
For instance, the Israeli legislature passed a law forbidding any investments in entities that transact business with Iran. In addition,
the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming
that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East or for
any resulting disruption in our operations. Although the Israeli government has in the past covered the reinstatement value of direct
damages that were caused by terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or,
if maintained, will be sufficient to compensate us fully for damages incurred, and the government may cease providing such coverage or
the coverage might not suffice to cover potential damages. Any losses or damages incurred by us could have a material adverse effect
on our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business
with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating
results, financial conditions or the expansion of our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
operations may be disrupted as a result of the obligation of management or key personnel to perform military service</i>.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
employees and consultants in Israel, including members of our senior management, may be obligated to perform one month, and in some cases
longer periods, of military reserve duty until they reach the age of 40 (or older, for citizens who hold certain positions in the Israeli
armed forces reserves) and, in the event of a military conflict or emergency circumstances, may be called to immediate and unlimited
active duty. In the event of severe unrest or other conflict, individuals could be required to serve in the military for extended periods
of time. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is
possible that there will be similar large-scale military reserve duty call-ups in the future. Our operations could be disrupted by the
absence of a significant number of our officers, directors, employees and consultants related to military service. Such disruption could
materially adversely affect our business and operations. Additionally, the absence of a significant number of the employees of our Israeli
suppliers and contractors related to military service or the absence for extended periods of one or more of their key employees for military
service may disrupt their operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Risk Factors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
incur significant additional costs as a result of being a public company subject to SEC reporting requirements in the United States,
and our management is required to devote substantial additional time to new compliance initiatives as well as to compliance with ongoing
United States reporting requirements.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a U.S. public reporting company, we are incurring significant additional accounting, legal, and other expenses in the future. Our management
and other personnel need to devote substantial time to the compliance requirements of being a U.S. public company; in addition, the implementation
of such compliance processes and systems may require us to hire outside consultants and incur other significant costs. Any future changes
in the laws and regulations affecting public companies in the United States and the rules and regulations adopted by the SEC and the
Nasdaq Market, for so long as they apply to us, will result in increased costs to us as we respond to such changes. These laws, rules,
and regulations could make it more difficult or more costly for us to obtain certain types of insurance, including director and officer
liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain
the same or similar coverage. The impact of these requirements could also make it more difficult for us to attract and retain qualified
persons to serve on our board of directors, on our board committees, if any, or as senior management.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we engage in future acquisitions or strategic partnerships, this may increase our capital requirements, dilute our shareholders, cause
us to incur debt or assume contingent liabilities, and subject us to other risks.</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may evaluate various acquisition opportunities and strategic partnerships, including licensing or acquiring complementary products, intellectual
property rights, technologies or businesses. Any potential acquisition or strategic partnership may entail numerous risks, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
    operating expenses and cash requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    assumption of additional indebtedness or contingent liabilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    issuance of our equity securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assimilation
    of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new
    personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    diversion of our management&#8217;s attention from our existing product programs and initiatives in pursuing such a strategic merger
    or acquisition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retention
    of key employees, the loss of key personnel and uncertainties in our ability to maintain key business relationships;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
    and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing
    products or product candidates and marketing approvals; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to generate revenue from acquired technology and/or products sufficient to meet our objectives in undertaking the acquisition
    or even to offset the associated acquisition and maintenance costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
4. INFORMATION ON THE COMPANY</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.&#160;History
and Development of the Company</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a development stage technology company that is seeking to revolutionize railway safety and the data-related market. We believe we
have developed cutting edge, AI based, industry-leading detection technology specifically designed for railways, with investments from
Knorr-Bremse, a world-class rail system manufacturer. We have developed our railway detection and systems to save lives, increase efficiency,
and dramatically reduce expenses for the railway operator.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated under the laws of the State of Israel in April 2016. Our principal executive offices are located at 15 Hatidhar St.
Ra&#8217;anana, 4366517 Israel. Our telephone number in Israel is +972-9-957-7706. Our website address is http://www.railvision.io/.
Information contained on or accessible through our website is not a part of this Annual Report on Form 20-F, and the inclusion of our
website address herein is an inactive textual reference only.&#160;Puglisi &amp; Associates, or Puglisi, serves as our authorized representative
in the United States for certain limited matters. Puglisi&#8217;s address is 850 Library Avenue, Newark, Delaware 19711.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file
electronically with the SEC at http://sec.gov. We use our website (http://www.railvision.io), LinkedIn (https://www.linkedin.com/company/rail-vision),
, and Facebook (https://www.facebook.com/railvision.io) as channels of distribution of Company information. The information we post through
this channel may be deemed material. Accordingly, investors should monitor our website, in addition to following our press releases,
SEC filings and public conference calls and webcasts. The contents of our website are not, however, a part of this Annual Report on Form
20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an emerging growth company, as defined in Section 2(a) of the Securities Act, as implemented under the JOBS Act. As such, we are
eligible to, and intend to, take advantage of certain exemptions from reporting requirements that generally apply to public companies,
including the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley
Act, compliance with new standards adopted by the Public Company Accounting Oversight Board which may require mandatory audit firm rotation
or auditor discussion and analysis, exemption from say on pay, say on frequency, and say on golden parachute voting requirements, and
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We will be an emerging
growth company until the earliest of: (i) the last day of the fiscal year during which we had total annual gross revenues of $1.07 billion
or more, (ii) the last day of the fiscal year following the fifth anniversary of the date of the first sale of the ordinary shares pursuant
to an effective registration statement (i.e., December 31, 2027), (iii) the date on which we have, during the previous three-year period,
issued more than $1 billion in non-convertible debt, or (iv) the date on which we are deemed a &#8220;large accelerated filer&#8221;
as defined in Regulation S-K under the Securities Act, which means the market value of our ordinary shares that is held by non-affiliates
exceeds $700 million as of the prior June 30th.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are exempt from certain rules and regulations under the Exchange Act that are applicable to other public
companies that are not foreign private issuers. For example, although we intend to report our financial results on a quarterly basis,
we will not be required to issue quarterly reports, proxy statements that comply with the requirements applicable to U.S. domestic reporting
companies, or individual executive compensation information that is as detailed as that required of U.S. domestic reporting companies.
We will also have four months after the end of each fiscal year to file our annual report with the SEC and will not be required to file
current reports as frequently or promptly as U.S. domestic reporting companies. Our senior management, directors, and principal shareholders
will be exempt from the requirements to report transactions in our equity securities and from the short-swing profit liability provisions
contained in Section&#160;16 of the Exchange Act. As a foreign private issuer, we will also not be subject to the requirements of Regulation&#160;FD
(Fair Disclosure) promulgated under the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.&#160;Business
Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We are a development stage
technology company that is seeking to revolutionize railway safety and the data-related market. We believe we have developed cutting edge,
AI based, industry-leading detection technology specifically designed for railways, with investments from Knorr-Bremse, a world-class
rail system manufacturer. We have developed our railway detection and systems to save lives, increase efficiency, and dramatically reduce
expenses for the railway operator. Following a long-term pilot with Israel Railways that was concluded in August 2022, in January 2023,
we signed an agreement with Israel Railways for the purchase of 10 Rail Vision Main Line Systems. In addition, our railway detection system
is currently in a pilot phase with several industry leading railway operators as we seek to move to the next stage of receiving commercial
orders. We believe that our technology will significantly increase railway safety around the world, while creating significant benefits
and adding value to everyone who relies on the train ecosystem: from passengers using trains for transportation to companies that use
railways to deliver goods and services. In addition, we believe that our technology has the potential to advance the revolutionary concept
of autonomous trains into a practical reality.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increasing electrification and automation of railways and trains are two key factors that are driving growth in the transportation market.
Autonomous trains are integrated with advanced systems to provide improved control over the train for stopping, departing and movement
between train stations &#8211; for example the operators are aiming to increase the density on a given track that&#8217;s to say more
trains per kilometer. From everyday passengers to train operators, there is a rising demand for safe, secure, and efficient transport
systems. Additionally, various technological advancements, such as the integration of the Internet of Things, or IoT, and artificial
intelligence, or AI, solutions into railway detection systems, are market categories expected to grow in the coming years. These technologies
aid in improving the overall operational efficiency and maintaining freight operations and systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Autonomous
trains, also known as driverless trains, are operated automatically without any human intervention, and are monitored from the control
station when communication is available. In case of any obstacle incurred in the route, the obstacle detection system commands the train
to stop and in parallel a message is sent to operational control center and to the attendant on the train if any, to further command
the train. Owing to increase in traffic congestion on road network, the need for smart and frequent trains has boosted the growth of
the global market. According to Allied Market Research, the autonomous train technology market was valued at $5.88 billion in 2018, and
is projected to reach $15.57 billion&#160;by 2026, growing at a CAGR of 12.9% from 2019 to 2026.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our founding in April 2016, we have developed unique railway detection systems for railway safety, based on image processing and deep
leaning technologies that provide early warnings to train driver of hazards on and around the railway track, including during severe
weather and in all lighting conditions. Our unique system uses special high resolution cameras to identify objects up to 2,000 meters
away, along with a computer unit that uses AI machine learning algorithms to analyze the images, identify objects on or near the tracks,
and warn the train driver of the obstacle and potential danger. In 2017, we were recognized as the winner of Deutche Banh&#8217;s MINDBOX
competition for our automated early warning systems to prevent railway accidents.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
railway detection system includes different types of cameras, including optics, visible light spectrum cameras (video) and thermal cameras
that transmit data to a ruggedized on-board computer which is designed to be suitable for the rough environment of a train&#8217;s locomotive.
Our railway detection and classification system includes an image-processing and machine-learning algorithm that processes the data for
identifying potential hazards on and around the track. These algorithms are designed to identify and classify objects such as people,
animals, vehicles, signs, signals along the track, and anomalies. Our railway detection system actively classifies objects by severity
to determine if an alarm should be signaled to the train driver. These data collection and classification capabilities can be extended
to further use-cases such as predictive maintenance and big-data analyses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our technology demonstrates capabilities and results that are better than existing solutions. Most of the currently available
safety solutions for the railway industry focus on stationary systems in dedicated hazardous locations, such as at level track crossings
and passenger train stations, among others. At these dedicated locations, different technologies are used for detecting obstacles that
are on the vicinity of level crossing tracks, and usually include different cameras and radars. The problem with this type of solution
is that the train is only monitored at specific points in the railroad junction, leaving the vast majority of the railway unprotected.
In addition, even when detected something on the level crossing tracks, the message has to be transmitted in a way that the driver would
be able to react on time. In recognition of the limitations of existing solutions, we integrate a collision avoidance system using long-range
real-time AI and electro-optics technologies on trains that is designed to address this unmet need. as well as providing solutions to
most of the challenges train operators face during transit such as collisions, derailments and other accidents caused by obstacles on
tracks, or poor infrastructure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Overview and Market Opportunity</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
railway is an essential form of transportation. Efficient and safe railway infrastructure plays a central role in the global economy.
The process of expanding and upgrading railways is taking place worldwide, driving the importance to produce safe and reliable railway
infrastructure. A lack of safety and inefficiency may reduce the reliability of train travel, decrease public usage and cause economic
damage, including heavier road traffic, more air pollution, and diminish to the quality of life in general.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Railway
accidents are generally attributed to several factors, such as the human factor, which include the driver&#8217;s failure to notice and
respond to obstacles on the track, the driver&#8217;s ability to react to potential dangers, and the driver&#8217;s field of view, which
is made worse in poor lighting or severe weather conditions. Other factors that cause railway accidents include faults in the railway
track signaling system, damaged infrastructure, and weather conditions such as rain, fog and snow.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the &#8220;Report on railway safety and interoperability in the EU, 2022&#8221;, the economic cost of significant accidents alone
was estimated at about EUR 3.2 billion in 2020. Progress has also been very uneven across the EU Member states, with variation in safety
levels remaining high. According to the U.S. Department of Transportation, in 2021, in the U.S. there were 8,094 train accidents and
incidents, 754 fatalities and 4,628 injuries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the braking distance required for a train to stop, train operators require advanced notice to stop a train in time and avoid an obstacle
on the track. The braking distance of a passenger train traveling at a moderate speed (i.e., 87 mi/h) is between 600 and 800 meters;
freight trains typically require a similar distance to safely brake &#8211; depending on the load size and speed of the train. Human
operators, however, do not have the capacity to detect obstructions on the railway track, and halt a train within these braking distances.
Our advanced technology is designed to address this human deficiency.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
railway detection system monitors the short and long-distance region of interest in front of the train, at an operational range of up
to 2,000 meters (1.2 miles), which is longer than the braking distance of most trains. Our system is designed to detect, classify and
alert train operators on real-time railway track obstacles, which allows the train operator to make educated decisions in how to best
operate the train, and to decide whether it is necessary to stop to avoid a collision. Additionally, after being integrated into the
train&#8217;s computer, our railway detection system&#8217;s artificial intelligence capabilities will facilitate by taking emergency
autonomous actions, such as halting the train, braking once an obstacle is classified, sounding a horn and flashing lights to alert others.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the past several years, there has been an increased demand for automated solutions in railway detection systems to make train travel
safer and more efficient. There are several technological systems available in the market today that have been designed to reduce the
risk of railway accidents, to avoid injuries and damage to property, to limit unplanned closures of railway tracks, to make railway transport
more efficient, and to increase the usage of existing railway infrastructure. Generally, such railway detection systems fall into two
main categories &#8211; those which are installed on the train (such as our railway detection system), and those that are fixed signaling
systems installed as part of the stationary infrastructure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.2in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the market potential for our railway detection systems that are installed on the train is large and ever growing, as every
single railway train or drivers&#8217; cabin worldwide is a potential customer. Based on our own internal research, we estimate there
are approximately 300,000 potential customers, and if considering two (2) systems per loco for each direction the potential can go significantly
higher.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to 2018 estimates of SCI, the global market for railway technology is estimated at approximately $200 billion with a steady growth curve
of 2.8% per year. According to currently displayed statistics on the U.S. Department of Transportation&#8217;s website, the freight train
industry in the United States is estimated at approximately $80 billion, as determined by the by the seven Class 1 railroads operating
in the United States. Additionally, according to the U.S. Department of Transportation it is estimated that $25 billion is spent annually
on maintaining and adding capacity to freight railroads. Also, according to McKinsey &amp; Company, in 2016, the cost of infrastructure
maintenance and renewal exceeds &#8364;25 billion per year across Europe and is rising.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
railway aftermarket revenue is anticipated to record a valuation of USD 120 billion by 2027, according to the&#160;most recent study
by Global Market Insights Inc. which anticipates that rising investments in rail and infrastructure maintenance combined with the penetration
of high-speed trains is expected to bolster the industry growth.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Railway
tracks are a controlled environment, usually owned by one entity in the country where they are located. An obstacle that causes an accident
on a train carrying hundreds of passengers or hauling thousands of tons of cargo might be a significant cost in the event of an accident
due to injuries and damaged property. In addition, the section of track that is damaged or occupied with the stuck train, which is in
any event restricted infrastructure, has to be closed until the investigation is completed, debris is collected and the infrastructure
is checked for safety before train travel on the railway tracks can continue. This affects the timetable of many other trains, which
causes an increase in downtime and the associated financial loss of such downtime. In addition, the reputation of the train operator
is damaged, and as a consequence, the train operator may experience a decrease in business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Current Train Vision Market Status and the Transition to Autonomous Train Vision</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
trains are equipped with certain advanced automated technologies to assist railway operators such as Automatic Train Control, or ATC,
and Automatic Train Protection, or ATP. ATC is a general group of systems that include mechanisms for controlling a train&#8217;s speed
in response to receiving external data. ATP is a system that, among other things, continuously verifies that the train&#8217;s speed
complies with the permitted speed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to ATC and ATP systems, there are currently other available technologies for Automatic Train Operation, or ATO, which include
components to promote safety and control all stages of operating the train, from acceleration to precision stopping. While there are
various levels of implementation of ATO, the most common use of ATO is on underground railways. For example, the London Underground uses
semi-automatic train operation on certain lines. The Light Railway in eastern London is even more advanced, and the driver&#8217;s cabin
has been replaced by a controller.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ATO
covers five Grades of Automation (GoA):</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
    0 refers to a train with a human driver who exercises full control of the train &#8211; starting, stopping, opening and closing doors,
    and operation in emergencies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
    1 refers to operation where the driver controls starting and stopping the train, operation of doors, emergencies and sudden deviations,
    with the assistance of ATP systems.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
    2 refers to semi-automatic operation, where stopping is automatic, but the driver starts the train, operates the doors, and drives
    the train in emergencies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
    3 refers to operation without a driver, where starting and stopping is automatic, but the controller operates the doors and drives
    the train in emergencies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
    4 refers to train operation without supervision; starting, stopping, door operation and operation in emergencies is all automatic
    with no staff on the train.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.85in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that railway companies will gradually implement autonomous trains. While a full transition to autonomous trains will require
the development of additional technologies beyond those currently available, we believe that our obstacle detection technology has the
potential to advance GoA 3 and GoA 4.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the autonomous train vision being promoted worldwide, an automatic detection system will be required to enable train operators
to detect obstacles in the train&#8217;s travel route beyond the braking distance of a train. An automatic detection system has about
twice the human detection capabilities during the day, and much more at night. As part of our efforts to advance operating levels of
GoA 3 and GoA 4, we are investing efforts in collaborations with train operators and train manufacturers to examine the integration of
our railway detection systems within various trains. We focus on detection systems, whereby the additional auxiliary systems required
for an autonomous train (ATC and ATP systems) will be provided by other manufacturers. Our railway detection system is a standalone product
that does not require any supportive additional equipment. The interface with an ATO concept of operation can be done at a later time,
since our railway detection system, once engaged, can be used regardless of the integration with other autonomous technologies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GoA
4 freight trains already operate in certain parts of the world (such as Rio Tinto Australia, and Iron Ore Canada). We believe that our
railway detection systems are ideal for these trains, and part of our strategy is to engage and collaborate with the operators of these
trains. To that end, we have signed a contract to supply demonstrations over several months of testing with the Autonomous GoA4 rail
operator Rio Tinto Iron Ore, as described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
GoA 4 freight trains, there are some very specific environments where trains are operated without drivers and rely on signaling systems
and a sterile testing environment, such as train lines in airports or underground train lines. Such autonomous lines are rare and can
only be implemented if the conditions are precise. These types of trains require a safety infrastructure that is separate from the railway
track in the external environment. This infrastructure is expensive to build and maintain, and therefore is not a viable option for most
operators. While these types of trains are rare and not our main strategic focus, we do believe that our system will be ideal for these
trains as well, as they require a solution that is installed on the train and capable of timely identifying potential hazards on and
around the track.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Solutions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
develop solutions for a number of verticals in the railway market:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">The
    RV2000 system for Main Line passenger and freight trains</span></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RV2000 Main Line System is an application of our railway detection system for passengers and freight trains that travels in main line.
The system includes an external sensor unit installed on the train along with an on-board computer system (see below). The on-board computer
system receives data from the external sensor unit and uses artificial intelligence to perform algorithmic calculations in real time
to identify potential hazards for the train operator.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="image_001.jpg"/>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
railway detection system is designed to discover and warn the train operator about hazards of up to 2,000 meters (1.2 miles) ahead of
the train. To detect hazards up to this distance, our railway detection system is dependent on a continuous line of sight that is not
obscured by buildings, curves in the track, or dense fog which can limit the detection range.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
braking distance of a train traveling at high speeds of about 160 KPH / 100 MPH is approximately 800 meters (0.5 miles). The RV2000 railway
detection system has been optimized to identify hazards at a distance more than 800 meters (0.5 miles) to provide the train operator
with enough time to react to the hazard, and stop the train if necessary. The braking distance of the train may differ as a result of
various factors, including weather conditions and the total weight of the train.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
railway detection system can technically interface with the train&#8217;s control and monitoring systems, such as the brake system. This
interface is achieved by setting up a communication interface between our railway detection system and the train&#8217;s existing operating
system. However, interfacing with the brake system or other systems of a train will require compliance with a more stringent level of
train safety (SIL) than the current safety levels we are certified for, as of the date of this Annual Report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
railway detection system is designed to detect and classify objects, indict their location on the track and the distance from the locomotive,
and detect the position of the switch. The switch is a device that is part of the railway track and is used to switch between two adjacent
tracks or merge two tracks into one track. It is important to detect the position of the switch because the switch selects the train&#8217;s
continued direction from the main track line on which the train is currently riding to another rail.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
advanced prototype of the RV2000 system was completed and finalized its first field test phase with Israel Railways in March 2022. We
are now updating the system and working on the next version of the system.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
a long-term pilot with Israel Railways that was concluded in August 2022, in January 2023, we signed an agreement with Israel Railways
for the purchase of 10 Rail Vision Main Line Systems. First delivery of the system is expected during Q4, 2023. The potential sales opportunity
with Israel Railways for our RV2000 system to be installed on up to 200 trains and assuming we can negotiate bidirectional installation,
the potential sale opportunity could be doubled to install up to 400 RV2000 systems on up to 200 trains.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_002.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rio
Tinto Iron Ore, or RTIO, the world&#8217;s second-largest metals and mining corporation has engaged us to work on part of its AutoHaul
autonomous train to improve train safety. RTIO has 60 operations in 35 countries, has 47,500 employees and 2,000 customers. The RTIO
fleet is autonomous and does not have the technical capability to foresee any obstacles or anomalies in front of the moving train. As
such, RTIO is exploring solutions that can detect, alert and respond to an obstacle on the tracks. In April 2021, we entered into an
equipment, personnel and services supply agreement with Hitachi Rail STS Australia Pty Ltd., or STS, which enables STS, as the principal
supplier, to supply Rio Tinto Railway Network with our RV2000 system for demonstrations and to examine the RV2000&#8217;s operational
performance. The long-term pilot was concluded in August 2022. Following the completion of the long-term pilot, the company submitted
a summary report of the pilot. Following a technical workshop with Rio Tinto that was performed in Nov. 2022, Rio Tinto should send the
company more detailed requirements for the next phase.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<span style="text-decoration:underline">The RV200 system for the Shunting Yard</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
RV200 system used at the shunting yard is meant to streamline work in the operational areas of railways (shunting yards) which are used
for the assembly, loading and unloading of freight trains.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shunting yard application of the railway detection system consists of two external sensor units installed on either side of the locomotive
that are linked to the central processing unit inside the train, and uses algorithms, artificial intelligence/deep learning neural nets,
to classify these obstacles in real time, at a range of up to 200 meters on and beside the track, under severe weather and poor visibility
conditions. These warnings are shown to the driver with some recommendations to stop or slow down. The system also has the technical
ability to interface with the locomotive&#8217;s control systems, such as the train&#8217;s brakes. This is done by setting up a communication
interface with existing systems in the train and doing so in accordance with the customer&#8217;s requirements. However, interfacing
with the brakes or other systems in the locomotive requires compliance with a stricter Safety Integrity Level (SIL) than the levels for
which we have currently have obtained certification (SIL 0). Rail Vision has completed a homologation process of a drive assist system
on trains in a use-case of Switch Yard (SIL-0 according to EN50126).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, we supplied a prototype of the RV200 system to Schweizerische Bundes Bahnen Cargo, or SBBC, for functional testing, which
began in April 2021. As of the date of this Annual Report on Form 20-F, SBB (the mother company of SBB cargo) is planning to issue a
tender for purchasing 9 systems for evaluation. For additional information, see &#8220;Business and Marketing Strategy&#8221; &#8211;
&#8220;Locomotives for shunting yards,&#8221; below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="image_003.jpg"/>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_004.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<span style="text-decoration:underline">The Light Rail Vehicle (LRV RV100) system for light rail and subways</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
cities utilize light railways and underground railways as part of the city&#8217;s public transportation system. Light railways in cities
also intersect with travel environments used by vehicles and pedestrians alike. This hybrid use of a road by cars, trains and people,
causes a greater risk of traffic safety incidents.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of a cooperation with Knorr Bremse, the company developed a preliminary prototype, LRV RV100 system. As of the date of this Annual
Report on Form 20-F, the Company does not allocate its efforts or resources within this segment. The Company will explore business opportunities
and will base its decision of whether or not to allocate resources within this segment on a case by case basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<span style="text-decoration:underline">Maintenance, Predictive maintenance applications based on measurements and data collection</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Predictive
maintenance as a feature in the current systems will be developed according to customer specific use-cases. The Company has developed
a preliminary paid prototype for one customer thus far. As of the date of this Annual Report on Form 20-F, the Company does not allocate
its efforts or resources towards this product. The Company will explore business opportunities and will base its decision of whether
or not to allocate resources towards this product on a case by case basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
and Marketing Strategy</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
vision is to become a global leading developer and supplier of innovative railway detection technologies to the railway industry. We
believe that our advanced technologies will enable safer train driving, reduce train accidents, increase the flow of traffic, and save
money for our customers. We also believe that the transition to autonomous train driving will not occur without an advanced detection
system such as ours.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
focus on the following three main segments of the market as described above:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Locomotives
for shunting yards</i> &#8211; We have focused on selling the RV200 system to shunting yard operators. Our railway detection system for
this market segment is at a relatively advanced stage, as we have a prototype of the RV200 system that is being tested by SBBC, a freight
train company in Switzerland. As of the date of this Annual Report on Form 20-F, SBB (the mother company of SBB cargo) is planning to
issue a tender for purchasing 9 systems for evaluation. Upon successful trial, the company estimation that the total potential is above
100 systems. We believe that SBBC&#8217;s reputation will assist us in the promotion and sales of our railway detection systems to other
customers in this segment. If the transaction with SBBC evolves into an order, we expect SBBC to order several dozen of our railway detection
systems. In addition to the transaction with SBBC, the Company has demonstrated the system to a Class I freight operator in the US. The
demonstration was successful, and we were asked to give an additional demonstration for the customer&#8217;s executives.
</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><i>Locomotives for passenger
and freight trains</i> &#8211; Our strategic focus on this market segment derives from the fact that it includes the largest number of
trains, and that the trains operating in this market segment are exposed to serious risks and the realistic probability for potentially
fatal accidents. We invest significant efforts in promoting sales to passenger and freight train operators. The sales processes for this
market segment includes a demonstration of the system&#8217;s capabilities according to specific requirements of each train operator.
In addition, we are engaged in the process of licensing systems that are intended for this market segment on the assumption that obtaining
a permit in one country may significantly facilitate the licensing process in another country. The Company has signed a contract with
Israel Railways to supply 10 systems. The delivery is expected to start during Q4 2023. The company believes that the first order for
such system by a commercial operator will have an impact on the market. The Company concluded a long-term pilot with Rio Tinto in August
2022. Following the completion of the long-term pilot, the Company submitted a summary report of the pilot. Following a technical workshop
with Rio Tinto that was performed in Nov. 2022, the Company expects to receive from Rio Tinto more detailed requirements for the next
phase.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Light
Rail Vehicle (LRV)</i> &#8211; As of the date of this Annual Report on Form 20-F, the Company does not allocate its efforts or resources
within this segment. The Company will explore business opportunities and will base its decision of whether or not to allocate resources
within this segment on a case by case basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategic focus is reflected in our marketing strategy:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    plan on increasing our marketing and sales department to reach more potential customers. Increasing the number of sales and marketing
    personnel will enable us to initiate and create additional opportunities while the sales and marketing personnel focus on and specialize
    in the territories that our strategy defines as most relevant.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are focused on the following markets: North America, Europe and Australia. The reason for the focus on these markets stems from an
    analysis we conducted to identify the most relevant countries likely to adopt our railway detection systems. We have defined several
    parameters which may indicate commercial viability of the market relevant to our railway detection systems. The parameters examined
    by us included, among other things, the total length of the railway tracks in the country examined, the number of passengers per
    kilometer/ mile of track traveled, the number of tons of goods per kilometer/ mile of track transported, the total number of trains
    in the country, the level of innovation in the country, and the openness to integrate new technologies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are investing in efforts to create and develop collaborations with leading train manufacturers. These collaborations are meant to
    be long-term, with the aim of integrating our railway detection systems into the future production lines of these train manufacturers.
    We believe that the railway detection systems we develop will be an integral part of future trains, and therefore it is important
    to invest marketing efforts as early as possible to promote partnerships with train manufacturers and increase market adoption of
    our railway detection systems.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leverage
    and develop our strategic partnership with Knorr-Bremse to serve as a non-exclusive distributor and be a local partner engaged in
    marketing, sales and the implementation of projects, including integration, installation and services regarding our products in the
    relevant markets in which Knorr-Bremse operates worldwide. As part of this marketing strategy, we will seek the assistance of Knorr-Bremse&#8217;s
    marketing team. Knorr-Bremse&#8217;s marketing staff promotes and sell our products to their existing customers.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to invest in advertising in traditional industry channels, social media networks and digital channels to better advertise
    and market our railway detection systems to potential customers in the railway industry.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    strive to increase collaborations with other companies operating in the railway industry, such as communications companies that are
    engaged in constructing communications infrastructure or companies that manufacture complementary products for the railway industry.
    Collaboration with types of companies may provide added value to our customers, whether it be in the field of data communications
    where customers seek to transfer data in real time from the trains to the control centers, or through cooperation with companies
    that manufacture additional auxiliary systems, such as sign manufacturers, and manufacturers of automatic coupling systems (systems
    that enable automatic coupling between a locomotive and a carriage or between carriages for towing) where our systems will provide
    a complementary solution.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Big
    data &#8211; Following the dissemination of our technology and products among many customers, we intend to offer our Main line and
    Shunting yard systems customers predictive maintenance services and digital mapping services based on the gathering of the visual
    information stored in its systems. We see big data services as one of its most important growth engines in the next 3-5 years.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Products and Applications</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently exploring a number of additional railway detection system applications that are in various stages of research and development,
as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maintenance
and predictive maintenance:</b> customers who have installed Rail Vision Main line and Shunting yard systems for real time identification
of objects, will have the option of receiving predictive track maintenance services, such as identification of vegetation invading the
tracks, damage to infrastructures, sunk pylons, etc. This railway detection system application will be able to collect the data from
the sensors and check for any changes in and around the track infrastructure in order to indicate possible defects in the infrastructures.
Currently, this application is in the initial research and development (R&amp;D) stage.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mapping
and updates &#8211; Geographic Information Systems (GIS)</b>: since trains travel the same route several times a day, the comparison
of observed data received by our railway detection system can discover infrastructures such as posts, signaling systems, electronics
boxes, and check their actual location using system measurements based on an image-based navigation (IBN) algorithm, and compare the
data with existing records and provide updates. This saves both time and money, as the expense of remapping a railway track is rarely
done, and usually forces stretches of track to be closed for such updates. This application of our railway detection system is in the
R&amp;D stage.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Big
Data</b>: this application of our system will be based on long-term collection of data from Company&#8217;s sensors installed on trains
to provide relevant data on infrastructure, train traffic and the surroundings. Analysis of the data will generate reports showing trends
in driver behavior and the surrounding area and conditions, which will help train operators reduce downtime caused by infrastructure
problems, and improve the synchronization of trains, as required by the customer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
this application is only at the start of the research and development stages and is also conditioned on the installation and operation
of about one hundred railway detection systems in order to obtain sufficient data for its operation, assuming the successful completion
of its development.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to offer the Big Data applications as an added value to our system to be installed at the customer and not as a separate product.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commercial
Agreements</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Israel
Railways</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has signed a contract with Israel Railways to supply 10 systems. The delivery is expected to start during Q4 2023. The Company
believe that the first order for such system by a commercial operator will have an impact on the market. The total amount is approximately
$1.40 million USD.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Knorr-Bremse</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into a series of strategic and investment agreements with Knorr-Bremse or affiliates of Knorr-Bremse. Knorr-Bremse is a
110 year old multi-billion dollar market cap company traded on the Frankfurt Stock Exchange. With more than 30,000 employees at over
100 locations in more than 30 countries around the globe Knorr-Bremse is a world leader in braking &amp; peripheral systems generating
total of sales of EUR 6.7 billion in 2021. As one of our strategic investors, Knorr-Bremse has invested approximately $25 million in
us. See &#8220;Major Shareholders and Related Party Transactions&#8212;Related Party Transactions&#8212;Knorr-Bremse&#8221; for additional
information</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>KBCH
Framework Agreement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, we entered into a framework agreement, or the Framework Agreement, with KBCH (a subsidiary of Knorr-Bremse operating in
Switzerland) regarding the supply of a prototype of our system to the shunting yard of a company operating cargo trains in Switzerland,
or SBBC. Under the Framework Agreement, we provided KBCH one prototype of the system which was installed on an operating locomotive in
an SBBC shunting yard, for the purpose of examining the operational performance of the system, or the Operational Function Test. In consideration
for the prototype provided in October 2020 for the Operational Function Test, KBCH paid us approximately EUR 244,000 (approx. $293,000).
The Company continues the cooperation with KBCH under the Framework Agreement for the upcoming tender. As of the date of this Annual
Report on Form 20-F, SBB (the mother company of SBB cargo) is planning to issue a tender for purchasing 9 systems for evaluation. Upon
successful trial, the Company estimates that the total potential is above 100 systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>LRV
System MOU</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Annual Report on Form 20-F, the Company does not allocate its efforts or resources within this segment. The Company
will explore business opportunities and will base its decision of whether or not to allocate resources within this segment on a case
by case basis.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Strategic
Partnership Agreement</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 19, 2021, we entered into a Strategic Partnership Agreement with Knorr-Bremse. Under the terms of the Strategic Partnership Agreement,
we will collaborate with Knorr-Bremse with respect to joint projects, based on the following principles: (a)(i) the expansion of the
Knorr-Bremse Railway Driver Assistance Systems to the field of environmental observation, or (ii) future collaboration in the areas of
barrier identification and classification systems in the railway industry; and (b) as part of the framework, we will provide Knorr-Bremse
the technology needed in order to fulfilling the customer&#8217;s requirements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement further provides, among other things, that (i) in the event that a customer is presented to us by Knorr-Bremse, subject to
the certain conditions, Knorr-Bremse will be entitled to serve as the main contractor for such project, (ii) for any joint project, the
parties will mutually agree on the identity of the main contractor and (iii) we will instruct and train the local Knorr-Bremse missions
to provide field support services for our systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implementation of the terms of the agreement is subject to future approvals and agreements between the parties and third parties, including
transactions that may be subject to the related party transaction rules under the Companies Act, and, as such, there is no certainty
that such transactions will be executed, in whole or in part.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the agreement will expire three years after the date of the agreement, or August 19, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Knorr-Bremse
has been in the railway business for 110 years, as a world leader in braking and other system operations. Knorr-Bremse has a global presence
with 30,000 employees at 100 sites in 30 countries and is trading on the Frankfurt Stock Exchange with sales totaling &#8364;6.7 billion
in 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Collaboration
Agreement with Israel Railways</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 3, 2016, we entered into a Cooperation Agreement with Israel Railways Ltd. (a governmental company fully owned by the State of
Israel), which was further amended on January 19, 2020.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the agreement, we undertook to fulfill certain functions for the development, marketing, distribution and sale of the system,
and Israel Railways undertook to provide us with services and the means to perform tests and experiments, mainly in logistics and manpower,
and to provide us with information on certain data that will be given at the discretion of Israel Railways.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the agreement, we agreed to pay Israel Railways the following payments: (i) during the period from August 3, 2016 and until the earliest
of (a) a period of 5 years from the date of our first commercial sale or (b) our initial public offering on April 4, 2022 or (c) a change
of control (as defined in the agreement), Israel Railways will be entitled to a payment of royalties in the amount of 2.75% of our net
sales, and (ii) during the period from August 3, 2016 until the earliest of: (a) our initial public offering on April 4, 2022 or (b)
a change of control (as defined in the agreement) Israel Railways will be entitled to 1.5% of the total proceeds from an IPO or consideration,
received by us or our shareholders, as a result of a change of control.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of our initial public offering, the Israel Railways became entitled to a consideration of 1.5% of the actual proceeds
from our initial public offering, which was approximately $213,000, and accordingly their right to royalties has expired.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement further provides that Israel Railways will be entitled to purchase our products and services at a price equal to half the lowest
price charged by us for those products and services to an unrelated third party.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the agreement and in consideration for services provided to us by Israel Railways, we granted Israel Railways warrants
to purchase 195,448 of our ordinary shares with a nominal exercise price. The warrants were initially exercisable upon the earlier of
an IPO or a change of control. According to amendments to the agreement we amended the warrant to extend the exercise period, until the
earlier of: (1) five business days following the day in which Israel Railways obtained the necessary governmental approvals; or (2) June
30, 2023. On January 25, 2023, Israel Railways provided notice of its exercise of the warrants, pursuant to which we issued 195,448 ordinary
shares to Israel Railways.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
agreement may be terminated by either party by providing a 60 days prior written notice. In addition, Israel Railways may terminate the
agreement with 30 days prior written notice in the event of a change of control in us. The agreement was terminated and canceled by the
parties on January 31, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our current and potential competitors have extensive track records and relationships within the rail industry and/or the automotive
industry. Many of our current and potential competitors have longer operating histories and more extensive name recognition than we have
and may also have greater financial, marketing, manufacturing, distribution and other resources than we have. In particular, we operate
in a market where most of our competitors are giant corporations such as Bosch Engineering GmbH, ALSTOM Holdings, Siemens Mobility GmbH
and Toshiba Infrastructure Systems &amp; Solutions Corporation with others such as 4Tel Pty Ltd and Cognitive Pilot LLC. Current and
future competitors may be able to respond more quickly to new or emerging technologies and changes in customer demands and to devote
greater resources to the development, promotion and sale of their products than we can.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
some of the competitors that have used existing systems from the motor vehicle world and adjusted them to the railway environment, we
develop our railway detection systems from the beginning to operate on trains. Additionally, in terms of the ability to identify hazards
at far longer distances, our railway detection system functions can not only discover obstacles on the tracks but also identify these
obstacles. We believe that our railway detection system&#8217;s contribution to train safety will be greater than that of existing railway
detection systems by our competitors. Thus, by our estimate, the railway detection systems offered by competitors for mainline trains
have relatively limited capabilities compared to the capabilities of our RV2000 system. From our own analysis, we believe that our competitors
offer a shorter range-detection distance and provide a lower detection probability of obstacles than the railway detection systems we
have developed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our competitors offer a shorter range-detection distance and provide a lower detection probability of obstacles. Our systems consist
of electro-optic sensors using artificial intelligence for automatic identification, classification of obstacles along the tracks at
distances which, to the best of our knowledge, are longer than those of the competition. Our railway detection systems also have a greater
degree of accuracy and higher probability to detect obstacles, which, to the best of our knowledge, results in fewer false alerts compared
to competing products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apart
from the expected contribution of our systems to increase the safety of train operations, our railway systems are also designed to help
in predictive maintenance of railway infrastructure, due to the constant monitoring of the railway tracks by its sensors. As far as we
know, this function does not exist in any competing systems.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best of our knowledge, several competing companies are developing systems to help drivers. Some derive from the world of trains,
others from the wheeled vehicle industry. These companies adapt technologies from the vehicle industry for use with trains, for long
distance identification of hazards, particularly in the LRV segment. These technologies are generally based on LIDAR technology and/or
radar scans with cameras, and as far as we know, have not yet been shown to be suitable for the railway environment, in terms of discovery
ranges and required performance. In addition, we don&#8217;t expect our LRV system to be sold at a lower price than competitors&#8217;
prices due to our use of more advanced components than our competitors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
differentiate our systems by focusing on their unique ability to use AI algorithms in real time to provide alerts to the driver throughout
the entire drive. In our estimation, the advantages of our technology over the competition are:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    railway detection system is based on passive technology that uses video images or thermal images, unlike other railway detection
    systems that are based on obstacle discovery using radar or lasers (which emit radiation along the railway track) in train stations,
    and already exist in the market for LRV and in level crossing &#8211; we do not know of any other system that reaches 2 kilometers
    classification.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    several field trials, our railway detection systems have shown an ability to identify objects at distances of up to 2,000 meters.
    Discovering obstacles at a long range is essential for effectively discovering obstacles since there is a long braking distances
    required by trains to come to a complete stop from the time the obstacle is identified.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    railway detection systems, compared to LIDAR technology, are less sensitive to platform speed or rocking motions, higher resolution
    and are able to classify obstacles at longer distances compared to competing railway detection systems.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    detection systems are based on passive technology, and are therefore not exposed to interference due to hot spots and reflection
    overload. Other technologies such as radar are sensitive to the presence of metallic objects (such as screws, springs and other metallic
    objects etc.) which are often found on or near railway tracks.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the following table gives representative details of various solutions currently available on the market in the field of identifying
obstacles on railway tracks. The following information is based on our beliefs, has been provided to us from publications by the various
competitors listed below and has not been independently verified by us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="5" style="border: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shunting Yard</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; width: 13%; text-align: left; font-size: 10pt">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 16%; border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Segment</b></span></td>
    <td style="width: 15%; border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product &amp; Features</b></span></td>
    <td style="width: 38%; border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitive Analysis</b></span></td>
    <td style="width: 18%; border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Homologation</b></span></td></tr>
  <tr>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cognitive Pilot LLC</b></span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shunting Yard</span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on a combination of daylight camera + radar</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Advantages:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.25in; margin: 0pt 0 0pt 0.5in">1.&#160;&#160;&#160;&#160;The system incorporates a short-range radar camera;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Disadvantages:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.25in; margin: 0pt 0 0pt 0.5in">1.&#160;&#160;&#160;&#160;To the best of the Company&#8217;s knowledge, the system is in development
    and has not yet been sold in serial production. No existing customers are known beyond demos.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.25in; margin: 0pt 0 0pt 0.5in">2.&#160;&#160;&#160;&#160;The Company understands that the system operates at shorter ranges
    than the Company&#8217;s system.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.25in; margin: 0pt 0 0pt 0.5in">3.&#160;&#160;&#160;&#160;To the best of the Company&#8217;s knowledge, the competitor&#8217;s system does
    not include a thermal camera, unlike the Company&#8217;s system, which has a thermal camera that enables visual identification even at night.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Toshiba Infrastructure Systems &amp; Solutions Corporation</b></span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shunting Yard</span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on a high resolution daylight camera with AI capabilities</span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;&#160;To
    the best of the Company&#8217;s knowledge, the detection ranges of Toshiba&#8217;s system are similar to the detection ranges of the Company&#8217;s system;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">2.&#160;&#160;&#160;&#160;The
    competitor is a train manufacturer with high technological and financial capabilities; able to integrate the system as an integral product
    in its systems;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;&#160;To
    the best of the Company&#8217;s knowledge, the system is still under development.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">2.&#160;&#160;&#160;&#160;To
    the best of the Company&#8217;s knowledge, the competing system does not include a thermal camera, unlike the Company&#8217;s system, which has a
    thermal camera that enables visual identification even at night.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bosch Engineering GmbH</b></span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shunting Yard</span></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tram forward collision warning (TFCW), Based on a solution from the
    wheeled vehicle industry, on the market since 2017. Approved for use with LRV under a European standard.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages: </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;&#160;According
    to public announcements, the system has been sold to LRV customers. Bosch&#8217;s past experience is an advantage.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">2.&#160;&#160;&#160;&#160;To
    the best of the Company&#8217;s knowledge, the Bosch system is sold at a competitive price at the LRV market</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">3.&#160;&#160;&#160;&#160;Bosch
    is a global company with high technological and financial capabilities compared to the Company.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">4.&#160;&#160;&#160;&#160;The
    system also includes short-range radar.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;&#160;To
    the best of the Company&#8217;s knowledge Bosch system is designed to the LRV market, not for shunting.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">2.&#160;&#160;&#160;&#160;Bosch&#8217;s
    system does not include a thermal camera like the system developed by the Company, which includes a thermal camera that allows visual
    identification even at night.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is aware that the competing system has a high false alarm
    rate.</p></td>
    <td style="border-bottom: black 1.5pt solid; border-right: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As the installation of such a system requires standardization, it can
    be assumed that Bosch has the standard required to install such a system in the cities where the system is installed.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
</table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="5" style="border: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shunting Yard</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; text-align: left; font-size: 10pt; width: 13%">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Segment</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product &amp; Features</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competitive Analysis</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Homologation</b></span></td></tr>
</table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTIV</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shunting Yard</span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The system is based on an array of day cameras with integrated AI.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 38%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;
    EU based company</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">2.&#160;&#160;&#160;
    Mobile system</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><b>1.&#160;&#160;&#160;
    </b>To the best of the Company&#8217;s knowledge, the ranges are lower than our system.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><b>2.&#160;&#160;&#160;
    </b>Depends on 4G/5G &#8211; might be a problem when there is no cellular connectivity.</p></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  <tr>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; border-left: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALSTROM Holdings</b></span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shunting Yard</span></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The system is based on an array of day cameras with integrated AI.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -0.25in">1.&#160;&#160;&#160;
    Alstom is a major player within the railways industry with high technological and financial capabilities</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -0.25in">2.&#160;&#160;&#160;
    Partnering with ELTA (major player in Radar&#8217;s)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.&#160;&#160;&#160;
    NA</p></td>
    <td style="border-right: black 1.5pt solid; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
  </table><div>
</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="5" style="border: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>Main Line</b></span></td></tr>
  <tr>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; text-align: left; vertical-align: bottom; width: 13%"><span style="font-size: 10pt"><b>&#160;Name</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 16%"><span style="font-size: 10pt"><b>Segment</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 15%"><span style="font-size: 10pt"><b>Product &amp; Features</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 38%"><span style="font-size: 10pt"><b>Competitive Analysis</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 18%"><span style="font-size: 10pt"><b>Homologation</b></span></td>
    </tr>
  <tr>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>4Tel Pty Ltd (AI machine)</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Main Line</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The system is based on an array of day cameras with integrated AI.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">A local competitor in Australia in the RIO TINTO project. The competitor
    may have an advantage due to its being a local manufacturer in Australia.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">To the best of the Company&#8217;s knowledge, the demo has been shown
    to a customer for a specific use.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">We are not aware of a standardization process that this competitor has initiated.&#160;</span></td>
    </tr>
  <tr>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>ELTA Systems Ltd</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Main Line</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The system is based on an array of day cameras with integrated AI.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;
    </span>ELTA is world leader in Radar technology with years of experience within Radar and EO systems.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Won the RDSO tender in India</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;
    </span>To the best of our knowledge, the system is still under development</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    </tr>
  <tr>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><b>Thales Group (RailBot)</b></span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Main Line</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt">Based on a daylight camera with AI capabilities</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Advantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -0.25in">1.<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;
    </span>Thales is a major player within the railways industry with high technological and financial capabilities.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disadvantages:</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">1.<span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;
    </span>To the best of the Company&#8217;s knowledge, the ranges are lower than our system.</p></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not aware of a standardization process that this competitor
    has initiated.&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td>
    </tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitive approach is in developing a unique know-how, achieving an advantage and differentiating our railway detection system technology
by incorporating advanced technological solutions. We believe that the railway detection system we are developing can provide an effective
economic solution for our customers, which includes a return of the investment brought about by the railway detection system&#8217;s
contribution to the train&#8217;s increased safety, the prevention of accidents and unplanned delays in train traffic, and improving
the accuracy of railway operations, all of which can save railway operators extensive operating costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Another
advantage of our railway detection system is the option, currently in development, to use the system as an aid to predictive maintenance
of railway infrastructure due to the system&#8217;s continuous monitoring of the railway tracks on which it travels.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apart
from that, we engage the competitive landscape by developing new products, and to the extent that such developments are successfully
completed, these products will enable us to face the competition. To provide our customers with additional added value, we are developing
maintenance, predictive maintenance, Big Data and GIS services, which may be added on top of our existing system components to make our
railway detection system more attractive to the customer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our railway detection system regularly monitors railway infrastructures and tracks, the system can record and store visual information.
Huge amounts of data are built up (Big Data) which, subject to contractual and legal restrictions, could be available to customers for
purposes such as identifying possible gaps and faults in tracks and other infrastructure, and updating maps. This capability is an added
value to the existing system. To the best of our knowledge, Siemens Mobility GmbH and the 4Tel Pty Ltd company also use infrastructure
monitoring capabilities that are based on artificial intelligence. We have no information about the veracity of this competitor&#8217;s
statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the autonomous train industry continues to develop, regulators, including the FRA and the ERA, may adapt existing regulations and create
new ones in order to ensure the compatibility of autonomous trains and autonomous train technology with regulatory expectations, requirements
relating to safety and legal liability. On March 29, 2018, for instance, the FRA issued a RFI regarding the &#8220;future of automation
in the railroad industry,&#8221; which is part of a broader effort by the U.S. Department of Transportation to advance the safe deployment
of autonomous technologies. We cannot anticipate what regulations will materialize from the FRA&#8217;s RFI, or from parallel inquiries
underway in other countries in which we operate. Likewise, we cannot predict the limitations, restrictions and controls nor the economic
consequences flowing from such regulations. Should restrictive regulations apply, they could delay the introduction of autonomous train
technology, cause us to redesign aspects of our products, impose additional costs and adversely affect our results of operations. We
cannot assure you that we have been or will be at all times in complete compliance with such laws, regulations and permits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we are subject to a number of laws and regulations that involve matters central to our business. These laws and regulations
involve privacy, data protection, intellectual property, competition, and other subjects. Many of the laws and regulations to which we
are subject are still evolving and being tested in courts and could be interpreted in ways that could harm our business. In addition,
the application and interpretation of these laws and regulations are often uncertain, particularly in the new and rapidly evolving industry
in which we operate. Because global laws and regulations have continued to develop and evolve rapidly, it is possible that we may not
be, or may not have been, compliant with each such applicable law or regulation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek patent protection as well as other effective intellectual property rights for our products and technologies in the United States
and internationally. Our policy is to pursue, maintain and defend intellectual property rights developed internally and to protect the
technology, inventions and improvements that are commercially important to the development of our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have eleven registered patents and 24 pending patent applications. Failure to gain approval for the patent applications filed by us or
a change in the patents granted to us, in whole or in part, and the promotion and creation of alternative technologies to our technology,
may adversely affect our status and ability to sell the system developed by it.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
provisional patent application is a preliminary application that establishes a priority date for the patenting process for the invention
concerned and provide certain provisional patent rights. We cannot be certain that patents will be granted with respect to any of our
pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our
existing patents or any patents granted to us in the future will be commercially useful in protecting our technology. Despite our efforts
to protect our intellectual property, any of our intellectual property and proprietary rights could be challenged, invalidated, circumvented,
infringed or misappropriated, or such intellectual property and proprietary rights may not be sufficient to permit us to take advantage
of current market trends or otherwise to provide competitive advantages. For more information, please see &#8220;Risks Related to our
Intellectual Property.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may be exposed to claims and/or suits regarding the use of proprietary rights of third parties who received approval for
the registration of a patent in respect of an application which had already been filed when we made use of such rights.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently party to any pending material legal proceedings. From time to time, we may become a party to litigation incident to
the ordinary course of our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement
costs, diversion of management resources and other factors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 15, 2023, we have five senior management positions, all of whom are engaged on a full-time basis. In addition to our senior
management, we have 60 employees in full or part-time capacities. All our employees are located in Israel.&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our employees are represented by labor unions or covered by collective bargaining agreements. We believe that we maintain good relations
with all our employees. However, in Israel, we are subject to certain Israeli labor laws, regulations and national labor court precedent
rulings, as well as certain provisions of collective bargaining agreements applicable to us by virtue of extension orders issued in accordance
with relevant labor laws by the Israeli Ministry of Economy and which apply such agreement provisions to our employees even though they
are not part of a union that has signed a collective bargaining agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our employment and consulting agreements include employees&#8217; and consultants&#8217; undertakings with respect to non-competition
and assignment to us of intellectual property rights developed in the course of employment and confidentiality. The enforceability of
such provisions is subject to Israeli law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.&#160;Organizational
Structure</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have no subsidiaries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.&#160;Property,
Plant and Equipment</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate headquarters, which includes our offices and research and development facility, is located at 15 Ha&#8217;Tidhar St., Ra&#8217;anana
4366517, Israel, where we currently occupy approximately 16,900 square feet. We lease our facilities and our lease ends in September
2026. At the end of the term, we have the option to extend the lease for an additional five years. Our monthly rent payment is NIS 91,000
(approximately $26,000). In 2023, the monthly rent payments will increase to an average of NIS 92,000 (approximately $26,000), and in
2026, the monthly rent will increase to NIS 96,175 (approximately $27,000).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consider our current space sufficient to meet our anticipated needs for the foreseeable future and believe our current space is suitable
for the conduct of our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
4A. UNRESOLVED STAFF COMMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF<br/>
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial
statements and the related notes included elsewhere in this annual report.&#160;The discussion below contains forward-looking statements
that are based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially
from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; and under &#8220;Risk Factors&#8221; elsewhere in this annual report. The following
discussion of the financial condition and results of operations is for the years ended December 31, 2022 and 2021. Discussion regarding
our financial condition and results of operations for the year ended December 31, 2021 as compared to the year ended December 31, 2020
is included in Item 5 of our Annual Report on Form 20-F for the year ended December 31, 2021, filed with the SEC on May 16, 2022 (the
&#8220;2021 Form 20-F&#8221;).</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We are a development stage
technology company that is seeking to revolutionize railway safety and the data-related market. We believe we have developed cutting edge,
AI based, industry-leading detection technology specifically designed for railways, with investments from Knorr-Bremse, a world-class
rail system manufacturer. We have developed our railway detection and systems to save lives, increase efficiency, and dramatically reduce
expenses for the railway operator. Following a long-term pilot with Israel Railways that was concluded in August 2022, in January 2023,
we signed an agreement with Israel Railways for the purchase of 10 Rail Vision Main Line Systems. Our railway detection system is currently
in the pilot phase with several industry leading railway operators as we seek to move to the next stage of receiving commercial orders.
We believe that our technology will significantly increase railway safety around the world, while creating significant benefits and adding
value to everyone who relies on the train ecosystem: from passengers using trains for transportation to companies that use railways to
deliver goods and services. In addition, we believe that our technology has the potential to advance the revolutionary concept of autonomous
trains into a practical reality.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Operating Results</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current operating expenses consist of two components&#160;&#8212;&#160;research and development expenses, and general and administrative
expenses. To date, we have not generated significant revenues.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expenses, net</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses consist primarily of salaries and related personnel expenses (including share-based payment), subcontractor&#8217;s
expenses and other related research and development expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of research and development expenses:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended <br/> December&#160;31,</span></td><td style="white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended <br/> December&#160;31,</span></td><td style="white-space: nowrap; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands
    of USD)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">608</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll and related expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,049</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,586</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subcontracted work and consulting</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R&amp;D consumables</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">318</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent and office maintenance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">355</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">390</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel
    and other expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">110</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,230</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,208</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that our research and development expenses will materially increase as we continue to develop our products and recruit additional
research and development employees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative Expenses</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses consist primarily of salaries and related expenses, share-based payment, professional service fees for accounting,
legal and bookkeeping, facilities, travel expenses and other general and administrative expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the breakdown of general and administrative expenses:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended<br/> December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    ended<br/> December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands
    of USD)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll and related
    expenses</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,845</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,508</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based payment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">411</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,451</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,133</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rent and office maintenance</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Marketing and other</td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">393</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,265</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,316</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Comparison
of the Year Ended December 31, 2022, to the Year Ended December&#160;31, 2021</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Results
of Operations</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands
    of USD)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">421</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">888</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenues</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(661</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(657</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(240</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,230</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,208</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative
    expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,265</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,316</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    loss</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,293</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial income,
    net</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,475</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,220</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenues</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenues for the Year ended December 31, 2022, amounted to $421,000 including $219,000, due to the completion of the demonstration with
a customer in the US and $202,000, due to the completion of the Long Term Pilot LTP with Rio Tinto.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Expenses</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses for the year ended December 31, 2022, amounted to $6,230,000 representing a decrease of $978,000 or
13.5% as compared to $7,208,000 for the year ended December 31, 2021. The decrease was primarily attributable to a decrease of $536,000
in payroll and related expenses related to employee&#8217;s resignation and significant changes in USD/NIS exchange rate, and a decrease
of $434,000 in share-based payments related to end of vesting periods of Israeli railways warrants and employees options in 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and administrative expenses</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses totaled $4,265,000 for the year ended December 31, 2022, an increase of $949,000 or 28.6% compared
to $3,316,000 for the year ended December 31, 2021. The increase was primarily attributable to an increase of $337,000 in salaries related
to salaries update and one time IPO bonuses, an increase of $366,000 in professional fees mainly due to public company expenses and an
increase of $233,000 in marketing and others mainly due to exhibition expenses and welfare expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
loss</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, our operating loss for the year ended December 31, 2022 was $10,735,000 compared an operating loss of $10,293,000
for the year ended December 31, 2021, an increase of $442,000 or 4.3%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
expense and income</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
expense and income consist of bank fees and other transactional costs and exchange rate differences.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognized net financial income of $260,000 for the year ended December 31, 2022, compared to net financial expenses of $73,000 for the
year ended December 31, 2021. The increase was primarily attributable to exchange rate differences and Interest from bank deposits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Loss</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, our net loss for the year ended December 31, 2022, was $10,475,000 compared to $10,220,000 for the year ended
December 31, 2021, an increase of $255,000 or 2.49%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="b_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Liquidity and Capital Resources</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception through December 31, 2022, we have funded our operations principally with approximately $13,575,000 (net of issuance expenses)
from the issuance of ordinary shares, Preferred Shares, and warrants. As of December 31, 2022, we had approximately $8,492,000 in cash
and cash equivalents.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below presents our cash flows for the periods indicated:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December&#160;31,</td><td style="white-space: nowrap; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December&#160;31,</td><td style="white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands of USD)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,981</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,948</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(29</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(273</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,127</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net increase (increase) in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,094</td><td style="text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities of $9,981,000 during the year ended December 31, 2022, was primarily used for payment of an aggregate
of approximately $6,894,000 in salaries and related personnel expenses. The remaining amount of $3,087,000 was used, for professional
services, travel, rent and other miscellaneous expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities of $9,948,000 during the year ended December 31, 2021, was primarily used for payment of an aggregate
of approximately $7,093,000 in salaries and related personnel expenses. The remaining amount of approximately $2,855,000 was used for
professional services, travel, rent and other miscellaneous expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities of $29,000 during 2022 and $273,000 during 2021, primarily reflected the purchase of fixed assets in
both periods.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities in the year ended December 31, 2022, consisted of $13,643,000 of net proceeds from our IPO in April
2022 and approximately $3,000,000 of pre-IPO Investment. Net cash provided by financing activities in the year ended December 31, 2021,
consisted of $5,127,000 of net proceeds from our issuance of Preferred A Shares and exercise of options to purchase ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2020, we and Knorr-Bremse Systeme f&#252;r Schienenfahrzeuge GmbH, or Knorr-Bremse, entered into an investment agreement
under which we issued 51,282 Preferred A shares to Knorr-Bremse, in consideration of a total investment of $10,000,000. The investment
amount was transferred to us in two equal installments, the first installment upon closing and the second installment on April 13, 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, pursuant to the terms of the agreement, we were granted a call option for an additional amount of $5,000,000 at the same price
per share and in exchange for the same class of shares. According to an amendment signed by and among the parties the exercise period
of the option was extended to be in full force and effect until March 31, 2022. On February 14, 2022, we and Knorr-Bremse signed a second
amendment to the investment agreement according to which from February 14, 2022 we are entitled to exercise the option in two installments
as follows: (i) to call for up to $2,000,000 out of the option amount no later than March 31, 2022; and (ii) to call for up to $2,286,000
out of the option amount no later than June 30, 2022. The aforesaid option expired on the closing of our initial public offering on April
4, 2022. On March 6, 2022, we issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of $195 per share, after we called
an amount of $2,000,000 out of the option amount.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">In January 2022, the Company
entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with its two main shareholders providing for financing in the aggregate
amount of $1,000 (the &#8220;Investment Amount&#8221;) which was subsequently amended in March 2022. The SAFE provides for the conversion
of the Investment Amount into the Company&#8217;s ordinary shares under certain circumstances including in particular in the case of an
Initial Public Offering (&#8220;IPO&#8221;) such that immediately prior to the closing of an IPO the Investment Amount shall automatically
convert into the number of shares and warrants equal to the Investment Amount divided by the IPO price. The warrants which shall be issued
shall have the same terms as the warrants to be issued in the IPO except such warrants shall not be registered under the Securities Act
of 1933, as amended, and shall not be tradeable. Immediately prior to the completion of the IPO on April 4, 2022, the Investment Amount
was automatically converted to 242,131 ordinary shares and 242,131 warrants to purchase ordinary shares, with an exercise price of $4.13
per share, immediately exercisable and will expire five years from the date of issuance.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2022, the Company completed its IPO, in which the Company issued 3,787,241 units. Each unit includes one ordinary share and
one warrant to purchase one ordinary share at an exercise price of $4.13. The warrants are exercisable at any time up to five years after
the IPO. Gross proceeds for the offering were approximately $15,647 (including exercise of over-allotment options as described below)
and net proceeds of approximately $13,587 after deducting underwriting discounts and commissions and offering expenses. The Company granted
Aegis Capital Corp, the underwriter (&#8220;Aegis&#8221;), a 45-day over-allotment option to purchase additional ordinary shares and/or
warrants to purchase additional ordinary shares up to 15% of the number of ordinary shares and warrants, respectively, sold in the IPO
solely to cover over-allotments, if any. On April 4, 2022, Aegis partially exercised its over-allotment option with respect to 568,086
warrants to purchase ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Outlook</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We have financed our operations
to date primarily through proceeds from sales of our Ordinary and Preferred Shares. We have incurred losses and generated negative cash
flows from operations since inception in April 2016. Since inception, we have not generated significant revenues from the sale of products,
and we do not expect to generate significant revenues from the sale of our products in the near future.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, our cash and cash equivalents were $8,492,000. We expect that we will require substantial additional capital to
complete the development of additional features of our system according to customers&#8217; requirements, including algorithm optimization,
cognitive layer development, system minimization and optical development, as well as to commercialize our products. In addition, our
operating plans may change as a result of many factors that may currently be unknown to us, and we may need to seek additional funds
sooner than planned. Our future capital requirements will depend on many factors, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    progress and costs of our research and development activities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of manufacturing our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities
    internally; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    magnitude of our general and administrative expenses.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
we can generate significant recurring revenues and profit, we expect to satisfy our future cash needs through debt or equity financings,
through the utilization of our current financial resources and sales of our products. We cannot be certain that additional funding will
be available to us when needed, on acceptable terms, if at all. If funds are not available, we may be required to delay, reduce the scope
of, or eliminate research or development plans for, or commercialization efforts with respect to our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
conditions raise substantial doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes
raising funds from existing shareholders and/or outside potential investors. However, there is no assurance such funding will be available
to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to successfully
complete the development of, and to commercialize, its products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our contractual obligations at December 31, 2022:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than<br/> 1 year</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-3
    years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5
    years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
    than<br/> 5 years</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="18" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(in thousands
    of U.S. dollars)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,079</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">326</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">629</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="b_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Research and development, patents and licenses, etc.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of our research and development programs and the amounts that we have incurred over the last two years pursuant to those
programs, please see &#8220;Item 5. Operating and Financial Review and Prospects&#8212; A. Operating Results&#8212; Operating Expenses&#8212;
Research and Development Expenses, net&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8212; A. Operating Results&#8212;
Comparison of the year ended December 31, 2022 to the year ended December 31, 2021&#8212; Research and Development Expenses.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Trend Information</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt; background-color: white">We
continue to closely monitor&#160;macro-economic conditions, including the headwinds caused by supply chain problems, inflation, increased
interest rates and other trends that have been adversely impacting economic activity on a global scale in the aftermath of the COVID-19
pandemic.&#160;We have been assessing, on an ongoing basis, the implications of those global conditions for our operations, supply chain,
liquidity, cash flow and product orders, and will act in an effort to mitigate adverse consequences as needed. To the extent inflation
increases our costs and expenses, we could consider price increases to offset those cost pressures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">Specific
developments that may potentially impact&#160;our operating performance in an adverse manner include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">further actions taken by central banks in Europe
and the U.S. to increase interest rates as a means to slow down inflation, which may worsen credit/financing conditions for our customers
who purchase our products; </span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential contraction of economic activities
and recessionary conditions that could arise as a result of interest rate increases and a decrease in consumer demand; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.4pt; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.5in"></td><td style="text-align: justify; width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the continued depreciated value of the Euro relative
to the U.S. dollar, which may have an adverse impact on the U.S.- denominated value of our European-derived revenues for purposes of our
financial statements.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">We
cannot&#160;provide any assurances as to the extent of our resilience to the adverse impact of these specific developments in future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; background-color: white">Other
than the foregoing and as disclosed elsewhere in this Annual Report on Form 20-F, we are not aware of any trends, uncertainties, demands,
commitments or events for the period from January 1, 2022 to the present time that are reasonably likely to have a material adverse effect
on our net revenue, income, profitability, liquidity or capital resources, or that would cause the disclosed financial information to
be not necessarily indicative of future operating results or financial condition.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Critical Accounting Estimates</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
describe our significant accounting policies more fully in Note 2 to our financial statements for the year ended December 31, 2022. We
believe that the accounting policies below are critical in order to fully understand and evaluate our financial condition and results
of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
appreciation of our critical accounting policies is necessary to understand our financial results. The accounting policies outlined below
are considered to be critical because they can materially affect our operating results and financial condition, as these policies may
require us to make difficult and subjective judgments regarding uncertainties. The accuracy of these estimates and the likelihood of
future changes depend on a range of possible outcomes and a number of underlying variables, many of which are beyond our control, and
there can be no assurance that our estimates are accurate.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s critical accounting estimate affecting the financial statements is its stock-based compensation:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
compensation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may grant options to its employees, directors and non-employees. The Company recognizes this compensation expense
at its fair value.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the Company&#8217;s assumptions can materially affect the estimate of the fair value of stock-based compensation and, consequently,
the related expense recognized. The assumptions used in the calculations of the fair value of stock-based payment awards is represented
by best estimates which involve inherent uncertainties and the application of judgment when considering inherent uncertainties. As a
result, if the Company&#8217;s assumptions change and different assumptions are used, the expense of a stock-based compensation award
could be materially different in the future than what was originally planned for.</span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="b_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Directors and Senior Management</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding our executive officers, and directors as of March 23, 2023:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Executive
    Officers</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shahar
    Hania</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ofer
    Naveh</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zachi
    Bar-Yehoshua</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ofer
    Grisaro</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
    President of Marketing and Sales</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amit
    Klir</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
    President of Research and Development</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Employee
    Directors</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    Cleobury</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keren
    Aslan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eli
    Yoresh </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximilian
    Eichhorn</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shmuel
    Donnerstein</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inbal
    Kreiss (1)(2)(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yossi
    Daskal (1)(2)(3)(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oz
    Adler (1)(2)(3)(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the audit committee.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
    of the compensation committee.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    director (as defined under Nasdaq Stock Market Listing Rules)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">External
    director (as defined under the Companies Law)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Senior
Management</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shahar
Hania, Chief Executive Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Shahar Hania</i> has served as our Chief Executive Officer since November 2020. Previously, Mr. Hania served as a member of our board
of directors from November 2020 to March 2022, and as our Vice President of Research and Development from April 2016 to March 2021. Mr.
Hania is an electro-optics expert with vast experience (since 1994) in the fields of combined electro-optics systems, detection, infrared
systems and lasers. Mr. Hania held senior system engineering positions in&#160;Bird Aerosystems Ltd. From April 2012 to May 2016, and
Elbit Systems Electro-Optics ELOP Ltd. From 2000 to 2012. Mr. Hania holds a B.Sc. in Physics and Electro-optics engineering from the
Jerusalem College of Technology, Israel and a M.Sc. in electro-optics engineering from Ben-Gurion University, Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ofer
Naveh, Chief Financial Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Ofer Naveh </i>has served as our Chief Financial Officer since June 2017. Mr. Naveh brings more than 15 years of experience in accounting
and financial management, at KPMG&#8217;s audit practice from December 1999 to November 2005, and in numerous financial and accounting
roles at public companies traded in Israel and the United States. Mr. Naveh served as chief financial officer of Accel Solutions Group
Ltd (formerly: Dolomite Holdings Ltd.), a public company organized under the laws of the State of Israel and listed on the Tel Aviv Stock
Exchange, or the TASE, from 2010 through June 2017. Since March 2021, Mr. Naveh has served as an external director of Upsellon Brands
Holdings Ltd (TASE: UPSL). Mr. Naveh holds a B.A. in Accounting and Business from the College of Management Academic Studies, Israel
and a M.A. in Law from Bar-Ilan University, Israel. Mr. Naveh is a Certified Public Accountant in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Zachi
Bar-Yehoshua, Chief Operating Officer</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Zachi Bar-Yehoshua </i>has served as our Vice president of Operations since June 2017. Mr. Bar-Yehoshua has combined managerial experience
of more than 20 years, both in the high-tech sector and traditional industries in several service and operation roles. Mr. Bar-Yehoshua
served as operation and customer manager at Zoko Enterprises Ltd., an infrastructure and transportation company, from June 2015 through
June 2017 and as vice president of technologies services at Team-Netcom Ltd. (Malam Group), a hardware development company, from March
2011 through May 2015. Mr. Bar-Yehoshua holds a B.A. in Management and M.B.A in Business Administration from the Open University of Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ofer
Grisaro, Vice President of Marketing and Sales</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Ofer Grisaro</i> has served as our Vice President of Marketing and Sales since February 1, 2021. Mr. Grisaro has more than 15 years of
experience in sales, marketing and business development. Prior to joining us, between February 2019 and January 2021, Mr. Grisaro worked
as a regional sales manager of NSO Technologies Ltd., a Cyber intelligence company. Prior to that, Mr. Grisaro worked as a sales director
at D.S.I.T. Solutions Ltd., an underwater surveillance company, between March 2017 and February 2019. Mr. Grisaro holds B.A. degree in
Management and an M.B.A. in International Marketing Pricing, both from the Ben Gurion University, Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amit
Klir, Vice President of Research and Development</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Amit Klir </i>has served as our Vice President of Technology, Research and Development since March 2021. Mr. Klir has more than 25 years
of experience in development and leadership of video and audio applications. Prior to joining us, Mr. Klir worked as the Head of Engineering
at Continuse Biometrics Ltd., an innovative medical company, between May 2015 and March 2021. Mr. Klir holds a B.Sc. degree in Electric
Engineering and Computers from the Ben Gurion University, Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Non-Employee
Directors</span></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mark
Cleobury, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Mr. Mark Cleobury</i>
has served on our board of directors since December 1, 2022 and was appointed as the Chairman on January 19, 2023. Mr Cleobury currently
serves as Senior Vice President of Knorr-Bremse&#8217;s Rail Systems Division, since April 2022. Prior to this role, Mr. Cleobury held
positions of increasing responsibility at Knorr-Bremse, including between July 2016 and April 2022, Mr. Cleobury served as a Member of
the Management Board of Knorr-Bremse Systems for Rail. Prior to that, between April 2011 and June 2016, Mr. Cleobury served as Vice President
Sales and Systems for Client Management Trains. Prior to that, between January 2007 and April 2011, he served as Manager Sales &amp;
Systems Trains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
his twenty years of tenure at Knorr-Bremse, in addition to his executive roles, Mr. Cleobury held several global directorship roles within
the Knorr-Bremse group, including serving as Vice President for the Knorr-Bremse Company in the U.S., a Director of Knorr-Bremse Investment
(UK) Ltd in the UK, Chairman of Knorr-Bremse Nordic Rail Services in Sweden, a Director of Knorr-Bremse Rail Systems (UK) Ltd in the
UK, a Member of the Board of Knorr-Bremse Rail Systems Italia S.r.L in Italy, a Member of the Supervisory Board of Knorr-Bremse systemy
Kolejowe Polska Sp. Zoo in Poland, a Director of Knorr-Bremse Systemes Ferroviares France SA in France, Consiglio D&#8217;Amministrazione
at Microelettrica Scientifica s.p.a in Italy, a Director of Knorr-Bremse Systems for Railways in Russia, and a Director of Knorr-Bremse
1520 in Russia.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shmuel
Donnerstein, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Shmuel Donnerstein </i>has served on our board of directors since June 2020. Mr. Donnerstein served as the Chairman of our board until
January 2023. Since 2008, Mr. Donnerstein serves as the Chairman of the board of directors of Rav Bariach (08) Industries Ltd, a leading
company in the door &amp; locks industry in Israel for over 40 years, and also served as the CEO until 2016. Mr. Donnerstein also serves
on the board of directors of Scoutam Ltd. (OTCMKTS: SCTC), Safe-Food Ltd., Rav Bariach Locking Products Ltd, Doors (08) Industries Ltd.,
Norieali Construction Industries Ltd. And Rav Bariach (08) Industries Ltd. Mr. Donnerstein holds a B.A. in Economics from Tel-Aviv University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eli
Yoresh, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Eli Yoresh</i> has served on our board of directors since August 2017. Mr. Yoresh is a seasoned executive with over 15 years of executive
and financial management experience, mainly with companies in the financial, technology and industrial sectors. Mr. Yoresh has served
as chief financial officer since March 2010, and as a director since October 2010, at Foresight Autonomous Holdings Ltd. (Nasdaq and
TASE: FRSX), one of our shareholders. Mr. Yoresh served as the chief executive officer of Tomcar Global Holdings Ltd., a global manufacturer
of off-road vehicles, from 2005 to 2008. In addition, since March 2014, Mr. Yoresh has served as a director at Nano Dimension Ltd. (Nasdaq
and TASE: NNDM). Mr. Yoresh&#8217;s previous directorships include Greenstone Industries Ltd. (TASE: GRTN) from January 2013 to June
2015, as the chairman of both Zmicha Investment House Ltd. (TASE: TZMI-M) from February 2013 to July 2015 and Gefen Biomed Investments
Ltd. (TASE: GEFEN) from April 2013 to July 2015. Mr. Yoresh holds a B.A. in Business Administration from the College of Management, Israel
and an M.A. in Law from Bar-Ilan University, Israel. Mr. Yoresh is a Certified Public Accountant in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximilian
Eichhorn, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Maximilian Eichhorn </i>has served on our board of directors since October 2020. Mr. Eichhorn has more than 15 years of experience in
the rail industry. Mr. Eichhorn currently serves as the Vice President Digital Products and Services of Knorr-Bremse&#8217;s Rail Systems
Division since November 2020. Prior to that Mr. Eichhorn worked for 20 years for Siemens and served as Vice President Mobility Operating
System and ATMS Software Solutions (July 2019 to September 2020), as Senior Vice President Strategy &amp; Business Development (May 2018
to June 2019), and as Vice President Digital Transformation (January 2018 to May 2018), at Siemens Mobility GmbH, a 100% daughter company
of Siemens AG. Prior to that, from January 2015 to December 2017, Mr. Eichhorn served as the Executive General Manager at Siemens Ltd.
And as the Managing Director / CEO at Siemens Rail Automation Pty. Ltd., both located in Melbourne, Australia. Since January 2022, he
also serves on the board of directors of Railnova S.A., Brussels, Belgium, a minority investment of Knorr-Bremse. Mr. Eichhorn holds
a Master of Science degree in Electrical Engineering from the Technical University of Vienna, Austria, and a Ph.D. degree at Business
Management from the University of Gottingen, Germany.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inbal
Kreiss, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mrs.
Inbal Kreiss</i> has served on our board of directors since March 2022. Mrs. Kreiss is currently the Head of Innovation at the Systems,
Missiles and Space Division of the Israeli Aerospace Industries Ltd. (IAI) and Chairwoman of RAKIA, Israel&#8217;s 2nd Scientific and
Technological Mission to the International Space Station. Since 2013, Mrs. Kreiss has served as Deputy Director of the Space Division
at IAI, leading the development, construction, launch and operation of observation and communication satellites for both Israeli and
foreign users. Prior to that, Mrs. Kreiss held various leadership positions within IAI, including chief engineer of Israel&#8217;s Arrow
2 anti-ballistic missile defense system from 2000 to 2006, and project manager of the Arrow 3 exo-atmospheric interceptor from 2007 to
2013. Mrs. Kreiss holds a B.Sc in chemical engineering from the Technion, Israeli Institute of Technology, an Executive Masters in Business
Administration from Tel Aviv University, and completed a visiting research fellowship at the Aeronautics &amp; Astronautics Department
of the Massachusetts Institute of Technology (MIT).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yossi
Daskal, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mr.
Daskal</i> has served on our board of directors since March 2022. Mr. Daskal serves as the President of Israel-Canada Chamber of Commerce
since 2013. From 2003 to 2019, Mr. Daskal established Bombardier Israel, working as Chief Country Representative, Project Manager, Financing
&amp; Head of Sales. Prior to that, Mr. Daskal was the General Manager of Chemitron Technologies from 1999 to 2003. Since 2021, he is
the chairman of the board of directors and the director of the finance committee of the Tel Aviv Museum of Art. Mr. Daskal has a Bachelors
of Arts in Mediterranean and Arabic History Science and a Masters of Arts in Political Science, and is completing a PhD in Decision-Making
from Haifa University.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Oz
Adler, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Mr. Adler</i>, CPA, has
served on our board of directors since June 2022. Mr. Adler currently serves as the chief executive officer and chief financial officer
of SciSparc Ltd. Mr. Adler has served as SciSparc&#8217;s chief financial officer since April 2018 and as its chief executive officer
since January 2022. Prior to that, from September&#160;2017 until March&#160;2018, he served as the VP Finance of SciSparc. From December
2020 to April 2021, Mr. Adler served as the chief financial officer of Medigus Ltd. Mr.&#160;Adler also worked in the audit department
of Kost Forer Gabbay&#160;&amp; Kasierer, a member of Ernst&#160;&amp; Young Global between December&#160;2012 and August&#160;2017.
Additionally, Mr.&#160;Adler currently serves on the board of directors of numerous private and publicly traded companies, including
Elbit Imaging Ltd. (TASE: EMITF), Clearmind Medicine Inc. (CSE: CMND) (OTC: CMNDF) (FSE:CWY), Jeffs&#8217; Brands Ltd., Polyrizon Ltd.
and Charging Robotics Ltd. Mr.&#160;Adler is a certified public accountant in Israel and holds a&#160;B.A. degree in Accounting and Business
Management from The College of Management, Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Keren
Aslan, Director</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mrs.
Keren Aslan</i> has served on our board of directors since February 1, 2023. Ms. Aslan currently serves as the chief financial officer
of Israel Post Ltd. Ms. Aslan served from April 2019 to September 2022 as chief executive officer of Superbus, a company in the Israeli
public transportation market. Prior to that, from 2012 to 2018, Ms. Aslan served as the chief financial officer of Israel Railways Ltd.,
leading its innovation department and its first public bonds raise on the Tel Aviv Stock Exchange. Ms. Aslan holds a B.A. degree in Economics
and Business Management from Tel Aviv University and a M.A degree in Economics from Tel Aviv University. Ms. Aslan also serves as a director
of Hanan Mor Group Holdings Ltd. and Rav Bariach (08) Industries Ltd., both listed on the Tel Aviv Stock Exchange, and Trans Israel Ltd.,
an Israeli government-owned corporation functioning as a project management agency of the Israeli Ministry of Transport and Road Safety.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Family
Relationships</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no family relationships between any members of our executive management and our directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Arrangements
for Election of Directors and Members of Management</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our amended and restated articles of association, shareholders are entitled to appoint a director to our board of directors for each
10% of our outstanding share capital that they own and in such case the appointment will be for an undefined period. As such, Knorr-Bremse
has appointed Mrs. Keren Aslan, Mr. Maximilian Eichhorn and Mark Cleobury to the board of directors, and Foresight has appointed Eli
Yoresh to the board of directors. Additional board members are elected at our shareholder&#8217;s annual meetings and in such case they
shall serve on the board of directors until the next annual general meeting (except for external directors which will serve for up to
three terms, each term of three years&#8217; period). In addition, our amended and restated articles allow our board of directors to
appoint directors to fill vacancies and/or as an addition to the board of directors (subject to the maximum number of directors) to serve
until the next annual general meeting. All of the elected directors, other than external directors, may be re-elected for an unlimited
number of terms upon completion of their then-current term of office. There are no other arrangements or understandings with major shareholders,
customers, suppliers or others pursuant to which any of our executive management or our directors were selected. See &#8220;Related Party
Transactions&#8221; for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Compensation</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents in the aggregate all compensation we paid to all of our directors and senior management as a group for the year
ended December 31, 2022. The table does not include any amounts we paid to reimburse any of such persons for costs incurred in providing
us with services during this period.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts reported in the table below reflect the cost to us in thousands of U.S. dollars, for the year ended December 31, 2022. Amounts
paid in NIS are translated into U.S. dollars at the rate of NIS 3.358 = $1.00, based on the average representative rate of exchange between
the NIS and the U.S. dollar as reported by the Bank of Israel in the year ended December 31, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Salary and<br/>
Related<br/>
Benefits</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Pension, <br/>
Retirement <br/>
and Other <br/>
Similar <br/>
Benefits</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Share <br/>
Based Compensation</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">All directors and senior management as a group, consisting of 12 persons (as of December 31, 2022).</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,454,771</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 11%">--</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">273,286</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, options to purchase 1,269,568 ordinary shares granted to our directors and executive officers were outstanding
under our Option Plan at a weighted average exercise price of $3.094 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
accordance with the Companies Law, we are required to disclose the compensation granted to our five most highly compensated officers.
The table below reflects the compensation granted during or with respect to the year ended December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">Executive Officer - Name and Principal Position (1) (2)<br/>
(in thousands, US dollars)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Salary<br/>
    and&#160;Related<br/>
    Benefits</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Share Based<br/>
    Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: 0pt; padding-left: 0pt">Shahar Hania, CEO</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">393</td><td style="white-space: nowrap; width: 1%; text-align: left">(3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;38</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">431</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0pt; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Ofer Naveh, CFO</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">297</td><td style="white-space: nowrap; text-align: left">(4)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">329</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0pt; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Shmuel Donnerstein, Director (former Chairman) <br/></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">149</td><td style="white-space: nowrap; text-align: left">(5)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">163</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0pt; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Amit Klir, VP R&amp;D</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">216</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">218</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0pt; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Zachi Bar- Yehoshua, COO</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">176</td><td style="white-space: nowrap; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">196</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">All amounts
                                            reported in the table are in terms of cost to us, as recorded in our financial statements.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Cash
                                            compensation amounts denominated in NIS were converted into U.S. dollars at the average conversion
                                            rate for the year ended December 31, 2022.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Includes
                                            a one-time IPO bonus to our Chief Executive Officer in the amount of NIS 312,000 (approximately
                                            $97,000).</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="background-color: white">(4)</span></td><td style="text-align: justify">Includes
                                            a one-time IPO bonus to our Chief Financial Officer in the amount of NIS 270,000 (approximately
                                            $84,000)</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="background-color: white">(5)</span></td><td style="text-align: justify"><span style="background-color: white">Includes
                                            </span>a one-time IPO bonus to our former Chairman in the amount of $50,000 (plus VAT)</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-indent: -14.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements and Service Agreements with Executive Officers</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into written employment agreements and/or service agreements with each of our executive officers. These agreements are terminable
by either party upon prior written notice ranging from 30 to 60 days. All of these agreements contain customary provisions regarding
noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions
may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to
which we have agreed to indemnify each of them up to a certain amount and to the extent that these liabilities are not covered by directors
and officers insurance. We contribute (usually following a trial period of three months) monthly amounts for the benefit and on behalf
of all our employees located in Israel to a pension fund pursuant to Section&#160;14 of Israel&#8217;s Severance Pay Law. Employees covered
by Section&#160;14 are entitled to monthly deposits at a rate of 8.33% of their monthly salary, made on their behalf by us. Payments
in accordance with Section&#160;14 release us from any future severance liabilities in respect of those employees. We do not set aside
or accrue any additional amounts to provide pension, severance, retirement or other similar benefits or expenses. Most of our executive
officers do not receive benefits upon the termination of their respective employment with us, other than benefits under Section&#160;14.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the completion of our initial public offering, we paid a one-time IPO bonus to our Chief Executive Officer in the amount of NIS 312,000
(approximately $97,000), and granted our Chief Executive Officer options to purchase 156,081 ordinary shares (equal to 0.75% of our post-IPO
share capital on a fully diluted basis), with an exercise price of $1.85 per share (equal to the average closing share price on the Nasdaq
over the first 30 calendar days that followed our initial public offering on April 4, 2022). Such options will vest one-third following
12 months from the completion date of our initial public offering and the balance on a quarterly basis during the following 24 months.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, with the completion of our initial public offering, we
paid a one-time IPO bonus to our Chief Financial Officer&#160;in the amount of NIS 270,000 (approximately $84,000), and granted our Chief
Financial Officer options to purchase 124,865 ordinary shares (equal to 0.6% of our post-IPO share capital on a fully diluted basis),
with an exercise price of $1.85 per share (equal to the average closing share price on the Nasdaq over the first 30 calendar days that
followed our initial public offering on April 4, 2022). Such options will vest one-third following 12 months from the completion date
of our initial public offering and the balance on quarterly basis during the following 24 months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors&#8217;
Service Contracts</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have written
agreements with any director providing for benefits upon the termination of his engagement with our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board members are each entitled to (i) an annual
fee of NIS 48,000 and a per meeting fee of NIS 2,000. Board members may waive there
right to receive the above fees or options or any part thereof, and director nominees may assign their right to remunerations to the
shareholder which appointed them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 21, 2020, we entered into a service agreement with Mr. Donnerstein under which he was engaged to serve as our active Chairman
of the board. On January 19, 2023, this service agreement was terminated as Mr. Donnerstein resigned from his position as chairman and
remained serving as a director. Pursuant to the agreement, in consideration for his services, Mr. Donnerstein was entitled to a monthly
fee of $3,000 (plus VAT) which was increased to $10,000 (plus VAT) following our initial public offering. In addition, with the completion
of our initial public offering, we paid Mr. Donnerstein a one-time IPO bonus in the amount of $50,000 (plus VAT) and granted <span style="background-color: white">Mr.
Donnerstein</span> options to purchase 266,216 ordinary shares, with an exercise price of $1.85 per share (equal to the average closing
share price on the Nasdaq over the first 30 calendar days that followed our initial public offering on April 4, 2022). Such options will
vest one-half following 12 months from the completion date of our initial public offering and the balance on quarterly basis during the
following 24 months.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Board Practices</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our amended and restated articles of association, our board of directors must consist of at least four (4) directors and not more than
thirteen (13) directors, including at least two external directors if required to be appointed under the Companies Law. Pursuant to the
Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and
may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for
our day-to-day management and have individual responsibilities established by our board of directors. Our Chief Executive Officer is
appointed by, and serves at the discretion of, our board of directors, subject to the services agreement that we have entered into with
him. All other executive officers are appointed by our Chief Executive Officer. Their terms of employment are subject to the approval
of the board of directors&#8217; compensation committee and of the board of directors, as well as our shareholders in the event such
terms deviate from our office holder compensation policy, and are subject to the terms of any applicable employment agreements that we
may enter into with them.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
director, except external directors and directors appointed by shareholders entitled to appoint a director for each 10% of the issued
and outstanding share capital of the company that the shareholders owns, will hold office until the annual general meeting of our shareholders
for the year in which his or her term expires, he or she resigns or upon the occurrence of certain events, in accordance with the Companies
Law and our amended and restated articles of association.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under certain circumstances, our amended and restated articles of association allow our board of directors to appoint directors
to fill vacancies on our board of directors or in addition to the acting directors (subject to the limitation on the number of directors),
until the next annual general meeting or special general meeting in which directors may be appointed or terminated. External directors
may be elected for up to two additional three-year terms after their initial three-year term under the circumstances described below,
with certain exceptions as described below. External directors may be removed from office only under the limited circumstances set forth
in the Companies Law. See &#8220;Directors, Senior Management and Employees&#8212;Board Practices&#8212;External Directors&#8221; below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, any shareholder holding at least one percent of our outstanding voting power may request that the board of directors
include a matter on the agenda of a general meeting to be held in the future, provided that the board determines that the matter is appropriate
to be considered in a general meeting including in order to nominate a director. Any such notice must include certain information, including
the consent of the proposed director nominee to serve as our director if elected, and a declaration signed by the nominee declaring that
he or she possess the requisite skills and has the availability to carry out his or her duties. Additionally, the nominee must provide
details of such skills, and demonstrate an absence of any limitation under the Companies Law that may prevent his or her election, and
affirm that all of the required election-information is provided to us, pursuant to the Companies Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, our board of directors must determine the minimum number of directors who are required to have accounting and financial
expertise. In determining the number of directors required to have such expertise, our board of directors must consider, among other
things, the type and size of the company and the scope and complexity of its operations. Our board of directors has determined that we
must have at least one director with accounting and financial expertise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may elect one director to serve as the chairman of the board of directors to preside at the meetings of the board
of directors, and may also remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any
of his or her relatives is permitted to serve as the chairman of the board of directors of a public company, and a public company may
not vest the chairman or any of his or her relatives with the chief executive officer&#8217;s authorities. In addition, a person who
reports, directly or indirectly, to the chief executive officer may not serve as the chairman of the board of directors; the chairman
may not be vested with authorities of a person who reports, directly or indirectly, to the chief executive officer; and the chairman
may not serve in any other position in the company or a controlled company, but he or she may serve as a director or chairman of a controlled
company. However, the Companies Law permits a company&#8217;s shareholders to determine, for a period not exceeding three years from
each such determination, that the chairman or his or her relative may serve as chief executive officer or be vested with the chief executive
officer&#8217;s authorities, and that the chief executive officer or his or her relative may serve as chairman or be vested with the
chairman&#8217;s authorities. Such determination of a company&#8217;s shareholders requires either: (1) the approval of at least a majority
of the shares of those shareholders present and voting on the matter (other than controlling shareholders and those having a personal
interest in the determination) (shares held by abstaining shareholders shall not be considered); or (2) that the total number of shares
opposing such determination does not exceed 2% of the total voting power in the company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors may, subject to the provisions of the Companies Law and certain limitations set forth therein, delegate its powers
to committees of the board, and it may, from time to time, revoke such delegation or alter the composition of any such committees. Unless
otherwise expressly provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition
and duties of our audit committee and compensation committee are described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors oversees how management monitors a company&#8217;s compliance with its risk management policies and procedures, and
reviews the adequacy of the risk management framework in relation to the risks faced by a company. The board of directors is assisted
in its oversight role by an internal auditor. The internal auditor undertakes both regular and ad hoc reviews of risk management controls
and procedures, the results of which are reported to the audit committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Diversity of the Board of Directors
</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><b>Board
Diversity Matrix (As of March 23, 2023)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: center; background-color: white"><span style="font-size: 7pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Country of Principal Executive Offices</span></td>
    <td style="width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Private Issuer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Prohibited under Home Country Law</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Number of Directors</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; background-color: white"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Part I: Gender Identity</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Female</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Male</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-Binary</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Did
Not<br/>
Disclose<br/>
Gender</b></p></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 52%">Directors</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">2</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">6</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">-</td><td style="width: 1%; text-align: center">&#160;</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">-</td><td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Part II: Demographic Background</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8195;</span></td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Underrepresented Individual in Home Country Jurisdiction</td><td style="text-align: center">&#160;</td>
    <td colspan="14" style="text-align: center">-</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LGBTQ+</td><td style="text-align: center">&#160;</td>
    <td colspan="14" style="text-align: center">-</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Did Not Disclose Demographic Background</td><td style="text-align: center">&#160;</td>
    <td colspan="14" style="text-align: center">8</td><td style="text-align: center">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>External
Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, an Israeli company whose shares have been offered to the public or whose shares are listed for trading on a stock
exchange in or outside of Israel is required to appoint at least two external directors to serve on its board of directors. External
directors must meet stringent standards of independence. Mr. Yossi Daskal and Mr. Oz Adler have agreed to serve as our external directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to regulations promulgated under the Companies law, at least one of the external directors is required to have &#8220;financial and accounting
expertise,&#8221; unless another member of the audit committee, who is an independent director under the Nasdaq Listing Rules, has &#8220;financial
and accounting expertise,&#8221; and the other external director or directors are required to have &#8220;professional expertise.&#8221;
An external director may not be appointed to an additional term unless: (1) such director has &#8220;accounting and financial expertise;&#8221;
or (2) he or she has &#8220;professional expertise,&#8221; and on the date of appointment for another term there is another external
director who has &#8220;accounting and financial expertise&#8221; and the number of &#8220;accounting and financial experts&#8221; on
the board of directors is at least equal to the minimum number determined appropriate by the board of directors. We have determined that
Mr. Oz Adler has accounting and financial expertise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director with accounting and financial expertise is a director who, due to his or her education, experience and skills, possesses a high
degree of proficiency in, and an understanding of, business &#8211; accounting matters and financial statements, such that he or she
is able to understand the financial statements of the company in depth and initiate a discussion about the manner in which financial
data is presented. A director is deemed to have &#8220;professional expertise&#8221; if he or she holds an academic degree in certain
fields or has at least five years of experience in certain senior positions. The board of directors is charged with determining whether
a director possesses financial and accounting expertise or professional qualifications.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">External
directors are elected by a majority vote at a shareholders&#8217; meeting, so long as either:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least a majority of the shares held by shareholders who are not controlling shareholders and do not have personal interest in the
    appointment (excluding a personal interest that did not result from the shareholder&#8217;s relationship with the controlling shareholder)
    have voted in favor of the proposal (shares held by abstaining shareholders shall not be considered); or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    total number of shares voted against the election of the external director, does not exceed 2% of the aggregate voting rights of
    our Company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law provides for an initial three-year term for an external director. Thereafter, an external director may be reelected by
shareholders to serve in that capacity for up to two additional three-year terms, provided that:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">his
    or her service for each such additional term is recommended by one or more shareholders holding at least one percent of the company&#8217;s
    voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling,
    disinterested shareholders voting for such reelection exceeds two percent of the aggregate voting rights in the company and subject
    to additional restrictions set forth in the Companies Law with respect to the affiliation of the external director nominee as described
    below;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">his
    or her service for each such additional term is recommended by the board of directors and is approved at a shareholders meeting by
    the same disinterested majority required for the initial election of an external director (as described above); or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    external director offered his or her service for each such additional term and was approved in accordance with the provisions of
    section (1) above.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of office for external directors for Israeli companies traded on certain foreign stock exchanges, including the Nasdaq Stock Market,
may be extended indefinitely in increments of additional three-year terms, in each case provided that the audit committee and the board
of directors of the company confirm that, in light of the external director&#8217;s expertise and special contribution to the work of
the board of directors and its committees, the reelection for such additional period(s) is beneficial to the company, and provided that
the external director is reelected subject to the same shareholder vote requirements as if elected for the first time (as described above).
Prior to the approval of the reelection of the external director at a general shareholders meeting, the company&#8217;s shareholders
must be informed of the term previously served by him or her and of the reasons why the board of directors and audit committee recommended
the extension of his or her term.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">External
directors may be removed only by a special general meeting of shareholders called by the board of directors after the board has determined
that circumstances allow such dismissal, at the same special majority of shareholders required for their election or by a court, and
in both cases only if the external directors cease to meet the statutory qualifications for their appointment or if they violate their
duty of loyalty to our company. In the event of a vacancy created by an external director which causes the company to have fewer than
two external directors, the board of directors is required under the Companies Law to call a shareholders meeting as soon as possible
to appoint such number of new external directors in order that the company thereafter has two external directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
committee of the board of directors that exercises the powers of the board of directors must include at least one external director,
except that the audit committee and the compensation committee must include all external directors then serving on the board of directors
and an external director must serve as the chair thereof. Under the Companies Law, external directors of a company are prohibited from
receiving, directly or indirectly, any compensation from the company other than for their services as external directors pursuant to
the Companies Law and the regulations promulgated thereunder. Compensation of an external director is determined prior to his or her
appointment and may not be changed during his or her term subject to certain exceptions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law provides that a person is not qualified to be appointed as an external director if (i) the person is a relative of a controlling
shareholder of the company, or (ii) if that person or his or her relative, partner, employer, another person to whom he or she was directly
or indirectly subordinate, or any entity under the person&#8217;s control, has or had, during the two years preceding the date of appointment
as an external director: (a) any affiliation or other disqualifying relationship with the company, with any person or entity controlling
the company or a relative of such person, or with any entity controlled by or under common control with the company; or (b) in the case
of a company with no shareholder holding 25% or more of its voting rights, had at the date of appointment as an external director, any
affiliation or other disqualifying relationship with a person then serving as chairman of the board or chief executive officer, with
a holder of 5% or more of the issued share capital or voting power in the company or with the most senior financial officer.</span></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;Controlling Shareholder&#8221; means a shareholder with the ability to direct the activities of the company, other than by
virtue of being an office holder. A shareholder is presumed to have &#8220;control&#8221; of the company and thus to be a controlling
shareholder of the company if the shareholder holds 50% or more of the &#8220;means of control&#8221; of the company. &#8220;Means of
control&#8221; is defined as (1) the right to vote at a general meeting of a company or a corresponding body of another corporation;
or (2) the right to appoint directors of the corporation or its general manager. For the purpose of approving related-party transactions,
the term also includes any shareholder that holds 25% or more of the voting rights of the company if the company has no shareholder that
owns more than 50% of its voting rights. For the purpose of determining the holding percentage stated above, two or more shareholders
who have a personal interest in a transaction that is brought for the company&#8217;s approval are deemed as joint holders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;relative&#8221; is defined in the Companies Law as a spouse, sibling, parent, grandparent or descendant; spouse&#8217;s sibling,
parent or descendant; and the spouse of each of the foregoing persons.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the term &#8220;affiliation&#8221; and the similar types of disqualifying relationships, as used above, include (subject
to certain exceptions):</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    employment relationship;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    business or professional relationship even if not maintained on a regular basis (excluding insignificant relationships);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">control;
    and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">service
    as an office holder, excluding service as a director in a private company prior to the initial public offering of its shares if such
    director was appointed as a director of the private company in order to serve as an external director following the initial public
    offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;office holder&#8221; is defined in the Companies Law as a general manager, chief business manager, deputy general manager,
vice general manager, any other person assuming the responsibilities of any of these positions regardless of that person&#8217;s title,
a director and any other manager directly subordinate to the general manager.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, no person may serve as an external director if that person&#8217;s position or professional or other activities create, or
may create, a conflict of interest with that person&#8217;s responsibilities as a director or otherwise interfere with that person&#8217;s
ability to serve as an external director or if the person is an employee of the Israel Securities Authority or of an Israeli stock exchange.
A person may furthermore not continue to serve as an external director if he or she received direct or indirect compensation from the
company including amounts paid pursuant to indemnification or exculpation contracts or commitments and insurance coverage, other than
for his or her service as an external director as permitted by the Companies Law and the regulations promulgated thereunder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the termination of an external director&#8217;s service on a board of directors, such former external director and his or her spouse
and children may not be provided a direct or indirect benefit by the company, its controlling shareholder or any entity under its controlling
shareholder&#8217;s control. This includes engagement as an office holder of the company or a company controlled by its controlling shareholder
or employment by, or provision of services to, any such company for consideration, either directly or indirectly, including through a
corporation controlled by the former external director. This restriction extends for a period of two years with regard to the former
external director and his or her spouse or child and for one year with respect to other relatives of the former external director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at the time at which an external director is appointed all members of the board of directors who are not controlling shareholders or
relatives of controlling shareholders of the company are of the same gender, the external director to be appointed must be of the other
gender. A director of a company may not be appointed as an external director of another company if at the same time a director of such
other company is acting as an external director of the first company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under regulations promulgated pursuant to the Companies Law, a company with no controlling shareholder whose shares are listed
for trading on specified exchanges outside of Israel, including the Nasdaq Capital Market, may adopt exemptions from various corporate
governance requirements of the Companies Law so long as such company satisfies the requirements of applicable foreign country laws and
regulations, including applicable stock exchange rules, that apply to companies organized in that country and relating to the appointment
of independent directors and the composition of audit and compensation committees. Such exemptions include an exemption from the requirement
to appoint external directors and the requirement that an external director be a member of certain committees, as well as the exemption
from limitations on directors&#8217; compensation. We may use these exemptions in the future if we do not have a controlling shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Independent
Directors Under the Companies Law</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law an &#8220;independent director&#8221; is either an external director or a director who meets the same non-affiliation
criteria as an external director, (except for (i) the requirement that the director be an Israeli resident (which does not apply to companies
such as ours whose securities have been offered outside of Israel or are listed outside of Israel) and (ii) the requirement for accounting
and financial expertise or professional qualifications) as determined by the audit committee, and who has not served as a director of
the company for more than nine consecutive years. For these purposes, ceasing to serve as a director for a period of two years or less
would not be deemed to sever the consecutive nature of such director&#8217;s service. Mrs. Inbal Kreiss has agreed to serve as our independent
director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
promulgated pursuant to the Companies Law provide that a director in a public company whose shares are listed for trading on specified
exchanges outside of Israel, including the Nasdaq Capital Market, who qualifies as an independent director under the relevant non-Israeli
rules and who meets certain non-affiliation criteria, which are less stringent than those applicable to independent directors as set
forth above, would be deemed an &#8220;independent&#8221; director pursuant to the Companies Law provided: (i) he or she has not served
as a director for more than nine consecutive years; (ii) he or she has been approved as such by the audit committee; and (iii) his or
her remuneration shall be in accordance with the Companies Law and the regulations promulgated thereunder. For these purposes, ceasing
to serve as a director for a period of two years or less would not be deemed to sever the consecutive nature of such director&#8217;s
service.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
pursuant to these regulations, such company may reappoint a person as an independent director for additional terms, beyond nine years,
which do not exceed three years each, if each of the audit committee and the board of directors determine, in that order, that in light
of the independent director&#8217;s expertise and special contribution to the board of directors and its committees, the reappointment
for an additional term is in the company&#8217;s best interest.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Alternate
Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions
set thereto, appoint a person as an alternate to act in his place, to remove the alternate and appoint another in his place and to appoint
an alternate in place of an alternate whose office is vacated for any reason whatsoever. Under the Companies Law, a person who is not
qualified to be appointed as a director, a person who is already serving as a director or a person who is already serving as an alternate
director for another director, may not be appointed as an alternate director. Nevertheless, a director who is already serving as a director
may be appointed as an alternate director for a member of a committee of the board of directors so long as he or she is not already serving
as a member of such committee, and if the alternate director is to replace an external director, he or she is required to be an external
director and to have either &#8220;financial and accounting expertise&#8221; or &#8220;professional expertise,&#8221; depending on the
qualifications of the external director he or she is replacing. A person who does not have the requisite &#8220;financial and accounting
experience&#8221; or the &#8220;professional expertise,&#8221; depending on the qualifications of the external director he or she is
replacing, may not be appointed as an alternate director for an external director. A person who is not qualified to be appointed as an
independent director, pursuant to the Companies Law, may not be appointed as an alternate director of an independent director qualified
as such under the Companies Law. Unless the appointing director limits the time or scope of the appointment, the appointment is effective
for all purposes until the appointing director ceases to be a director or terminates the appointment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee is comprised of at least three directors, including all of the external directors (one of whom must serve as chair of
the committee). The audit committee may not include the chairman of the board; a controlling shareholder of the company or a relative
of a controlling shareholder; a director employed by or providing services on a regular basis to the company, to a controlling shareholder
or to an entity controlled by a controlling shareholder; or a director who derives most of his or her income from a controlling shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a majority of the members of the audit committee of a publicly-traded company must be independent directors under the Companies
Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our audit committee are Mr. Yossi Daskal, Mrs. Inbal Kreiss and Mr. Oz Adler.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee will also act as a committee for review of our financial statements as required under the Companies Law, and in such
capacity will oversee and monitor our accounting; financial reporting processes and controls, audits of the financial statements, compliance
with legal and regulatory requirements as they relate to financial statements or accounting matters, and the independent registered public
accounting firm&#8217;s qualifications, independence and performance; and provide the board of directors with reports on the foregoing.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, our audit committee is responsible for:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    whether there are deficiencies in the business management practices of our company, and making recommendations to the board of directors
    to improve such practices;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and
    whether such transaction is extraordinary or material under Companies Law) (see &#8220;Directors, Senior Management and Employees&#8212;Board
    Practices&#8212;Approval of Related Party Transactions under Israeli law&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    the approval process for transactions that are &#8216;non-negligible&#8217; (i.e., transactions with a controlling shareholder that
    are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as
    determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may
    be determined annually in advance by the audit committee;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining
    our internal controls and internal auditor&#8217;s performance, including whether the internal auditor has sufficient resources and
    tools to dispose of its responsibilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
    the board of directors approves the working plan of the internal auditor, examining such working plan before its submission to the
    board of directors and proposing amendments thereto;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining
    the scope of our auditor&#8217;s work and compensation and submitting a recommendation with respect thereto to our board of directors
    or shareholders, depending on which of them is considering the appointment of our auditor; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the handling of employees&#8217; complaints as to the management of our business and the protection to be provided
    to such employees.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee may not conduct any discussions or approve any actions requiring its approval (see &#8220;Directors, Senior Management
and Employees&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli law&#8221;), unless at the time of the
approval a majority of the committee&#8217;s members are present, which majority consists of independent directors under the Companies
Law, including at least one external director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
Stock Market Requirements for Audit Committee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nasdaq Listing Rules, we are required to maintain an audit committee consisting of at least three members, all of whom are independent
and are financially literate and one of whom has accounting or related financial management expertise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, the members of our audit committee are Mr. Yossi Daskal and Mr. Oz Adler, who will serve as external directors, and Mrs.
Inbal Kreiss, who will serve as an independent director, each of whom is &#8220;independent,&#8221; as such term is defined in under
Nasdaq Listing Rules. The members of our audit committee meet the requirements for financial literacy under the Nasdaq Listing Rules.
Our board of directors has determined that each member of our audit committee is an audit committee financial expert as defined by the
SEC rules and has the requisite financial experience as defined by the Nasdaq Listing Rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted an audit committee charter setting forth among others, the responsibilities of the audit committee consistent
with the rules of the SEC and Nasdaq Listing Rules (in addition to the requirements for such committee under the Companies Law).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the board of directors of any public company must establish a compensation committee. The compensation committee must
be comprised of at least three directors, including all of the external directors, who must constitute a majority of the members of the
compensation committee. Each compensation committee member that is not an external director must be a director whose compensation does
not exceed an amount that may be paid to an external director. The compensation committee is subject to the same Companies Law restrictions
as the audit committee as to (a) who may not be a member of the committee and (b)&#160;who may not be present during committee deliberations
as described above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our compensation committee are Mr. Yossi Daskal, Mr. Oz Adler and Mrs. Inbal Kreiss, each of whom is &#8220;independent,&#8221;
as such term is defined under the Nasdaq Listing Rules. Our compensation committee complies with the provisions of the Companies Law,
the regulations promulgated thereunder, and our amended and restated articles of association, on all aspects referring to its independence,
authorities and practice. Our compensation committee follows home country practice as opposed to complying with the compensation committee
membership and charter requirements prescribed under the Nasdaq Listing Rules. Our board of directors has adopted a compensation committee
charter.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation committee reviews and recommends to our board of directors, with respect to our executive officers&#8217; and directors&#8217;:
(1) annual base compensation; (2) annual incentive bonus, including the specific goals and amount; (3) equity compensation; (4) employment
agreements, severance arrangements, and change in control agreements and provisions; (5) retirement grants and/or retirement bonuses;
and (6) any other benefits, compensation, compensation policies or arrangements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duties of the compensation committee include the recommendation to the company&#8217;s board of directors of a policy regarding the terms
of engagement of office holders, to which we refer as a compensation policy. Such policy must be adopted by the company&#8217;s board
of directors, after considering the recommendations of the compensation committee. The compensation policy is then brought for approval
by our shareholders, which requires a special majority (see &#8220;Directors, Senior Management and Employees&#8212;Board Practices&#8212;Approval
of Related Party Transactions under Israeli law&#8221;). Under the Companies Law, the board of directors may adopt the compensation policy
if it is not approved by the shareholders, provided that after the shareholders oppose the approval of such policy, the compensation
committee and the board of directors revisit the matter and determine that adopting the compensation policy would be in the best interest
of the company. Our board has adopted a compensation policy which was approved by our shareholders on March 27, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers
and directors, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment
or engagement. The compensation policy must relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s
business and its long-term strategy, and creation of appropriate incentives for executives. It must also consider, among other things,
the company&#8217;s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following
additional factors:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    knowledge, skills, expertise and accomplishments of the relevant director or executive;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    director&#8217;s or executive&#8217;s roles and responsibilities and prior compensation agreements with him or her;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relationship between the cost of the terms of service of an office holder and the average and median compensation of the other employees
    of the company (including those employed through manpower companies), including the impact of disparities in salary upon work relationships
    in the company;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possibility of reducing variable compensation at the discretion of the board of directors; and the possibility of setting a limit
    on the exercise value of non-cash variable compensation; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    to severance compensation, the period of service of the director or executive, the terms of his or her compensation during such service
    period, the company&#8217;s performance during that period of service, the person&#8217;s contribution towards the company&#8217;s
    achievement of its goals and the maximization of its profits, and the circumstances under which the person is leaving the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation policy must also include the following principles:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    link between variable compensation and long-term performance and measurable criteria;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relationship between variable and fixed compensation, and the ceiling for the value of variable compensation at the time of its grant;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    conditions under which a director or executive would be required to repay compensation paid to him or her if it was later shown that
    the data upon which such compensation was based was inaccurate and was required to be restated in the company&#8217;s financial statements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    minimum holding or vesting period for variable, equity-based compensation; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maximum
    limits for severance compensation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation policy must also consider appropriate incentives from a long-term perspective.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee is also responsible for:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    whether a compensation policy should continue in effect, if the then-current policy has a term of greater than three years (approval
    of either a new compensation policy or the continuation of an existing compensation policy must in any case occur every three years);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to the board of directors periodic updates to the compensation policy;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
    implementation of the compensation policy;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    whether the terms of compensation of certain office holders of the company need not be brought to approval of the shareholders; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    whether to approve the terms of compensation of office holders that require the committee&#8217;s approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Internal
Auditor</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee.
Our internal auditor is Mrs. Dana Spira, who has been serving as our internal auditor since May 2022. Mrs. Spira is a Certified Public
Accountant and holds a B.A. degree in accounting and business and L.L.B law from Reichman University, Israel</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
role of the internal auditor is to examine, among other things, whether a company&#8217;s actions comply with the law and proper business
procedure. The audit committee is required to oversee the activities, and to assess the performance of the internal auditor as well as
to review the internal auditor&#8217;s work plan. An internal auditor may not be an interested party or office holder, or a relative
of any interested party or office holder, and may not be a member of the company&#8217;s independent accounting firm or its representative.
The Companies Law defines an interested party as a holder of 5% or more of the outstanding shares or voting rights of a company, any
person or entity that has the right to nominate or appoint at least one director or the general manager of the company or any person
who serves as a director or as the general manager of a company. We intend to appoint an internal auditor.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remuneration
of Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, remuneration of directors is subject to the approval of the compensation committee, thereafter by the board of directors
and thereafter, unless exempted under the regulations promulgated under the Companies Law, by the general meeting of the shareholders.
External directors are entitled to remuneration (including reimbursement of expenses) subject to the provisions and limitations set forth
in the regulations promulgated under the Companies Law. Where the director is also a controlling shareholder, the requirements for approval
of transactions with controlling shareholders apply.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no service contracts between us, on the one hand, and our directors in their capacity as directors, on the other hand, providing
for benefits upon termination of service.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiduciary
Duties of Office Holders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law imposes a duty of care and a duty of loyalty on all office holders of a company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would
have acted under the same circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
    on the advisability of a given action brought for his approval or performed by him by virtue of his position; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    other important information pertaining to these actions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duty of loyalty of an office holder requires an office holder to act in good faith and for the benefit of the company, and includes a
duty to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
    from any conflict of interest between the performance of his duties in the company and his performance of his other duties or personal
    affairs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
    from any action that is competitive with the company&#8217;s business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
    from exploiting any business opportunity of the company to receive a personal gain for himself or others; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose
    to the company any information or documents relating to the company&#8217;s affairs which the office holder has received due to his
    position as an office holder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insurance</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, a company may obtain insurance for any of its office holders against the following liabilities incurred due to acts
he or she performed as an office holder, if and to the extent provided for in the company&#8217;s articles of association:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">breach
    of his or her duty of care to the company or to another person, to the extent such a breach arises out of the negligent conduct of
    the office holder;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    breach of his or her duty of loyalty to the company, provided that the office holder acted in good faith and had reasonable cause
    to assume that his or her act would not prejudice the company&#8217;s interests; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    financial liability imposed upon him or her in favor of another person.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 23, 2023 the Compensation
Committee of our Board of Directors resolved to approve the renewal of the Company&#8217;s directors&#8217; and officers&#8217; insurance
policy, for a period of 12 months as of March 31, 2023, of a $7.5 million coverage, and an annual premium not to exceed $313,415, pursuant
to the applicable regulations under Companies Law.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2022, our board of directors approved the purchase of a run-off insurance policy for directors and officers, which will cover
past events. The insurance amount is NIS 18 million (approximately US$ 5.6 million) in aggregate plus reasonable legal defense costs,
with Company retention for claims in North America of NIS 90,000 (approximately US$ 28,125) and Company retention for other claims of
NIS 18,000 (approximately US$ 5,600). The policy is for seven (7) years as of April 4, 2022, and cost NIS 49,140 (approximately US$ 15,260).
The purchase of the run-off director and officer insurance policy was approved by the Company&#8217;s shareholders on June 6, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Indemnification</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law provide that a company may indemnify an office holder against the following liabilities and expenses incurred for acts
performed by him or her as an office holder, either pursuant to an undertaking made in advance of an event or following an event, provided
its articles of association include a provision authorizing such indemnification:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity
    as an office holder, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify
    an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which,
    in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify
    is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and
    such undertaking shall detail the abovementioned foreseen events and amount or criteria;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
    litigation expenses, including attorneys&#8217; fees, expended by the office holder (a) as a result of an investigation or proceeding
    instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment
    (as defined in the Companies Law) was filed against such office holder as a result of such investigation or proceeding; and (2) no
    financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as
    a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense
    that does not require proof of criminal intent; and (b) in connection with a monetary sanction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
    litigation expenses, including attorneys&#8217; fees, expended by the office holder or imposed on him or her by a court: (1) in proceedings
    that the company institutes, or that another person institutes on the company&#8217;s behalf, against him or her; (2) in a criminal
    proceedings of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal
    intent; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
    incurred by an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation
    expenses and reasonable attorneys&#8217; fees. An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters
    H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement
    Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exculpation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, an Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but
may exculpate in advance an office holder from his or her liability to the company, in whole or in part, for damages caused to the company
as a result of a breach of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such
exculpation is included in its articles of association.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitations</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law provides that we may not exculpate or indemnify an office holder nor enter into an insurance contract that would provide
coverage for any liability incurred as a result of any of the following: (1) a breach by the office holder of his or her duty of loyalty
unless (in the case of indemnity or insurance only, but not exculpation) the office holder acted in good faith and had a reasonable basis
to believe that the act would not prejudice us; (2) a breach by the office holder of his or her duty of care if the breach was carried
out intentionally or recklessly (as opposed to merely negligently); (3) any act or omission committed with the intent to derive an illegal
personal benefit; or (4) any fine, monetary sanction, penalty or forfeit levied against the office holder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation
committee and the board of directors and, with respect to certain office holders or under certain circumstances, also by the shareholders
(see &#8220;Directors, Senior Management and Employees&#8212;Board Practices&#8212;Approval of Related Party Transactions under Israeli
Law&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association permits us to exculpate, indemnify and insure our office holders to the fullest extent permitted
or to be permitted by the Companies Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into agreements with each of our directors and executive officers exculpating them from liability to us for damages caused
to us as a result of a breach of duty of care and undertaking to indemnify them, in each case, to the fullest extent permitted by our
amended and restated articles of association and the Companies Law, to the extent that these liabilities are not covered by insurance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approval
of Related Party Transactions under Israeli Law</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described
above, if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    office holder acts in good faith and the act or its approval does not cause harm to the company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    office holder disclosed the nature of his or her interest in the transaction (including any significant fact or document) to the
    company at a reasonable time before the company&#8217;s approval of such matter.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
of Personal Interests of an Office Holder</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at
which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information
known to him or her relating to any existing or proposed transaction by the company. If the transaction is an extraordinary transaction,
the office holder must also disclose any personal interest held by:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    office holder&#8217;s relatives; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    corporation in which the office holder or his or her relatives holds 5% or more of the shares or voting rights, serves as a director
    or general manager or has the right to appoint at least one director or the general manager.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
office holder is not, however, obliged to disclose a personal interest if it derives solely from the personal interest of his or her
relative in a transaction that is not considered an extraordinary transaction. Under the Companies Law, an extraordinary transaction
is a transaction:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    in the ordinary course of business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    on market terms; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    is likely to have a material effect on the company&#8217;s profitability, assets or liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders
to make such disclosures to our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, once an office holder complies with the above disclosure requirement, the board of directors may approve a transaction
between the company and an office holder, or a third party in which an office holder has a personal interest, unless the articles of
association provide otherwise and provided that the transaction is in the company&#8217;s interest. If the transaction is an extraordinary
transaction in which an office holder has a personal interest, first the audit committee and then the board of directors, in that order,
must approve the transaction. Under specific circumstances, shareholder approval may also be required. Generally, a person who has a
personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may not be present at
such a meeting unless the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present
in order to present the transaction that is subject to approval. A director who has a personal interest in a transaction, which is considered
at a meeting of the board of directors or the audit committee, may not be present at this meeting or vote on this matter, unless a majority
of the members of the board of directors or the audit committee, as the case may be, has a personal interest. If a majority of the board
of directors has a personal interest, then shareholder approval is generally also required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
of Personal Interests of a Controlling Shareholder</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the disclosure requirements that apply to an office holder also apply to a controlling shareholder of a public company.
Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a
private placement in which a controlling shareholder has a personal interest, as well as transactions for the provision of services whether
directly or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder controls, and transactions
concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder&#8217;s relative, whether
as an office holder or an employee, require the approval of the audit committee or the compensation committee, as the case may be, the
board of directors and a majority of the shares voted by the shareholders of the company participating and voting on the matter in a
shareholders&#8217; meeting. In addition, the shareholder approval must fulfill one of the following requirements:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
    least a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting
    must be voted in favor of approving the transaction, excluding abstentions; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more
    than 2% of the voting rights in the company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest
with a term of more than three years requires the abovementioned approval every three years; however, such transactions not involving
the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer
term is reasonable under the circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction
with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in
the vote in question. Failure to so indicate will result in the invalidation of that shareholder&#8217;s vote.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval
of the Compensation of Directors and Executive Officers</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors</i>.
Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval
of the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general
meeting of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided
that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation
committee and board of directors, shareholder approval by a special majority will be required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Executive
officers other than the chief executive officer.</i>&#160;The Companies Law requires the approval of the compensation of a public company&#8217;s
executive officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company&#8217;s
board of directors, and (iii) only if such compensation arrangement is inconsistent with the company&#8217;s stated compensation policy,
the company&#8217;s shareholders by a special majority. However, if the shareholders of the company do not approve a compensation arrangement
with an executive officer that is inconsistent with the company&#8217;s stated compensation policy, the compensation committee and board
of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of directors provides
detailed reasons for their decision.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief
executive officer.</i>&#160;Under the Companies Law, the compensation of a public company&#8217;s chief executive officer is required
to be approved by: (i) the company&#8217;s compensation committee; (ii) the company&#8217;s board of directors, and (iii) the company&#8217;s
shareholders by a special majority. However, if the shareholders of the company do not approve the compensation arrangement with the
chief executive officer, the compensation committee and board of directors may override the shareholders&#8217; decision if each of the
compensation committee and the board of directors provides detailed reasons for their decision. In addition, the compensation committee
may exempt the engagement terms of a candidate to serve as the chief executive officer from shareholders&#8217; approval, if the compensation
committee determines that the compensation arrangement is consistent with the company&#8217;s stated compensation policy, that the chief
executive officer did not have a prior business relationship with the company or a controlling shareholder of the company, and that subjecting
the approval to a shareholder vote would impede the company&#8217;s ability to attain the candidate to serve as the company&#8217;s chief
executive officer (and provide detailed reasons for the latter).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of the compensation committee and the board of directors, with regard to the office holders and directors above, must
be in accordance with the company&#8217;s stated compensation policy; however, under special circumstances, the compensation committee
and the board of directors may approve compensation terms of a chief executive officer that are inconsistent with the company&#8217;s
compensation policy provided that they have considered those provisions that must be included in the compensation policy according to
the Companies Law and that shareholder approval was obtained by a special majority requirement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Duties
of Shareholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, a shareholder has a duty to refrain from abusing its power in the company and to act in good faith and in an acceptable
manner in exercising its rights and performing its obligations toward the company and other shareholders, including, among other things,
in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendment
    of the articles of association;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
    in the company&#8217;s authorized share capital;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">merger;
    and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    approval of related party transactions and acts of office holders that require shareholder approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of
contract will also apply to a breach of the above mentioned duties, and in the event of oppression of other shareholders, additional
remedies are available to the injured shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any
shareholder that, under a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder,
or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not
describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in
the event of a breach of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not have any controlling shareholder as defined by the Companies Law. See &#8220;Major Shareholders and Related Party Transactions.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Employees.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 4.B. Business Overview&#8212;Employees.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Share Ownership.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 7.A. Major Shareholders&#8221; below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
Incentive Plan</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain one equity incentive plan (the &#8220;Option Plan&#8221;).
As of March 23, 2023, the number of ordinary shares reserved for issuance under the Option Plan was 2,332,352. As of March 23, 2023, 1,900,896
options to purchase 1,900,896 ordinary shares were issued and outstanding, of which 827,458 options were vested as of that date, with
an exercise price approximately $1.85-6.139 per share. Our board may, at any time during the term of the Option Plan increase the number
of shares available for grant under the Option Plan subject to any required approval of the our shareholders of such increase if so required
under applicable laws and/or our incorporation documents and/or any shareholders agreement, as shall be in effect from time to time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Option Plan was adopted by our board of directors on January 31, 2017, and awards may be granted under the Option Plan until January
31, 2027. Our Option Plan was last amended on September 13, 2022. Our employees, directors, officers, and services providers, including
those who are our controlling shareholders, as well as those of our affiliated companies, are eligible to participate in this Option
Plan.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Option Plan is administered by our board of directors, regarding the granting of options and the terms of option grants, including exercise
price, method of payment, vesting schedule, acceleration of vesting and the other matters necessary in the administration of this Option
Plan. Eligible Israeli employees, officers and directors, would qualify for provisions of Section 102(b)(2) of the Tax Ordinance. Pursuant
to such Section 102(b)(2), qualifying options and shares issued upon exercise of such options are held in trust and registered in the
name of a trustee selected by the board of directors. The trustee may not release these options or shares to the holders thereof for
two years from the date of the registration of the options in the name of the trustee. Under Section 102, any tax payable by an employee
from the grant or exercise of the options is deferred until the transfer of the options or ordinary shares by the trustee to the employee
or upon the sale of the options or ordinary shares, and gains may qualify to be taxed as capital gains at a rate equal to 25%, subject
to compliance with specified conditions. Our Israeli non-employee service providers and controlling shareholders may only be granted
options under Section 3(9) of the Tax Ordinance, which does not provide for similar tax benefits. The Option Plan also permits granting
options to Israeli grantees who do not qualify under Section 102(b)(2).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a default, our Option Plan provides that upon termination of employment for any reason, other than in the event of death or disability,
all unvested options will expire and all vested options will generally be exercisable for one&#160;month following such termination,
if we initiate such termination, or two weeks following such termination, if an employee initiates such termination, or such other period
as determined by the Option Plan administrator, subject to the terms of the Option Plan and the governing option agreement. Notwithstanding
the foregoing, in the event the employment is terminated for cause (including, inter alia, a breach of confidentiality or non-compete
obligations to us, and commission of an act involving moral turpitude or an act that causes harm&#160;to us) all options granted to such
employee, whether vested or unvested, will not be exercisable and will terminate on the date of the termination of his employment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
termination of employment due to death or disability, all the options vested at the time of termination will generally be exercisable
for six months, or such other period as determined by the Option Plan administrator, subject to the terms of the Option Plan and the
governing option agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>F. Disclosure of a registrant&#8217;s action to
recover erroneously awarded compensation.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="b_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Major Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding beneficial ownership of our ordinary shares as of March 23, 2023 by:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our outstanding ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors and executive officers; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our directors and executive officers as a group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules of the SEC, and includes voting or investment power with respect to ordinary shares.
Ordinary shares issuable under share options or warrants that are exercisable within 60 days after March 23, 2023 are deemed outstanding
for the purpose of computing the percentage ownership of the person holding the options or warrants but are not deemed outstanding for
the purpose of computing the percentage ownership of any other person.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in the footnotes to this table, we believe that the shareholders named in this table have sole voting and investment power
with respect to all shares shown to be beneficially owned by them, based on information provided to us by such shareholders. Unless otherwise
noted below, each beneficial owner&#8217;s address is: c/o Rail Vision Ltd., 15 Ha&#8217;Tidhar St., Ra&#8217;anana, 4366517 Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">No.&#160;of&#160;Shares<br/>
    Beneficially<br/>
    Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Percentage<br/>
    Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Holders of more than 5% of our voting securities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Knorr-Bremse (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,853,578</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">35.06</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foresight Autonomous Holdings Ltd. (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,688,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.46</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">L.I.A. Pure Capital Ltd.(3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">869,470</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.35</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Directors and senior management who are not 5% holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shahar Hania (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,694</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.09</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Ofer Naveh(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">96,930</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.60</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Zachi Bar-Yehoshua (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">35,200</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.22</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shmuel Donnerstein* (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">401,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.44</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Eli Yoresh *(8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">30,163</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Ofer Grisaro (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.05</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amit Klir (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.05</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Maximilian Eichhorn* (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Keren Aslan * (12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Yossi Daskal * (13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Inbal Kreiss * (14)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.08</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Oz Adler* (15)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mark Cleobury*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All directors and senior management as a group (13 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,107,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.61</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
director of the Company.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 5,248,427 ordinary shares and (ii)&#160;605,151 warrants to purchase 605,151 ordinary shares. The shareholder is Knorr-Bremse
    Systeme f&#252;r Schienenfahrzeuge GmbH, which is a 100% subsidiary of Knorr-Bremse AG which is a German company publicly traded
    on the Frankfurt Stock Exchange. As of January 1, 2023, Marc Llistosella is the chief executive officer of Knorr-Bremse AG.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 2,446,152 ordinary shares, and (ii)&#160;242,280&#160;warrants to purchase 242,280&#160;ordinary shares. Foresight Autonomous
    Holdings Ltd. is an Israeli company publicly traded on the Nasdaq. The chief executive officer of Foresight is Haim Siboni, and its
    address is 7 Golda Meir, Ness Ziona 7403650 Israel.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    solely on a Schedule 13G filed with the SEC on January 13, 2023. Consists of (i) 717,450 ordinary shares with sole voting power,
    and (ii) 152,020 ordinary shares with shared voting power. Kfir Silberman is the officer, sole director, chairman of the board of
    directors and controlling shareholder of L.I.A. Pure Capital, and its address is 20 Raoul Wallenberg Street, Tel Aviv, Israel 6971916.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
    of (i) 406,560 ordinary shares, and (ii) 94,138 options vested within 60 days, exercisable at a weighted average exercise price of
    $5.17 and expiring in January 2028, October 2030 and May 2032. Does not include options to purchase 134,855, ordinary shares exercisable
    at $1.85 per share and expiring in May 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(5)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 96,930 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in January 2028, January 2030 and May 2032. Does not include
    options to purchase 83,243 ordinary shares exercisable at $1.85 per share and expiring in May 2032, that vest in more than 60 days
    from the date hereof.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify">&#160;</td>
    <td style="font-size: 10pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">(6)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 35,200 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in January 2028 and January 2030. Does not include options
    to purchase 4,000 ordinary shares exercisable at $1.85 per share and expiring in September 2032, that vest in more than 60 days from
    the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(7)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of (i) 34,232 ordinary shares, and (ii)
    367,148 options vested within 60 days, exercisable at a weighted average exercise price of $5.10 and expiring in October 2030 and
    May 2032. Does not include options to purchase 177,500 ordinary shares exercisable at $1.85 per share and expiring in May 2032, that
    vest in more than 60 days from the date hereof. </span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(8)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 30,163 options vested within 60 days,
    exercisable at a weighted average exercise price of $4.25 and expiring in January 2028 and September 2032. Does not include options
    to purchase 26,621 ordinary shares exercisable at $1.85 per share and expiring in May 2032, that vest in more than 60 days from the
    date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(9)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 8,333 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in September 2032. Does not include options to purchase 41,667
    ordinary shares exercisable at $1.85 per share and expiring in September 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(10)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 8,333 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in September 2032. Does not include options to purchase 41,667
    ordinary shares exercisable at $1.85 per share and expiring in September 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(11)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Does not include options to purchase 39,932 ordinary
    shares exercisable at $1.85 per share which Mr. Eichhorn is entitled to receive that have not yet been granted.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(12)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Does not include options to purchase 39,932 ordinary
    shares exercisable at $1.85 per share which were approved by the board of directors in March 2023 and are subject to approval by
    our shareholders.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(13)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 13,311 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in May 2032. Does not include options to purchase 26,621 ordinary
    shares exercisable at $1.85 per share and expiring in June 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(14)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Consists of 13,311 options vested within 60 days,
    exercisable at a weighted average exercise price of $1.85 and expiring in May 2032. Does not include options to purchase 26,621 ordinary
    shares exercisable at $1.85 per share and expiring in June 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 0.35in"><span style="font-size: 10pt">(15)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Does not include options to purchase 39,932 ordinary
    shares exercisable at $1.85 per share and expiring in June 2032, that vest in more than 60 days from the date hereof.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Changes in Ownership of Major Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">To our knowledge, other than as disclosed in the table above, our other filings with the SEC and this Annual Report,
there has been no significant change in the percentage ownership held by any major shareholder since January 1, 2020. The major shareholders
listed above do not have voting rights with respect to their ordinary shares that are different from the voting rights of other holders
of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Record
Holders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 14, 2023, there were 69 holders of record of our ordinary shares, out of which one holder of record had a registered address
in the United States. These numbers are not representative of the number of beneficial holders of our shares nor is it representative
of where such beneficial holders reside, since many of these shares were held of record by brokers or other nominees.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not controlled by another corporation, by any foreign government or by any natural or legal persons, except that that Knorr-Bremse
beneficially owns approximately 35%, and Foresight beneficially owns approximately 16% of our outstanding ordinary shares as of the date
of this Annual Report. There are no arrangements known to us which would result in a change in control of our company at a subsequent
date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Related Party Transactions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the material terms of those transactions with related parties to which we are party since January 1, 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into written employment or services agreements with each of our executive officers. All of these agreements contain customary
provisions regarding noncompetition, confidentiality of information and assignment of inventions. However, the enforceability of the
noncompetition provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer
and director pursuant to which we have agreed to indemnify each of them up to a certain amount and to the extent that these liabilities
are not covered by directors and officers insurance.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Options</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception we have granted options to purchase our ordinary shares to certain of our officers and directors. Such option agreements
may contain acceleration provisions upon certain merger, acquisition, or change of control transactions. We describe our Option Plan
under &#8220;Management&#8212;Equity Incentive Plan.&#8221; If the relationship between us and an executive officer or a director is
terminated, except for cause (as defined in the various Option Plan agreements), options that are vested will generally remain exercisable
for one month following the date of such termination if we initiate such termination or two weeks following the date of such termination,
if an executive officer or a director initiates such termination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a party to an amended and restated investors rights agreement, dated as of October 13, 2020, or Investors Rights Agreement, with
our founders, or the Founders, and two of our major shareholders, Knorr-Bremse Systeme f&#252;r Schienenfahrzeuge GmbH, a company incorporated
under the laws of Germany, or KB, and Foresight Autonomous Holdings Ltd., or Foresight, and, together with KB and the Founders, the Right
Holders. Pursuant to the Investors Rights Agreement, the Right Holders are entitled to certain registration rights following the closing
of our initial public offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Knorr-Bremse</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 2019, we entered into an investment agreement, or the
March 2019 Investment Agreement, with Knorr-Bremse Systeme f&#252;r Schienenfahrzeuge GmbH, or Knorr-Bremse, according to which, we issued
to Knorr-Bremse an aggregate amount of 1,803,296 ordinary shares, at a price of $5.54 per share for a total investment of $10,000,000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the March 2019 Investment Agreement, we also granted Knorr-Bremse warrants to purchase 655,732 ordinary shares with
an exercise price of $5.54, which can be exercised in the event of the exercise of certain warrants held by our other shareholders. Warrants
to purchase 132,308 ordinary shares have been exercised in consideration of approximately $734,000. All the remaining warrants expired.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2020, we entered into an additional investment agreement with Knorr-Bremse, or the Additional Investment Agreement, which
was amended on December 2, 2021, pursuant to which we issued to Knorr-Bremse 51,282 Preferred A shares at a price of $195 per share for
a total investment of $10,000,000.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Additional Investment Agreement, Knorr-Bremse agreed
that in the event that we do not complete additional capital raising in the amount of at least $3 million by September 30, 2021, we had
an option during the period from October 1, 2021 to March 31, 2022, to demand that Knorr-Bremse invest in us an additional amount of $5
million in consideration for the allotment of 25,641 Preferred A shares, at a price of $195 per share, subject to certain limitations.
On February 14, 2022, we and Knorr-Bremse signed a second amendment to the Additional Investment Agreement according to which from February
14, 2022, we are entitled to exercise the option in two installments as follows: (i) to call for up to $2,000,000 out of the option amount
no later than March 31, 2022; and (ii) to call for up to $2,286,000 out of the option amount no later than June 30, 2022. The aforesaid
option expired on the closing of our initial public offering on April 4, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2022, we issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of $195 per share, after we called an amount
of $2,000,000 out of the option amount.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the completion of the IPO on April 4, 2022, 61,538 Preferred A shares were automatically converted into 2,707,672 ordinary shares
(after giving effect to the issuance of 10,256 Preferred A shares described above).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2021, we reached a co-operation and business development agreement with Knorr-Bremse India Pvt. Ltd., in which Knorr-Bremse India
Pvt. Ltd. provided a joint proposal to a tender published by the Ministry of Railways of the Government of India for obstacle detection
systems for trains in the RV2000 system market segment. As part of the joint bid Knorr-Bremse India Pvt. Ltd. provided a guarantee of
$27,000 to secure our proposal. On January 10, 2022, Knorr-Bremse informed us they did not receive the tender. However, the parties intend
to collaborate on future projects. See &#8220;Business &#8211; Commercial Agreements&#8221; for additional commercial agreements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SAFE</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2022, we entered into a SAFE with two of our current shareholders providing for financing in the aggregate amount of $1,000,000
(KB in the amount of $714,286 and Foresight in the amount of $285,714) which was subsequently amended in March 2022. Upon our initial
public offering on April 4, 2022, the SAFE converted into an aggregate of 242,131 ordinary shares and warrants to purchase 242,131 ordinary
shares. The warrants issued have the same terms as the warrants issued in our initial public offering except that such warrants shall
be unregistered and shall not be tradeable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
Relationships</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we do business with other companies affiliated with our principal shareholders, as described above. We believe that all
such arrangements have been entered into in the ordinary course of business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Interests of Experts and Counsel</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
8. FINANCIAL INFORMATION.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_036"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Statements and Other Financial Information.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 18. Financial Statements.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 4.B. Business Overview&#8212;Legal Proceedings.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our ordinary shares and do not anticipate paying any cash dividends in the foreseeable
future. However, we may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings.
Under the Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders
of a company unless the company&#8217;s articles of association provide otherwise. Our amended and restated articles of association do
not require shareholder approval of a dividend distribution and will provide that dividend distributions may be determined by our board
of directors. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on
then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business
prospects and other factors our board of directors may deem relevant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Companies Law, the distribution of dividends is limited to the greater of retained earnings or earnings generated over the previous
two years, according to our then last reviewed or audited financial statements, provided that the end of the period to which the financial
statements relate is not more than six months prior to the date of the distribution. If we do not meet such criteria, we may only distribute
dividends with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and the court,
if applicable, determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing
and foreseeable obligations as they become due.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of dividends may be subject to Israeli withholding taxes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_037"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Significant Changes</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as otherwise described in this Annual Report on Form 20-F and as set forth below, no significant change has occurred in our operations
since the date of our financial statements included in this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_038"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9. THE OFFER AND LISTING</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_039"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Offer and Listing Details</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2022, our ordinary shares and warrants commenced trading on the Nasdaq Capital Market under the symbols &#8220;RVSN,&#8221;
and &#8220;RVSNW,&#8221; respectively.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_040"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Plan of Distribution</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_041"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Markets</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares are listed on the Nasdaq Capital Market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_042"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Selling Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_043"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Dilution</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_044"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
Expenses of the Issue</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_045"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
10. ADDITIONAL INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_046"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Share Capital</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_047"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Articles of Association</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of our Amended and Restated Articles of Association is attached as Exhibit 1.1 to this Annual Report. Other than as disclosed below,
the information called for by this Item is set forth in Exhibit 2.1 to this Annual Report and is incorporated by reference into this
Annual Report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_048"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Material Contracts</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not entered into any material contracts other than in the ordinary course of business and other than those described in Item 4.
&#8220;Information on Our Company,&#8221; Item 7B &#8220;Major Shareholders and Related Party Transactions - Related Party Transactions&#8221;
or elsewhere in this Annual Report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_049"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
Exchange Controls</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of
the shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that are,
or have been, in a state of war with Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_050"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.
Taxation.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership
and disposition of our ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign, or other taxing jurisdiction.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ISRAELI
TAX CONSIDERATIONS AND GOVERNMENT PROGRAMS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of the material Israeli tax laws applicable to us and certain Israeli Government programs. The following
also contains a discussion of material Israeli tax consequences concerning the ownership and disposition of our ordinary shares purchased
by investors in this offering. To the extent that the discussion is based on new tax legislation which has not been subject to judicial
or administrative interpretation, there can be no assurance that the tax authorities will accept the views expressed in this discussion.
This summary is based on laws and regulations in effect as of the date hereof, and is not intended, and should not be taken, as legal
or professional tax advice and is not exhaustive of all possible tax considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Corporate Tax Structure in Israel</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
resident companies are generally subject to corporate tax. The current corporate tax rate, as from 2018 is 23% However, the effective
tax rate payable by a company that derives income from a Preferred Enterprise (as discussed below) may be considerably less.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
gains derived by an Israeli resident company are generally subject to tax at the prevailing corporate tax rate. Under Israeli tax legislation,
a corporation will be considered as an &#8220;Israeli resident company&#8221; if it meets one of the following: (i) it was incorporated
in Israel; or (ii) the control and management of its business are exercised in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Law
for the Encouragement of Industry (Taxes), 5729-1969&#160;</i>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax
benefits for &#8220;Industrial Companies.&#8221;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as an Israeli resident-company, of which 90% or more of its income
in any tax year, other than income from defense loans, is derived from an &#8220;Industrial Enterprise&#8221; located in Israel owned
by it. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial
production.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following corporate tax benefits, among others, are available to Industrial Companies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of the cost of purchased a patent, rights to use a patent, and know-how, which are used for the development or promotion of the Industrial
    Enterprise, over an eight-year period and certain other intangible property rights (other than goodwill), commencing on the year
    in which such rights were first exercised;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    straight-line deduction of expenses related to a public offering over a three&#8211;year period commencing in the year of offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility
for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority. There is no assurance
that we qualify as an Industrial Company or that the benefits described above will be available in the future.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Encouragement of Research, Development and Technological Innovation in the Industry Law, 5744-1984&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Encouragement of Research, Development and Technological Innovation in the Industry Law, 5744-1984, or the Innovation Law, and its
related regulations, research and development programs which meet specified criteria and are approved by the Israeli Innovation Authority,
or the IIA, are eligible for grants of up to 50% of the project&#8217;s expenditure, as determined by the research committee, in exchange
for the payment of royalties from the revenues generated from the sale of products and related services developed, in whole or in part,
pursuant to, or as a result of, a research and development program funded by the IIA. The royalties are generally at a range of 3.0%
to 5.0% of revenues until the entire grant is repaid, together with an annual interest (as determined in the Innovation Law). Following
the full payment of such royalties and interest, there is generally no further liability for royalty payments. Nonetheless, the restrictions
under the Innovation Law (as generally specified below) will continue to apply even after our company has repaid the grants, including
accrued interest, in full.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
main obligations under the Innovation Law which are applicable to us as a grant recipient are:&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Local
manufacturing obligation</i>: The terms of the Innovation Law require that the manufacture of products developed with IIA grants be performed
in Israel. Manufacturing activity may not be transferred outside of Israel, unless the prior approval of the IIA is received. However,
this does not restrict the export of products that incorporate the funded technology. Ordinarily, as a condition to obtaining approval
to manufacture outside Israel, we would be required to pay royalties at an increased rate (usually 1% in addition to the standard rate)
and increased royalties cap between 120% and 300% of the grants, depending on the manufacturing volume that is performed outside Israel.
The transfer of no more than 10% of the manufacturing capacity in the aggregate outside of Israel is exempt under the Innovation Law
from obtaining the prior approval of the IIA. A company requesting funds from the IIA also has the option of declaring in its IIA grant
application its intention to perform part of its manufacturing outside Israel, thus avoiding the need to obtain additional approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transfer
of know-how outside of Israel:</i>&#160;The know-how developed within the framework of the IIA plan may not be transferred to third parties
outside Israel without the prior approval of the IIA. The approval, however, is not required for the export of any products developed
using grants received from the IIA. The IIA approval to transfer know-how created, in whole or in part, in connection with an IIA-funded
project, to a third party outside Israel is subject to payment of a redemption fee to the IIA calculated according to a formula provided
under the Innovation Law that is based, in general, on the ratio between the aggregate IIA grants to the company&#8217;s aggregate investments
in the project that was funded by these IIA grants, multiplied by the transaction consideration. The regulations promulgated under the
Innovation Law establish a cap of the redemption fee payable to the IIA under the above mentioned formulas and differentiate between
two situations: (i) in the event that the funded company sells its IIA funded know-how, in whole or in part, or is sold as part of an
merger and acquisition, or M&amp;A, transaction, and subsequently ceases to conduct business in Israel, the maximum redemption fee under
the above mentioned formulas will be no more than six times the total grants received from the IIA, including accrued interest; (ii)
in the event that following the transactions described above the company undertakes to continue its research and development activity
in Israel for at least three years following such transfer and maintain at least 75% of its research and development staff employees
it had for the six months before the know-how was transferred, while keeping the same scope of employment for such research and development
staff, then the company is eligible for a reduced cap of the redemption fee of no more than three times the amounts received (plus accrued
interest) for the applicable know-how being transferred, or the entire amount received from the National Authority for Technological
Innovation, or NATI, as applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
payment of such redemption fee, the know-how and the production rights for the products supported by such funding cease to be subject
to the Innovation Law. Transfer of such funded know-how to an Israeli entity is subject to the IIA approval and to an undertaking of
the recipient Israeli entity to comply with the provisions of the Innovation Law and related regulations, including the restrictions
on the transfer of know-how and the obligation to pay royalties, as further described in the Innovation Law and related regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Licensing
rules:</i>&#160;In May 2017, the IIA issued new rules for licensing know-how developed with the IIA&#8217;s funding outside of Israel,
or the Licensing Rules, which allow a company to enter into licensing arrangements or grant other rights in know-how developed under
the IIA&#8217;s programs outside of Israel, subject to the prior consent of the IIA and payment of license fees, calculated in accordance
with the Licensing Rules. The payment of the license fees will not discharge a company from the obligations to pay royalties or other
payments to the IIA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
reporting obligations:</i>&#160;A recipient of grants under the Innovation Law is required to notify the IIA of certain events enumerated
in the Innovation Law. In addition, the IIA may from time to time audit sales of products by companies which received funding from the
IIA and this may lead to additional royalties being payable on additional product candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not received any grants from the IIA. In the future, we may apply for such grants. In the event that a company has received IIA
grants, the abovementioned restrictions and requirements for payment may impair the ability of such a company to sell its technology
outside of Israel, or to outsource manufacturing or otherwise transfer know-how outside Israel and may require it to obtain the approval
or the IIA for certain actions and transactions and pay additional royalties or other payments to the IIA. If such a company fails to
comply with the Innovation Law, it may be subject to mandatory repayment of grants, together with interest and penalties, as well as
be exposed to criminal charges.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Benefits for Research and Development under the Encouragement of Industrial Research and Development Law, 5744-1984</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
tax law allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, related to scientific research
and development, for the year in which they are incurred. Expenditures are deemed related to scientific research and development projects,
if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    research and development must be for the promotion of the company; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    research and development is carried out by or on behalf of the company seeking such tax deduction.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific
research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is
related to an expense invested in an asset depreciable under the general depreciation rules of the Ordinance. Expenditures related to
scientific research and development that were not approved are deductible in equal amounts over three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time we may apply the IIA for approval to allow a tax deduction for all research and development expenses during the year incurred.
There can be no assurance that such application will be accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Law
for the Encouragement of Capital Investments, 5719-1959</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives
for capital investments in production facilities (or other eligible assets).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Law was significantly amended effective as of April&#160;1, 2005, as of January&#160;1, 2011, and as of January&#160;1, 2017
(the &#8220;2017 Amendment&#8221;). The 2017 Amendment introduces new benefits for Technology Enterprises, alongside the existing tax
benefits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Benefits Under the 2017 Amendment</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December&#160;29, 2016, and is effective as of
January&#160;1, 2017. The 2017 Amendment provides new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described
below, and is in addition to the other existing tax benefits programs under the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment provides that a technology company satisfying certain conditions will qualify as a &#8220;Preferred Technological Enterprise&#8221;
and will thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income,&#8221;
as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technological Enterprise located in development
zone &#8220;A.&#8221; In addition, a Preferred Technological Company will enjoy a reduced corporate tax rate of 12% on capital gain derived
from the sale of certain &#8220;Benefitted Intangible Assets&#8221; (as defined in the Investment Law) to a related foreign company if
the Benefitted Intangible Assets were acquired from a foreign company on or after January&#160;1, 2017, for at least NIS 200&#160;million,
and the sale receives prior approval from 7the IIA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment further provides that a technological company satisfying certain conditions (including a group turnover of at least NIS
10&#160;billion) will qualify as a &#8220;Special Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate
tax rate of 6% on &#8220;Preferred Technological Income&#8221; regardless of the company&#8217;s geographic location within Israel. In
addition, a Special Preferred Technological Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the
sale of certain &#8220;Benefitted Intangible Assets&#8221; to a related foreign company if the Benefitted Intangible Assets were either
developed by the Special Preferred Technological Enterprise or acquired from a foreign company on or after January&#160;1, 2017, and
the sale received prior approval from IIA. A Special Preferred Technological Enterprise that acquires Benefitted Intangible Assets from
a foreign company for more than NIS 500&#160;million will be eligible for these benefits for at least ten&#160;years, subject to certain
approvals as specified in the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
distributed by a Preferred Technological Enterprise or a Special Preferred Technological Enterprise, paid out of Preferred Technological
Income, are generally subject to withholding tax at source at the rate of 20% or such lower rate as may be provided in an applicable
tax treaty. However, if such dividends are paid to an Israeli company, no tax is required to be withheld. If such dividends are distributed
to a foreign company and other conditions are met, the withholding tax rate will be 4%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
in the future we generate taxable income, to the extent that we qualify as a &#8220;Preferred Company,&#8221; the benefits provided under
the Investment Law could potentially reduce our corporate tax liabilities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation
of our Shareholders</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capital
Gains</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
capital gain tax is imposed on the disposal of capital assets by an Israeli resident, and on the disposal of such assets by a non-Israeli
resident if those assets are either (i) located in Israel; (ii) are shares or a right to a share in an Israeli resident corporation,
or (iii) represent, directly or indirectly, rights to assets located in Israel. The Israeli Income Tax Ordinance of 1961 (New Version),
or the Ordinance, distinguishes between &#8220;Real Gain&#8221; and the &#8220;Inflationary Surplus.&#8221; The Inflationary Surplus
is a portion of the total capital gain which is equivalent to the increase of the relevant asset&#8217;s purchase price which is attributable
to the increase in the Israeli consumer price index or the foreign exchange rate differences in certain cases, between the date of purchase
and the date of sale. The Real Gain is the excess of the total capital gain over Inflationary Surplus. Inflationary Surplus generated
from December 31, 1993, is not subject to tax in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
Gain accrued by individuals on the sale of our ordinary shares will be taxed at the rate of 25%. However, if the individual shareholder
is a &#8220;Substantial Shareholder&#8221; (i.e., a person who holds, directly or indirectly, alone or together with such person&#8217;s
relative or another person who collaborates with such person on a permanent basis, 10% or more of one of the Israeli resident company&#8217;s
&#8220;means of control.&#8221; &#8220;Means of control&#8221; generally includes the right to vote, receive profits, nominate a director
or an officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, and all regardless
of the source of such right) at the time of sale or at any time during the preceding 12 months period, such gain will be taxed at the
rate of 30%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
Capital Gain derived by corporations will be generally subject to a corporate tax rate of 23% (in 2021).&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
Gains Taxes is Applicable also to Non-Israeli Resident Shareholders</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-Israeli resident who derives capital gains from the sale, exchange or disposition of shares in an Israeli resident company listed
on a non-Israeli stock exchange may be exempt from Israeli tax so long as the following cumulative conditions are met: (i) the shares
were purchased upon or after the registration of the securities on the stock exchange, (ii) the seller does not have a permanent establishment
in Israel to which the derived capital gain is attributed, and (iii) the capital gains are neither subject to section 101 of the Ordinance,
nor to the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985. However, non-Israeli corporations will not be entitled to the
foregoing exemption if Israeli residents (i) have a controlling interest of more than 25% in such non-Israeli corporation, or (ii) are
the beneficiaries of or are entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.
Furthermore, such exemption is not applicable to a person whose gains from selling or otherwise disposing of the securities are deemed
to be business income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
a sale of shares by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty
(subject to the receipt in advance of a valid certificate from the Israel Tax Authority, or the ITA). For example, under Convention Between
the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended,
or the U.S.-Israel Tax Treaty, the sale, exchange or other disposition of shares by a shareholder who is a United States resident (for
purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits afforded to such a resident by the
U.S.-Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli capital gains tax unless either: (i) the capital
gain arising from such sale, exchange or disposition is attributed to real estate located in Israel; (ii) the capital gain arising from
such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising from the such sale, exchange or disposition
is attributed to a permanent establishment of the Treaty U.S. Resident maintained in Israel, under certain terms; (iv) such Treaty U.S.
Resident holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period
preceding the sale, exchange or disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was
present in Israel for 183 days or more during the relevant taxable year. In any of these cases, the sale, exchange or disposition of
our ordinary shares would be subject to Israeli tax, to the extent applicable. However, under the U.S.-Israel Tax Treaty, such Treaty
U.S. Resident would be permitted to claim a credit for the tax against the U.S. federal income tax imposed with respect to the sale,
exchange or disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The United States-Israel Tax Treaty
does not provide such credit against any U.S. state or local taxes.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some instances where our shareholders may be liable for Israeli tax on the sale of their ordinary shares, the payment of the consideration
may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax
on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions involving a sale of
all of the shares of an Israeli resident company, in the form of a merger or otherwise, the Israeli Tax Authority may require from shareholders
who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption from the
Israeli Tax Authority to confirm their status as non-Israeli residents, and, in the absence of such declarations or exemptions, may require
the purchaser of the shares to withhold taxes at source.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Israeli
residents (whether individuals or corporations) are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary
shares at the rate of 25% (or 30% in the case such shareholder is considered a &#8220;substantial shareholder&#8221; at any point in
the preceding 12 month period), which tax will be withheld at source, unless relief is provided in an applicable tax treaty between Israel
and the shareholder&#8217;s country of residence. However, a distribution of dividends to non-Israeli residents is subject to withholding
tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred (including Preferred Technological)
Enterprise. If the dividend is attributable in part to income derived from a Preferred Enterprise or a Preferred Technological Enterprise,
the withholding rate will be a blended rate reflecting the relative portions of the types of income. We cannot assure you that we will
designate the profits that we may distribute in a way that will reduce shareholders&#8217; tax liability. Such dividends are generally
subject to Israeli withholding tax at a rate of 25% so long as the shares are registered with a nominee company (whether the recipient
is a substantial shareholder or not) and 20% if the dividend is distributed from income attributed to a Preferred Enterprise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
a reduced tax rate may be provided under an applicable tax treaty. For example, under the United States-Israel Tax Treaty, the maximum
rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty U.S. Resident is 25%. However,
generally, the maximum rate of withholding tax on dividends not generated by a Preferred Enterprise, that are paid to a United States
corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the dividend is distributed as well
as during the previous tax year is 12.5%, provided that not more than 25% of the gross income for such preceding year consists of certain
types of dividends and interest. If dividends are distributed from income attributed to a Preferred Enterprise, or a Preferred Technological
Enterprise and the foregoing conditions are met, such dividends are subject to a withholding tax rate of 15% for a shareholder that is
a United States corporation.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Excess
Tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the provisions of an applicable tax treaty, individuals who are subject to income tax in Israel (whether any such individual is an
Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on annual income (including, but not
limited to, income derived from dividends, interest and capital gains) exceeding NIS 651,600 for 2020, which amount is linked to the
annual change in the Israeli consumer price index.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Exchange Regulations</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-residents
of Israel who hold our ordinary shares are able to receive any dividends, and any amounts payable upon the dissolution, liquidation and
winding up of our affairs, repayable in non-Israeli currency at the rate of exchange prevailing at the time of conversion. However, Israeli
income tax is generally required to have been paid or withheld on these amounts. In addition, the statutory framework for the potential
imposition of currency exchange control has not been eliminated, and may be restored at any time by administrative action.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estate
and Gift Tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
law presently does not impose estate or gift taxes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
U.S. FEDERAL INCOME TAX CONSIDERATIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
FOLLOWING SUMMARY IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH
HIS OR HER OWN TAX ADVISOR AS TO THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND SALE OF COMMON SHARES, INCLUDING
THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND POSSIBLE CHANGES IN THE TAX LAWS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion summarizes certain U.S. federal income tax consequences to a &#8220;U.S. Holder&#8221; arising from the purchase,
ownership and sale of the Common Shares. For this purpose, a &#8220;U.S. Holder&#8221; is a holder of Common Shares that is, for U.S.
federal income tax purposes: (1) an individual citizen or resident of the United States; (2) a corporation (or entity treated as a corporation
for U.S. federal income tax purposes) created or organized under the laws of the United States or the District of Columbia or any political
subdivision thereof; (3) an estate, the income of which is includable in gross income for U.S. federal income tax purposes regardless
of its source; or (4) a trust if (A) a court within the United States is able to exercise primary supervision over the administration
of the trust and one or more U.S. persons have authority to control all substantial decisions of the trust, or (B) the trust has a valid
election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not purport to be a comprehensive description of all of the U.S. federal income tax considerations that may be relevant
to a decision to purchase our Common Shares. This summary generally considers only U.S. Holders that will own our Common Shares as capital
assets and does not consider the U.S. federal income tax consequences to a person that is not a U.S. Holder, nor does it describe the
rules applicable to determine a taxpayer&#8217;s status as a U.S. Holder. This summary is based on the provisions of the Internal Revenue
Code of 1986, as amended, or the Code, final, temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative
and judicial interpretations thereof, and the income tax treaty currently in force between the United States and Israel, or the Treaty,
all as in effect as of the date hereof and all of which are subject to change, possibly on a retroactive basis, and all of which are
open to differing interpretations. We will not seek a ruling from the Internal Revenue Service, or the IRS, with regard to the U.S. federal
income tax treatment of an investment in our Common Shares by U.S. Holders and, therefore, can provide no assurances that the IRS will
agree with the conclusions set forth below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular U.S. Holder based on such
U.S. Holder&#8217;s particular circumstances, such as the alternative minimum tax and the net investment income tax, and does not discuss
any estate, gift, generation-skipping transfer, state, local, excise or non-U.S. tax considerations. In addition, this discussion does
not address the U.S. federal income tax treatment of a U.S. Holder who is subject to special rules under the Code, including: (1) a bank,
insurance company, regulated investment company, or other financial institution; (2) a broker or dealer in securities or foreign currency;
(3) a person who acquired our Common Shares in connection with employment or other performance of services; (4) a U.S. Holder that holds
our Common Shares as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction transaction
for U.S. federal income tax purposes; (5) a tax-exempt organization, qualified retirement plan, individual retirement account or other
tax-deferred account; (6) real estate investment trusts or grantor trusts; (7) a U.S. expatriate or a former long-term resident of the
United States; or (8) a person having a functional currency other than the U.S. dollar. This discussion does not address the U.S. federal
income tax treatment of a U.S. Holder that owns, directly, indirectly or constructively, at any time, Common Shares representing 10%
or more of the stock of our Company. Additionally, the U.S. federal income tax treatment of partnerships (or other pass-through entities)
or persons who hold Common Shares through a partnership or other pass-through entity are not addressed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Each
prospective investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing,
holding or disposing of our Common Shares, including the effects of applicable state, local, foreign or other tax laws and possible changes
in the tax laws.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of Dividends Paid on Common Shares</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to pay dividends in the foreseeable future. In the event that we do pay dividends, and subject to the discussion under
the heading &#8220;Passive Foreign Investment Company Rules&#8221; below and the discussion of &#8220;qualified dividend income&#8221;
below, a U.S. Holder will be required to include in gross income as ordinary income the amount of any distribution paid on the Common
Shares (including the amount of any Israeli tax withheld on the date of the distribution), to the extent that such distribution does
not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes. The amount of a distribution
that exceeds our earnings and profits will be treated first as a non-taxable return of capital, reducing the U.S. Holder&#8217;s tax
basis for the Common Shares to the extent thereof, and then as capital gain. We do not expect to maintain calculations of our earnings
and profits under U.S. federal income tax principles and, therefore, U.S. Holders should expect that the entire amount of any distribution
generally will be reported as dividend income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, preferential tax rates for &#8220;qualified dividend income&#8221; and long-term capital gains are applicable for U.S. Holders
that are individuals, estates or trusts. For this purpose, &#8220;qualified dividend income&#8221; means, inter alia, dividends received
from a &#8220;qualified foreign corporation,&#8221; provided that certain holding-period requirements and other conditions are satisfied.
A &#8220;qualified foreign corporation&#8221; is a corporation that is entitled to the benefits of a comprehensive tax treaty with the
United that the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which includes
an exchange of information program. The IRS has stated that the Treaty satisfies this requirement and we believe we are eligible for
the benefits of the Treaty. In addition, our dividends will be qualified dividend income if our Common Shares are readily tradable on
Nasdaq or another established securities market in the United States. However, we will not be a qualified foreign corporation if we are
a PFIC, as described below under &#8220;Passive Foreign Investment Company Rules,&#8221; for the taxable year in which we pay a dividend
or for the preceding taxable year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
distributions paid by us in NIS will be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange
in effect on the date the dividend is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS
for U.S. federal income tax purposes equal to such U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars
or otherwise disposes of them, any subsequent gain or loss in respect of such NIS arising from exchange rate fluctuations will be U.S.
source ordinary exchange gain or loss.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain conditions and limitations, non-refundable withholding taxes (at a rate not in excess of any applicable tax treaty rate),
if any, on dividends paid by us may be treated as foreign taxes eligible for credit against a U.S. Holder&#8217;s U.S. federal income
tax liability under the U.S. foreign tax credit rules. However, as a result of recent changes to the U.S. foreign tax credit rules, a
withholding tax generally will need to satisfy certain additional requirements in order to be considered a creditable tax for a U.S.
Holder. We have not determined whether these requirements have been met and, accordingly, no assurance can be given that any withholding
tax on dividends paid by us will be creditable. For purposes of calculating the U.S. foreign tax credit, dividends paid with respect
to our Common Shares generally will be treated as foreign source income and as passive category income. In lieu of claiming a foreign
tax credit, a U.S. Holder may deduct foreign taxes, including any foreign income tax imposed with respect to their Common Shares, in
computing their taxable income, subject to generally applicable limitations under U.S. federal income tax law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules relating to the determination of the foreign tax credit are complex, and each U.S. Holder should consult its tax advisors to determine
whether and to what extent such U.S. Holder will be entitled to this credit.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of the Sale, Exchange or other Disposition of Common Shares</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided under the PFIC rules described below under &#8220;Passive Foreign Investment Company Rules,&#8221; upon the sale, exchange
or other disposition of our Common Shares, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between
such U.S. Holder&#8217;s tax basis for the Common Shares, determined in U.S. dollars, and the U.S. dollar value of the amount realized
on the disposition (or its U.S. dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if
the amount realized is denominated in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of Common
Shares will be long-term capital gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition.
Individuals who recognize long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses
is subject to various limitations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Passive
Foreign Investment Company Rules</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
treatment of U.S. Holders of Common Shares could be materially different from that described above if we are treated as a PFIC for U.S.
federal income tax purposes. We will be treated as a PFIC for U.S. federal income tax purposes for any taxable year with respect to which
either:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%
    or more of our gross income constitutes passive income for purposes of the PFIC rules; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%
    or more of our assets (generally determined on the basis of a quarterly average value) are held for the production of, or produce,
    passive income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
this purpose, passive income generally consists of rents, dividends, interest, royalties, gains from the disposition of passive assets
and gains from certain commodities and securities transactions. Cash generally is treated as generating passive income. The value of
goodwill is an active asset to the extent attributable to activities that produce active income. The determination of whether a foreign
corporation is a PFIC is based upon the composition of such foreign corporation&#8217;s income and assets (including, among others, its
proportionate share of the income and assets of any other corporation in which it owns, directly or indirectly, 25% (by value) of the
stock), and the nature of such foreign corporation&#8217;s activities. A separate determination must be made after the close of each
taxable year as to whether a foreign corporation was a PFIC for that year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the projected composition of our income and valuation of our assets, we may have been a PFIC during 2022, and although we have not
determined whether we will be a PFIC in 2023, or in any subsequent year, our operating results for any such years may cause us to be
a PFIC. The tests for determining PFIC status are applied annually after the close of the taxable year, and therefore our possible status
as a PFIC may be subject to change. Further, because the value of our goodwill may be determined based on the market value of the Common
Shares, a decrease in the market value of the Common Shares and/or an increase in cash or other passive assets would increase the relative
percentage of our passive assets. The application of the PFIC rules is subject to uncertainty in several respects and, therefore, no
assurances can be provided that we will not be a PFIC for any taxable year. If we are treated as a PFIC during a U.S. Holder&#8217;s
holding period for Common Shares, we will, with respect to such U.S. Holder, continue to be treated as a PFIC, regardless of whether
we satisfied either of the qualification tests in subsequent years, subject to certain exceptions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we currently are or become a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon
receipt of certain &#8220;excess distributions&#8221; by us and upon disposition of our Common Shares at a gain: (1) have such excess
distribution or gain allocated ratably over the U.S. Holder&#8217;s holding period for the Common Shares, as the case may be; (2) the
amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC
would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest
rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would
be imposed with respect to the resulting tax attributable to each such other taxable year. Distributions received by a U.S. Holder in
a taxable year that are greater than 125% of the average annual distributions received during the shorter of the three preceding taxable
years or the U.S. Holder&#8217;s holding period for the Common Shares will be treated as excess distributions. Indirect investments in
a PFIC may also be subject to these special U.S. federal income tax rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an alternative to the foregoing rules, a U.S. Holder may make a mark-to-market election with respect to the Common Shares, provided such
Common Shares are treated as &#8220;marketable stock.&#8221; The Common Shares generally will be treated as marketable stock if they
are regularly traded on a &#8220;qualified exchange or other market,&#8221; as defined in applicable U.S. Treasury regulations. The Common
Shares will be marketable stock as long as they remain listed on Nasdaq, which is a qualified exchange for this purpose, and are regularly
traded.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a U.S. Holder makes a valid mark-to-market election with respect to the Common Shares, the holder generally will (i) include as ordinary
income for each taxable year that we are a PFIC the excess, if any, of the fair market value of Common Shares held at the end of the
taxable year over the adjusted tax basis of such Common Shares and (ii) deduct as an ordinary loss in each such taxable year the excess,
if any, of the adjusted tax basis of the Common Shares over the fair market value of such Common Shares held at the end of the taxable
year, but such deduction will only be allowed to the extent of the net amount previously included in income as a result of the mark-to-
market election. The U.S. Holder&#8217;s adjusted tax basis in the Common Shares would be adjusted to reflect any income or loss resulting
from the mark-to-market election. If a U.S. Holder makes a mark-to-market election in respect of the Common Shares and we cease to be
classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that we
are not classified as a PFIC. If a U.S. Holder makes a mark-to-market election, any gain such U.S. Holder recognizes upon the sale or
other disposition of the Common Shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as
ordinary loss, but such loss will only be treated as ordinary loss to the extent of the net amount previously included in income as a
result of the mark-to-market election.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are determined to be a PFIC, we do not intend to provide the information necessary for a U.S. Holder to make a qualified electing
fund, or QEF, election with respect to the Common Shares which, if available, would result in a tax treatment different from (and generally
less adverse than) the general tax treatment for PFICs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder that owns (or is deemed to own) shares in a PFIC during any taxable year of the U.S. Holder generally is required to file
an IRS Form 8621 with such U.S. Holder&#8217;s U.S. federal income tax return and provide such other information as the IRS may require.
Failure to file IRS Form 8621 for each applicable taxable year may result in substantial penalties and the statute of limitations on
the assessment and collection of U.S. federal income taxes of such U.S. Holder for the related taxable year may not close until three
years after the date on which the required information is filed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules dealing with PFICs are very complex and are affected by various factors in addition to those described above. Accordingly, U.S.
Holders of Common Shares are urged to consult their tax advisors concerning the application of the PFIC rules to their Common Shares
under their particular circumstances</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Additional
Reporting Requirements</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. Holders holding specified foreign financial assets with an aggregate value in excess of the applicable dollar thresholds are required
to report information to the IRS relating to such assets, subject to certain exceptions (including an exception for specified foreign
financial assets held in accounts maintained by U.S. financial institutions), by attaching a complete IRS Form 8938 to their tax return,
for each year in which they hold such assets. Failure to file IRS Form 8938 for each applicable taxable year may result in substantial
penalties and the statute of limitations on the assessment and collection of U.S. federal income taxes of such U.S. Holder for the related
taxable year may not close until three years after the date on which the required information is filed. U.S. Holders should consult their
tax advisors regarding the effect, if any, of these rules on the ownership and disposition of the Common Shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Information
Reporting and Backup Withholding</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
reporting requirements may apply to cash received in redemption of the Common Shares, dividends paid on the Common Shares and the proceeds
received on the disposition of the Common Shares effected within the United States (and, in certain cases, outside the United States),
in each case other than with respect to U.S. Holders that are exempt recipients (such as corporations). Backup withholding may apply
to such amounts if the U.S. Holder fails to provide an accurate taxpayer identification number (generally on an IRS Form W-9 provided
to the paying agent of the U.S. Holder&#8217;s broker) or is otherwise subject to backup withholding. U.S. Holders should consult their
tax advisors regarding the application of the U.S. information reporting and backup withholding rules.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_051"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.
Dividends and Paying Agents</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_052"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.
Statement by Experts</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_053"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.
Documents on Display</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to certain information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those
requirements will file reports with the SEC.&#160;The SEC maintains an internet site at http://www.sec.gov that contains reports, proxy
and information statements and other information regarding issuers that file electronically with the SEC. Our filings with the SEC will
also be available to the public through the SEC&#8217;s website at www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements,
and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained
in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports
and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the
Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required
by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm,
and may submit to the SEC, on a Form 6-K, unaudited quarterly financial information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_054"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.
Subsidiary Information.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>J. Annual Report to Security Holders.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_055"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures about Market Risk</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial
position due to adverse changes in financial market prices and rates. Our current investment policy is to invest available cash in bank
deposits with banks that have a credit rating of at least A-minus. Accordingly, some of our cash and cash equivalents is held in deposits
that bear interest. Given the current low rates of interest we receive, we will not be adversely affected if such rates are reduced.
Our market risk exposure is primarily a result of U.S. dollar/NIS exchange rates, which is discussed in detail in the following paragraph.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Exchange Risk</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations and cash flow are subject to fluctuations due to changes in U.S. dollar/NIS currency exchange rates. A certain
portion of our cash and cash equivalents is held in U.S. dollars, and the vast majority of our expenses is denominated in NIS. Changes
of 5% and 10% in the U.S. dollar/NIS exchange rate would increase/decrease our operating expenses for the year ended December 31, 2022
by approximately 4.24% and 8.09%, respectively. However, these historical figures may not be indicative of future exposure, as we expect
that the percentage of our NIS denominated expenses will decrease in the near future as our operations expand globally, therefore reducing
our exposure to exchange rate fluctuations. Currently, we do not hedge our foreign currency exchange risk. In the future, we may enter
into formal currency hedging transactions to decrease the risk of financial exposure from fluctuations in the exchange rates of our principal
operating currencies. These measures, however, may not adequately protect us from the material adverse effects of such fluctuations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
risk</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
monitor forecasts of our liquidity reserve (comprising cash and cash equivalents). We generally carry this out based on our expected
cash flows in accordance with practice and limits set by our management. We are in the process of expanding our operations and the expenses
associated therewith and we are therefore exposed to liquidity risk. However, we believe that our existing funds will enable us to fund
our operating expenses and capital expenditure requirements for the twelve months following the date of this Annual Report on Form 20-F.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_056"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;12.
DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_057"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.
Debt Securities.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_058"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.
Warrants and rights.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_059"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.
Other Securities.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_060"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.
American Depositary Shares</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_061"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART&#160;II</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_062"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;13.
DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_063"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no material modifications to the rights of security holders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_064"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. CONTROLS AND PROCEDURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Disclosure Controls and Procedures</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our
disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31,
2022, or the Evaluation Date. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure
controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to
be included in periodic filings under the Exchange Act and that such information is accumulated and communicated to management, including
our principal executive and financial officers,&#160;as appropriate to allow timely decisions regarding required disclosure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remediation
Efforts on Previously Reported Material Weaknesses </i></b></span></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the audit of our financial statements for the years ended December 31, 2020 and 2021, material weaknesses were identified in our internal
control over financial reporting. A material weakness is a deficiency or combination of deficiencies in internal control over financial
reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will
not be prevented or detected on a timely basis by the company&#8217;s internal controls. The material weaknesse that was identified was
related to our entity level control components relating to documenting our financial reporting process.In 2022, we implemented controls
to remedy this material weakness. In 2022, we hired our controller which joined our CFO as part of a process of evaluating the adequacy
of our accounting personnel staffing level and other matters related to our internal control over financial reporting. We engaged outside
consultants (which is also our Internal auditor) and adopt a detailed work plan to assess and document the adequacy of internal control
over financial reporting and we validated through testing that controls are functioning as documented and implement a continuous reporting
and improvement process for internal control over financial reporting. In May 2022, we added a financial expert to the audit committee
of the board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of these remediation activities and based on testing of the new and modified controls for operating effectiveness, our management
concluded that we remediated the previously reported material weakness as of December 31, 2022.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Management&#8217;s Annual Report on Internal Control over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined
in Rule 13a-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive
Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting
based principally on the framework and criteria established in Internal Control - Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway Commission as of the end of the period covered by this report. Based on that evaluation,
our management has concluded that our internal control over financial reporting was effective as of December 31, 2022 at providing reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles.<b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Attestation Report of the Registered Public Accounting Firm</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 20-F does not include an attestation report of our independent registered public accounting firm regarding internal
control over financial reporting due to an exemption for emerging growth companies provided in the JOBS Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Changes in Internal Control over Financial Reporting</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, there were no changes in our internal control over financial reporting that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16. [RESERVED]</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16A. AUDIT COMMITTEE FINANCIAL EXPERT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that Mr. Oz Adler, is an audit committee financial expert as such term is defined by the SEC rules
and has the requisite financial experience as defined by the Nasdaq Rules. Each of the members of our audit committee is &#8220;independent&#8221;
as such term is defined in Rule 10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq
Rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="b_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16B.
CODE OF ETHICS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has adopted a Code of Ethics applicable to all of our directors and employees, including our Chief Executive Officer,
Chief Financial Officer, controller or principal accounting officer, or other persons performing similar functions, which is a &#8220;code
of ethics&#8221; as defined in Item 16B of Form 20-F promulgated by the SEC. The full text of the Code of Ethics is posted on our website
at <i>www.railvision.io.</i> Information contained on, or that can be accessed through, our website does not constitute a part of this
a part of this Annual Report on Form 20-F and is not incorporated by reference herein. If we make any amendment to the Code of Ethics
or grant any waivers, including any implicit waiver, from a provision of the Code of Ethics, we will disclose the nature of such amendment
or waiver on our website to the extent required by the rules and regulations of the SEC. We have not granted any waivers under our Code
of Business Conduct and Ethics.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16C.
PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brightman
Almagor Zohar &amp; Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm, or Deloitte, has served
as our principal independent registered public accounting firm for the year ended December 31, 2022, and 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding fees paid or to be paid by us to Brightman Almagor Zohar &amp; Co., a firm in the Deloitte
Global Network, an independent registered public accounting firm, for all services, including audit services, for the years ended December
31, 2022, and 2021:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">(USD in thousands)</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Audit fees (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">120</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Audit-related fees (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Tax fees (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">All other fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">361</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">126</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
fees consist of professional services provided in connection with the audit of our annual financial statements.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related
fees consist of services in connection with our initial public offering.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
fees consist of fees for professional services for tax compliance, tax advice, and tax audits</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Approval
of Auditors&#8217; Compensation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee has a pre-approval policy for the engagement of our independent registered public accounting firm to perform certain
audit and non-audit services. Pursuant to this policy, which is designed to assure that such engagements do not impair the independence
of our auditors, the audit committee pre-approves annually a catalog of specific audit and non-audit services in the categories of audit
services, audit-related services and tax services that may be performed by our independent registered public accounting firm. If a type
of service, that is to be provided by our auditors, has not received such general pre-approval, it will require specific pre-approval
by our audit committee. The policy prohibits retention of the independent registered public accounting firm to perform the prohibited
non-audit functions defined in applicable SEC rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-indent: -63.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-indent: -63.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16E.
PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16F.
CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16G.
CORPORATE GOVERNANCE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sarbanes-Oxley Act, as well as related rules subsequently implemented by the SEC, require foreign private issuers, such as us, to comply
with various corporate governance practices. In addition, following the listing of our ordinary shares and warrants on the Nasdaq Capital
Market, we are required to comply with the Nasdaq Listing Rules. Under those rules, we may elect to follow certain corporate governance
practices permitted under the Companies Law in lieu of compliance with corresponding corporate governance requirements otherwise imposed
by the Nasdaq Listing Rules for U.S. domestic issuers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Israeli law and practice and subject to the exemption set forth in Rule&#160;5615 of the Nasdaq Listing Rules, we have
elected to follow the provisions of the Companies Law, rather than the Nasdaq Listing Rules, with respect to the following requirements:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution
    of periodic reports to shareholders; proxy solicitation.</i>&#160;As opposed to the Nasdaq Listing Rules, which require listed issuers
    to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute
    periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports
    to shareholders but to make such reports available through a public website. In addition to making such reports available on a public
    website, we currently make our audited financial statements available to our shareholders at our offices and will only mail such
    reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC&#8217;s proxy solicitation
    rules.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quorum</i>.
    While the Nasdaq Listing Rules require that the quorum for purposes of any meeting of the holders of a listed company&#8217;s common
    voting stock, as specified in the company&#8217;s bylaws, be no less than 33 1/3% of the company&#8217;s outstanding issued and outstanding
    share capital, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and
    percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provides
    that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement
    of business at a general meeting. However, the quorum set forth in our amended and restated articles of association with respect
    to an adjourned meeting consists of any number of shareholders present in person or by proxy.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination
    of our directors.</i>&#160;Our amended and restated articles of association provides that shareholders are entitled to appoint a director to the Company&#8217;s board of directors for each 10% of the Company&#8217;s
    outstanding share capital that they own and such appointment shall be for undefined period. Additional board members are elected
    at our shareholder&#8217;s annual meetings and in such case they shall serve on the board of directors until the next annual general
    meeting (except for external directors which will serve for up to three terms, each term of three years&#8217; period). In addition,
    our amended and restated articles allow our board of directors to appoint directors to fill vacancies and/or as an addition to the
    board of directors (subject to the maximum number of directors) to serve until the next annual general meeting. All of the elected
    directors, other than external directors, may be re-elected for an unlimited number of terms upon completion of their then-current
    term of office. The nominations for directors are made in accordance with the provisions of our amended and restated articles of
    association and the Companies Law. Nominations need not be made by a nominating committee of our board of directors consisting solely
    of independent directors, as required under the Nasdaq Listing Rules.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
    of officers.</i>&#160;Israeli law and our amended and restated articles of association does not require that the independent members
    of our board of directors (or a compensation committee composed solely of independent members of our board of directors) determine
    an executive officer&#8217;s compensation, as is generally required under the Nasdaq Listing Rules with respect to the chief executive
    officer and all other executive officers. Instead, compensation of executive officers is determined and approved by our compensation
    committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder
    compensation policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the
    Companies Law.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Independent
    directors.</i>&#160;Israeli law does not require that a majority of the directors serving on our board of directors be &#8220;independent,&#8221;
    as defined under Nasdaq Stock Market Rule&#160;5605(a)(2), and rather requires we have at least two external directors who meet the
    requirements of the Companies Law, as described below under &#8220;Directors, Senior Management and Employees&#8212;Board Practices&#8212;External
    Directors.&#8221; The definition of independent director under Nasdaq Listing Rules and external director under the Companies Law
    overlap to a significant degree such that we would generally expect the directors serving as external directors to satisfy the requirements
    to be independent under Nasdaq Listing Rules. However, it is possible for a director to qualify as an &#8217;&#8216;external director&#8217;&#8217;
    under the Companies Law without qualifying as an &#8217;&#8216;independent director&#8217;&#8217; under the Nasdaq Listing Rules,
    or vice-versa. Our board of directors has determined that Mr. Yossi Daskal, Oz Adler, and Mrs. Inbal Kreiss are &#8220;independent&#8221;
    for purposes of the Nasdaq Listing Rules. We are required, however, to ensure that all members of our Audit Committee are &#8220;independent&#8221;
    under the applicable Nasdaq and SEC criteria for independence (as we cannot exempt ourselves from compliance with that SEC independence
    requirement, despite our status as a foreign private issuer), and we must also ensure that a majority of the members of our Audit
    Committee are &#8220;independent directors&#8221; as defined in the Companies Law. Furthermore, Israeli law does not require, nor
    do our independent directors conduct, regularly scheduled meetings at which only they are present, which the Nasdaq Listing Rules
    otherwise require.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    approval.</i>&#160;We will seek shareholder approval for all corporate actions requiring such approval under the requirements of
    the Companies Law, rather than seeking approval for corporate actions in accordance with Nasdaq Stock Market Rule&#160;5635. In particular,
    under this Nasdaq Stock Market rule, shareholder approval is generally required for: (i)&#160;an acquisition of shares or assets
    of another company that involves the issuance of 20% or more of the acquirer&#8217;s shares or voting rights or if a director, officer
    or 5% shareholder has greater than a 5% interest in the target company or the consideration to be received; (ii)&#160;the issuance
    of shares leading to a change of control; (iii)&#160;adoption or amendment of equity compensation arrangements (although under the
    provisions of the Companies Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation
    plan); and (iv)&#160;issuances of 20% or more of the shares or voting rights (including securities convertible into, or exercisable
    for, equity) of a listed company via a private placement (and/or via sales by directors, officers or 5% shareholders) if such equity
    is issued (or sold) at below the greater of the book or market value of shares. By contrast, under the Companies Law, shareholder
    approval is required for, among other things: (i)&#160;transactions with directors concerning the terms of their service or indemnification,
    exemption and insurance for their service (or for any other position that they may hold at a company), for which approvals of the
    compensation committee, board of directors and shareholders are all required, (ii)&#160;extraordinary transactions with controlling
    shareholders of publicly held companies, which require the special approval, and (iii)&#160;terms of employment or other engagement
    of the controlling shareholder of us or such controlling shareholder&#8217;s relative, which require special approval. In addition,
    under the Companies Law, a merger requires approval of the shareholders of each of the merging companies.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval
    of Related Party Transactions</i>. All related party transactions are approved in accordance with the requirements and procedures
    for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit
    committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for
    specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required
    under the Nasdaq Listing Rules.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>
</div><div><a id="b_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16H.
MINE SAFETY DISCLOSURE</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-indent: -63.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-indent: -63.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16I.
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART&#160;III</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_076"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;17.
FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to provide financial statements and related information pursuant to Item&#160;18.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_077"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;18.
FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements and the related notes required by this Item are included in this Annual Report on Form 20-F beginning on page&#160;F-1.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_078"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;19.
EXHIBITS.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 10%; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 89%; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Exhibit
    Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">1.1</span></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex3-2_railvision.htm">Amended and Restated Articles of Association of the Company, as currently in effect (included as Exhibit 3.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">2.1*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="f20f2022ex2-1_railvisionltd.htm">Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">2.2</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex4-3_railvision.htm">Form of Warrant (included as Exhibit 4.3 to the Registration Statement on Form F-1 as filed with the Securities and Exchange Commission March 24, 2022, as amended, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex4-1_railvision.htm">Form of Underwriter&#8217;s Warrant (included as Exhibit 4.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.2</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex4-2_railvision.htm">Form of Warrant Agent Agreement (included as Exhibit 4.2 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.3</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex10-1_railvision.htm">Form of Indemnification Agreement (included as Exhibit 10.1 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.4*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><a href="f20f2022ex4-4_railvisionltd.htm"><span style="font-size: 10pt">Rail Vision Ltd. Amended Share Option Plan, amended as of September 13, 2022</span></a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.5</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex10-3_railvision.htm">Compensation Policy (included as Exhibit 10.3 to the Registration Statement on Form F-1 as filed with the Securities and Exchange Commission March 24, 2022, as amended, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.6</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022014921/ea156933ex10-4_railvision.htm">Amended and Restated Investors&#8217; Rights Agreement between the Company, Knorr-Bremse and Foresight, dated October 13, 2020 (included as Exhibit 10.4 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference)</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.7</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022011664/ea156426ex10-6_railvision.htm">Framework agreement between the Company and Knorr-Bremse Rail Systems Schweiz AG, dated August 2020 (included as Exhibit 10.6 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.8</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022011664/ea156426ex10-7_railvision.htm">Investment Agreement between the Company and Knorr-Bremse, dated October 13, 2020 (included as Exhibit 10.7 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">4.9</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1743905/000121390022011664/ea156426ex10-8_railvision.htm">Strategic Partnership Agreement by and between the Company and Knorr-Bremse, dated August 19, 2021 (included as Exhibit 10.8 to our Registration Statement on Form F-1 as filed with the Securities and Exchange Commission on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">12.1*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="f20f2022ex12-1_railvisionltd.htm">Certification of the Chief Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">12.2*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="f20f2022ex12-2_railvisionltd.htm">Certification of the Chief Financial Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">13.1*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="f20f2022ex13-1_railvisionltd.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">13.2*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><a href="f20f2022ex13-2_railvisionltd.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350</a></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">101</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">The following financial information
    from Rail Vision Ltd.&#8217;s Annual Report on Form&#160;20-F&#160;for the year ended December 31, 2022, formatted in Inline Extensible
    Business Reporting Language (XBRL): (i)&#160;Statement of Financial Position, (ii) Statements of Comprehensive Loss, (iii) Statements
    of Changes in Equity, (iv) Statements of Cash Flows and (iv)&#160;Notes to Financial Statements.*</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="b_079"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant hereby certifies that it meets all of the requirements for filing on Form&#160;20-F and that it has duly caused and authorized
the undersigned to sign this Annual Report on Form 20-F filed on its behalf.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RAIL
    VISION LTD.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 23, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Shahar Hania</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shahar
    Hania</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></span></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 24pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">Rail Vision Ltd.</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">As of December 31, 2022</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 93 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">Rail Vision Ltd.</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">As of December 31, 2022</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">TABLE OF CONTENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 85%; text-align: justify">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Page</b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><a href="#a_001">Report of Independent Registered Public Accounting Firm (PCAOB ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">1197</ix:nonNumeric>)</a></b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-2</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Financial Statements:</span></b></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_002">Balance Sheets</a></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-3</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_003">Statements of Comprehensive Loss</a></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">F-<span style="font-family: Times New Roman, Times, Serif">4</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_004">Statements of Convertible Preferred Shares and Shareholders&#8217; Equity</a></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">F-<span style="font-family: Times New Roman, Times, Serif">5 - F-6</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_005">Statements of Cash Flows</a></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">F-<span style="font-family: Times New Roman, Times, Serif">7</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="text-align: justify">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_006">Notes to the Financial Statements</a></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">F-8 - F-25</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 94; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><img alt="" src="fin_001.jpg"/>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>To the Shareholders and Board of Directors
of</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RAIL VISION LTD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying balance sheets
of Rail Vision Ltd. (the &#8220;Company&#8221;) as of December 31, 2022 and 2021 and the related statements of comprehensive loss, change
in convertible preferred shares and shareholders&#8217; equity and cash flows for each of the three years in the period ended December 31,
2022 and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of
its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles
generally accepted in the United States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
1 to the financial statements, the Company&#8217;s lack of sufficient revenues and substantial operating losses raise substantial doubt
about its ability to continue as a going concern. Management&#8217;s plans concerning these matters are also described in Note 1 to the
financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to
assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well
as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 40%; text-align: justify">/<span style="font-family: Times New Roman, Times, Serif">s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName">Brightman Almagor Zohar &amp; Co.</ix:nonNumeric></span></td> <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certified Public Accountants</span></td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A Firm in the Deloitte Global Network</span></td> <td style="text-align: justify">&#160;</td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 23, 2023</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor since
2016.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="fin_002.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Balance
Sheets</b><br/>
(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="text-decoration:underline">ASSETS</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="text-decoration:underline">Current assets</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">8,270</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">1,649</ix:nonFraction></td><td style="width: 1%; text-align: left"></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Restricted cash</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd">200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReceivablesNetCurrent" scale="3" unitRef="usd">115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReceivablesNetCurrent" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">3</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">472</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">8,832</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">2,408</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Operating lease - right of use asset</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">1,151</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">1,433</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">Fixed assets, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">4</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">449</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">570</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">1,600</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">2,003</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">10,432</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">4,411</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; text-align: left">LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trade accounts payable</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd">56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd">139</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current operating lease liability</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">281</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd">299</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">Other accounts payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">5</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="3" unitRef="usd">1,032</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrent" scale="3" unitRef="usd">1,114</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">1,369</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">1,552</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Non-current operating lease liability</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">1,221</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">2,167</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">2,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; text-align: left">Temporary equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">Preferred A shares, NIS <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares">0.01</ix:nonFraction></ix:nonFraction> par value; Authorized <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares">100,000</ix:nonFraction></ix:nonFraction> shares; Issued and outstanding: <span style="-sec-ix-hidden: hidden-fact-2"><span style="-sec-ix-hidden: hidden-fact-3">No</span></span> shares as at December 31, 2022 and <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesOutstanding" scale="0" unitRef="shares">51,282</ix:nonFraction></ix:nonFraction> shares as of December 31, 2021;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" unitRef="usd">9,965</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; text-align: left">Shareholders&#8217; equity (deficit)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ordinary shares, NIS <ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares">0.01</ix:nonFraction></ix:nonFraction> par value; Authorized <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">99,900,000</ix:nonFraction></ix:nonFraction> shares; Issued and outstanding: <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">15,896,040</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">9,157,324</ix:nonFraction></ix:nonFraction> shares as of December 31, 2022 and 2021</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd">46</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd">25</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">63,033</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">35,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">54,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">44,339</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold; text-align: left">Total shareholders&#8217; equity (deficit)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">8,265</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" sign="-" unitRef="usd">8,327</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold; text-align: left">TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">10,432</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">4,411</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The accompanying notes are an integral part
of the financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Statements of Comprehensive Loss</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(U.S. dollars in thousands, except share and
per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended December 31,</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Note</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2022</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2021</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2020</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Revenues</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 9%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">421</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">888</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#8212;</div></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Cost of revenues</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">661</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">657</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#8212;</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Gross profit <span style="font: normal 10pt Times New Roman, Times, Serif">(loss)</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" sign="-" unitRef="usd">240</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">231</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">&#8212;</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research and development expenses, net</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">9</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">6,230</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">7,208</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">7,205</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">General and administrative expenses</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">10</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">4,265</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">3,316</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">3,500</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Operating loss</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">10,735</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">10,293</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">10,705</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Financial income (expenses), net</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd">260</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd">73</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" sign="-" unitRef="usd">2</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt">Net loss</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,475</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,220</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,707</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt"><b style="-sec-ix-hidden: hidden-fact-9; -sec-ix-hidden: hidden-fact-8; -sec-ix-hidden: hidden-fact-7">Basic and diluted loss per ordinary share </b></td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.74</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">1.12</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">1.17</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-indent: -10pt; text-align: justify; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-12; -sec-ix-hidden: hidden-fact-11; -sec-ix-hidden: hidden-fact-10">Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share(*)</div></td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares">14,174,422</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares">9,148,143</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares">9,136,600</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C).</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The accompanying notes are an integral part
of the financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Statements of Convertible Preferred Shares
and Changes in Shareholders&#8217; Equity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(U.S. dollars in thousands, except share and
per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Convertible Preferred A Shares</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font: 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><div style="font: 9pt Times New Roman, Times, Serif; padding: 0in 0in 1pt"><p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ordinary&#160;Shares(**)</b></p> </div></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: center"><b>Additional</b></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: 9pt Times New Roman, Times, Serif; text-align: center"><b>Total shareholders&#8217;</b></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">USD</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">USD</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> paid in<br/>
 capital</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Accumulated Deficit</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> equity<br/>
 (deficit)</td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 40.5%; text-align: left">BALANCE AS OF DECEMBER 31, 2019</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">&#160;</div></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">&#160;</div></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">9,136,600</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">25</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">33,052</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right">(<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">23,412</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">)</td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; width: 7%; text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">9,665</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; text-align: justify">CHANGES DURING 2020:</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of convertible preferred shares, net of issuance costs(***)</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" id="ix_10_fact" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares">51,282</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" id="ix_11_fact" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd">4,965</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based payment</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">1,949</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">1,949</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,707</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,707</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: justify">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">BALANCE AS OF DECEMBER 31, 2020</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">51,282</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">4,965</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">9,136,600</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">25</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">35,001</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" sign="-" unitRef="usd">34,119</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">)</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">907</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; text-align: left">CHANGES DURING 2021:</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of convertible preferred shares</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountIssued1" scale="3" unitRef="usd">5,000</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of shares as a result of exercise of options</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c21" decimals="INF" format="ixt:num-dot-decimal" id="ix_7_fact" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">20,724</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">127</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">127</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based payment</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">859</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">859</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">&#8212;</div></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,220</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,220</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">BALANCE AS OF DECEMBER 31, 2021</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">51,282</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">9,965</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-left: Black 1.5pt solid; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="INF" format="ixt:num-dot-decimal" id="ix_8_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">9,157,324</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" id="ix_9_fact" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">25</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">35,987</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" sign="-" unitRef="usd">44,339</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">)</td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt">&#160;</td>
    <td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="font: 9pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" sign="-" unitRef="usd">8,327</ix:nonFraction></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US">Represents an amount less than $1.</ix:footnote></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left">(**)</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C)</ix:footnote></td>
</tr></table><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left">(***)</td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US">Issuance costs in the amount of approximately $35.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The accompanying notes are an integral part
of the financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Statements of Convertible Preferred Shares
and Changes in Shareholders&#8217; Equity (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(U.S. dollars in thousands, except share and
per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible Preferred A Shares</td><td style="border-right: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><div style="padding: 0in 0in 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ordinary Shares(**)</b></p> </div></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><b>Additional</b></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center"><b>Total shareholders&#8217;</b></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">USD</td><td style="border-right: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">USD</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> paid in<br/>
 capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/>
 Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> equity<br/>
 (deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left"><span style="text-decoration:underline">CHANGES DURING 2022:</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="border-right: Black 1.5pt solid; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40.5%; text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Issuance of convertible preferred shares</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" unitRef="shares">10,256</ix:nonFraction></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountIssued1" scale="3" unitRef="usd">2,000</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">&#8212;</div></td><td style="width: 0.5%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" sign="-" unitRef="shares">61,538</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" sign="-" unitRef="usd">11,965</ix:nonFraction></td><td style="border-right: Black 1.5pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" id="ix_12_fact" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" unitRef="shares">2,707,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" id="ix_13_fact" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd">11,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd">11,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs(***)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">&#8212;</div></td><td style="border-right: Black 1.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" id="ix_14_fact" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares">3,787,241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" id="ix_15_fact" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" id="ix_21_fact" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">13,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_22_fact" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">13,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Conversion of convertible debt into ordinary shares upon completion of initial public offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">&#8212;</div></td><td style="border-right: Black 1.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" id="ix_16_fact" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" scale="0" unitRef="shares">242,131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" id="ix_17_fact" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" scale="3" unitRef="usd">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" scale="3" unitRef="usd">999</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" scale="3" unitRef="usd">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Issuance of ordinary shares as a result of exercise of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">&#8212;</div></td><td style="border-right: Black 1.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" id="ix_18_fact" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares">1,672</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif">(*)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -5.65pt; padding-left: 5.65pt">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">&#8212;</div></td><td style="border-right: Black 1.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd">505</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -5.65pt; padding-left: 5.65pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">&#8212;</div></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,475</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,475</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -5.65pt; padding-left: 5.65pt">BALANCE AS OF DECEMBER 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#8212;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">&#8212;</div></td><td style="border-right: Black 1.5pt solid; padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" id="ix_19_fact" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">15,896,040</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" id="ix_20_fact" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">46</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">63,033</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" sign="-" unitRef="usd">54,814</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" unitRef="usd">8,265</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">Represents an amount less than $1.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.35in; text-align: left">(**)</td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares effected on February 13, 2022 (see note 1C)</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.35in; text-align: left">(***)</td><td style="text-align: justify"><ix:footnote id="ix_6_footnote" xml:lang="en-US">Issuance costs in the amount of approximately $2,060.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The accompanying notes are an integral part
of the financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Statements of Cash Flows</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(U.S. dollars in thousands)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Cash flows from operating activities</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Loss for the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,475</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,220</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">10,707</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: justify">Adjustments to reconcile loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">150</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">190</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">1,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">2,281</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Change in operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ChangeInOperatingLeaseLiability" scale="3" unitRef="usd">159</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ChangeInOperatingLeaseLiability" scale="3" unitRef="usd">91</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ChangeInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd">134</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.125in">Decrease (increase) in other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" sign="-" unitRef="usd">163</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" unitRef="usd">381</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" sign="-" unitRef="usd">15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 0.125in">Increase (decrease) in trade accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd">83</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd">86</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.125in">Increase (decrease) in other accounts payable</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" sign="-" unitRef="usd">82</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" sign="-" unitRef="usd">540</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" unitRef="usd">973</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">9,981</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">9,948</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">7,200</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: justify">Cash flows from investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Purchase of fixed assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">29</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">273</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">122</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt">&#160;</td>
    <td style="font-size: 1pt; text-align: left">&#160;</td><td style="font-size: 1pt; text-align: right">&#160;</td><td style="font-size: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">29</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">273</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">122</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-decoration: underline; text-align: justify">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Issuance of preferred A shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" scale="3" unitRef="usd">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" scale="3" unitRef="usd">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" scale="3" unitRef="usd">4,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Proceeds from a convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" unitRef="usd">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Proceeds from exercise of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd">127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Issuance of ordinary shares and warrants, net of issuance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd">13,643</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">16,653</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">5,127</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">4,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Increase (decrease) in cash, cash equivalents and restricted cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" unitRef="usd">6,643</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">5,094</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" sign="-" unitRef="usd">2,357</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Cash, cash equivalents and restricted cash at the beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">1,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">6,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">9,300</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt">Cash, cash equivalents and restricted cash at the end of the period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">8,492</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">1,849</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">6,943</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b><span style="text-decoration:underline">Non Cash Activities:</span></b></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Obtaining a right-of-use asset in exchange for a lease liability</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability" scale="3" unitRef="usd">458</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability" scale="3" unitRef="usd">35</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Conversion of preferred shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ConversionOfPreferredShares" scale="3" unitRef="usd">11,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Conversion of a convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:ConversionOfAConvertibleDebt" scale="3" unitRef="usd">1,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Decrease of deferred expenses against additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" scale="3" unitRef="usd">56</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">&#8212;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The accompanying notes are an integral part
of the financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 - GENERAL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>A</b>.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Reporting Entity:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Rail Vision Ltd. (the &#8220;Company&#8221;)
was incorporated and registered in Israel on April 18, 2016. The Company is a development-stage technology Company that is engaged in
the design, development and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency
and predictive maintenance. The Company&#8217;s railway detection systems include different types of cameras, including optics, visible
light spectrum cameras (video) and thermal cameras that transmit data to a ruggedized on-board computer which is designed to be suitable
for the rough environment of a train&#8217;s locomotive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s ordinary shares and
warrants began trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on March 31, 2022, under the symbols &#8220;RVSN&#8221; and
&#8220;RVSNW,&#8221; respectively (see Note 8B (8) below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s activities are
subject to significant risks and uncertainties. The Company has incurred significant losses since the date of its inception and anticipates
that it will continue to incur significant losses until it will be able to successfully commercialize its products. Failure to obtain
this necessary capital when needed may force the Company to delay, limit or terminate its product development efforts or other operations.&#160;In
addition, the Company is subject to risks including, among other things, competition associated with the industry in general, risks associated
with financing, liquidity requirements, rapidly changing customer requirements, the loss of key personnel and the effect of planned expansion
of operations on the future results of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>B.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Going Concern:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">To date, the Company has not generated
significant revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to
generate substantial operating losses and to continue to fund its operations primarily through the utilization of its current financial
resources, sales of its products, and through additional raises of capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Such conditions raise substantial
doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes raising funds from existing shareholders
and/or outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained
on terms favorable to the Company or will provide the Company with sufficient funds to successfully complete the development of, and
to commercialize, its products. These financial statements do not include any adjustments relating to the recoverability and classification
of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue
as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9" id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>C.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Issuance of bonus shares:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation id="_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On February 13, 2022, the Company
effected a bonus shares issuances under Israeli law to reflect the effect of 44-for-1 forward share split of the Company&#8217;s ordinary
shares. Accordingly, (i) for each one share of outstanding ordinary shares, 43 additional ordinary shares were issued and distributed
to the holder thereof; (ii) the number of ordinary shares issuable upon the exercise of each outstanding convertible preferred shares,
warrant and option was proportionately increased by 43 additional ordinary shares; (iii) the exercise price of each outstanding option
to purchase ordinary shares was proportionately adjusted; (iv) the authorized number of ordinary shares was increased in order to reflect
such issuance of bonus shares; and (v) the par value of ordinary shares was not adjusted as result of this issuance of bonus shares.
All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the
issuance of the bonus shares.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 - SIGNIFICANT ACCOUNTING
POLICIES </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>Basis of Presentation:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The financial statements have been
prepared in conformity with accounting principles generally accepted in United Sates of America (&#8220;US GAAP&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements
and accompanying notes. The Company&#8217;s management believes that the estimates, judgments and assumptions used are reasonable based
upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures
made. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="rvsn_FinancialStatementPolicyTextBlock-c0_cont_1" escape="true" name="rvsn:FinancialStatementPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>C.</b></td><td style="text-align: justify"><b>Financial statement in U.S. dollars:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation continuedAt="rvsn_FinancialStatementPolicyTextBlock-c0_cont_2" id="rvsn_FinancialStatementPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The functional currency of the Company
is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;) since the dollar is the currency of the primary economic environment in which
the Company has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="rvsn_FinancialStatementPolicyTextBlock-c0_cont_3" id="rvsn_FinancialStatementPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Transactions and balances denominated
in dollars are presented at their original amounts. Transactions and balances denominated in foreign currencies have been re-measured
to dollars.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation id="rvsn_FinancialStatementPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">All transaction gains and losses
from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of comprehensive
loss as financial income or expenses, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 129pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>D.</b></td><td style="text-align: justify"><b>Cash and cash equivalents and restricted cash:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Cash equivalents are short-term highly
liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired, readily convertible
to known amounts of cash and subject to an insignificant risk. Restricted cash consists of deposits pledged to a bank that provided guarantee
in connection with an operating lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>E.</b></td><td style="text-align: justify"><b>Fair value of financial instruments:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The carrying values of cash and cash
equivalents, restricted cash, trade accounts payable, accrued expenses and employees and related expenses recorded in other accounts
payable, approximate their fair value due to the short-term maturity of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; defines fair value as the price that would be received from selling an
asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining
the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or
most advantageous market in which it would transact. The Company also considers assumptions that market participants would use when pricing
the asset or liability, such as, inherent risk, transfer restrictions and risk of nonperformance.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:nonNumeric contextRef="c0" continuedAt="rvsn_FixedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="rvsn:FixedAssetsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Fixed assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:continuation continuedAt="rvsn_FixedAssetsPolicyTextBlock-c0_cont_2" id="rvsn_FixedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful
lives of the assets. The annual depreciation rates are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">&#160;</span></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock"><ix:continuation id="rvsn_FixedAssetsPolicyTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">%</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="rvsn:OfficeFurnitureAndEquipment" scale="-2" unitRef="pure">7</ix:nonFraction>-<ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="rvsn:OfficeFurnitureAndEquipment" scale="-2" unitRef="pure">15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 69%; text-align: left">Computer software and electronic equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 28%; text-align: center"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="rvsn:ComputerSoftwareAndElectronicEquipment" scale="-2" unitRef="pure">33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c36" decimals="2" format="ixt:num-dot-decimal" name="rvsn:LaboratoryEquipment" scale="-2" unitRef="pure">7</ix:nonFraction>-<ix:nonFraction contextRef="c37" decimals="2" format="ixt:num-dot-decimal" name="rvsn:LaboratoryEquipment" scale="-2" unitRef="pure">15</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><ix:nonNumeric contextRef="c0" name="rvsn:LeaseholdImprovements">Over the shorter of the lease term (including the option) or useful life</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 318.95pt; text-align: justify; text-indent: -318.95pt">NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>G.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">The
Company&#8217;s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired,
the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During
2022 and 2021, no impairment losses were recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_PensionAndOtherPostretirementPlansPolicy-c0_cont_1" escape="true" name="us-gaap:PensionAndOtherPostretirementPlansPolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>H.</b></td><td style="text-align: justify"><b>Accrued post-employment benefit:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_PensionAndOtherPostretirementPlansPolicy-c0_cont_2" id="_PensionAndOtherPostretirementPlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under Israeli employment laws, employees
of the Company are covered under Section 14 of the Severance Compensation Act, 1963 (&#8220;Section 14&#8221;) for a portion of their salaries.
According to Section 14, these employees are entitled to receive monthly deposits (payments) made by the Company on their behalf with
insurance companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation id="_PensionAndOtherPostretirementPlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Payments in accordance with Section
14 release the Company from any future severance payments (under the Israeli Severance Compensation Act, 1963) with respect of those
employees. The obligation to make the monthly deposits is expensed as incurred. In addition, the aforementioned deposits are not recorded
as an asset in the Company&#8217;s balance sheet, and there is no liability recorded as the Company does not have a future obligation to make
any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>I.</b></td><td style="text-align: justify"><b>Revenue recognition:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company applies ASC 606 &#8220;Revenue
from contracts with customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, revenue is measured as the amount of consideration the Company
expects to be entitled to, in exchange for transferring products or providing services to its customers and is recognized when or as
performance obligations under the terms of contracts with the Company&#8217;s customers are satisfied. ASC 606 prescribes a five-step
model for recognizing revenue from contracts with customers: (i) identify contract(s) with the customer; (ii) identify the separate performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the separate performance obligations
in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are
distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined
with other promised goods and services. The Company then allocates the transaction price (the amount of consideration the Company expects
to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated
revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenues from product sales are recognized
upon the transfer of control, which is generally upon shipment or delivery.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Deferred revenue represents amounts
received by the Company for which the related revenues have not been recognized because one or more of the revenue recognition criteria
have not been met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The current portion of deferred revenue
represents the amount to be recognized within one year from the balance sheet date based on the estimated performance period of the underlying
performance obligation, see Note 5 below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 318.95pt; text-align: justify; text-indent: -318.95pt">NOTE
2 - SIGNIFICANT ACCOUNTING POLICIES (Cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>J.</b></td><td style="text-align: justify"><b>Share-based payment:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 28.35pt">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company
applies ASC 718-10, &#8220;Share-Based Payment,&#8221; (&#8220;ASC 718-10&#8221;) which requires the measurement and recognition of compensation
expenses for all share-based payment awards granted to employees and directors including share options granted under the Company&#8217;s incentive
share option plan based on estimated fair values<b>.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 167.8pt">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 718-10 requires companies to
estimate the fair value of share-based payment awards on the date of grant. The portion of the grant-date fair value of the share-based
payment award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s statements
of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company estimates the fair value of share options granted as share-based payment awards using a Black-Scholes option pricing model.
The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are share price, expected volatility
and the expected option term (the time from the grant date until the options are exercised or expire).&#160;Expected volatility is estimated
based on volatility of similar companies in the technology sector. The expected option term is calculated for options granted to employees
and directors using the &#8220;simplified&#8221; method, and grants to non-employees are based on the contractual term.&#160;The Company
has historically not paid dividends and has no foreseeable plans to pay dividends. The risk-free interest rate is based on the yield
from Israel Treasury zero-coupon bonds with an equivalent term. Changes in the determination of each of the inputs can affect the fair
value of the share options granted and the results of operations of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>K.</b></td><td style="text-align: justify"><b>Leases:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On January 1, 2019, the Company early
adopted ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements
as of such date. The Company leases office space and vehicles under operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Operating leases are included in
operating lease right of use (&#8220;ROU&#8221;) assets and operating lease liabilities in the Company&#8217;s balance sheets. ROU assets represent
the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining
lease payments over the lease term. The Company&#8217;s incremental borrowing rate is used in determining the present value of lease
payments because rate implicit in the Company&#8217;s leases is not readily determinable. The operating lease ROU asset excludes lease incentives.
The expected lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised.
Operating lease expense for is recognized on a straight-line basis over the lease term, variable payments are expensed in the periods
incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company has made an accounting
policy election not to recognize ROU assets and lease liabilities that arise from leases with initial terms of 12 months or less. Instead,
the Company continues to record such lease expenses on a straight-line basis over the lease term in the statements of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>L.</b></td><td style="text-align: justify"><b>Research and development expenses, net:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Research and development expenses,
net, are charged to the statements of comprehensive loss as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>M.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Basic loss per ordinary share is
computed by dividing the net loss by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share
is computed by dividing the net loss by the weighted average number of ordinary shares outstanding plus the number of additional ordinary
shares that would have been outstanding if all potentially dilutive ordinary shares had been issued, using the treasury stock method.
Potentially dilutive ordinary shares were excluded from the diluted loss per share calculation because they were anti-dilutive.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_OtherCurrentAssetsTextBlock-c0_cont_1" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 - OTHER CURRENT ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_OtherCurrentAssetsTextBlock-c0_cont_2" id="_OtherCurrentAssetsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>Composition:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_OtherCurrentAssetsTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GovernmentContractReceivable" scale="3" unitRef="usd">27</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GovernmentContractReceivable" scale="3" unitRef="usd">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deposits at the Chamber of Commerce</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="3" unitRef="usd">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="3" unitRef="usd">54</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Deferred offering expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherDeferredCostsNet" scale="3" unitRef="usd">56</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deferred expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" unitRef="usd">197</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd">13</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd">31</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd">52</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">225</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">472</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 - FIXED ASSETS, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_2" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 60pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify">Cost:</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">767</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">754</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">197</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">196</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">178</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">177</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">136</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">136</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">1,278</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd">1,263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Accumulated depreciation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computers and software</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">565</ix:nonFraction></td><td style="text-align: left"></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">535</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">79</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">55</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">126</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c43" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">57</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">59</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">46</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">829</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd">693</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Carrying amount</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">449</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left"></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">570</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IntangibleAssetsDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">Depreciation
expenses for the years ended December 31, 2022, and 2021 were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" unitRef="usd">150</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" unitRef="usd">142</ix:nonFraction>, respectively.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 - OTHER ACCOUNTS
PAYABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_2" id="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Employees and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">824</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">828</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd">208</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" unitRef="usd">199</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deferred revenues (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" id="ix_23_fact" name="us-gaap:DeferredRevenueCurrent" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="3" unitRef="usd">1,032</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableOtherCurrentAndNoncurrent" scale="3" unitRef="usd">1,114</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_2"><ix:continuation id="_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US">See also Note 6H below.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 6  - COMMITMENTS AND CONTINGENCIES LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric><div>



</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"></td><td style="width: 24px; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>Collaboration Agreement with Israel Railways Ltd. (&#8220;Israel
Railways&#8221;):</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In August 2016, the Company and Israel
Railways entered into an agreement for cooperation between the parties, which was further amended on January 19, 2020, and on July 1,
2021 (&#8220;the Railway Agreement&#8221;). Under the Railway Agreement, the Company undertook to fulfill certain functions for the development,
marketing, distribution and sale of the systems, and Israel Railways undertook to provide the Company with services and the means to perform
tests and experiments, mainly in the form of logistics and manpower, and to provide the Company with information on certain data that
will be provided at the discretion of Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Pursuant to the Railway Agreement,
the Company agreed to pay Israel Railways the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the period from August 3, 2016 until the earliest of (a) a period of <ix:nonNumeric contextRef="c46" format="ixt-sec:duryear" name="rvsn:PeriodOfFirstCommercialSales">5</ix:nonNumeric> years from the date of the first commercial sale or (b) the date
of an initial public offering or (c) a change of control (as defined in the Railway Agreement), Israel Railways will be entitled to a
payment of royalties in the amount of <ix:nonFraction contextRef="c47" decimals="4" format="ixt:num-dot-decimal" name="rvsn:RoyaltyPaymentsPercentage" scale="-2" unitRef="pure">2.75</ix:nonFraction>% of the Company&#8217;s net sales.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the period from August 3, 2016 until the earliest of: (a) the date of an initial public offering, (b) a change of control (as defined
in the Railways Agreement) Israel Railways will be entitled to a payment of a total of <ix:nonFraction contextRef="c46" decimals="3" format="ixt:num-dot-decimal" name="rvsn:PaymentOfTotalProceedsFromConsiderationPercentage" scale="-2" unitRef="pure">1.5</ix:nonFraction>% of the total proceeds from an Initial Public Offering (&#8220;IPO&#8221;) or consideration,
received by the Company or its shareholders, as a result of change of control (as defined in the Railway Agreement).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Upon the completion of the initial
public offeringon April 4, 2022 (see Note 8B(8)) the Company paid to Israeli Railways a consideration of <ix:nonFraction contextRef="c48" decimals="3" format="ixt:num-dot-decimal" name="rvsn:PaymentOfTotalProceedFromConsiderationPercentage" scale="-2" unitRef="pure">1.5</ix:nonFraction>% of the actual IPO proceeds,
which was approximately $<ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="rvsn:PaymentOfTotalProceedFromConsiderationPercentage" scale="-2" unitRef="pure">213</ix:nonFraction> and its right for payment of royalties has expired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement further provides
that Israel Railways will be entitled to purchase the Company&#8217;s products and services at a price equal to half the lowest price charged
by the Company for those products and services to an unrelated third party.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In addition, as part of the Railway
Agreement and in consideration for services provided to the Company by Israel Railways, the Company granted Israel Railways an option
to purchase <ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="rvsn:OptionToPurchaseOrdinaryShares" scale="0" unitRef="shares">195,448</ix:nonFraction> of the Company&#8217;s ordinary shares at their par value (see also Note 8D(1)).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement may be terminated
by either party, with 60 days&#8217; prior written notice. Also, in the event of a change of control in the Company, Israel Railways may terminate
the Railway Agreement with 30 days&#8217; prior written notice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement was terminated
and canceled by the parties under an agreement signed on January 31, 2023 (see Note 14A below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Memorandum of Understanding with Israel Railways: </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 12, 2021, the Company signed
a non-binding Memorandum of Understanding (&#8220;MOU&#8221;) with Israel Railways which summarizes the general terms and conditions to
be included in a detailed commercial agreement between the parties (the &#8220;Railways Commercial Agreement&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_14" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the MOU, the Company and
Israel Railways will conduct negotiations in good faith, with a view to entering into the Railways Commercial Agreement as soon as possible
before May 31, 2022. During the negotiations, Israel Railways has started conducting technical tests and analysis of the Company&#8217;s Main
Line system on a locomotive of Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_15" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Subsequent to December 31, 2022 on
January 31, 2023 the Company signed the Railways Commercial Agreement with Israel Railways. See Note 14A below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_16" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_15"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>C.</b></td><td style="text-align: justify"><b>Service Agreement with a Consultant:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_17" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In December 2020, the Company entered
into a service agreement with a consultant (the &#8220;Consultant&#8221;) according to which the Consultant will lead, control and consult
the Company&#8217;s management in its negotiations with Israel Railways relating the Homologation Process (as defined below) and the commercial
sales of the Company&#8217;s systems to Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 6  - COMMITMENTS AND CONTINGENCIES LIABILITIES (Cont.)</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>C.</b></td><td style="text-align: justify"><b>Service Agreement with a Consultant: (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_18" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The &#8220;Homologation Process&#8221;
will include defining and receiving all the required written licenses, consents and approvals, both in Israel and abroad, for installing
the Company&#8217;s systems on Israel Railways locomotives for operational use.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_19" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#8220;Commercial Sales&#8221; shall
include negotiating and signing supply agreement(s) or purchase orders between the Company and Israel Railways under which Israel Railways
shall purchase from the Company at least five (5) Systems, the supply and installation of at least five Systems on Israel Railways locomotives
and receiving the entire consideration by the Company from Israel Railways under the above supply agreements or purchase orders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_20" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">If a written consent is received by
the Company from the authorized representatives of Israel Railways to enter into a Homologation Process with the Company, subject to
its successful completion and enter into negotiations regarding the purchase of the Company&#8217;s systems by Israel Railways (the &#8220;Triggering
Event&#8221;), then:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_21" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_20"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="rvsn_ServiceAgreementWithAConsultantDescription-c0_cont_1" name="rvsn:ServiceAgreementWithAConsultantDescription"><span style="font-family: Times New Roman, Times, Serif">Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#8220;Homologation Bonus&#8221;).</span></ix:nonNumeric></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_22" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_21"><ix:continuation id="rvsn_ServiceAgreementWithAConsultantDescription-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#8220;Commercial Bonus&#8221;).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_23" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The signing of the MOU on August 12,
2021 mentioned in Note 6B above constitutes the occurrence of the Triggering Event as defined above, and accordingly on December 20, 2021,
the Company granted options to the Consultant for the purchase of <ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="rvsn:OptionToPurchaseOrdinaryShares" scale="0" unitRef="shares">25,080</ix:nonFraction> of the Company&#8217;s ordinary shares at an exercise price of
$<ix:nonFraction contextRef="c51" decimals="4" format="ixt:num-dot-decimal" name="rvsn:ExercisePrice" scale="0" unitRef="usdPershares">6.1393</ix:nonFraction> per share. The Consultant will be eligible to exercise the options upon completion of both the Homologation Process and the sale
process for a period of 24 months from the date of their grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_24" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Consultant&#8217;s right for the
Homologation Bonus and the Commercial Bonus has expired on August 12, 2022 and February 12, 2023, respectively, as the periods of 12 and
18 months, respectively, from the occurrence of the Triggering Event has passed without the completion of both terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_25" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In return for his services, in addition
to the bonus, the Company agreed to pay the Consultant a monthly remuneration in the amount of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:PaymentOfMonthlyRemunerationAmount" scale="3" unitRef="usd">3</ix:nonFraction>, plus VAT.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_26" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The service agreement with the Consultant
is in effect from November 1, 2020, until the completion of the services determined in the agreement, as detailed above. Either party
may terminate the agreement with 30 days&#8217; notice. On July 29, 2021, the Company sent a termination notice to the Consultant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_27" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_26"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>D.</b></td><td style="text-align: justify"><b>Memorandum of Understanding between the Company and Knorr-Bremse:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_28" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On September 17, 2020, a non-binding
memorandum of understanding (the &#8220;Knorr-Bremse MOU&#8221;) was signed between the Company and Knorr-Bremse Systeme f&#252;r Schienenfahrzeuge
GmbH, an affiliate of Knorr-Bremse AG (&#8220;Knorr-Bremse&#8221;) regarding cooperation between the parties with respect to Light Rail
Vehicle (&#8220;LRV&#8221;) systems.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_29" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Following the signing of the Knorr-Bremse
MOU, in December 2020, Knorr-Bremse placed a purchase order to the Company for developing two prototypes of the LRV system according to
specifications required by Knorr Bremse (the &#8220;Knorr Bremse Purchase Order&#8221;). In return for the development of the two prototypes,
Knorr Bremse paid the Company a total of approximately EUR <ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:TotalAmountPaid" scale="3" unitRef="eur">397</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="rvsn:TotalAmountPaid" scale="0" unitRef="usd">471</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_30" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2021 the Company
completed its commitment according to the Knorr Bremse Purchase Order for the supply of the two LRV prototype systems to Knorr-Bremse.
Accordingly, the Company recognized revenues in 2021 from the sale of the two LRV prototype systems and the related services in a total
amount of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:DevelopmentAndSales" scale="3" unitRef="usd">471</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 6  - COMMITMENTS AND CONTINGENCIES LIABILITIES (Cont.)</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_31" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_30"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Framework agreement with Knorr-Bremse Rail Systems Schweiz AG (&#8220;KBCH&#8221;):</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_32" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In August 2020, the Company entered
into a framework agreement (the &#8220;KBCH Framework Agreement&#8221;) with KBCH (a subsidiary of Knorr-Bremse operating in Switzerland)
regarding the supply of a prototype of the Company&#8217;s shunting yard system to Schweizerische Bundes Bahnen Cargo (&#8220;SBBC&#8221;),
a freight train company in Switzerland.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_33" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under the KBCH Framework Agreement,
the Company provided KBCH with one prototype of the shunting yard system which has been installed on a shunting locomotive in the SBBC
shunting yard, for the purpose of examining the operational performance of the shunting yard system (the &#8220;Operational Function Test&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_34" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In consideration for the prototype
provided for the Operational Function Test, KBCH paid the Company the amount of approximately EUR <ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:PaymentOfOperationalFunctionTest" scale="3" unitRef="eur">244</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:PaymentOfOperationalFunctionTest" scale="3" unitRef="usd">292</ix:nonFraction>). In
addition, in order to support the Operational Function Test procedure, the Company undertook to provide various professionals, as needed,
in exchange for payment at the maximum rates and amounts determined in the KBCH Framework Agreement. Accordingly, during 2021, KBCH paid
the Company an additional amount of approximately. EUR <ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="eur">110</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">125</ix:nonFraction>) for the Company&#8217;s services supporting the installation
and operation of the system and its participation in part of the overall licensing process of the operating concept that were fully provided
during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_35" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_34"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As the delivery of the prototype and
the provision of the services described above were identified by the Company as a single performance obligation, during 2021, the Company
recognized revenues from the sale of the prototype and the related services in the total amount of approximately $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" scale="3" unitRef="usd">417</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_36" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_35"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Strategic partnership agreement between the Company and Knorr-Bremse </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_37" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_36"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 19, 2021, the Company entered
into a strategic partnership agreement which summarizes the understandings for strategic cooperation between the parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_38" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_37"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The agreement was approved by the Company&#8217;s
Board of Directors on August 25, 2021 and by the Company&#8217;s General Meeting on August 26, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_39" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_38"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>G.</b></td><td style="text-align: justify"><b>Agreement for supplying equipment and services with Hitachi Rail STS Australian Pty Ltd. (&#8220;STS&#8221;)</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_40" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_39"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In April 2021, the Company entered
into an agreement to supply equipment, personnel and services with STS, which enables STS, as the main supplier, to supply to an Australian
railway company Rio Tinto Railway Network, a prototype of the Company&#8217;s Main Line system, for demonstrations and examining the operational
activity of the Main Line system (the &#8220;Long-Term Pilot&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_41" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_40"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In September 2022, the Company completed
the Long-Term Pilot and accordingly recognized revenues in the year ended December 31, 2022 from the Long Term Pilot in the total amount
of EUR <ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:DeferredRevenuesInOtherAccountsPayable" scale="3" unitRef="eur">192</ix:nonFraction> thousands (approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:DeferredRevenuesInOtherAccountsPayable" scale="3" unitRef="usd">202</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_42" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_41"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>H.</b></td><td style="text-align: justify">In September 2021 the Company received a purchase order (&#8220;PO&#8221;) from a customer in the United
States (the &#8220;U.S. Customer&#8221;) for a Proof of Concept (&#8220;POC&#8221;) regarding to a detection system which will focus on
railway infrastructure inspection and is based on the Company&#8217;s sensors and algorithmic capabilities, utilizing cloud computing
to handle data collections and measurements. In October 2021, the U.S. Customer paid the Company a total amount of $<ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FilmCosts" scale="3" unitRef="usd">87</ix:nonFraction> as an advance payment
according to the PO. As of December 31, 2021 the Company&#8217;s recorded deferred revenues in the amount of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent" scale="3" unitRef="usd">87</ix:nonFraction> in other accounts payable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_42"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In March 2022, the Company completed
the POC and accordingly recognized revenues in the year ended December 31, 2022 from the POC in the total amount of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="3" unitRef="usd">219</ix:nonFraction>.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_1" escape="true" name="rvsn:ConvertiblePreferredSharesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 7  - CONVERTIBLE PREFERRED SHARES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>



</div><div>

</div><ix:continuation continuedAt="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_2" id="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_1"><p style="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify"><b>Issuance of Preferred A Shares&#160;</b></p></ix:continuation><div>

</div><ix:continuation continuedAt="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_3" id="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On October 13, 2020, the Company and Knorr-Bremse
entered into an investment agreement under which the Company issued <ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares">51,282</ix:nonFraction> Preferred A shares to Knorr-Bremse, in exchange for a total
investment of $<ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetInvestmentIncome" scale="3" unitRef="usd">10,000</ix:nonFraction>. As of December 31, 2021, the net proceeds, after deducting closing costs and fees, amounted to $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="3" unitRef="usd">9,965</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_4" id="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In addition, the Company was given, under
the investment agreement, an option to demand Knorr-Bremse to invest an additional amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" unitRef="usd">5,000</ix:nonFraction> at the same price per share (the
&#8220;Call Option&#8221;), provided the existence of circumstances as detailed in the investment agreement. The Call Option was accounted
as a derivative and valued at zero. On December 2, 2021, and February 14, 2022 the Company and Knorr-Bremse signed two amendments to
the investment agreement, according to which, the Company will be entitled to exercise its option in 2 installments as follows: <ix:nonNumeric contextRef="c0" name="rvsn:InvestmentAgreementDescription">(i) up
to $2,000 will be exercisable through March 31, 2022; and (ii) up to $2,286 will be exercisable through June 30, 2022. The aforesaid
option shall expire on the closing of the Company&#8217;s IPO if such shall occur prior to June 30, 2022. On March 6, 2022, the Company
exercised its first installment of $2,000 and as a result issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of
$195 per share.</ix:nonNumeric>&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_5" id="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Preferred A shares were entitled to all the
rights of the Company&#8217;s ordinary shares and additional rights regarding liquidation preference and listing rights. Holders of Preferred
A shares were entitled, at their option, to convert the Preferred A shares at any time into the Company&#8217;s ordinary shares in a
1:44 ratio. In addition, prior to the Company&#8217;s IPO, all Preferred A shares will be immediately converted into the Company&#8217;s ordinary
shares in a 1:44 ratio, and, accordingly, all rights stated are revoked upon their conversion into the Company&#8217;s ordinary shares.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="rvsn_ConvertiblePreferredSharesTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Immediately prior to the completion of the
IPO on April 4, 2022 (see Note 8B(8)), <ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares">61,538</ix:nonFraction> Preferred A shares were automatically converted into <ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares">2,707,672</ix:nonFraction> ordinary shares (after giving
effect to the issuance of <ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares">10,256</ix:nonFraction> Preferred A shares described above).&#160;</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:nonNumeric><div>



</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>The rights of ordinary shares are as follows:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The ordinary shares confer upon the
holders the right to receive notice to participate and vote in general meetings of shareholders of the Company, the right to receive dividends,
if declared, and the right to participate in a distribution of the surplus of assets upon liquidation of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Regarding Issuance of bonus shares
see Note 2C above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Issuance of ordinary shares and warrants: </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">In August and November 2016, the Company raised gross proceeds
of $<ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">1,960</ix:nonFraction> (net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued
an aggregate of <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="rvsn:AggregateSharesIssued" scale="0" unitRef="shares">1,465,992</ix:nonFraction> ordinary shares at a price of $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">1.36</ix:nonFraction> per share and three series of warrants (A, B and C) to purchase <ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="rvsn:WarrantsPurchase" scale="0" unitRef="shares"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="rvsn:WarrantsPurchase" scale="0" unitRef="shares"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="rvsn:WarrantsPurchase" scale="0" unitRef="shares">3,135,572</ix:nonFraction></ix:nonFraction></ix:nonFraction>
ordinary shares.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">From January 10, 2018 through November
2, 2018, series A and C warrants were exercised into <ix:nonFraction contextRef="c62" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">1,639,000</ix:nonFraction></ix:nonFraction> ordinary shares for an aggregate of $<ix:nonFraction contextRef="c64" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd"><ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">7,158</ix:nonFraction></ix:nonFraction>. The remaining series C warrants
to purchase <ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExpired" scale="0" unitRef="shares">17,732</ix:nonFraction> ordinary shares expired on November 2, 2018.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY (Cont.)</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Issuance of Ordinary shares and warrants (Cont</b>.):</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During May 2019, series B warrants
to purchase <ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">234,608</ix:nonFraction> of the Company&#8217;s ordinary shares were exercised for an aggregate of $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExercisedAmount" scale="3" unitRef="shares">1,411</ix:nonFraction> and series B warrants to purchase
<ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">1,281,456</ix:nonFraction> ordinary shares expired on May 1, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">In September and October 2017, the Company raised $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities" scale="3" unitRef="usd">5,192</ix:nonFraction>
(net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued an aggregate
of <ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">951,676</ix:nonFraction> ordinary shares at a price of $<ix:nonFraction contextRef="c71" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">6.14</ix:nonFraction> per share and <ix:nonFraction contextRef="c71" decimals="-3" format="ixt-sec:numwordsen" name="rvsn:GrossProceeds" scale="3" unitRef="usd">two</ix:nonFraction> series of warrants (D and E) to purchase <ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">951,676</ix:nonFraction> ordinary shares.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During March 2019, series D warrants
to purchase <ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">81,884</ix:nonFraction> of the Company&#8217;s ordinary shares were exercised for an aggregate of $<ix:nonFraction contextRef="c74" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExercisedAmount" scale="3" unitRef="shares">470</ix:nonFraction> and series D warrants to purchase <ix:nonFraction contextRef="c75" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">214,500</ix:nonFraction>
ordinary shares expired on March 19, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During April 2019, series E warrants
to purchase <ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">303,512</ix:nonFraction> of the Company&#8217;s ordinary shares were exercised for an aggregate of $<ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExercisedAmount" scale="3" unitRef="shares">1,711</ix:nonFraction> and series E warrants to purchase
<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">434,016</ix:nonFraction> ordinary shares expired on April 6, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in">(3)</td><td style="text-align: justify">From February through May 2018, the Company raised gross proceeds of $<ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">2,511</ix:nonFraction> (net) through private placements
of its ordinary shares (the &#8220;2018 Private Placement&#8221;). The Company issued an aggregate of <ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="rvsn:AggregateOrdinaryShares" scale="0" unitRef="shares">184,844</ix:nonFraction> ordinary shares.&#160;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The investment transaction detailed
in Note 8B (4) below, triggered anti-dilution rights that were included in the above mentioned private placement, and accordingly an additional
<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" unitRef="shares">510,752</ix:nonFraction> ordinary shares were issued to the investors in the 2018 Private Placement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in">(4)</td><td style="text-align: justify">On March 19, 2019, the Company and Knorr-Bremse entered into an agreement whereby Knorr-Bremse invested
$<ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:InvestedAgreement" scale="3" unitRef="usd">9,941</ix:nonFraction> (after deducting closing costs and fees) in the Company in consideration of an issuance of an aggregate number of <ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares">1,803,296</ix:nonFraction> ordinary
shares of the Company at a price per share equal to $<ix:nonFraction contextRef="c81" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares">5.54</ix:nonFraction>.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Knorr-Bremse were also issued warrants
to purchase up to <ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">655,732</ix:nonFraction> of the Company&#8217;s ordinary shares at an exercise price per share of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceDecrease" scale="0" unitRef="usdPershares">5.54</ix:nonFraction> (the &#8220;KB Warrants&#8221;).
The KB Warrants shall become exercisable (i) only upon an exercise of warrants of the respective class (i.e. series B warrants, series
D warrants and series E warrants, as the case may be), and (ii) only for the number of additional ordinary shares in accordance with the
formula of approximately <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="rvsn:WarrantsPercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% of the number of issued ordinary shares originating from the exercised KB warrants of the respective class,
all as specified in the agreement. During March 2019 through May 2019, all of the KB warrants have been exercised or expired (see also
Note 8B(1) &#8211; (2) above).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in">(5)</td><td style="text-align: justify">During April &#8211; June 2021, an aggregate of options to purchase <ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExercisedAmount" scale="0" unitRef="shares">20,724</ix:nonFraction> Ordinary Shares were exercised
by former Company employees resulting in proceeds of $<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ExcessStockSharesIssued" scale="3" unitRef="shares">127</ix:nonFraction>.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in">(6)</td><td style="text-align: justify">During March 2022, options to purchase <ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="rvsn:OrdinarySharesExercisedAmount" scale="0" unitRef="shares">1,672</ix:nonFraction> Ordinary Shares were exercised by former Company employees
resulting in proceeds of $<ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">10</ix:nonFraction>.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in">(7)</td><td style="text-align: justify">In January 2022, the Company entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with
its two main shareholders providing for financing in the aggregate amount of $<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">1,000</ix:nonFraction> (the &#8220;Investment Amount&#8221;) which was subsequently
amended in March 2022.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The SAFE provides for the conversion
of the Investment Amount into the Company&#8217;s ordinary shares under certain circumstances including in particular in the case of an
initial public offering such that immediately prior to the closing of an initial public offering the Investment Amount shall automatically
convert into the number of shares and warrants equal to the Investment Amount divided by the initial public offering price. The warrants
which shall be issued shall have the same terms as the warrants to be issued in the initial public offering except such warrants shall
not be registered under the Securities Act of 1933, as amended, and shall not be tradeable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY (Cont.)</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Issuance of Ordinary shares and warrants (Cont</b>.):</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Immediately prior to the completion
of the IPO on April 4, 2022 (see Note 8B(8) below) the Investment Amount was automatically converted to <ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendsShares" scale="0" unitRef="shares">242,131</ix:nonFraction> ordinary shares and <ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="rvsn:WarrantsPurchase" scale="0" unitRef="shares">242,131</ix:nonFraction>
warrants to purchase ordinary shares, with an exercise price of $<ix:nonFraction contextRef="c57" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceDecrease" scale="0" unitRef="usdPershares">4.13</ix:nonFraction> per share, immediately exercisable and will expire five years from
the date of issuance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(8)</td><td style="text-align: justify">On April 4, 2022, the Company completed its IPO, in which
the Company issued <ix:nonFraction contextRef="c87" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares">3,787,241</ix:nonFraction> units. <ix:nonNumeric contextRef="c87" name="rvsn:WarrantsDescription">Each unit includes one ordinary share and one warrant to purchase one ordinary share at an exercise
price of $4.13. The warrants are exercisable at any time up to five years after the IPO.</ix:nonNumeric></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_22" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Gross proceeds for the offering were
approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:GrossProceeds" scale="3" unitRef="usd">15,647</ix:nonFraction> (including exercise of over-allotment options as described below) and net proceeds of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:NetProceeds" scale="3" unitRef="usd">13,587</ix:nonFraction> after
deducting underwriting discounts and commissions and offering expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_23" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company granted Aegis Capital
Corp, the underwriter (&#8220;Aegis&#8221;), a 45-day over-allotment option to purchase additional ordinary shares and/or warrants to
purchase additional ordinary shares up to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="rvsn:NumberOfOrdinarySharesAndWarrantsPercentage" scale="-2" unitRef="pure">15</ix:nonFraction>% of the number of ordinary shares and warrants, respectively, sold in the IPO solely to cover
over-allotments, if any. On April 4, 2022, Aegis partially exercised its over-allotment option with respect to <ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares">568,086</ix:nonFraction> warrants to purchase
ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_24" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_23"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>C.</b></td><td style="text-align: justify"><b>Equity Incentive Plan:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_25" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In January 2017, the Board authorized
an incentive share option plan which was amended on March 21, 2022, and on September 13,2022 (&#8220;2017 Plan&#8221;). The 2017 Plan
provides for the grant of incentive share options to employees and service providers of the Company. Awards may be granted under the 2017
Plan until January 31, 2027.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_26" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the 2017 Plan, the aggregate
number of ordinary shares that may be issued pursuant to awards will not exceed <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendsShares" scale="0" unitRef="shares">2,332,352</ix:nonFraction> ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_27" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_26"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>D.</b></td><td style="text-align: justify"><b>Shares and options to service providers:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_28" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The fair value for the options to
service providers was estimated on their grant date determined using a Black-Scholes option pricing model, with the following weighted-average
assumptions: weighted average volatility of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure">70</ix:nonFraction>%, risk free interest rates of <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="rvsn:RiskFreeInterestRate" scale="-2" unitRef="pure">1.4</ix:nonFraction>%, dividend yields of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="rvsn:DividendYields" scale="-2" unitRef="pure">0</ix:nonFraction>% and a weighted average life
of the options of up to <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric> years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_29" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_28"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">As part of the Railway Agreement entered into on August 3,
2016, which was amended on January 19, 2020, and on July 1, 2021, the Company issued options to purchase up to <ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares">195,448</ix:nonFraction> ordinary shares
of the Company, with an exercise price of NIS <ix:nonFraction contextRef="c89" decimals="2" format="ixt:num-dot-decimal" name="rvsn:ExercisePricePerShares" scale="0" unitRef="ilsPershares">0.01</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c90" decimals="3" format="ixt:num-dot-decimal" name="rvsn:ExercisePricePerShares" scale="0" unitRef="usdPershares">0.003</ix:nonFraction>) per share. The options were exercisable on each issuance date
and recorded as deferred expenses which are amortized over <ix:nonNumeric contextRef="c90" format="ixt-sec:duryear" name="rvsn:AmortizedOver">5</ix:nonNumeric> years beginning August 2016. In respect of such option issuance an amount
of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="3" unitRef="usd">196</ix:nonFraction>, $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="3" unitRef="usd">331</ix:nonFraction>, were recorded in the Company&#8217;s statements of comprehensive loss for the years ended December 31, 2021 and 2020,
respectively included in research and development expenses and no expenses were recorded in the year ended December 31, 2022 According
to amendments to the option agreement the warrants will expire at the earlier of the following: (1) the passing of five business days
following Israel Railways&#8217; receipt of a government approval; or (2) June 30, 2023. On January 25, 2023, Israel Railways notified
the Company that it exercises its option and accordingly the Company issued <ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendsShares" scale="0" unitRef="shares">195,448</ix:nonFraction> ordinary shares to Israel Railways.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_30" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_29"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">On January 4, 2018, the Company granted to three consulting
service providers options to purchase <ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares">98,120</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction contextRef="c92" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:StockOptionExercisePriceIncrease" scale="0" unitRef="usdPershares">6.1393</ix:nonFraction> per share. One third of the options vested
upon the first year anniversary and the remainder of the options vested in eight quarterly tranches over a period of two years.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_31" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_30"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Regarding the grant of options to a Consultant in connection
with the Company&#8217;s arrangement with Israel Railways, see Note 6C above.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_32" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_31"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Regarding the grant of warrants to an IR service provider,
subsequent to December 31, 2022, see Note 14D below.</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY (Cont.)</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_33" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_32"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Options to employees</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_34" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_33"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The fair value of options was estimated using the Black-Scholes
option pricing model, which was based on the following assumptions: weighted average volatility of <ix:nonFraction contextRef="c93" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PercentageOfWeightedAverageCostInventory" scale="-2" unitRef="pure">68</ix:nonFraction>%, risk free interest rates of <ix:nonFraction contextRef="c94" decimals="4" format="ixt:num-dot-decimal" name="rvsn:RiskFreeInterestRate" scale="-2" unitRef="pure">0.43</ix:nonFraction>%-<ix:nonFraction contextRef="c95" decimals="4" format="ixt:num-dot-decimal" name="rvsn:RiskFreeInterestRate" scale="-2" unitRef="pure">2.83</ix:nonFraction>%,
dividend yields of <ix:nonFraction contextRef="c96" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" unitRef="pure">0</ix:nonFraction>% and expected life of the options of up to <ix:nonNumeric contextRef="c96" format="ixt-sec:duryear" name="rvsn:OptionsExpire">6</ix:nonNumeric> years.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_35" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_34"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">The following table summarizes the option activity for options
to employees, officers and directors:</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_36" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="34" style="text-align: center; border-bottom: Black 1.5pt solid"><div style="padding: 0in 0in 1pt; border-bottom: Black 0.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>For
                                            the year ended December 31,</b></span></p> </div></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%; text-align: left"><span style="font-size: 9pt">Outstanding
    as of beginning of period</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,264,868</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" id="ix_24_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">(*)</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"><span style="font-size: 9pt">7.5</span></ix:nonNumeric></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,639,792</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c111" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"><span style="font-size: 9pt">8.9</span></ix:nonNumeric></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c10" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">706,728</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c112" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"><span style="font-size: 9pt">4.9</span></ix:nonNumeric></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">Granted</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">1,058,890</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">1.85</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares">1,502,248</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares">1,672</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares">20,724</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Forfeited
    or expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares">421,190</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares">354,200</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares">569,184</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Outstanding
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,900,896</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">2.20</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"><span style="font-size: 9pt">8.2</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,264,868</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c115" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"><span style="font-size: 9pt">7.5</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares">1,639,792</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c111" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"><span style="font-size: 9pt">6.5</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Exercisable
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars" scale="0" unitRef="shares">805,062</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod" scale="0" unitRef="usdPershares">2.46</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"><span style="font-size: 9pt">6.6</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars" scale="0" unitRef="shares">683,723</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" name="rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"><span style="font-size: 9pt">7.4</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars" scale="0" unitRef="shares">595,980</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod" scale="0" unitRef="usdPershares">6.14</ix:nonFraction></span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"><span style="font-size: 9pt">6.8</span></ix:nonNumeric></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_37" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_36"><ix:continuation id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_8_footnote" xml:lang="en-US">Regarding repricing during 2022, see Note 8E(3)(k) below.</ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_38" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_37"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted average fair value of
options granted during the year ended December 31, 2022, was $<ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">0.479</ix:nonFraction> per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_39" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_38"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2022, the total
unrecognized share-based payment expenses related to nonvested awards was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:SharebasedPaymentExpensesRelatedToNonvestedAwards" scale="3" unitRef="usd">498</ix:nonFraction>, which is expected to be recognized over the next <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="rvsn:ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm">2.75</ix:nonNumeric>
years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_40" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_39"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>(3)</b></td><td style="text-align: justify"><b>Options granted:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -14.2pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_41" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_40"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">a)</td><td style="text-align: justify">On January 4, 2018, the Company granted options to purchase
<ix:nonFraction contextRef="c97" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares"><ix:nonFraction contextRef="c98" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares">452,496</ix:nonFraction></ix:nonFraction> ordinary shares to its employees and directors at an exercise price of $<ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">6.14</ix:nonFraction> per share. These options expire <ix:nonNumeric contextRef="c92" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">10</ix:nonNumeric> years after their
grant date and vest over three years. One third of the options vested upon the first-year anniversary of the grant date and the remainder
of the options vested in eight equal quarterly tranches over a period of two years thereafter. For the year ended December 31, 2020,
the Company recorded an expense of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">409</ix:nonFraction>. For the year ended December 31, 2021, the Company recorded a net reversal of previously recognized
expense of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TerminationLoans" scale="3" unitRef="usd">9</ix:nonFraction> due to termination of several employees in respect for such grant. No expenses have been recorded for the year ended December
31, 2022.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_42" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_41"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><ix:nonNumeric contextRef="c99" continuedAt="rvsn_OptionsGrantedDescription-c99_cont_1" name="rvsn:OptionsGrantedDescription">b)</ix:nonNumeric></td><td style="text-align: justify"><ix:continuation id="rvsn_OptionsGrantedDescription-c99_cont_1">On June 24, 2018, the Company granted options to purchase 188,100
ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their grant
date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested
in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2021 and 2020, the Company
recorded an expense of $89 and $303, respectively, in respect for such grant.</ix:continuation> No expenses have been recorded for the year ended December
31, 2022.</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: none"><b>NOTE </b></span><b>8</b>  <span style="text-decoration: none"><b>- SHAREHOLDERS&#8217; EQUITY (Cont.)</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Options to employees (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78pt; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left"><b>(3)</b></td><td style="text-align: justify"><b>Options granted: (Cont.)</b></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 78pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_43" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_42"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">c)</td><td style="text-align: justify">On January 22, 2020, <ix:nonNumeric contextRef="c100" name="rvsn:OptionsGrantedDescription">the Company granted options to purchase
671,308 ordinary shares to its employees at an exercise price of $6.14 per share (of which options to purchase 74,580 ordinary shares
were to the Company&#8217;s former CEO that were forfeited at the end of his employment in December 2020). These options expire 10 years
after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022, 2021 and 2020, the
Company recorded an expense of $163, $380 and $812, respectively, in respect for such grant.</ix:nonNumeric></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_44" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_43"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">d)</td><td style="text-align: justify">In October 2020, the Company granted to its former chairman
of the Board options to purchase <ix:nonFraction contextRef="c101" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares">556,820</ix:nonFraction> ordinary shares are exercisable at an exercise price of $<ix:nonFraction contextRef="c102" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">6.14</ix:nonFraction> per share. The options vest as
follows: <ix:nonNumeric contextRef="c102" name="rvsn:OptionsGrantedDescription">(1) options to purchase 139,205 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2)
options to purchase 278,410 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in
the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 139,205
ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October
13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company&#8217;s
Board at the time of vesting.</ix:nonNumeric></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_45" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_44"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">In the event that the Company effectuates
an initial public offering, <ix:nonFraction contextRef="c102" decimals="2" format="ixt:num-dot-decimal" name="rvsn:UnvestedOptionsPercentage" scale="-2" unitRef="pure">25</ix:nonFraction>% of his unvested options (i.e., <ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" unitRef="shares">139,216</ix:nonFraction> options) shall be accelerate and considered fully vested immediately
prior to the closing of the IPO. Accordingly, upon the completion of the IPO on April 4, 2022 (see Note 8B(8)), <ix:nonFraction contextRef="c103" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares">139,216</ix:nonFraction> have been accelerate
and are considered fully vested.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_46" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_45"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">As of December 31, 2022, a total
of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" scale="0" unitRef="shares">278,410</ix:nonFraction> of the former chairman&#8217;s options has expired as the periods of 18 and 24 months has passed and the Company did not reach
the required cumulative order backlogs, as detailed above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_47" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_46"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd">133</ix:nonFraction>, $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd">332</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashExpense" scale="3" unitRef="usd">199</ix:nonFraction>,respectively, in respect for such grants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_48" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_47"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in">e)</td><td style="text-align: justify">In October 2020, <ix:nonNumeric contextRef="c104" continuedAt="rvsn_OptionsGrantedDescription-c104_cont_1" name="rvsn:OptionsGrantedDescription">the Company granted to its CEO options to purchase 61,600 ordinary shares at an exercise
price of $6.14 per share vest as follows: (1) options to purchase 30,800 ordinary shares will vest on the condition that the Company generates,
no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and
(2) options to purchase the remaining 30,800 ordinary shares will vest on the condition that the Company generates, no later than October
12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog);
and all subject to him serving in his position at the time of vesting.</ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_49" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_48"><ix:continuation continuedAt="rvsn_OptionsGrantedDescription-c104_cont_2" id="rvsn_OptionsGrantedDescription-c104_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">As of December 31, 2022, a total
of 30,800 of the CEO&#8217;s options has expired as the period of 24 months has passed and the Company did not reach the required cumulative
order backlog, as detailed above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_50" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_49"><ix:continuation id="rvsn_OptionsGrantedDescription-c104_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $20, $12 and $12 , respectively, in respect for such grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-decoration: none"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: none"><b>NOTE </b></span><b>8</b>  <span style="text-decoration: none"><b>- SHAREHOLDERS&#8217; EQUITY (Cont.)</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Options to employees (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><b>(3)</b></td><td style="text-align: justify"><b>Options granted: (Cont.)</b></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_51" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_50"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><ix:nonNumeric contextRef="c105" continuedAt="rvsn_OptionsGrantedDescription-c105_cont_1" name="rvsn:OptionsGrantedDescription">f)</ix:nonNumeric></td><td style="text-align: justify"><ix:continuation id="rvsn_OptionsGrantedDescription-c105_cont_1">On November 3, 2020, the Company granted options to purchase 107,800 ordinary shares to its employees
at an exercise price of $6.14 per share. These options expire 10 years after their grant date and vest over three years in nine tranches.
One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years
thereafter. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an expense of $46, $62 and $14, respectively, in
respect for such grant.</ix:continuation></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_52" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_51"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><ix:nonNumeric contextRef="c106" continuedAt="rvsn_OptionsGrantedDescription-c106_cont_1" name="rvsn:OptionsGrantedDescription">g)</ix:nonNumeric></td><td style="text-align: justify"><ix:continuation id="rvsn_OptionsGrantedDescription-c106_cont_1">On May 11, 2022, the Company granted to three officers options to purchase 547,162 ordinary shares including
266,216 to its former chairman of the Board, 156,081 to its CEO and 124,865 to its CFO, at an exercise price of $1.85 per share (equal
to the average closing share price on the Nasdaq over the first 30 calendar days following the IPO on April 4, 2022). These options expire
10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022. The Company recorded
an expense of $61, in respect for such grant.</ix:continuation></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_53" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_52"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in">h)</td><td style="text-align: justify">On May 11, 2022, and June 6, 2022, <ix:nonNumeric contextRef="c107" name="rvsn:OptionsGrantedDescription">the Company granted to four of its directors&#8217; options to purchase
119,796 ordinary shares and 39,932 ordinary shares, respectively, with an exercise price of $1.85 per share. Such options will vest one-third
following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following
36 months. For the year ended December 31, 2022, the Company recorded an expense of $17 in respect for such grant.</ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_54" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_53"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><ix:nonNumeric contextRef="c108" continuedAt="rvsn_OptionsGrantedDescription-c108_cont_1" name="rvsn:OptionsGrantedDescription">i)</ix:nonNumeric></td><td style="text-align: justify"><ix:continuation id="rvsn_OptionsGrantedDescription-c108_cont_1">On September 13, 2022 the Company granted 252,000 options to its employees at an exercise price of $1.85
per share. These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested
on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended
December 31, 2022, the Company recorded an expense of $10, in respect for such grant.</ix:continuation></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_55" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_54"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><ix:nonNumeric contextRef="c109" continuedAt="rvsn_OptionsGrantedDescription-c109_cont_1" name="rvsn:OptionsGrantedDescription">j)</ix:nonNumeric></td><td style="text-align: justify"><ix:continuation id="rvsn_OptionsGrantedDescription-c109_cont_1">On September 13, 2022 the Company granted 100,000 options to two of its officers at an exercise price
of $1.85 per share. These options expire 10 years after their grant date and vest in twelve equal quarterly tranches over a period of
three years. For the years ended December 31, 2022, the Company recorded an expense of $4, in respect for such grant.</ix:continuation></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_56" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_55"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in">k)</td><td style="text-align: justify">On September 13, 2022, <ix:nonNumeric contextRef="c110" continuedAt="rvsn_OptionsGrantedDescription-c110_cont_1" name="rvsn:OptionsGrantedDescription">in accordance with the terms of the 2017 Plan, the Board approved a modification
of 375,716 outstanding options held by officers and employees that had an exercise price of $6.14&#160;per share and reduced the exercise
price to $1.85&#160;per share. This resolution was effective from November 3, 2022, after receiving approval from the Israeli Tax Authorities.
The Company calculated the fair value of such options immediately before and after the modification.&#160;The Company immediately recognized
the additional fair value attributable to vested options, approximately $51, as share based payment expenses. The additional fair value
resulting from the modification, approximately $30, is being expensed over the remaining vesting period of the modified options.</ix:nonNumeric></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_57" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_56"><ix:continuation id="rvsn_OptionsGrantedDescription-c110_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">The modification of 368,170 additional
outstanding options held by the Company&#8217;s CEO and two Directors was approved by the Board and is subject to an approval by the Company&#8217;s
shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration: none"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY (Cont.)</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_58" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_57"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Share Based Payment Expense:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_59" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_58"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The total share-based payment expense
related to options granted to employees and service providers comprised, at each period, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_59"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Cost of revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">8</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd">36</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">174</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="3" unitRef="usd">1,119</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">323</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">411</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">1,162</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Total share-based payment expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd">505</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd">1,055</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd">2,281</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 9  - RESEARCH AND DEVELOPMENT, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>



</div><div>

</div><ix:continuation id="_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">5,049</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">5,586</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">5,065</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">174</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">608</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">1,119</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">R&amp;D consumables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" scale="3" unitRef="usd">160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" scale="3" unitRef="usd">318</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" scale="3" unitRef="usd">390</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">355</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">390</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">359</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">132</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd">123</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Subcontracted work and consulting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:SubcontractedWorkAndConsulting" scale="3" unitRef="usd">15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:SubcontractedWorkAndConsulting" scale="3" unitRef="usd">64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:SubcontractedWorkAndConsulting" scale="3" unitRef="usd">82</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Travel and other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">347</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">67</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">6,230</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">7,208</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c121" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd">7,205</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock-c0_cont_1" escape="true" name="rvsn:DisclosureOfGeneralAndAdministrativeTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE&#160;10  - GENERAL AND ADMINISTRATIVE</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation id="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">1,845</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">1,508</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpensesRelatedParty" scale="3" unitRef="usd">1,563</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">323</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">411</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" unitRef="usd">1,162</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Professional services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd">1,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd">1,133</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd">555</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Travel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TravelAndEntertainmentExpense" scale="3" unitRef="usd">26</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostMaintenance" scale="3" unitRef="usd">120</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" unitRef="usd">67</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Marketing and others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="3" unitRef="usd">393</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="3" unitRef="usd">7</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">4,265</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left"></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">3,316</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">3,500</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE&#160;11  - TAXES ON INCOME</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p></ix:nonNumeric><div>



</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>A.</b></td><td style="text-align: justify">The Company is subject to income taxes under Israeli tax laws:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">The Israeli corporate tax rate was <ix:nonFraction contextRef="c122" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c123" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c124" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in 2022, 2021 and
2020.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">As of December 31, 2022, the Company generated net operating
losses of approximately $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd">42,795</ix:nonFraction>, which may be carried forward and offset against taxable income in the future for an indefinite period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">The Company is still in its development stage and has not
yet generated revenues. Therefore, it is more likely than not that sufficient taxable income will not be available for the tax losses
to be utilized in the foreseeable future. Therefore, a valuation allowance was recorded to cover the entire balance of the deferred tax
assets.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>Deferred tax assets:</b></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Deferred taxes due to carryforward losses</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd">9,843</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd">8,396</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">9,843</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">8,396</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Income tax expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">4.</td><td style="text-align: justify">The Company has no uncertain tax positions and foreign sources
of income.</td>
</tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 12
- TRANSACTIONS AND BALANCES WITH RELATED PARTIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 28.35pt">&#160;</p></ix:nonNumeric><div>



</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Parties considered to be related to
the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common
control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families
of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>Transactions:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfRelatedPartyTransactionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:RevenuesFromRelatedParties" scale="3" unitRef="usd">888</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">__</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Severance payment to former Company CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd">234</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">General and administrative expenses (*)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_25_fact" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" unitRef="usd">147</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">__</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4"><ix:continuation id="_ScheduleOfRelatedPartyTransactionsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_9_footnote" xml:lang="en-US">One time IPO bonus in the amount of $<ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" unitRef="usd">97</ix:nonFraction> and $<ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="0" unitRef="usd">50</ix:nonFraction> to the Company&#8217;s
CEO and its former chairman, respectively.</ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>


</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 - TRANSACTIONS AND BALANCES
WITH RELATED PARTIES (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Balances:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfClosedBlockAssetsAndLiabilities-c0_cont_1" escape="true" name="us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Accounts receivable (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c128" decimals="-3" format="ixt:num-dot-decimal" id="ix_26_fact" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd">27</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">__</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7"><ix:continuation id="_ScheduleOfClosedBlockAssetsAndLiabilities-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify"><ix:footnote id="ix_10_footnote" xml:lang="en-US">See Note 6D above.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: 0pt"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_1" escape="true" name="rvsn:LeasesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 13 &#8211; LEASES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_2" id="rvsn_LeasesDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On April 4, 2021, the Company signed
an amendment to the lease of the Company&#8217;s offices in Raanana, Israel, according to which, instead of the additional lease period under
the option in the lease, the Company extended the lease period for another five years beginning on September 9, 2021 (the date the current
lease period ends) until September 8, 2026 (the &#8220;Lease Update&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_3" id="rvsn_LeasesDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the Lease Update, the
monthly rent for the Company&#8217;s offices (excluding parking and management fees) will be approximately NIS <ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="ils">79</ix:nonFraction> thousand (approx. $<ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd">25</ix:nonFraction>) in
the first two years, NIS <ix:nonFraction contextRef="c130" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="ils">82</ix:nonFraction> thousand (approx. $<ix:nonFraction contextRef="c130" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd">26</ix:nonFraction>) in the third and fourth lease years and NIS <ix:nonFraction contextRef="c131" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="ils">83</ix:nonFraction> thousand (approx. $<ix:nonFraction contextRef="c131" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRent" scale="3" unitRef="usd">26</ix:nonFraction>) in the fifth
year. All the amounts are linked to the Consumer Price Index.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_4" id="rvsn_LeasesDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the Lease Update, <ix:nonNumeric contextRef="c0" name="us-gaap:LesseeOperatingLeaseDescription">the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_5" id="rvsn_LeasesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">At the time of the amendment, the Company
updated its lease liability and right-of-use asset in a total amount of approx. $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd">458</ix:nonFraction>, which reflects the expected lease term until <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="us-gaap:LeaseExpirationDate1">September
8, 2026</ix:nonNumeric>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_6" id="rvsn_LeasesDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">For the years ended December 31, 2022
2021 and 2020, operating lease expenses recorded in the Statements of Comprehensive Loss were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BenefitsLossesAndExpenses" scale="3" unitRef="usd">357</ix:nonFraction>, $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BenefitsLossesAndExpenses" scale="3" unitRef="usd">405</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BenefitsLossesAndExpenses" scale="3" unitRef="usd">375</ix:nonFraction>, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_7" id="rvsn_LeasesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Future lease payments under operating
leases as of December 31, 2022 were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_8" id="rvsn_LeasesDisclosureTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd">326</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd">312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" unitRef="usd">317</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" unitRef="usd">219</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total future lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="rvsn:FutureLeasePayments" scale="3" unitRef="usd">1,174</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationImputedInterest" scale="3" unitRef="usd">95</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease liability balance</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd">1,079</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Rail Vision Ltd. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notes to
Financial Statements<br/>
</b>(U.S. dollars in thousands, except share and per share data)</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="rvsn_LeasesDisclosureTextBlock-c0_cont_9" id="rvsn_LeasesDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted average lease term and
weighted average discount rate as of December 31, 2022 was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="rvsn_LeasesDisclosureTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Operating leases weighted average remaining lease term (in years)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c2" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">3.75</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating leases weighted average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure">5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 14 - SUBSEQUENT EVENTS </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"></td><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>Israel Railways</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">1)</td><td style="text-align: justify">Following the Railways MOU with Israel Railways as detailed
in Note 6B. above on January 31, 2023 the Company signed an agreement with Israel Railways to purchase ten (10) Rail Vision Main Line
Systems and related services for a total amount of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" unitRef="usd">1.4</ix:nonFraction> million.</td>
</tr></table><p style="text-align: justify; margin-top: 0; margin-bottom: 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_4" id="_SubsequentEventsTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"></td><td style="width: 0.25in; text-align: left">2)</td><td style="text-align: justify">Regarding the exercise of Israel Railways options subsequent
to December 31, 2022, see Note 8D(1) above.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_5" id="_SubsequentEventsTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 48px"></td><td style="text-align: justify; width: 24px"><b>B.</b></td><td style="text-align: justify">On <span>January 19, 2023, the Company announced the appointment of an
existing director,&#160;Mark Cleobury, as Chairman of the Board. Mr. Cleobury succeeds Shmuel Donnerstein who served as the Company&#8217;s
Chairman since 2020. Donnerstein will continue to serve Rail Vision as a Board member.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 48px"></td><td style="text-align: justify; width: 24px"><b>C.</b></td><td style="text-align: justify">On February 16, 2023, <ix:nonNumeric contextRef="c0" name="us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription">a leading US-based rail and leasing services company purchased a Switch Yard System
for $140,000 with support, to evaluate its performance during a six-month trial.</ix:nonNumeric> The Company&#8217;s new customer offers a suite of rail-centric
services including in-plant rail switching and material handling services.&#160;</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-25</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>



</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentAccountingStandard">U.S. GAAP</ix:nonNumeric>
<ix:nonFraction contextRef="c2" id="hidden-fact-1" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-2" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-3" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-4" name="us-gaap:Revenues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-5" name="us-gaap:CostOfRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="us-gaap:GrossProfit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-7" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.74</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-8" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">1.12</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-9" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">1.17</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-10" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">14174422</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="INF" id="hidden-fact-11" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">9136600</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="INF" id="hidden-fact-12" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">9148143</ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-13" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-14" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-18" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-23" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-24" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-26" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-27" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-28" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-29" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-30" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-31" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-32" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-34" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-35" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-36" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-37" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-38" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-39" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-40" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-42" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-43" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-44" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-45" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-46" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-47" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-48" name="us-gaap:ConversionOfStockAmountIssued1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-49" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-50" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-51" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-52" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-53" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-54" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-55" name="rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-56" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-57" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-58" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-59" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-60" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-61" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-62" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-63" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-64" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-65" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-66" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-67" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-68" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-69" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-70" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-71" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-72" name="rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-73" name="rvsn:ConversionOfPreferredShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-74" name="rvsn:ConversionOfPreferredShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-75" name="rvsn:ConversionOfAConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-76" name="rvsn:ConversionOfAConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-77" name="rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-78" name="rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-79" name="us-gaap:OtherDeferredCostsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-80" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-81" name="us-gaap:DeferredRevenueCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-82" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-83" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c118" id="hidden-fact-84" name="us-gaap:CostOfRevenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-85" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-86" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-87" name="rvsn:RevenuesFromRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-88" name="rvsn:RevenuesFromRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-89" name="us-gaap:SeveranceCosts1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-90" name="us-gaap:OtherGeneralAndAdministrativeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-91" name="us-gaap:OtherGeneralAndAdministrativeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-92" name="us-gaap:AccountsReceivableNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c128" id="hidden-fact-93" name="us-gaap:OtherAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001743905</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="rvsn-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact ix_1_fact ix_2_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-34 hidden-fact-58" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_3_fact ix_4_fact hidden-fact-15 hidden-fact-16 hidden-fact-21 hidden-fact-22 hidden-fact-25 hidden-fact-26 ix_5_fact ix_6_fact hidden-fact-28 hidden-fact-29 ix_7_fact hidden-fact-34 hidden-fact-37 hidden-fact-38 hidden-fact-41 hidden-fact-42 ix_8_fact ix_9_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_10_fact ix_11_fact hidden-fact-15 hidden-fact-16 hidden-fact-17 hidden-fact-18 hidden-fact-19" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-44 hidden-fact-45 ix_12_fact ix_13_fact ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact hidden-fact-58 hidden-fact-61 hidden-fact-62 hidden-fact-64 hidden-fact-65 ix_19_fact ix_20_fact" toRefs="ix_5_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-50 hidden-fact-51 ix_14_fact ix_15_fact ix_21_fact hidden-fact-52 ix_22_fact" toRefs="ix_6_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-81 ix_23_fact" toRefs="ix_7_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_24_fact" toRefs="ix_8_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_25_fact hidden-fact-90 hidden-fact-91" toRefs="ix_9_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-92 ix_26_fact" toRefs="ix_10_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-08-01</xbrli:startDate>
    <xbrli:endDate>2016-08-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-08-01</xbrli:startDate>
    <xbrli:endDate>2016-08-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-04-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-04-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-01</xbrli:startDate>
    <xbrli:endDate>2021-12-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">rvsn:KnorrBremseRailSystemsSchweizAGMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-13</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-04-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-04-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2016-08-01</xbrli:startDate>
    <xbrli:endDate>2016-08-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSfoqWPmxUjxzf9cAxxP8d7yfyYG9uDyI20w==] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-07-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-10</xbrli:startDate>
    <xbrli:endDate>2018-11-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-10</xbrli:startDate>
    <xbrli:endDate>2018-11-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-11-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-05-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-05-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2017-09-01</xbrli:startDate>
    <xbrli:endDate>2017-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-11-01</xbrli:startDate>
    <xbrli:endDate>2018-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-11-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-03-19</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-04-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-04-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-02-01</xbrli:startDate>
    <xbrli:endDate>2018-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-05-01</xbrli:startDate>
    <xbrli:endDate>2018-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-03-01</xbrli:startDate>
    <xbrli:endDate>2019-03-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-03-01</xbrli:startDate>
    <xbrli:endDate>2022-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-04-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-01</xbrli:startDate>
    <xbrli:endDate>2022-04-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-15</xbrli:startDate>
    <xbrli:endDate>2021-07-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-01-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-01-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-01</xbrli:startDate>
    <xbrli:endDate>2018-01-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rvsn:EmployeesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-01</xbrli:startDate>
    <xbrli:endDate>2018-01-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-01</xbrli:startDate>
    <xbrli:endDate>2018-01-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-01-01</xbrli:startDate>
    <xbrli:endDate>2018-01-24</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-01-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:October2020Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:November32020Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-01</xbrli:startDate>
    <xbrli:endDate>2022-11-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:May112022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-01</xbrli:startDate>
    <xbrli:endDate>2022-05-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-01</xbrli:startDate>
    <xbrli:endDate>2022-05-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2022-09-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:September132022Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2022-09-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:September132022Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rvsn:TwoThousandSeventeenPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-01</xbrli:startDate>
    <xbrli:endDate>2022-09-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:MemberUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:MemberUnitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:FirstTwoYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:ThirdAndFourthLeaseYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001743905</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:FifthLeaseYearMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="eur">
  <xbrli:measure>iso4217:EUR</xbrli:measure>
</xbrli:unit><xbrli:unit id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>f20f2022ex2-1_railvisionltd.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
2.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF THE SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
descriptions of the securities contained herein summarize the material terms and provisions of the ordinary shares and warrants of Rail
Vision Ltd. (the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;our&rdquo; or &ldquo;us&rdquo;), registered under Section 12 of the
Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 21, 2023, our authorized share capital consisted of 100,000,000 ordinary shares, par value NIS 0.01 per share, of which
16,091,458 ordinary shares were issued and outstanding as of such date. All of our outstanding ordinary
shares have been validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and are not subject to any
preemptive rights. All descriptions of our share capital set forth herein give effect to the issuance of bonus shares under Israeli
law to all of our shareholders on a basis of 43 bonus shares for each ordinary share outstanding (equivalent to a 44-for-1 share
split) simultaneously with the completion of the initial public offering and the customary adjustments to our outstanding options
and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rights
Attached to Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares shall confer upon the holders thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal
    right to attend and to vote at all of our general meetings, whether regular or special, with each ordinary share entitling the holder
    thereof, which attend the meeting and participate at the voting, either in person electronically or by a proxy or by a written ballot,
    to one vote;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal
    right to participate in distribution of dividends, if any, whether payable in cash or in bonus shares, in distribution of assets
    or in any other distribution, on a per share pro rata basis; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">equal
    right to participate, upon our dissolution, in the distribution of our assets legally available for distribution, on a per share
    pro rata basis.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Nasdaq Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2022, our ordinary shares and warrants commenced trading on the Nasdaq Capital Market under the symbols &ldquo;RVSN,&rdquo;
and &ldquo;RVSNW,&rdquo; respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amended
and Restated Articles of Association</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transfer
of Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ordinary shares that are fully paid are issued in registered form and may be freely transferred under our Amended and Restated Articles
of Association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules of a stock exchange
on which the shares are listed for trade.&nbsp; The ownership or voting of our ordinary shares by non-residents of Israel is not restricted
in any way by our Amended and Restated Articles of Association or the laws of the State of Israel, except for ownership by nationals
of some countries that are, or have been, in a state of war with Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Election
of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our amended and restated articles of association, shareholders are entitled to appoint a director to our board of directors for each
10% of our outstanding share capital that they own and in such case the appointment will be for an undefined period. Additional board
members are elected at our shareholder&rsquo;s annual meetings and in such case they shall serve on the board of directors until the
next annual general meeting (except for external directors which will serve for up to three terms, each term of three years&rsquo; period).
In addition, our amended and restated articles allow our board of directors to appoint directors to fill vacancies and/or as an addition
to the board of directors (subject to the maximum number of directors) to serve until the next annual general meeting. All of the elected
directors, other than external directors, may be re-elected for an unlimited number of terms upon completion of their then-current term
of office. External directors are elected for an initial term of three years and may be removed from office pursuant to the terms of
the Companies Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dividend
and Liquidation Rights</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ordinary shares confer upon the holders the right to receive notice to participate and vote in general meetings of shareholders of the
Company, the right to receive dividends, if declared, and the right to participate in a distribution of the surplus of assets upon liquidation
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Annual
and Special Meetings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, we are required to hold an annual general meeting of our shareholders once every calendar year, at such time and place
which shall be determined by our board of directors, that must be no later than 15 months after the date of the previous annual general
meeting. All meetings other than the annual general meeting of shareholders are referred to as special general meetings. Our board of
directors may call special meetings whenever it sees fit and upon the written request of: (a) any two of our directors or such number
of directors equal to one quarter of the members of our board of directors; and/or (b) one or more shareholders holding, in the aggregate,
either (i) 5% or more of our outstanding voting power or (ii) 5% or more of our outstanding issued shares and 1% of our outstanding voting
power.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolutions
regarding the following matters must be passed at a general meeting of our shareholders:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments
    to our amended and restated articles of association;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment
    or termination of our auditors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment
    of directors, including external directors;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval
    of acts and transactions requiring general meeting approval pursuant to the provisions of the Companies Law and any other applicable
    law;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases
    or reductions of our authorized share capital; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    merger (as such term is defined in the Companies Law).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Notice
Requirement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law requires that a notice of any annual or special shareholders meeting be provided at least 21 days prior to the meeting,
and if the agenda of the meeting includes, among other matters, the appointment or removal of directors, the approval of transactions
with office holders or interested or related parties, or an approval of a merger, notice must be provided at least 35 days prior to the
meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Quorum
Requirements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted under the Companies Law, under our amended and restated articles of association, the quorum required for our general meetings
consists of at least two shareholders present in person, by proxy or written ballot, who hold or represent between them at least 25%
of the total outstanding voting rights. If within half an hour of the time set forth for the general meeting a quorum is not present,
the general meeting shall stand adjourned the same day of the following week, at the same hour and in the same place, or to such other
date, time and place as prescribed in the notice to the shareholders and in such adjourned meeting, if no quorum is present within half
an hour of the time arranged, any number of shareholders participating in the meeting, shall constitute a quorum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Adoption
of Resolutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association provide that all resolutions of our shareholders require a simple majority vote, unless
otherwise required under the Companies Law or our amended and restated articles of association. A shareholder may vote in a general meeting
in person, by proxy or by a written ballot.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changing
Rights Attached to Shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise provided by the terms of the shares and subject to any applicable law, in order to change the rights attached to any class
of shares, such change must be adopted at a general meeting of the affected class or by a written consent of all the shareholders of
the affected class.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
enlargement of an existing class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached
to the previously issued shares of such class or of any other class, unless otherwise provided by the terms of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Limitations
on the Right to Own Securities in Our Company</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations on the right to own our securities. In certain circumstances the IPO warrants have restrictions upon the exercise
of such warrants if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our ordinary shares upon such
exercise, as further described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Provisions
Restricting Change in Control of Our Company</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no specific provisions of our amended and restated articles of association that would have an effect of delaying, deferring or preventing
a change in control of the Company or that would operate only with respect to a merger, acquisition or corporate restructuring involving
us. However, as described below, certain provisions of the Companies Law may have such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law includes provisions that allow a merger transaction and requires that each company that is a party to the merger have the
transaction approved by its board of directors and, unless certain requirements described under the Companies Law are met, a vote of
the majority of shareholders, and, in the case of the target company, also a majority vote of each class of its shares. For purposes
of the shareholder vote of each party, unless a court rules otherwise, the merger will not be deemed approved if shares representing
a majority of the voting power present at the shareholders meeting and which are not held by the other party to the merger (or by any
person or group of persons acting in concert who holds 25% or more of the voting power or the right to appoint 25% or more of the directors
of the other party) vote against the merger. If, however, the merger involves a merger with a company&rsquo;s own controlling shareholder
or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority
requirement that governs all extraordinary transactions with controlling shareholders.&nbsp;Upon the request of a creditor of either
party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that as
a result of the merger the surviving company will be unable to satisfy the obligations of any of the parties to the merger, and may further
give instructions to secure the rights of creditors. In addition, a merger may not be completed unless at least (1) 50 days have passed
from the time that the requisite proposals for approval of the merger were filed with the Israeli Registrar of Companies by each merging
company and (2) 30 days have passed since the merger was approved by the shareholders of each merging company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law also provides that an acquisition of shares in an Israeli public company must be made by means of a &ldquo;special&rdquo;
tender offer if as a result of the acquisition (1) the purchaser would become a holder of 25% or more of the voting rights in the company,
unless there is already another holder of at least 25% or more of the voting rights in the company or (2) the purchaser would become
a holder of more than 45% of the voting rights in the company, unless there is already a holder of more than 45% of the voting rights
in the company. These requirements do not apply if, in general, the acquisition (1) was made in a private placement that received shareholders&rsquo;
approval, subject to certain conditions, (2) was from a holder of 25% or more of the voting rights in the company which resulted in the
acquirer becoming a holder of 25% or more of the voting rights in the company, or (3) was from a holder of more than 45% of the voting
rights in the company which resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company. A &ldquo;special&rdquo;
tender offer must be extended to all shareholders. In general, a &ldquo;special&rdquo; tender offer may be consummated only if (1) at
least 5% of the voting power attached to the company&rsquo;s outstanding shares will be acquired by the offeror and (2) the offer is
accepted by a majority of the offerees who notified the company of their position in connection with such offer (excluding the offeror,
controlling shareholders, holders of 25% or more of the voting rights in the company or anyone on their behalf, or any person having
a personal interest in the acceptance of the tender offer). If a special tender offer is accepted, then the purchaser or any person or
entity controlling it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender
offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year
from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial
special tender offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
as a result of an acquisition of shares, the acquirer will hold more than 90% of an Israeli company&rsquo;s outstanding shares, the acquisition
must be made by means of a tender offer for all of the outstanding shares. In general, if less than 5% of the outstanding shares are
not tendered in the tender offer and more than half of the offerees who have no personal interest in the offer tendered their shares,
all the shares that the acquirer offered to purchase will be transferred to it by operation of law. However, a tender offer will also
be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company
or of the applicable class of shares. Shareholders may request appraisal rights in connection with a full tender offer for a period of
six months following the consummation of the tender offer, but the acquirer is entitled to stipulate, under certain conditions, that
tendering shareholders will forfeit such appraisal rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lastly,
Israeli tax law treats some acquisitions, such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably
than U.S. tax laws. For example, Israeli tax law may, under certain circumstances, subject a shareholder who exchanges his ordinary shares
for shares in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in Our Capital</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association enable us to increase or reduce our share capital. Any such changes are subject to the provisions
of the Companies Law and must be approved by a resolution duly passed by our shareholders at a general meeting by voting on such change
in the capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain terms and provisions of the 4,355,327 warrants sold in our initial public offering, all of which remain
outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercisability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original
issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise
notice and, at any time a registration statement registering the issuance of the ordinary shares underlying the warrants under the Securities
Act is effective and available for the issuance of such shares, by payment in full in immediately available funds for the number of ordinary
shares purchased upon such exercise. If a registration statement registering the issuance of the ordinary shares underlying the warrants
under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the warrant through
a cashless exercise, in which case the holder would receive upon such exercise the net number of ordinary shares determined according
to the formula set forth in the Warrant. No fractional shares will be issued in connection with the exercise of a warrant. In lieu of
fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercise
Limitation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder does not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially
own in excess of 4.99% of the number of ordinary shares outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the warrants. However, any holder may increase or decrease such percentage to
any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days following
notice from the holder to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercise
Price</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price per whole ordinary share purchasable upon exercise of the warrants is $4.13&nbsp;per share, which is 100% of the public
offering price of the units sold in the IPO, with each unit consisting of one of the Company&rsquo;s ordinary shares, and one warrant
to purchase one ordinary share. The units have no stand-alone rights and will not be certificated or issued as stand-alone securities.
The exercise price of the warrant is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock
splits, stock combinations, reclassifications or similar events affecting our ordinary shares and also upon any distributions of assets,
including cash, stock or other property to our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transferability</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fundamental
Transactions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization or
reclassification of our ordinary shares, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding ordinary shares, or any
person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding ordinary shares, the holders
of the warrants will be entitled to receive upon exercise of the warrants the kind and amount of securities, cash or other property that
the holders would have received had they exercised the warrants immediately prior to such fundamental transaction without regard to any
limitations on exercised contained in the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rights
as a Stockholder</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the warrants or by virtue of such holder&rsquo;s ownership of our ordinary shares, the holder of a warrant does
not have the rights or privileges of a holder of our ordinary shares, including any voting rights, until the holder exercises the warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Governing
Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants are governed by New York law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any other securities that are registered under Section 12 of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>f20f2022ex4-4_railvisionltd.htm
<DESCRIPTION>RAIL VISION LTD. AMENDED SHARE OPTION PLAN, AMENDED AS OF SEPTEMBER 13, 2022
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.4</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RAIL VISION LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED SHARE OPTION PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify"><U>Purpose</U>: The purpose of this Share Option Plan is to
provide an additional incentive to Employees, Directors, Consultants and certain other Service Providers of the Company (as defined below)
and any Affiliate of the Company (as defined below) to further the growth, development and financial success of the Company by providing
them with opportunities to purchase Shares (as defined below) of the Company pursuant to this Share Option Plan and to promote the success
of the Company&rsquo;s business.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify"><U>Definitions</U>: For the purposes of this Share Option Plan,
the following terms shall have the meaning ascribed thereto below:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify"><B>&ldquo;Additional Rights&rdquo; </B>means any distribution
of rights, including an issuance of bonus shares and stock dividends (but excluding cash dividends), in connection with Section 102 Trustee
Options (as defined below) and/or the Shares issued upon exercise of such Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify"><B>&ldquo;Afflliate(s)&rdquo; </B>means a present or future
company that either (i) controls the Company or is controlled by the Company; or (ii) is controlled by the same person or entity that
controls the Company, provided that for the purpose of grants made under Section 102, such company is an &ldquo;employing company&rdquo;
within the meaning of Section 102(a) of the Tax Ordinance (as defined below).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify"><B>&ldquo;Board&rsquo;&rsquo; </B>means the Board of Directors
of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify"><B>&ldquo;Cause&rdquo; </B>means any of the following: (i)
a serious breach of trust, including but not limited to, theft, embezzlement, self-dealing, and/or breach of fiduciary duties; (ii) the
Optionee (as defined below) has committed any flagrant criminal offense; (iii) a material breach by the Optionee of any agreement between
the Optionee and the Company and/or any Affiliate, which has not been remedied within thirty (30) days after the Optionee has received
a written demand for performance from the Company; or (iv) any other circumstance justifying termination or dismissal without severance
payment according to Israeli law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify"><B>&ldquo;Committee&rdquo; </B>means a committee of Directors
(as defined below) to which the Board may delegate power to act under or pursuant to the provisions of the Plan. In the absence of any
such delegation, the Committee will consist of the entire Board.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify"><B>&ldquo;Company&rdquo; </B>means Rail Vision Ltd., a company
incorporated under the laws of the State of Israel.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">g)</TD><TD STYLE="text-align: justify"><B>&ldquo;Companies Law&rdquo; </B>means the Israeli Companies
Law 5759-1999, as amended.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">h)</TD><TD STYLE="text-align: justify"><B>&ldquo;Consultant&rdquo; </B>means any person or entity
that is engaged by the Company or any Affiliate of the Company to render consulting or advisory services to such entity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">i)</TD><TD STYLE="text-align: justify"><B>&ldquo;Controlling Shareholder&rdquo; </B>has the meaning
ascribed to it in Section 32(i) of the Tax Ordinance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">j)</TD><TD STYLE="text-align: justify"><B>&ldquo;Corporate Transaction&rdquo; </B>means the consummation
of any of the following transactions or series of related transactions to which the Company is a party:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">i) any person becomes a beneficial owner,
directly or indirectly, of either (A) 50% or more of the then-outstanding Shares or (B) securities of the Company representing 50% or
more of the combined voting power of the Company&rsquo;s then outstanding securities eligible to vote for the election of directors; provided,
however, that for purposes of this subsection i), the following acquisitions of shares or the Company&rsquo;s voting securities shall
not constitute a Change in Control: (w) an acquisition directly from the Company pursuant to share issuances, share purchases, or similar
acquisitions by Company shareholders, (x) an acquisition by the Company or an Affiliate, (y) an acquisition by any employee benefit plan
(or related trust) sponsored or maintained by the Company or any Affiliate, or (z) an acquisition pursuant to a Non-Qualifying Transaction
(as defined in subsection (ii) below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify">ii)    the
consummation of a reorganization, merger, consolidation, statutory share exchange or similar form of corporate transaction involving the
Company or an Affiliate (a &ldquo;Reorganization&rdquo;), or the sale or other disposition of all or substantially all of the Company&rsquo;s
assets (a &ldquo;Sale&rdquo;) or the acquisition of assets or stock of another corporation or other entity (an &ldquo;Acquisition&rdquo;),
unless immediately following such Reorganization, Sale or Acquisition: (A) all or substantially all of the individuals and entities who
were the beneficial owners, respectively, of the outstanding Shares and outstanding Company&rsquo;s voting securities immediately prior
to such Reorganization, Sale or Acquisition beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding
Shares and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors,
as the case may be, of the entity resulting from such Reorganization, Sale or Acquisition (including, without limitation, an entity which
as a result of such transaction owns the Company or all or substantially all of the Company&rsquo;s assets or shares either directly or
through one or more subsidiaries, the &ldquo;Surviving Entity&rdquo;) in substantially the same proportions as their ownership, immediately
prior to such Reorganization, Sale or Acquisition, of the outstanding Shares and outstanding voting securities, as the case may be, and
(B) no person (other than (x) the Company or any Affiliate, (y) the Surviving Entity or its ultimate parent entity, or (z) any employee
benefit plan (or related trust) sponsored or maintained by any of the foregoing) is the beneficial owner, directly or indirectly, of 50%
or more of the total ordinary shares or 50% or more of the total voting power of the outstanding voting securities eligible to elect directors
of the Surviving Entity (any Reorganization, Sale or Acquisition which satisfies all of the criteria specified in (A) and (B) above shall
be deemed to be a &ldquo;Non-Qualifying Transaction&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">k)</TD><TD STYLE="text-align: justify"><B>&ldquo;Director&rdquo; </B>means a member of the Board
of Directors of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">l)</TD><TD STYLE="text-align: justify"><B>&ldquo;Disability&rdquo; </B>means a complete and permanent
inability, due to illness or injury, to perform the duties of the Optionee&rsquo;s engagement at such time when the disability commenced, as
determined by the Committee based on medical evidence acceptable to it.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">m)</TD><TD STYLE="text-align: justify"><B>&ldquo;Employee&rdquo; </B>means any person, including
officers and Directors, employed by the Company or any Affiliate of the Company. A person employed by the Company or any Affiliate of
the Company shall not cease to be an Employee for the purposes of the Plan in the case of (i) any leave of absence approved by the Company,
or (ii) transfer between locations of the Company, or (iii) transfer of employment between the Company and any Affiliate or any successor
thereto. With regard to Section 102 Trustee Options and Section 102 Non-Trustee Options (as defined below), &ldquo;Employee&rdquo; includes
Directors and office holders <I>(&ldquo;Nosei Misra&rdquo;</I> as such term is defined in the Israeli Companies Law), and excludes any
person who is a Controlling Shareholder prior to and/or after the issuance of the Shares issued upon exercise of the Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">n)</TD><TD STYLE="text-align: justify"><B>&ldquo;Exercise Price&rdquo; </B>means the price per Share
determined by the Committee in accordance with Section 10 below, which is to be paid to the Company in order to exercise an Option and
purchase the Share(s) covered thereby.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">o)</TD><TD STYLE="text-align: justify"><B>&ldquo;Expiration Date&rdquo; </B>of an Option means the
earlier of: (i) the lapse of ten (10) years from the date such Option was granted; or (ii) the expiration date set forth in the Option
Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">p)</TD><TD STYLE="text-align: justify"><B>&ldquo;Fair Market Value&rdquo; </B>means, as of any date,
the value of a Share determined as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">i)</TD><TD STYLE="text-align: justify">If the Shares are admitted to trading on any established stock
exchange or a national market system, including without limitation the Nasdaq National Market or the Nasdaq Small Cap Market of the Nasdaq
Stock Market, the Fair Market Value shall be the closing sale price of a Share on the principal exchange on which Shares are then trading
(or as reported on any composite index which includes such principal exchange), on the trading day immediately preceding such date, or
if Shares were not traded on such date, then on the next preceding date of which a trade occurred, as reported in <I>The Wall Street
Journal</I> or such other source as the Committee deems reliable;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">ii)</TD><TD STYLE="text-align: justify">If the Shares are not traded on an exchange, but are admitted
to quotation on the Nasdaq or other comparable quotation system, the Fair Market Value shall be the mean between closing representative
bid and asked prices for the Shares on the trading day immediately preceding such date or, if no bid and ask prices were reported on
such date, then on the last date preceding such date on which both bid and ask prices were reported, all as reported by Nasdaq or such
other comparable quotation system; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">iii)</TD><TD STYLE="text-align: justify">If the Shares are not publicly traded on an exchange and not
quoted on Nasdaq or a comparable quotation system, the Fair Market Value shall be determined in good faith by the Committee.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 52pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">iv)</TD><TD STYLE="text-align: justify">Without derogating from the foregoing and solely for the purpose
of determining the tax liability, in the case of Capital Gain Option Through a Trustee (as defined below), the Fair Market Value of a
Share at grant shall be determined in accordance with the provisions of Section 102(b)(3) of the Tax Ordinance as further detailed in
Section 17(b) below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">q)</TD><TD STYLE="text-align: justify"><B>&ldquo;IPO&rdquo; </B>means an initial underwritten public
offering of the Shares of the Company pursuant to an effective registration statement under the United States Securities Act of 1933,
as amended or the Israeli Securities Law, 5728-1968. as amended or equivalent law of another jurisdiction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">r)</TD><TD STYLE="text-align: justify"><B>&ldquo;Lock-up Period&rdquo; </B>means the period during
which the Section 102 Trustee Options granted to an Optionee or, upon exercise thereof the underlying Shares as well as any Additional
Rights distributed in connection therewith are to be held by the Trustee (as defined below) on behalf of the Optionee, in accordance
with Section 102 (as defined below) and pursuant to the tax route which the Company elects.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">s)</TD><TD STYLE="text-align: justify"><B>&ldquo;Notice of Exercise&rdquo; </B>has the meaning ascribed
to it in Section 11 below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">t)</TD><TD STYLE="text-align: justify"><B>&ldquo;Option(s)&rdquo; </B>means a right to purchase
Shares granted under Section 8 below in accordance with the provisions of the Option Agreement, and subject to the terms specified in
the Plan, whether a Section 102 Trustee Option, Section 102 Non-Trustee Option, Section 3(i) Option, or option issued under other tax
regimes.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">u)</TD><TD STYLE="text-align: justify"><B>&ldquo;Optionee(s)&rdquo; </B>means the holder of an outstanding
Option granted under the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">v)</TD><TD STYLE="text-align: justify"><B>&ldquo;Option Agreement&rdquo; </B>means a written or
electronic agreement between the Company and the Optionee evidencing the terms and conditions of an individual grant of Option, as further
specified in Section 8 below. The Option Agreement is subject to the terms and conditions of the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">w)</TD><TD STYLE="text-align: justify"><B>&ldquo;Plan&rdquo; </B>means this Share Option Plan, as
amended from time to time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">x)</TD><TD STYLE="text-align: justify"><B>&ldquo;Proxy Holder&rsquo; </B>means the Chairman of the Board,
as shall be in office from time to time or any other person designated by the Board to act as proxy holder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">y)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 3(i)&rdquo; </B>means that certain Section
3(i) of the Tax Ordinance, and any regulations, rules, orders or procedures promulgated thereunder, all as amended.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">z)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 3(i) Option&rdquo; </B>means an Option granted
pursuant to Section 3(i).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">aa)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 102&rdquo; </B>means that certain Section
102 of the Tax Ordinance, and any regulations, rules, orders or procedures promulgated thereunder, including the Income Tax Rules (Tax
Relief for Issuance of Shares to Employees), 2003, all as amended.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">bb)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 102 Trustee Option&rdquo; </B>means an
Option that by its terms qualifies and is intended to qualify under the provisions of Section 102(b) of the Tax Ordinance (including
the Section 102(b) Route Election (as defined below)), as either:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">cc)</TD><TD STYLE="text-align: justify"><B>&ldquo;Ordinary Income Option Through a Trustee&rdquo;
</B>for the special tax treatment under Section 102(b)(1) and the &ldquo;Ordinary Income Route&rdquo;, or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">i)</TD><TD STYLE="text-align: justify"><B>&ldquo;Capital Gain Option Through a Trustee&rdquo; </B>for
the special tax treatment under Section 102(b)(2) and the &ldquo;Capital Route&rdquo;.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">ii)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 102(b) Route Election&rdquo; </B>means the
right of the Company to choose either the &ldquo;Capital Route&rdquo; (as set under Section 102(b)(2)), or the &ldquo;Ordinary Income
Route&rdquo; (as set under Section 102(b)(1)), but subject to the provisions of Section 102(g) of the Tax Ordinance, as further specified
in Section 6 below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">dd)</TD><TD STYLE="text-align: justify"><B>&ldquo;Section 102 Non-Trustee Option&rdquo; </B>means
an Option that by its terms does not qualify or is not intended to qualify as a Section 102 Trustee Option and is granted not through
a trustee under the terms of Section 102(c) of the Tax Ordinance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">ee)</TD><TD STYLE="text-align: justify"><B>&ldquo;Service Provider&rdquo; </B>means an Employee,
officer, Director or Consultant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">ff)</TD><TD STYLE="text-align: justify"><B>&ldquo;Share(s)&rdquo; </B>means an Ordinary Share, nominal
value NIS 0.01 of the Company, as adjusted in accordance with Section 13 of the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">gg)</TD><TD STYLE="text-align: justify"><B>&ldquo;Tax Ordinance&rdquo; </B>means the Israeli Income
Tax Ordinance (New Version), 1961, as amended.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">hh)</TD><TD STYLE="text-align: justify"><B>&ldquo;Trust Agreement&rdquo; </B>means a written agreement
between the Company and the Trustee, which sets forth the terms and conditions of the trust and is in accordance with the provisions
of Section 102(b).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">ii)</TD><TD STYLE="text-align: justify"><B>&ldquo;Trustee&rsquo;&rsquo; </B>means a person or an entity,
appointed by the Company and approved in accordance with the provisions of Section 102, to hold in trust on behalf of the Optionees the
granted Options, or upon exercise thereof, the Shares, as well as any Additional Rights granted in connection therewith, in accordance
with the provisions of Section 102.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">jj)</TD><TD STYLE="text-align: justify">&ldquo;<B><U>Repricing</U></B><U>&rdquo;</U> shall mean (i)
reducing the exercise price of an Option, (ii) cancel outstanding Options in exchange for cash, other equity awards or Options with an
Exercise Price that is less than the Exercise Price of the original Options, or (iii) cancel outstanding Options with an Exercise Price
that is less than the then current Fair Market Value of a Share in exchange for other equity awards, cash or other property.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify"><U>Interpretation</U>: Unless the context otherwise indicates,
words expressed in the singular shall include the plural and vice versa and the use of the neuter, masculine, or feminine gender is for
convenience only and shall be deemed to mean and include the neuter, masculine or feminine gender, as appropriate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify"><U>Administration</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">The Committee shall have the power to administer the Plan.
Notwithstanding the above, the Board shall automatically have a residual authority if no Committee shall be constituted or if such Committee
shall cease to operate for any reason whatsoever.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Subject to the terms and conditions of this Plan, and subject
to the approval of any relevant authorities and to applicable laws, the Committee shall have full power and authority, at all times,
to: (i) select the Service Providers to whom Options may from time to time be granted hereunder, and to grant the Options to the said
Service Providers; (ii) determine the terms and provisions of the Option Agreements (which need not be identical) including, but not
limited to, the type of Option to be granted, the number of Shares to be covered by an Option, the Exercise Price, the times or conditions
upon which and the extent to which an Option shall be vested and may be exercised and the nature and duration of any restrictions applicable
to the Options or the underlying Shares, including as to transferability or exercise of the same; (iii) accelerate the right of an Optionee
to exercise, in whole or in part, any Option, or extend such right; (iv) amend the terms of any outstanding Option in any manner to achieve
Repricing; (v) approve forms of Option Agreement for use under the Plan; (vi) make a Section 102(b) Route Election (subject to the limitations
set under Section 102(g)); (vii) interpret and construe the provisions of the Plan and the Option Agreements; (viii) determine the Fair
Market Value of the Shares; (ix) adopt sub-plans, Plan addenda and appendices to the Plan as the Committee deems desirable, to accommodate
foreign laws, regulations and practice. The provisions of such sub-plans, Plan addenda and appendices to the Plan may take precedence
over other provisions of the Plan, but unless otherwise superseded by the terms of such sub-plans, Plan addenda and appendices to the
Plan, the provisions of the Plan shall govern their operation; (x) exercise such powers and perform such acts as are deemed necessary
or expedient to promote the best interests of the Company with respect to the Plan, including but not limited to prescribe, amend and
rescind any rules and regulations relating to the Plan (including rules and regulations relating to sub-plans. Plan addenda and appendices
to the Plan established for the purpose of satisfying applicable foreign laws); and (xi) take all other action and determine any other
matter which is necessary or desirable for, or incidental to, the administration of the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">The interpretation and construction by the Committee of any
provision of the Plan (including sub-plans, Plan addenda and appendices to the Plan), the Option Agreement or of any Option thereunder
shall be final and conclusive, unless otherwise determined by the Board.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify"><U>Reserved Shares</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">The Company, during the term of this Plan, shall reserve
and keep available such number of Shares as shall be sufficient to satisfy&#1523; the requirements of the Plan. The Shares subject to
the Plan may be either authorized but unissued Shares or reacquired Shares, subject to applicable laws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Any Shares under the Plan, in respect of which the right
hereunder of an Optionee to purchase the same shall for any reason terminate, become cancelled, expire or otherwise cease to exist, shall
again be available for grant through Options under the Plan (unless the Plan has terminated); provided, however, that any Shares not
issued or tendered to the Company related to the payment of the Exercise Price of an Option or tax withholding obligations as provided
under Section 17 shall not be available for grant through Options under the Plan. No fraction of Shares may be issued under the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">The Board may, at any time during the term of the Plan, increase
the number of Shares available for grant under the Plan. The approval of the Company&rsquo;s shareholders of such increase shall be obtained
if so required under applicable laws and/or the Company&rsquo;s incorporation documents and/or any shareholders agreement, as shall be
in effect from time to time.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">6.</TD><TD STYLE="text-align: justify"><U>Section 102(b) Route Election</U>: No Section 102 Trustee
Options may be granted under this Plan to any eligible Optionee, unless and until, the Company&rsquo;s election of the type of Section 102
Trustee Options either as &ldquo;Ordinary Income Option Through a Trustee&rdquo; or as &ldquo;Capital Gain Option Through a Trustee&rdquo;
is appropriately filed with the Income Tax Authorities. The Section 102(b) Route Election shall obligate the Company to grant <I>only
</I>the type of Section 102 Trustee Option it has elected, and shall apply to all Optionees who were granted Section 102 Trustee Options
during the period indicated herein, to the extent required under and in accordance with the provisions of Section 102(g) of the Tax Ordinance
and the applicable regulations. For avoidance of doubt, it is clarified that the Company does not obligate itself to file a Section 102(b)
Route Election, and in any case, such Section 102(b) Route Election shall be at the sole discretion of the Company. It is further clarified
that such Section 102(b) Route Election shall not prevent the Company from granting Section 102 Non-Trustee Options simultaneously.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">7.</TD><TD STYLE="text-align: justify"><U>Eligible Optionees</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Subject to the terms and conditions of the Plan and any restriction
imposed by applicable laws, Options may be granted to Service Providers, as selected by the Committee in its sole discretion, <I>provided
however,</I> that, (i) Section 102 Trustee Options and Section 102 Non-Trustee Options may be granted only to Israeli Employees of the
Company and any Affiliate thereof, and provided further that, such Affiliate corporation is an &ldquo;employing company&rdquo; within the
meaning of Section 102(a) of the Tax Ordinance; and (ii) Section 3(i) Options may be granted only to Israeli (a) Consultants; and/or
(b) employees, Directors and/or officers of the Company or any Affiliate who are Controlling Shareholders prior to and/or after the issuance
of the Shares underlying the Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Eligibility to participate in the Plan does not confer any
right to be granted with Options under the Plan. Participation in the Plan is voluntary. The grant of an Option to a Service Provider
hereunder, shall neither entitle such Service Provider to participate, nor disqualify him from participating, in any other grant of Options
pursuant to this Plan or any other share incentive or stock option plan of the Company or any Affiliate of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">8.</TD><TD STYLE="text-align: justify"><U>Issuance of Options</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Options may be granted at any time after the Plan shall become
effective as specified in Section 18 hereof, subject to obtaining all the necessary approvals (if any) from any regulatory body or governmental
agency having jurisdiction over the Company and/or any Affiliate and/or any Optionee. In the case of Section 102 Trustee Options, Options
may be granted only after the passage of thirty (30) days (or a shorter period as and if approved by the tax authorities) following the
delivery by the Company to the appropriate Israeli Income Tax Authorities of a request for approval of the Plan and the Trustee according
to Section 102. Notwithstanding the above, if within ninety (90) days of delivery of the abovementioned request, the tax officer notifies
the Company of its decision not to approve the Plan, the Options, which were intended to be granted as a Section 102 Trustee Options,
shall be deemed to be Section 102 Non-Trustee Options, unless otherwise was approved by the tax officer. The date of grant of each Option
shall be the date specified by the Committee at the time such Option is granted and subject to the applicable laws and regulations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">An Option Agreement shall evidence each Option granted pursuant
to the Plan. The Option Agreement shall state, <I>inter alia,</I> the number of Shares covered thereby, the type of Option granted thereunder,
the vesting schedule (including any performance-based vesting criteria) and any acceleration thereof, the Exercise Price and such other
terms and conditions as the Committee in its discretion may prescribe, provided that they are consistent with this Plan and applicable
laws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">9.</TD><TD STYLE="text-align: justify"><U>Trustee</U>: In connection with the grant of any Section
102 Trustee Options, the following shall apply:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained in the
Plan. Section 102 Trustee Options, which shall be granted under the Plan and any Shares issued upon exercise of such Options shall be
issued to the Trustee who shall hold the same in trust for the benefit of the Optionee at least for the Lock-up Period. Upon the conclusion
of the Lock-up Period and subject to any further period included in the Plan and/or in the Option Agreement, the Trustee may release
Section 102 Trustee Options or Shares issued upon exercise of such Options to Optionee only after the Optionee&rsquo;s full payment of his
tax liability in connection therewith due pursuant to the Tax Ordinance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Notwithstanding the above, in the event an Optionee shall
elect to release the Section 102 Trustee Options and/or the Shares issued upon exercise of such Options prior to the conclusion of the
Lock-up Period, the sanctions under Section 102 shall apply to and shall be borne solely by the Optionee.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">Any Additional Rights distributed to the Optionee on account
of Section 102 Trustee Options shall be deposited with and/or issued to the Trustee for the benefit of the Optionee, and shall be held
by the Trustee for the applicable Lock-up Period in accordance with the provisions of Section 102 and the elected tax route.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify">The Company, any Affiliate of the Company (if applicable),
the Trustee and the Optionee shall comply with the Tax Ordinance, Section 102 and the provisions of the Trust Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify">Upon receipt of Section 102 Trustee Options, Optionee will
sign the Option Agreement, which shall be deemed as the Optionee&rsquo;s undertaking to exempt the Trustee from any liability in respect
of any action or decision duly taken and <I>bona fide</I> executed in relation with the Plan and any Option, Share, Additional Right
or other rights received by the Optionee in connection therewith.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify">The Committee shall determine and approve the terms of engagement
of the Trustee, and shall be authorized to designate from time to time a new Trustee and replace either of them at its sole discretion,
and in the event of replacement of any existing Trustee, to instruct the transfer of all Options and Shares held by such Trustee at such
time to its successor.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">g)</TD><TD STYLE="text-align: justify">For as long as the Trustee holds Shares in trust for the
benefit of the Optionee, the Trustee shall not use the voting rights vested in such Shares, and shall not exercise such rights in any
way whatsoever. In the event the right to vote such Shares is held by the Trustee pursuant to Section 102, then upon the exercise of
any Section 102 Trustee Option by the Optionee, the Trustee shall execute an irrevocable voting proxy in such form as may be prescribed
by the Committee in accordance with the provisions of Section 11(j) of the Plan and the provisions of Section 102.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">10.</TD><TD STYLE="text-align: justify"><U>Option Exercise Price and Consideration</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">The Exercise Price shall be determined by the Committee on
the date of grant of an Option, on an individual basis, subject to any guidelines as may be determined by the Board from time to time
and any applicable law; provided, however, that the Exercise Price shall be not less than the nominal value of the Shares underlying
the Option.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">The consideration to be paid for the Shares to be issued
upon exercise of an Option, including the method of payment, shall be determined by the Committee subject to applicable laws. Such consideration
may consist of, without limitation, (1) cash, or (2) check or wire transfer, or (3) at the discretion of the Committee, consideration
received by the Company under a broker-assisted sale and remittance program acceptable to the Committee, or (4) at the discretion of
the Committee, any combination of the foregoing methods of payment.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">11.</TD><TD STYLE="text-align: justify"><U>Vesting and Exercise of Options</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Each Option Agreement shall provide the vesting schedule
for the Option as determined by the Committee. The Committee shall have the authority to determine the vesting schedule and accelerate
the vesting of any outstanding Option at such time and under such circumstances as it, in its sole discretion, deems appropriate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">The Option Agreement may contain performance goals and measurements
(which, in the case of Options granted in accordance with Section 102, shall, if then required, be subject to obtaining a specific tax
ruling or determination from the appropriate Israeli Income Tax Authorities), and the provisions with respect to any Option need not
be the same as the provisions with respect to any other Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">Options shall be exercisable pursuant to the terms under
which they were awarded and subject to the terms and conditions of this Plan and the Option Agreement; provided, however, that in no
event shall an Option be exercisable after its Expiration Date, as further specified in Section 11(d) below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: 1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: 1pt">Unless the Committee
provides otherwise, vesting of Options granted hereunder shall be suspended during any unpaid leave of absence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify">Anything herein to the contrary notwithstanding, if any Option,
or any part thereof, has not been exercised prior to its Expiration Date and the Shares covered thereby not paid for until such date,
then such Option, or such part thereof, and the right to acquire such Shares shall terminate, and all interests and rights of the Optionee
in and to the same shall expire.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify">Options may be exercised only to purchase whole Shares, and
in no case may a fraction of a Share be purchased. If any fractional Share would be deliverable upon exercise, including but not limited
to, as a result of adjustments as provided in Section 14 hereof, such fraction shall be rounded up one-half or less, or otherwise rounded
down, to the nearest whole number of Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify">An Option, or any part thereof, shall be exercisable by the
Optionee&rsquo;s signing and returning to the Company at its principal office, on any business day, a &ldquo;Notice of Exercise&rdquo; in such
form and substance as may be prescribed by the Committee from time to time and in accordance with the requirements of applicable laws,
which exercise shall be effective upon receipt of such signed notice by the Company at its principal office. The Notice of Exercise shall
specify the number of Shares with respect to which the Option is being exercised and shall be accompanied by payment of the aggregate
Exercise Price due with respect to the Shares to be purchased. Such payment may consist of any consideration and method of payment authorized
by the Committee and permitted by the Option Agreement and the Plan. If required under applicable laws, the Notice of Exercise shall
also be accompanied by payment of the aggregate withholding taxes due with respect to the exercise of Options and/or purchased Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">g)</TD><TD STYLE="text-align: justify">If applicable laws require the Company to take any action
with respect to the Shares specified in the Notice of Exercise before the issuance thereof, then the date of their issuance shall be
extended for the period necessary to take such action.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">h)</TD><TD STYLE="text-align: justify">Prior to exercise, the Optionee shall have none of the rights
and privileges of a shareholder of the Company in respect to any Shares purchasable upon the exercise of any part of an Option. Until
the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the
Company), no right to receive dividends or any other rights as a shareholder shall exist with respect to the Shares, notwithstanding
the exercise of the Option. The Company shall issue (or cause to be issued) such Shares promptly after the Option is exercised, subject
to the provisions of Section 15 hereof. No adjustment will be made for a dividend or other right, for which the record date precedes
the date of issuance of the Shares, except as provided in Section 13 hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">i)</TD><TD STYLE="text-align: justify">Except and to the extent otherwise expressly provided herein,
the Shares acquired under an Option shall be subject to the provisions of the Company&rsquo;s incorporation documents, as amended from time
to time and/or any other shareholders agreement in effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">j)</TD><TD STYLE="text-align: justify">To the extent permitted by applicable law, an Option Agreement
may include a requirement that concurrently with the exercise of any Option and as a condition precedent to such exercise and the issuance
of any Shares in respect thereof, the Optionee shall sign and deliver to the Company an irrevocable power of attorney and voting proxy
in such form as may be prescribed by the Committee. By this proxy, the Optionee&rsquo;s right to vote any acquired Shares shall be assigned
to the Proxy Holder, who shall vote such Shares on any issue brought before the shareholders of the Company in accordance with the majority
vote of the shareholders of the Company (as voted by the shareholders without taking such acquired Shares in consideration). Such power
of attorney and voting proxy shall expire and be of no further force and effect upon the consummation of an IPO.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">12.</TD><TD STYLE="text-align: justify"><I><U>Net Exercise</U></I>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Notwithstanding the provisions of Section
11 above, the Board may determine that in lieu of exercising Options for cash, the Optionee may elect to receive Shares equal to the aggregate
value of the Options (or the portion thereof being exercised) against payment of the par value of such exercised Shares, by written notice
of such election to the Company, in which event the Company shall issue to the Optionee, for no additional consideration (other than the
par value of such exercised Shares), that number of Shares computed using the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X =</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y (A-B)</FONT></TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.7pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-N</FONT></TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt">Where</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">X =   The number
of Shares to be issued to the Grantee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Y =   The number
of Vested Options that the Grantee wishes to exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">A =   The Fair
Market Value of one (1) Share, which, if the Shares are traded on a stock exchange, will be considered as the average known closing price
(or closing bid if no sales have been reported) of the Company&rsquo;s share on the applicable stock exchange in the 30 days prior to
the date of delivery of the exercise notice by the Optionee to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">B =   The Exercise
Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">N =   Par
Value of Exercise Share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">13.</TD><TD STYLE="text-align: justify"><U>Termination of Relationship as a Service Provider</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Except as provided below, an Option, or any part thereof,
may not be exercised unless the Optionee is then a Service Provider of the Company or any Affiliate thereof, and unless the Optionee
has remained continuously a Service Provider since the date of grant of the Option, unless the Committee determines that a longer period
is applicable or such longer period is otherwise set forth in the Option Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Unless otherwise approved by the Committee or set forth in
the Option Agreement, if an Optionee ceases to be a Service Provider of the Company or any Affiliate thereof for any reason (including,
but not limited to retirement, but excluding termination by reasons of Cause, Optionee&rsquo;s Disability or death, for which events there
are special rules in Sections 13(c) and 13(d) below), all Options granted to the Optionee, which are vested and exercisable at the time
of such termination, may be exercised within one (1) month following the date of such termination if the Company initiates such termination
or two (2) weeks following the date of such termination, if the Service Provider initiates such termination but in no event later than
the Expiration Date of such Option, as set forth in the Option Agreement. If, after termination, the Option is not so exercised within
the time specified herein, the Option shall terminate, and the Shares covered by the unexercised portion of such Option shall revert
to the Plan. Unless the Committee or the Option Agreement provide otherwise, any Options which are not vested and exercisable at the
date of such termination, shall terminate, and the Shares covered by such unvested Option shall revert to the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">Unless otherwise approved by the Committee or set forth in
the Option Agreement, if an Optionee ceases to be a Service Provider of the Company or any Affiliate thereof as a result of Optionee&rsquo;s
Disability or death, all Options granted to the Optionee, which are vested and exercisable at the time of such termination, may, unless
earlier terminated in accordance with the Option Agreement, be exercised within six (6) months, following the Optionee&rsquo;s termination,
but in no event later than the Expiration Date of such Option, as set forth in the Option Agreement. In the case of Optionee&rsquo;s death,
such Option may be exercised by the personal representative of the Optionee&rsquo;s estate or by the person or persons to whom the Option is
transferred pursuant to the Optionee&rsquo;s will or the laws of inheritance or by the Optionee&rsquo;s designated beneficiary or beneficiaries
of that Option. If, after termination, the Option is not so exercised within the time specified herein, the Option shall terminate, and
the Shares covered by the unexercised portion of such Option shall revert to the Plan. Unless the Committee or the Option Agreement provide
otherwise, any Options which are not vested and exercisable at the date of such termination, shall terminate and the Shares covered by
such unvested Option shall revert to the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify">Notwithstanding the above, if an Optionee ceases to be a
Service Provider of the Company or any Affiliate thereof for Cause, all outstanding Options granted to such Optionee (whether vested
or not) shall, to the extent not theretofore exercised, expire immediately upon the earlier of: (i) the date of such termination; or
(ii) the time of delivery of the notice of termination for Cause, unless otherwise determined by the Committee. The Shares covered by
such expired Options shall revert to the Plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify">In addition and notwithstanding Sections 13(b) through 13(d)
above, if after termination of relationship as a Service Provider, Optionee does not comply in full with any of non- compete, non-solicitation,
confidentiality or any other requirement of any agreement between the Optionee and the Company (or any Affiliate thereof engaging the
Optionee), the Committee may, in its sole discretion, refuse to allow the exercise of the Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify">For the purpose of this Section 13, termination of relationship
as a Service Provider shall be deemed to be effective upon the date, which is designated by the Company (or any Affiliate thereof engaging
the Optionee) as the last day of the Optionee&rsquo;s service with the Company or any Affiliate thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">g)</TD><TD STYLE="text-align: justify">For the purpose of this Section 13, a transfer of the Optionee
from the service of the Company to any Affiliate (and vise versa) or between Affiliates shall not be deemed a termination of relationship
as a Service Provider, unless otherwise determined by the Committee.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">14.</TD><TD STYLE="text-align: justify"><U>Adjustments, Liquidation and Corporate Transaction</U>: Upon
the occurrence of any of the following described events, an Optionee&rsquo;s right to purchase Shares under the Plan shall be adjusted as hereinafter
provided.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify"><U>Changes in Capitalization</U>. The number and type of
Shares which have been authorized for issuance under the Plan but as to which no Option have yet been granted or which have been returned
to the Plan upon cancellation or expiration of an Option, and the number and type of Shares covered by each outstanding Option, as well
as the Exercise Price per Share covered by each such outstanding Option, shall be proportionately adjusted for any increase or decrease
in the number or type of issued Shares resulting from a stock split, reverse stock split, stock dividend, recapitalization, combination
or reclassification of the Shares, or any other increase or decrease in the number of issued Shares effected without receipt of consideration
by the Company, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under
the Plan. The conversion of any convertible securities of the Company shall not be deemed to have been &ldquo;effected without receipt
of consideration&rdquo;. Such adjustment shall be made by the Committee, in its sole discretion. The Company shall not be required to
issue fractional Shares or other securities under the Plan as a result of such adjustment and any fractional interest in a Share or other
security that would otherwise be delivered upon the exercise of an Option will be rounded, as detailed in Section 11(e) hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify"><U>Dissolution or Liquidation</U>. In the event of dissolution
or liquidation of the Company, the Company shall have no obligation to notify the Optionees of such event and any Options that have not
been previously exercised will terminate immediately prior to such dissolution or liquidation. Notwithstanding the above, in the event
of a voluntary liquidation of the Company, which is not within the frame of a Corporate Transaction, the Committee shall notify each
Optionee as soon as practicable prior to the effective date of such proposed transaction, and any Options that have not been previously
exercised will terminate immediately prior to such proposed liquidation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify"><U>Corporate Transaction</U>. In the event of a Corporate
Transaction, each outstanding Option shall be treated as the Committee determines, including, without limitation, that each Option may
(i) be assumed or substituted for an equivalent option by the successor corporation or a parent or subsidiary of the successor corporation.
In the case of such assumption or substitution of Options, appropriate adjustments shall be made in the number and type of Shares covered
by each outstanding Option, as well as the Exercise Price per Share covered by each such outstanding Option, and all other terms and
conditions of the Options, such as the vesting dates, shall remain in force; or (ii) be terminated in exchange for a cash payment (if
any) equal to the excess of the Fair Market Value of the Shares subject to such Option (either to the extent then exercisable or, at
the discretion of the Committee, the Option being made fully exercisable for purposes of this Section 14(c)) over the Exercise Price
thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt">For the purposes of
this Section 14(c), the Option shall be considered assumed if, following the Corporate Transaction, the Option confers the right to purchase
or receive, for each Share covered by the Option immediately prior to the Corporate Transaction, the consideration, if any, (whether stock,
cash, or other securities or property) received in the Corporate Transaction by holders of Ordinary Shares for each Ordinary Share held
on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the
holders of a majority of the outstanding Ordinary Shares); provided, however, that if such consideration received in the Corporate Transaction
is not solely in securities of the successor corporation or its Parent or Subsidiary, the Committee may, with the consent of the successor
corporation, provide for the consideration to be received upon the exercise of the Option, for each Ordinary Share subject to the Option,
to be solely in securities of the successor corporation or its Parent or Subsidiary equal in fair market value to the per share consideration
received by holders of Ordinary Shares in the Corporate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 1pt">Unless the Committee
or the Option Agreement provide otherwise, in the event that the Option is not assumed, substituted or exchanged during and/or immediately
following the Corporate Transaction, the Option shall terminate as of the date of the closing of the Corporate Transaction and the Committee
shall notify the Optionee in writing or electronically of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">The Committee shall not be required to
treat all Options similarly in the transaction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify"><U>Dividend Distribution. </U>In the event the Company shall
distribute a cash, in kind, or similar dividend with respect to all of its issued and outstanding ordinary shares, and the record date
for determining the right to receive such dividends is before the Expiration Date of exercise such Options, then the Option Exercise
Price payable upon exercise of each outstanding Option shall be adjusted and reduced by the amount of such dividend payment per Share;
provided, however, that no dividends or Additional Rights may be issued with respect to any unvested Options.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">e)</TD><TD STYLE="text-align: justify"><U>Issuance of Rights</U>. In the event that the Company
shall offer to its shareholders rights to purchase any securities, by the method of rights offering, than the Exercise Price shall not
be adjusted. However, the amount of shares issuable upon the exercise of Options not yet exercised prior to the effective date with respect
to the right to purchase rights under the rights offering (in this Section 14(e) &ndash; the &ldquo;Effective Date&rdquo;), shall be adjusted
according to the benefit component of the rights, if any, as it is expressed in the ratio between the price of an ordinary share on the
end of the Effective Date and the price of an ordinary share as a result of such rights offering, as recorded by the stock exchange,
as applicable (ex rights rate).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">f)</TD><TD STYLE="text-align: justify">Upon each adjustment of the Exercise Price and/or number
of Shares, the Company shall notify Holder within a reasonable time setting forth the adjustments to the Exercise Price, class and/or
number of Shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">15.</TD><TD STYLE="text-align: justify"><U>Limited Transferability and Restrictions on Sale of Options/Shares</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">No Option may be sold, pledged, assigned, hypothecated or
transferred other than by will or by the laws of descent and distribution, and may be exercised during the lifetime of the Optionee,
only by the Optionee. The terms of the Plan and the Option Agreement shall be binding upon the executors, administrators, heirs, successors
and assigns of the Optionee. Any attempted sale, transfer, assignment, pledge, hypothecation or other disposition of any Option or of
any rights granted thereunder contrary to the provisions of this Plan shall be null and void.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Without derogating from the provisions of Section 15(a) above,
with regard to Section 102 Trustee Option and the Shares issued upon exercise of such Options, as long as such Options and/or Shares
are held by the Trustee on behalf of the Optionee, all rights of the Optionee with respect thereto are personal and cannot be transferred,
assigned, pledged or mortgaged, other than by will or by the laws of descent and distribution.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">Shares acquired upon exercise of an Option shall be subject
to such restrictions on transfer and/or sale as are generally applicable to Ordinary Shares of the Company, including but not limited
to (i) restrictions detailed in the Company&rsquo;s incorporation documents, as may be amended from time to time; and (ii) restrictions detailed
in any shareholders agreements (as applicable to other shareholders of Ordinary Shares of the Company), as amended from time to time,
regardless of whether or not the Optionee is a party to such agreements.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify">In the event the Shares shall be registered for trading in
any public market, the Committee may impose certain limitations on the Optionee&rsquo;s right to sell the Shares (including a lock-up
period) as may be requested by the Company&rsquo;s underwriters or as the Committee may, in its absolute discretion, determine to be
necessary or advisable, and Optionee shall unconditionally agree and accept any such limitations.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">16.</TD><TD STYLE="text-align: justify"><U>Conditions Upon Issuance of Shares</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Shares shall not be issued pursuant to the exercise of an
Option unless the exercise of such Option and the issuance and delivery of such Shares shall comply with applicable laws and shall be
further subject to the approval of counsel for the Company with respect to such compliance. Without derogating from the generality of
the foregoing, the Company shall not be required to issue or deliver any Shares (or any certificate or certificates for such Shares)
purchased upon exercise of any Option (or portion thereof) prior to the completion of any registration or other qualification of such
Shares, if so required under any applicable law and/or under the rulings or regulations of any governmental regulatory body which the
Committee shall, in its absolute discretion, determine to be necessary or advisable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">As a condition to the exercise of an Option, the Committee
may require the Optionee exercising such Option to represent and warrant at the time of such exercise, if, in the opinion of counsel
for the Company such representation is required in order to comply with any registration exemption requirement, that (i) the Shares are
being purchased only for investment and without any present intention to sell or distribute such Shares; and (ii) the Optionee shall
not sell, transfer or otherwise dispose of any of the Shares so purchased by him, except in compliance with the applicable securities
laws, and the rules and regulations thereunder. Furthermore, the Company shall have the authority to endorse upon the certificate or
certificates representing the Shares such legends referring to the foregoing restrictions, and any other applicable restriction, as it
may deem appropriate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">17.</TD><TD STYLE="text-align: justify"><U>Tax Consequences</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Any tax consequences arising from the grant or exercise of
any Option, from the payment for Shares covered thereby, from the sale, transfer or disposition of such Shares or from any other event
or act (of the Optionee, the Company or any Affiliate of the Company or the Trustee (if applicable)) hereunder, shall be borne solely
by the Optionee. The Company or any Affiliate or the Trustee (if applicable) shall withhold taxes according to the requirements under
the applicable laws, and it may take steps as it may deem necessary for withholding all due taxes, including, but not limited to (i)
to the extent permitted by applicable laws, deducting the amount so required to be withheld from any other amount then or thereafter
payable to an Optionee, and/or (ii) requiring an Optionee to pay to the Company or any Affiliate or to the Trustee (as the case may be)
the amount so required to be withheld as a condition for the issuance, delivery, distribution or release of any Shares. Furthermore,
such Optionee shall agree to indemnify the Company, any Affiliate that engages the Optionee and the Trustee, if applicable, and hold
them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities
relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Optionee. Except as otherwise required
by applicable laws, the Company shall not be required to release any Share certificate to an Optionee until all required payments have
been fully made.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">Without derogating from the definition of Fair Market Value
in Section 2 above, and solely for the purpose of determining the tax liability with respect to the grant of Capital Gain Option Through
a Trustee pursuant to Section 102, in the event the Shares of the Company are listed for trade on any established stock exchange or national
market system or in the event the Shares of the Company will be registered for trade within ninety (90) days following the date of grant
of such Options, the Fair Market Value of the Shares on the date of grant shall be equal to the average value of the Company&rsquo;s
Shares on the thirty (30) trading days preceding the date of grant or on the thirty (30) trading days following the date of registration
for trade, as the case may be, all in accordance with the provisions of Section 102(b)(3) of the Tax Ordinance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">With regard to Section 102 Non-Trustee Option, in the event
an Optionee shall cease to be employed by or, if applicable, cease to render his services to the Company or any Affiliate, for any reason,
the Optionee shall be obligated to provide the Company and/or its Affiliate with a security or guarantee, in the degree and manner satisfactory
to them, to cover any future tax obligation resulting from the disposition of the Options and/or the Shares acquired thereunder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">d)</TD><TD STYLE="text-align: justify">With regard to Section 102 Trustee Options, the provisions
of the Plan and the Option Agreement shall be subject to the provisions of Section 102 and the tax officer&rsquo;s approval, which shall be
deemed an integral part of the Plan and the Option Agreement. To the extent that Section 102 and/or the tax officer&rsquo;s approval require
the Plan and/or the Option Agreement to contain specified provisions in order to qualify the Options for preferential tax treatment,
such provisions shall be deemed to be stated herein and/or in the Option Agreement, as applicable, and to be binding upon the Company,
any Affiliate and the Optionee.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">18.</TD><TD STYLE="text-align: justify"><U>Term, Amendment and Termination of the Plan</U>:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">The Plan shall become effective upon the later of: (i) its
adoption by the Board; or (ii) its approval by the Company&rsquo;s shareholders, but only if such shareholders&rsquo; approval is required
under applicable laws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">The Committee, at any time and from time to time, may terminate,
suspend or amend the Plan. The Committee shall obtain approval from the Company&rsquo;s shareholders of any Plan amendment to the extent
necessary to comply with applicable laws. Other than in respect of a Corporate Transaction (in which case, the provisions of Section
14(c) above shall govern), no amendment, suspension or termination of the Plan shall impair the rights of any Optionee, unless mutually
agreed otherwise between the Optionee and the Committee, which agreement must be in writing and signed by the Optionee and the Company.
Termination of the Plan shall not affect the Committee&rsquo;s ability to exercise the powers granted to it hereunder with respect to
Options granted under the Plan prior to the date of such termination.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">19.</TD><TD STYLE="text-align: justify"><U>Participation by Optionees Outside Israel</U>. Notwithstanding
anything in the Plan to the contrary, with respect to any employee who is resident outside of Israel, the Committee may, in its sole
discretion, amend the terms of the Plan in order to conform such terms with the requirements of local law or to meet the objectives of
the Plan. The Committee may, where appropriate, establish one or more sub-plans for this purpose.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">20.</TD><TD STYLE="text-align: justify"><U>Inability to Obtain Authority</U>: The inability of the Company
to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&rsquo;s counsel to be necessary
to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue
or sell such Shares as to which such requisite authority shall not have been obtained.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">21.</TD><TD STYLE="text-align: justify"><U>Continuance of Engagement</U>: Neither the Plan nor any Option
granted hereunder shall impose any obligation on the Company or its Affiliates, to continue its relationship with an Optionee as a Service
Provider, and nothing in the Plan, in any Option Agreement or in any Option granted pursuant thereto shall confer upon any Optionee any
right with respect to continuing the Optionee&rsquo;s relationship as a Service Provider with the Company or its Affiliate nor shall it interfere
in any way with his right or the Company&rsquo;s or its Affiliate&rsquo;s right to terminate such relationship at any time, with or without Cause,
and with or without notice.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">22.</TD><TD STYLE="text-align: justify"><U>Non-Exclusivity of the Plan</U>: The Plan shall not be construed
as creating any limitations on the power of the Board or the Committee to adopt such other incentive arrangements as either may deem
desirable, including without limitation, the granting of stock options otherwise than under the Plan, and such arrangements may be either
generally applicable or applicable only in specific cases.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">23.</TD><TD STYLE="text-align: justify"><U>Governing Law and Jurisdiction</U>: This Plan and all instruments
issued thereunder or in connection therewith shall be governed by and construed and enforced in accordance with the laws of the State
of Israel, without giving effect to the principles of conflict of laws thereof. Any dispute arising out of this Plan and all instruments
issued thereunder or in connection therewith shall be resolved exclusively by the appropriate court in the State of Israel.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">24.</TD><TD STYLE="text-align: justify"><U>Application of Funds</U>: The proceeds received by the Company
from the sale of Shares pursuant to Options will be used for general corporate purposes of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">25.</TD><TD STYLE="text-align: justify"><U>Severability</U>: If any term or other provision of this
Plan is determined to be invalid, illegal or incapable of being enforced by any applicable laws, the invalidity of such term or provision
of the Plan shall not affect the validity or enforceability of any other provision of the Plan, which shall remain in full force and
effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: center">*****</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: center">15</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>f20f2022ex12-1_railvisionltd.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Shahar Hania, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 20&ndash;F of Rail Vision Ltd.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a&ndash;15(e) and 15d&ndash;15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
    effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period covered
    by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control
    over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Shahar Hania</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shahar
    Hania</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>f20f2022ex12-2_railvisionltd.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
12.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO EXCHANGE ACT RULE 13a-14(a) or 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Ofer Naveh, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this annual report on Form 20&ndash;F of Rail Vision Ltd.;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a&ndash;15(e) and 15d&ndash;15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the
    effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period covered
    by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control
    over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing
    the equivalent function):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ofer Naveh</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ofer
    Naveh</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>f20f2022ex13-1_railvisionltd.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. Section 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Rail
Vision Ltd. (the &ldquo;Company&rdquo;), the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to
18 U.S.C. Section 1350, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Shahar Hania</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shahar
    Hania</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>f20f2022ex13-2_railvisionltd.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
13.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. Section 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the filing of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Rail
Vision Ltd. (the &ldquo;Company&rdquo;), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to
18 U.S.C. Section 1350, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 23, 2023</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ofer Naveh</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ofer
    Naveh</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $2 ?@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML:?I311WER$>0$HF"[,!U. "<#C)Z<UQWQ?MH(/A7=Q11(L<$EJL:@?< F0
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M9]9?]ZHE\++I_$BY1116!V!1110 4444 %%%% !1110 4444 %%%% !1110
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MZCFK,>M:?<Q74_V&ZC$05BBR*00QQQQP*VM?6YS>W:T:V.GTS7G$@A*R227
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MKU>PM$L+""U3[L2!<^I[G\ZX_P &:;YUY)?.OR0?*GNQ_P !_.N[J2@HHHH
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MMM54Z]2?:OI3P2 /"FG # %M'C\JVI[,YZN\3HZ***L HHHH **** "BBB@
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M@DG!8\D#.!GL!7/W'@Q9!:FWU"2"6/4O[4ED\I6,\^,<^BX.,#L!S76#..:
M%HHHH AG65H)%A<)*5(1F&0&QP2*XM)=?D\976@C7Y=L6E172RFUBR96D=3D
M;?N_*./UKNJYN+1+]/'L^O--;_99;%+/R@&W@*[.&STZL1B@#,T/Q:(=0U*R
MU>YEDD.LO8VTH@/EI\B%$9E& 220,\FME_%>DK>1VS3OF7S1"XC8K,T8)=4(
MZD 'CO@XSBL"7P=JSK<*MW9?O=>CUA<J_ 4J?+^OR#GWZ5-IO@^_TI[BWAN-
M.ELD,KVC26>+A2^[Y7DSRHW'D $@ 9ZT :%OXXT6Z2S>(WA2]*BV<V<H68F,
MR#:=N#\JG\1BI+3QGHU]+9)$UROVN9[>-I+9U59EW;HF)'RO\K<'TK.M/"VI
MVVF>$K3[39N=$8&1MKCS0(FB&/0X8GGN*@M_!^K0PVD9NK$^1K<NJL0K\ARY
MV#W'F'GV'% &C<>++&^T^^73;F5+K[!+>6TC0D"1$R-Z[A@@-CKZCL:T_#-W
M/?\ A72+RY??<7%E#+*^ -S,@).![FN5M_ ^KQS_ &F?4[2XNO[.N;"65H7#
M3>8RE9&.X\_+R!QV&*ZSP_IT^D^'=-TZX>.2:TMHX&>,$*VQ0N0#TR!0!JT4
M44 %-8$J0"02.H[4ZB@#@M&\2:E:^(+K1-=GW07-U+#I>HJBKN9>L+@#:''5
M>,,,]QBKMAXKAT[0K>;6;R:XN3;O=S.D'W(5;#.0HP%''OUJP/#!O])U/3M:
M$$D5W<O/&UL65HB3E6!/1U(!!'>LB^\":I=:/#I9UB.6V&ER64@GA)_>MG$X
M 8#=SSG..U &[+XQTB._GLE:ZEFMPC3>3:R.J*ZLZL2!C:0IYI+7QAI=_#!+
M:_:Y/M 5K9?LSJ;@%-^4R!N '4]!TZXK/T_POJUG=:U-)=V<C:A8P6R[4==C
MQHR;CR>#N)Q[4MGX2OK.S\,R)=P#4-$@:U^ZWE3Q,BJP/=3\BL#S@C'(- &A
M!XQTJXFLH;<W$SWB3-"$A;EHL^8AST<$8VGFI]+\36.KPZ?/9K</'?I))"QA
M( 5#@EO[O) YK*;P0K:6D<5])!?C4VU(W4:?=D=CYBJ.P*,R?K6AX?\ #,.@
M75^\$I:WGF+VT&W"VR-\S(OL7+-^(]* *&LZK?3^*DT"TENK,-827(NH(E<A
MPZ!3@Y!49.1CG(J;2_$VGIX>L[G^T+G4B\4DHE-OB61$8AV**!@ \=/3J:FF
MTC43XVCUN*6V-LEBUIY1#;R2X?=GIU7&/>N<LO &J6%AI)@O=-DO;&.:"07-
MH98)HI)/,^[D%64]"#S0!IP>*(W\5W$XU-&T'^Q(M05R $7,C OG&>54<&I=
M,UR[OO']_89N$L4TV&XC@G@$95VD<$CC)!"CKT.:I:KX#N-6N;R.6]ABM+C2
MH[ -%%M='20R"0*/EQN/W?0=:T](T/5H?$LFN:I>VDLLFGQV;QV\+*,H[MN!
M+'KOZ4 7-0\3Z7ICW"W$KK':LBW4JQEDMRV-N\CIP0?8$$X%9;:GJ&K^+;_2
MK>XN+&.P2VE25(5=9-Q<N'SU5E4 8P1R:+WP?//)X@MH+N-=.UW#7*.A+Q,4
M$;E#T.Y5'7H>>>E7=+T2]T[Q3J5^9+<V5W!!"D:[O,01!@"2>#G?^E '02?=
MKR/XIRVUM?6%S=SA(DCD C3!ED;(X4'I[L>![]*]<D^[7A7QN7=J^D9W%1#+
MD#H?F7K5?99E_P O$>>:EJ][K112!#:1G,4"?=7W_P!IO]H\^F*K)*8%*KU/
M7C-+]IQ@*B_4BE$NYC\H(]EYK,Z!!/,[?-@_\ %7K2WGNO-;*)%$NZ61P%1!
MVR?4] .I-.M;99+5[R[;[+81MM,NW+.W]R,?Q-^@ZG%4KK4IM4>&WAC%MI\,
M@,5NAR ?[S'^-_5CTZ# I7 QIKA!<2]OF/%:&GWVG1VKK=;2Y;C*9XQ69>Q@
M7LW 'SGI]:=921PSXD@25#U!'/X4M#=\ST-ZWU72+8$1D#/?8:)M5TB<@RE6
MQTRAJ>"TTZ>,/'!"P_W>E9[W-G&[(VCME20<**I:F#T9'+<Z0(T$6=ZR!LA3
MR._-:;:]H_DL%4[RN,^560%V3&XCL1/;'[T31X:/]/UJ22ZLF4@:0ZGUV]*J
MS0KFHFOZ=N7,N !_=-.;7M+;CSO_ !PUDZ7;BXD87%E&J@<$IUJ343IUJ#''
M:Q/-W&.%^M2V-1;>AG7EU#+>S21L-C-E>.U=AX,N4%@-N687\)(QU!##^=<'
MM4G/0GVKT+X?VPDL\JJ!EU"%G)'WE )Q64K6.F+D[H]CU*;R--C)9O,D4(H#
MC).WG_>..O91TYK"@M%:\FFXPV!@>W_ZZ76+ES;6)PA$DL41!7(53CIZ>P[G
MD]JFN9([/S(HSF1B6 ]NF:R6A!#)="*=[!% 0JLF<]V)R/TKD/&5XUIIB6<>
MW]_PP)Y"C_/Z5!XAUF73]6EAB^8O!'B3.2I!(S]<FN/6YNM6O;R2\D+2RKAG
M/1 ,8QZ=ZT2);)8K,RW_ )C<*AX&,5KVBR2E@2N%/ J,+"D8;)<@_/ST%6D0
MQD8 .><@XH;&D68R(]JA20>_;\Z]U\''/AFQ/K G\J\0LFLGAN)+ZZ:!(X\I
M'MWM*V< *.GUKV[P;_R+%A_U[I_*KI=3&MO$Z"BBBM22AJFIVVCZ=-?WC2+;
M0*7E9(V<JHZG"@G JN_B'3X]"AUHM,;&8(R.MN[,P<@*=H&[G([=Q6F\:R1M
M'(H9&!#*1D$'M7 ^%K*]MM1D\*7$4AL="N//MYV!Q+ V3;IGN4RP/_7-?6@#
MMK.]6\BD<0W$021H\3Q%"<=P#U!['O5RO*$\57=O YN=4!TT:Y>VL]Y+(<0H
MN?)5G3E%)[\=!SS5IVU>WM](N6UB_P!1@U&&;33-!NC D8EK><#M@ J7Z'AJ
M /3:S;K6;*TO5LFDDDNV3S!##&TCA,XW$*#@9XR:Y_P5)J-_ LNHO=+<:=&=
M.G#R,4GG1COEP>H.%(/^T1VJMI%Q%HOQ!\3+JTJV[:B\$UE/,=J31+'M**QX
MRK;LKU^;/>@#K-.U.SU:&2:RF\Q(Y6A?*%2KKU4@@$$5?K@_%>L0Q2016%]+
M;O<P74J&-O*CFD1% ;>!EF'91][DGA:YR3Q%=W^G7DY\03QR)X5@U#$,RIMN
M@'R0,=RJY'3GWH ]?HKR>[\2:E92SR66IRW<ESH<%^\6X2>6YE42/&H&1B,L
M=H_NCBBZUV?[/;75GXK$NGW>LV<4;0.2(T;B5/,?)8'@X_AS^% 'K%%>6:MK
M<VCZPEK;ZW>2&QU*PMIOM<OS>2^T.=H'SJ0V3(V.>!TKU('(R* %HHHH *J7
M>HV=CM%U=10E\[ [ %L=<#O5NN(T!\_$WQ4M^1]L"6WV(/U^R[.=GMYF[=CO
MC/:@#KK6\M;Z(RVEQ%/&&*EXG# $=1D=ZLUQ/B+41H\LT.BW,%O-+!=7LT44
M:EGD14&\EOE"@D;OXB2,=ZRI?%&NWEG-/;WT%MCPU#JZA(0^V8[BR\GE3MQZ
MT >ET5YI>>,M7TI9+R:2&>*?1H=06-HPHMF:1$;D<E 'W'/]WK4U[K_B&V*"
M/4+)H9]4LH('4I-((IFVN'V@+VRI'.#SZT >BT5YUJ/B/5M(ODA.JPWGV;4+
M*RN#Y"QK^]*A]^>=^'##9P!C/>O1,Y'% "T444 %%%% %6^O[33;1[N]N8K:
MW3[\LK!57ZD]*KR:WI<.FIJ<NH6R6+XVW+2 1G)P,-TYJW=6T%Y:36MQ&LD$
MR-'(C=&4C!!_"N \+O<RE?!E[O=M N!YTC#B:V7#6I].?ES_ -<FH [NRO[7
M48GELYUF1)&B9E[,IP1^!JW7F]OXPU/-O9W$T8>XU6_LQ<_)%@0L0BC<"NX]
M><YVFEFUOQ'9II;WVIV^-0MY[-'M(U>-;Y2?)()'.]0P*] PX.* /1ZJ7>HV
M5CL%U=10E\[ [ %L=<#O7.>$-6U#7((I[JX<-:0_9;^$QJ/],5B).0.BX[<$
M,*K>'G!^(_BQ=0(^W#[/]D#]?LFS^#_9W[]V._7M0!UUM>6U[#YMK<13QY*[
MXG##(ZC([U9KA_$FI_V*UQ%HMS!!*]M=W\L44:EFD0+\Y+?*%!/S?Q$D8[UF
MW7BC7;FRO+JUOX;?R_#D.KJJVZOB4ARRY)Y4[,>HH ]*HKS6\\8ZMI)GN)IH
M9HI-)M[]$,846[/*L;<CDH V[G^[UQ4E]X@\0VAB5-1L6AN-4L[>%U*32"*;
M(8/M 7.1E2.H//K0!Z-17G6H>)=7TG4(;<ZI#>"#4K.PN6\A8U_>@;]^>=_S
M!AL^4#&>]>BT ,D^[7@/QYDE35]&$<C*##-G'?YEKWZ3[M>$?&U9I=?T.WM;
M9KB[ECE6) N[G<O0=S^E5]EF3^-'EEK<O#9RM=*&&"82PP2W^%:MMLL[2/4=
M80)&X+6]DAVRW/N?[D?^UU/0>M4)Y+72<_O%O]6S\\I(>&W]E[2/[_=';/6L
MSSWGN'N;IWE=SN=W;<6/N>]9'07[K4+W5K@3W3KL0;(HD&U(U_NHO8?J>^:L
MPN%*J(U&".E48KN+ \Q2N35D7EM&!EUX/ H CL=1ATOQ+]LN=/AU""*1MUO.
M<))G(Y^G7\*J^8EQ>W$ZP)"KLSI$GW8P3PH]ATJO,P^TRG/&\G]:D1U*MMZX
MJ+:G;&S6Y:LKUH)LC@GCV/UK5ELH-2D\[SI8GP RHU<R$?(.&P3C-:T5SY+(
M48X JD[&4XJ70L3:1=6XWV=P\IZ-'(WWA_*EBT17A#RS3Q.1ED# A:LP:O;N
MI\QPC*.0>]9&I:Q)= QP_)%T]V_^M5\S,53;=B2>_%I;_9+25GP3F5NH]A_C
M6623SWIF_G&!BE$@W8'3UK-W9U1Y8JR+4-W;Q:;<VTFGQ2W$K*8[IG8-"!U
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MHU4J$4 ]0!UJ2BB@ ICQI(NUU5AZ,,T^B@!I4'&0..GM33#$3DQ(3_NBI**
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M,4]<'M5ZB@#/ET;3)V@,^GVLOV<$0[X5/E@C!V\<9[U ?#.AX<?V/8@/"(&
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M%>K^$;&?3/#=E8W(7SX($C?:<C<!S@UN>6*<!BG9+8/>;3ET'4444BPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
EB@ HHHH **** "BBBD 4444P"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $, =L# 2(  A$! Q$!_\0
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MD2Z%'$S2Z5.^GRGG:@W1,?=.@_#%0'7;C32(]:LWA4#_ (^X?GA;ZGJOX@4
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M32'*<\9Z>U/5XBI"KGT!%0.5*#UI(CD*>^*5D,L-% W6/G\:AF:)+>1$##)
MY.>]/9L $&LZZND^[SG=2]!C;9Q&C<KDG(P.]0!?DRCE7#DG!QD4MNY$4Q.3
M@ #*YZGU[5$'VRA2<\')'T-4B7L:%N?]%D:24MD8QUV\UK:?KPT^0A)I$+
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MTV2ZC\MOF'3UH$7O,!Y!I"]4UG38#O'3UIWF@]"*8%@R4W?5=I.#@T&4#DD
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M.OZT$E+46)*8YZG^51O>P?V>(?+;S ,9!XI!<(%.8ED8]WSQ]*K,X 9M@/\
M2FQ")(H1@ZDDCC%08R.11YA)/3\*4'-(!K(N.^:0(,=*1MH(PQ)SR<U*HW'B
M@ ?8K#9R,<\5=N7LULXS#)F7@%<?K4MVEE 0D<?F?NP=P8]3WJ@(XW8C[O&1
MFBPV/@E<7$>T DG'/TJ*69XHHR,'=SS4?FLA&W&>F<=*C#-.P5R..!Q0(FBN
MY&E7<%V[@#Q6WXDG>*6((1@\\CVKGXQMN%3G[P]N];OB956:#/N.OH!2 QQ>
M7&" 5Y_V:<MY/\P+#./E^7O43J8XR%+$9ZCI4E@-\_.>/F_(TP!KNZP%+=NA
M6FFXD;:& YSGCK5N_8%E)/(%401TSWXH OI#>2()%)6-CPV1Q43R31R,LCYV
MDJ<]ZMI<7!@$"(-OE[EXYS4*V%U.Q>08)))SWI1;UN-VZ$:LFU7\T?-P0!DB
MID9YOEB$CGV &:MVFF1H?WV./7FM**2&%?W2\^IQ_*F(RTLKZ*%V((R,[,YS
M]:M:.;E+IBUNX&S%/GNR$.",!@/F/4_U_P#KTJ7DD<ROY94'Y<LV*8R&1+VW
M*QF$E3][(Z<G^E=-"?,"E7]L UABXNKARL>WKAN,#/U.:LQP394M*%*_W1S^
M=(1JO*47(<YSU*YJBVJRI<R1- K;20"K]?TITN]HV\M%+]MQP#5:9"E]%$I0
MA]S',8XY&/UI#1L>81&7W*< $CZU%]M4XZ ]P>U9D42S.T2L-RCG,(^GK3+5
M?M$TN?)"QR$ B/EL$^_^<"@I6ZFU'.TJLR%<*<')HFN'M\^9@'W[UGNCF88B
M7R<<DD _7K3&C,K,J(6(Z_/VI:BT+KW4ZOM\C/I@=:>MQ-PS*J=MK9JIY5P,
M-YCY'J,XI7:[=!'O5@P!P1@\4N9]@L@O=1GMR@1AD_E4+ZA)=6[Q3M\P4G I
MP>XCDB+19$9['K22W&$D3R"27R&"]J')]$4K7NRO!9//8O/ )&>(_O ,845/
MIC2QSRQX=B$+,""<8_\ UU*NHP0VCQ1@1%EPV%QN/O1%=0)ODC*K(^%8YZC(
MH]IW0./9DL>IMYX611%YR!MQXQCC ]J=:.Q265[ME9,%5+XS^9JC>+ 9U*@8
M"C[K']:AN-MP278CZ52E%A[.1I?;9+9-ZJRB3D$' .,YIEQKKV[Q_*2<$;@_
M/6H-0LXQ;P.6D SC=GAL^W;']:AMH8XG;>6*@CT-)330>S=]">;6$E*33P>8
M!E0&P<=^XJ#^U[+_ *!Z?]\+_A23)'=$A"T85BN.O-5_[/\ ^GD_]\U2G%;A
M*G)OW1K:I;E@=JD#H$1O\*8=0B+,1#,?3Y<8_.GKI$6[YYY7'IG'ZU(ND6BY
MW1L_NQZ4&96;4U SY##ZNHIIU<CI''GWD)_D*OKIMN$P+<$#H6Z_G4RVT:@-
MY*AEZ' S0,RO[:N2N42('OA&.*7[?J,I  ;)'RXA S^9K8$:AON@9]L4,43[
MV?P[TM (I7\_351G&]E&[/KWK-$.H2Y(E(7MF8]/PJU<QF1XBL+LN3N7!JS"
MDD4**8MH48YXH S1I5S)G?.O3ON/]:>NBY)W3?\ ?* 5H/=PQ_ZRZB4^A<<5
M"VL:?&?FNPY_V033 8FC0CJ\I'INQ4HTFT49()_WF)J!M?M,_)',_P!$_P :
MC_MQY'V16$C'J S8I 7UL+1#D0Q?]\YJS'% F-J@#V4"L1M4U%E++:P18X^8
MG/ZXJN^I7A^_?VL8_P!A02/YT =,64<!:7<" =H ]2*Y%[YWX?4;AS_TS4@?
MTJ(M'+N(ANYL==[]/YT6 ZR2YMH_]9)$._S.*HW=[I,R!)+A,+SB/)_E6-':
MS.1Y>GQ*,?><DX^M3QV-\X!#01 _W4' ^O-%@N4;YK42#['O9,<[@1S^-4VD
M9@. %Z9 J]J%O-;RJ)9&D)&0Q'Z534-SY8;)'([4Q$(^49!Y[49W!BS8)XJ0
MIGU/O2^3E3B@"JSYD..YJ>&9X@Q !)'>E$.W.1FE,61QWI (TPW' _6A9PN3
MMY(P,TWRR>]1JO/6@!P [L1W'&<FGGF*,Y^;FF[6V9 W =3Z>](^'BC5>2,\
M"F!<L;1[RY)4K^[(9B?K6WKMDUW&LH<)Y0+8()R,#_"J?AQ"KW*L"K;5[?6M
M;5P39.>G3@#%2WJ5;0Y&5U*;5SG.3Z4U&=!A.">#5Q+1G/S#'X5<BT].IP35
M$F:EO-*=QRP/K6E;6<:$-+ A-7%B5.% R*=VZ4 .C,>[   ]!3X[J&8E8G0X
M["J<IF) B0=/FSVIL7F1I(YC&_\ A&W&?R[4EH,U!*%'(S39I8-IRO09/%4F
MN-K+NB< ]3UQ0LB&0N>8X1YC<=3T4?B2*JXA9FC2;8+5I/+X)7'WNI_S[4^Z
M^SI&ADA:0-TVC)6H()@LC0,_[X'+ C'/]:L.S*G8\\GI2N!:LYH9[<,J,NTX
M;(PV?\_UJX(UD7#.Q!]6(K!MKA([[RC(N)\#KT;L?\^M;4;$#!X(."/2@"T+
M<,OR2$>X:HVL5,OFNY=]NT9.!C\*<G(P2:<1V)H B-O&C$B-06/+ 4D-G'%N
M\H<$DD9[TI!(Y%1%&7_5OL/IVI 6R,#!4XI"$./ZU3-TT3;9@X']Y>13PD4J
MAUE<]P0U %AG9!E6)]LYJ+SI'.&CZ^H-1".13PVX>FX@T[[0JC#F2,^K<BC0
M"55 8,4.?8Y%2;\';L&!4:L67<DBL/4#/\J4L^#@9HLAW8$QDX9,"FM:6SCE
M5S]*42@ ^8N/3!S36NE495%/^\M+E\QW[H:UBD@"[CA1A1NQ@?Y-1-IKYVI(
MXQSV-/\ M_S<HH_W<UIQ6;31)*KC#J#2LQ\R,N>UN3;QJ6 .X_.Q/S8Z#';'
M/YU6,-R@)/ED^S]:W&LYDF3!!SP"#[&J]]9L8AYAP3\HP.QJN47.^AD+YT,3
M.T+_ #.6..>PI#.<]#5JQTR:&:<0W& R8.Y.V:'CD+G$V/;-#BF-5)(<]]:1
MD%[B%?\ @8J%];L$'_'P"?1%)_I7/JNFQ-EI6D']U(SS^)I6N;$?ZJTG.?[S
M #^5%B39;Q#:Y^6.>0>RX_K4!U]VSY=DY'^T_P#]:J"WLB +'8PJ.GS\TZ%]
M1D.(MD6>A1 !^=%@+8U74IWQ#:QCMT+4DDVLE@&E2//<!1^IJ V6IRG]Y).1
MW.[ _2I!H#2=9/F[[\D#\:8B*4S<B;5U^@E_PJNXL2,M=32-_ND_SK5CT2",
M8D4.?[P.,5932H8)"47KW;G]* , -9D;8[.9F^H&:E267(6+3XE([N2:Z);-
M%QLB1&!Y(7%3&+*@9&/3F@#  U9SCY8E'\2( !^-*VG7CG=<7KLF<<,<G\*Z
M!8\*-RCWXI0@YSP!R.:0S 70X@<R%Y<GITQ5B/1[5.-FY3U+=?TK7902 2.>
M@/6DX/'&/:@"HME$@!$2C'W05'%3"$*JC&>?6I]I[$9[#M3?+QUE ST&* &$
M(%;.XYX-,WJK;<#Z4^2!5RTDA5/[[87/TS5&;4M,MACS_,8=D&[/]/UH DN8
MXKM%21-P4YSG!!K,NM+D&!:1DAAAB3_*EE\098_9K0\]2[=?P%56U'5;O<$?
MRQZ1#'ZT ))I\MO'ND38H[L0!542P@Y$B_@:1]-NY3ND+,_JYR:/[(G_ +I-
M  &0]&'YTN >A'YTTZ8ZC)!QZU$]NB=6% $C@#G)SVJHK!00034H@R,@''J:
ML16,CX*IE3^'Z4"*GS,0<<#H*DBB;.5SDUI1Z>5 WC\0,8^HJPL 0<+C(P<#
M /UI@2Z+ 8C,2P!) Z?6M._V>2WF?=) &!WJK9KC)8E3G\ZM7JEX%(Y'F DC
ML*E[E+8S1& N ./05(BL#SMQ^M.P,@8H+?W<9%42(0,XZ$T@.>,]*7:[#)ZY
MZT[;D<T 1XP>!^5//"G/!I^P[?PZ^E,D(1/3CO2&0RS;06.,=:@>7R7L(#]^
M>59Y?IT0?S/XTJP"YNH82V(SEY".R#DFLZ\G:ZOY+@@ E\KSPH'0?AQ3$7;6
M0-=W&\?-O/.,X[5<+D@@.ISU!6H@BK>>;R!.N\8]?XA^=6A&QY_F,4@,>[0V
M\R2JH /4 5JO=@>1<2$>5-\I?LKCL?8C!^N:BNH%>(JP.[MBJ]DAD:73IC\D
MR@*?[CC[I_/C\: -[[2(T#,"W;Y1TJTCAUZ&N4L[U[1A#*'=%."N.4QU_P#U
M5OV\D; RQME7YW!LBF!;92,X'&*C.5XV_CBI(WW<4\C<?E[4@(#AE(8 @]C5
M=K.+):,LC]B#TJRT9R=IZ#IZ_C2 [>J]: *GGW%N/WBB11QD<$?C3UGBN,+N
M&3_"XP?_ *]3G&,\ ?6JTEHCGC YZ8_7% P>T7?N5BC^HX-()+N'^(2K_M=?
MS%1_Z1;\!BZC^%OF!_J*>EW"W#@Q-TY.5_.@"1;^)@/.C>/WQD5*@@G4^6ZN
M/8YJ%U4C<P&#P&SU^E5WM$;)3AN@(XV_ES0!=6W1&SM5O7<.*OP74:##0[ .
MZGBL02W<&=LN] /^6@SG\>M.744VC[3"Z ]&7YA1<5CH?M<3O'M<\-SGZ&J6
MK2>9Y03)X;D52B:.8$PW"R>V>:D=ID'"L1W%/F"QC1SW,$C/]J(##"_O.IST
MJ^\LH<@.,?05.)(7 ,\$3$\<CFG[83S\E%PM8HV^CP(61U#'&,YZ5*-,M!U4
MY'=GS5L[6PN>_08I"%$AZ$>H'2D,584"@ KM'3BG>2N 2N3].M,+$O@@@?G2
MEMK KEO9>U #N%/*CGBG$J#VXX.:B,A7+;#DGUZ4Q',A.&!Z[PO04 3G+$;4
MYQV'04B.N0?EZ9SG^M,#8!^; ]2*?Y9/S+U]: %#D'CD]3FE^<D,3QTYI63R
MXPTS #U=L8_.JDNM:=;];@.P[1@M^O2@"TT;'@C=WZ4XQL>6DP,=  !6%/XH
M4C$%J6/K(W]!_C5*36-3N"0CK$".D:X/Y]: .H>,1C<S(H[ECBJ4NK:?"J^;
M=!W7M""?_K5S#1O-)B:<N_7+$G]:N1Z2[QAH]C-WYSBBP%Z7Q,NX_9K,N>FZ
M0_T%4WU;5;IPJ2>4.PC7'_UZOQ:;##!N<!I<X9""!CM@]*DBL8(Q\F8VSTSF
MG8#$%E<7$N9FD8]R^35I=)5""2&'L.:VT4A#E]PQT-1RO!;KOF,2C_:;!/X=
M:!%9-/A1MX#*>G7.*G$2!2,*Q'?;6=/KD*'$$?F'^\>!^547NKVZ!W2%5[@'
M%(9L37MO GSR+N'0#DU0EUEY"5MX<Y[L/Z55MK-97(8D#&=S X/X5I6^F^4"
MS-%*K8P"#MH S=EW>EBS.^.JH*L0::-H,@:-L_W<UK+;QJ %C"^H4\"I]NX@
M[^G0=?Y4P*<%E&I8HH#C^)6//YU8$8XW@ ]*G9&^5%8=N35D6"$?-< 'OA/Z
MU$I1CNQJ+>Q16WW9.<YX&>U*(.A.#FKLELD8RLN[ZKC%5;B>*-/G9E!_BY%.
M,D]@::W*4LIAEQCY%&"<&B2Z9HS'%@(V-I8XZ^F:ANYSY8>W)8C &[YN]($G
MD:W>.-F^<,1T[4P+:V\A&"<,.N*>L(QG!SV.*1#.T9W1J@7C&>34P#ELE3N)
MZ]* !81C&#^(I1$IX'4]JE 9NBY_&C'S#"^_(I 1-"  2N./PJI(H(WMM ZX
M/7^569Y8PP0M&"V&(+8R/:J=P7F>.WA8YF.WA]PQZF@&5Y'%OILL^,/<G8@]
M(QU_,UGI!_HI8KDGG)JUJTJ27:PQ_P"IB 1>,C _^O5A( %4;'X''[L&F2,L
MPUU9>4/]:OS1^[#J/Q'\JDC#21[DVD'L5Q^?%0P#[+=@%MA8C&0<@]C5VX41
M2+<*H$,QPX)(V/W'XT7U';0@! )#%.G0'']!5:X CF24?=Z$@YJYD!_]9$#U
M_P!<PILZAH3G83U7$FX_@#0!%?Q++*ER.!/PQ!Z2#K^?6H87FMILQD!CRR_P
M,,?SJY9 7=H]H_WFX4MV<?=/XCBFP(D\6R6+YE."!@'-&X%ZTN4N%.UBK ?,
MCCD?XU=13D,).O)RIK#>-X) TF5;&(W3J/KZU>M[SE1.H5CTDQPPI7MN.U]C
M5"!AU0_7BFFV8CC!]PPI@<#H,GU _6G@,QQ@=.O:F20M!*#DID>BFH_(?)&U
M\_0U9=>?ZYI!D<;N^<]* *QB=1@JW3IMJ*2U5CTPW8#I^6.:M^8XS\YZ^M!F
MDYVL<#KUH S##+;$M&[!CV0?+]"#3A<@',\?;.^,Y_,=JO\ VAP!D]^],DC#
M/D>6K]V4'_)H&1*RR*7C*NOHIY'X4UE5F#%/F[$]1^M1/;B/<^&+CD-&<'\J
M<LLX3,JB9!UYPR_6E?N.U]BO+9QL,J!O)SN+#/Z4])9;8A%=Y?J0<?C5E&68
M_NG"G^XQ*F@LR-ABP/NY']*:U%JB#^TEW$3VK 9X8<Y_"I5NK J,3;1Z8/%&
MQ-Y;Y=WKYN#4+P,S%M\7/T_PHL%R4WA=AM&,]^U3*Y;U9BOW<5+)#%#@R*B(
M.<N0O/X]JK2:QI=H#ME#MZ1+G]>!3 E03AMZ@@[< =.*?L<L=L3;<<ECR?7@
M<5DS^*P 1;VN1ZR'^@K-GU[5+D[1*8P?X8EVT@.JE@6)?WS!$X)#L%'TJE+J
MVFP B297.<[85SS]>E<LT<\K;YI#GU=LFK$.F-)@CY@?PQ3 TY/$R(S?9[0'
M/0R'I^ JC-K>I7+9#",=/W:XQ^-3Q::\8.^$ ]MIR:FCLRI+-A@.1N(.?P[4
M",K[-<3ONGD=O4G+&GQV2=6WA1W*_P!*Z  -#@QC&<?+U IYB3?\F5XZ>M &
M;%IJ2)^ZF3/LN#5B*U-NPR 3W8@&K/E(J?=.3C (I2H"%MN%ZEY.!^=  L,$
MB^9) %[YQC=2K!;X+?=/4#;5&?5+* %=_G'TB''YG_ U0FUNYE8_9XUA!XR/
MF;\ST_#%%P.D/E11[WG$:_WI,J*S;C7[:$D1LUPP/\(VK^9Y_2N?D665O,N9
M22>[G)JS9VD<K'<0H'1F&1BD,EGUN_NLB,K A_YYK@_GUJHUM(2&E+NS?4Y_
M&M<Z.C$-YYD7MA<#\*O1K+%C#,T?3#=*=A&3;6,;P@NQA<\<+FKMO8_9,E9<
M,W ;N:O!-S!AM&.QIZP _-MYZ4#(MDA4!MNX]_\ &E2!01D9'^>U6?*"[E(3
M(& P-*/E.T?WAWS0!&%((&!CMGK4FSGK]:<5!Y&,GIUYI&+;1@84<Y;^E(!%
M4!LE>1TSVK/N+RXLP45PQ\S R.<5>:0!R"X&!T[BLJ_BN;B9&"_(.?3GI2:3
MW&FUL6;.YGN)E:1]T?EAVVCG)[59>".16..2#CN0.^ :S[5+F%0"$"D8&W)Z
M>M78S*!D\(#GD\#\:$DM@O?<6WL(($PJ#+'H>V:L^4$XP&).>#G%-0R=SD'[
MV!WI06#!7'S=\M@#MQ0,E5&)W*5V@\D\@^U/R@? VDCU[5 J@%L@8''/&#_C
M3B^&8,%.#C.,[: %9>3QO.,GH"*CW @9;UP.E('&W!#<^O\ /%0F0E%(C8L.
M.F H^M #%/EAR)F ST=1@>N*JI+M6ZU!@N__ %4>#_%3KZ8LH@#;7<@;3\Q;
M)],?YQ5/5W6WABLD8 1+D^['_/ZTT)E"!1)<DD8'3.[@_6M3R75\K!EL<A7Q
MC\<U5TZ)%4^8H/&2,G^E7E^RM(=R@*>A#$<TR2*ZAQ&79778/O$YS]*N:8BW
M,,D)W$$9D#G)R,88?I2;+=F"AS] X_PJI'/-97N^/ED8 CMR>AJ))VT*BTGJ
M*S2V]P\$TTQD09X0$$=C3UN5;.9CG')>$9Q4CFXO+/+@I>HI9=HQN&>E10AY
M$5Q=2$D<%EZ4T[@U8K1X@NP054-P&(YSV^E6KO;%<I>*@*3C##^ZXJO>QF-1
M)(RRN3]XBK5LRW]HT+D?O!D''1Q1LPW0BR _*T<8]\G- 0(YQB2,CE<U':3%
MAY16,.AP0X[BKZ+O;)MTSZALTVA(BBFDMX0Z$M'G!0]15R*6*9 59RO<!N15
M*6T?AU5T;J2#FKVG7MI 7AGA WX#-C.#_.LIMP5UJ6K2T9.",C&XKC^+'\Z0
MKQG*Y^O\J?>I;VC1N+@%9QA1GG%,#A0%4G'8 <5<)J:NB91<0P20O08Y%1Y"
MOSUZCTJ96W;O[PXQTS[TT+AP2N/RS5$D(4L<J, C/6E'RD'.2><&I"A!93TZ
MY)Z4@12&.SDG"GUH&1@,YQYF,_[(P*ADC21B))U+#C&TC^56%R"2K#//(/%(
MAQEP""PZG - %:40! "%<]B@P:2&241G:ZN%'S(QY%6?*GWA&FP3T#>GK4;P
M"0E9ID.., XI.*Z#4F-CEA<X?<C#INY&?K4F&[1%O?"\TU(DBB"N870# 7=@
MK]#5.22)9&")*5!XXJ;R0[19RQ2XG;<[,Q/.6:I!9[1ND8_0"MZ"RMG7&XL<
M=2<&I&TM=ORN?^!<YK2Q)B06L4F,Y3W89K5AT^(@%9<_05*(EWLH0$KU(7H:
M/+)D "D#T[BG80TZ60N[8'/8T\0(J<9'OBIB&6$*2<^A.<_2GPROYBB,9('(
M4<#]*0$23F-BH9F<<;=N34CE';=(O7J2*2ZU.WA/[^:$.O\ "B!V/^'YUD7/
MB!679;6J#'\<G)/OCI_.@#8C/5T0MS][@#%5+B^LK?/F7+.Q.2L)W9/IGI7/
MS7EW>G$TS,O89^4?ATI%MQGYVP3V R:0S1FUZ1N+>!$_VW^=O\!^549'N;MM
M\TK/[LW2IH[61N(XPN.I<\UH6=D\#,S['/\ M<\TP,B.W#<(&D/3Y>E7[>QF
MCD!EA^0]5!_K6W$3(N&15(X.T<?A3'AV.7#2 'L6XHL(BAM[5D9?LRQGN>N?
MQJ7R45^@QC!XZU8C5E4$ 9SD&I\#*EL 9QDGCZ\T 5XE!PJ@XQSMZ5*B*N-R
ML23@%ABGXX.U0V/N@9Q^-*3\S*6&?0&@8W"X4@!>.G' ]*<2-Q*C !R?E/6D
M 7Y<*2#U 7% < Q(FTDDX7L/;- $K?>Z<=>1UI!&K9+-M!Y)QC--VNH/EC?&
M/O'/--W-&V^-<!NJA^2/QI 2#;\PR2H[8QBH-PD7Y7^8D+ZD?A^%!CV$[9(P
M.3@H<_SIP60<LY)VC@CG\J!B&-E.,,6'KRU((TCE!9SR0"N.P[5(P&YG5 -Q
MV_,1Z=>E*J@$*%&">JCD_P!!0 T*)#E1N7D<'J*&7+J,+]W&5I6SM*Y.U3PJ
M^E.9,!5  P><]O>D,0(5'S':W'4Y-*TJR$>6VU2-O')SFGA?G)5"Q W9[Y]<
M4QQB15.0<[3M.2?7_(H #&JJ0%PQ/0GD>U  1>02!W'/(%/9"I*(S*,XX.6*
MD>G:JLBLC;%SE1@9.?S]Z '!A,WWL J1M=?EQ_C3!;R1+O$^Y5&?F? 'X5#)
M]DN!LEDDWGDADR%('6J]Z3;*%MRKL[8(V=/Z<T""V</(]U,A"PJ27D')/;'H
M,5/:F.VTN;4[E 9)OF&0"0#T S5.XC=X[33%<F2=LR$]0HY-2^([J)8X[!%P
M-H(Y^[V'Z4Q%>SG4Q%(X4?:<D,,GFK7G XQ9J68=-I7%<['-+;R*\;E6 QD5
MLIJ%R5203-A1SA00*8$K2 1&-HF4 _ZU1G]*CD/F@NGF*,CC;WJZ+N^**^PN
M.N/+)R/SILMQ+)@268)SQ\AX&.OUI 16S*MND+R_Z2N?+ Z8'.,TRZM$=!>A
MR(V'[S ^ZWK@5!(8X9(YBF C9*G^7ZU:MM3MWN&B&-LH^>/^[6;O%W1>ZL5<
M1"(N+G( SM<=_P Z;8O,K%"0 !N5<]#GM4L]O;6LBQ3*VQLE'4XR/\:SIN90
M4=RA;[P."HZ=?6K>J)6C-2]C'GQW<:967 ;'8_Y_E5N,2L%"^5GN2!DU!"J3
M6[VP8E'7=&Q.>?6H;8#&V>3YD.W=Z'TIIW0FK,U DV3B.+ ZC@'^=1R0.0V(
M1OZJRGO3(HTE'_'T%93@@\9J0VX1"QDZ#!ZC'OQ0!"8,1HLR287)5L\*3ZT1
M22PQ[T)>+HP]#Z>U6C'*T94,K+[DU'F:W&<#9T*DY!%9N/8N,K:,FBFCF.Y<
ME\8()YJP71T;!VD>O3Z5EQQBX=OLX(=><]!CL/K4T5VZ'9."".-V*:G;20."
M>L2ZKAPV IP/FR0<>])@*8\M[$;N32*RNIW*"".&7O2?*K*S(V.@RO/US5D$
MA6/:.A &3S3<$+D#(Q@  ?I2E08QD,!['@4W"JH+D9QU '6@!BV\<3[F7Y\9
MR?:D\O=*CF(8SEPV<X[4Z-U0DF-@W<GC IZL73)8;&.0N* (IF6*4!+6,@]
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6N34I;+A2J]^<<TOE9YWO_P!]4@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #X 8 # 2(  A$! Q$!_\0
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M%UH4\F^%_+D*,\9 W#E>HY'-<[<ZAJ"_#/56.I7K7&E>(396UR;A_-\H7"*
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M:.4R;94=?NN&7!##U%5K#P;INGZW'K(FO[C44M_LWVBXNW<LF<X89P>?;]:
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M?QK.;X?Z2_A:?PXUQ?G3IYC.Z^<-Q8OO/S8SC=S0!TUQ))# \D<,D[*,B)"
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MG%IAE+OO8 ;\=1^5=M DD=O&D[K)(J@,RKM!/KC)Q^=3Y%&11= %%&11FBZ
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M$3QD-N!4\D>]9;-S753UB81Z^H5)"<-4.ZI(,NW&*T:T!]/4OP$RR!$4LQZ
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M7[8I '3.#7+NT\77>OXUT?P^N'?XAZ K'(-XO5?8UM33YEJ0[6/K:BBBO1,
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M@E2N,?G4.]DX;D5VK78S E@><&IX]0E5=F\.O]R2H\JXR#_]:HG3/O563T:
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M[&U=^((T/E:;&=W_ #W;K^ J"SMUNYC->3L[D_,#U_.M&S\,0PQ&:>Y0%?O
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M3P;IMK:?$+02%E5Q=KM^4[6X/.>E==.LG)>9#CHSZDHHHKTCF"BBB@ HHHH
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MA^;.>@-.%'FE<'*R)!'B?S)8]\S_ "@HIRH],^G;-226T:7./LUP9,;BZR
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MA1)R+02/&>F5-;L,=U"SQ*!*,X,C$Y_(=JF9K\Q_+!"3ZEB?Z5VTY>ST3O\
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8B3C!Z#;S111&A",M <VSV^BBBNTS/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #W 8T# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&HG^T+Q5_L-9Q&)!L'[_  5 Q]TX&>Y]: .PT_47OI;Q6L;JU%O.85:=0!,
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MB32;O5KI8[C3UOM*E54+1$$JZ*,?,=Y3 .>& H ]$K.LM1>ZO+^%K&ZMTM9
MBRS* DX*@[D.>0.E<=X6UK4/$&DZ!;RWEQ%J<$DO]K#*[MT)V.C#&!N<J1C'
M&<5GW^H:IJ'A_P"(]M=ZG,PT[S%MGA"Q,BB /MR!TR<'N: /38I8YXDEB=7C
M=0RLIR&!Y!%9'B?Q);^%M(.I7=M<S0B1(SY"@[2S!03DC R17)Z7J%U9V?@O
MP[;7LZ'5+(SR7+[6>...%#Y<>1@9+#D@X /?I5\>VVLV7PVUR#4[Z&]47UNU
ME+MQ((3/'M$F  2#D9'44 >I5G:MJUGHMD;J\D*1[EC554LTCL<*BJ.68G@
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M\;_"@_#?Q8OW;EOPOC1=]@/8+%M1C=C=W1? X*2';],?U]*3[3<%B?.EY/\
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M@^"K&*[UK2UE9E\BXBG7 SDJ#P?SK@".<5Z/X,G2/QAI5@JD,UM+<.P/]T'
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M.D3AM#O]=N+P6&D,&GE+RA2J$AE4EF4L/E.T'D8I$\0:Q9V5G.E]%Y9 6/\
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M*4"(%N-.8\DX1N ?KUJS#\4=/\@":SF\XL?G7@*,\<9YJ>61/L9=COY--MI
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M\GT4?XUW6:XCX6Q&'P/ 3R7FD;]<?TKLRU;&\5H>6?%J;=JEA#G[MN6_-O\
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MJ,OP93_ECK3#_?@_P-3R(.5G!QZ]%C$EJX/7*2X_#D=*?>:W9S'_ $:WG3@
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+O2:**!!1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>fin_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q .(# 2(  A$! Q$!_\0
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MW5S^TH[PG[+X82.7LTMYO'Y!!_.M?4/V<]$GO99;'5KRVA9B1"P5PF3G /7
M''.3[U#!^S=I2RJ;C7;QXOX@B*I_,@T >J>#->;Q+X.TK6)$C26Z@5I%C^ZK
M]& ]L@U\/GO7W5H&@V/AG0K;2--C9+6V4A%9BQR26))/J23^->2?\,W:,?\
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?!!1VHHH 4=*:.M%% "GO2]J**3 2BBBF M%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>fin_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "T M<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#TJG9:G9:A-<16MQ'-
M);,$E"<[21G'Y5=/(KEO#D0A\6^*U2,)&+BVV # Q]G2@#H;RZM["UENKJ58
MH8UW.[= !1:W4%Y:Q7-O*LD,JAT<'A@>AKF?$@N]9URST2UBC>"WV7UWYS%5
M< D1QY /5ANZ?P^]9#W<7AFTU33M=LTEMC-]JLXHG+*WFN<QY(&-K9/L&]J
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M =[%XATR:]%HMTID+F)3M(5G'50W0G@\>U6;_5+32[=9[R79&S!%(4DECT
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MEN1N<X4LC!6/H&(P:X.TE19XVD:0^'(]8'V9Y<X \HXSG_EF).GX4DNE:S=
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MCDTM)F@!HB100J*,]< 4X  D@ $TM% #7C1_O(K8]1FD:)&P&13CID9Q3Z*
M&[0#D >E!13C*@XZ<=*=10 PQKNW;1N]>].  &  /I2T4 )@9SCFFM&CD%D4
MD=,@&GT4 )@9X&,]:  !C'%+10 W8O'RCCIQTI=HP>!SU]Z7-% $?DQF593&
MN]5*JV.0#C(_0?E3F16X901[BG44 -VCCY1QT/I2-&KCYE#8Z9&:?FC- "$
M]0#1@'J*,TN: &LBL02JDCID4N/:EHH 3 /;I2%0WWE![\CO3J* &&-&()0$
MCH<"E**3DJ"<8S3J* &+&JCY44?04H4*NU1@#H!3J* &[0,X'6D$: $!%P>H
MQUI]% #%C15*JB@'L!0(T"[0BA?3'%/HH :J*@PJ@#V&*4J"<X&1T-+10 QH
MT?&Y%;'3(S3@H'8 TM% ";0!@#%)L7CY1QTXZ4ZB@!NT<_*.>O'6HGM())XI
MVA0RP@B-R.4!ZX]*GS1F@!K(KC#*"/0C-*5!&"!CTI:* $*@C! Q2%0PP5!'
MH:=10 B@*,  #T%(44J5*@@]L<4ZB@!GEKMV[%VCH,4JHJ_=4#Z#%.HH KFT
M0WZW?.\1&+';!(/]*GQD8(I:* &E 1@@$>A'%((U& $4 >@I]% "* HP!@>U
M!&>".*6B@!JHJ#"J%'H!BEVC&,#'I2T4 ,$2 Y"*#["H+BPM[F>">6)7E@8M
M&_=<C!Y_I5JB@"(1*N=J*,]<#&:2WMHK6WC@@C5(XQA5 P!4U% #0B[MVT;C
MU.*-BA]VT;O7%.S29H :(T#[PHW>N!FE9%<890P]^:=10 PQH5VE%*^F!B@Q
MH5VE%V^F.*?10 SRUV[=B[?3''Y4Y55!A0 /0"ESS10!3DT^.358=0);S8H7
MB4 \88J3_P"@BFW.D6%Y,9;BUCE<C!9O3TJ]10!F?\(]I/'^@Q<=.O%(?#ND
ME=IL(MOIBM2B@#*;PWH[H8VTZ!D/!4C(/X5%'X3T&%P\6DVJ,!@,J8(_&MJB
M@#+/AS2&()T^$D=R,T-X=TAQAM/A(]",XK4HH S/^$>TG_GQBZ8[T@\.Z0HP
M-/A ] ,9K4HH R_^$>TG(/V"'(Z''2D_X1S1\%?[.AP>2,=:U:* ,L>'=(&W
M&GP@+TQVH'AW2 Q8:?"&/<"M2B@#+7PYI"9VZ?",]>,9H_X1W2",?8(L8Q^%
M:E% $<4201)'&H5%& H["BI** (;N4P6<TR@%HT9@#W(&:\]@^+-C!I]B][:
MRO<26<5S<"' $>\X  )R3SG [ UV7B%-1FT6>/39;:*9U*F2Y!VJI!!/%<UX
M?\(^'9+&S$,_GWME:QVL]Q [(9% XW#TXXH T9O&T<?]K2KI=V]IIBL9K@%0
MI(56VKSDG#"DNO'=E:Z=%>&SN7632QJ81 "VPE1M^OSCVX-69;?0'T^^@D=#
M;ZI++YXWD^8X78^.XP(\?A26/A/2HH$DM9+K!M?LT4GVE\I#D$*O/ &T4 5)
M?'EM#X:@ULVA,4Q;;&+A-V "3WZ\8Q69!\18GO[N\<,-(CTF&^C4J!(6=RN/
MSP*UW^'_ (?DB@1[>5O)DDD#F9LL9  ^>><@ 4^#P1X=ABDM5M<K):+:LC2L
M3Y2L67OU#'.: ,R/XG6,LRVT>G74ETUTEJ(XV5@692P(;."."#Z5H:7XT_M&
M^M+9](N[9;F::W661E*B6+=N7@YQ\IY]J?#X;T-+E,O++/ITRW.9)23&VTX)
M_ FK]GI&F-#8W5LI:.*62\MWW'&Z7<6/T.]OSH V**HVNKV%Y<"WM[J.2;R_
M,V*>=N2,_F#4MM?6UXTXMITE,$ABD"G.UQU!H LT5!=W<-C:RW-S((X8UW.Q
M[#UJ56#*&!X/2@!U%%% !1110 4444 1S/Y:@Y'WE!SZ$X_K4E0SGY!_OIWQ
M_$*FH **** .6\5>+HO#&K:+;W$8^S7[RK)+R3'M7(P!UR36;I?Q%COM/OKY
MK(M#!?O:1^7(J[@!D,=Y7'%;NNV6COJFEZEJES'!+9/(UOYD@56++AL@]>U9
M$_@K08")3=R6_G7SW2L90 TDBX*X/!R.E %75_B(MG&+FSM_/BDT9M2C1EPW
M#  DYP ,\_2GV7C^2TT:PO-=L7B:Z192T0551'("\%R3USQV-79?!.A;H+1I
M'#_V8^GQQ^9@F#<"?QSCFF:AX!T6YD@,\\Z 6\=F%\S 94Y7Z'Z=<4 =B#FE
MJ">YBM(?,FD"(6"AF]2< ?F0*6YN8K.UEN;B01PQ(7=VZ*HY)H FHI"P"EB0
M !DFH1=P,L+B>,K-_JSN&'XSQZ\<T 3T4"H3<PB[^R^8//V>9Y??;G&?SH F
MHI@D5G=58$H<,!V. ?Y$&FQW$<DLD:N"\1 < _=)&1^A% $M%%% !1110 44
M44 %00S&6>X3Y?W4@48Z_=4\_P#?53U4MR!<WG/_ "U'4C^XGY4 6QT%%%%
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MM74R^);*WNS:SQ7$3 J,L@VX9@@.0>FXXS['T-)>>);*R:4REA%"LK2/@_\
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MG585^5(WD"8..N$')ZYK:TF^\^(V\\XDNXR^\8 8J)&16([9VT ))HT$IO\
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M#='C.-V<G/'6IO#4E_%,EKJ;O)=-;ARXN!(C%=H8@ #;RW% '3T444 %%%%
M!1110 4444 %%%% $<[*D$CNI954DJ!G(Q5/R;&]L[>)X(S"55HXI /EXX&/
M85+JL;RZ1>1Q@F1X750,Y)(..E<39Z'=16DLDMNYO/M5FR/L<E8T2$28./\
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>rvsn-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:36 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.RailVision.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:rvsn="http://www.RailVision.com/20221231" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="rvsn-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="rvsn-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="rvsn-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="rvsn-20221231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet" id="rvsn_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals" id="rvsn_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement" id="rvsn_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals" id="rvsn_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Statements of Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ShareholdersEquityType2or3" id="rvsn_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Statements of Convertible Preferred Shares and Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConsolidatedCashFlow" id="rvsn_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/General" id="rvsn_r_General">
        <link:definition>007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/SignificantAccountingPolicies" id="rvsn_r_SignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/OtherCurrentAssets" id="rvsn_r_OtherCurrentAssets">
        <link:definition>009 - Disclosure - Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/FixedAssetsNet" id="rvsn_r_FixedAssetsNet">
        <link:definition>010 - Disclosure - Fixed Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/OtherAccountsPayable" id="rvsn_r_OtherAccountsPayable">
        <link:definition>011 - Disclosure - Other Accounts Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities" id="rvsn_r_CommitmentsandContingenciesLiabilities">
        <link:definition>012 - Disclosure - Commitments and Contingencies Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConvertiblePreferredShares" id="rvsn_r_ConvertiblePreferredShares">
        <link:definition>013 - Disclosure - Convertible Preferred Shares</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ShareholdersEquity" id="rvsn_r_ShareholdersEquity">
        <link:definition>014 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNet" id="rvsn_r_ResearchandDevelopmentNet">
        <link:definition>015 - Disclosure - Research and Development, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/GeneralandAdministrative" id="rvsn_r_GeneralandAdministrative">
        <link:definition>016 - Disclosure - General and Administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TaxesonIncome" id="rvsn_r_TaxesonIncome">
        <link:definition>017 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties" id="rvsn_r_TransactionsandBalanceswithRelatedParties">
        <link:definition>018 - Disclosure - Transactions and Balances with Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/Leases" id="rvsn_r_Leases">
        <link:definition>019 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/SubsequentEvents" id="rvsn_r_SubsequentEvents">
        <link:definition>020 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/AccountingPoliciesByPolicy" id="rvsn_r_AccountingPoliciesByPolicy">
        <link:definition>021 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/SignificantAccountingPoliciesTables" id="rvsn_r_SignificantAccountingPoliciesTables">
        <link:definition>022 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/OtherCurrentAssetsTables" id="rvsn_r_OtherCurrentAssetsTables">
        <link:definition>023 - Disclosure - Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/FixedAssetsNetTables" id="rvsn_r_FixedAssetsNetTables">
        <link:definition>024 - Disclosure - Fixed Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/OtherAccountsPayableTables" id="rvsn_r_OtherAccountsPayableTables">
        <link:definition>025 - Disclosure - Other Accounts Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ShareholdersEquityTables" id="rvsn_r_ShareholdersEquityTables">
        <link:definition>026 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNetTables" id="rvsn_r_ResearchandDevelopmentNetTables">
        <link:definition>027 - Disclosure - Research and Development, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/GeneralandAdministrativeTables" id="rvsn_r_GeneralandAdministrativeTables">
        <link:definition>028 - Disclosure - General and Administrative (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TaxesonIncomeTables" id="rvsn_r_TaxesonIncomeTables">
        <link:definition>029 - Disclosure - Taxes on Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables" id="rvsn_r_TransactionsandBalanceswithRelatedPartiesTables">
        <link:definition>030 - Disclosure - Transactions and Balances with Related Parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/LeasesTables" id="rvsn_r_LeasesTables">
        <link:definition>031 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable" id="rvsn_r_ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable">
        <link:definition>032 - Disclosure - Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofothercurrentassetsTable" id="rvsn_r_ScheduleofothercurrentassetsTable">
        <link:definition>033 - Disclosure - Other Current Assets (Details) - Schedule of other current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/FixedAssetsNetDetails" id="rvsn_r_FixedAssetsNetDetails">
        <link:definition>034 - Disclosure - Fixed Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleoffixedassetsnetTable" id="rvsn_r_ScheduleoffixedassetsnetTable">
        <link:definition>035 - Disclosure - Fixed Assets, Net (Details) - Schedule of fixed assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable" id="rvsn_r_ScheduleofotheraccountspayableTable">
        <link:definition>036 - Disclosure - Other Accounts Payable (Details) - Schedule of other accounts payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails" id="rvsn_r_CommitmentsandContingenciesLiabilitiesDetails">
        <link:definition>037 - Disclosure - Commitments and Contingencies Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ConvertiblePreferredSharesDetails" id="rvsn_r_ConvertiblePreferredSharesDetails">
        <link:definition>038 - Disclosure - Convertible Preferred Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ShareholdersEquityDetails" id="rvsn_r_ShareholdersEquityDetails">
        <link:definition>039 - Disclosure - Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" id="rvsn_r_ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable">
        <link:definition>040 - Disclosure - Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSftKE8LQ+M85GqxRhDJ3xLSbzjZIjgTof9Q==] CSR-->
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" id="rvsn_r_ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable">
        <link:definition>041 - Disclosure - Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable" id="rvsn_r_ScheduleofresearchanddevelopmentTable">
        <link:definition>042 - Disclosure - Research and Development, Net (Details) - Schedule of research and development</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable" id="rvsn_r_ScheduleofgeneralandadministrativeTable">
        <link:definition>043 - Disclosure - General and Administrative (Details) - Schedule of general and administrative</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TaxesonIncomeDetails" id="rvsn_r_TaxesonIncomeDetails">
        <link:definition>044 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable" id="rvsn_r_ScheduleofdeferredtaxassetsTable">
        <link:definition>045 - Disclosure - Taxes on Income (Details) - Schedule of deferred tax assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails" id="rvsn_r_TransactionsandBalanceswithRelatedPartiesDetails">
        <link:definition>046 - Disclosure - Transactions and Balances with Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleoftransactionsTable" id="rvsn_r_ScheduleoftransactionsTable">
        <link:definition>047 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofbalancesTable" id="rvsn_r_ScheduleofbalancesTable">
        <link:definition>048 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/LeasesDetails" id="rvsn_r_LeasesDetails">
        <link:definition>049 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable" id="rvsn_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable">
        <link:definition>050 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" id="rvsn_r_ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable">
        <link:definition>051 - Disclosure - Leases (Details) - Schedule of weighted average lease term and weighted average discount rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/SubsequentEventsDetails" id="rvsn_r_SubsequentEventsDetails">
        <link:definition>052 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.RailVision.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
  <xs:element name="ScheduleOfOtherCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfOtherCurrentAssetsAbstract"/>
  <xs:element name="ScheduleOfFixedAssetsNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfFixedAssetsNetAbstract"/>
  <xs:element name="ScheduleOfOtherAccountsPayableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfOtherAccountsPayableAbstract"/>
  <xs:element name="ConvertiblePreferredSharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConvertiblePreferredSharesAbstract"/>
  <xs:element name="ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract"/>
  <xs:element name="ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract"/>
  <xs:element name="ScheduleOfResearchAndDevelopmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfResearchAndDevelopmentAbstract"/>
  <xs:element name="DisclosureOfGeneralAndAdministrativeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DisclosureOfGeneralAndAdministrativeAbstract"/>
  <xs:element name="ScheduleOfGeneralAndAdministrativeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfGeneralAndAdministrativeAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfDeferredTaxAssetsAbstract"/>
  <xs:element name="ScheduleOfTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfTransactionsAbstract"/>
  <xs:element name="ScheduleOfBalancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfBalancesAbstract"/>
  <xs:element name="LeasesDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesDisclosureAbstract"/>
  <xs:element name="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract11"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract12"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract14"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract15"/>
  <xs:element name="ChangesDuring2020Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ChangesDuring2020Abstract"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract17"/>
  <xs:element name="ChangesDuring2021Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ChangesDuring2021Abstract"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract18"/>
  <xs:element name="ChangesDuring2022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ChangesDuring2022Abstract"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract19"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract20"/>
  <xs:element name="UnlabeledAbstract21" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract21"/>
  <xs:element name="UnlabeledAbstract22" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract22"/>
  <xs:element name="UnlabeledAbstract23" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract23"/>
  <xs:element name="UnlabeledAbstract24" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract24"/>
  <xs:element name="UnlabeledAbstract25" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract25"/>
  <xs:element name="UnlabeledAbstract26" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract26"/>
  <xs:element name="UnlabeledAbstract27" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract27"/>
  <xs:element name="CostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_CostAbstract"/>
  <xs:element name="UnlabeledAbstract28" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract28"/>
  <xs:element name="AccumulatedDepreciationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_AccumulatedDepreciationAbstract"/>
  <xs:element name="UnlabeledAbstract29" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract29"/>
  <xs:element name="UnlabeledAbstract30" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract30"/>
  <xs:element name="UnlabeledAbstract31" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract31"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DeferredTaxAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract32" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnlabeledAbstract32"/>
  <xs:element name="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
  <xs:element name="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares"/>
  <xs:element name="ChangeInOperatingLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ChangeInOperatingLeaseLiability"/>
  <xs:element name="ObtainingARightofuseAssetInExchangeForALeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability"/>
  <xs:element name="ConversionOfPreferredShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConversionOfPreferredShares"/>
  <xs:element name="ConversionOfAConvertibleDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConversionOfAConvertibleDebt"/>
  <xs:element name="DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital"/>
  <xs:element name="GeneralTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_GeneralTable"/>
  <xs:element name="GeneralLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_GeneralLineItems"/>
  <xs:element name="FixedAssetsNetTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_FixedAssetsNetTable"/>
  <xs:element name="FixedAssetsNetLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FixedAssetsNetLineItems"/>
  <xs:element name="ConvertiblePreferredSharesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConvertiblePreferredSharesTextBlock"/>
  <xs:element name="ConvertiblePreferredSharesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_ConvertiblePreferredSharesTable"/>
  <xs:element name="ConvertiblePreferredSharesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConvertiblePreferredSharesLineItems"/>
  <xs:element name="DisclosureOfGeneralAndAdministrativeTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock"/>
  <xs:element name="GeneralandAdministrativeTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_GeneralandAdministrativeTable"/>
  <xs:element name="GeneralandAdministrativeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_GeneralandAdministrativeLineItems"/>
  <xs:element name="LeasesDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesDisclosureTextBlock"/>
  <xs:element name="LeasesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_LeasesTable"/>
  <xs:element name="LeasesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesLineItems"/>
  <xs:element name="FinancialStatementPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FinancialStatementPolicyTextBlock"/>
  <xs:element name="FixedAssetsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FixedAssetsPolicyTextBlock"/>
  <xs:element name="FixedAssetsNetTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_FixedAssetsNetTablesTable"/>
  <xs:element name="FixedAssetsNetTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FixedAssetsNetTablesLineItems"/>
  <xs:element name="ScheduleOfGeneralAndAdministrativeTableTexBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock"/>
  <xs:element name="GeneralandAdministrativeTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_GeneralandAdministrativeTablesTable"/>
  <xs:element name="GeneralandAdministrativeTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_GeneralandAdministrativeTablesLineItems"/>
  <xs:element name="LeasesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_LeasesTablesTable"/>
  <xs:element name="LeasesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesTablesLineItems"/>
  <xs:element name="OfficeFurnitureAndEquipment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OfficeFurnitureAndEquipment"/>
  <xs:element name="ComputerSoftwareAndElectronicEquipment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ComputerSoftwareAndElectronicEquipment"/>
  <xs:element name="LaboratoryEquipment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LaboratoryEquipment"/>
  <xs:element name="LeaseholdImprovements" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeaseholdImprovements"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
  <xs:element name="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems"/>
  <xs:element name="WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"/>
  <xs:element name="NumberOfOptionsExercisableAtEndOfPeriodinDollars" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars"/>
  <xs:element name="WeightedAverageExercisePriceExercisableAtEndOfPeriod" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod"/>
  <xs:element name="WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"/>
  <xs:element name="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
  <xs:element name="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems"/>
  <xs:element name="SubcontractedWorkAndConsulting" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_SubcontractedWorkAndConsulting"/>
  <xs:element name="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable"/>
  <xs:element name="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems"/>
  <xs:element name="RevenuesFromRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_RevenuesFromRelatedParties"/>
  <xs:element name="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable"/>
  <xs:element name="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems"/>
  <xs:element name="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
  <xs:element name="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems"/>
  <xs:element name="FutureLeasePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FutureLeasePayments"/>
  <xs:element name="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
  <xs:element name="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems"/>
  <xs:element name="CommitmentsandContingenciesLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable"/>
  <xs:element name="CommitmentsandContingenciesLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems"/>
  <xs:element name="PeriodOfFirstCommercialSales" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_PeriodOfFirstCommercialSales"/>
  <xs:element name="RoyaltyPaymentsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_RoyaltyPaymentsPercentage"/>
  <xs:element name="PaymentOfTotalProceedsFromConsiderationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage"/>
  <xs:element name="PaymentOfTotalProceedFromConsiderationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_PaymentOfTotalProceedFromConsiderationPercentage"/>
  <xs:element name="OptionToPurchaseOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OptionToPurchaseOrdinaryShares"/>
  <xs:element name="ServiceAgreementWithAConsultantDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ServiceAgreementWithAConsultantDescription"/>
  <xs:element name="ExercisePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ExercisePrice"/>
  <xs:element name="PaymentOfMonthlyRemunerationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_PaymentOfMonthlyRemunerationAmount"/>
  <xs:element name="TotalAmountPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_TotalAmountPaid"/>
  <xs:element name="DevelopmentAndSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DevelopmentAndSales"/>
  <xs:element name="PaymentOfOperationalFunctionTest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_PaymentOfOperationalFunctionTest"/>
  <xs:element name="DeferredRevenuesInOtherAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DeferredRevenuesInOtherAccountsPayable"/>
  <xs:element name="ConvertiblePreferredSharesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_ConvertiblePreferredSharesDetailsTable"/>
  <xs:element name="ConvertiblePreferredSharesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ConvertiblePreferredSharesDetailsLineItems"/>
  <xs:element name="InvestmentAgreementDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_InvestmentAgreementDescription"/>
  <xs:element name="ShareholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_ShareholdersEquityDetailsTable"/>
  <xs:element name="ShareholdersEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ShareholdersEquityDetailsLineItems"/>
  <xs:element name="GrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_GrossProceeds"/>
  <xs:element name="AggregateSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="rvsn_AggregateSharesIssued"/>
  <xs:element name="WarrantsPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WarrantsPurchase"/>
  <xs:element name="OrdinarySharesExpired" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OrdinarySharesExpired"/>
  <xs:element name="OrdinarySharesExercisedAmount" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OrdinarySharesExercisedAmount"/>
  <xs:element name="AggregateOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_AggregateOrdinaryShares"/>
  <xs:element name="InvestedAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_InvestedAgreement"/>
  <xs:element name="WarrantsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WarrantsPercentage"/>
  <xs:element name="WarrantsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="rvsn_WarrantsDescription"/>
  <xs:element name="NetProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_NetProceeds"/>
  <xs:element name="NumberOfOrdinarySharesAndWarrantsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage"/>
  <xs:element name="RiskFreeInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_RiskFreeInterestRate"/>
  <xs:element name="DividendYields" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DividendYields"/>
  <xs:element name="ExercisePricePerShares" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ExercisePricePerShares"/>
  <xs:element name="AmortizedOver" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_AmortizedOver"/>
  <xs:element name="OptionsExpire" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OptionsExpire"/>
  <xs:element name="SharebasedPaymentExpensesRelatedToNonvestedAwards" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm"/>
  <xs:element name="OptionsGrantedDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_OptionsGrantedDescription"/>
  <xs:element name="UnvestedOptionsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_UnvestedOptionsPercentage"/>
  <xs:element name="TaxesonIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_TaxesonIncomeDetailsTable"/>
  <xs:element name="TaxesonIncomeDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_TaxesonIncomeDetailsLineItems"/>
  <xs:element name="TransactionsandBalanceswithRelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable"/>
  <xs:element name="TransactionsandBalanceswithRelatedPartiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems"/>
  <xs:element name="LeasesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="rvsn_LeasesDetailsTable"/>
  <xs:element name="LeasesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_LeasesDetailsLineItems"/>
  <xs:element name="EmployeesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_EmployeesMember"/>
  <xs:element name="FifthLeaseYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FifthLeaseYearMember"/>
  <xs:element name="FirstTwoYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_FirstTwoYearsMember"/>
  <xs:element name="KnorrBremseRailSystemsSchweizAGMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_KnorrBremseRailSystemsSchweizAGMember"/>
  <xs:element name="May112022Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_May112022Member"/>
  <xs:element name="November32020Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_November32020Member"/>
  <xs:element name="October2020Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_October2020Member"/>
  <xs:element name="September132022Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_September132022Member"/>
  <xs:element name="SeriesCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_SeriesCMember"/>
  <xs:element name="SeriesDMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_SeriesDMember"/>
  <xs:element name="SeriesEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_SeriesEMember"/>
  <xs:element name="ThirdAndFourthLeaseYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_ThirdAndFourthLeaseYearsMember"/>
  <xs:element name="TwoThousandSeventeenPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_TwoThousandSeventeenPlanMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="rvsn_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>rvsn-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:36 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedBalanceSheet" roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedIncomeStatement" roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedCashFlow" roleURI="http://www.RailVision.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofotheraccountspayableTable" roleURI="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ReceivablesNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSfgMrCK40KV52OSuA3DdtfhV0PqDTborRyw==] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangeInOperatingLeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ChangeInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="rvsn_ChangeInOperatingLeaseLiability" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>rvsn-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:36 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedBalanceSheet" roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedIncomeStatement" roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityType2or3" roleURI="http://www.RailVision.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedCashFlow" roleURI="http://www.RailVision.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_General" roleURI="http://www.RailVision.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SignificantAccountingPolicies" roleURI="http://www.RailVision.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherCurrentAssets" roleURI="http://www.RailVision.com/role/OtherCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNet" roleURI="http://www.RailVision.com/role/FixedAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherAccountsPayable" roleURI="http://www.RailVision.com/role/OtherAccountsPayable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_CommitmentsandContingenciesLiabilities" roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConvertiblePreferredShares" roleURI="http://www.RailVision.com/role/ConvertiblePreferredShares"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquity" roleURI="http://www.RailVision.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ResearchandDevelopmentNet" roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_GeneralandAdministrative" roleURI="http://www.RailVision.com/role/GeneralandAdministrative"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncome" roleURI="http://www.RailVision.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedParties" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_Leases" roleURI="http://www.RailVision.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SubsequentEvents" roleURI="http://www.RailVision.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_AccountingPoliciesByPolicy" roleURI="http://www.RailVision.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SignificantAccountingPoliciesTables" roleURI="http://www.RailVision.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherCurrentAssetsTables" roleURI="http://www.RailVision.com/role/OtherCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNetTables" roleURI="http://www.RailVision.com/role/FixedAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherAccountsPayableTables" roleURI="http://www.RailVision.com/role/OtherAccountsPayableTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityTables" roleURI="http://www.RailVision.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ResearchandDevelopmentNetTables" roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_GeneralandAdministrativeTables" roleURI="http://www.RailVision.com/role/GeneralandAdministrativeTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncomeTables" roleURI="http://www.RailVision.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedPartiesTables" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_LeasesTables" roleURI="http://www.RailVision.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofothercurrentassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoffixedassetsnetTable" roleURI="http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofotheraccountspayableTable" roleURI="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" roleURI="http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" roleURI="http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofresearchanddevelopmentTable" roleURI="http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofgeneralandadministrativeTable" roleURI="http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofdeferredtaxassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoftransactionsTable" roleURI="http://www.RailVision.com/role/ScheduleoftransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofbalancesTable" roleURI="http://www.RailVision.com/role/ScheduleofbalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable" roleURI="http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" roleURI="http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNetDetails" roleURI="http://www.RailVision.com/role/FixedAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_CommitmentsandContingenciesLiabilitiesDetails" roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConvertiblePreferredSharesDetails" roleURI="http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityDetails" roleURI="http://www.RailVision.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncomeDetails" roleURI="http://www.RailVision.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedPartiesDetails" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_LeasesDetails" roleURI="http://www.RailVision.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SubsequentEventsDetails" roleURI="http://www.RailVision.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.RailVision.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangeInOperatingLeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ChangeInOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="rvsn_ChangeInOperatingLeaseLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConversionOfPreferredShares" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfPreferredShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rvsn_ConversionOfPreferredShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConversionOfAConvertibleDebt" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfAConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rvsn_ConversionOfAConvertibleDebt" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:href="rvsn-20221231.xsd#rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/General">
    <loc xlink:type="locator" xlink:label="rvsn_GeneralLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_GeneralLineItems" xlink:to="rvsn_GeneralTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherCurrentAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNet">
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_FixedAssetsNetLineItems" xlink:to="rvsn_FixedAssetsNetTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_FixedAssetsNetLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherAccountsPayable">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConvertiblePreferredShares">
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_ConvertiblePreferredSharesLineItems" xlink:to="rvsn_ConvertiblePreferredSharesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesLineItems" xlink:to="rvsn_ConvertiblePreferredSharesTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ResearchandDevelopmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/GeneralandAdministrative">
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_GeneralandAdministrativeLineItems" xlink:to="rvsn_GeneralandAdministrativeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeLineItems" xlink:to="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/Leases">
    <loc xlink:type="locator" xlink:label="rvsn_LeasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_LeasesLineItems" xlink:to="rvsn_LeasesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDisclosureTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesLineItems" xlink:to="rvsn_LeasesDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_FinancialStatementPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FinancialStatementPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="rvsn_FinancialStatementPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="rvsn_FixedAssetsPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementPlansPolicy" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherCurrentAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNetTables">
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_FixedAssetsNetTablesLineItems" xlink:to="rvsn_FixedAssetsNetTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_FixedAssetsNetTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherAccountsPayableTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ResearchandDevelopmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/GeneralandAdministrativeTables">
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_GeneralandAdministrativeTablesLineItems" xlink:to="rvsn_GeneralandAdministrativeTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeTablesLineItems" xlink:to="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_LeasesTablesLineItems" xlink:to="rvsn_LeasesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesTablesLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesTablesLineItems" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OfficeFurnitureAndEquipment" xlink:href="rvsn-20221231.xsd#rvsn_OfficeFurnitureAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="rvsn_OfficeFurnitureAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ComputerSoftwareAndElectronicEquipment" xlink:href="rvsn-20221231.xsd#rvsn_ComputerSoftwareAndElectronicEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="rvsn_ComputerSoftwareAndElectronicEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_LaboratoryEquipment" xlink:href="rvsn-20221231.xsd#rvsn_LaboratoryEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="rvsn_LaboratoryEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeaseholdImprovements" xlink:href="rvsn-20221231.xsd#rvsn_LeaseholdImprovements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="rvsn_LeaseholdImprovements" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofothercurrentassetsTable">
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_GovernmentContractReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_Deposits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDeferredCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherDeferredCostsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoffixedassetsnetTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable">
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherAccountsPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable">
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable">
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSftffnjq6VVe4WqKjeVj5z9/MXRGmaIX0rQ==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostMaintenance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostMaintenance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_CostMaintenance" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_Depreciation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_SubcontractedWorkAndConsulting" xlink:href="rvsn-20221231.xsd#rvsn_SubcontractedWorkAndConsulting"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="rvsn_SubcontractedWorkAndConsulting" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable">
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_ProfessionalFees" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostMaintenance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostMaintenance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_CostMaintenance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_MarketingExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="rvsn_DeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="rvsn_DeferredTaxAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoftransactionsTable">
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfTransactionsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="rvsn_RevenuesFromRelatedParties" xlink:href="rvsn-20221231.xsd#rvsn_RevenuesFromRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfTransactionsAbstract" xlink:to="rvsn_RevenuesFromRelatedParties" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfTransactionsAbstract" xlink:to="us-gaap_SeveranceCosts1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ScheduleOfTransactionsAbstract" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofbalancesTable">
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MemberUnitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MemberUnitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_MemberUnitsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="us-gaap_OtherAssetsCurrent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_FutureLeasePayments" xlink:href="rvsn-20221231.xsd#rvsn_FutureLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="rvsn_FutureLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_OperatingLeaseLiability" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable">
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_KnorrBremseRailSystemsSchweizAGMember" xlink:href="rvsn-20221231.xsd#rvsn_KnorrBremseRailSystemsSchweizAGMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="rvsn_KnorrBremseRailSystemsSchweizAGMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_PeriodOfFirstCommercialSales" xlink:href="rvsn-20221231.xsd#rvsn_PeriodOfFirstCommercialSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_PeriodOfFirstCommercialSales" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_RoyaltyPaymentsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_RoyaltyPaymentsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_RoyaltyPaymentsPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedsFromConsiderationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfTotalProceedFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedFromConsiderationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_PaymentOfTotalProceedFromConsiderationPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionToPurchaseOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_OptionToPurchaseOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_OptionToPurchaseOrdinaryShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ServiceAgreementWithAConsultantDescription" xlink:href="rvsn-20221231.xsd#rvsn_ServiceAgreementWithAConsultantDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_ServiceAgreementWithAConsultantDescription" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ExercisePrice" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_ExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfMonthlyRemunerationAmount" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfMonthlyRemunerationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_PaymentOfMonthlyRemunerationAmount" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_TotalAmountPaid" xlink:href="rvsn-20221231.xsd#rvsn_TotalAmountPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_TotalAmountPaid" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_DevelopmentAndSales" xlink:href="rvsn-20221231.xsd#rvsn_DevelopmentAndSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_DevelopmentAndSales" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfOperationalFunctionTest" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfOperationalFunctionTest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_PaymentOfOperationalFunctionTest" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_OtherExpenses" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_DeferredRevenuesInOtherAccountsPayable" xlink:href="rvsn-20221231.xsd#rvsn_DeferredRevenuesInOtherAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_DeferredRevenuesInOtherAccountsPayable" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FilmCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FilmCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_FilmCosts" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConvertiblePreferredSharesDetails">
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="rvsn_ConvertiblePreferredSharesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ConvertiblePreferredSharesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_NetInvestmentIncome" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_InvestmentAgreementDescription" xlink:href="rvsn-20221231.xsd#rvsn_InvestmentAgreementDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="rvsn_InvestmentAgreementDescription" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_ShareholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesCMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rvsn_SeriesCMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesDMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesDMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rvsn_SeriesDMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesEMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="rvsn_SeriesEMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_October2020Member" xlink:href="rvsn-20221231.xsd#rvsn_October2020Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="rvsn_October2020Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_November32020Member" xlink:href="rvsn-20221231.xsd#rvsn_November32020Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="rvsn_November32020Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_May112022Member" xlink:href="rvsn-20221231.xsd#rvsn_May112022Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="rvsn_May112022Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_September132022Member" xlink:href="rvsn-20221231.xsd#rvsn_September132022Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="rvsn_September132022Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_OptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_EmployeesMember" xlink:href="rvsn-20221231.xsd#rvsn_EmployeesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="rvsn_EmployeesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_TwoThousandSeventeenPlanMember" xlink:href="rvsn-20221231.xsd#rvsn_TwoThousandSeventeenPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="rvsn_TwoThousandSeventeenPlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_GrossProceeds" xlink:href="rvsn-20221231.xsd#rvsn_GrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_GrossProceeds" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_AggregateSharesIssued" xlink:href="rvsn-20221231.xsd#rvsn_AggregateSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_AggregateSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsPurchase" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPurchase"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_WarrantsPurchase" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OrdinarySharesExpired" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExpired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_OrdinarySharesExpired" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OrdinarySharesExercisedAmount" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExercisedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_OrdinarySharesExercisedAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_AggregateOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_AggregateOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_AggregateOrdinaryShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_InvestedAgreement" xlink:href="rvsn-20221231.xsd#rvsn_InvestedAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_InvestedAgreement" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_WarrantsPercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendsShares" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsDescription" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_WarrantsDescription" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_NetProceeds" xlink:href="rvsn-20221231.xsd#rvsn_NetProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_NetProceeds" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOrdinarySharesAndWarrantsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_RiskFreeInterestRate" xlink:href="rvsn-20221231.xsd#rvsn_RiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_RiskFreeInterestRate" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_DividendYields" xlink:href="rvsn-20221231.xsd#rvsn_DividendYields"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_DividendYields" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ExercisePricePerShares" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePricePerShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_ExercisePricePerShares" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_AmortizedOver" xlink:href="rvsn-20221231.xsd#rvsn_AmortizedOver"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_AmortizedOver" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceIncrease" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionsExpire" xlink:href="rvsn-20221231.xsd#rvsn_OptionsExpire"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_OptionsExpire" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:href="rvsn-20221231.xsd#rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:href="rvsn-20221231.xsd#rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_OtherExpenses" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TerminationLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TerminationLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_TerminationLoans" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionsGrantedDescription" xlink:href="rvsn-20221231.xsd#rvsn_OptionsGrantedDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_OptionsGrantedDescription" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnvestedOptionsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_UnvestedOptionsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_UnvestedOptionsPercentage" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_OtherNoncashExpense" order="45" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="rvsn_TaxesonIncomeDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_TaxesonIncomeDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_TaxesonIncomeDetailsLineItems" xlink:to="rvsn_TaxesonIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="rvsn_LeasesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="rvsn_LeasesDetailsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_FirstTwoYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_FirstTwoYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="rvsn_FirstTwoYearsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_ThirdAndFourthLeaseYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_ThirdAndFourthLeaseYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="rvsn_ThirdAndFourthLeaseYearsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="rvsn_FifthLeaseYearMember" xlink:href="rvsn-20221231.xsd#rvsn_FifthLeaseYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="rvsn_FifthLeaseYearMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="us-gaap_BenefitsLossesAndExpenses" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>rvsn-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:36 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total shareholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Other Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Other Accounts Payable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl" xml:lang="en-US">Other accounts payable, total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of options, Outstanding at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Number of options, Outstanding at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Outstanding at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted average exercise price, Outstanding at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xml:lang="en-US">Option Indexed to Issuer&apos;s Equity, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract" xlink:to="rvsn_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl0" xml:lang="en-US">Other current assets, total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract0" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract0" xlink:to="rvsn_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease - right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Fixed assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract1" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract1" xlink:to="rvsn_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract2" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract2" xlink:to="rvsn_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Trade accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl" xml:lang="en-US">Other accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract3" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract3" xlink:to="rvsn_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Non-current operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract4" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract4" xlink:to="rvsn_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Preferred A shares, NIS 0.01 par value; Authorized 100,000 shares; Issued and outstanding: No shares as at December 31, 2022 and 51,282 shares as of December 31, 2021;</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred A shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred A shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred A shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred A shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract5" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract5" xlink:to="rvsn_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares, NIS 0.01 par value; Authorized 99,900,000 shares; Issued and outstanding: 15,896,040 and 9,157,324 shares as of December 31, 2022 and 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract6" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract6" xlink:to="rvsn_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract7" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract7" xlink:to="rvsn_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract8" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract8" xlink:to="rvsn_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract9" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract9" xlink:to="rvsn_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract10" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract10" xlink:to="rvsn_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract11" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract11" xlink:to="rvsn_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Financial income (expenses), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract12" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract12" xlink:to="rvsn_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract13" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract13" xlink:to="rvsn_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted loss per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Basic and diluted loss per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract14" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract14" xlink:to="rvsn_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share(*) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract15" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract15" xlink:to="rvsn_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangesDuring2020Abstract" xlink:href="rvsn-20221231.xsd#rvsn_ChangesDuring2020Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ChangesDuring2020Abstract_lbl" xml:lang="en-US">CHANGES DURING 2020:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2020Abstract" xlink:to="rvsn_ChangesDuring2020Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of convertible preferred shares, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Issuance of convertible preferred shares, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">(in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">(in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract16" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract16" xlink:to="rvsn_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract17" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract17" xlink:to="rvsn_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangesDuring2021Abstract" xlink:href="rvsn-20221231.xsd#rvsn_ChangesDuring2021Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ChangesDuring2021Abstract_lbl" xml:lang="en-US">CHANGES DURING 2021:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2021Abstract" xlink:to="rvsn_ChangesDuring2021Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Issuance of convertible preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Issuance of convertible preferred shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of shares as a result of exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of shares as a result of exercise of options (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract18" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract18" xlink:to="rvsn_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangesDuring2022Abstract" xlink:href="rvsn-20221231.xsd#rvsn_ChangesDuring2022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ChangesDuring2022Abstract_lbl" xml:lang="en-US">CHANGES DURING 2022:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2022Abstract" xlink:to="rvsn_ChangesDuring2022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl" xml:lang="en-US">Conversion of convertible debt into ordinary shares upon completion of initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl" xml:lang="en-US">Conversion of convertible debt into ordinary shares upon completion of initial public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract19" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract19" xlink:to="rvsn_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract20" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract20" xlink:to="rvsn_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Increase (decrease) in trade accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xml:lang="en-US">Increase (decrease) in other accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract21" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract21"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract21_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract21" xlink:to="rvsn_UnlabeledAbstract21_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract22" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract22"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract22_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract22" xlink:to="rvsn_UnlabeledAbstract22_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract23" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract23"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract23_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract23" xlink:to="rvsn_UnlabeledAbstract23_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract24" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract24"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract24_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract24" xlink:to="rvsn_UnlabeledAbstract24_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Issuance of preferred A shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from a convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract25" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract25"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract25_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract25" xlink:to="rvsn_UnlabeledAbstract25_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract26" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract26"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract26_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract26" xlink:to="rvsn_UnlabeledAbstract26_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract27" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract27"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract27_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract27" xlink:to="rvsn_UnlabeledAbstract27_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non Cash Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl" xml:lang="en-US">Obtaining a right-of-use asset in exchange for a lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:to="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConversionOfPreferredShares" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfPreferredShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ConversionOfPreferredShares_lbl" xml:lang="en-US">Conversion of preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfPreferredShares" xlink:to="rvsn_ConversionOfPreferredShares_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConversionOfAConvertibleDebt" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfAConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ConversionOfAConvertibleDebt_lbl" xml:lang="en-US">Conversion of a convertible debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfAConvertibleDebt" xlink:to="rvsn_ConversionOfAConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:href="rvsn-20221231.xsd#rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl" xml:lang="en-US">Decrease of deferred expenses against additional paid in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:to="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and development expense, total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ChangeInOperatingLeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ChangeInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="rvsn_ChangeInOperatingLeaseLiability_lbl" xml:lang="en-US">Change in operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangeInOperatingLeaseLiability" xlink:to="rvsn_ChangeInOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Decrease (increase) in other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred A Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of straight-line method over the estimated useful lives of the assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OfficeFurnitureAndEquipment" xlink:href="rvsn-20221231.xsd#rvsn_OfficeFurnitureAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OfficeFurnitureAndEquipment_lbl" xml:lang="en-US">Office furniture and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OfficeFurnitureAndEquipment" xlink:to="rvsn_OfficeFurnitureAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ComputerSoftwareAndElectronicEquipment" xlink:href="rvsn-20221231.xsd#rvsn_ComputerSoftwareAndElectronicEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ComputerSoftwareAndElectronicEquipment_lbl" xml:lang="en-US">Computer software and electronic equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ComputerSoftwareAndElectronicEquipment" xlink:to="rvsn_ComputerSoftwareAndElectronicEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LaboratoryEquipment" xlink:href="rvsn-20221231.xsd#rvsn_LaboratoryEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_LaboratoryEquipment_lbl" xml:lang="en-US">Laboratory equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LaboratoryEquipment" xlink:to="rvsn_LaboratoryEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeaseholdImprovements" xlink:href="rvsn-20221231.xsd#rvsn_LeaseholdImprovements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_LeaseholdImprovements_lbl" xml:lang="en-US">Leasehold improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeaseholdImprovements" xlink:to="rvsn_LeaseholdImprovements_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">OTHER CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GovernmentContractReceivable_lbl" xml:lang="en-US">Government institutions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentContractReceivable" xlink:to="us-gaap_GovernmentContractReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Deposits_lbl" xml:lang="en-US">Deposits at the Chamber of Commerce</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDeferredCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherDeferredCostsNet_lbl" xml:lang="en-US">Deferred offering expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCostsNet" xlink:to="us-gaap_OtherDeferredCostsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">FIXED ASSETS, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of fixed assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_CostAbstract" xlink:href="rvsn-20221231.xsd#rvsn_CostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_CostAbstract_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_CostAbstract" xlink:to="rvsn_CostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract28" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract28"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract28_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract28" xlink:to="rvsn_UnlabeledAbstract28_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_AccumulatedDepreciationAbstract" xlink:href="rvsn-20221231.xsd#rvsn_AccumulatedDepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_AccumulatedDepreciationAbstract_lbl" xml:lang="en-US">Accumulated depreciation:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AccumulatedDepreciationAbstract" xlink:to="rvsn_AccumulatedDepreciationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract29" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract29"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract29_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract29" xlink:to="rvsn_UnlabeledAbstract29_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract30" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract30"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract30_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract30" xlink:to="rvsn_UnlabeledAbstract30_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER ACCOUNTS PAYABLE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ConvertiblePreferredSharesTextBlock_lbl" xml:lang="en-US">CONVERTIBLE PREFERRED SHARES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesTextBlock" xlink:to="rvsn_ConvertiblePreferredSharesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&apos; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of option activity for options to employees, officers and directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of options, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract31" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract31"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract31_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract31" xlink:to="rvsn_UnlabeledAbstract31_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod_lbl" xml:lang="en-US">Weighted average remaining contractual life, Outstanding at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" xlink:to="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars_lbl" xml:lang="en-US">Number of options, Exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars" xlink:to="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod_lbl" xml:lang="en-US">Weighted average exercise price, Exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod" xlink:to="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars_lbl" xml:lang="en-US">Weighted average remaining contractual life, Exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" xlink:to="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of total share-based payment expense related to options granted to employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total share-based payment expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US">RESEARCH AND DEVELOPMENT, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl" xml:lang="en-US">Schedule of research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl" xml:lang="en-US">Payroll and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xml:lang="en-US">Share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment_lbl" xml:lang="en-US">R&amp;D consumables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" xlink:to="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostMaintenance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostMaintenance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostMaintenance_lbl" xml:lang="en-US">Rent and office maintenance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMaintenance" xlink:to="us-gaap_CostMaintenance_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_SubcontractedWorkAndConsulting" xlink:href="rvsn-20221231.xsd#rvsn_SubcontractedWorkAndConsulting"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_SubcontractedWorkAndConsulting_lbl" xml:lang="en-US">Subcontracted work and consulting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SubcontractedWorkAndConsulting" xlink:to="rvsn_SubcontractedWorkAndConsulting_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TravelAndEntertainmentExpense_lbl" xml:lang="en-US">Travel and other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TravelAndEntertainmentExpense" xlink:to="us-gaap_TravelAndEntertainmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TravelAndEntertainmentExpense_lbl0" xml:lang="en-US">Travel expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TravelAndEntertainmentExpense" xlink:to="us-gaap_TravelAndEntertainmentExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl" xml:lang="en-US">GENERAL AND ADMINISTRATIVE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" xlink:to="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock_lbl" xml:lang="en-US">Schedule of general and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock" xlink:to="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketingExpense_lbl" xml:lang="en-US">Marketing and others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Total general and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_DeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DeferredTaxAssetsAbstract" xlink:to="rvsn_DeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Deferred taxes due to carryforward losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnlabeledAbstract32" xlink:href="rvsn-20221231.xsd#rvsn_UnlabeledAbstract32"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnlabeledAbstract32_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract32" xlink:to="rvsn_UnlabeledAbstract32_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Income tax expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">TRANSACTIONS AND BALANCES WITH RELATED PARTIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_RevenuesFromRelatedParties" xlink:href="rvsn-20221231.xsd#rvsn_RevenuesFromRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_RevenuesFromRelatedParties_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RevenuesFromRelatedParties" xlink:to="rvsn_RevenuesFromRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeveranceCosts1_lbl" xml:lang="en-US">Severance payment to former Company CEO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities_lbl" xml:lang="en-US">Schedule of balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" xlink:to="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDisclosureTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_LeasesDisclosureTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDisclosureTextBlock" xlink:to="rvsn_LeasesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future lease payments under operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FutureLeasePayments" xlink:href="rvsn-20221231.xsd#rvsn_FutureLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FutureLeasePayments_lbl" xml:lang="en-US">Total future lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FutureLeasePayments" xlink:to="rvsn_FutureLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average lease term and weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating leases weighted average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Operating leases weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of options, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl0" xml:lang="en-US">Granted options shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of options, Forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and software	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Laboratory equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and office equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share Based Payment Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MemberUnitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MemberUnitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MemberUnitsMember_lbl" xml:lang="en-US">Balance [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MemberUnitsMember" xlink:to="us-gaap_MemberUnitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xml:lang="en-US">Lease Contractual Term [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciation_lbl" xml:lang="en-US">Depreciation expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_PeriodOfFirstCommercialSales" xlink:href="rvsn-20221231.xsd#rvsn_PeriodOfFirstCommercialSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_PeriodOfFirstCommercialSales_lbl" xml:lang="en-US">Period of first commercial sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PeriodOfFirstCommercialSales" xlink:to="rvsn_PeriodOfFirstCommercialSales_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_RoyaltyPaymentsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_RoyaltyPaymentsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_RoyaltyPaymentsPercentage_lbl" xml:lang="en-US">Royalty payments, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RoyaltyPaymentsPercentage" xlink:to="rvsn_RoyaltyPaymentsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedsFromConsiderationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage_lbl" xml:lang="en-US">Payment of total proceeds from consideration, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage" xlink:to="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfTotalProceedFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedFromConsiderationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_PaymentOfTotalProceedFromConsiderationPercentage_lbl" xml:lang="en-US">Payment of total proceeds from consideration, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfTotalProceedFromConsiderationPercentage" xlink:to="rvsn_PaymentOfTotalProceedFromConsiderationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionToPurchaseOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_OptionToPurchaseOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OptionToPurchaseOrdinaryShares_lbl" xml:lang="en-US">Option to purchase ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionToPurchaseOrdinaryShares" xlink:to="rvsn_OptionToPurchaseOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ServiceAgreementWithAConsultantDescription" xlink:href="rvsn-20221231.xsd#rvsn_ServiceAgreementWithAConsultantDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ServiceAgreementWithAConsultantDescription_lbl" xml:lang="en-US">Service agreement with a consultant description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ServiceAgreementWithAConsultantDescription" xlink:to="rvsn_ServiceAgreementWithAConsultantDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ExercisePrice" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ExercisePrice_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ExercisePrice" xlink:to="rvsn_ExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfMonthlyRemunerationAmount" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfMonthlyRemunerationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_PaymentOfMonthlyRemunerationAmount_lbl" xml:lang="en-US">Payment of monthly remuneration amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfMonthlyRemunerationAmount" xlink:to="rvsn_PaymentOfMonthlyRemunerationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TotalAmountPaid" xlink:href="rvsn-20221231.xsd#rvsn_TotalAmountPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_TotalAmountPaid_lbl" xml:lang="en-US">Company total amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TotalAmountPaid" xlink:to="rvsn_TotalAmountPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_DevelopmentAndSales" xlink:href="rvsn-20221231.xsd#rvsn_DevelopmentAndSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DevelopmentAndSales_lbl" xml:lang="en-US">Development and sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DevelopmentAndSales" xlink:to="rvsn_DevelopmentAndSales_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_PaymentOfOperationalFunctionTest" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfOperationalFunctionTest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_PaymentOfOperationalFunctionTest_lbl" xml:lang="en-US">Payment of operational function test</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfOperationalFunctionTest" xlink:to="rvsn_PaymentOfOperationalFunctionTest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Installation and operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" xlink:to="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_DeferredRevenuesInOtherAccountsPayable" xlink:href="rvsn-20221231.xsd#rvsn_DeferredRevenuesInOtherAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DeferredRevenuesInOtherAccountsPayable_lbl" xml:lang="en-US">Deferred revenues in other accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DeferredRevenuesInOtherAccountsPayable" xlink:to="rvsn_DeferredRevenuesInOtherAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FilmCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FilmCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FilmCosts_lbl" xml:lang="en-US">Capital cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FilmCosts" xlink:to="us-gaap_FilmCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent_lbl" xml:lang="en-US">Deferred revenue in the amount of other accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" xlink:to="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_lbl" xml:lang="en-US">Additional payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetInvestmentIncome_lbl" xml:lang="en-US">Total investment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentIncome" xlink:to="us-gaap_NetInvestmentIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Net proceeds, costs and fees (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl" xml:lang="en-US">Additional amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_InvestmentAgreementDescription" xlink:href="rvsn-20221231.xsd#rvsn_InvestmentAgreementDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_InvestmentAgreementDescription_lbl" xml:lang="en-US">Investment agreement description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestmentAgreementDescription" xlink:to="rvsn_InvestmentAgreementDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Conversion shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Issuance of preferred A shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GrossProceeds" xlink:href="rvsn-20221231.xsd#rvsn_GrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_GrossProceeds_lbl" xml:lang="en-US">Gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GrossProceeds" xlink:to="rvsn_GrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_AggregateSharesIssued" xlink:href="rvsn-20221231.xsd#rvsn_AggregateSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_AggregateSharesIssued_lbl" xml:lang="en-US">Aggregate shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AggregateSharesIssued" xlink:to="rvsn_AggregateSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsPurchase" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPurchase"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WarrantsPurchase_lbl" xml:lang="en-US">Warrants purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsPurchase" xlink:to="rvsn_WarrantsPurchase_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessStockSharesIssued_lbl" xml:lang="en-US">Warrants purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesIssued" xlink:to="us-gaap_ExcessStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OrdinarySharesExpired" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExpired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OrdinarySharesExpired_lbl" xml:lang="en-US">Ordinary shares expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExpired" xlink:to="rvsn_OrdinarySharesExpired_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OrdinarySharesExercisedAmount" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExercisedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OrdinarySharesExercisedAmount_lbl" xml:lang="en-US">Ordinary shares exercised amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExercisedAmount" xlink:to="rvsn_OrdinarySharesExercisedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities_lbl" xml:lang="en-US">Gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" xlink:to="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_AggregateOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_AggregateOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_AggregateOrdinaryShares_lbl" xml:lang="en-US">Aggregate ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AggregateOrdinaryShares" xlink:to="rvsn_AggregateOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Additional shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_InvestedAgreement" xlink:href="rvsn-20221231.xsd#rvsn_InvestedAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_InvestedAgreement_lbl" xml:lang="en-US">Invested agreement (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestedAgreement" xlink:to="rvsn_InvestedAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Aggregate number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Company at a price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WarrantsPercentage_lbl" xml:lang="en-US">Warrants percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsPercentage" xlink:to="rvsn_WarrantsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xml:lang="en-US">Ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share issued price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_WarrantsDescription" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_WarrantsDescription_lbl" xml:lang="en-US">Warrants, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsDescription" xlink:to="rvsn_WarrantsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_NetProceeds" xlink:href="rvsn-20221231.xsd#rvsn_NetProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_NetProceeds_lbl" xml:lang="en-US">Net proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NetProceeds" xlink:to="rvsn_NetProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOrdinarySharesAndWarrantsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage_lbl" xml:lang="en-US">Percentage of number of ordinary shares and warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage" xlink:to="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Weighted average volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_RiskFreeInterestRate" xlink:href="rvsn-20221231.xsd#rvsn_RiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_RiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RiskFreeInterestRate" xlink:to="rvsn_RiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_DividendYields" xlink:href="rvsn-20221231.xsd#rvsn_DividendYields"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_DividendYields_lbl" xml:lang="en-US">Dividend yields</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DividendYields" xlink:to="rvsn_DividendYields_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Weighted average life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ExercisePricePerShares" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePricePerShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ExercisePricePerShares_lbl" xml:lang="en-US">Exercise price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ExercisePricePerShares" xlink:to="rvsn_ExercisePricePerShares_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_AmortizedOver" xlink:href="rvsn-20221231.xsd#rvsn_AmortizedOver"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_AmortizedOver_lbl" xml:lang="en-US">Amortized over</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AmortizedOver" xlink:to="rvsn_AmortizedOver_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_lbl" xml:lang="en-US">Research and development expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl" xml:lang="en-US">Option exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl" xml:lang="en-US">Percentage weighted average volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividend yields</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionsExpire" xlink:href="rvsn-20221231.xsd#rvsn_OptionsExpire"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OptionsExpire_lbl" xml:lang="en-US">Options expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionsExpire" xlink:to="rvsn_OptionsExpire_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value of options granted per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:href="rvsn-20221231.xsd#rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl" xml:lang="en-US">Share-based payment expenses related to nonvested awards (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:to="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:href="rvsn-20221231.xsd#rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:to="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Options expire term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TerminationLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TerminationLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TerminationLoans_lbl" xml:lang="en-US">Termination amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TerminationLoans" xlink:to="us-gaap_TerminationLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_OptionsGrantedDescription" xlink:href="rvsn-20221231.xsd#rvsn_OptionsGrantedDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_OptionsGrantedDescription_lbl" xml:lang="en-US">Options granted, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionsGrantedDescription" xlink:to="rvsn_OptionsGrantedDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_UnvestedOptionsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_UnvestedOptionsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_UnvestedOptionsPercentage_lbl" xml:lang="en-US">Unvested options percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnvestedOptionsPercentage" xlink:to="rvsn_UnvestedOptionsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Vested shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Options shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Recorded an expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xml:lang="en-US">Net operating losses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">IPO bonus amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Monthly office rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Lease, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Lease liability and right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease term, date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BenefitsLossesAndExpenses_lbl" xml:lang="en-US">Operating lease expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BenefitsLossesAndExpenses" xlink:to="us-gaap_BenefitsLossesAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Total amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription_lbl" xml:lang="en-US">Agreements executive officers, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates in the preparation of financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FinancialStatementPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FinancialStatementPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FinancialStatementPolicyTextBlock_lbl" xml:lang="en-US">Financial statement in U.S. dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FinancialStatementPolicyTextBlock" xlink:to="rvsn_FinancialStatementPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair value of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FixedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsPolicyTextBlock" xlink:to="rvsn_FixedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PensionAndOtherPostretirementPlansPolicy_lbl" xml:lang="en-US">Accrued post-employment benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="us-gaap_PensionAndOtherPostretirementPlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted net loss per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_KnorrBremseRailSystemsSchweizAGMember" xlink:href="rvsn-20221231.xsd#rvsn_KnorrBremseRailSystemsSchweizAGMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl" xml:lang="en-US">KBCH [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_KnorrBremseRailSystemsSchweizAGMember" xlink:to="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl0" xml:lang="en-US">Knorr-Bremse Rail Systems Schweiz AG [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_KnorrBremseRailSystemsSchweizAGMember" xlink:to="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl0"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSfmneIL7XqoVWTqRs8ADLo49yduXkyR4+8g==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Preferred A Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAMember_lbl" xml:lang="en-US">Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAMember" xlink:to="us-gaap_SeriesAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBMember_lbl" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBMember" xlink:to="us-gaap_SeriesBMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesCMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_SeriesCMember_lbl" xml:lang="en-US">Series C [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesCMember" xlink:to="rvsn_SeriesCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesDMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesDMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_SeriesDMember_lbl" xml:lang="en-US">Series D [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesDMember" xlink:to="rvsn_SeriesDMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_SeriesEMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_SeriesEMember_lbl" xml:lang="en-US">Series E [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesEMember" xlink:to="rvsn_SeriesEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">KB Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OptionMember_lbl" xml:lang="en-US">Options to employees [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OptionMember_lbl0" xml:lang="en-US">Options Held [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_EmployeesMember" xlink:href="rvsn-20221231.xsd#rvsn_EmployeesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_EmployeesMember" xlink:to="rvsn_EmployeesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ChiefExecutiveOfficerMember_lbl0" xml:lang="en-US">CEO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_October2020Member" xlink:href="rvsn-20221231.xsd#rvsn_October2020Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_October2020Member_lbl" xml:lang="en-US">October 2020 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_October2020Member" xlink:to="rvsn_October2020Member_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_November32020Member" xlink:href="rvsn-20221231.xsd#rvsn_November32020Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_November32020Member_lbl" xml:lang="en-US">November 3, 2020 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_November32020Member" xlink:to="rvsn_November32020Member_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_May112022Member" xlink:href="rvsn-20221231.xsd#rvsn_May112022Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_May112022Member_lbl" xml:lang="en-US">May 11 ,2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_May112022Member" xlink:to="rvsn_May112022Member_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_September132022Member" xlink:href="rvsn-20221231.xsd#rvsn_September132022Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_September132022Member_lbl" xml:lang="en-US">September 13,2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_September132022Member" xlink:to="rvsn_September132022Member_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TwoThousandSeventeenPlanMember" xlink:href="rvsn-20221231.xsd#rvsn_TwoThousandSeventeenPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_TwoThousandSeventeenPlanMember_lbl" xml:lang="en-US">Two Thousand Seventeen Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TwoThousandSeventeenPlanMember" xlink:to="rvsn_TwoThousandSeventeenPlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FirstTwoYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_FirstTwoYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FirstTwoYearsMember_lbl" xml:lang="en-US">First Two Lease Years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FirstTwoYearsMember" xlink:to="rvsn_FirstTwoYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ThirdAndFourthLeaseYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_ThirdAndFourthLeaseYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_ThirdAndFourthLeaseYearsMember_lbl" xml:lang="en-US">Third and Fourth Lease Years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ThirdAndFourthLeaseYearsMember" xlink:to="rvsn_ThirdAndFourthLeaseYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FifthLeaseYearMember" xlink:href="rvsn-20221231.xsd#rvsn_FifthLeaseYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FifthLeaseYearMember_lbl" xml:lang="en-US">Fifth Lease Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FifthLeaseYearMember" xlink:to="rvsn_FifthLeaseYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralTable_lbl" xml:lang="en-US">General [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralTable" xlink:to="rvsn_GeneralTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralLineItems_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralLineItems" xlink:to="rvsn_GeneralLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FixedAssetsNetTable_lbl" xml:lang="en-US">Fixed Assets, Net [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsNetTable" xlink:to="rvsn_FixedAssetsNetTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FixedAssetsNetLineItems_lbl" xml:lang="en-US">Fixed Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsNetLineItems" xlink:to="rvsn_FixedAssetsNetLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesTable_lbl" xml:lang="en-US">Convertible Preferred Shares [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesTable" xlink:to="rvsn_ConvertiblePreferredSharesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesLineItems_lbl" xml:lang="en-US">Convertible Preferred Shares [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesLineItems" xlink:to="rvsn_ConvertiblePreferredSharesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeTable_lbl" xml:lang="en-US">General and Administrative [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeTable" xlink:to="rvsn_GeneralandAdministrativeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeLineItems_lbl" xml:lang="en-US">General and Administrative [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeLineItems" xlink:to="rvsn_GeneralandAdministrativeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesTable_lbl" xml:lang="en-US">Leases [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesTable" xlink:to="rvsn_LeasesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesLineItems_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesLineItems" xlink:to="rvsn_LeasesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FixedAssetsNetTablesTable_lbl" xml:lang="en-US">Fixed Assets, Net (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsNetTablesTable" xlink:to="rvsn_FixedAssetsNetTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_FixedAssetsNetTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_FixedAssetsNetTablesLineItems_lbl" xml:lang="en-US">Fixed Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsNetTablesLineItems" xlink:to="rvsn_FixedAssetsNetTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeTablesTable_lbl" xml:lang="en-US">General and Administrative (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeTablesTable" xlink:to="rvsn_GeneralandAdministrativeTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_GeneralandAdministrativeTablesLineItems_lbl" xml:lang="en-US">General and Administrative [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeTablesLineItems" xlink:to="rvsn_GeneralandAdministrativeTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesTablesTable_lbl" xml:lang="en-US">Leases (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesTablesTable" xlink:to="rvsn_LeasesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="rvsn_LeasesTablesLineItems_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesTablesLineItems" xlink:to="rvsn_LeasesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Public Utility, Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Public Utility, Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) - Schedule of option activity for options to employees, officers and directors [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:to="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) - Schedule of option activity for options to employees, officers and directors [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xml:lang="en-US">Option Indexed to Issuer&apos;s Equity, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) - Schedule of total share-based payment expense related to options granted to employees [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:to="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) - Schedule of total share-based payment expense related to options granted to employees [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable_lbl" xml:lang="en-US">Schedule of Research and Development Assets Acquired Other than Through Business Combination [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems_lbl" xml:lang="en-US">Research and Development Assets Acquired Other than Through Business Combination [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable_lbl" xml:lang="en-US">General and Administrative (Details) - Schedule of general and administrative [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:to="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems_lbl" xml:lang="en-US">Schedule of general and administrative [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable_lbl" xml:lang="en-US">Transactions and Balances with Related Parties (Details) - Schedule of balances [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems_lbl" xml:lang="en-US">Transactions and Balances with Related Parties (Details) - Schedule of balances [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable_lbl" xml:lang="en-US">Leases (Details) - Schedule of future lease payments under operating leases [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:to="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems_lbl" xml:lang="en-US">Schedule of future lease payments under operating leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable_lbl" xml:lang="en-US">Leases (Details) - Schedule of weighted average lease term and weighted average discount rate [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:to="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems_lbl" xml:lang="en-US">Schedule of weighted average lease term and weighted average discount rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies Liabilities (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesDetailsTable_lbl" xml:lang="en-US">Convertible Preferred Shares (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesDetailsTable" xlink:to="rvsn_ConvertiblePreferredSharesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesDetailsLineItems_lbl" xml:lang="en-US">Convertible Preferred Shares (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesDetailsLineItems" xlink:to="rvsn_ConvertiblePreferredSharesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Financial Instruments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateDomain_lbl" xml:lang="en-US">Award Date [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateDomain" xlink:to="us-gaap_AwardDateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsTable_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsTable" xlink:to="rvsn_ShareholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ShareholdersEquityDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareholdersEquityDetailsLineItems_lbl" xml:lang="en-US">Shareholders&apos; Equity (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareholdersEquityDetailsLineItems" xlink:to="rvsn_ShareholdersEquityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TaxesonIncomeDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TaxesonIncomeDetailsTable_lbl" xml:lang="en-US">Taxes on Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TaxesonIncomeDetailsTable" xlink:to="rvsn_TaxesonIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TaxesonIncomeDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TaxesonIncomeDetailsLineItems_lbl" xml:lang="en-US">Taxes on Income (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TaxesonIncomeDetailsLineItems" xlink:to="rvsn_TaxesonIncomeDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable_lbl" xml:lang="en-US">Transactions and Balances with Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems_lbl" xml:lang="en-US">Transactions and Balances with Related Parties (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:to="rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsTable_lbl" xml:lang="en-US">Leases (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsTable" xlink:to="rvsn_LeasesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDetailsLineItems_lbl" xml:lang="en-US">Leases (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDetailsLineItems" xlink:to="rvsn_LeasesDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_AggregateSharesIssued_lbl0" xml:lang="en-US">Issuance of aggregate ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AggregateSharesIssued" xlink:to="rvsn_AggregateSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ChangeInOperatingLeaseLiability_lbl0" xml:lang="en-US">Amount of change in operating lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangeInOperatingLeaseLiability" xlink:to="rvsn_ChangeInOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ComputerSoftwareAndElectronicEquipment_lbl0" xml:lang="en-US">Percentage of computer software and electronic equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ComputerSoftwareAndElectronicEquipment" xlink:to="rvsn_ComputerSoftwareAndElectronicEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ConversionOfAConvertibleDebt_lbl0" xml:lang="en-US">Amount of conversion of a convertible debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfAConvertibleDebt" xlink:to="rvsn_ConversionOfAConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ConversionOfPreferredShares_lbl0" xml:lang="en-US">Amount of conversion of preferred shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfPreferredShares" xlink:to="rvsn_ConversionOfPreferredShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl0" xml:lang="en-US">Amount of decrease of deferred expenses against additional paid in capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:to="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl0" xml:lang="en-US">Disclosure of General and Administrative.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" xlink:to="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_FinancialStatementPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of financial statement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FinancialStatementPolicyTextBlock" xlink:to="rvsn_FinancialStatementPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_GrossProceeds_lbl0" xml:lang="en-US">Gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GrossProceeds" xlink:to="rvsn_GrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_InvestedAgreement_lbl0" xml:lang="en-US">t is a type of shareholders agreement which serves to regulate the relationships between the founding shareholders who have incorporated or are to incorporate a company and the investor who shall finance their growth.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestedAgreement" xlink:to="rvsn_InvestedAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_InvestmentAgreementDescription_lbl0" xml:lang="en-US">Investment agreement description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestmentAgreementDescription" xlink:to="rvsn_InvestmentAgreementDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_LaboratoryEquipment_lbl0" xml:lang="en-US">Percentage of laboratory equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LaboratoryEquipment" xlink:to="rvsn_LaboratoryEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_LeaseholdImprovements_lbl0" xml:lang="en-US">The term of leasehold improvements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeaseholdImprovements" xlink:to="rvsn_LeaseholdImprovements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_NetProceeds_lbl0" xml:lang="en-US">Net proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NetProceeds" xlink:to="rvsn_NetProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl0" xml:lang="en-US">Amount of obtaining a right-of-use asset in exchange for a lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:to="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_OfficeFurnitureAndEquipment_lbl0" xml:lang="en-US">Percentage of office furniture and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OfficeFurnitureAndEquipment" xlink:to="rvsn_OfficeFurnitureAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_OrdinarySharesExercisedAmount_lbl0" xml:lang="en-US">Ordinary shares exercised amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExercisedAmount" xlink:to="rvsn_OrdinarySharesExercisedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_OrdinarySharesExpired_lbl0" xml:lang="en-US">Ordinary shares expired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExpired" xlink:to="rvsn_OrdinarySharesExpired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_RiskFreeInterestRate_lbl0" xml:lang="en-US">Risk free interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RiskFreeInterestRate" xlink:to="rvsn_RiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_RoyaltyPaymentsPercentage_lbl0" xml:lang="en-US">This percentage for royalty payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RoyaltyPaymentsPercentage" xlink:to="rvsn_RoyaltyPaymentsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ServiceAgreementWithAConsultantDescription_lbl0" xml:lang="en-US">Service agreement with a consultant description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ServiceAgreementWithAConsultantDescription" xlink:to="rvsn_ServiceAgreementWithAConsultantDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl0" xml:lang="en-US">Expected term of award under share-based payment arrangement, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:to="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl0" xml:lang="en-US">Share based payment expenses related to non-vesting condition is any condition that does not determine whether the entity receives the services that entitle the counterparty to receive cash, other assets or equity instruments of the entity under a share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:to="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0" xml:lang="en-US">The amount is conversion of convertible debt into ordinary shares upon completion of initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl0" xml:lang="en-US">Number of shares conversion of convertible debt into ordinary shares upon completion of initial public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_SubcontractedWorkAndConsulting_lbl0" xml:lang="en-US">The amount is subcontracted work and consulting.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SubcontractedWorkAndConsulting" xlink:to="rvsn_SubcontractedWorkAndConsulting_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_TotalAmountPaid_lbl0" xml:lang="en-US">The company amount to be paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TotalAmountPaid" xlink:to="rvsn_TotalAmountPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_UnvestedOptionsPercentage_lbl0" xml:lang="en-US">Unvested options percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnvestedOptionsPercentage" xlink:to="rvsn_UnvestedOptionsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="rvsn_WarrantsDescription_lbl0" xml:lang="en-US">Warrants description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsDescription" xlink:to="rvsn_WarrantsDescription_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements_lbl0" xml:lang="en-US">Recorded Unconditional Purchase Obligation, Amount of Maturities and Sinking Fund Requirements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" xlink:to="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ExercisePricePerShares_lbl0" xml:lang="en-US">Exercise Price Per Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ExercisePricePerShares" xlink:to="rvsn_ExercisePricePerShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl0" xml:lang="en-US">Other Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl1" xml:lang="en-US">Obtaining ARightofuse Asset In Exchange For ALease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:to="rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FirstTwoYearsMember_lbl0" xml:lang="en-US">First Two Years Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FirstTwoYearsMember" xlink:to="rvsn_FirstTwoYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities_lbl0" xml:lang="en-US">Sale Leaseback Transaction, Gross Proceeds, Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" xlink:to="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ChangesDuring2022Abstract_lbl0" xml:lang="en-US">Changes During2022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2022Abstract" xlink:to="rvsn_ChangesDuring2022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl0" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WarrantsDescription_lbl1" xml:lang="en-US">Warrants Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsDescription" xlink:to="rvsn_WarrantsDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsShares_lbl0" xml:lang="en-US">Preferred Stock Dividends, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl0" xml:lang="en-US">Lessee, Operating Lease, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BenefitsLossesAndExpenses_lbl0" xml:lang="en-US">Benefits, Losses and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BenefitsLossesAndExpenses" xlink:to="us-gaap_BenefitsLossesAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl0" xml:lang="en-US">Accounts Payable, Trade, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OptionsGrantedDescription_lbl0" xml:lang="en-US">Options Granted Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionsGrantedDescription" xlink:to="rvsn_OptionsGrantedDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_PeriodOfFirstCommercialSales_lbl0" xml:lang="en-US">Period Of First Commercial Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PeriodOfFirstCommercialSales" xlink:to="rvsn_PeriodOfFirstCommercialSales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl0" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingExpense_lbl0" xml:lang="en-US">Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingExpense" xlink:to="us-gaap_MarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LaboratoryEquipment_lbl1" xml:lang="en-US">Laboratory Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LaboratoryEquipment" xlink:to="rvsn_LaboratoryEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WarrantsPurchase_lbl0" xml:lang="en-US">Warrants Purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsPurchase" xlink:to="rvsn_WarrantsPurchase_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GovernmentContractReceivable_lbl0" xml:lang="en-US">Government Contract Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentContractReceivable" xlink:to="us-gaap_GovernmentContractReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract18" xlink:to="rvsn_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract19" xlink:to="rvsn_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract16" xlink:to="rvsn_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract17" xlink:to="rvsn_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl0" xml:lang="en-US">Lease Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0" xml:lang="en-US">Percentage of Weighted Average Cost Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract21_lbl0" xml:lang="en-US">Unlabeled Abstract21</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract21" xlink:to="rvsn_UnlabeledAbstract21_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract22_lbl0" xml:lang="en-US">Unlabeled Abstract22</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract22" xlink:to="rvsn_UnlabeledAbstract22_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ChangeInOperatingLeaseLiability_lbl1" xml:lang="en-US">Change In Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangeInOperatingLeaseLiability" xlink:to="rvsn_ChangeInOperatingLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl0" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract20" xlink:to="rvsn_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract25_lbl0" xml:lang="en-US">Unlabeled Abstract25</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract25" xlink:to="rvsn_UnlabeledAbstract25_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract26_lbl0" xml:lang="en-US">Unlabeled Abstract26</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract26" xlink:to="rvsn_UnlabeledAbstract26_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract23_lbl0" xml:lang="en-US">Unlabeled Abstract23</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract23" xlink:to="rvsn_UnlabeledAbstract23_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract24_lbl0" xml:lang="en-US">Unlabeled Abstract24</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract24" xlink:to="rvsn_UnlabeledAbstract24_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl0" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract29_lbl0" xml:lang="en-US">Unlabeled Abstract29</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract29" xlink:to="rvsn_UnlabeledAbstract29_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract27_lbl0" xml:lang="en-US">Unlabeled Abstract27</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract27" xlink:to="rvsn_UnlabeledAbstract27_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract28_lbl0" xml:lang="en-US">Unlabeled Abstract28</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract28" xlink:to="rvsn_UnlabeledAbstract28_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MemberUnitsMember_lbl0" xml:lang="en-US">Member Units [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MemberUnitsMember" xlink:to="us-gaap_MemberUnitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Awards Fair Value Assumptions Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:to="rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBMember_lbl0" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBMember" xlink:to="us-gaap_SeriesBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetInvestmentIncome_lbl0" xml:lang="en-US">Net Investment Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetInvestmentIncome" xlink:to="us-gaap_NetInvestmentIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract32_lbl0" xml:lang="en-US">Unlabeled Abstract32</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract32" xlink:to="rvsn_UnlabeledAbstract32_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract30_lbl0" xml:lang="en-US">Unlabeled Abstract30</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract30" xlink:to="rvsn_UnlabeledAbstract30_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract31_lbl0" xml:lang="en-US">Unlabeled Abstract31</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract31" xlink:to="rvsn_UnlabeledAbstract31_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl0" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract_lbl" xml:lang="en-US">Schedule Of Option Activity For Options To Employees Officers And Directors Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract" xlink:to="rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Other Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfOtherCurrentAssetsAbstract" xlink:to="rvsn_ScheduleOfOtherCurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OfficeFurnitureAndEquipment_lbl1" xml:lang="en-US">Office Furniture And Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OfficeFurnitureAndEquipment" xlink:to="rvsn_OfficeFurnitureAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_SubcontractedWorkAndConsulting_lbl1" xml:lang="en-US">Subcontracted Work And Consulting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SubcontractedWorkAndConsulting" xlink:to="rvsn_SubcontractedWorkAndConsulting_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionMember_lbl1" xml:lang="en-US">Options Held [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl0" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage_lbl0" xml:lang="en-US">Number Of Ordinary Shares And Warrants Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage" xlink:to="rvsn_NumberOfOrdinarySharesAndWarrantsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl1" xml:lang="en-US">Knorr Bremse Rail Systems Schweiz AGMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_KnorrBremseRailSystemsSchweizAGMember" xlink:to="rvsn_KnorrBremseRailSystemsSchweizAGMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FifthLeaseYearMember_lbl0" xml:lang="en-US">Fifth Lease Year Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FifthLeaseYearMember" xlink:to="rvsn_FifthLeaseYearMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract10" xlink:to="rvsn_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract11" xlink:to="rvsn_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract14" xlink:to="rvsn_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract15" xlink:to="rvsn_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accounts Payable, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract12" xlink:to="rvsn_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract13" xlink:to="rvsn_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl0" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_SeriesEMember_lbl0" xml:lang="en-US">Series EMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesEMember" xlink:to="rvsn_SeriesEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAMember_lbl0" xml:lang="en-US">Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAMember" xlink:to="us-gaap_SeriesAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DividendYields_lbl0" xml:lang="en-US">Dividend Yields</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DividendYields" xlink:to="rvsn_DividendYields_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract2" xlink:to="rvsn_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract1" xlink:to="rvsn_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract4" xlink:to="rvsn_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract3" xlink:to="rvsn_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract0" xlink:to="rvsn_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract9" xlink:to="rvsn_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract6" xlink:to="rvsn_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract5" xlink:to="rvsn_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract8" xlink:to="rvsn_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract7" xlink:to="rvsn_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Deposits_lbl0" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Deposits" xlink:to="us-gaap_Deposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_May112022Member_lbl0" xml:lang="en-US">May112022 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_May112022Member" xlink:to="rvsn_May112022Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl1" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_SeriesDMember_lbl0" xml:lang="en-US">Series DMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesDMember" xlink:to="rvsn_SeriesDMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnlabeledAbstract" xlink:to="rvsn_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent_lbl0" xml:lang="en-US">Other Liabilities and Deferred Revenue, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" xlink:to="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WarrantsPercentage_lbl0" xml:lang="en-US">Warrants Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WarrantsPercentage" xlink:to="rvsn_WarrantsPercentage_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_RevenuesFromRelatedParties_lbl0" xml:lang="en-US">Revenues From Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RevenuesFromRelatedParties" xlink:to="rvsn_RevenuesFromRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DevelopmentAndSales_lbl0" xml:lang="en-US">Development And Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DevelopmentAndSales" xlink:to="rvsn_DevelopmentAndSales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_October2020Member_lbl0" xml:lang="en-US">October2020 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_October2020Member" xlink:to="rvsn_October2020Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_RoyaltyPaymentsPercentage_lbl1" xml:lang="en-US">Royalty Payments Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RoyaltyPaymentsPercentage" xlink:to="rvsn_RoyaltyPaymentsPercentage_lbl1"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfTransactionsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfTransactionsAbstract_lbl" xml:lang="en-US">Schedule Of Transactions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfTransactionsAbstract" xlink:to="rvsn_ScheduleOfTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock_lbl0" xml:lang="en-US">Schedule Of General And Administrative Table Tex Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock" xlink:to="rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl1" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableOtherCurrent_lbl0" xml:lang="en-US">Accounts Payable, Other, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="us-gaap_AccountsPayableOtherCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GeneralandAdministrativeTablesLineItems_lbl0" xml:lang="en-US">Generaland Administrative Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GeneralandAdministrativeTablesLineItems" xlink:to="rvsn_GeneralandAdministrativeTablesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_LeasesDisclosureAbstract" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDisclosureAbstract_lbl" xml:lang="en-US">Leases Disclosure Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDisclosureAbstract" xlink:to="rvsn_LeasesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US">Stockholders&apos; Equity, Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ChangesDuring2020Abstract_lbl0" xml:lang="en-US">Changes During2020 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2020Abstract" xlink:to="rvsn_ChangesDuring2020Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesDisclosureTextBlock_lbl0" xml:lang="en-US">Leases Disclosure Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesDisclosureTextBlock" xlink:to="rvsn_LeasesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OrdinarySharesExercisedAmount_lbl1" xml:lang="en-US">Ordinary Shares Exercised Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExercisedAmount" xlink:to="rvsn_OrdinarySharesExercisedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FixedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Fixed Assets Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsPolicyTextBlock" xlink:to="rvsn_FixedAssetsPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_GrossProceeds_lbl1" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_GrossProceeds" xlink:to="rvsn_GrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DeferredTaxAssetsAbstract" xlink:to="rvsn_DeferredTaxAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_lbl0" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl0" xml:lang="en-US">Director [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfBalancesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfBalancesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfBalancesAbstract_lbl" xml:lang="en-US">Schedule Of Balances Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfBalancesAbstract" xlink:to="rvsn_ScheduleOfBalancesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_RiskFreeInterestRate_lbl1" xml:lang="en-US">Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_RiskFreeInterestRate" xlink:to="rvsn_RiskFreeInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesRelatedParty_lbl0" xml:lang="en-US">Costs and Expenses, Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesRelatedParty" xlink:to="us-gaap_CostsAndExpensesRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_September132022Member_lbl0" xml:lang="en-US">September132022 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_September132022Member" xlink:to="rvsn_September132022Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeveranceCosts1_lbl0" xml:lang="en-US">Severance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl0" xml:lang="en-US">Other Current Assets [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl0" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciation_lbl0" xml:lang="en-US">Cost, Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TwoThousandSeventeenPlanMember_lbl0" xml:lang="en-US">Two Thousand Seventeen Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TwoThousandSeventeenPlanMember" xlink:to="rvsn_TwoThousandSeventeenPlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage_lbl0" xml:lang="en-US">Payment Of Total Proceeds From Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage" xlink:to="rvsn_PaymentOfTotalProceedsFromConsiderationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementPlansPolicy_lbl0" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="us-gaap_PensionAndOtherPostretirementPlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_UnvestedOptionsPercentage_lbl1" xml:lang="en-US">Unvested Options Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_UnvestedOptionsPercentage" xlink:to="rvsn_UnvestedOptionsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl0" xml:lang="en-US">Temporary Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl0" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConversionOfAConvertibleDebt_lbl1" xml:lang="en-US">Conversion Of AConvertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfAConvertibleDebt" xlink:to="rvsn_ConversionOfAConvertibleDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl0" xml:lang="en-US">Cost of Goods and Services Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl0" xml:lang="en-US">Deferred Revenue, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TerminationLoans_lbl0" xml:lang="en-US">Termination Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TerminationLoans" xlink:to="us-gaap_TerminationLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl0" xml:lang="en-US">Restricted Cash, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeaseholdImprovements_lbl1" xml:lang="en-US">Leasehold Improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeaseholdImprovements" xlink:to="rvsn_LeaseholdImprovements_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl0" xml:lang="en-US">Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl1" xml:lang="en-US">Disclosure Of General And Administrative Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock" xlink:to="rvsn_DisclosureOfGeneralAndAdministrativeTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_PaymentOfMonthlyRemunerationAmount_lbl0" xml:lang="en-US">Payment Of Monthly Remuneration Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfMonthlyRemunerationAmount" xlink:to="rvsn_PaymentOfMonthlyRemunerationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod_lbl0" xml:lang="en-US">Weighted Average Exercise Price Exercisable At End Of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod" xlink:to="rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_SeriesCMember_lbl0" xml:lang="en-US">Series CMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SeriesCMember" xlink:to="rvsn_SeriesCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Exercisable At End Of Periodin Dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" xlink:to="rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl0" xml:lang="en-US">Schedule of Research and Development Assets Acquired Other than Through Business Combination [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_CostAbstract_lbl0" xml:lang="en-US">Cost Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_CostAbstract" xlink:to="rvsn_CostAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OrdinarySharesExpired_lbl1" xml:lang="en-US">Ordinary Shares Expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OrdinarySharesExpired" xlink:to="rvsn_OrdinarySharesExpired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl0" xml:lang="en-US">Stock Option, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FilmCosts_lbl0" xml:lang="en-US">Film, Capitalized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FilmCosts" xlink:to="us-gaap_FilmCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_TotalAmountPaid_lbl1" xml:lang="en-US">Total Amount Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_TotalAmountPaid" xlink:to="rvsn_TotalAmountPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ComputerSoftwareAndElectronicEquipment_lbl1" xml:lang="en-US">Computer Software And Electronic Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ComputerSoftwareAndElectronicEquipment" xlink:to="rvsn_ComputerSoftwareAndElectronicEquipment_lbl1"/>
    <loc xlink:type="locator" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DisclosureOfGeneralAndAdministrativeAbstract_lbl" xml:lang="en-US">Disclosure Of General And Administrative Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DisclosureOfGeneralAndAdministrativeAbstract" xlink:to="rvsn_DisclosureOfGeneralAndAdministrativeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_PaymentOfOperationalFunctionTest_lbl0" xml:lang="en-US">Payment Of Operational Function Test</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfOperationalFunctionTest" xlink:to="rvsn_PaymentOfOperationalFunctionTest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ServiceAgreementWithAConsultantDescription_lbl1" xml:lang="en-US">Service Agreement With AConsultant Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ServiceAgreementWithAConsultantDescription" xlink:to="rvsn_ServiceAgreementWithAConsultantDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities_lbl0" xml:lang="en-US">Schedule of Closed Block Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" xlink:to="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl0" xml:lang="en-US">Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ThirdAndFourthLeaseYearsMember_lbl0" xml:lang="en-US">Third And Fourth Lease Years Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ThirdAndFourthLeaseYearsMember" xlink:to="rvsn_ThirdAndFourthLeaseYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Research and Development [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Lease Term And Weighted Average Discount Rate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract" xlink:to="rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ChangesDuring2021Abstract_lbl0" xml:lang="en-US">Changes During2021 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ChangesDuring2021Abstract" xlink:to="rvsn_ChangesDuring2021Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod_lbl0" xml:lang="en-US">Weighted Average Remaining Contractual Life Outstanding At End Of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" xlink:to="rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfFixedAssetsNetAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfFixedAssetsNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfFixedAssetsNetAbstract_lbl" xml:lang="en-US">Schedule Of Fixed Assets Net Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfFixedAssetsNetAbstract" xlink:to="rvsn_ScheduleOfFixedAssetsNetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl0" xml:lang="en-US">Payments for Rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Public Utility Property, Plant, and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract_lbl" xml:lang="en-US">Schedule Of Total Share Based Payment Expense Related To Options Granted To Employees Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract" xlink:to="rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl0" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest_lbl0" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Imputed Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DeferredRevenuesInOtherAccountsPayable_lbl0" xml:lang="en-US">Deferred Revenues In Other Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DeferredRevenuesInOtherAccountsPayable" xlink:to="rvsn_DeferredRevenuesInOtherAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TravelAndEntertainmentExpense_lbl1" xml:lang="en-US">Travel and Entertainment Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TravelAndEntertainmentExpense" xlink:to="us-gaap_TravelAndEntertainmentExpense_lbl1"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfResearchAndDevelopmentAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfResearchAndDevelopmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfResearchAndDevelopmentAbstract_lbl" xml:lang="en-US">Schedule Of Research And Development Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfResearchAndDevelopmentAbstract" xlink:to="rvsn_ScheduleOfResearchAndDevelopmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_lbl0" xml:lang="en-US">Research and Development Expense, Software (Excluding Acquired in Process Cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OptionsExpire_lbl0" xml:lang="en-US">Options Expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionsExpire" xlink:to="rvsn_OptionsExpire_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US">Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment_lbl0" xml:lang="en-US">Impaired Financing Receivable, with No Related Allowance, Average Recorded Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" xlink:to="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_AmortizedOver_lbl0" xml:lang="en-US">Amortized Over</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AmortizedOver" xlink:to="rvsn_AmortizedOver_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FixedAssetsNetTablesLineItems_lbl0" xml:lang="en-US">Fixed Assets Net Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FixedAssetsNetTablesLineItems" xlink:to="rvsn_FixedAssetsNetTablesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesTextBlock_lbl0" xml:lang="en-US">Convertible Preferred Shares Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesTextBlock" xlink:to="rvsn_ConvertiblePreferredSharesTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_OptionToPurchaseOrdinaryShares_lbl0" xml:lang="en-US">Option To Purchase Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_OptionToPurchaseOrdinaryShares" xlink:to="rvsn_OptionToPurchaseOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_PaymentOfTotalProceedFromConsiderationPercentage_lbl0" xml:lang="en-US">Payment Of Total Proceed From Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_PaymentOfTotalProceedFromConsiderationPercentage" xlink:to="rvsn_PaymentOfTotalProceedFromConsiderationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_AggregateSharesIssued_lbl1" xml:lang="en-US">Aggregate Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AggregateSharesIssued" xlink:to="rvsn_AggregateSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostMaintenance_lbl0" xml:lang="en-US">Cost, Maintenance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMaintenance" xlink:to="us-gaap_CostMaintenance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription_lbl0" xml:lang="en-US">Securities Sold under Agreements to Repurchase, Measurement Difference Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfGeneralAndAdministrativeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfGeneralAndAdministrativeAbstract_lbl" xml:lang="en-US">Schedule Of General And Administrative Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfGeneralAndAdministrativeAbstract" xlink:to="rvsn_ScheduleOfGeneralAndAdministrativeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars_lbl0" xml:lang="en-US">Number Of Options Exercisable At End Of Periodin Dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars" xlink:to="rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl1" xml:lang="en-US">Stock Issued During Period Conversion Of Convertible Debt Into Ordinary Shares Upon Completion Of Initial Public Offering Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ConvertiblePreferredSharesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConvertiblePreferredSharesAbstract_lbl" xml:lang="en-US">Convertible Preferred Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConvertiblePreferredSharesAbstract" xlink:to="rvsn_ConvertiblePreferredSharesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_AccumulatedDepreciationAbstract_lbl0" xml:lang="en-US">Accumulated Depreciation Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AccumulatedDepreciationAbstract" xlink:to="rvsn_AccumulatedDepreciationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl1" xml:lang="en-US">Decrease Of Deferred Expenses Against Additional Paid In Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:to="rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_EmployeesMember_lbl0" xml:lang="en-US">Employees Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_EmployeesMember" xlink:to="rvsn_EmployeesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl0" xml:lang="en-US">Stock Repurchased During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl0" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="rvsn_ScheduleOfDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl1" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl0" xml:lang="en-US">Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCostsNet_lbl0" xml:lang="en-US">Other Deferred Costs, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCostsNet" xlink:to="us-gaap_OtherDeferredCostsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl1" xml:lang="en-US">Sharebased Payment Expenses Related To Nonvested Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:to="rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_November32020Member_lbl0" xml:lang="en-US">November32020 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_November32020Member" xlink:to="rvsn_November32020Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_AggregateOrdinaryShares_lbl0" xml:lang="en-US">Aggregate Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_AggregateOrdinaryShares" xlink:to="rvsn_AggregateOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1" xml:lang="en-US">Stock Issued During Period Conversion Of Convertible Debt Into Ordinary Shares Upon Completion Of Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:to="rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FutureLeasePayments_lbl0" xml:lang="en-US">Future Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FutureLeasePayments" xlink:to="rvsn_FutureLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_InvestmentAgreementDescription_lbl1" xml:lang="en-US">Investment Agreement Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestmentAgreementDescription" xlink:to="rvsn_InvestmentAgreementDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl1" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_InvestedAgreement_lbl1" xml:lang="en-US">Invested Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_InvestedAgreement" xlink:to="rvsn_InvestedAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_LeasesTablesLineItems_lbl0" xml:lang="en-US">Leases Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_LeasesTablesLineItems" xlink:to="rvsn_LeasesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ConversionOfPreferredShares_lbl1" xml:lang="en-US">Conversion Of Preferred Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ConversionOfPreferredShares" xlink:to="rvsn_ConversionOfPreferredShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherAccountsPayableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfOtherAccountsPayableAbstract_lbl" xml:lang="en-US">Schedule Of Other Accounts Payable Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfOtherAccountsPayableAbstract" xlink:to="rvsn_ScheduleOfOtherAccountsPayableAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_NetProceeds_lbl1" xml:lang="en-US">Net Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_NetProceeds" xlink:to="rvsn_NetProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessStockSharesIssued_lbl0" xml:lang="en-US">Excess Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesIssued" xlink:to="us-gaap_ExcessStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl0" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_FinancialStatementPolicyTextBlock_lbl1" xml:lang="en-US">Financial Statement Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_FinancialStatementPolicyTextBlock" xlink:to="rvsn_FinancialStatementPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <loc xlink:type="locator" xlink:label="rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract_lbl" xml:lang="en-US">Schedule Of Future Lease Payments Under Operating Leases Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="rvsn_ExercisePrice_lbl0" xml:lang="en-US">Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="rvsn_ExercisePrice" xlink:to="rvsn_ExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>rvsn-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 23 13:30:36 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedBalanceSheet" roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedIncomeStatement" roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityType2or3" roleURI="http://www.RailVision.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConsolidatedCashFlow" roleURI="http://www.RailVision.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_General" roleURI="http://www.RailVision.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SignificantAccountingPolicies" roleURI="http://www.RailVision.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherCurrentAssets" roleURI="http://www.RailVision.com/role/OtherCurrentAssets"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNet" roleURI="http://www.RailVision.com/role/FixedAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherAccountsPayable" roleURI="http://www.RailVision.com/role/OtherAccountsPayable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_CommitmentsandContingenciesLiabilities" roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConvertiblePreferredShares" roleURI="http://www.RailVision.com/role/ConvertiblePreferredShares"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquity" roleURI="http://www.RailVision.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ResearchandDevelopmentNet" roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNet"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_GeneralandAdministrative" roleURI="http://www.RailVision.com/role/GeneralandAdministrative"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncome" roleURI="http://www.RailVision.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedParties" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_Leases" roleURI="http://www.RailVision.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SubsequentEvents" roleURI="http://www.RailVision.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_AccountingPoliciesByPolicy" roleURI="http://www.RailVision.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SignificantAccountingPoliciesTables" roleURI="http://www.RailVision.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherCurrentAssetsTables" roleURI="http://www.RailVision.com/role/OtherCurrentAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNetTables" roleURI="http://www.RailVision.com/role/FixedAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_OtherAccountsPayableTables" roleURI="http://www.RailVision.com/role/OtherAccountsPayableTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityTables" roleURI="http://www.RailVision.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ResearchandDevelopmentNetTables" roleURI="http://www.RailVision.com/role/ResearchandDevelopmentNetTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_GeneralandAdministrativeTables" roleURI="http://www.RailVision.com/role/GeneralandAdministrativeTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncomeTables" roleURI="http://www.RailVision.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedPartiesTables" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_LeasesTables" roleURI="http://www.RailVision.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofothercurrentassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoffixedassetsnetTable" roleURI="http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofotheraccountspayableTable" roleURI="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" roleURI="http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" roleURI="http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofresearchanddevelopmentTable" roleURI="http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofgeneralandadministrativeTable" roleURI="http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofdeferredtaxassetsTable" roleURI="http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoftransactionsTable" roleURI="http://www.RailVision.com/role/ScheduleoftransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofbalancesTable" roleURI="http://www.RailVision.com/role/ScheduleofbalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable" roleURI="http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" roleURI="http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_FixedAssetsNetDetails" roleURI="http://www.RailVision.com/role/FixedAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_CommitmentsandContingenciesLiabilitiesDetails" roleURI="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ConvertiblePreferredSharesDetails" roleURI="http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_ShareholdersEquityDetails" roleURI="http://www.RailVision.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TaxesonIncomeDetails" roleURI="http://www.RailVision.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_TransactionsandBalanceswithRelatedPartiesDetails" roleURI="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_LeasesDetails" roleURI="http://www.RailVision.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#rvsn_r_SubsequentEventsDetails" roleURI="http://www.RailVision.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="rvsn-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.RailVision.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockSharesIssued1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" xlink:href="rvsn-20221231.xsd#rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInOperatingLeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ChangeInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ChangeInOperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ObtainingARightofuseAssetInExchangeForALeaseLiability" xlink:href="rvsn-20221231.xsd#rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ObtainingARightofuseAssetInExchangeForALeaseLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfPreferredShares" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfPreferredShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ConversionOfPreferredShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfAConvertibleDebt" xlink:href="rvsn-20221231.xsd#rvsn_ConversionOfAConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ConversionOfAConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" xlink:href="rvsn-20221231.xsd#rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/General">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralTable"/>
    <loc xlink:type="locator" xlink:label="GeneralLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="GeneralTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralTable" xlink:to="GeneralLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherCurrentAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNet">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsNetTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTable"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsNetLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="FixedAssetsNetTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsNetTable" xlink:to="FixedAssetsNetLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsNetLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherAccountsPayable">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConvertiblePreferredShares">
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTable"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesAbstract" xlink:to="ConvertiblePreferredSharesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesTable" xlink:to="ConvertiblePreferredSharesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesLineItems" xlink:to="ConvertiblePreferredSharesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquity">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ResearchandDevelopmentNet">
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/GeneralandAdministrative">
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralAndAdministrativeAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTable"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralAndAdministrativeAbstract" xlink:to="GeneralandAdministrativeTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeTable" xlink:to="GeneralandAdministrativeLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralAndAdministrativeTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeLineItems" xlink:to="DisclosureOfGeneralAndAdministrativeTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/Leases">
    <loc xlink:type="locator" xlink:label="LeasesDisclosureAbstract" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTable"/>
    <loc xlink:type="locator" xlink:label="LeasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDisclosureAbstract" xlink:to="LeasesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesTable" xlink:to="LeasesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="LeasesDisclosureTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesLineItems" xlink:to="LeasesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialStatementPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FinancialStatementPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FinancialStatementPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsPolicyTextBlock" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="FixedAssetsPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementPlansPolicy" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherCurrentAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsNetTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesTable"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsNetTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_FixedAssetsNetTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="FixedAssetsNetTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsNetTablesTable" xlink:to="FixedAssetsNetTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsNetTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/OtherAccountsPayableTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ResearchandDevelopmentNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/GeneralandAdministrativeTables">
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralAndAdministrativeAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DisclosureOfGeneralAndAdministrativeAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesTable"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfGeneralAndAdministrativeAbstract" xlink:to="GeneralandAdministrativeTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeTablesTable" xlink:to="GeneralandAdministrativeTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfGeneralAndAdministrativeTableTexBlock" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeTablesLineItems" xlink:to="ScheduleOfGeneralAndAdministrativeTableTexBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="LeasesDisclosureAbstract" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesTablesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesTable"/>
    <loc xlink:type="locator" xlink:label="LeasesTablesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDisclosureAbstract" xlink:to="LeasesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesTablesTable" xlink:to="LeasesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesTablesLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesTablesLineItems" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OfficeFurnitureAndEquipment" xlink:href="rvsn-20221231.xsd#rvsn_OfficeFurnitureAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="OfficeFurnitureAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ComputerSoftwareAndElectronicEquipment" xlink:href="rvsn-20221231.xsd#rvsn_ComputerSoftwareAndElectronicEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="ComputerSoftwareAndElectronicEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LaboratoryEquipment" xlink:href="rvsn-20221231.xsd#rvsn_LaboratoryEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="LaboratoryEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseholdImprovements" xlink:href="rvsn-20221231.xsd#rvsn_LeaseholdImprovements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems" xlink:to="LeaseholdImprovements" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofothercurrentassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherCurrentAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherCurrentAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_GovernmentContractReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Deposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_Deposits" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDeferredCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDeferredCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherDeferredCostsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentAssetsAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoffixedassetsnetTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFixedAssetsNetAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfFixedAssetsNetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFixedAssetsNetAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_EquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofotheraccountspayableTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherAccountsPayableAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOtherAccountsPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherAccountsPayableAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrentAndNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract" xlink:to="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable" xlink:to="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZugr+e48WYbLTD7KJWiWAqfpRYHno6M70nHmE7zHxxcTOu4JiMTAci6EBuGJ+tgrhYTQCxpWKtRvlWy4Ovax070oM9fCRgnSe2JAFkwa37H5CQSYpFfDPcIQDhCX/gC7zJw/QECMfVc1bo6Vbj5LijpLu7Ln/2Izp/CjjQu2XSfjKolYS+We2Ap2xuiG0eNXOsoxJ6LDTcew==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="NumberOfOptionsExercisableAtEndOfPeriodinDollars" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageExercisePriceExercisableAtEndOfPeriod" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="WeightedAverageExercisePriceExercisableAtEndOfPeriod" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" xlink:href="rvsn-20221231.xsd#rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems" xlink:to="WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract" xlink:to="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable" xlink:to="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_CostOfRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfResearchAndDevelopmentAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfResearchAndDevelopmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentAbstract" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable" xlink:to="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostMaintenance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostMaintenance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_CostMaintenance" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_Depreciation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubcontractedWorkAndConsulting" xlink:href="rvsn-20221231.xsd#rvsn_SubcontractedWorkAndConsulting"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="SubcontractedWorkAndConsulting" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGeneralAndAdministrativeAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfGeneralAndAdministrativeAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable"/>
    <loc xlink:type="locator" xlink:label="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:href="rvsn-20221231.xsd#rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeneralAndAdministrativeAbstract" xlink:to="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable" xlink:to="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_CostsAndExpensesRelatedParty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_ProfessionalFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_TravelAndEntertainmentExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostMaintenance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostMaintenance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_CostMaintenance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_MarketingExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoftransactionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionsAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenuesFromRelatedParties" xlink:href="rvsn-20221231.xsd#rvsn_RevenuesFromRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsAbstract" xlink:to="RevenuesFromRelatedParties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsAbstract" xlink:to="us-gaap_SeveranceCosts1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsAbstract" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofbalancesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBalancesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable"/>
    <loc xlink:type="locator" xlink:label="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalancesAbstract" xlink:to="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MemberUnitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MemberUnitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_MemberUnitsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable" xlink:to="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems" xlink:to="us-gaap_OtherAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable" xlink:to="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FutureLeasePayments" xlink:href="rvsn-20221231.xsd#rvsn_FutureLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="FutureLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract" xlink:to="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable" xlink:to="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/FixedAssetsNetDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="KnorrBremseRailSystemsSchweizAGMember" xlink:href="rvsn-20221231.xsd#rvsn_KnorrBremseRailSystemsSchweizAGMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="KnorrBremseRailSystemsSchweizAGMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsTable" xlink:to="CommitmentsandContingenciesLiabilitiesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PeriodOfFirstCommercialSales" xlink:href="rvsn-20221231.xsd#rvsn_PeriodOfFirstCommercialSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="PeriodOfFirstCommercialSales" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyPaymentsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_RoyaltyPaymentsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="RoyaltyPaymentsPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfTotalProceedsFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedsFromConsiderationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="PaymentOfTotalProceedsFromConsiderationPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfTotalProceedFromConsiderationPercentage" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfTotalProceedFromConsiderationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="PaymentOfTotalProceedFromConsiderationPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionToPurchaseOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_OptionToPurchaseOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="OptionToPurchaseOrdinaryShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ServiceAgreementWithAConsultantDescription" xlink:href="rvsn-20221231.xsd#rvsn_ServiceAgreementWithAConsultantDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="ServiceAgreementWithAConsultantDescription" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="ExercisePrice" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfMonthlyRemunerationAmount" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfMonthlyRemunerationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="PaymentOfMonthlyRemunerationAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalAmountPaid" xlink:href="rvsn-20221231.xsd#rvsn_TotalAmountPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="TotalAmountPaid" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DevelopmentAndSales" xlink:href="rvsn-20221231.xsd#rvsn_DevelopmentAndSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="DevelopmentAndSales" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfOperationalFunctionTest" xlink:href="rvsn-20221231.xsd#rvsn_PaymentOfOperationalFunctionTest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="PaymentOfOperationalFunctionTest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_OtherExpenses" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredRevenuesInOtherAccountsPayable" xlink:href="rvsn-20221231.xsd#rvsn_DeferredRevenuesInOtherAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="DeferredRevenuesInOtherAccountsPayable" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FilmCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FilmCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_FilmCosts" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesLiabilitiesDetailsLineItems" xlink:to="us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ConvertiblePreferredSharesDetails">
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesAbstract" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredSharesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ConvertiblePreferredSharesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesAbstract" xlink:to="ConvertiblePreferredSharesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsTable" xlink:to="ConvertiblePreferredSharesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_NetInvestmentIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentAgreementDescription" xlink:href="rvsn-20221231.xsd#rvsn_InvestmentAgreementDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="InvestmentAgreementDescription" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertiblePreferredSharesDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/ShareholdersEquityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_ShareholdersEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EmployeesMember" xlink:href="rvsn-20221231.xsd#rvsn_EmployeesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="EmployeesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_DirectorMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_ChiefExecutiveOfficerMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSeventeenPlanMember" xlink:href="rvsn-20221231.xsd#rvsn_TwoThousandSeventeenPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="TwoThousandSeventeenPlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_OptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesCMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesCMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesDMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesDMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesDMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesEMember" xlink:href="rvsn-20221231.xsd#rvsn_SeriesEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesEMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="October2020Member" xlink:href="rvsn-20221231.xsd#rvsn_October2020Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="October2020Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="November32020Member" xlink:href="rvsn-20221231.xsd#rvsn_November32020Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="November32020Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="May112022Member" xlink:href="rvsn-20221231.xsd#rvsn_May112022Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="May112022Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="September132022Member" xlink:href="rvsn-20221231.xsd#rvsn_September132022Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="September132022Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_RangeAxis" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="ShareholdersEquityDetailsLineItems" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="GrossProceeds" xlink:href="rvsn-20221231.xsd#rvsn_GrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="GrossProceeds" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateSharesIssued" xlink:href="rvsn-20221231.xsd#rvsn_AggregateSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="AggregateSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPurchase" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPurchase"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="WarrantsPurchase" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesExpired" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExpired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="OrdinarySharesExpired" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesExercisedAmount" xlink:href="rvsn-20221231.xsd#rvsn_OrdinarySharesExercisedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="OrdinarySharesExercisedAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateOrdinaryShares" xlink:href="rvsn-20221231.xsd#rvsn_AggregateOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="AggregateOrdinaryShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestedAgreement" xlink:href="rvsn-20221231.xsd#rvsn_InvestedAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="InvestedAgreement" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="WarrantsPercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendsShares" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsDescription" xlink:href="rvsn-20221231.xsd#rvsn_WarrantsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="WarrantsDescription" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceeds" xlink:href="rvsn-20221231.xsd#rvsn_NetProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="NetProceeds" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOrdinarySharesAndWarrantsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_NumberOfOrdinarySharesAndWarrantsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="NumberOfOrdinarySharesAndWarrantsPercentage" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RiskFreeInterestRate" xlink:href="rvsn-20221231.xsd#rvsn_RiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="RiskFreeInterestRate" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DividendYields" xlink:href="rvsn-20221231.xsd#rvsn_DividendYields"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="DividendYields" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePricePerShares" xlink:href="rvsn-20221231.xsd#rvsn_ExercisePricePerShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="ExercisePricePerShares" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizedOver" xlink:href="rvsn-20221231.xsd#rvsn_AmortizedOver"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="AmortizedOver" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceIncrease" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsExpire" xlink:href="rvsn-20221231.xsd#rvsn_OptionsExpire"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="OptionsExpire" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedPaymentExpensesRelatedToNonvestedAwards" xlink:href="rvsn-20221231.xsd#rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="SharebasedPaymentExpensesRelatedToNonvestedAwards" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" xlink:href="rvsn-20221231.xsd#rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_OtherExpenses" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TerminationLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TerminationLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_TerminationLoans" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsGrantedDescription" xlink:href="rvsn-20221231.xsd#rvsn_OptionsGrantedDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="OptionsGrantedDescription" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnvestedOptionsPercentage" xlink:href="rvsn-20221231.xsd#rvsn_UnvestedOptionsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="UnvestedOptionsPercentage" order="41.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="42.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" order="43.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsLineItems" xlink:to="us-gaap_OtherNoncashExpense" order="44.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TaxesonIncomeDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="TaxesonIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="TaxesonIncomeDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="TransactionsandBalanceswithRelatedPartiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_ChiefExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsTable" xlink:to="TransactionsandBalanceswithRelatedPartiesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransactionsandBalanceswithRelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="LeasesDisclosureAbstract" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsTable" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LeasesDetailsLineItems" xlink:href="rvsn-20221231.xsd#rvsn_LeasesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDisclosureAbstract" xlink:to="LeasesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstTwoYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_FirstTwoYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="FirstTwoYearsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdAndFourthLeaseYearsMember" xlink:href="rvsn-20221231.xsd#rvsn_ThirdAndFourthLeaseYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="ThirdAndFourthLeaseYearsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FifthLeaseYearMember" xlink:href="rvsn-20221231.xsd#rvsn_FifthLeaseYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="FifthLeaseYearMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsTable" xlink:to="LeasesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_PaymentsForRent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseExpirationDate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesDetailsLineItems" xlink:to="us-gaap_BenefitsLossesAndExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.RailVision.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="rvsn-20221231.xsd#rvsn_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503653120560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RAIL
VISION LTD.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RVSN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">16,091,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001743905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15
Ha&#8217;Tidhar St<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ra&#8217;anana<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4366517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Brightman Almagor Zohar & Co.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15
Ha&#8217;Tidhar St<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ra&#8217;anana<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">4366517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Shahar
Hania<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+972-9-957-7706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">972-9-957-7706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">marketing@railvision.io<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646055984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,270<span></span>
</td>
<td class="nump">$ 1,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">8,832<span></span>
</td>
<td class="nump">2,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease - right of use asset</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">1,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Fixed assets, net</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non current assets</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">10,432<span></span>
</td>
<td class="nump">4,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade accounts payable</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts payable</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,369<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liability</a></td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,221<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,167<span></span>
</td>
<td class="nump">2,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred A shares, NIS 0.01 par value; Authorized 100,000 shares; Issued and outstanding: No shares as at December 31, 2022 and 51,282 shares as of December 31, 2021;</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity (deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, NIS 0.01 par value; Authorized 99,900,000 shares; Issued and outstanding: 15,896,040 and 9,157,324 shares as of December 31, 2022 and 2021</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">63,033<span></span>
</td>
<td class="nump">35,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(54,814)<span></span>
</td>
<td class="num">(44,339)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity (deficit)</a></td>
<td class="nump">8,265<span></span>
</td>
<td class="num">(8,327)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 10,432<span></span>
</td>
<td class="nump">$ 4,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646928944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred A shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred A shares, authorized</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred A shares, issued</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">51,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred A shares, outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">51,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, authorized</a></td>
<td class="nump">99,900,000<span></span>
</td>
<td class="nump">99,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="nump">15,896,040<span></span>
</td>
<td class="nump">9,157,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">15,896,040<span></span>
</td>
<td class="nump">9,157,324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652935120">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 421<span></span>
</td>
<td class="nump">$ 888<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(661)<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(240)<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,230)<span></span>
</td>
<td class="num">(7,208)<span></span>
</td>
<td class="num">(7,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,265)<span></span>
</td>
<td class="num">(3,316)<span></span>
</td>
<td class="num">(3,500)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,735)<span></span>
</td>
<td class="num">(10,293)<span></span>
</td>
<td class="num">(10,705)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income (expenses), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">260<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10,475)<span></span>
</td>
<td class="num">$ (10,220)<span></span>
</td>
<td class="num">$ (10,707)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted loss per ordinary share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
<td class="num">$ (1.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share(*) (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14,174,422<span></span>
</td>
<td class="nump">9,148,143<span></span>
</td>
<td class="nump">9,136,600<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646886480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Comprehensive Loss (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Basic and diluted loss per ordinary share (in Dollars per share)</a></td>
<td class="num">$ (0.74)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
<td class="num">$ (1.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share</a></td>
<td class="nump">14,174,422<span></span>
</td>
<td class="nump">9,148,143<span></span>
</td>
<td class="nump">9,136,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644754000">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Statements of Convertible Preferred Shares and Changes in Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Convertible Preferred A Shares</div></th>
<th class="th" colspan="2"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 33,052<span></span>
</td>
<td class="num">$ (23,412)<span></span>
</td>
<td class="nump">$ 9,665<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,136,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of convertible preferred shares, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 4,965<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of convertible preferred shares, net of issuance costs (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">51,282<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,949<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,707)<span></span>
</td>
<td class="num">(10,707)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,965<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">35,001<span></span>
</td>
<td class="num">(34,119)<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51,282<span></span>
</td>
<td class="nump">9,136,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Issuance of convertible preferred shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Issuance of convertible preferred shares (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of shares as a result of exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">127<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of shares as a result of exercise of options (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">859<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,220)<span></span>
</td>
<td class="num">(10,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,965<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">35,987<span></span>
</td>
<td class="num">(44,339)<span></span>
</td>
<td class="num">(8,327)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51,282<span></span>
</td>
<td class="nump">9,157,324<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Issuance of convertible preferred shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Issuance of convertible preferred shares (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,256<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (11,965)<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">11,957<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(61,538)<span></span>
</td>
<td class="nump">2,707,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">13,575<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,787,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering', window );">Conversion of convertible debt into ordinary shares upon completion of initial public offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">999<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares', window );">Conversion of convertible debt into ordinary shares upon completion of initial public offering (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">242,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of shares as a result of exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">10<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of shares as a result of exercise of options (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based payment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,475)<span></span>
</td>
<td class="num">(10,475)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">(in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 63,033<span></span>
</td>
<td class="num">$ (54,814)<span></span>
</td>
<td class="nump">$ 8,265<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,896,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C)</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Issuance costs in the amount of approximately $35.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Represents an amount less than $1.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Retroactively adjusted to reflect the issuance of bonus shares effected on February 13, 2022 (see note 1C)</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Issuance costs in the amount of approximately $2,060.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is conversion of convertible debt into ordinary shares upon completion of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares conversion of convertible debt into ordinary shares upon completion of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647005088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Loss for the year</a></td>
<td class="num">$ (10,475)<span></span>
</td>
<td class="num">$ (10,220)<span></span>
</td>
<td class="num">$ (10,707)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based payment</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">2,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ChangeInOperatingLeaseLiability', window );">Change in operating lease liability</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Decrease (increase) in other current assets</a></td>
<td class="nump">163<span></span>
</td>
<td class="num">(381)<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Increase (decrease) in trade accounts payable</a></td>
<td class="num">(83)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Increase (decrease) in other accounts payable</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(540)<span></span>
</td>
<td class="nump">973<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(9,981)<span></span>
</td>
<td class="num">(9,948)<span></span>
</td>
<td class="num">(7,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Issuance of preferred A shares</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">4,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from a convertible debt</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of ordinary shares and warrants, net of issuance expenses</a></td>
<td class="nump">13,643<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">16,653<span></span>
</td>
<td class="nump">5,127<span></span>
</td>
<td class="nump">4,965<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">6,643<span></span>
</td>
<td class="num">(5,094)<span></span>
</td>
<td class="num">(2,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">1,849<span></span>
</td>
<td class="nump">6,943<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">8,492<span></span>
</td>
<td class="nump">1,849<span></span>
</td>
<td class="nump">6,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non Cash Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability', window );">Obtaining a right-of-use asset in exchange for a lease liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConversionOfPreferredShares', window );">Conversion of preferred shares</a></td>
<td class="nump">11,965<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConversionOfAConvertibleDebt', window );">Conversion of a convertible debt</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital', window );">Decrease of deferred expenses against additional paid in capital</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ChangeInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of change in operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ChangeInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ConversionOfAConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of conversion of a convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ConversionOfAConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ConversionOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of conversion of preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ConversionOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of deferred expenses against additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obtaining a right-of-use asset in exchange for a lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644616032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GeneralLineItems', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 - GENERAL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>A</b>.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Reporting Entity:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Rail Vision Ltd. (the &#8220;Company&#8221;)
was incorporated and registered in Israel on April 18, 2016. The Company is a development-stage technology Company that is engaged in
the design, development and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency
and predictive maintenance. The Company&#8217;s railway detection systems include different types of cameras, including optics, visible
light spectrum cameras (video) and thermal cameras that transmit data to a ruggedized on-board computer which is designed to be suitable
for the rough environment of a train&#8217;s locomotive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s ordinary shares and
warrants began trading on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) on March 31, 2022, under the symbols &#8220;RVSN&#8221; and
&#8220;RVSNW,&#8221; respectively (see Note 8B (8) below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company&#8217;s activities are
subject to significant risks and uncertainties. The Company has incurred significant losses since the date of its inception and anticipates
that it will continue to incur significant losses until it will be able to successfully commercialize its products. Failure to obtain
this necessary capital when needed may force the Company to delay, limit or terminate its product development efforts or other operations.&#160;In
addition, the Company is subject to risks including, among other things, competition associated with the industry in general, risks associated
with financing, liquidity requirements, rapidly changing customer requirements, the loss of key personnel and the effect of planned expansion
of operations on the future results of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>B.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Going Concern:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">To date, the Company has not generated
significant revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to
generate substantial operating losses and to continue to fund its operations primarily through the utilization of its current financial
resources, sales of its products, and through additional raises of capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Such conditions raise substantial
doubts about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plan includes raising funds from existing shareholders
and/or outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained
on terms favorable to the Company or will provide the Company with sufficient funds to successfully complete the development of, and
to commercialize, its products. These financial statements do not include any adjustments relating to the recoverability and classification
of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue
as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>C.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Issuance of bonus shares:</b></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On February 13, 2022, the Company
effected a bonus shares issuances under Israeli law to reflect the effect of 44-for-1 forward share split of the Company&#8217;s ordinary
shares. Accordingly, (i) for each one share of outstanding ordinary shares, 43 additional ordinary shares were issued and distributed
to the holder thereof; (ii) the number of ordinary shares issuable upon the exercise of each outstanding convertible preferred shares,
warrant and option was proportionately increased by 43 additional ordinary shares; (iii) the exercise price of each outstanding option
to purchase ordinary shares was proportionately adjusted; (iv) the authorized number of ordinary shares was increased in order to reflect
such issuance of bonus shares; and (v) the par value of ordinary shares was not adjusted as result of this issuance of bonus shares.
All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the
issuance of the bonus shares.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_GeneralLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_GeneralLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503740214816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 - SIGNIFICANT ACCOUNTING
POLICIES </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>Basis of Presentation:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The financial statements have been
prepared in conformity with accounting principles generally accepted in United Sates of America (&#8220;US GAAP&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements
and accompanying notes. The Company&#8217;s management believes that the estimates, judgments and assumptions used are reasonable based
upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures
made. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>C.</b></td><td style="text-align: justify"><b>Financial statement in U.S. dollars:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The functional currency of the Company
is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;) since the dollar is the currency of the primary economic environment in which
the Company has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Transactions and balances denominated
in dollars are presented at their original amounts. Transactions and balances denominated in foreign currencies have been re-measured
to dollars.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">All transaction gains and losses
from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of comprehensive
loss as financial income or expenses, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 129pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>D.</b></td><td style="text-align: justify"><b>Cash and cash equivalents and restricted cash:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Cash equivalents are short-term highly
liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired, readily convertible
to known amounts of cash and subject to an insignificant risk. Restricted cash consists of deposits pledged to a bank that provided guarantee
in connection with an operating lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>E.</b></td><td style="text-align: justify"><b>Fair value of financial instruments:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The carrying values of cash and cash
equivalents, restricted cash, trade accounts payable, accrued expenses and employees and related expenses recorded in other accounts
payable, approximate their fair value due to the short-term maturity of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; defines fair value as the price that would be received from selling an
asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining
the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or
most advantageous market in which it would transact. The Company also considers assumptions that market participants would use when pricing
the asset or liability, such as, inherent risk, transfer restrictions and risk of nonperformance.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Fixed assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful
lives of the assets. The annual depreciation rates are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">%</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 69%; text-align: left">Computer software and electronic equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 28%; text-align: center">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Over the shorter of the lease term (including the option) or useful life</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>G.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">The
Company&#8217;s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired,
the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During
2022 and 2021, no impairment losses were recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>H.</b></td><td style="text-align: justify"><b>Accrued post-employment benefit:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under Israeli employment laws, employees
of the Company are covered under Section 14 of the Severance Compensation Act, 1963 (&#8220;Section 14&#8221;) for a portion of their salaries.
According to Section 14, these employees are entitled to receive monthly deposits (payments) made by the Company on their behalf with
insurance companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Payments in accordance with Section
14 release the Company from any future severance payments (under the Israeli Severance Compensation Act, 1963) with respect of those
employees. The obligation to make the monthly deposits is expensed as incurred. In addition, the aforementioned deposits are not recorded
as an asset in the Company&#8217;s balance sheet, and there is no liability recorded as the Company does not have a future obligation to make
any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>I.</b></td><td style="text-align: justify"><b>Revenue recognition:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company applies ASC 606 &#8220;Revenue
from contracts with customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, revenue is measured as the amount of consideration the Company
expects to be entitled to, in exchange for transferring products or providing services to its customers and is recognized when or as
performance obligations under the terms of contracts with the Company&#8217;s customers are satisfied. ASC 606 prescribes a five-step
model for recognizing revenue from contracts with customers: (i) identify contract(s) with the customer; (ii) identify the separate performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the separate performance obligations
in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are
distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined
with other promised goods and services. The Company then allocates the transaction price (the amount of consideration the Company expects
to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated
revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenues from product sales are recognized
upon the transfer of control, which is generally upon shipment or delivery.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Deferred revenue represents amounts
received by the Company for which the related revenues have not been recognized because one or more of the revenue recognition criteria
have not been met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The current portion of deferred revenue
represents the amount to be recognized within one year from the balance sheet date based on the estimated performance period of the underlying
performance obligation, see Note 5 below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>J.</b></td><td style="text-align: justify"><b>Share-based payment:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company
applies ASC 718-10, &#8220;Share-Based Payment,&#8221; (&#8220;ASC 718-10&#8221;) which requires the measurement and recognition of compensation
expenses for all share-based payment awards granted to employees and directors including share options granted under the Company&#8217;s incentive
share option plan based on estimated fair values<b>.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 167.8pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 718-10 requires companies to
estimate the fair value of share-based payment awards on the date of grant. The portion of the grant-date fair value of the share-based
payment award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s statements
of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company estimates the fair value of share options granted as share-based payment awards using a Black-Scholes option pricing model.
The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are share price, expected volatility
and the expected option term (the time from the grant date until the options are exercised or expire).&#160;Expected volatility is estimated
based on volatility of similar companies in the technology sector. The expected option term is calculated for options granted to employees
and directors using the &#8220;simplified&#8221; method, and grants to non-employees are based on the contractual term.&#160;The Company
has historically not paid dividends and has no foreseeable plans to pay dividends. The risk-free interest rate is based on the yield
from Israel Treasury zero-coupon bonds with an equivalent term. Changes in the determination of each of the inputs can affect the fair
value of the share options granted and the results of operations of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>K.</b></td><td style="text-align: justify"><b>Leases:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On January 1, 2019, the Company early
adopted ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements
as of such date. The Company leases office space and vehicles under operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Operating leases are included in
operating lease right of use (&#8220;ROU&#8221;) assets and operating lease liabilities in the Company&#8217;s balance sheets. ROU assets represent
the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining
lease payments over the lease term. The Company&#8217;s incremental borrowing rate is used in determining the present value of lease
payments because rate implicit in the Company&#8217;s leases is not readily determinable. The operating lease ROU asset excludes lease incentives.
The expected lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised.
Operating lease expense for is recognized on a straight-line basis over the lease term, variable payments are expensed in the periods
incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company has made an accounting
policy election not to recognize ROU assets and lease liabilities that arise from leases with initial terms of 12 months or less. Instead,
the Company continues to record such lease expenses on a straight-line basis over the lease term in the statements of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>L.</b></td><td style="text-align: justify"><b>Research and development expenses, net:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Research and development expenses,
net, are charged to the statements of comprehensive loss as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>M.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Basic loss per ordinary share is
computed by dividing the net loss by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share
is computed by dividing the net loss by the weighted average number of ordinary shares outstanding plus the number of additional ordinary
shares that would have been outstanding if all potentially dilutive ordinary shares had been issued, using the treasury stock method.
Potentially dilutive ordinary shares were excluded from the diluted loss per share calculation because they were anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647708512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">OTHER CURRENT ASSETS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 - OTHER CURRENT ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>Composition:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deposits at the Chamber of Commerce</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Deferred offering expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deferred expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">52</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">225</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">472</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647797008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_FixedAssetsNetLineItems', window );"><strong>Fixed Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">FIXED ASSETS, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 - FIXED ASSETS, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 60pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify">Cost:</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">767</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">754</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,278</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,263</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Accumulated depreciation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computers and software</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">565</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">535</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">126</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">829</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Carrying amount</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">449</td><td style="padding-bottom: 4pt; text-align: left"/><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">570</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">Depreciation
expenses for the years ended December 31, 2022, and 2021 were $150 and $142, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_FixedAssetsNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_FixedAssetsNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647799488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accounts Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Other Accounts Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCOUNTS PAYABLE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 - OTHER ACCOUNTS
PAYABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Employees and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">824</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">828</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deferred revenues (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,114</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">See also Note 6H below.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647646704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES LIABILITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 6  - COMMITMENTS AND CONTINGENCIES LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>Collaboration Agreement with Israel Railways Ltd. (&#8220;Israel
Railways&#8221;):</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In August 2016, the Company and Israel
Railways entered into an agreement for cooperation between the parties, which was further amended on January 19, 2020, and on July 1,
2021 (&#8220;the Railway Agreement&#8221;). Under the Railway Agreement, the Company undertook to fulfill certain functions for the development,
marketing, distribution and sale of the systems, and Israel Railways undertook to provide the Company with services and the means to perform
tests and experiments, mainly in the form of logistics and manpower, and to provide the Company with information on certain data that
will be provided at the discretion of Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Pursuant to the Railway Agreement,
the Company agreed to pay Israel Railways the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the period from August 3, 2016 until the earliest of (a) a period of 5 years from the date of the first commercial sale or (b) the date
of an initial public offering or (c) a change of control (as defined in the Railway Agreement), Israel Railways will be entitled to a
payment of royalties in the amount of 2.75% of the Company&#8217;s net sales.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During
the period from August 3, 2016 until the earliest of: (a) the date of an initial public offering, (b) a change of control (as defined
in the Railways Agreement) Israel Railways will be entitled to a payment of a total of 1.5% of the total proceeds from an Initial Public Offering (&#8220;IPO&#8221;) or consideration,
received by the Company or its shareholders, as a result of change of control (as defined in the Railway Agreement).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Upon the completion of the initial
public offeringon April 4, 2022 (see Note 8B(8)) the Company paid to Israeli Railways a consideration of 1.5% of the actual IPO proceeds,
which was approximately $213 and its right for payment of royalties has expired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement further provides
that Israel Railways will be entitled to purchase the Company&#8217;s products and services at a price equal to half the lowest price charged
by the Company for those products and services to an unrelated third party.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In addition, as part of the Railway
Agreement and in consideration for services provided to the Company by Israel Railways, the Company granted Israel Railways an option
to purchase 195,448 of the Company&#8217;s ordinary shares at their par value (see also Note 8D(1)).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement may be terminated
by either party, with 60 days&#8217; prior written notice. Also, in the event of a change of control in the Company, Israel Railways may terminate
the Railway Agreement with 30 days&#8217; prior written notice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Railway Agreement was terminated
and canceled by the parties under an agreement signed on January 31, 2023 (see Note 14A below).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Memorandum of Understanding with Israel Railways: </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 12, 2021, the Company signed
a non-binding Memorandum of Understanding (&#8220;MOU&#8221;) with Israel Railways which summarizes the general terms and conditions to
be included in a detailed commercial agreement between the parties (the &#8220;Railways Commercial Agreement&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the MOU, the Company and
Israel Railways will conduct negotiations in good faith, with a view to entering into the Railways Commercial Agreement as soon as possible
before May 31, 2022. During the negotiations, Israel Railways has started conducting technical tests and analysis of the Company&#8217;s Main
Line system on a locomotive of Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Subsequent to December 31, 2022 on
January 31, 2023 the Company signed the Railways Commercial Agreement with Israel Railways. See Note 14A below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>C.</b></td><td style="text-align: justify"><b>Service Agreement with a Consultant:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In December 2020, the Company entered
into a service agreement with a consultant (the &#8220;Consultant&#8221;) according to which the Consultant will lead, control and consult
the Company&#8217;s management in its negotiations with Israel Railways relating the Homologation Process (as defined below) and the commercial
sales of the Company&#8217;s systems to Israel Railways.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The &#8220;Homologation Process&#8221;
will include defining and receiving all the required written licenses, consents and approvals, both in Israel and abroad, for installing
the Company&#8217;s systems on Israel Railways locomotives for operational use.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#8220;Commercial Sales&#8221; shall
include negotiating and signing supply agreement(s) or purchase orders between the Company and Israel Railways under which Israel Railways
shall purchase from the Company at least five (5) Systems, the supply and installation of at least five Systems on Israel Railways locomotives
and receiving the entire consideration by the Company from Israel Railways under the above supply agreements or purchase orders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">If a written consent is received by
the Company from the authorized representatives of Israel Railways to enter into a Homologation Process with the Company, subject to
its successful completion and enter into negotiations regarding the purchase of the Company&#8217;s systems by Israel Railways (the &#8220;Triggering
Event&#8221;), then:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#8220;Homologation Bonus&#8221;).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#8220;Commercial Bonus&#8221;).</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The signing of the MOU on August 12,
2021 mentioned in Note 6B above constitutes the occurrence of the Triggering Event as defined above, and accordingly on December 20, 2021,
the Company granted options to the Consultant for the purchase of 25,080 of the Company&#8217;s ordinary shares at an exercise price of
$6.1393 per share. The Consultant will be eligible to exercise the options upon completion of both the Homologation Process and the sale
process for a period of 24 months from the date of their grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Consultant&#8217;s right for the
Homologation Bonus and the Commercial Bonus has expired on August 12, 2022 and February 12, 2023, respectively, as the periods of 12 and
18 months, respectively, from the occurrence of the Triggering Event has passed without the completion of both terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In return for his services, in addition
to the bonus, the Company agreed to pay the Consultant a monthly remuneration in the amount of approximately $3, plus VAT.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The service agreement with the Consultant
is in effect from November 1, 2020, until the completion of the services determined in the agreement, as detailed above. Either party
may terminate the agreement with 30 days&#8217; notice. On July 29, 2021, the Company sent a termination notice to the Consultant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>D.</b></td><td style="text-align: justify"><b>Memorandum of Understanding between the Company and Knorr-Bremse:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On September 17, 2020, a non-binding
memorandum of understanding (the &#8220;Knorr-Bremse MOU&#8221;) was signed between the Company and Knorr-Bremse Systeme f&#252;r Schienenfahrzeuge
GmbH, an affiliate of Knorr-Bremse AG (&#8220;Knorr-Bremse&#8221;) regarding cooperation between the parties with respect to Light Rail
Vehicle (&#8220;LRV&#8221;) systems.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Following the signing of the Knorr-Bremse
MOU, in December 2020, Knorr-Bremse placed a purchase order to the Company for developing two prototypes of the LRV system according to
specifications required by Knorr Bremse (the &#8220;Knorr Bremse Purchase Order&#8221;). In return for the development of the two prototypes,
Knorr Bremse paid the Company a total of approximately EUR 397 thousand (approximately $471).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2021 the Company
completed its commitment according to the Knorr Bremse Purchase Order for the supply of the two LRV prototype systems to Knorr-Bremse.
Accordingly, the Company recognized revenues in 2021 from the sale of the two LRV prototype systems and the related services in a total
amount of approximately $471.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Framework agreement with Knorr-Bremse Rail Systems Schweiz AG (&#8220;KBCH&#8221;):</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In August 2020, the Company entered
into a framework agreement (the &#8220;KBCH Framework Agreement&#8221;) with KBCH (a subsidiary of Knorr-Bremse operating in Switzerland)
regarding the supply of a prototype of the Company&#8217;s shunting yard system to Schweizerische Bundes Bahnen Cargo (&#8220;SBBC&#8221;),
a freight train company in Switzerland.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under the KBCH Framework Agreement,
the Company provided KBCH with one prototype of the shunting yard system which has been installed on a shunting locomotive in the SBBC
shunting yard, for the purpose of examining the operational performance of the shunting yard system (the &#8220;Operational Function Test&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In consideration for the prototype
provided for the Operational Function Test, KBCH paid the Company the amount of approximately EUR 244 thousand (approximately $292). In
addition, in order to support the Operational Function Test procedure, the Company undertook to provide various professionals, as needed,
in exchange for payment at the maximum rates and amounts determined in the KBCH Framework Agreement. Accordingly, during 2021, KBCH paid
the Company an additional amount of approximately. EUR 110 thousand (approximately $125) for the Company&#8217;s services supporting the installation
and operation of the system and its participation in part of the overall licensing process of the operating concept that were fully provided
during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As the delivery of the prototype and
the provision of the services described above were identified by the Company as a single performance obligation, during 2021, the Company
recognized revenues from the sale of the prototype and the related services in the total amount of approximately $417.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Strategic partnership agreement between the Company and Knorr-Bremse </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 19, 2021, the Company entered
into a strategic partnership agreement which summarizes the understandings for strategic cooperation between the parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The agreement was approved by the Company&#8217;s
Board of Directors on August 25, 2021 and by the Company&#8217;s General Meeting on August 26, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>G.</b></td><td style="text-align: justify"><b>Agreement for supplying equipment and services with Hitachi Rail STS Australian Pty Ltd. (&#8220;STS&#8221;)</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In April 2021, the Company entered
into an agreement to supply equipment, personnel and services with STS, which enables STS, as the main supplier, to supply to an Australian
railway company Rio Tinto Railway Network, a prototype of the Company&#8217;s Main Line system, for demonstrations and examining the operational
activity of the Main Line system (the &#8220;Long-Term Pilot&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In September 2022, the Company completed
the Long-Term Pilot and accordingly recognized revenues in the year ended December 31, 2022 from the Long Term Pilot in the total amount
of EUR 192 thousands (approximately $202).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>H.</b></td><td style="text-align: justify">In September 2021 the Company received a purchase order (&#8220;PO&#8221;) from a customer in the United
States (the &#8220;U.S. Customer&#8221;) for a Proof of Concept (&#8220;POC&#8221;) regarding to a detection system which will focus on
railway infrastructure inspection and is based on the Company&#8217;s sensors and algorithmic capabilities, utilizing cloud computing
to handle data collections and measurements. In October 2021, the U.S. Customer paid the Company a total amount of $87 as an advance payment
according to the PO. As of December 31, 2021 the Company&#8217;s recorded deferred revenues in the amount of $87 in other accounts payable.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In March 2022, the Company completed
the POC and accordingly recognized revenues in the year ended December 31, 2022 from the POC in the total amount of approximately $219.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647053152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConvertiblePreferredSharesLineItems', window );"><strong>Convertible Preferred Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConvertiblePreferredSharesTextBlock', window );">CONVERTIBLE PREFERRED SHARES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 7  - CONVERTIBLE PREFERRED SHARES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify"><b>Issuance of Preferred A Shares&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On October 13, 2020, the Company and Knorr-Bremse
entered into an investment agreement under which the Company issued 51,282 Preferred A shares to Knorr-Bremse, in exchange for a total
investment of $10,000. As of December 31, 2021, the net proceeds, after deducting closing costs and fees, amounted to $9,965.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In addition, the Company was given, under
the investment agreement, an option to demand Knorr-Bremse to invest an additional amount of $5,000 at the same price per share (the
&#8220;Call Option&#8221;), provided the existence of circumstances as detailed in the investment agreement. The Call Option was accounted
as a derivative and valued at zero. On December 2, 2021, and February 14, 2022 the Company and Knorr-Bremse signed two amendments to
the investment agreement, according to which, the Company will be entitled to exercise its option in 2 installments as follows: (i) up
to $2,000 will be exercisable through March 31, 2022; and (ii) up to $2,286 will be exercisable through June 30, 2022. The aforesaid
option shall expire on the closing of the Company&#8217;s IPO if such shall occur prior to June 30, 2022. On March 6, 2022, the Company
exercised its first installment of $2,000 and as a result issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of
$195 per share.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Preferred A shares were entitled to all the
rights of the Company&#8217;s ordinary shares and additional rights regarding liquidation preference and listing rights. Holders of Preferred
A shares were entitled, at their option, to convert the Preferred A shares at any time into the Company&#8217;s ordinary shares in a
1:44 ratio. In addition, prior to the Company&#8217;s IPO, all Preferred A shares will be immediately converted into the Company&#8217;s ordinary
shares in a 1:44 ratio, and, accordingly, all rights stated are revoked upon their conversion into the Company&#8217;s ordinary shares.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Immediately prior to the completion of the
IPO on April 4, 2022 (see Note 8B(8)), 61,538 Preferred A shares were automatically converted into 2,707,672 ordinary shares (after giving
effect to the issuance of 10,256 Preferred A shares described above).&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ConvertiblePreferredSharesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ConvertiblePreferredSharesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ConvertiblePreferredSharesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ConvertiblePreferredSharesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647610560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 8  - SHAREHOLDERS&#8217; EQUITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>The rights of ordinary shares are as follows:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The ordinary shares confer upon the
holders the right to receive notice to participate and vote in general meetings of shareholders of the Company, the right to receive dividends,
if declared, and the right to participate in a distribution of the surplus of assets upon liquidation of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Regarding Issuance of bonus shares
see Note 2C above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Issuance of ordinary shares and warrants: </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">In August and November 2016, the Company raised gross proceeds
of $1,960 (net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued
an aggregate of 1,465,992 ordinary shares at a price of $1.36 per share and three series of warrants (A, B and C) to purchase 3,135,572
ordinary shares.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">From January 10, 2018 through November
2, 2018, series A and C warrants were exercised into 1,639,000 ordinary shares for an aggregate of $7,158. The remaining series C warrants
to purchase 17,732 ordinary shares expired on November 2, 2018.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During May 2019, series B warrants
to purchase 234,608 of the Company&#8217;s ordinary shares were exercised for an aggregate of $1,411 and series B warrants to purchase
1,281,456 ordinary shares expired on May 1, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">In September and October 2017, the Company raised $5,192
(net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued an aggregate
of 951,676 ordinary shares at a price of $6.14 per share and two series of warrants (D and E) to purchase 951,676 ordinary shares.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During March 2019, series D warrants
to purchase 81,884 of the Company&#8217;s ordinary shares were exercised for an aggregate of $470 and series D warrants to purchase 214,500
ordinary shares expired on March 19, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During April 2019, series E warrants
to purchase 303,512 of the Company&#8217;s ordinary shares were exercised for an aggregate of $1,711 and series E warrants to purchase
434,016 ordinary shares expired on April 6, 2019.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">From February through May 2018, the Company raised gross proceeds of $2,511 (net) through private placements
of its ordinary shares (the &#8220;2018 Private Placement&#8221;). The Company issued an aggregate of 184,844 ordinary shares.&#160;</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The investment transaction detailed
in Note 8B (4) below, triggered anti-dilution rights that were included in the above mentioned private placement, and accordingly an additional
510,752 ordinary shares were issued to the investors in the 2018 Private Placement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">(4)</td><td style="text-align: justify">On March 19, 2019, the Company and Knorr-Bremse entered into an agreement whereby Knorr-Bremse invested
$9,941 (after deducting closing costs and fees) in the Company in consideration of an issuance of an aggregate number of 1,803,296 ordinary
shares of the Company at a price per share equal to $5.54.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Knorr-Bremse were also issued warrants
to purchase up to 655,732 of the Company&#8217;s ordinary shares at an exercise price per share of $5.54 (the &#8220;KB Warrants&#8221;).
The KB Warrants shall become exercisable (i) only upon an exercise of warrants of the respective class (i.e. series B warrants, series
D warrants and series E warrants, as the case may be), and (ii) only for the number of additional ordinary shares in accordance with the
formula of approximately 20% of the number of issued ordinary shares originating from the exercised KB warrants of the respective class,
all as specified in the agreement. During March 2019 through May 2019, all of the KB warrants have been exercised or expired (see also
Note 8B(1) &#8211; (2) above).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">During April &#8211; June 2021, an aggregate of options to purchase 20,724 Ordinary Shares were exercised
by former Company employees resulting in proceeds of $127.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">(6)</td><td style="text-align: justify">During March 2022, options to purchase 1,672 Ordinary Shares were exercised by former Company employees
resulting in proceeds of $10.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">(7)</td><td style="text-align: justify">In January 2022, the Company entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with
its two main shareholders providing for financing in the aggregate amount of $1,000 (the &#8220;Investment Amount&#8221;) which was subsequently
amended in March 2022.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The SAFE provides for the conversion
of the Investment Amount into the Company&#8217;s ordinary shares under certain circumstances including in particular in the case of an
initial public offering such that immediately prior to the closing of an initial public offering the Investment Amount shall automatically
convert into the number of shares and warrants equal to the Investment Amount divided by the initial public offering price. The warrants
which shall be issued shall have the same terms as the warrants to be issued in the initial public offering except such warrants shall
not be registered under the Securities Act of 1933, as amended, and shall not be tradeable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Immediately prior to the completion
of the IPO on April 4, 2022 (see Note 8B(8) below) the Investment Amount was automatically converted to 242,131 ordinary shares and 242,131
warrants to purchase ordinary shares, with an exercise price of $4.13 per share, immediately exercisable and will expire five years from
the date of issuance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(8)</td><td style="text-align: justify">On April 4, 2022, the Company completed its IPO, in which
the Company issued 3,787,241 units. Each unit includes one ordinary share and one warrant to purchase one ordinary share at an exercise
price of $4.13. The warrants are exercisable at any time up to five years after the IPO.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Gross proceeds for the offering were
approximately $15,647 (including exercise of over-allotment options as described below) and net proceeds of approximately $13,587 after
deducting underwriting discounts and commissions and offering expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company granted Aegis Capital
Corp, the underwriter (&#8220;Aegis&#8221;), a 45-day over-allotment option to purchase additional ordinary shares and/or warrants to
purchase additional ordinary shares up to 15% of the number of ordinary shares and warrants, respectively, sold in the IPO solely to cover
over-allotments, if any. On April 4, 2022, Aegis partially exercised its over-allotment option with respect to 568,086 warrants to purchase
ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>C.</b></td><td style="text-align: justify"><b>Equity Incentive Plan:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In January 2017, the Board authorized
an incentive share option plan which was amended on March 21, 2022, and on September 13,2022 (&#8220;2017 Plan&#8221;). The 2017 Plan
provides for the grant of incentive share options to employees and service providers of the Company. Awards may be granted under the 2017
Plan until January 31, 2027.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the 2017 Plan, the aggregate
number of ordinary shares that may be issued pursuant to awards will not exceed 2,332,352 ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>D.</b></td><td style="text-align: justify"><b>Shares and options to service providers:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The fair value for the options to
service providers was estimated on their grant date determined using a Black-Scholes option pricing model, with the following weighted-average
assumptions: weighted average volatility of 70%, risk free interest rates of 1.4%, dividend yields of 0% and a weighted average life
of the options of up to 5 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">As part of the Railway Agreement entered into on August 3,
2016, which was amended on January 19, 2020, and on July 1, 2021, the Company issued options to purchase up to 195,448 ordinary shares
of the Company, with an exercise price of NIS 0.01 (approximately $0.003) per share. The options were exercisable on each issuance date
and recorded as deferred expenses which are amortized over 5 years beginning August 2016. In respect of such option issuance an amount
of $196, $331, were recorded in the Company&#8217;s statements of comprehensive loss for the years ended December 31, 2021 and 2020,
respectively included in research and development expenses and no expenses were recorded in the year ended December 31, 2022 According
to amendments to the option agreement the warrants will expire at the earlier of the following: (1) the passing of five business days
following Israel Railways&#8217; receipt of a government approval; or (2) June 30, 2023. On January 25, 2023, Israel Railways notified
the Company that it exercises its option and accordingly the Company issued 195,448 ordinary shares to Israel Railways.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">On January 4, 2018, the Company granted to three consulting
service providers options to purchase 98,120 ordinary shares at an exercise price of $6.1393 per share. One third of the options vested
upon the first year anniversary and the remainder of the options vested in eight quarterly tranches over a period of two years.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Regarding the grant of options to a Consultant in connection
with the Company&#8217;s arrangement with Israel Railways, see Note 6C above.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Regarding the grant of warrants to an IR service provider,
subsequent to December 31, 2022, see Note 14D below.</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>E.</b></td><td style="text-align: justify"><b>Options to employees</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The fair value of options was estimated using the Black-Scholes
option pricing model, which was based on the following assumptions: weighted average volatility of 68%, risk free interest rates of 0.43%-2.83%,
dividend yields of 0% and expected life of the options of up to 6 years.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">The following table summarizes the option activity for options
to employees, officers and directors:</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="34" style="text-align: center; border-bottom: Black 1.5pt solid"><div style="padding: 0in 0in 1pt; border-bottom: Black 0.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>For
                                            the year ended December 31,</b></span></p> </div></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%; text-align: left"><span style="font-size: 9pt">Outstanding
    as of beginning of period</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">1,264,868</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">(*)</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">7.5</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">1,639,792</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">8.9</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">706,728</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">4.9</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">Granted</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1,058,890</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1.85</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1,502,248</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(1,672</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(20,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Forfeited
    or expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(421,190</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(354,200</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(569,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Outstanding
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,900,896</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">2.20</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">8.2</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,264,868</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">7.5</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,639,792</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.5</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Exercisable
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">805,062</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">2.46</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.6</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">683,723</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">7.4</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">595,980</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.8</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Regarding repricing during 2022, see Note 8E(3)(k) below.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted average fair value of
options granted during the year ended December 31, 2022, was $0.479 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">As of December 31, 2022, the total
unrecognized share-based payment expenses related to nonvested awards was $498, which is expected to be recognized over the next 2.75
years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><b>(3)</b></td><td style="text-align: justify"><b>Options granted:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -14.2pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">a)</td><td style="text-align: justify">On January 4, 2018, the Company granted options to purchase
452,496 ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their
grant date and vest over three years. One third of the options vested upon the first-year anniversary of the grant date and the remainder
of the options vested in eight equal quarterly tranches over a period of two years thereafter. For the year ended December 31, 2020,
the Company recorded an expense of $409. For the year ended December 31, 2021, the Company recorded a net reversal of previously recognized
expense of $9 due to termination of several employees in respect for such grant. No expenses have been recorded for the year ended December
31, 2022.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">b)</td><td style="text-align: justify">On June 24, 2018, the Company granted options to purchase 188,100
ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their grant
date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested
in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2021 and 2020, the Company
recorded an expense of $89 and $303, respectively, in respect for such grant. No expenses have been recorded for the year ended December
31, 2022.</td>
</tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">c)</td><td style="text-align: justify">On January 22, 2020, the Company granted options to purchase
671,308 ordinary shares to its employees at an exercise price of $6.14 per share (of which options to purchase 74,580 ordinary shares
were to the Company&#8217;s former CEO that were forfeited at the end of his employment in December 2020). These options expire 10 years
after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022, 2021 and 2020, the
Company recorded an expense of $163, $380 and $812, respectively, in respect for such grant.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">d)</td><td style="text-align: justify">In October 2020, the Company granted to its former chairman
of the Board options to purchase 556,820 ordinary shares are exercisable at an exercise price of $6.14 per share. The options vest as
follows: (1) options to purchase 139,205 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2)
options to purchase 278,410 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in
the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 139,205
ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October
13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company&#8217;s
Board at the time of vesting.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">In the event that the Company effectuates
an initial public offering, 25% of his unvested options (i.e., 139,216 options) shall be accelerate and considered fully vested immediately
prior to the closing of the IPO. Accordingly, upon the completion of the IPO on April 4, 2022 (see Note 8B(8)), 139,216 have been accelerate
and are considered fully vested.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">As of December 31, 2022, a total
of 278,410 of the former chairman&#8217;s options has expired as the periods of 18 and 24 months has passed and the Company did not reach
the required cumulative order backlogs, as detailed above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $133, $332 and $199,respectively, in respect for such grants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">e)</td><td style="text-align: justify">In October 2020, the Company granted to its CEO options to purchase 61,600 ordinary shares at an exercise
price of $6.14 per share vest as follows: (1) options to purchase 30,800 ordinary shares will vest on the condition that the Company generates,
no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and
(2) options to purchase the remaining 30,800 ordinary shares will vest on the condition that the Company generates, no later than October
12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog);
and all subject to him serving in his position at the time of vesting.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">As of December 31, 2022, a total
of 30,800 of the CEO&#8217;s options has expired as the period of 24 months has passed and the Company did not reach the required cumulative
order backlog, as detailed above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $20, $12 and $12 , respectively, in respect for such grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">f)</td><td style="text-align: justify">On November 3, 2020, the Company granted options to purchase 107,800 ordinary shares to its employees
at an exercise price of $6.14 per share. These options expire 10 years after their grant date and vest over three years in nine tranches.
One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years
thereafter. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an expense of $46, $62 and $14, respectively, in
respect for such grant.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">g)</td><td style="text-align: justify">On May 11, 2022, the Company granted to three officers options to purchase 547,162 ordinary shares including
266,216 to its former chairman of the Board, 156,081 to its CEO and 124,865 to its CFO, at an exercise price of $1.85 per share (equal
to the average closing share price on the Nasdaq over the first 30 calendar days following the IPO on April 4, 2022). These options expire
10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022. The Company recorded
an expense of $61, in respect for such grant.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">h)</td><td style="text-align: justify">On May 11, 2022, and June 6, 2022, the Company granted to four of its directors&#8217; options to purchase
119,796 ordinary shares and 39,932 ordinary shares, respectively, with an exercise price of $1.85 per share. Such options will vest one-third
following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following
36 months. For the year ended December 31, 2022, the Company recorded an expense of $17 in respect for such grant.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">i)</td><td style="text-align: justify">On September 13, 2022 the Company granted 252,000 options to its employees at an exercise price of $1.85
per share. These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested
on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended
December 31, 2022, the Company recorded an expense of $10, in respect for such grant.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">j)</td><td style="text-align: justify">On September 13, 2022 the Company granted 100,000 options to two of its officers at an exercise price
of $1.85 per share. These options expire 10 years after their grant date and vest in twelve equal quarterly tranches over a period of
three years. For the years ended December 31, 2022, the Company recorded an expense of $4, in respect for such grant.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in">k)</td><td style="text-align: justify">On September 13, 2022, in accordance with the terms of the 2017 Plan, the Board approved a modification
of 375,716 outstanding options held by officers and employees that had an exercise price of $6.14&#160;per share and reduced the exercise
price to $1.85&#160;per share. This resolution was effective from November 3, 2022, after receiving approval from the Israeli Tax Authorities.
The Company calculated the fair value of such options immediately before and after the modification.&#160;The Company immediately recognized
the additional fair value attributable to vested options, approximately $51, as share based payment expenses. The additional fair value
resulting from the modification, approximately $30, is being expensed over the remaining vesting period of the modified options.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify">The modification of 368,170 additional
outstanding options held by the Company&#8217;s CEO and two Directors was approved by the Board and is subject to an approval by the Company&#8217;s
shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Share Based Payment Expense:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The total share-based payment expense
related to options granted to employees and service providers comprised, at each period, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Cost of revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">411</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,162</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Total share-based payment expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">505</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,055</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,281</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652926528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">RESEARCH AND DEVELOPMENT, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 9  - RESEARCH AND DEVELOPMENT, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,049</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,586</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,065</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">R&amp;D consumables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">359</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Subcontracted work and consulting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Travel and other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">110</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,230</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,208</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,205</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI https://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503648796672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GeneralandAdministrativeLineItems', window );"><strong>General and Administrative [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DisclosureOfGeneralAndAdministrativeTextBlock', window );">GENERAL AND ADMINISTRATIVE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE&#160;10  - GENERAL AND ADMINISTRATIVE</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,845</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,508</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,563</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,162</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Professional services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">555</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Travel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Marketing and others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">393</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,265</td><td style="padding-bottom: 4pt; text-align: left"/><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,316</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DisclosureOfGeneralAndAdministrativeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of General and Administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DisclosureOfGeneralAndAdministrativeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_GeneralandAdministrativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_GeneralandAdministrativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652926528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE&#160;11  - TAXES ON INCOME</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>A.</b></td><td style="text-align: justify">The Company is subject to income taxes under Israeli tax laws:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">The Israeli corporate tax rate was 23% in 2022, 2021 and
2020.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">As of December 31, 2022, the Company generated net operating
losses of approximately $42,795, which may be carried forward and offset against taxable income in the future for an indefinite period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">The Company is still in its development stage and has not
yet generated revenues. Therefore, it is more likely than not that sufficient taxable income will not be available for the tax losses
to be utilized in the foreseeable future. Therefore, a valuation allowance was recorded to cover the entire balance of the deferred tax
assets.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>Deferred tax assets:</b></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Deferred taxes due to carryforward losses</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">9,843</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">8,396</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,843</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,396</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Income tax expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">4.</td><td style="text-align: justify">The Company has no uncertain tax positions and foreign sources
of income.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647618864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions and Balances with Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">TRANSACTIONS AND BALANCES WITH RELATED PARTIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>NOTE 12
- TRANSACTIONS AND BALANCES WITH RELATED PARTIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Parties considered to be related to
the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common
control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families
of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>Transactions:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">888</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">__</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Severance payment to former Company CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">General and administrative expenses (*)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">147</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">__</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">One time IPO bonus in the amount of $97 and $50 to the Company&#8217;s
CEO and its former chairman, respectively.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>B.</b></td><td style="text-align: justify"><b>Balances:</b></td></tr></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Accounts receivable (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">87</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">__</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">See Note 6D above.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503648924800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesLineItems', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDisclosureTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 13 &#8211; LEASES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On April 4, 2021, the Company signed
an amendment to the lease of the Company&#8217;s offices in Raanana, Israel, according to which, instead of the additional lease period under
the option in the lease, the Company extended the lease period for another five years beginning on September 9, 2021 (the date the current
lease period ends) until September 8, 2026 (the &#8220;Lease Update&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the Lease Update, the
monthly rent for the Company&#8217;s offices (excluding parking and management fees) will be approximately NIS 79 thousand (approx. $25) in
the first two years, NIS 82 thousand (approx. $26) in the third and fourth lease years and NIS 83 thousand (approx. $26) in the fifth
year. All the amounts are linked to the Consumer Price Index.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">According to the Lease Update, the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">At the time of the amendment, the Company
updated its lease liability and right-of-use asset in a total amount of approx. $458, which reflects the expected lease term until September
8, 2026.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">For the years ended December 31, 2022
2021 and 2020, operating lease expenses recorded in the Statements of Comprehensive Loss were $357, $405 and $375, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Future lease payments under operating
leases as of December 31, 2022 were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">317</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">219</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total future lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,174</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease liability balance</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,079</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The weighted average lease term and
weighted average discount rate as of December 31, 2022 was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Operating leases weighted average remaining lease term (in years)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating leases weighted average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652926528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 14 - SUBSEQUENT EVENTS </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>A.</b></td><td style="text-align: justify"><b>Israel Railways</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">1)</td><td style="text-align: justify">Following the Railways MOU with Israel Railways as detailed
in Note 6B. above on January 31, 2023 the Company signed an agreement with Israel Railways to purchase ten (10) Rail Vision Main Line
Systems and related services for a total amount of approximately $1.4 million.</td>
</tr></table><p style="text-align: justify; margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">2)</td><td style="text-align: justify">Regarding the exercise of Israel Railways options subsequent
to December 31, 2022, see Note 8D(1) above.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 48px"/><td style="text-align: justify; width: 24px"><b>B.</b></td><td style="text-align: justify">On <span>January 19, 2023, the Company announced the appointment of an
existing director,&#160;Mark Cleobury, as Chairman of the Board. Mr. Cleobury succeeds Shmuel Donnerstein who served as the Company&#8217;s
Chairman since 2020. Donnerstein will continue to serve Rail Vision as a Board member.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 48px"/><td style="text-align: justify; width: 24px"><b>C.</b></td><td style="text-align: justify">On February 16, 2023, a leading US-based rail and leasing services company purchased a Switch Yard System
for $140,000 with support, to evaluate its performance during a six-month trial. The Company&#8217;s new customer offers a suite of rail-centric
services including in-plant rail switching and material handling services.&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646928656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>Basis of Presentation:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The financial statements have been
prepared in conformity with accounting principles generally accepted in United Sates of America (&#8220;US GAAP&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates in the preparation of financial statements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements
and accompanying notes. The Company&#8217;s management believes that the estimates, judgments and assumptions used are reasonable based
upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures
made. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_FinancialStatementPolicyTextBlock', window );">Financial statement in U.S. dollars</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>C.</b></td><td style="text-align: justify"><b>Financial statement in U.S. dollars:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The functional currency of the Company
is the U.S. dollar (&#8220;dollar&#8221; or &#8220;$&#8221;) since the dollar is the currency of the primary economic environment in which
the Company has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Transactions and balances denominated
in dollars are presented at their original amounts. Transactions and balances denominated in foreign currencies have been re-measured
to dollars.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">All transaction gains and losses
from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of comprehensive
loss as financial income or expenses, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 129pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents and restricted cash</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>D.</b></td><td style="text-align: justify"><b>Cash and cash equivalents and restricted cash:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Cash equivalents are short-term highly
liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired, readily convertible
to known amounts of cash and subject to an insignificant risk. Restricted cash consists of deposits pledged to a bank that provided guarantee
in connection with an operating lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>E.</b></td><td style="text-align: justify"><b>Fair value of financial instruments:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The carrying values of cash and cash
equivalents, restricted cash, trade accounts payable, accrued expenses and employees and related expenses recorded in other accounts
payable, approximate their fair value due to the short-term maturity of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; defines fair value as the price that would be received from selling an
asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining
the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or
most advantageous market in which it would transact. The Company also considers assumptions that market participants would use when pricing
the asset or liability, such as, inherent risk, transfer restrictions and risk of nonperformance.</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_FixedAssetsPolicyTextBlock', window );">Fixed assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>F.</b></td><td style="text-align: justify"><b>Fixed assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful
lives of the assets. The annual depreciation rates are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">&#160;</span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">%</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 69%; text-align: left">Computer software and electronic equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 28%; text-align: center">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Over the shorter of the lease term (including the option) or useful life</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 48px"/><td style="width: 24px"><b>G.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets:</b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-weight: normal">The
Company&#8217;s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired,
the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During
2022 and 2021, no impairment losses were recognized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Accrued post-employment benefit</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>H.</b></td><td style="text-align: justify"><b>Accrued post-employment benefit:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Under Israeli employment laws, employees
of the Company are covered under Section 14 of the Severance Compensation Act, 1963 (&#8220;Section 14&#8221;) for a portion of their salaries.
According to Section 14, these employees are entitled to receive monthly deposits (payments) made by the Company on their behalf with
insurance companies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Payments in accordance with Section
14 release the Company from any future severance payments (under the Israeli Severance Compensation Act, 1963) with respect of those
employees. The obligation to make the monthly deposits is expensed as incurred. In addition, the aforementioned deposits are not recorded
as an asset in the Company&#8217;s balance sheet, and there is no liability recorded as the Company does not have a future obligation to make
any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>I.</b></td><td style="text-align: justify"><b>Revenue recognition:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company applies ASC 606 &#8220;Revenue
from contracts with customers&#8221; (&#8220;ASC 606&#8221;). Under ASC 606, revenue is measured as the amount of consideration the Company
expects to be entitled to, in exchange for transferring products or providing services to its customers and is recognized when or as
performance obligations under the terms of contracts with the Company&#8217;s customers are satisfied. ASC 606 prescribes a five-step
model for recognizing revenue from contracts with customers: (i) identify contract(s) with the customer; (ii) identify the separate performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the separate performance obligations
in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are
distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined
with other promised goods and services. The Company then allocates the transaction price (the amount of consideration the Company expects
to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated
revenue when (or as) each performance obligation is satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Revenues from product sales are recognized
upon the transfer of control, which is generally upon shipment or delivery.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Deferred revenue represents amounts
received by the Company for which the related revenues have not been recognized because one or more of the revenue recognition criteria
have not been met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The current portion of deferred revenue
represents the amount to be recognized within one year from the balance sheet date based on the estimated performance period of the underlying
performance obligation, see Note 5 below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based payment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>J.</b></td><td style="text-align: justify"><b>Share-based payment:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 28.35pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company
applies ASC 718-10, &#8220;Share-Based Payment,&#8221; (&#8220;ASC 718-10&#8221;) which requires the measurement and recognition of compensation
expenses for all share-based payment awards granted to employees and directors including share options granted under the Company&#8217;s incentive
share option plan based on estimated fair values<b>.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 167.8pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ASC 718-10 requires companies to
estimate the fair value of share-based payment awards on the date of grant. The portion of the grant-date fair value of the share-based
payment award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#8217;s statements
of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company estimates the fair value of share options granted as share-based payment awards using a Black-Scholes option pricing model.
The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are share price, expected volatility
and the expected option term (the time from the grant date until the options are exercised or expire).&#160;Expected volatility is estimated
based on volatility of similar companies in the technology sector. The expected option term is calculated for options granted to employees
and directors using the &#8220;simplified&#8221; method, and grants to non-employees are based on the contractual term.&#160;The Company
has historically not paid dividends and has no foreseeable plans to pay dividends. The risk-free interest rate is based on the yield
from Israel Treasury zero-coupon bonds with an equivalent term. Changes in the determination of each of the inputs can affect the fair
value of the share options granted and the results of operations of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>K.</b></td><td style="text-align: justify"><b>Leases:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On January 1, 2019, the Company early
adopted ASU 2016-02, Leases (Topic 842) (&#8220;ASU 2016-02&#8221;) using the modified retrospective approach for all lease arrangements
as of such date. The Company leases office space and vehicles under operating leases.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Operating leases are included in
operating lease right of use (&#8220;ROU&#8221;) assets and operating lease liabilities in the Company&#8217;s balance sheets. ROU assets represent
the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining
lease payments over the lease term. The Company&#8217;s incremental borrowing rate is used in determining the present value of lease
payments because rate implicit in the Company&#8217;s leases is not readily determinable. The operating lease ROU asset excludes lease incentives.
The expected lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised.
Operating lease expense for is recognized on a straight-line basis over the lease term, variable payments are expensed in the periods
incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company has made an accounting
policy election not to recognize ROU assets and lease liabilities that arise from leases with initial terms of 12 months or less. Instead,
the Company continues to record such lease expenses on a straight-line basis over the lease term in the statements of comprehensive loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses, net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>L.</b></td><td style="text-align: justify"><b>Research and development expenses, net:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Research and development expenses,
net, are charged to the statements of comprehensive loss as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted net loss per ordinary share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 48px"/><td style="width: 24px; text-align: left"><b>M.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per ordinary share:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Basic loss per ordinary share is
computed by dividing the net loss by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share
is computed by dividing the net loss by the weighted average number of ordinary shares outstanding plus the number of additional ordinary
shares that would have been outstanding if all potentially dilutive ordinary shares had been issued, using the treasury stock method.
Potentially dilutive ordinary shares were excluded from the diluted loss per share calculation because they were anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_FinancialStatementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_FinancialStatementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_FixedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_FixedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647716800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock', window );">Schedule of straight-line method over the estimated useful lives of the assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">%</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 69%; text-align: left">Computer software and electronic equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 28%; text-align: center">33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">7-15</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">Over the shorter of the lease term (including the option) or useful life</td><td style="text-align: left">&#160;</td></tr>
</table><p style="margin: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84167750&amp;loc=d3e42232-110370<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647610560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of other current assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deposits at the Chamber of Commerce</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Deferred offering expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Deferred expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">&#8212;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">52</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">225</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">472</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647750624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_FixedAssetsNetTablesLineItems', window );"><strong>Fixed Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of fixed assets, net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 60pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify">Cost:</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Computers and software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">767</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">754</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">136</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,278</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,263</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-weight: bold; text-align: justify">Accumulated depreciation:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computers and software</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">565</td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">535</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Laboratory equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Furniture and office equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">126</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Leasehold improvement</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">59</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">829</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Carrying amount</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">449</td><td style="padding-bottom: 4pt; text-align: left"/><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">570</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"><span style="font-weight: normal">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_FixedAssetsNetTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_FixedAssetsNetTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652926528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Accounts Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Other Accounts Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other accounts payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Employees and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">824</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">828</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Deferred revenues (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,114</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">See also Note 6H below.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647817664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of option activity for options to employees, officers and directors</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="34" style="text-align: center; border-bottom: Black 1.5pt solid"><div style="padding: 0in 0in 1pt; border-bottom: Black 0.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>For
                                            the year ended December 31,</b></span></p> </div></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Amount
    of options</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average exercise price</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighted
    average remaining contractual life</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">$</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%; text-align: left"><span style="font-size: 9pt">Outstanding
    as of beginning of period</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">1,264,868</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">(*)</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">7.5</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">1,639,792</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">8.9</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">706,728</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 9pt">4.9</span></td><td style="width: 0.5%; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">Granted</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1,058,890</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1.85</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right">&#8212;</td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">1,502,248</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Exercised</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(1,672</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">(20,724</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Forfeited
    or expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(421,190</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(354,200</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(569,184</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-size: 1pt; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Outstanding
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,900,896</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">2.20</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">8.2</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,264,868</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">7.5</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">1,639,792</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.5</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-size: 9pt">Exercisable
    as of end of period</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">805,062</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">2.46</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.6</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">683,723</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">7.4</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">595,980</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.14</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 9pt">6.8</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Regarding repricing during 2022, see Note 8E(3)(k) below.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Schedule of total share-based payment expense related to options granted to employees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Cost of revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">&#8212;</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">323</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">411</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,162</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt">Total share-based payment expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">505</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,055</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,281</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647704784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock', window );">Schedule of research and development</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,049</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,586</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,065</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">R&amp;D consumables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">359</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">132</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Subcontracted work and consulting</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Travel and other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">110</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">67</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,230</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,208</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,205</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature and amounts of capitalized costs of a research and development nature that were acquired in a transaction other than a business combination, the amount of such assets charged to expense during the period, and identification of the income statement caption in which the charges are included.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647708512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GeneralandAdministrativeTablesLineItems', window );"><strong>General and Administrative [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock', window );">Schedule of general and administrative</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,845</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,508</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,563</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">411</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,162</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Professional services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">555</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Travel expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Marketing and others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">393</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,265</td><td style="padding-bottom: 4pt; text-align: left"/><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,316</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_GeneralandAdministrativeTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_GeneralandAdministrativeTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647677824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>Deferred tax assets:</b></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Deferred taxes due to carryforward losses</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">9,843</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">8,396</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,843</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,396</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 4pt">Income tax expenses</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">&#8212;</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644698480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions and Balances with Related Parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: justify">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">888</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">__</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Severance payment to former Company CEO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">234</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">General and administrative expenses (*)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">147</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">__</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">One time IPO bonus in the amount of $97 and $50 to the Company&#8217;s
CEO and its former chairman, respectively.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities', window );">Schedule of balances</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Accounts receivable (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif">__</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">87</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Other current assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">__</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">See Note 6D above.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of summarized financial data of the closed block, typically including the liabilities of the closed block, assets allocated thereto, and maximum expected future earnings from the operations thereof.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 805<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124505872&amp;loc=d3e30806-158569<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 805<br> -Section 55<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124502525&amp;loc=d3e31071-158570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646926272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesTablesLineItems', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future lease payments under operating leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">317</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">2026</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">219</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total future lease payments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,174</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(95</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total lease liability balance</span></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,079</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of weighted average lease term and weighted average discount rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Operating leases weighted average remaining lease term (in years)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating leases weighted average discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652944752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems', window );"><strong>Public Utility, Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ComputerSoftwareAndElectronicEquipment', window );">Computer software and electronic equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeaseholdImprovements', window );">Leasehold improvements</a></td>
<td class="text">Over the shorter of the lease term (including the option) or useful life<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems', window );"><strong>Public Utility, Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OfficeFurnitureAndEquipment', window );">Office furniture and equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LaboratoryEquipment', window );">Laboratory equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems', window );"><strong>Public Utility, Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OfficeFurnitureAndEquipment', window );">Office furniture and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LaboratoryEquipment', window );">Laboratory equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ComputerSoftwareAndElectronicEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of computer software and electronic equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ComputerSoftwareAndElectronicEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LaboratoryEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of laboratory equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LaboratoryEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The term of leasehold improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OfficeFurnitureAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of office furniture and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OfficeFurnitureAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646906464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Assets (Details) - Schedule of other current assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ScheduleOfOtherCurrentAssetsAbstract', window );"><strong>Schedule Of Other Current Assets Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentContractReceivable', window );">Government institutions</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits at the Chamber of Commerce</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDeferredCostsNet', window );">Deferred offering expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets, total</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ScheduleOfOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ScheduleOfOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentContractReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables that are derived from government contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55295-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentContractReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503647707808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Depreciation expenses</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646110016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fixed Assets, Net (Details) - Schedule of fixed assets, net - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">$ 1,278<span></span>
</td>
<td class="nump">$ 1,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Carrying amount</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and office equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503649282576">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Other Accounts Payable (Details) - Schedule of other accounts payable - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ScheduleOfOtherAccountsPayableAbstract', window );"><strong>Schedule Of Other Accounts Payable Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent', window );">Employees and related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 824<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent', window );">Other accounts payable, total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,032<span></span>
</td>
<td class="nump">$ 1,114<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See also Note 6H below.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ScheduleOfOtherAccountsPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ScheduleOfOtherAccountsPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred and payable classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableOtherCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644410912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Liabilities (Details)<br> $ / shares in Units, &#8364; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 07, 2022</div></th>
<th class="th"><div>Aug. 03, 2016</div></th>
<th class="th">
<div>Dec. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingencies Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_RoyaltyPaymentsPercentage', window );">Royalty payments, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PaymentOfTotalProceedFromConsiderationPercentage', window );">Payment of total proceeds from consideration, percentage</a></td>
<td class="nump">213.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionToPurchaseOrdinaryShares', window );">Option to purchase ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ServiceAgreementWithAConsultantDescription', window );">Service agreement with a consultant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#8220;Homologation Bonus&#8221;).
-Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#8220;Commercial Bonus&#8221;).
&#160;<span></span>
</td>
<td class="text">Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#8220;Homologation Bonus&#8221;).
-Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#8220;Commercial Bonus&#8221;).
&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ExercisePrice', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PaymentOfMonthlyRemunerationAmount', window );">Payment of monthly remuneration amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TotalAmountPaid', window );">Company total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="nump">&#8364; 397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DevelopmentAndSales', window );">Development and sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Installation and operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">&#8364; 110<span></span>
</td>
<td class="nump">$ 409,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DeferredRevenuesInOtherAccountsPayable', window );">Deferred revenues in other accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FilmCosts', window );">Capital cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent', window );">Deferred revenue in the amount of other accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Additional payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingencies Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PeriodOfFirstCommercialSales', window );">Period of first commercial sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PaymentOfTotalProceedsFromConsiderationPercentage', window );">Payment of total proceeds from consideration, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PaymentOfTotalProceedFromConsiderationPercentage', window );">Payment of total proceeds from consideration, percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionToPurchaseOrdinaryShares', window );">Option to purchase ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,448<span></span>
</td>
<td class="nump">195,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=rvsn_KnorrBremseRailSystemsSchweizAGMember', window );">Knorr-Bremse Rail Systems Schweiz AG [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems', window );"><strong>Commitments and Contingencies Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_PaymentOfOperationalFunctionTest', window );">Payment of operational function test</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292,000<span></span>
</td>
<td class="nump">&#8364; 244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DeferredRevenuesInOtherAccountsPayable', window );">Deferred revenues in other accounts payable | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DeferredRevenuesInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DeferredRevenuesInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DevelopmentAndSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DevelopmentAndSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OptionToPurchaseOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OptionToPurchaseOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_PaymentOfMonthlyRemunerationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_PaymentOfMonthlyRemunerationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_PaymentOfOperationalFunctionTest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_PaymentOfOperationalFunctionTest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_PaymentOfTotalProceedFromConsiderationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_PaymentOfTotalProceedFromConsiderationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_PaymentOfTotalProceedsFromConsiderationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_PaymentOfTotalProceedsFromConsiderationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_PeriodOfFirstCommercialSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_PeriodOfFirstCommercialSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_RoyaltyPaymentsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This percentage for royalty payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_RoyaltyPaymentsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ServiceAgreementWithAConsultantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service agreement with a consultant description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ServiceAgreementWithAConsultantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_TotalAmountPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The company amount to be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_TotalAmountPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FilmCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of capitalized film cost for film predominantly monetized on its own and films predominantly monetized with other films and license agreements as group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=120154689&amp;loc=SL120155198-107958<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120154689&amp;loc=d3e54369-107958<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126939063&amp;loc=d3e53371-107955<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FilmCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations and noncurrent portion of deferred revenue not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>States the combined aggregate amount of maturities and sinking fund requirements for a long-term unconditional purchase obligation that has been recognized on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=rvsn_KnorrBremseRailSystemsSchweizAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=rvsn_KnorrBremseRailSystemsSchweizAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644750720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Shares (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 04, 2022</div></th>
<th class="th"><div>Oct. 13, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConvertiblePreferredSharesDetailsLineItems', window );"><strong>Convertible Preferred Shares (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">61,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Total investment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds, costs and fees (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Additional amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_InvestmentAgreementDescription', window );">Investment agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) up
to $2,000 will be exercisable through March 31, 2022; and (ii) up to $2,286 will be exercisable through June 30, 2022. The aforesaid
option shall expire on the closing of the Company&#8217;s IPO if such shall occur prior to June 30, 2022. On March 6, 2022, the Company
exercised its first installment of $2,000 and as a result issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of
$195 per share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Conversion shares</a></td>
<td class="nump">2,707,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Issuance of preferred A shares</a></td>
<td class="nump">10,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Preferred A Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ConvertiblePreferredSharesDetailsLineItems', window );"><strong>Convertible Preferred Shares (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ConvertiblePreferredSharesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ConvertiblePreferredSharesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_InvestmentAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment agreement description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_InvestmentAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503628253248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details)<br> $ / shares in Units, &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="13">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2022</div></th>
<th class="th"><div>Sep. 13, 2022</div></th>
<th class="th"><div>May 11, 2022</div></th>
<th class="th">
<div>Apr. 04, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 04, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 25, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 22, 2020</div></th>
<th class="th">
<div>Jan. 19, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 19, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 24, 2018</div></th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 02, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 01, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 06, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 11, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GrossProceeds', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,960<span></span>
</td>
<td class="nump">$ 2,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_AggregateSharesIssued', window );">Aggregate shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,465,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsPurchase', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OrdinarySharesExercisedAmount', window );">Ordinary shares exercised amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_AggregateOrdinaryShares', window );">Aggregate ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,752<span></span>
</td>
<td class="nump">510,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_InvestedAgreement', window );">Invested agreement (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Aggregate number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,803,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Company at a price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceDecrease', window );">Exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsPercentage', window );">Warrants percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,332,352<span></span>
</td>
<td class="nump">2,332,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_NetProceeds', window );">Net proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_NumberOfOrdinarySharesAndWarrantsPercentage', window );">Percentage of number of ordinary shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted average volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_RiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DividendYields', window );">Dividend yields</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ExercisePricePerShares', window );">Exercise price per share | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_AmortizedOver', window );">Amortized over</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost', window );">Research and development expenses (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceIncrease', window );">Option exercise price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards', window );">Share-based payment expenses related to nonvested awards (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">2 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="nump">20,724<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options expire term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">&#8364; 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TerminationLoans', window );">Termination amount (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">i)On September 13, 2022 the Company granted 252,000 options to its employees at an exercise price of $1.85
per share. These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested
on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended
December 31, 2022, the Company recorded an expense of $10, in respect for such grant.<span></span>
</td>
<td class="text">the Company granted to four of its directors&#8217; options to purchase
119,796 ordinary shares and 39,932 ordinary shares, respectively, with an exercise price of $1.85 per share. Such options will vest one-third
following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following
36 months. For the year ended December 31, 2022, the Company recorded an expense of $17 in respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1) options to purchase 139,205 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2)
options to purchase 278,410 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in
the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 139,205
ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October
13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company&#8217;s
Board at the time of vesting.<span></span>
</td>
<td class="text">the Company granted options to purchase
671,308 ordinary shares to its employees at an exercise price of $6.14 per share (of which options to purchase 74,580 ordinary shares
were to the Company&#8217;s former CEO that were forfeited at the end of his employment in December 2020). These options expire 10 years
after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022, 2021 and 2020, the
Company recorded an expense of $163, $380 and $812, respectively, in respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">b)On June 24, 2018, the Company granted options to purchase 188,100
ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their grant
date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested
in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2021 and 2020, the Company
recorded an expense of $89 and $303, respectively, in respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_UnvestedOptionsPercentage', window );">Unvested options percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278,410<span></span>
</td>
<td class="nump">278,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Recorded an expense (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">KB Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">655,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=rvsn_October2020Member', window );">October 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company granted to its CEO options to purchase 61,600 ordinary shares at an exercise
price of $6.14 per share vest as follows: (1) options to purchase 30,800 ordinary shares will vest on the condition that the Company generates,
no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and
(2) options to purchase the remaining 30,800 ordinary shares will vest on the condition that the Company generates, no later than October
12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog);
and all subject to him serving in his position at the time of vesting.As of December 31, 2022, a total
of 30,800 of the CEO&#8217;s options has expired as the period of 24 months has passed and the Company did not reach the required cumulative
order backlog, as detailed above.&#160;For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $20, $12 and $12 , respectively, in respect for such grant.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=rvsn_November32020Member', window );">November 3, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">f)On November 3, 2020, the Company granted options to purchase 107,800 ordinary shares to its employees
at an exercise price of $6.14 per share. These options expire 10 years after their grant date and vest over three years in nine tranches.
One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years
thereafter. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an expense of $46, $62 and $14, respectively, in
respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=rvsn_May112022Member', window );">May 11 ,2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">g)On May 11, 2022, the Company granted to three officers options to purchase 547,162 ordinary shares including
266,216 to its former chairman of the Board, 156,081 to its CEO and 124,865 to its CFO, at an exercise price of $1.85 per share (equal
to the average closing share price on the Nasdaq over the first 30 calendar days following the IPO on April 4, 2022). These options expire
10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022. The Company recorded
an expense of $61, in respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=rvsn_September132022Member', window );">September 13,2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">j)On September 13, 2022 the Company granted 100,000 options to two of its officers at an exercise price
of $1.85 per share. These options expire 10 years after their grant date and vest in twelve equal quarterly tranches over a period of
three years. For the years ended December 31, 2022, the Company recorded an expense of $4, in respect for such grant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,787,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsDescription', window );">Warrants, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each unit includes one ordinary share and one warrant to purchase one ordinary share at an exercise
price of $4.13. The warrants are exercisable at any time up to five years after the IPO.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember', window );">Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GrossProceeds', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsPurchase', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,639,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBMember', window );">Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsPurchase', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,608<span></span>
</td>
<td class="nump">1,281,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OrdinarySharesExercisedAmount', window );">Ordinary shares exercised amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,411,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesCMember', window );">Series C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GrossProceeds', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WarrantsPurchase', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="nump">3,135,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,639,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OrdinarySharesExpired', window );">Ordinary shares expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesDMember', window );">Series D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GrossProceeds', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OrdinarySharesExercisedAmount', window );">Ordinary shares exercised amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,711,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesEMember', window );">Series E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Warrants purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">951,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,512<span></span>
</td>
<td class="nump">434,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsShares', window );">Ordinary shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember', window );">Options to employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfWeightedAverageCostInventory', window );">Percentage weighted average volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend yields</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsExpire', window );">Options expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember', window );">Options to employees [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_RiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.43%<span></span>
</td>
<td class="nump">0.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember', window );">Options to employees [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_RiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.83%<span></span>
</td>
<td class="nump">2.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rvsn_TwoThousandSeventeenPlanMember', window );">Two Thousand Seventeen Plan [Member] | September 13,2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_OptionsGrantedDescription', window );">Options granted, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">in accordance with the terms of the 2017 Plan, the Board approved a modification
of 375,716 outstanding options held by officers and employees that had an exercise price of $6.14&#160;per share and reduced the exercise
price to $1.85&#160;per share. This resolution was effective from November 3, 2022, after receiving approval from the Israeli Tax Authorities.
The Company calculated the fair value of such options immediately before and after the modification.&#160;The Company immediately recognized
the additional fair value attributable to vested options, approximately $51, as share based payment expenses. The additional fair value
resulting from the modification, approximately $30, is being expensed over the remaining vesting period of the modified options.The modification of 368,170 additional
outstanding options held by the Company&#8217;s CEO and two Directors was approved by the Board and is subject to an approval by the Company&#8217;s
shareholders.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=rvsn_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsLineItems', window );"><strong>Shareholders' Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_AggregateOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_AggregateOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_AggregateSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of aggregate ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_AggregateSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_AmortizedOver">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_AmortizedOver</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DividendYields">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DividendYields</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ExercisePricePerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ExercisePricePerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_GrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_GrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_InvestedAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>t is a type of shareholders agreement which serves to regulate the relationships between the founding shareholders who have incorporated or are to incorporate a company and the investor who shall finance their growth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_InvestedAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_NetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_NetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_NumberOfOrdinarySharesAndWarrantsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_NumberOfOrdinarySharesAndWarrantsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OptionsExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OptionsExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OptionsGrantedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OptionsGrantedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OrdinarySharesExercisedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares exercised amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OrdinarySharesExercisedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_OrdinarySharesExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ordinary shares expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_OrdinarySharesExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_RiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk free interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_RiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payment expenses related to non-vesting condition is any condition that does not determine whether the entity receives the services that entitle the counterparty to receive cash, other assets or equity instruments of the entity under a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ShareholdersEquityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ShareholdersEquityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_UnvestedOptionsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unvested options percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_UnvestedOptionsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WarrantsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WarrantsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WarrantsPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WarrantsPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of excess stock shares of an entity that have been sold or granted to shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfWeightedAverageCostInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfWeightedAverageCostInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow before closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 51<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51840-112757<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 50<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51831-112757<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=123386837&amp;loc=d3e51843-112757<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TerminationLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definite liabilities to third parties under a termination loan agreement, whether or not guaranteed in whole or in part by the government.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 405<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126938292&amp;loc=d3e56288-109415<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TerminationLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=rvsn_October2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=rvsn_October2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=rvsn_November32020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=rvsn_November32020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=rvsn_May112022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=rvsn_May112022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=rvsn_September132022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=rvsn_September132022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rvsn_SeriesCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rvsn_SeriesDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rvsn_SeriesEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rvsn_SeriesEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rvsn_TwoThousandSeventeenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rvsn_TwoThousandSeventeenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=rvsn_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=rvsn_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644785328">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems', window );"><strong>Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,264,868<span></span>
</td>
<td class="nump">1,639,792<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">706,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average remaining contractual life, Outstanding at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,058,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,502,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(139,216)<span></span>
</td>
<td class="num">(1,672)<span></span>
</td>
<td class="num">(20,724)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(421,190)<span></span>
</td>
<td class="num">(354,200)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(569,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, Outstanding at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,896<span></span>
</td>
<td class="nump">1,264,868<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,639,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod', window );">Weighted average remaining contractual life, Outstanding at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars', window );">Number of options, Exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,062<span></span>
</td>
<td class="nump">683,723<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">595,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod', window );">Weighted average exercise price, Exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars', window );">Weighted average remaining contractual life, Exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems', window );"><strong>Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Forfeited</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod', window );">Weighted average exercise price, Exercisable at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.14<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Regarding repricing during 2022, see Note 8E(3)(k) below.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503649262512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees - Share Based Payment Expense [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems', window );"><strong>Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based payment expense</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="nump">$ 2,281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646908480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development, Net (Details) - Schedule of research and development - Research and Development Expense [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems', window );"><strong>Research and Development Assets Acquired Other than Through Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Payroll and related expenses</a></td>
<td class="nump">$ 5,049<span></span>
</td>
<td class="nump">$ 5,586<span></span>
</td>
<td class="nump">$ 5,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Share-based payment</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment', window );">R&amp;D consumables</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostMaintenance', window );">Rent and office maintenance</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_SubcontractedWorkAndConsulting', window );">Subcontracted work and consulting</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TravelAndEntertainmentExpense', window );">Travel and other expenses</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense, total</a></td>
<td class="nump">$ 6,230<span></span>
</td>
<td class="nump">$ 7,208<span></span>
</td>
<td class="nump">$ 7,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_SubcontractedWorkAndConsulting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is subcontracted work and consulting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_SubcontractedWorkAndConsulting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of maintenance incurred and directly related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of average investment of impaired financing receivables for which there is no related allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5258-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TravelAndEntertainmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses incurred for travel and entertainment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TravelAndEntertainmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503646907056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative (Details) - Schedule of general and administrative - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems', window );"><strong>Schedule of general and administrative [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesRelatedParty', window );">Payroll and related expenses</a></td>
<td class="nump">$ 1,845<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">$ 1,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Share-based payment</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional services</a></td>
<td class="nump">1,451<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TravelAndEntertainmentExpense', window );">Travel expenses</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostMaintenance', window );">Rent and office maintenance</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing and others</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total general and administrative</a></td>
<td class="nump">$ 4,265<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of maintenance incurred and directly related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs of sales and operating expenses for the period incurred from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TravelAndEntertainmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses incurred for travel and entertainment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TravelAndEntertainmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503649163312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TaxesonIncomeDetailsLineItems', window );"><strong>Taxes on Income (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Net operating losses (in Dollars)</a></td>
<td class="nump">$ 42,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TaxesonIncomeDetailsLineItems', window );"><strong>Taxes on Income (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Corporate tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_TaxesonIncomeDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_TaxesonIncomeDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644898256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of deferred tax assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Deferred taxes due to carryforward losses</a></td>
<td class="nump">$ 9,843<span></span>
</td>
<td class="nump">$ 8,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(9,843)<span></span>
</td>
<td class="num">(8,396)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Income tax expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503645548288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions and Balances with Related Parties (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems', window );"><strong>Transactions and Balances with Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">IPO bonus amount</a></td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems', window );"><strong>Transactions and Balances with Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">IPO bonus amount</a></td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503648857344">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Transactions and Balances with Related Parties (Details) - Schedule of transactions - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_ScheduleOfTransactionsAbstract', window );"><strong>Schedule Of Transactions Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_RevenuesFromRelatedParties', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 888<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance payment to former Company CEO</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 147<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">One time IPO bonus in the amount of $97 and $50 to the Company&#8217;s
CEO and its former chairman, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_RevenuesFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_RevenuesFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_ScheduleOfTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_ScheduleOfTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644384800">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Transactions and Balances with Related Parties (Details) - Schedule of balances - Balance [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems', window );"><strong>Transactions and Balances with Related Parties (Details) - Schedule of balances [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 6D above.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126942793&amp;loc=d3e3073-115593<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_MemberUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_MemberUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503653348944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lease, description</a></td>
<td class="text">the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.<span></span>
</td>
<td class="text">the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Lease liability and right of use asset</a></td>
<td class="nump">$ 458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease term, date</a></td>
<td class="text">Sep.  08,  2026<span></span>
</td>
<td class="text">Sep.  08,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Operating lease expenses</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=rvsn_FirstTwoYearsMember', window );">First Two Lease Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Monthly office rent</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">&#8362; 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=rvsn_ThirdAndFourthLeaseYearsMember', window );">Third and Fourth Lease Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Monthly office rent</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=rvsn_FifthLeaseYearMember', window );">Fifth Lease Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsLineItems', window );"><strong>Leases (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Monthly office rent</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">&#8362; 83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=rvsn_FirstTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=rvsn_FirstTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=rvsn_ThirdAndFourthLeaseYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=rvsn_ThirdAndFourthLeaseYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=rvsn_FifthLeaseYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=rvsn_FifthLeaseYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503644777056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of future lease payments under operating leases<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems', window );"><strong>Schedule of future lease payments under operating leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_FutureLeasePayments', window );">Total future lease payments</a></td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest', window );">Less imputed interest</a></td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability balance</a></td>
<td class="nump">$ 1,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_FutureLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_FutureLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>If disclosed, the amount of imputed interest necessary to reduce an unconditional purchase obligation to present value on an unrecorded unconditional purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25376-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652914208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of weighted average lease term and weighted average discount rate<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems', window );"><strong>Schedule of weighted average lease term and weighted average discount rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases weighted average remaining lease term (in years)</a></td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases weighted average discount rate</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rvsn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140503652914208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total amount</a></td>
<td class="nump">$ 1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription', window );">Agreements executive officers, description</a></td>
<td class="text">a leading US-based rail and leasing services company purchased a Switch Yard System
for $140,000 with support, to evaluate its performance during a six-month trial.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of measurement difference between recognized amounts and resulting measurement differences for securities sold under agreements to repurchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20225997-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>f20f2022_railvisionltd_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rvsn="http://www.RailVision.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rvsn-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2016-08-03</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2016-08-03</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-07</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-07</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-20</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">rvsn:KnorrBremseRailSystemsSchweizAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-13</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-13</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2016-08-01</startDate>
            <endDate>2016-08-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-11</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-11</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-10</startDate>
            <endDate>2018-11-02</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-10</startDate>
            <endDate>2018-11-02</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-02</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-01</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-02</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2019-03-19</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-19</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-06</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rvsn:SeriesEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-06</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-19</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-19</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-25</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rvsn:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-24</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-22</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:October2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:November32020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-03</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:May112022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-11</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-11</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-13</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:September132022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-13</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">rvsn:September132022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rvsn:TwoThousandSeventeenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-13</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:MemberUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:MemberUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:FirstTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:ThirdAndFourthLeaseYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001743905</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">rvsn:FifthLeaseYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <dei:DocumentType contextRef="c0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0">001-41334</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">RAIL VISION LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">15 Ha&#x2019;Tidhar St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0">Ra&#x2019;anana</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c0">4366517</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1">Shahar Hania</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1">15 Ha&#x2019;Tidhar St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c1">Ra&#x2019;anana</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c1">4366517</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c1">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="c1">+972-9-957-7706</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1">972-9-957-7706</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1">marketing@railvision.io</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle contextRef="c0">Ordinary shares, par value NIS 0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">RVSN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">16091488</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">true</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0">1197</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0">Brightman Almagor Zohar &amp; Co.</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" unitRef="usd">8270000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">1649000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c2" decimals="-3" unitRef="usd">222000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c3" decimals="-3" unitRef="usd">200000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c2" decimals="-3" unitRef="usd">115000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c3" decimals="-3" unitRef="usd">87000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">225000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">472000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">8832000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">2408000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c2" decimals="-3" unitRef="usd">1151000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" unitRef="usd">1433000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" unitRef="usd">449000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="-3" unitRef="usd">570000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AssetsNoncurrent contextRef="c2" decimals="-3" unitRef="usd">1600000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">2003000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="-3" unitRef="usd">10432000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-3" unitRef="usd">4411000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c2" decimals="-3" unitRef="usd">56000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c3" decimals="-3" unitRef="usd">139000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c2" decimals="-3" unitRef="usd">281000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="-3" unitRef="usd">299000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c2" decimals="-3" unitRef="usd">1032000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent contextRef="c3" decimals="-3" unitRef="usd">1114000</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">1369000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">1552000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="-3" unitRef="usd">798000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="-3" unitRef="usd">1221000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c2" decimals="-3" unitRef="usd">2167000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="-3" unitRef="usd">2773000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c2" decimals="2" unitRef="ilsPershares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c3" decimals="2" unitRef="ilsPershares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">51282</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">51282</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c3" decimals="-3" unitRef="usd">9965000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c2" decimals="2" unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c3" decimals="2" unitRef="ilsPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="0" unitRef="shares">99900000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="0" unitRef="shares">99900000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c2" decimals="0" unitRef="shares">15896040</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="0" unitRef="shares">15896040</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="0" unitRef="shares">9157324</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="0" unitRef="shares">9157324</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c2" decimals="-3" unitRef="usd">46000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c3" decimals="-3" unitRef="usd">25000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" unitRef="usd">63033000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="-3" unitRef="usd">35987000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" unitRef="usd">-54814000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" unitRef="usd">-44339000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c2" decimals="-3" unitRef="usd">8265000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c3" decimals="-3" unitRef="usd">-8327000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">10432000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">4411000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">421000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c4" decimals="-3" unitRef="usd">888000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" unitRef="usd">661000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c4" decimals="-3" unitRef="usd">657000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" unitRef="usd">-240000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c4" decimals="-3" unitRef="usd">231000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" unitRef="usd">6230000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c4" decimals="-3" unitRef="usd">7208000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c5" decimals="-3" unitRef="usd">7205000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">4265000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c4" decimals="-3" unitRef="usd">3316000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c5" decimals="-3" unitRef="usd">3500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-10735000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-10293000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-10705000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-3" unitRef="usd">260000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c4" decimals="-3" unitRef="usd">73000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c5" decimals="-3" unitRef="usd">-2000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-10475000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-10220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-10707000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="2" unitRef="usdPershares">-0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c4" decimals="2" unitRef="usdPershares">-1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c5" decimals="2" unitRef="usdPershares">-1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c0"
      decimals="INF"
      id="ix_0_fact"
      unitRef="shares">14174422</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c4"
      decimals="INF"
      id="ix_1_fact"
      unitRef="shares">9148143</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c5"
      decimals="INF"
      id="ix_2_fact"
      unitRef="shares">9136600</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:SharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ix_3_fact"
      unitRef="shares">9136600</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="-3" id="ix_4_fact" unitRef="usd">25000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="-3" unitRef="usd">33052000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" unitRef="usd">-23412000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" unitRef="usd">9665000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c11"
      decimals="INF"
      id="ix_10_fact"
      unitRef="shares">51282</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c11"
      decimals="-3"
      id="ix_11_fact"
      unitRef="usd">4965000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c13" decimals="-3" unitRef="usd">1949000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c5" decimals="-3" unitRef="usd">1949000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c14" decimals="-3" unitRef="usd">-10707000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-10707000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c15" decimals="INF" unitRef="shares">51282</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c15" decimals="-3" unitRef="usd">4965000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ix_5_fact"
      unitRef="shares">9136600</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c16" decimals="-3" id="ix_6_fact" unitRef="usd">25000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c17" decimals="-3" unitRef="usd">35001000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c18" decimals="-3" unitRef="usd">-34119000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c19" decimals="-3" unitRef="usd">907000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="c20" decimals="-3" unitRef="usd">5000000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c21"
      decimals="INF"
      id="ix_7_fact"
      unitRef="shares">20724</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c22" decimals="-3" unitRef="usd">127000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c4" decimals="-3" unitRef="usd">127000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c22" decimals="-3" unitRef="usd">859000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c4" decimals="-3" unitRef="usd">859000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c23" decimals="-3" unitRef="usd">-10220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-10220000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c24" decimals="INF" unitRef="shares">51282</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c24" decimals="-3" unitRef="usd">9965000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c25"
      decimals="INF"
      id="ix_8_fact"
      unitRef="shares">9157324</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c25" decimals="-3" id="ix_9_fact" unitRef="usd">25000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c26" decimals="-3" unitRef="usd">35987000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c27" decimals="-3" unitRef="usd">-44339000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c3" decimals="-3" unitRef="usd">-8327000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="c28" decimals="INF" unitRef="shares">10256</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="c28" decimals="-3" unitRef="usd">2000000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c28" decimals="INF" unitRef="shares">-61538</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c28" decimals="-3" unitRef="usd">-11965000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="c29"
      decimals="INF"
      id="ix_12_fact"
      unitRef="shares">2707672</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c29"
      decimals="-3"
      id="ix_13_fact"
      unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c30" decimals="-3" unitRef="usd">11957000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c0" decimals="-3" unitRef="usd">11965000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c29"
      decimals="INF"
      id="ix_14_fact"
      unitRef="shares">3787241</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c29"
      decimals="-3"
      id="ix_15_fact"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c30"
      decimals="-3"
      id="ix_21_fact"
      unitRef="usd">13575000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="-3" id="ix_22_fact" unitRef="usd">13587000</us-gaap:StockIssuedDuringPeriodValueOther>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares
      contextRef="c29"
      decimals="INF"
      id="ix_16_fact"
      unitRef="shares">242131</rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering
      contextRef="c29"
      decimals="-3"
      id="ix_17_fact"
      unitRef="usd">1000</rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering contextRef="c30" decimals="-3" unitRef="usd">999000</rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering contextRef="c0" decimals="-3" unitRef="usd">1000000</rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c29"
      decimals="INF"
      id="ix_18_fact"
      unitRef="shares">1672</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c30" decimals="-3" unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="-3" unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c30" decimals="-3" unitRef="usd">505000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c0" decimals="-3" unitRef="usd">505000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss contextRef="c31" decimals="-3" unitRef="usd">-10475000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-10475000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c33"
      decimals="INF"
      id="ix_19_fact"
      unitRef="shares">15896040</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c33"
      decimals="-3"
      id="ix_20_fact"
      unitRef="usd">46000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c34" decimals="-3" unitRef="usd">63033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c35" decimals="-3" unitRef="usd">-54814000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c2" decimals="-3" unitRef="usd">8265000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-10475000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-10220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">-10707000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" unitRef="usd">150000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c4" decimals="-3" unitRef="usd">142000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c5" decimals="-3" unitRef="usd">190000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" unitRef="usd">505000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c4" decimals="-3" unitRef="usd">1055000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c5" decimals="-3" unitRef="usd">2281000</us-gaap:ShareBasedCompensation>
    <rvsn:ChangeInOperatingLeaseLiability contextRef="c0" decimals="-3" unitRef="usd">159000</rvsn:ChangeInOperatingLeaseLiability>
    <rvsn:ChangeInOperatingLeaseLiability contextRef="c4" decimals="-3" unitRef="usd">91000</rvsn:ChangeInOperatingLeaseLiability>
    <rvsn:ChangeInOperatingLeaseLiability contextRef="c5" decimals="-3" unitRef="usd">-134000</rvsn:ChangeInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c0" decimals="-3" unitRef="usd">-163000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c4" decimals="-3" unitRef="usd">381000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c5" decimals="-3" unitRef="usd">-15000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c0" decimals="-3" unitRef="usd">-83000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c4" decimals="-3" unitRef="usd">87000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c5" decimals="-3" unitRef="usd">-86000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c0" decimals="-3" unitRef="usd">-82000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c4" decimals="-3" unitRef="usd">-540000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c5" decimals="-3" unitRef="usd">973000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="usd">-9981000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c4" decimals="-3" unitRef="usd">-9948000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="-3" unitRef="usd">-7200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" unitRef="usd">29000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c4" decimals="-3" unitRef="usd">273000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c5" decimals="-3" unitRef="usd">122000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" unitRef="usd">-29000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c4" decimals="-3" unitRef="usd">-273000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c5" decimals="-3" unitRef="usd">-122000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="c0" decimals="-3" unitRef="usd">2000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="c4" decimals="-3" unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="c5" decimals="-3" unitRef="usd">4965000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c0" decimals="-3" unitRef="usd">1000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="-3" unitRef="usd">10000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c4" decimals="-3" unitRef="usd">127000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c0" decimals="-3" unitRef="usd">13643000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" unitRef="usd">16653000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c4" decimals="-3" unitRef="usd">5127000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c5" decimals="-3" unitRef="usd">4965000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="-3" unitRef="usd">6643000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c4" decimals="-3" unitRef="usd">-5094000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c5" decimals="-3" unitRef="usd">-2357000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">1849000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" unitRef="usd">6943000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c10" decimals="-3" unitRef="usd">9300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" unitRef="usd">8492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">1849000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" unitRef="usd">6943000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability contextRef="c4" decimals="-3" unitRef="usd">458000</rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability>
    <rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability contextRef="c5" decimals="-3" unitRef="usd">35000</rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability>
    <rvsn:ConversionOfPreferredShares contextRef="c0" decimals="-3" unitRef="usd">11965000</rvsn:ConversionOfPreferredShares>
    <rvsn:ConversionOfAConvertibleDebt contextRef="c0" decimals="-3" unitRef="usd">1000000</rvsn:ConversionOfAConvertibleDebt>
    <rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital contextRef="c0" decimals="-3" unitRef="usd">56000</rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 1 - GENERAL&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;A&lt;/b&gt;.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Reporting Entity:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Rail Vision Ltd. (the &#x201c;Company&#x201d;)
was incorporated and registered in Israel on April 18, 2016. The Company is a development-stage technology Company that is engaged in
the design, development and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency
and predictive maintenance. The Company&#x2019;s railway detection systems include different types of cameras, including optics, visible
light spectrum cameras (video) and thermal cameras that transmit data to a ruggedized on-board computer which is designed to be suitable
for the rough environment of a train&#x2019;s locomotive.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s ordinary shares and
warrants began trading on the Nasdaq Capital Market (&#x201c;Nasdaq&#x201d;) on March 31, 2022, under the symbols &#x201c;RVSN&#x201d; and
&#x201c;RVSNW,&#x201d; respectively (see Note 8B (8) below).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company&#x2019;s activities are
subject to significant risks and uncertainties. The Company has incurred significant losses since the date of its inception and anticipates
that it will continue to incur significant losses until it will be able to successfully commercialize its products. Failure to obtain
this necessary capital when needed may force the Company to delay, limit or terminate its product development efforts or other operations.&#160;In
addition, the Company is subject to risks including, among other things, competition associated with the industry in general, risks associated
with financing, liquidity requirements, rapidly changing customer requirements, the loss of key personnel and the effect of planned expansion
of operations on the future results of the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Going Concern:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;To date, the Company has not generated
significant revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to
generate substantial operating losses and to continue to fund its operations primarily through the utilization of its current financial
resources, sales of its products, and through additional raises of capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Such conditions raise substantial
doubts about the Company&#x2019;s ability to continue as a going concern. Management&#x2019;s plan includes raising funds from existing shareholders
and/or outside potential investors. However, there is no assurance such funding will be available to the Company or that it will be obtained
on terms favorable to the Company or will provide the Company with sufficient funds to successfully complete the development of, and
to commercialize, its products. These financial statements do not include any adjustments relating to the recoverability and classification
of assets, carrying amounts or the amount and classification of liabilities that may be required should the Company be unable to continue
as a going concern.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"/&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 24px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Issuance of bonus shares:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On February 13, 2022, the Company
effected a bonus shares issuances under Israeli law to reflect the effect of 44-for-1 forward share split of the Company&#x2019;s ordinary
shares. Accordingly, (i) for each one share of outstanding ordinary shares, 43 additional ordinary shares were issued and distributed
to the holder thereof; (ii) the number of ordinary shares issuable upon the exercise of each outstanding convertible preferred shares,
warrant and option was proportionately increased by 43 additional ordinary shares; (iii) the exercise price of each outstanding option
to purchase ordinary shares was proportionately adjusted; (iv) the authorized number of ordinary shares was increased in order to reflect
such issuance of bonus shares; and (v) the par value of ordinary shares was not adjusted as result of this issuance of bonus shares.
All share amounts, share prices, and exercise prices have been adjusted retroactively within these financial statements to reflect the
issuance of the bonus shares.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 - SIGNIFICANT ACCOUNTING
POLICIES &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of Presentation:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The financial statements have been
prepared in conformity with accounting principles generally accepted in United Sates of America (&#x201c;US GAAP&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements
and accompanying notes. The Company&#x2019;s management believes that the estimates, judgments and assumptions used are reasonable based
upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures
made. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Financial statement in U.S. dollars:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The functional currency of the Company
is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;) since the dollar is the currency of the primary economic environment in which
the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Transactions and balances denominated
in dollars are presented at their original amounts. Transactions and balances denominated in foreign currencies have been re-measured
to dollars.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;All transaction gains and losses
from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of comprehensive
loss as financial income or expenses, as appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 129pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents and restricted cash:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired, readily convertible
to known amounts of cash and subject to an insignificant risk. Restricted cash consists of deposits pledged to a bank that provided guarantee
in connection with an operating lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fair value of financial instruments:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The carrying values of cash and cash
equivalents, restricted cash, trade accounts payable, accrued expenses and employees and related expenses recorded in other accounts
payable, approximate their fair value due to the short-term maturity of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;ASC 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; defines fair value as the price that would be received from selling an
asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining
the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or
most advantageous market in which it would transact. The Company also considers assumptions that market participants would use when pricing
the asset or liability, such as, inherent risk, transfer restrictions and risk of nonperformance.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fixed assets:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful
lives of the assets. The annual depreciation rates are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 69%; text-align: left"&gt;Computer software and electronic equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 28%; text-align: center"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;Over the shorter of the lease term (including the option) or useful life&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Impairment of long-lived assets:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;The
Company&#x2019;s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired,
the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During
2022 and 2021, no impairment losses were recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Accrued post-employment benefit:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Under Israeli employment laws, employees
of the Company are covered under Section 14 of the Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;) for a portion of their salaries.
According to Section 14, these employees are entitled to receive monthly deposits (payments) made by the Company on their behalf with
insurance companies.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Payments in accordance with Section
14 release the Company from any future severance payments (under the Israeli Severance Compensation Act, 1963) with respect of those
employees. The obligation to make the monthly deposits is expensed as incurred. In addition, the aforementioned deposits are not recorded
as an asset in the Company&#x2019;s balance sheet, and there is no liability recorded as the Company does not have a future obligation to make
any additional payments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Revenue recognition:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company applies ASC 606 &#x201c;Revenue
from contracts with customers&#x201d; (&#x201c;ASC 606&#x201d;). Under ASC 606, revenue is measured as the amount of consideration the Company
expects to be entitled to, in exchange for transferring products or providing services to its customers and is recognized when or as
performance obligations under the terms of contracts with the Company&#x2019;s customers are satisfied. ASC 606 prescribes a five-step
model for recognizing revenue from contracts with customers: (i) identify contract(s) with the customer; (ii) identify the separate performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the separate performance obligations
in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;At contract inception, once the contract
is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are
distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined
with other promised goods and services. The Company then allocates the transaction price (the amount of consideration the Company expects
to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated
revenue when (or as) each performance obligation is satisfied.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Revenues from product sales are recognized
upon the transfer of control, which is generally upon shipment or delivery.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Deferred revenue represents amounts
received by the Company for which the related revenues have not been recognized because one or more of the revenue recognition criteria
have not been met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The current portion of deferred revenue
represents the amount to be recognized within one year from the balance sheet date based on the estimated performance period of the underlying
performance obligation, see Note 5 below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Share-based payment:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company
applies ASC 718-10, &#x201c;Share-Based Payment,&#x201d; (&#x201c;ASC 718-10&#x201d;) which requires the measurement and recognition of compensation
expenses for all share-based payment awards granted to employees and directors including share options granted under the Company&#x2019;s incentive
share option plan based on estimated fair values&lt;b&gt;.&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 167.8pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;ASC 718-10 requires companies to
estimate the fair value of share-based payment awards on the date of grant. The portion of the grant-date fair value of the share-based
payment award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#x2019;s statements
of comprehensive loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company estimates the fair value of share options granted as share-based payment awards using a Black-Scholes option pricing model.
The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are share price, expected volatility
and the expected option term (the time from the grant date until the options are exercised or expire).&#160;Expected volatility is estimated
based on volatility of similar companies in the technology sector. The expected option term is calculated for options granted to employees
and directors using the &#x201c;simplified&#x201d; method, and grants to non-employees are based on the contractual term.&#160;The Company
has historically not paid dividends and has no foreseeable plans to pay dividends. The risk-free interest rate is based on the yield
from Israel Treasury zero-coupon bonds with an equivalent term. Changes in the determination of each of the inputs can affect the fair
value of the share options granted and the results of operations of the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On January 1, 2019, the Company early
adopted ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements
as of such date. The Company leases office space and vehicles under operating leases.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Operating leases are included in
operating lease right of use (&#x201c;ROU&#x201d;) assets and operating lease liabilities in the Company&#x2019;s balance sheets. ROU assets represent
the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining
lease payments over the lease term. The Company&#x2019;s incremental borrowing rate is used in determining the present value of lease
payments because rate implicit in the Company&#x2019;s leases is not readily determinable. The operating lease ROU asset excludes lease incentives.
The expected lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised.
Operating lease expense for is recognized on a straight-line basis over the lease term, variable payments are expensed in the periods
incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company has made an accounting
policy election not to recognize ROU assets and lease liabilities that arise from leases with initial terms of 12 months or less. Instead,
the Company continues to record such lease expenses on a straight-line basis over the lease term in the statements of comprehensive loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Research and development expenses, net:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Research and development expenses,
net, are charged to the statements of comprehensive loss as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per ordinary share:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Basic loss per ordinary share is
computed by dividing the net loss by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share
is computed by dividing the net loss by the weighted average number of ordinary shares outstanding plus the number of additional ordinary
shares that would have been outstanding if all potentially dilutive ordinary shares had been issued, using the treasury stock method.
Potentially dilutive ordinary shares were excluded from the diluted loss per share calculation because they were anti-dilutive.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of Presentation:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The financial statements have been
prepared in conformity with accounting principles generally accepted in United Sates of America (&#x201c;US GAAP&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates in the preparation of financial statements:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements
and accompanying notes. The Company&#x2019;s management believes that the estimates, judgments and assumptions used are reasonable based
upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures
made. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <rvsn:FinancialStatementPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Financial statement in U.S. dollars:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The functional currency of the Company
is the U.S. dollar (&#x201c;dollar&#x201d; or &#x201c;$&#x201d;) since the dollar is the currency of the primary economic environment in which
the Company has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Transactions and balances denominated
in dollars are presented at their original amounts. Transactions and balances denominated in foreign currencies have been re-measured
to dollars.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;All transaction gains and losses
from re-measurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of comprehensive
loss as financial income or expenses, as appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 129pt"&gt;&#160;&lt;/p&gt;</rvsn:FinancialStatementPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents and restricted cash:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Cash equivalents are short-term highly
liquid investments that are readily convertible to cash with maturities of three months or less as of the date acquired, readily convertible
to known amounts of cash and subject to an insignificant risk. Restricted cash consists of deposits pledged to a bank that provided guarantee
in connection with an operating lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fair value of financial instruments:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The carrying values of cash and cash
equivalents, restricted cash, trade accounts payable, accrued expenses and employees and related expenses recorded in other accounts
payable, approximate their fair value due to the short-term maturity of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;ASC 820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; defines fair value as the price that would be received from selling an
asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining
the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or
most advantageous market in which it would transact. The Company also considers assumptions that market participants would use when pricing
the asset or liability, such as, inherent risk, transfer restrictions and risk of nonperformance.&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <rvsn:FixedAssetsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fixed assets:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Fixed
assets are stated at cost, less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful
lives of the assets. The annual depreciation rates are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 69%; text-align: left"&gt;Computer software and electronic equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 28%; text-align: center"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;Over the shorter of the lease term (including the option) or useful life&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;</rvsn:FixedAssetsPolicyTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 69%; text-align: left"&gt;Computer software and electronic equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 28%; text-align: center"&gt;33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7-15&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;Over the shorter of the lease term (including the option) or useful life&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <rvsn:OfficeFurnitureAndEquipment contextRef="c36" decimals="2" unitRef="pure">0.07</rvsn:OfficeFurnitureAndEquipment>
    <rvsn:OfficeFurnitureAndEquipment contextRef="c37" decimals="2" unitRef="pure">0.15</rvsn:OfficeFurnitureAndEquipment>
    <rvsn:ComputerSoftwareAndElectronicEquipment contextRef="c0" decimals="2" unitRef="pure">0.33</rvsn:ComputerSoftwareAndElectronicEquipment>
    <rvsn:LaboratoryEquipment contextRef="c36" decimals="2" unitRef="pure">0.07</rvsn:LaboratoryEquipment>
    <rvsn:LaboratoryEquipment contextRef="c37" decimals="2" unitRef="pure">0.15</rvsn:LaboratoryEquipment>
    <rvsn:LeaseholdImprovements contextRef="c0">Over the shorter of the lease term (including the option) or useful life</rvsn:LeaseholdImprovements>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Impairment of long-lived assets:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;The
Company&#x2019;s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired,
the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. During
2022 and 2021, no impairment losses were recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Accrued post-employment benefit:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Under Israeli employment laws, employees
of the Company are covered under Section 14 of the Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;) for a portion of their salaries.
According to Section 14, these employees are entitled to receive monthly deposits (payments) made by the Company on their behalf with
insurance companies.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Payments in accordance with Section
14 release the Company from any future severance payments (under the Israeli Severance Compensation Act, 1963) with respect of those
employees. The obligation to make the monthly deposits is expensed as incurred. In addition, the aforementioned deposits are not recorded
as an asset in the Company&#x2019;s balance sheet, and there is no liability recorded as the Company does not have a future obligation to make
any additional payments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;I.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Revenue recognition:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company applies ASC 606 &#x201c;Revenue
from contracts with customers&#x201d; (&#x201c;ASC 606&#x201d;). Under ASC 606, revenue is measured as the amount of consideration the Company
expects to be entitled to, in exchange for transferring products or providing services to its customers and is recognized when or as
performance obligations under the terms of contracts with the Company&#x2019;s customers are satisfied. ASC 606 prescribes a five-step
model for recognizing revenue from contracts with customers: (i) identify contract(s) with the customer; (ii) identify the separate performance
obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the separate performance obligations
in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;At contract inception, once the contract
is determined to be within the scope of ASC 606, the Company assesses whether the goods or services promised within each contract are
distinct and, therefore, represent a separate performance obligation. Goods and services that are determined not to be distinct are combined
with other promised goods and services. The Company then allocates the transaction price (the amount of consideration the Company expects
to be entitled to from a customer in exchange for the promised goods or services) to each performance obligation and recognizes the associated
revenue when (or as) each performance obligation is satisfied.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Revenues from product sales are recognized
upon the transfer of control, which is generally upon shipment or delivery.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Deferred revenue represents amounts
received by the Company for which the related revenues have not been recognized because one or more of the revenue recognition criteria
have not been met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The current portion of deferred revenue
represents the amount to be recognized within one year from the balance sheet date based on the estimated performance period of the underlying
performance obligation, see Note 5 below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;J.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Share-based payment:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company
applies ASC 718-10, &#x201c;Share-Based Payment,&#x201d; (&#x201c;ASC 718-10&#x201d;) which requires the measurement and recognition of compensation
expenses for all share-based payment awards granted to employees and directors including share options granted under the Company&#x2019;s incentive
share option plan based on estimated fair values&lt;b&gt;.&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 167.8pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;ASC 718-10 requires companies to
estimate the fair value of share-based payment awards on the date of grant. The portion of the grant-date fair value of the share-based
payment award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company&#x2019;s statements
of comprehensive loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company estimates the fair value of share options granted as share-based payment awards using a Black-Scholes option pricing model.
The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are share price, expected volatility
and the expected option term (the time from the grant date until the options are exercised or expire).&#160;Expected volatility is estimated
based on volatility of similar companies in the technology sector. The expected option term is calculated for options granted to employees
and directors using the &#x201c;simplified&#x201d; method, and grants to non-employees are based on the contractual term.&#160;The Company
has historically not paid dividends and has no foreseeable plans to pay dividends. The risk-free interest rate is based on the yield
from Israel Treasury zero-coupon bonds with an equivalent term. Changes in the determination of each of the inputs can affect the fair
value of the share options granted and the results of operations of the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;K.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On January 1, 2019, the Company early
adopted ASU 2016-02, Leases (Topic 842) (&#x201c;ASU 2016-02&#x201d;) using the modified retrospective approach for all lease arrangements
as of such date. The Company leases office space and vehicles under operating leases.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Operating leases are included in
operating lease right of use (&#x201c;ROU&#x201d;) assets and operating lease liabilities in the Company&#x2019;s balance sheets. ROU assets represent
the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities were recognized based on the present value of the remaining
lease payments over the lease term. The Company&#x2019;s incremental borrowing rate is used in determining the present value of lease
payments because rate implicit in the Company&#x2019;s leases is not readily determinable. The operating lease ROU asset excludes lease incentives.
The expected lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised.
Operating lease expense for is recognized on a straight-line basis over the lease term, variable payments are expensed in the periods
incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company has made an accounting
policy election not to recognize ROU assets and lease liabilities that arise from leases with initial terms of 12 months or less. Instead,
the Company continues to record such lease expenses on a straight-line basis over the lease term in the statements of comprehensive loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;L.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Research and development expenses, net:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Research and development expenses,
net, are charged to the statements of comprehensive loss as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;M.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per ordinary share:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Basic loss per ordinary share is
computed by dividing the net loss by the weighted average number of ordinary shares outstanding during the year. Diluted loss per share
is computed by dividing the net loss by the weighted average number of ordinary shares outstanding plus the number of additional ordinary
shares that would have been outstanding if all potentially dilutive ordinary shares had been issued, using the treasury stock method.
Potentially dilutive ordinary shares were excluded from the diluted loss per share calculation because they were anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 - OTHER CURRENT ASSETS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;Composition:&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Government institutions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Deposits at the Chamber of Commerce&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Deferred offering expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Deferred expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;225&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;472&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Government institutions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Deposits at the Chamber of Commerce&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Deferred offering expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Deferred expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Prepaid expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;225&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;472&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:GovernmentContractReceivable contextRef="c2" decimals="-3" unitRef="usd">27000</us-gaap:GovernmentContractReceivable>
    <us-gaap:GovernmentContractReceivable contextRef="c3" decimals="-3" unitRef="usd">100000</us-gaap:GovernmentContractReceivable>
    <us-gaap:Deposits contextRef="c2" decimals="-3" unitRef="usd">49000</us-gaap:Deposits>
    <us-gaap:Deposits contextRef="c3" decimals="-3" unitRef="usd">54000</us-gaap:Deposits>
    <us-gaap:OtherDeferredCostsNet contextRef="c3" decimals="-3" unitRef="usd">56000</us-gaap:OtherDeferredCostsNet>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">197000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:PrepaidExpenseCurrent contextRef="c2" decimals="-3" unitRef="usd">118000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c3" decimals="-3" unitRef="usd">13000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">31000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">52000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">225000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">472000</us-gaap:OtherAssetsCurrent>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 - FIXED ASSETS, NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 60pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"&gt;Cost:&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; text-align: justify"&gt;Accumulated depreciation:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Computers and software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;565&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;59&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;829&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;Carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;449&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;570&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Depreciation
expenses for the years ended December 31, 2022, and 2021 were $150 and $142, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 60pt; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"&gt;Cost:&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Computers and software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,278&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-weight: bold; text-align: justify"&gt;Accumulated depreciation:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Computers and software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;565&lt;/td&gt;&lt;td style="text-align: left"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Laboratory equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and office equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;59&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;829&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;Carrying amount&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;449&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;570&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c38" decimals="-3" unitRef="usd">767000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c39" decimals="-3" unitRef="usd">754000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c40" decimals="-3" unitRef="usd">197000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c41" decimals="-3" unitRef="usd">196000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c42" decimals="-3" unitRef="usd">178000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c43" decimals="-3" unitRef="usd">177000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c44" decimals="-3" unitRef="usd">136000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c45" decimals="-3" unitRef="usd">136000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c2" decimals="-3" unitRef="usd">1278000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="-3" unitRef="usd">1263000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c38" decimals="-3" unitRef="usd">565000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c39" decimals="-3" unitRef="usd">535000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c40" decimals="-3" unitRef="usd">79000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c41" decimals="-3" unitRef="usd">55000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c42" decimals="-3" unitRef="usd">126000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c43" decimals="-3" unitRef="usd">57000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c44" decimals="-3" unitRef="usd">59000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c45" decimals="-3" unitRef="usd">46000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c2" decimals="-3" unitRef="usd">829000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="-3" unitRef="usd">693000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" unitRef="usd">449000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">570000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation contextRef="c0" decimals="-3" unitRef="usd">150000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation contextRef="c4" decimals="-3" unitRef="usd">142000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 - OTHER ACCOUNTS
PAYABLE&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Employees and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;828&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Deferred revenues (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;87&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,114&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;See also Note 6H below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Employees and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;824&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;828&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Deferred revenues (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;87&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,114&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;See also Note 6H below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">824000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">828000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">208000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">199000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="c3" decimals="-3" id="ix_23_fact" unitRef="usd">87000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="c2" decimals="-3" unitRef="usd">1032000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:AccountsPayableOtherCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">1114000</us-gaap:AccountsPayableOtherCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 6  - COMMITMENTS AND CONTINGENCIES LIABILITIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px; text-align: left"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Collaboration Agreement with Israel Railways Ltd. (&#x201c;Israel
Railways&#x201d;):&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In August 2016, the Company and Israel
Railways entered into an agreement for cooperation between the parties, which was further amended on January 19, 2020, and on July 1,
2021 (&#x201c;the Railway Agreement&#x201d;). Under the Railway Agreement, the Company undertook to fulfill certain functions for the development,
marketing, distribution and sale of the systems, and Israel Railways undertook to provide the Company with services and the means to perform
tests and experiments, mainly in the form of logistics and manpower, and to provide the Company with information on certain data that
will be provided at the discretion of Israel Railways.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Pursuant to the Railway Agreement,
the Company agreed to pay Israel Railways the following:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the period from August 3, 2016 until the earliest of (a) a period of 5 years from the date of the first commercial sale or (b) the date
of an initial public offering or (c) a change of control (as defined in the Railway Agreement), Israel Railways will be entitled to a
payment of royalties in the amount of 2.75% of the Company&#x2019;s net sales.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;During
the period from August 3, 2016 until the earliest of: (a) the date of an initial public offering, (b) a change of control (as defined
in the Railways Agreement) Israel Railways will be entitled to a payment of a total of 1.5% of the total proceeds from an Initial Public Offering (&#x201c;IPO&#x201d;) or consideration,
received by the Company or its shareholders, as a result of change of control (as defined in the Railway Agreement).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Upon the completion of the initial
public offeringon April 4, 2022 (see Note 8B(8)) the Company paid to Israeli Railways a consideration of 1.5% of the actual IPO proceeds,
which was approximately $213 and its right for payment of royalties has expired.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Railway Agreement further provides
that Israel Railways will be entitled to purchase the Company&#x2019;s products and services at a price equal to half the lowest price charged
by the Company for those products and services to an unrelated third party.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In addition, as part of the Railway
Agreement and in consideration for services provided to the Company by Israel Railways, the Company granted Israel Railways an option
to purchase 195,448 of the Company&#x2019;s ordinary shares at their par value (see also Note 8D(1)).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Railway Agreement may be terminated
by either party, with 60 days&#x2019; prior written notice. Also, in the event of a change of control in the Company, Israel Railways may terminate
the Railway Agreement with 30 days&#x2019; prior written notice.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Railway Agreement was terminated
and canceled by the parties under an agreement signed on January 31, 2023 (see Note 14A below).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Memorandum of Understanding with Israel Railways: &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On August 12, 2021, the Company signed
a non-binding Memorandum of Understanding (&#x201c;MOU&#x201d;) with Israel Railways which summarizes the general terms and conditions to
be included in a detailed commercial agreement between the parties (the &#x201c;Railways Commercial Agreement&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;According to the MOU, the Company and
Israel Railways will conduct negotiations in good faith, with a view to entering into the Railways Commercial Agreement as soon as possible
before May 31, 2022. During the negotiations, Israel Railways has started conducting technical tests and analysis of the Company&#x2019;s Main
Line system on a locomotive of Israel Railways.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Subsequent to December 31, 2022 on
January 31, 2023 the Company signed the Railways Commercial Agreement with Israel Railways. See Note 14A below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Service Agreement with a Consultant:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In December 2020, the Company entered
into a service agreement with a consultant (the &#x201c;Consultant&#x201d;) according to which the Consultant will lead, control and consult
the Company&#x2019;s management in its negotiations with Israel Railways relating the Homologation Process (as defined below) and the commercial
sales of the Company&#x2019;s systems to Israel Railways.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The &#x201c;Homologation Process&#x201d;
will include defining and receiving all the required written licenses, consents and approvals, both in Israel and abroad, for installing
the Company&#x2019;s systems on Israel Railways locomotives for operational use.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#x201c;Commercial Sales&#x201d; shall
include negotiating and signing supply agreement(s) or purchase orders between the Company and Israel Railways under which Israel Railways
shall purchase from the Company at least five (5) Systems, the supply and installation of at least five Systems on Israel Railways locomotives
and receiving the entire consideration by the Company from Israel Railways under the above supply agreements or purchase orders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;If a written consent is received by
the Company from the authorized representatives of Israel Railways to enter into a Homologation Process with the Company, subject to
its successful completion and enter into negotiations regarding the purchase of the Company&#x2019;s systems by Israel Railways (the &#x201c;Triggering
Event&#x201d;), then:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#x201c;Homologation Bonus&#x201d;).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.05pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#x201c;Commercial Bonus&#x201d;).&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The signing of the MOU on August 12,
2021 mentioned in Note 6B above constitutes the occurrence of the Triggering Event as defined above, and accordingly on December 20, 2021,
the Company granted options to the Consultant for the purchase of 25,080 of the Company&#x2019;s ordinary shares at an exercise price of
$6.1393 per share. The Consultant will be eligible to exercise the options upon completion of both the Homologation Process and the sale
process for a period of 24 months from the date of their grant.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Consultant&#x2019;s right for the
Homologation Bonus and the Commercial Bonus has expired on August 12, 2022 and February 12, 2023, respectively, as the periods of 12 and
18 months, respectively, from the occurrence of the Triggering Event has passed without the completion of both terms.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In return for his services, in addition
to the bonus, the Company agreed to pay the Consultant a monthly remuneration in the amount of approximately $3, plus VAT.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The service agreement with the Consultant
is in effect from November 1, 2020, until the completion of the services determined in the agreement, as detailed above. Either party
may terminate the agreement with 30 days&#x2019; notice. On July 29, 2021, the Company sent a termination notice to the Consultant.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Memorandum of Understanding between the Company and Knorr-Bremse:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On September 17, 2020, a non-binding
memorandum of understanding (the &#x201c;Knorr-Bremse MOU&#x201d;) was signed between the Company and Knorr-Bremse Systeme f&#xfc;r Schienenfahrzeuge
GmbH, an affiliate of Knorr-Bremse AG (&#x201c;Knorr-Bremse&#x201d;) regarding cooperation between the parties with respect to Light Rail
Vehicle (&#x201c;LRV&#x201d;) systems.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Following the signing of the Knorr-Bremse
MOU, in December 2020, Knorr-Bremse placed a purchase order to the Company for developing two prototypes of the LRV system according to
specifications required by Knorr Bremse (the &#x201c;Knorr Bremse Purchase Order&#x201d;). In return for the development of the two prototypes,
Knorr Bremse paid the Company a total of approximately EUR 397 thousand (approximately $471).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;As of December 31, 2021 the Company
completed its commitment according to the Knorr Bremse Purchase Order for the supply of the two LRV prototype systems to Knorr-Bremse.
Accordingly, the Company recognized revenues in 2021 from the sale of the two LRV prototype systems and the related services in a total
amount of approximately $471.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Framework agreement with Knorr-Bremse Rail Systems Schweiz AG (&#x201c;KBCH&#x201d;):&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In August 2020, the Company entered
into a framework agreement (the &#x201c;KBCH Framework Agreement&#x201d;) with KBCH (a subsidiary of Knorr-Bremse operating in Switzerland)
regarding the supply of a prototype of the Company&#x2019;s shunting yard system to Schweizerische Bundes Bahnen Cargo (&#x201c;SBBC&#x201d;),
a freight train company in Switzerland.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Under the KBCH Framework Agreement,
the Company provided KBCH with one prototype of the shunting yard system which has been installed on a shunting locomotive in the SBBC
shunting yard, for the purpose of examining the operational performance of the shunting yard system (the &#x201c;Operational Function Test&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In consideration for the prototype
provided for the Operational Function Test, KBCH paid the Company the amount of approximately EUR 244 thousand (approximately $292). In
addition, in order to support the Operational Function Test procedure, the Company undertook to provide various professionals, as needed,
in exchange for payment at the maximum rates and amounts determined in the KBCH Framework Agreement. Accordingly, during 2021, KBCH paid
the Company an additional amount of approximately. EUR 110 thousand (approximately $125) for the Company&#x2019;s services supporting the installation
and operation of the system and its participation in part of the overall licensing process of the operating concept that were fully provided
during the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;As the delivery of the prototype and
the provision of the services described above were identified by the Company as a single performance obligation, during 2021, the Company
recognized revenues from the sale of the prototype and the related services in the total amount of approximately $417.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Strategic partnership agreement between the Company and Knorr-Bremse &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On August 19, 2021, the Company entered
into a strategic partnership agreement which summarizes the understandings for strategic cooperation between the parties.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The agreement was approved by the Company&#x2019;s
Board of Directors on August 25, 2021 and by the Company&#x2019;s General Meeting on August 26, 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;G.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Agreement for supplying equipment and services with Hitachi Rail STS Australian Pty Ltd. (&#x201c;STS&#x201d;)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In April 2021, the Company entered
into an agreement to supply equipment, personnel and services with STS, which enables STS, as the main supplier, to supply to an Australian
railway company Rio Tinto Railway Network, a prototype of the Company&#x2019;s Main Line system, for demonstrations and examining the operational
activity of the Main Line system (the &#x201c;Long-Term Pilot&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In September 2022, the Company completed
the Long-Term Pilot and accordingly recognized revenues in the year ended December 31, 2022 from the Long Term Pilot in the total amount
of EUR 192 thousands (approximately $202).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;H.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;In September 2021 the Company received a purchase order (&#x201c;PO&#x201d;) from a customer in the United
States (the &#x201c;U.S. Customer&#x201d;) for a Proof of Concept (&#x201c;POC&#x201d;) regarding to a detection system which will focus on
railway infrastructure inspection and is based on the Company&#x2019;s sensors and algorithmic capabilities, utilizing cloud computing
to handle data collections and measurements. In October 2021, the U.S. Customer paid the Company a total amount of $87 as an advance payment
according to the PO. As of December 31, 2021 the Company&#x2019;s recorded deferred revenues in the amount of $87 in other accounts payable.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In March 2022, the Company completed
the POC and accordingly recognized revenues in the year ended December 31, 2022 from the POC in the total amount of approximately $219.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <rvsn:PeriodOfFirstCommercialSales contextRef="c46">P5Y</rvsn:PeriodOfFirstCommercialSales>
    <rvsn:RoyaltyPaymentsPercentage contextRef="c47" decimals="4" unitRef="pure">0.0275</rvsn:RoyaltyPaymentsPercentage>
    <rvsn:PaymentOfTotalProceedsFromConsiderationPercentage contextRef="c46" decimals="3" unitRef="pure">0.015</rvsn:PaymentOfTotalProceedsFromConsiderationPercentage>
    <rvsn:PaymentOfTotalProceedFromConsiderationPercentage contextRef="c48" decimals="3" unitRef="pure">0.015</rvsn:PaymentOfTotalProceedFromConsiderationPercentage>
    <rvsn:PaymentOfTotalProceedFromConsiderationPercentage contextRef="c49" decimals="2" unitRef="pure">2.13</rvsn:PaymentOfTotalProceedFromConsiderationPercentage>
    <rvsn:OptionToPurchaseOrdinaryShares contextRef="c50" decimals="0" unitRef="shares">195448</rvsn:OptionToPurchaseOrdinaryShares>
    <rvsn:ServiceAgreementWithAConsultantDescription contextRef="c0">Subject
to satisfactory completion of the Homologation Process no later than 12 months as of the Triggering Event, the Company shall pay the
Consultant a onetime bonus payment of NIS 150,000, plus VAT (approximately $47) (the &#x201c;Homologation Bonus&#x201d;).
-Subject
to satisfactory completion of Commercial Sales, no later than 18 months as of the Triggering Event, the Company shall pay the Consultant
a onetime bonus payment of NIS 350,000, plus VAT (approximately $109) (the &#x201c;Commercial Bonus&#x201d;).
&#160;</rvsn:ServiceAgreementWithAConsultantDescription>
    <rvsn:OptionToPurchaseOrdinaryShares contextRef="c51" decimals="0" unitRef="shares">25080</rvsn:OptionToPurchaseOrdinaryShares>
    <rvsn:ExercisePrice contextRef="c51" decimals="4" unitRef="usdPershares">6.1393</rvsn:ExercisePrice>
    <rvsn:PaymentOfMonthlyRemunerationAmount contextRef="c0" decimals="-3" unitRef="usd">3000</rvsn:PaymentOfMonthlyRemunerationAmount>
    <rvsn:TotalAmountPaid contextRef="c0" decimals="-3" unitRef="eur">397000</rvsn:TotalAmountPaid>
    <rvsn:TotalAmountPaid contextRef="c0" decimals="0" unitRef="usd">471</rvsn:TotalAmountPaid>
    <rvsn:DevelopmentAndSales contextRef="c0" decimals="-3" unitRef="usd">471000</rvsn:DevelopmentAndSales>
    <rvsn:PaymentOfOperationalFunctionTest contextRef="c52" decimals="-3" unitRef="eur">244000</rvsn:PaymentOfOperationalFunctionTest>
    <rvsn:PaymentOfOperationalFunctionTest contextRef="c52" decimals="-3" unitRef="usd">292000</rvsn:PaymentOfOperationalFunctionTest>
    <us-gaap:OtherExpenses contextRef="c0" decimals="-3" unitRef="eur">110000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="c0" decimals="-3" unitRef="usd">125000</us-gaap:OtherExpenses>
    <us-gaap:RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements contextRef="c2" decimals="-3" unitRef="usd">417000</us-gaap:RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements>
    <rvsn:DeferredRevenuesInOtherAccountsPayable contextRef="c52" decimals="-3" unitRef="eur">192000</rvsn:DeferredRevenuesInOtherAccountsPayable>
    <rvsn:DeferredRevenuesInOtherAccountsPayable contextRef="c0" decimals="-3" unitRef="usd">202000</rvsn:DeferredRevenuesInOtherAccountsPayable>
    <us-gaap:FilmCosts contextRef="c53" decimals="-3" unitRef="usd">87000</us-gaap:FilmCosts>
    <us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent contextRef="c3" decimals="-3" unitRef="usd">87000</us-gaap:OtherLiabilitiesAndDeferredRevenueNoncurrent>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries contextRef="c0" decimals="-3" unitRef="usd">219000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <rvsn:ConvertiblePreferredSharesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 7  - CONVERTIBLE PREFERRED SHARES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify"&gt;&lt;b&gt;Issuance of Preferred A Shares&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On October 13, 2020, the Company and Knorr-Bremse
entered into an investment agreement under which the Company issued 51,282 Preferred A shares to Knorr-Bremse, in exchange for a total
investment of $10,000. As of December 31, 2021, the net proceeds, after deducting closing costs and fees, amounted to $9,965.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In addition, the Company was given, under
the investment agreement, an option to demand Knorr-Bremse to invest an additional amount of $5,000 at the same price per share (the
&#x201c;Call Option&#x201d;), provided the existence of circumstances as detailed in the investment agreement. The Call Option was accounted
as a derivative and valued at zero. On December 2, 2021, and February 14, 2022 the Company and Knorr-Bremse signed two amendments to
the investment agreement, according to which, the Company will be entitled to exercise its option in 2 installments as follows: (i) up
to $2,000 will be exercisable through March 31, 2022; and (ii) up to $2,286 will be exercisable through June 30, 2022. The aforesaid
option shall expire on the closing of the Company&#x2019;s IPO if such shall occur prior to June 30, 2022. On March 6, 2022, the Company
exercised its first installment of $2,000 and as a result issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of
$195 per share.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Preferred A shares were entitled to all the
rights of the Company&#x2019;s ordinary shares and additional rights regarding liquidation preference and listing rights. Holders of Preferred
A shares were entitled, at their option, to convert the Preferred A shares at any time into the Company&#x2019;s ordinary shares in a
1:44 ratio. In addition, prior to the Company&#x2019;s IPO, all Preferred A shares will be immediately converted into the Company&#x2019;s ordinary
shares in a 1:44 ratio, and, accordingly, all rights stated are revoked upon their conversion into the Company&#x2019;s ordinary shares.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Immediately prior to the completion of the
IPO on April 4, 2022 (see Note 8B(8)), 61,538 Preferred A shares were automatically converted into 2,707,672 ordinary shares (after giving
effect to the issuance of 10,256 Preferred A shares described above).&#160;&lt;/p&gt;</rvsn:ConvertiblePreferredSharesTextBlock>
    <us-gaap:PreferredStockSharesIssued contextRef="c54" decimals="0" unitRef="shares">51282</us-gaap:PreferredStockSharesIssued>
    <us-gaap:NetInvestmentIncome contextRef="c55" decimals="-3" unitRef="usd">10000000</us-gaap:NetInvestmentIncome>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c4" decimals="-3" unitRef="usd">9965000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts contextRef="c0" decimals="-3" unitRef="usd">5000000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <rvsn:InvestmentAgreementDescription contextRef="c0">(i) up
to $2,000 will be exercisable through March 31, 2022; and (ii) up to $2,286 will be exercisable through June 30, 2022. The aforesaid
option shall expire on the closing of the Company&#x2019;s IPO if such shall occur prior to June 30, 2022. On March 6, 2022, the Company
exercised its first installment of $2,000 and as a result issued to Knorr-Bremse, a total of 10,256 Preferred A shares at a price of
$195 per share.</rvsn:InvestmentAgreementDescription>
    <us-gaap:PreferredStockSharesIssued contextRef="c56" decimals="0" unitRef="shares">61538</us-gaap:PreferredStockSharesIssued>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="c56" decimals="0" unitRef="shares">2707672</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="c57" decimals="0" unitRef="shares">10256</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 8  - SHAREHOLDERS&#x2019; EQUITY&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;The rights of ordinary shares are as follows:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The ordinary shares confer upon the
holders the right to receive notice to participate and vote in general meetings of shareholders of the Company, the right to receive dividends,
if declared, and the right to participate in a distribution of the surplus of assets upon liquidation of the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 80pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Regarding Issuance of bonus shares
see Note 2C above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Issuance of ordinary shares and warrants: &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In August and November 2016, the Company raised gross proceeds
of $1,960 (net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued
an aggregate of 1,465,992 ordinary shares at a price of $1.36 per share and three series of warrants (A, B and C) to purchase 3,135,572
ordinary shares.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;From January 10, 2018 through November
2, 2018, series A and C warrants were exercised into 1,639,000 ordinary shares for an aggregate of $7,158. The remaining series C warrants
to purchase 17,732 ordinary shares expired on November 2, 2018.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;During May 2019, series B warrants
to purchase 234,608 of the Company&#x2019;s ordinary shares were exercised for an aggregate of $1,411 and series B warrants to purchase
1,281,456 ordinary shares expired on May 1, 2019.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In September and October 2017, the Company raised $5,192
(net proceeds, after deducting closing costs and fees) through private placements of its ordinary shares. The Company issued an aggregate
of 951,676 ordinary shares at a price of $6.14 per share and two series of warrants (D and E) to purchase 951,676 ordinary shares.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;During March 2019, series D warrants
to purchase 81,884 of the Company&#x2019;s ordinary shares were exercised for an aggregate of $470 and series D warrants to purchase 214,500
ordinary shares expired on March 19, 2019.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;During April 2019, series E warrants
to purchase 303,512 of the Company&#x2019;s ordinary shares were exercised for an aggregate of $1,711 and series E warrants to purchase
434,016 ordinary shares expired on April 6, 2019.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;From February through May 2018, the Company raised gross proceeds of $2,511 (net) through private placements
of its ordinary shares (the &#x201c;2018 Private Placement&#x201d;). The Company issued an aggregate of 184,844 ordinary shares.&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The investment transaction detailed
in Note 8B (4) below, triggered anti-dilution rights that were included in the above mentioned private placement, and accordingly an additional
510,752 ordinary shares were issued to the investors in the 2018 Private Placement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;(4)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On March 19, 2019, the Company and Knorr-Bremse entered into an agreement whereby Knorr-Bremse invested
$9,941 (after deducting closing costs and fees) in the Company in consideration of an issuance of an aggregate number of 1,803,296 ordinary
shares of the Company at a price per share equal to $5.54.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Knorr-Bremse were also issued warrants
to purchase up to 655,732 of the Company&#x2019;s ordinary shares at an exercise price per share of $5.54 (the &#x201c;KB Warrants&#x201d;).
The KB Warrants shall become exercisable (i) only upon an exercise of warrants of the respective class (i.e. series B warrants, series
D warrants and series E warrants, as the case may be), and (ii) only for the number of additional ordinary shares in accordance with the
formula of approximately 20% of the number of issued ordinary shares originating from the exercised KB warrants of the respective class,
all as specified in the agreement. During March 2019 through May 2019, all of the KB warrants have been exercised or expired (see also
Note 8B(1) &#x2013; (2) above).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;(5)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During April &#x2013; June 2021, an aggregate of options to purchase 20,724 Ordinary Shares were exercised
by former Company employees resulting in proceeds of $127.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;(6)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During March 2022, options to purchase 1,672 Ordinary Shares were exercised by former Company employees
resulting in proceeds of $10.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;(7)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In January 2022, the Company entered into a Simple Agreement for Future Equity (&#x201c;SAFE&#x201d;) with
its two main shareholders providing for financing in the aggregate amount of $1,000 (the &#x201c;Investment Amount&#x201d;) which was subsequently
amended in March 2022.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The SAFE provides for the conversion
of the Investment Amount into the Company&#x2019;s ordinary shares under certain circumstances including in particular in the case of an
initial public offering such that immediately prior to the closing of an initial public offering the Investment Amount shall automatically
convert into the number of shares and warrants equal to the Investment Amount divided by the initial public offering price. The warrants
which shall be issued shall have the same terms as the warrants to be issued in the initial public offering except such warrants shall
not be registered under the Securities Act of 1933, as amended, and shall not be tradeable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Immediately prior to the completion
of the IPO on April 4, 2022 (see Note 8B(8) below) the Investment Amount was automatically converted to 242,131 ordinary shares and 242,131
warrants to purchase ordinary shares, with an exercise price of $4.13 per share, immediately exercisable and will expire five years from
the date of issuance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(8)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On April 4, 2022, the Company completed its IPO, in which
the Company issued 3,787,241 units. Each unit includes one ordinary share and one warrant to purchase one ordinary share at an exercise
price of $4.13. The warrants are exercisable at any time up to five years after the IPO.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Gross proceeds for the offering were
approximately $15,647 (including exercise of over-allotment options as described below) and net proceeds of approximately $13,587 after
deducting underwriting discounts and commissions and offering expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Company granted Aegis Capital
Corp, the underwriter (&#x201c;Aegis&#x201d;), a 45-day over-allotment option to purchase additional ordinary shares and/or warrants to
purchase additional ordinary shares up to 15% of the number of ordinary shares and warrants, respectively, sold in the IPO solely to cover
over-allotments, if any. On April 4, 2022, Aegis partially exercised its over-allotment option with respect to 568,086 warrants to purchase
ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Equity Incentive Plan:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;In January 2017, the Board authorized
an incentive share option plan which was amended on March 21, 2022, and on September 13,2022 (&#x201c;2017 Plan&#x201d;). The 2017 Plan
provides for the grant of incentive share options to employees and service providers of the Company. Awards may be granted under the 2017
Plan until January 31, 2027.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;According to the 2017 Plan, the aggregate
number of ordinary shares that may be issued pursuant to awards will not exceed 2,332,352 ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Shares and options to service providers:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The fair value for the options to
service providers was estimated on their grant date determined using a Black-Scholes option pricing model, with the following weighted-average
assumptions: weighted average volatility of 70%, risk free interest rates of 1.4%, dividend yields of 0% and a weighted average life
of the options of up to 5 years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 106pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;As part of the Railway Agreement entered into on August 3,
2016, which was amended on January 19, 2020, and on July 1, 2021, the Company issued options to purchase up to 195,448 ordinary shares
of the Company, with an exercise price of NIS 0.01 (approximately $0.003) per share. The options were exercisable on each issuance date
and recorded as deferred expenses which are amortized over 5 years beginning August 2016. In respect of such option issuance an amount
of $196, $331, were recorded in the Company&#x2019;s statements of comprehensive loss for the years ended December 31, 2021 and 2020,
respectively included in research and development expenses and no expenses were recorded in the year ended December 31, 2022 According
to amendments to the option agreement the warrants will expire at the earlier of the following: (1) the passing of five business days
following Israel Railways&#x2019; receipt of a government approval; or (2) June 30, 2023. On January 25, 2023, Israel Railways notified
the Company that it exercises its option and accordingly the Company issued 195,448 ordinary shares to Israel Railways.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 4, 2018, the Company granted to three consulting
service providers options to purchase 98,120 ordinary shares at an exercise price of $6.1393 per share. One third of the options vested
upon the first year anniversary and the remainder of the options vested in eight quarterly tranches over a period of two years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Regarding the grant of options to a Consultant in connection
with the Company&#x2019;s arrangement with Israel Railways, see Note 6C above.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(4)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Regarding the grant of warrants to an IR service provider,
subsequent to December 31, 2022, see Note 14D below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;E.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Options to employees&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The fair value of options was estimated using the Black-Scholes
option pricing model, which was based on the following assumptions: weighted average volatility of 68%, risk free interest rates of 0.43%-2.83%,
dividend yields of 0% and expected life of the options of up to 6 years.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The following table summarizes the option activity for options
to employees, officers and directors:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="34" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;div style="padding: 0in 0in 1pt; border-bottom: Black 0.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;For
                                            the year ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;Outstanding
    as of beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,264,868&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,639,792&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;706,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,058,890&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1.85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,502,248&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(1,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(20,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(421,190&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(354,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 1pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(569,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 1pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;Outstanding
    as of end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,900,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;2.20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,264,868&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,639,792&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;Exercisable
    as of end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;805,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;2.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;683,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;595,980&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Regarding repricing during 2022, see Note 8E(3)(k) below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The weighted average fair value of
options granted during the year ended December 31, 2022, was $0.479 per share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;As of December 31, 2022, the total
unrecognized share-based payment expenses related to nonvested awards was $498, which is expected to be recognized over the next 2.75
years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;(3)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Options granted:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify; text-indent: -14.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;a)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 4, 2018, the Company granted options to purchase
452,496 ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their
grant date and vest over three years. One third of the options vested upon the first-year anniversary of the grant date and the remainder
of the options vested in eight equal quarterly tranches over a period of two years thereafter. For the year ended December 31, 2020,
the Company recorded an expense of $409. For the year ended December 31, 2021, the Company recorded a net reversal of previously recognized
expense of $9 due to termination of several employees in respect for such grant. No expenses have been recorded for the year ended December
31, 2022.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;b)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On June 24, 2018, the Company granted options to purchase 188,100
ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their grant
date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested
in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2021 and 2020, the Company
recorded an expense of $89 and $303, respectively, in respect for such grant. No expenses have been recorded for the year ended December
31, 2022.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;c)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 22, 2020, the Company granted options to purchase
671,308 ordinary shares to its employees at an exercise price of $6.14 per share (of which options to purchase 74,580 ordinary shares
were to the Company&#x2019;s former CEO that were forfeited at the end of his employment in December 2020). These options expire 10 years
after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022, 2021 and 2020, the
Company recorded an expense of $163, $380 and $812, respectively, in respect for such grant.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;d)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In October 2020, the Company granted to its former chairman
of the Board options to purchase 556,820 ordinary shares are exercisable at an exercise price of $6.14 per share. The options vest as
follows: (1) options to purchase 139,205 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2)
options to purchase 278,410 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in
the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 139,205
ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October
13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company&#x2019;s
Board at the time of vesting.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;In the event that the Company effectuates
an initial public offering, 25% of his unvested options (i.e., 139,216 options) shall be accelerate and considered fully vested immediately
prior to the closing of the IPO. Accordingly, upon the completion of the IPO on April 4, 2022 (see Note 8B(8)), 139,216 have been accelerate
and are considered fully vested.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;As of December 31, 2022, a total
of 278,410 of the former chairman&#x2019;s options has expired as the periods of 18 and 24 months has passed and the Company did not reach
the required cumulative order backlogs, as detailed above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $133, $332 and $199,respectively, in respect for such grants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;e)&lt;/td&gt;&lt;td style="text-align: justify"&gt;In October 2020, the Company granted to its CEO options to purchase 61,600 ordinary shares at an exercise
price of $6.14 per share vest as follows: (1) options to purchase 30,800 ordinary shares will vest on the condition that the Company generates,
no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and
(2) options to purchase the remaining 30,800 ordinary shares will vest on the condition that the Company generates, no later than October
12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog);
and all subject to him serving in his position at the time of vesting.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;As of December 31, 2022, a total
of 30,800 of the CEO&#x2019;s options has expired as the period of 24 months has passed and the Company did not reach the required cumulative
order backlog, as detailed above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $20, $12 and $12 , respectively, in respect for such grant.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 119.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;f)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 3, 2020, the Company granted options to purchase 107,800 ordinary shares to its employees
at an exercise price of $6.14 per share. These options expire 10 years after their grant date and vest over three years in nine tranches.
One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years
thereafter. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an expense of $46, $62 and $14, respectively, in
respect for such grant.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;g)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May 11, 2022, the Company granted to three officers options to purchase 547,162 ordinary shares including
266,216 to its former chairman of the Board, 156,081 to its CEO and 124,865 to its CFO, at an exercise price of $1.85 per share (equal
to the average closing share price on the Nasdaq over the first 30 calendar days following the IPO on April 4, 2022). These options expire
10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022. The Company recorded
an expense of $61, in respect for such grant.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;h)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May 11, 2022, and June 6, 2022, the Company granted to four of its directors&#x2019; options to purchase
119,796 ordinary shares and 39,932 ordinary shares, respectively, with an exercise price of $1.85 per share. Such options will vest one-third
following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following
36 months. For the year ended December 31, 2022, the Company recorded an expense of $17 in respect for such grant.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On September 13, 2022 the Company granted 252,000 options to its employees at an exercise price of $1.85
per share. These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested
on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended
December 31, 2022, the Company recorded an expense of $10, in respect for such grant.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;j)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On September 13, 2022 the Company granted 100,000 options to two of its officers at an exercise price
of $1.85 per share. These options expire 10 years after their grant date and vest in twelve equal quarterly tranches over a period of
three years. For the years ended December 31, 2022, the Company recorded an expense of $4, in respect for such grant.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;k)&lt;/td&gt;&lt;td style="text-align: justify"&gt;On September 13, 2022, in accordance with the terms of the 2017 Plan, the Board approved a modification
of 375,716 outstanding options held by officers and employees that had an exercise price of $6.14&#160;per share and reduced the exercise
price to $1.85&#160;per share. This resolution was effective from November 3, 2022, after receiving approval from the Israeli Tax Authorities.
The Company calculated the fair value of such options immediately before and after the modification.&#160;The Company immediately recognized
the additional fair value attributable to vested options, approximately $51, as share based payment expenses. The additional fair value
resulting from the modification, approximately $30, is being expensed over the remaining vesting period of the modified options.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"&gt;The modification of 368,170 additional
outstanding options held by the Company&#x2019;s CEO and two Directors was approved by the Board and is subject to an approval by the Company&#x2019;s
shareholders.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 110.15pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;F.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Share Based Payment Expense:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The total share-based payment expense
related to options granted to employees and service providers comprised, at each period, as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Cost of revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;323&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;411&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,162&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total share-based payment expense&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;505&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,055&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,281&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <rvsn:GrossProceeds contextRef="c58" decimals="-3" unitRef="usd">1960000</rvsn:GrossProceeds>
    <rvsn:AggregateSharesIssued contextRef="c2" decimals="0" unitRef="shares">1465992</rvsn:AggregateSharesIssued>
    <us-gaap:SaleOfStockPricePerShare contextRef="c2" decimals="2" unitRef="usdPershares">1.36</us-gaap:SaleOfStockPricePerShare>
    <rvsn:WarrantsPurchase contextRef="c59" decimals="0" unitRef="shares">3135572</rvsn:WarrantsPurchase>
    <rvsn:WarrantsPurchase contextRef="c60" decimals="0" unitRef="shares">3135572</rvsn:WarrantsPurchase>
    <rvsn:WarrantsPurchase contextRef="c61" decimals="0" unitRef="shares">3135572</rvsn:WarrantsPurchase>
    <us-gaap:ExcessStockSharesIssued contextRef="c62" decimals="0" unitRef="shares">1639000</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesIssued contextRef="c63" decimals="0" unitRef="shares">1639000</us-gaap:ExcessStockSharesIssued>
    <rvsn:GrossProceeds contextRef="c64" decimals="-3" unitRef="usd">7158000</rvsn:GrossProceeds>
    <rvsn:GrossProceeds contextRef="c65" decimals="-3" unitRef="usd">7158000</rvsn:GrossProceeds>
    <rvsn:OrdinarySharesExpired contextRef="c66" decimals="0" unitRef="shares">17732</rvsn:OrdinarySharesExpired>
    <us-gaap:ExcessStockSharesIssued contextRef="c67" decimals="0" unitRef="shares">234608</us-gaap:ExcessStockSharesIssued>
    <rvsn:OrdinarySharesExercisedAmount contextRef="c68" decimals="-3" unitRef="shares">1411000</rvsn:OrdinarySharesExercisedAmount>
    <us-gaap:ExcessStockSharesIssued contextRef="c68" decimals="0" unitRef="shares">1281456</us-gaap:ExcessStockSharesIssued>
    <us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities contextRef="c69" decimals="-3" unitRef="usd">5192000</us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities>
    <us-gaap:ExcessStockSharesIssued contextRef="c70" decimals="0" unitRef="shares">951676</us-gaap:ExcessStockSharesIssued>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c71" decimals="2" unitRef="usdPershares">6.14</us-gaap:WarrantExercisePriceIncrease>
    <rvsn:GrossProceeds contextRef="c71" decimals="-3" unitRef="usd">2000</rvsn:GrossProceeds>
    <us-gaap:ExcessStockSharesIssued contextRef="c72" decimals="0" unitRef="shares">951676</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesIssued contextRef="c73" decimals="0" unitRef="shares">81884</us-gaap:ExcessStockSharesIssued>
    <rvsn:OrdinarySharesExercisedAmount contextRef="c74" decimals="-3" unitRef="shares">470000</rvsn:OrdinarySharesExercisedAmount>
    <us-gaap:ExcessStockSharesIssued contextRef="c75" decimals="0" unitRef="shares">214500</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesIssued contextRef="c76" decimals="0" unitRef="shares">303512</us-gaap:ExcessStockSharesIssued>
    <rvsn:OrdinarySharesExercisedAmount contextRef="c77" decimals="-3" unitRef="shares">1711000</rvsn:OrdinarySharesExercisedAmount>
    <us-gaap:ExcessStockSharesIssued contextRef="c78" decimals="0" unitRef="shares">434016</us-gaap:ExcessStockSharesIssued>
    <rvsn:GrossProceeds contextRef="c79" decimals="-3" unitRef="usd">2511000</rvsn:GrossProceeds>
    <rvsn:AggregateOrdinaryShares contextRef="c80" decimals="0" unitRef="shares">184844</rvsn:AggregateOrdinaryShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="c0" decimals="0" unitRef="shares">510752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <rvsn:InvestedAgreement contextRef="c81" decimals="-3" unitRef="usd">9941000</rvsn:InvestedAgreement>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c74" decimals="0" unitRef="shares">1803296</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c81" decimals="2" unitRef="usdPershares">5.54</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ExcessStockSharesIssued contextRef="c82" decimals="0" unitRef="shares">655732</us-gaap:ExcessStockSharesIssued>
    <us-gaap:WarrantExercisePriceDecrease contextRef="c0" decimals="2" unitRef="usdPershares">5.54</us-gaap:WarrantExercisePriceDecrease>
    <rvsn:WarrantsPercentage contextRef="c0" decimals="2" unitRef="pure">0.20</rvsn:WarrantsPercentage>
    <rvsn:OrdinarySharesExercisedAmount contextRef="c83" decimals="0" unitRef="shares">20724</rvsn:OrdinarySharesExercisedAmount>
    <us-gaap:ExcessStockSharesIssued contextRef="c83" decimals="-3" unitRef="shares">127000</us-gaap:ExcessStockSharesIssued>
    <rvsn:OrdinarySharesExercisedAmount contextRef="c84" decimals="0" unitRef="shares">1672</rvsn:OrdinarySharesExercisedAmount>
    <rvsn:GrossProceeds contextRef="c85" decimals="-3" unitRef="usd">10000</rvsn:GrossProceeds>
    <rvsn:GrossProceeds contextRef="c86" decimals="-3" unitRef="usd">1000000</rvsn:GrossProceeds>
    <us-gaap:PreferredStockDividendsShares contextRef="c57" decimals="0" unitRef="shares">242131</us-gaap:PreferredStockDividendsShares>
    <rvsn:WarrantsPurchase contextRef="c57" decimals="0" unitRef="shares">242131</rvsn:WarrantsPurchase>
    <us-gaap:WarrantExercisePriceDecrease contextRef="c57" decimals="2" unitRef="usdPershares">4.13</us-gaap:WarrantExercisePriceDecrease>
    <us-gaap:SharesIssuedPricePerShare contextRef="c87" decimals="0" unitRef="usdPershares">3787241</us-gaap:SharesIssuedPricePerShare>
    <rvsn:WarrantsDescription contextRef="c87">Each unit includes one ordinary share and one warrant to purchase one ordinary share at an exercise
price of $4.13. The warrants are exercisable at any time up to five years after the IPO.</rvsn:WarrantsDescription>
    <rvsn:GrossProceeds contextRef="c0" decimals="-3" unitRef="usd">15647000</rvsn:GrossProceeds>
    <rvsn:NetProceeds contextRef="c0" decimals="-3" unitRef="usd">13587000</rvsn:NetProceeds>
    <rvsn:NumberOfOrdinarySharesAndWarrantsPercentage contextRef="c0" decimals="2" unitRef="pure">0.15</rvsn:NumberOfOrdinarySharesAndWarrantsPercentage>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c88" decimals="0" unitRef="shares">568086</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PreferredStockDividendsShares contextRef="c0" decimals="0" unitRef="shares">2332352</us-gaap:PreferredStockDividendsShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="2" unitRef="pure">0.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <rvsn:RiskFreeInterestRate contextRef="c0" decimals="3" unitRef="pure">0.014</rvsn:RiskFreeInterestRate>
    <rvsn:DividendYields contextRef="c0" decimals="2" unitRef="pure">0</rvsn:DividendYields>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c0">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c89" decimals="0" unitRef="shares">195448</us-gaap:StockRepurchasedDuringPeriodShares>
    <rvsn:ExercisePricePerShares contextRef="c89" decimals="2" unitRef="ilsPershares">0.01</rvsn:ExercisePricePerShares>
    <rvsn:ExercisePricePerShares contextRef="c90" decimals="3" unitRef="usdPershares">0.003</rvsn:ExercisePricePerShares>
    <rvsn:AmortizedOver contextRef="c90">P5Y</rvsn:AmortizedOver>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="c0" decimals="-3" unitRef="usd">196000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="c4" decimals="-3" unitRef="usd">331000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:PreferredStockDividendsShares contextRef="c91" decimals="0" unitRef="shares">195448</us-gaap:PreferredStockDividendsShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c92" decimals="0" unitRef="shares">98120</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockOptionExercisePriceIncrease contextRef="c92" decimals="4" unitRef="usdPershares">6.1393</us-gaap:StockOptionExercisePriceIncrease>
    <us-gaap:PercentageOfWeightedAverageCostInventory contextRef="c93" decimals="2" unitRef="pure">0.68</us-gaap:PercentageOfWeightedAverageCostInventory>
    <rvsn:RiskFreeInterestRate contextRef="c94" decimals="4" unitRef="pure">0.0043</rvsn:RiskFreeInterestRate>
    <rvsn:RiskFreeInterestRate contextRef="c95" decimals="4" unitRef="pure">0.0283</rvsn:RiskFreeInterestRate>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="c96" decimals="2" unitRef="pure">0</us-gaap:PreferredStockDividendRatePercentage>
    <rvsn:OptionsExpire contextRef="c96">P6Y</rvsn:OptionsExpire>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="34" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;div style="padding: 0in 0in 1pt; border-bottom: Black 0.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;For
                                            the year ended December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Amount
    of options&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Weighted
    average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 9pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 23.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;Outstanding
    as of beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,264,868&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,639,792&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;706,728&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,058,890&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1.85&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,502,248&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(1,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(20,724&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;Forfeited
    or expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(421,190&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(354,200&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 1pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;(569,184&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 1pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-size: 1pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-size: 1pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;Outstanding
    as of end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,900,896&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;2.20&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;8.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,264,868&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;1,639,792&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;Exercisable
    as of end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;805,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;2.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;683,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;7.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;595,980&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.14&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Regarding repricing during 2022, see Note 8E(3)(k) below.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.75pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c3" decimals="INF" unitRef="shares">1264868</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c3"
      decimals="2"
      id="ix_24_fact"
      unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c19" decimals="INF" unitRef="shares">1639792</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c111" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c4">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c10" decimals="INF" unitRef="shares">706728</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c112" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c5">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c0" decimals="INF" unitRef="shares">1058890</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">1.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c5" decimals="INF" unitRef="shares">1502248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="c113" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c0" decimals="INF" unitRef="shares">1672</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c4" decimals="INF" unitRef="shares">20724</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="c114" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c0" decimals="INF" unitRef="shares">421190</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="c0" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c4" decimals="INF" unitRef="shares">354200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="c114" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c5" decimals="INF" unitRef="shares">569184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="c113" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c2" decimals="INF" unitRef="shares">1900896</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c2" decimals="2" unitRef="usdPershares">2.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod contextRef="c0">P8Y2M12D</rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c3" decimals="INF" unitRef="shares">1264868</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c115" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod contextRef="c4">P7Y6M</rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c19" decimals="INF" unitRef="shares">1639792</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="c111" decimals="2" unitRef="usdPershares">6.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod contextRef="c5">P6Y6M</rvsn:WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod>
    <rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars contextRef="c0" decimals="INF" unitRef="shares">805062</rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars>
    <rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod contextRef="c0" decimals="2" unitRef="usdPershares">2.46</rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod>
    <rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars contextRef="c0">P6Y7M6D</rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars>
    <rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars contextRef="c4" decimals="INF" unitRef="shares">683723</rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars>
    <rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod contextRef="c114" decimals="2" unitRef="usdPershares">6.14</rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod>
    <rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars contextRef="c4">P7Y4M24D</rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars>
    <rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars contextRef="c5" decimals="INF" unitRef="shares">595980</rvsn:NumberOfOptionsExercisableAtEndOfPeriodinDollars>
    <rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod contextRef="c113" decimals="2" unitRef="usdPershares">6.14</rvsn:WeightedAverageExercisePriceExercisableAtEndOfPeriod>
    <rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars contextRef="c5">P6Y9M18D</rvsn:WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="c0" decimals="3" unitRef="usdPershares">0.479</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <rvsn:SharebasedPaymentExpensesRelatedToNonvestedAwards contextRef="c0" decimals="-3" unitRef="usd">498000</rvsn:SharebasedPaymentExpensesRelatedToNonvestedAwards>
    <rvsn:ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm contextRef="c0">P2Y9M</rvsn:ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c97" decimals="0" unitRef="shares">452496</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c98" decimals="0" unitRef="shares">452496</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c92" decimals="2" unitRef="usdPershares">6.14</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c92">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:OtherExpenses contextRef="c5" decimals="-3" unitRef="usd">409000</us-gaap:OtherExpenses>
    <us-gaap:TerminationLoans contextRef="c3" decimals="-3" unitRef="usd">9000</us-gaap:TerminationLoans>
    <rvsn:OptionsGrantedDescription contextRef="c99">b)On June 24, 2018, the Company granted options to purchase 188,100
ordinary shares to its employees and directors at an exercise price of $6.14 per share. These options expire 10 years after their grant
date and vest over three years in nine tranches. One third of the options vested upon the first-year anniversary and the reminder vested
in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2021 and 2020, the Company
recorded an expense of $89 and $303, respectively, in respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c100">the Company granted options to purchase
671,308 ordinary shares to its employees at an exercise price of $6.14 per share (of which options to purchase 74,580 ordinary shares
were to the Company&#x2019;s former CEO that were forfeited at the end of his employment in December 2020). These options expire 10 years
after their grant date and vest over three years in nine tranches. One-third of the options vested on September 18, 2020 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022, 2021 and 2020, the
Company recorded an expense of $163, $380 and $812, respectively, in respect for such grant.</rvsn:OptionsGrantedDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c101" decimals="0" unitRef="shares">556820</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c102" decimals="2" unitRef="usdPershares">6.14</us-gaap:WarrantExercisePriceIncrease>
    <rvsn:OptionsGrantedDescription contextRef="c102">(1) options to purchase 139,205 ordinary shares vested in one tranche at the end of 12 months from October 13, 2020; and (2)
options to purchase 278,410 ordinary shares will vest in the event that the Company generate a cumulative order backlog (as defined in
the option agreement) in the amount of not less than $7,000 by the end of 18 months from October 13, 2020; (3) options to purchase 139,205
ordinary shares will vest in the event that the Company reaches a cumulative order backlog of $15,000 by the end of 24 months from October
13, 2020 (including the first cumulative order backlog); and all subject to him serving as the active Chairman of the Company&#x2019;s
Board at the time of vesting.</rvsn:OptionsGrantedDescription>
    <rvsn:UnvestedOptionsPercentage contextRef="c102" decimals="2" unitRef="pure">0.25</rvsn:UnvestedOptionsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="c102" decimals="0" unitRef="shares">139216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c103" decimals="0" unitRef="shares">139216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="c0" decimals="0" unitRef="shares">278410</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:OtherNoncashExpense contextRef="c0" decimals="-3" unitRef="usd">133000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="c4" decimals="-3" unitRef="usd">332000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense contextRef="c5" decimals="-3" unitRef="usd">199000</us-gaap:OtherNoncashExpense>
    <rvsn:OptionsGrantedDescription contextRef="c104">the Company granted to its CEO options to purchase 61,600 ordinary shares at an exercise
price of $6.14 per share vest as follows: (1) options to purchase 30,800 ordinary shares will vest on the condition that the Company generates,
no later than October 12, 2022, a cumulative order backlog (as defined in the option agreement) in an amount not less than $10,000; and
(2) options to purchase the remaining 30,800 ordinary shares will vest on the condition that the Company generates, no later than October
12, 2024 a cumulative order backlog (as defined above) in an amount not less than $20,000 (including the first cumulative order backlog);
and all subject to him serving in his position at the time of vesting.As of December 31, 2022, a total
of 30,800 of the CEO&#x2019;s options has expired as the period of 24 months has passed and the Company did not reach the required cumulative
order backlog, as detailed above.&#160;For the years ended December 31,
2022, 2021 and 2020, the Company recorded an expense of $20, $12 and $12 , respectively, in respect for such grant.&#160;</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c105">f)On November 3, 2020, the Company granted options to purchase 107,800 ordinary shares to its employees
at an exercise price of $6.14 per share. These options expire 10 years after their grant date and vest over three years in nine tranches.
One-third of the options vested on November 3, 2021, and the remainder vest in eight equal quarterly tranches over a period of two years
thereafter. For the years ended December 31, 2022, 2021 and 2020, the Company recorded an expense of $46, $62 and $14, respectively, in
respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c106">g)On May 11, 2022, the Company granted to three officers options to purchase 547,162 ordinary shares including
266,216 to its former chairman of the Board, 156,081 to its CEO and 124,865 to its CFO, at an exercise price of $1.85 per share (equal
to the average closing share price on the Nasdaq over the first 30 calendar days following the IPO on April 4, 2022). These options expire
10 years after their grant date and vest over three years in nine tranches. One-third of the options vested on May 11, 2023 and the remainder
vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended December 31, 2022. The Company recorded
an expense of $61, in respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c107">the Company granted to four of its directors&#x2019; options to purchase
119,796 ordinary shares and 39,932 ordinary shares, respectively, with an exercise price of $1.85 per share. Such options will vest one-third
following 12 months from the grant date of such options, second one-third following 24 months from the grant date and the balance following
36 months. For the year ended December 31, 2022, the Company recorded an expense of $17 in respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c108">i)On September 13, 2022 the Company granted 252,000 options to its employees at an exercise price of $1.85
per share. These options expire 10 years after their grant date and vest over three years in nine tranches. One-third of the options vested
on September 13, 2023 and the remainder vest in eight equal quarterly tranches over a period of two years thereafter. For the years ended
December 31, 2022, the Company recorded an expense of $10, in respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c109">j)On September 13, 2022 the Company granted 100,000 options to two of its officers at an exercise price
of $1.85 per share. These options expire 10 years after their grant date and vest in twelve equal quarterly tranches over a period of
three years. For the years ended December 31, 2022, the Company recorded an expense of $4, in respect for such grant.</rvsn:OptionsGrantedDescription>
    <rvsn:OptionsGrantedDescription contextRef="c110">in accordance with the terms of the 2017 Plan, the Board approved a modification
of 375,716 outstanding options held by officers and employees that had an exercise price of $6.14&#160;per share and reduced the exercise
price to $1.85&#160;per share. This resolution was effective from November 3, 2022, after receiving approval from the Israeli Tax Authorities.
The Company calculated the fair value of such options immediately before and after the modification.&#160;The Company immediately recognized
the additional fair value attributable to vested options, approximately $51, as share based payment expenses. The additional fair value
resulting from the modification, approximately $30, is being expensed over the remaining vesting period of the modified options.The modification of 368,170 additional
outstanding options held by the Company&#x2019;s CEO and two Directors was approved by the Board and is subject to an approval by the Company&#x2019;s
shareholders.&#160;</rvsn:OptionsGrantedDescription>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Cost of revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;323&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;411&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,162&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total share-based payment expense&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;505&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,055&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,281&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:CostOfRevenue contextRef="c116" decimals="-3" unitRef="usd">8000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c117" decimals="-3" unitRef="usd">36000</us-gaap:CostOfRevenue>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c116" decimals="-3" unitRef="usd">174000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c117" decimals="-3" unitRef="usd">608000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c118" decimals="-3" unitRef="usd">1119000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c116" decimals="-3" unitRef="usd">323000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c117" decimals="-3" unitRef="usd">411000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c118" decimals="-3" unitRef="usd">1162000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c116" decimals="-3" unitRef="usd">505000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c117" decimals="-3" unitRef="usd">1055000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c118" decimals="-3" unitRef="usd">2281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 9  - RESEARCH AND DEVELOPMENT, NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Payroll and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,586&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Share-based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;R&amp;amp;D consumables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Rent and office maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Subcontracted work and consulting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Travel and other expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;347&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;110&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,230&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,208&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,205&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Payroll and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,586&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Share-based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;R&amp;amp;D consumables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Rent and office maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;359&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;132&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;123&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Subcontracted work and consulting&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;82&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Travel and other expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;347&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;110&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;67&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,230&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,208&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,205&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c119" decimals="-3" unitRef="usd">5049000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c120" decimals="-3" unitRef="usd">5586000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c121" decimals="-3" unitRef="usd">5065000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c119" decimals="-3" unitRef="usd">174000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c120" decimals="-3" unitRef="usd">608000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c121" decimals="-3" unitRef="usd">1119000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment contextRef="c119" decimals="-3" unitRef="usd">160000</us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment>
    <us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment contextRef="c120" decimals="-3" unitRef="usd">318000</us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment>
    <us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment contextRef="c121" decimals="-3" unitRef="usd">390000</us-gaap:ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment>
    <us-gaap:CostMaintenance contextRef="c119" decimals="-3" unitRef="usd">355000</us-gaap:CostMaintenance>
    <us-gaap:CostMaintenance contextRef="c120" decimals="-3" unitRef="usd">390000</us-gaap:CostMaintenance>
    <us-gaap:CostMaintenance contextRef="c121" decimals="-3" unitRef="usd">359000</us-gaap:CostMaintenance>
    <us-gaap:Depreciation contextRef="c119" decimals="-3" unitRef="usd">130000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c120" decimals="-3" unitRef="usd">132000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c121" decimals="-3" unitRef="usd">123000</us-gaap:Depreciation>
    <rvsn:SubcontractedWorkAndConsulting contextRef="c119" decimals="-3" unitRef="usd">15000</rvsn:SubcontractedWorkAndConsulting>
    <rvsn:SubcontractedWorkAndConsulting contextRef="c120" decimals="-3" unitRef="usd">64000</rvsn:SubcontractedWorkAndConsulting>
    <rvsn:SubcontractedWorkAndConsulting contextRef="c121" decimals="-3" unitRef="usd">82000</rvsn:SubcontractedWorkAndConsulting>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c119" decimals="-3" unitRef="usd">347000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c120" decimals="-3" unitRef="usd">110000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c121" decimals="-3" unitRef="usd">67000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c119" decimals="-3" unitRef="usd">6230000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c120" decimals="-3" unitRef="usd">7208000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c121" decimals="-3" unitRef="usd">7205000</us-gaap:ResearchAndDevelopmentExpense>
    <rvsn:DisclosureOfGeneralAndAdministrativeTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE&#160;10  - GENERAL AND ADMINISTRATIVE&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Payroll and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,508&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Share-based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Professional services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;555&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Rent and office maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Marketing and others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,265&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,316&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</rvsn:DisclosureOfGeneralAndAdministrativeTextBlock>
    <rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Payroll and related expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,508&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,563&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Share-based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Professional services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;555&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Travel expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Rent and office maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Marketing and others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,265&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"/&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,316&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c0" decimals="-3" unitRef="usd">1845000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c4" decimals="-3" unitRef="usd">1508000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:CostsAndExpensesRelatedParty contextRef="c5" decimals="-3" unitRef="usd">1563000</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c0" decimals="-3" unitRef="usd">323000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c4" decimals="-3" unitRef="usd">411000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c5" decimals="-3" unitRef="usd">1162000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProfessionalFees contextRef="c0" decimals="-3" unitRef="usd">1451000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c4" decimals="-3" unitRef="usd">1133000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c5" decimals="-3" unitRef="usd">555000</us-gaap:ProfessionalFees>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c0" decimals="-3" unitRef="usd">115000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c4" decimals="-3" unitRef="usd">48000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c5" decimals="-3" unitRef="usd">26000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:CostMaintenance contextRef="c0" decimals="-3" unitRef="usd">118000</us-gaap:CostMaintenance>
    <us-gaap:CostMaintenance contextRef="c4" decimals="-3" unitRef="usd">130000</us-gaap:CostMaintenance>
    <us-gaap:CostMaintenance contextRef="c5" decimals="-3" unitRef="usd">120000</us-gaap:CostMaintenance>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="-3" unitRef="usd">20000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c4" decimals="-3" unitRef="usd">11000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c5" decimals="-3" unitRef="usd">67000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:MarketingExpense contextRef="c0" decimals="-3" unitRef="usd">393000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="c4" decimals="-3" unitRef="usd">75000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="c5" decimals="-3" unitRef="usd">7000</us-gaap:MarketingExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">4265000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c4" decimals="-3" unitRef="usd">3316000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c5" decimals="-3" unitRef="usd">3500000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE&#160;11  - TAXES ON INCOME&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company is subject to income taxes under Israeli tax laws:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Israeli corporate tax rate was 23% in 2022, 2021 and
2020.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;As of December 31, 2022, the Company generated net operating
losses of approximately $42,795, which may be carried forward and offset against taxable income in the future for an indefinite period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;3.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company is still in its development stage and has not
yet generated revenues. Therefore, it is more likely than not that sufficient taxable income will not be available for the tax losses
to be utilized in the foreseeable future. Therefore, a valuation allowance was recorded to cover the entire balance of the deferred tax
assets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"/&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Deferred tax assets:&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify; padding-bottom: 1.5pt"&gt;Deferred taxes due to carryforward losses&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;9,843&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;8,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;Income tax expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;4.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company has no uncertain tax positions and foreign sources
of income.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c122" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c123" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c124" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c2" decimals="-3" unitRef="usd">42795000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"/&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;Deferred tax assets:&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify; padding-bottom: 1.5pt"&gt;Deferred taxes due to carryforward losses&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;9,843&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;8,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,396&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt"&gt;Income tax expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-85"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c2" decimals="-3" unitRef="usd">9843000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c3" decimals="-3" unitRef="usd">8396000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="-3" unitRef="usd">9843000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="-3" unitRef="usd">8396000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;NOTE 12
- TRANSACTIONS AND BALANCES WITH RELATED PARTIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 28.35pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Parties considered to be related to
the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common
control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families
of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully
pursuing its own separate interests.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Transactions:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif"&gt;__&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;888&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Severance payment to former Company CEO&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;General and administrative expenses (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;147&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;One time IPO bonus in the amount of $97 and $50 to the Company&#x2019;s
CEO and its former chairman, respectively.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Balances:&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Accounts receivable (1)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif"&gt;__&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;87&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 6D above.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: justify"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif"&gt;__&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;888&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Severance payment to former Company CEO&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;234&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;General and administrative expenses (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;147&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;One time IPO bonus in the amount of $97 and $50 to the Company&#x2019;s
CEO and its former chairman, respectively.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <rvsn:RevenuesFromRelatedParties contextRef="c4" decimals="-3" unitRef="usd">888000</rvsn:RevenuesFromRelatedParties>
    <us-gaap:SeveranceCosts1 contextRef="c5" decimals="-3" unitRef="usd">234000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ix_25_fact" unitRef="usd">147000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c125" decimals="0" unitRef="usd">97</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c126" decimals="0" unitRef="usd">50</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Accounts receivable (1)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif"&gt;__&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;87&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;__&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;See Note 6D above.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities>
    <us-gaap:AccountsReceivableNet
      contextRef="c128"
      decimals="-3"
      id="ix_26_fact"
      unitRef="usd">87000</us-gaap:AccountsReceivableNet>
    <us-gaap:OtherAssetsCurrent contextRef="c127" decimals="-3" unitRef="usd">27000</us-gaap:OtherAssetsCurrent>
    <rvsn:LeasesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 &#x2013; LEASES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On April 4, 2021, the Company signed
an amendment to the lease of the Company&#x2019;s offices in Raanana, Israel, according to which, instead of the additional lease period under
the option in the lease, the Company extended the lease period for another five years beginning on September 9, 2021 (the date the current
lease period ends) until September 8, 2026 (the &#x201c;Lease Update&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;According to the Lease Update, the
monthly rent for the Company&#x2019;s offices (excluding parking and management fees) will be approximately NIS 79 thousand (approx. $25) in
the first two years, NIS 82 thousand (approx. $26) in the third and fourth lease years and NIS 83 thousand (approx. $26) in the fifth
year. All the amounts are linked to the Consumer Price Index.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;According to the Lease Update, the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;At the time of the amendment, the Company
updated its lease liability and right-of-use asset in a total amount of approx. $458, which reflects the expected lease term until September
8, 2026.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;For the years ended December 31, 2022
2021 and 2020, operating lease expenses recorded in the Statements of Comprehensive Loss were $357, $405 and $375, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Future lease payments under operating
leases as of December 31, 2022 were as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 87%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liability balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,079&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The weighted average lease term and
weighted average discount rate as of December 31, 2022 was as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Operating leases weighted average remaining lease term (in years)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating leases weighted average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</rvsn:LeasesDisclosureTextBlock>
    <us-gaap:PaymentsForRent contextRef="c129" decimals="-3" unitRef="ils">79000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c129" decimals="-3" unitRef="usd">25000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c130" decimals="-3" unitRef="ils">82000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c130" decimals="-3" unitRef="usd">26000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c131" decimals="-3" unitRef="ils">83000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c131" decimals="-3" unitRef="usd">26000</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="c0">the
Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031 with a monthly rent
of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c0" decimals="-3" unitRef="usd">458000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LeaseExpirationDate1 contextRef="c0">2026-09-08</us-gaap:LeaseExpirationDate1>
    <us-gaap:BenefitsLossesAndExpenses contextRef="c0" decimals="-3" unitRef="usd">357000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses contextRef="c4" decimals="-3" unitRef="usd">405000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses contextRef="c5" decimals="-3" unitRef="usd">375000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 87%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,174&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(95&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total lease liability balance&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,079&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c2" decimals="-3" unitRef="usd">326000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c2" decimals="-3" unitRef="usd">312000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c2" decimals="-3" unitRef="usd">317000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c2" decimals="-3" unitRef="usd">219000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <rvsn:FutureLeasePayments contextRef="c2" decimals="-3" unitRef="usd">1174000</rvsn:FutureLeasePayments>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationImputedInterest contextRef="c2" decimals="-3" unitRef="usd">95000</us-gaap:UnrecordedUnconditionalPurchaseObligationImputedInterest>
    <us-gaap:OperatingLeaseLiability contextRef="c2" decimals="-3" unitRef="usd">1079000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Operating leases weighted average remaining lease term (in years)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating leases weighted average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c2">P3Y9M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c2" decimals="2" unitRef="pure">0.05</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 - SUBSEQUENT EVENTS &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 48px"/&gt;&lt;td style="width: 24px"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Israel Railways&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Following the Railways MOU with Israel Railways as detailed
in Note 6B. above on January 31, 2023 the Company signed an agreement with Israel Railways to purchase ten (10) Rail Vision Main Line
Systems and related services for a total amount of approximately $1.4 million.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="text-align: justify; margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Regarding the exercise of Israel Railways options subsequent
to December 31, 2022, see Note 8D(1) above.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99.25pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 48px"/&gt;&lt;td style="text-align: justify; width: 24px"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On &lt;span&gt;January 19, 2023, the Company announced the appointment of an
existing director,&#160;Mark Cleobury, as Chairman of the Board. Mr. Cleobury succeeds Shmuel Donnerstein who served as the Company&#x2019;s
Chairman since 2020. Donnerstein will continue to serve Rail Vision as a Board member.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 48px"/&gt;&lt;td style="text-align: justify; width: 24px"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February 16, 2023, a leading US-based rail and leasing services company purchased a Switch Yard System
for $140,000 with support, to evaluate its performance during a six-month trial. The Company&#x2019;s new customer offers a suite of rail-centric
services including in-plant rail switching and material handling services.&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c0" decimals="-5" unitRef="usd">1400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription contextRef="c0">a leading US-based rail and leasing services company purchased a Switch Yard System
for $140,000 with support, to evaluate its performance during a six-month trial.</us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription>
    <dei:DocumentAccountingStandard contextRef="c0" id="hidden-fact-0">U.S. GAAP</dei:DocumentAccountingStandard>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="c2"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c2"
      id="hidden-fact-2"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c2"
      id="hidden-fact-3"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="c5"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="c5"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="hidden-fact-7"
      unitRef="usdPershares">-0.74</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c4"
      decimals="2"
      id="hidden-fact-8"
      unitRef="usdPershares">-1.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c5"
      decimals="2"
      id="hidden-fact-9"
      unitRef="usdPershares">-1.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-10"
      unitRef="shares">14174422</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="hidden-fact-11"
      unitRef="shares">9136600</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="hidden-fact-12"
      unitRef="shares">9148143</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c6"
      id="hidden-fact-13"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c6"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c12"
      id="hidden-fact-15"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c12"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c13"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c14"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c5"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c11"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c12"
      id="hidden-fact-21"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c12"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c14"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c11"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c12"
      id="hidden-fact-25"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c12"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c13"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="c21"
      id="hidden-fact-28"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c21"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c22"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c23"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c4"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c21"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c23"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c21"
      id="hidden-fact-37"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c21"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c23"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c20"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c21"
      id="hidden-fact-41"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c21"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c22"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="c29"
      id="hidden-fact-44"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c29"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c30"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c31"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c0"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c31"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c28"
      id="hidden-fact-50"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c28"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c31"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares
      contextRef="c28"
      id="hidden-fact-53"
      unitRef="shares"
      xsi:nil="true"/>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering
      contextRef="c28"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering
      contextRef="c31"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c28"
      id="hidden-fact-56"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c28"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c29"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c31"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c28"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c29"
      id="hidden-fact-61"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c29"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c28"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c29"
      id="hidden-fact-64"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c29"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c30"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c32"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c4"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c5"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c4"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c5"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:ObtainingARightofuseAssetInExchangeForALeaseLiability
      contextRef="c0"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:ConversionOfPreferredShares
      contextRef="c4"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:ConversionOfPreferredShares
      contextRef="c5"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:ConversionOfAConvertibleDebt
      contextRef="c4"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:ConversionOfAConvertibleDebt
      contextRef="c5"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital
      contextRef="c4"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital
      contextRef="c5"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherDeferredCostsNet
      contextRef="c2"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="c2"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c5"
      id="hidden-fact-82"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c113"
      id="hidden-fact-83"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="c118"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c2"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c3"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:RevenuesFromRelatedParties
      contextRef="c0"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <rvsn:RevenuesFromRelatedParties
      contextRef="c5"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SeveranceCosts1
      contextRef="c0"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="c4"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="c5"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNet
      contextRef="c127"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherAssetsCurrent
      contextRef="c128"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001743905</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-34"
          xlink:label="hidden-fact-34"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-58"
          xlink:label="hidden-fact-58"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents an amount less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-34"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-58"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-16"
          xlink:label="hidden-fact-16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-38"
          xlink:label="hidden-fact-38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-21"
          xlink:label="hidden-fact-21"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-37"
          xlink:label="hidden-fact-37"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-26"
          xlink:label="hidden-fact-26"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-42"
          xlink:label="hidden-fact-42"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-28"
          xlink:label="hidden-fact-28"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-41"
          xlink:label="hidden-fact-41"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-25"
          xlink:label="hidden-fact-25"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-29"
          xlink:label="hidden-fact-29"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-22"
          xlink:label="hidden-fact-22"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-15"
          xlink:label="hidden-fact-15"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares
effected on February 13, 2022 (see note 1C)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-16"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-38"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-21"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-37"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-26"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-42"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-28"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-41"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-25"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-29"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-22"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-34"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-15"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-19"
          xlink:label="hidden-fact-19"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-18"
          xlink:label="hidden-fact-18"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-17"
          xlink:label="hidden-fact-17"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Issuance costs in the amount of approximately $35.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-16"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-19"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-18"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-17"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-15"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-62"
          xlink:label="hidden-fact-62"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-45"
          xlink:label="hidden-fact-45"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-61"
          xlink:label="hidden-fact-61"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-64"
          xlink:label="hidden-fact-64"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-44"
          xlink:label="hidden-fact-44"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-65"
          xlink:label="hidden-fact-65"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Retroactively adjusted to reflect the issuance of bonus shares effected on February 13, 2022 (see note 1C)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-62"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-45"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-58"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-61"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-64"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-44"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-65"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-52"
          xlink:label="hidden-fact-52"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-51"
          xlink:label="hidden-fact-51"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-50"
          xlink:label="hidden-fact-50"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Issuance costs in the amount of approximately $2,060.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-52"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-51"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-50"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-81"
          xlink:label="hidden-fact-81"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See also Note 6H below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-81"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Regarding repricing during 2022, see Note 8E(3)(k) below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-90"
          xlink:label="hidden-fact-90"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-91"
          xlink:label="hidden-fact-91"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">One time IPO bonus in the amount of $97 and $50 to the Company&#x2019;s
CEO and its former chairman, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-90"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-91"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-92"
          xlink:label="hidden-fact-92"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 6D above.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-92"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0_##/C.GSV!Q3\%JA$='PB-GYL3,!$TXM>L1Q%KI'9X,,PX;J3 #; +22!?
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MR$!FR7.K!0ACZ"7V-5#6"[#O-?.PV4D9L6$!FZSK0HL<M(4)1.J,TO+C$#$
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MZ9"=N^$-&>KGW6H%@E#[V>:69L'SGCJ<8A4F=@LW(J!(_<BY K[PC-C;J2P
MZH,MU6F%%Z<A=Y;^_CUF1T-7Z E2]J?@PF"8H1W.%TJ#+ZTPN/$R7$0?L+J"
MCS\I0^:JINL(95W1.1]>22JR7-C+GBF4^2)MK'HE.%[GIG,AVJ,;B&I^AZP%
M1LK;7-HV2>77XR-*?(A0[BG=.<24="K1VYL7U;9-SU0@ =!6)N9"ZQ[SCME
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M#<)Y#%;D2/%)2G9)D7E&X8C>M-Z\&B5)[_Q&* 5W?D\_$Y\?1TS(4F8<'KG
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M1GE)L.G 1ZVHH.Q6AV_MQAO5O4*:6J@11Y"&,];CWD,12=_1W2YT_5^)CPI
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M!5,JP'_+E7E=@'/' GR3YT6=Q@*O;*,2_IEN(U!0E"?\ 365YGPE<E%&&=^
MO:?YBLBJ#!/&S[CTVV*SC?(G:WR?)'U($Y$GE<72)?APG,$*B44[]1XPR8#=
M(W@2;"5=-(0H:J^J*;=90UM'525 5L1MEH*1)9%YIZ)JPC^)582"6O'W5=5$
M.3 -MRR*'):1@F.5$-(^W;<\6A0/8L*N)[W;=]0!U#]&91GE=?6"G3GG_'W.
MKYH5@ A]]P$6V2Q &:[M3"V3(%Y&:242OBJ+JN+;LHB%2"H&>YPZUGQJ\[,<
MPH.^#G):UK ,.'H3HQ9XG!45_5U4M:1C*41U#EN41;-:PY/I XIPFX$9 J)+
M<TKQKSX/TN(T52DP*Q(6@>!7JQ)$5A/?CN5/ VL^=W<E (SB9E(^I\[$F_(M
M4$I?*^V6(%=P@E00#5I>_.S*XM=TR]MSTGQ3QFM >^Y9CA=8P<QE.[2^*XL-
M_S'*&[SHV(A53M@RK<7-7/F%I;>]DMMT>S\*H$Y\%65,6DASV-^QIM[<LFU[
MATD(Q'PHDM.9Y02A\E>!L1C5H?;K=F(F8\[,FGF[,A1?MRDX P>K[0Q&<C#A
M-TV)"_\</>&%><O2]?@6KN=;4SL<F+^"F1WE#^4PRB@HWW%(@#M;FVICCN6&
M<&\P/<0@\D$AQIE/V)E+#G,OMK7D&C>YB^M"N<QLU&5. \N9N^Q_TT%Z0D*G
MG0=@/;-=S@?N,9TX_M ]'HM1Y[BA;V_[GK%G&\-*X,:^G=R,VPEH*@S]W]-,
M_)EM&LG-J)%PU_&MP+:'GMTW$60"62 KT;Q=@1BS/F^WX[QYMF<%D!_]KCXP
MZ_O [;@/^.!^ /6'/$#R,6U]P#N7J/9.+$J"-6VARN7#(^(&T>@"TP[%C4-6
MSL:MG)_A)B@CUWY)H/I1/?I1/TI?.B_/GW4(BABA;X6^/^Y,:?X@JAK7Y) &
MYE4DRX5$U%&:0?A)<QF'PVM^YI_S!=8Q( 7($5:BI,WJ]")),YD3J&RI7H.S
MD2[3/,Z:A&"=1$>QG.-V<#M<WA&*3$.B."9J5]D3L9,D*3X092R 2#,+=H%;
M[B8% %90MZP5D!:IS<=E"7H'QNZ&QMY7-1+U4UZ4Y<4U1!@P;'B0^*=P11*'
MT$IB?%S#%XNG_NV2%I#GZ=R:^V :QV*D(KU5<8XY907Y6]GF5K![:B1&/?7G
M#8$YY0TA^*([[QR"*='U?=/$R0X>Q:\-Y)W ZFDP"?Q)GSF2?915A5; *!0T
M6WQ^&@0R\!X'"$A,WB+"#EGH:TA0SV5^NN:_* ):/V%HZ\87^'R6@3G'Q:9%
MG&B1"7Z6G@,T@-U1&FMN;L8$13Z0N!5468,"(?V%IR=BLAN<-4PR XI'$<S"
MD@)7CE%D&X"=A3B7/G&6:LH0%O&>3KF=@^Q($!-W\B:RC\>T7E,E@@V-)HOH
MX2U@U]<4:GR1(<Q]I[GKUE=Z':Y=@+_#!3+@)0(G/M7!]T_7SPK,8J@&X!DO
MI\O40 KM4",1=8C+X*RXC-K#W'8=P4X+(7*#+)">C@%G6&>@Y3(%<E@WD#$Z
M+SFF1(178#YGP7D_^.F;?FQR!!;7L79PM]BB2@8Q%]#+]?F=%N3]6-QC"]+Q
M!F2OG5)LMEGQ!(B $FPRDC@(JA=T''<&A$[/A_)R(8$=HP7S%_<94O@!4M@!
M4FR@9$89I:X0)!TFT/0AE-^GL+#@5RV0HIF_:^H&Z%$=BS/EX?=7[VZU:Y-)
M,PRCF+YA\M\OB8$N*'?)0F&])?":QXID:69:8]&F:&!7F6)@Z6%BROLN3%[1
M?=WVZQ2D_(@FW"PJP$FX)WMB$=RKXEZG!QERD7I%EBIHR.$+V*+$;A]3=KRS
MIY34,;#9P-XECT59HSSBM(R;354C E0J)&NM48D/0%!J@1#P4!B!V ^@ I"R
M;199&L/%I2##JIIX+6-\NMF())7  6Z!K$@"=3A3X6G/0N-<2FB.FKH 2$IC
M^/#$I'0,"738-%+_=^%J? ?9 2'CEHG".'D4;:3.VH@FU:VCAP9&^9G AGHB
MH'T.QKVI-)R;&6KWF!+YOOW%UQC*,2GNQU[@8GE1XSI@NFDEO4BJ')>[%S$
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M-XV,4K*FP$^)KNL_]LH-,UV-Y'>P5Y9*5.RY_0N.#H27MN#OJGBCO&V!>")
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M=R@5-@+WM-^?:O;NF/&SY]#>F7K8XPHE#Z>AXQ[O RRA28MN6G>?Z2IS5+8
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MR4BWDF'%@Z)P3Z=_$64T0M0^Q[RI>NZH=KI[9 H].Z3ZE%3?&\64E="8MMW
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M;#F;+*YO8'(WA>GL<?;U?GX[NWN@'LT>#I$]"G>8[-W]PPP&< 9'@SD_J':
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M!8UM5!9 ]TLIS<O&!MC_"/I_ 5!+ P04    " #W@7=6DME]".X#  !""
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M&&S3C9N)-U7H@&OCJ9^&84$?,&C9@/9S0W3;"0<X?!)-_@%02P,$%     @
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M"V7QT>>6!=ZDH$D SW.E[/:##'3O]ME_4$L#!!0    ( />!=U8Y&6[.)P0
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MLC&2OCZJ7),$JSD3$=S_;!1(NL/:ED\%HA8+\L>%-MSZ"G,BCG+:7LWSH!-
MGHK&J^7RJ!:,=M^K-5Z$STZZ73V[Q%#22.P[$,&AIA7OW2C$9NGO3><6'9/V
M<NF^=E?S>7LC?5_>WNM4<DM.!T'@@D*3Z-/'$'1[5[8#JVI_/\V5)>G^M:0-
M1.T6T/Q"T>G8#ER"[@_+Z#]02P,$%     @ ]X%W5F7(2 <L$@  9S<  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C(N>&ULM5M=<QNYL7V?7X%2<E-2%46)
M\N=J;5?)]N[&N;M9E[5.'F[=!W &)!$/!PPP(YGY]?=TXV,PY&BL;.J^2/S
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MO]_H<E-D:@$= 6$[@!SO-_99?=W!!QS%%80 $#M%K\.8%"N&[*38_U9="Z^
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M[*\7_42+IFOI:Z'I@M"][NA&AM((T/>-H#@;)F:#Z8ZW^@=02P,$%     @
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M&Y55H/NUE.8@6 ?MG\'D+U!+ P04    " #W@7=6BCI?$<T"   $!@  &0
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M96EJ>+.B,8W:.=![J93='5R"_> ?_P-02P,$%     @ ]X%W5M(^PH)Y @
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MZ<H8V7$GY[@0-,TW0S94"!KGISO  3!E(.^'E(JGA=I?*??3O/\!4$L#!!0
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M5FSZP133H)7]K-#+/I=<O<T43L:W<HT<KI*$5844,"-/9$$13J<H24;%&5S
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M ^3["\[SS0O5P/9!>9/_ E!+ P04    " #W@7=6G+&-J.8$  #;%@  &0
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MNB1$)]?8(;$NB?5(S" Q\^U9JB=OZ$?OZ!:Y3IO$^B3FD)A+8AZ)^206D-B
MQ(8D-B*Q\=M77;5R7:T?EU'D.@4:KP+-5X$&K$ 35E 1FRFCY,IK'97,NYA3
M2'W'W8?Y8ME""M5:J*:@FHIJ&JJU44U'M0ZJ=5&MAVH&JIFH9J&:C6I]5'-V
MVN'-?PWY^&IS%UVGAVH^J@6H-D"U(:J-4&V,:J(@R$N7:RS'QKA@<URP02ZP
M),_6; ?STLJY-9NR^[(K+MN02_?S5U>ZH".U%JHIJ*;NM,/K79M7\M''+ U=
M9QO5=%3KH%KWK*/;0]=IH)J):A:JV:C61S4'U5Q4\U#-1[4 U0:H-D2U$:J-
M44T4I'?Y0@WEV'@6;#X+-J"%2G'90JV:%FK5W$(MG>ABD1VO/%F%Y5JEJS!2
M:Z&:@FHJJFFHUD8U'=4ZJ-9%M1ZJ&:AFHIJ%:O9.RXR*W]1OZD=5<Q]=JX-J
M+JIYJ.:C6H!J U0;HMH(U<:H)@I"O'R]AG)LD LVR04;Y0++\FR]EDZH+^=.
M]/I)3";3I/EA.,NKT]")\U&MA6H*JJFHIJ%:&]5T5.N@6A?5>JAFH)J):A:J
MV:C61S4'U5Q4\U#-1[5@IQW6W@VY<MTXGJ;LS,<-T:T;H=H8U41!+)>OP-AI
M\%F.S6C!AK3 4CI;@:5SX2>M<W,J,'W^$JW6R67\7Y91]!C-U^==DI:KEJ[)
M2*V%:@JJJ:BFH5H;U714ZZ!:%]5ZJ&:@FKG3#B^MNKVM'\W;8J'KM%&MCVH.
MJKFHYJ&:CVH!J@U0;8AJ(U0;HYHH"//R=1O*L3$NV!P7;) ++,FS=5LZH[]\
M[I3^\^?'S]%26MSG?86&3NN/:BU44U!-134-U=JHIJ-:!]6ZJ-9#-0/53/G$
MU.LWE5KUMGE<L:'3]Z-:']4<5'-1S4,U']4"5!N@VA#51J@V1C51$./E*S9V
MPG^68Z-<L%DNL##/5FSIK/]R_K3_OR\>G\+Y-RE<2R%V(P':! #56JBFH)J*
M:AJJM5%-1[4.JG51K8=J!JJ9\MN)VAM7C?IQ48?.](]J?51S4,U%-0_5?%0+
M4&V :D-4&Z':&-5$0=*7+^K8]@ LQ^:X8(-<8$F>+>K2'@%R?I. HSM#O[>,
M0]L(H%H+U92==AB$]2NY=M1' %VGAFIM5--1K8-J753KH9J!:B:J6:AFHUH?
MU1Q4<U'-0S4?U8(3[X)O/PX,T'4.46V$:F-4$P697;X\8]L&L!R;ST)A.2S)
ML^59VCM /K=Y0%RF1?-U^.5D^X!\I73]A3800#4%U514TU"MC6HZJG50K8MJ
M/50S4,U$-0O5;%3KHYJ#:BZJ>:CFHUJPTVX/ZK3*U9O;"\YXT!#=KA&JC5%-
M%$1R^>J+[1; <FPZ"S:>!9;/V>HK;1D@E^L9,%VMGJ/)R0(,;16 :BU44^03
M4T6?:J6)KE5#M3:JZ:C60;4NJO50S4 U$]4L5+-1K8]J#JJYJ.:AFH]JP:GW
MP5JM6GM[]^:9#QRBVS="M3&JB8+<+5]BL9T$6([-7Z&P');3F1*KFG83J.9W
M$S"C=;E> OE>V4H+U5JHIJ":BFH:JK5134>U#JIU4:V':@:JF:AFH9J-:GU4
M<U#-134/U7Q4"ZIO>S#(M<;-]5$UAJYTB&HC5!NCFBC(\=(E&\NQ.2[8(!=L
MD@LLRK,E6]I,H)K?3,!^'8I,[ME,[]X\FK%6"N<3Z>MN_/)D)8<V$4"U%JHI
MJ*:BFH9J;5334:V#:EU4ZZ&:@6HFJEFH9J-:']4<5'-1S4,U']6"G98=CY0;
MQX7<.8\:HELV0K4QJHF"U"Y?H+%-!%B.S6?!!K3 $CI;H%73 BV_B8#]O+Q[
M"%=G]1#(ITH786@/ 5134$VMOITW_?9&KAZUJ=;0E;9134>USHD#(M\VZO6;
M[!'IHFOMH9J!:B:J6:AFHUH?U1Q4<U'-0S4?U0)4&Z#:$-5&J#9&-5$0SN7K
M,+8Y ,NQ$2W8C!8JQ67KL+0Y0#6_.< @FGYYV$Q-^Q(MDZ_+7A:S<#V=3=??
M3I9B:)L 5&NAFH)J*JIIJ-9&-1W5.JC61;4>JAFH9J*:A6HVJO51S4$U%]4\
M5/-1+=AIV6^ZWHQKGO&@(;I=(U0;HYHHB.;R51C;((#EV'06;#P++)^S55C:
M("#^,:\*<Z:K?TGWRRB2IO-U%*]A+2W#]<G;*/.ETA48J;5034$U%=4T5&NC
MFHYJ'53KHEH/U0Q4,U'-0C4;U?JHYJ":BVH>JOFH%NPTN9*IKBKR\8079SYN
MB&[="-7&J"8*PKE\'89R;$0+-J,%&]("2^EL'99.^%_-G_"_-7V93J+Y1/HV
MC6:3TX.1Z"S_J-9"-0755%334*V-:CJJ=5"MBVH]5#-0S40U"]5L5.NCFH-J
M+JIYJ.:C6K#3,E]N'9=>A0\9HMLT0K4QJHF"*"Y?=;&3]K,<F\R"C6:!97.V
MZDHG[:_F3]K_9@QR-KT__=T7.A,_JK5034$U%=4T5&NCFHYJ'53KHEH/U0Q4
M,U'-0C4;U?JHYJ":BVH>JOFH%A3D2T/Z%H7+4Y_F!]^]Y!#=@Q&JC5%-%,1W
M^4J-G8F?Y=@<%VR0"RS)LY5:.A-_M=1,_&EKI7]+/Z=3\9\LW=#9]U&MA6H*
MJJFHIJ%:&]5T5.OLM.NC48[C"_W1V?=1S=AI<BV["Y6C/@XFNE8+U6Q4ZZ.:
M@VHNJGFHYJ-:@&H#5!NBV@C5QJ@F"I*Z?%'&SK_/<FQ""S:B!9;1V:(LG7^_
MFC__OGA<+-?3_XLFTN(E6IXLOM"I]U&MA6H*JJFHIJ%:&]5T5.N@6A?5>JAF
M%+PTW__^P$2WPT(U&]7ZJ.:@FHMJ'JKYJ!:@V@#5AJ@V0K4QJHF"+"]?MK$3
M][,<F^V"#7>!I7NV;$LG[J_F3]SOQ&:XO'O8S$$VB5ZBV>+I,9JOI>C/IVB^
MBLZ<:A:=U!_56JBFH)J*:AJJM5%-1[4.JG51K8=J!JJ9J&:AFHUJ?51S4,U%
M-0_5?%0+=EIFJMG;YO$%:>0JAR=663MNN3)"5SE&-5&0V.6+,W;*?Y9CTUFP
M\2RP?,X49[5TRO]:_I3_UM-ZNIC'I1C1>3Q_765K-%1KH9J":NI.D^6#=Y3F
ME5R[/1H"T]#5ME%-1[4.JG51K8=J!JJ9J&:AFHUJ?51S4,U%-0_5?%0+4&V
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M;SN8$&LJ7U5_FOFIU24<*"\'Z)+N7"D5C!T].2@*=% !$)T3%%X'5 ]YXW=
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MKO#@KAX3O(N!T 'X?L:Y6C?T!]K;7? '4$L#!!0    ( />!=U;SVLG(V0,
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MZ#11&\N9A(4F9B,$U=_&P-5N%+2"P\8-6Q?6;81I4M(UW(*]*Q<:K;!&R9D
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M77#&.S^ #X+K5,&")YB<$K@4:AMO<(AW%EQDG&-\#3W_#01>$'0X-'\^W.^
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M%[SK$26VK%N@>J)%:6O\6FCJ&.PPI:X1I=E ZQLA]&%B#FC[T.@?4$L#!!0
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M2D/=U@U3ND!1V07T?25)7C6Q">HK.?H-4$L#!!0    ( />!=U8H B)"P@0
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MTONL.)DI;@3-]='#@@I!4WT98Q1AI@3D\Q6EXNU&=5"=CTW_ 5!+ P04
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MBQ@]R*XB=QTMZK8*+H7&FMHVUWB)@303<+P00K]T3&$=KL7T-U!+ P04
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M4$L! A0#%     @ ]X%W5K!58,OS @  1PH  !@              ("!L10
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( />!=U8P:5$"
MG 0  !00   8              " @=H7  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " #W@7=6ISPT$MT"  #H!P  &
M@(&L'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ ]X%W
M5F?=RV"."0  3DP  !@              ("!OQ\  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( />!=U9R-& BJ@8  $8A   8
M      " @8,I  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" #W@7=6@6!D!VD(  "P$P  &               @(%C,   >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ]X%W5L]?W=Y6$0  BR\  !@
M             ("! CD  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( />!=U9^UC08F@(  *X%   9              " @8Y*  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ]X%W5A=>3@_W @
M>P8  !D              ("!7TT  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " #W@7=6B3E7BXD"  !C!0  &0              @(&-
M4   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( />!=U8U
M@@4>]1   $PS   9              " @4U3  !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ ]X%W5H<@-$N7!0  ? T  !D
M     ("!>60  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( />!=U9Z8R%\400  !X)   9              "
M@;^+  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ ]X%W
M5L@<7&<$!0  PPL  !D              ("!1Y   'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " #W@7=6.1ENSB<$  "\"   &0
M        @(&"E0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( />!=U9ER$@'+!(  &<W   9              " @>"9  !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ]X%W5OV7URNG @  Q@4
M !D              ("!0ZP  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " #W@7=6<*K 88X"  "8!0  &0              @($AKP
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( />!=U8 ,-AX
MP (  ",&   9              " @>:Q  !X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ ]X%W5O"&7$)\ @  6 4  !D
M ("!W;0  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #W
M@7=6/S\V9Q@$  #O"0  &0              @(&0MP  >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( />!=U;5DTYIX (  !@&   9
M          " @=^[  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#
M%     @ ]X%W5HHZ7Q'- @  ! 8  !D              ("!]KX  'AL+W=O
M<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #W@7=6TC["@GD"  !K
M!0  &0              @('ZP0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM
M;%!+ 0(4 Q0    ( />!=U9+$_<U& ,  . &   9              " @:K$
M  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ ]X%W5NY7
MZ\NM @  >P8  !D              ("!^<<  'AL+W=O<FMS:&5E=',O<VAE
M970S,BYX;6Q02P$"% ,4    " #W@7=6:L0T 4\#  #V"@  &0
M    @('=R@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M />!=U90BCVX(@,  -H)   9              " @6/.  !X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ ]X%W5C;M_1UI @  MP4  !D
M             ("!O-$  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " #W@7=6[]E]W?<#  !;$P  &0              @(%<U   >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( />!=U:C/FSKZ@(
M '\(   9              " @8K8  !X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ ]X%W5L-T(%7?"   -$\  !D              ("!
MJ]L  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #W@7=6
MG+&-J.8$  #;%@  &0              @('!Y   >&PO=V]R:W-H965T<R]S
M:&5E=#,Y+GAM;%!+ 0(4 Q0    ( />!=U81W=I/>3P  $]X!  9
M      " @=[I  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%
M  @ ]X%W5@N:!3%:!@  82H  !D              ("!CB8! 'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #W@7=6M]OG-C8#  #I"0
M&0              @($?+0$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+
M 0(4 Q0    ( />!=U;SVLG(V0,  *P,   9              " @8PP 0!X
M;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ ]X%W5BX!*>B.
M P  -0P  !D              ("!G#0! 'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"% ,4    " #W@7=6+ #"><L"   U"@  &0
M@(%A. $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( />!
M=U;M.;2S;P(  + &   9              " @6,[ 0!X;"]W;W)K<VAE971S
M+W-H965T-#8N>&UL4$L! A0#%     @ ]X%W5D>WN)AR @  70<  !D
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M=#4Q+GAM;%!+ 0(4 Q0    ( />!=U8*X*GF-0(  %P%   9
M  " @0)/ 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @
M]X%W5F7!L >R @  W@4  !D              ("!;E$! 'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6Q02P$"% ,4    " #W@7=6O$JC@WT#  #Q%P  #0
M            @ %75 $ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( />!=U:7
MBKL<P    !,"   +              "  ?]7 0!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( />!=U:)<1'>5 0  #PC   /              "  >A8 0!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " #W@7=6?'[I&]0!  #&'P  &@
M        @ %I70$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " #W@7=6*F32ILH!  ";'P  $P              @ %U7P$ 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     /0 ] *(0  !P80$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>132</ContextCount>
  <ElementCount>292</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>39</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Statements of Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Statements of Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Statements of Convertible Preferred Shares and Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Statements of Convertible Preferred Shares and Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/OtherCurrentAssets</Role>
      <ShortName>Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Fixed Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/FixedAssetsNet</Role>
      <ShortName>Fixed Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Other Accounts Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/OtherAccountsPayable</Role>
      <ShortName>Other Accounts Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Commitments and Contingencies Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities</Role>
      <ShortName>Commitments and Contingencies Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Convertible Preferred Shares</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConvertiblePreferredShares</Role>
      <ShortName>Convertible Preferred Shares</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Research and Development, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ResearchandDevelopmentNet</Role>
      <ShortName>Research and Development, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - General and Administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/GeneralandAdministrative</Role>
      <ShortName>General and Administrative</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Transactions and Balances with Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties</Role>
      <ShortName>Transactions and Balances with Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/OtherCurrentAssetsTables</Role>
      <ShortName>Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/OtherCurrentAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Fixed Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/FixedAssetsNetTables</Role>
      <ShortName>Fixed Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/FixedAssetsNet</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Other Accounts Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/OtherAccountsPayableTables</Role>
      <ShortName>Other Accounts Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/OtherAccountsPayable</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ShareholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Research and Development, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ResearchandDevelopmentNetTables</Role>
      <ShortName>Research and Development, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ResearchandDevelopmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - General and Administrative (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/GeneralandAdministrativeTables</Role>
      <ShortName>General and Administrative (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/GeneralandAdministrative</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Taxes on Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TaxesonIncomeTables</Role>
      <ShortName>Taxes on Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TaxesonIncome</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Transactions and Balances with Related Parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables</Role>
      <ShortName>Transactions and Balances with Related Parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Other Current Assets (Details) - Schedule of other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofothercurrentassetsTable</Role>
      <ShortName>Other Current Assets (Details) - Schedule of other current assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/OtherCurrentAssetsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Fixed Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/FixedAssetsNetDetails</Role>
      <ShortName>Fixed Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/FixedAssetsNetTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Fixed Assets, Net (Details) - Schedule of fixed assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleoffixedassetsnetTable</Role>
      <ShortName>Fixed Assets, Net (Details) - Schedule of fixed assets, net</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/FixedAssetsNetTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Other Accounts Payable (Details) - Schedule of other accounts payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofotheraccountspayableTable</Role>
      <ShortName>Other Accounts Payable (Details) - Schedule of other accounts payable</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/OtherAccountsPayableTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Commitments and Contingencies Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingencies Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Convertible Preferred Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ConvertiblePreferredSharesDetails</Role>
      <ShortName>Convertible Preferred Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ConvertiblePreferredShares</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ShareholdersEquityTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable</Role>
      <ShortName>Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ShareholdersEquityTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable</Role>
      <ShortName>Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ShareholdersEquityTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Research and Development, Net (Details) - Schedule of research and development</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable</Role>
      <ShortName>Research and Development, Net (Details) - Schedule of research and development</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/ResearchandDevelopmentNetTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - General and Administrative (Details) - Schedule of general and administrative</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable</Role>
      <ShortName>General and Administrative (Details) - Schedule of general and administrative</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/GeneralandAdministrativeTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TaxesonIncomeTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Taxes on Income (Details) - Schedule of deferred tax assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of deferred tax assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TaxesonIncomeTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Transactions and Balances with Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails</Role>
      <ShortName>Transactions and Balances with Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleoftransactionsTable</Role>
      <ShortName>Transactions and Balances with Related Parties (Details) - Schedule of transactions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofbalancesTable</Role>
      <ShortName>Transactions and Balances with Related Parties (Details) - Schedule of balances</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/LeasesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable</Role>
      <ShortName>Leases (Details) - Schedule of future lease payments under operating leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/LeasesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Leases (Details) - Schedule of weighted average lease term and weighted average discount rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable</Role>
      <ShortName>Leases (Details) - Schedule of weighted average lease term and weighted average discount rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/LeasesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="f20f2022_railvisionltd.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.RailVision.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.RailVision.com/role/SubsequentEvents</ParentRole>
      <Position>53</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 7 fact(s) appearing in ix:hidden were eligible for transformation: dei:DocumentAccountingStandard, us-gaap:EarningsPerShareDiluted, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding -  f20f2022_railvisionltd.htm 14470, 14477, 14478, 14479, 14480, 14481, 14482</Log>
  </Logs>
  <InputFiles>
    <File doctype="20-F" original="f20f2022_railvisionltd.htm">f20f2022_railvisionltd.htm</File>
    <File>f20f2022ex12-1_railvisionltd.htm</File>
    <File>f20f2022ex12-2_railvisionltd.htm</File>
    <File>f20f2022ex13-1_railvisionltd.htm</File>
    <File>f20f2022ex13-2_railvisionltd.htm</File>
    <File>f20f2022ex2-1_railvisionltd.htm</File>
    <File>f20f2022ex4-4_railvisionltd.htm</File>
    <File>rvsn-20221231.xsd</File>
    <File>rvsn-20221231_cal.xml</File>
    <File>rvsn-20221231_def.xml</File>
    <File>rvsn-20221231_lab.xml</File>
    <File>rvsn-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>fin_002.jpg</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="526">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f20f2022_railvisionltd.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 526,
    "http://xbrl.sec.gov/dei/2022": 43
   },
   "contextCount": 132,
   "dts": {
    "calculationLink": {
     "local": [
      "rvsn-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rvsn-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f20f2022_railvisionltd.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rvsn-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rvsn-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rvsn-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 455,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 81,
    "http://www.RailVision.com/20221231": 12,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 97
   },
   "keyCustom": 57,
   "keyStandard": 235,
   "memberCustom": 13,
   "memberStandard": 26,
   "nsprefix": "rvsn",
   "nsuri": "http://www.RailVision.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.RailVision.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Other Current Assets",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.RailVision.com/role/OtherCurrentAssets",
     "shortName": "Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Fixed Assets, Net",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.RailVision.com/role/FixedAssetsNet",
     "shortName": "Fixed Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Other Accounts Payable",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.RailVision.com/role/OtherAccountsPayable",
     "shortName": "Other Accounts Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Commitments and Contingencies Liabilities",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities",
     "shortName": "Commitments and Contingencies Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:ConvertiblePreferredSharesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Convertible Preferred Shares",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.RailVision.com/role/ConvertiblePreferredShares",
     "shortName": "Convertible Preferred Shares",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:ConvertiblePreferredSharesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Shareholders' Equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.RailVision.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Research and Development, Net",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.RailVision.com/role/ResearchandDevelopmentNet",
     "shortName": "Research and Development, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:DisclosureOfGeneralAndAdministrativeTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - General and Administrative",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.RailVision.com/role/GeneralandAdministrative",
     "shortName": "General and Administrative",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:DisclosureOfGeneralAndAdministrativeTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Taxes on Income",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.RailVision.com/role/TaxesonIncome",
     "shortName": "Taxes on Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Transactions and Balances with Related Parties",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties",
     "shortName": "Transactions and Balances with Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.RailVision.com/role/ConsolidatedBalanceSheet",
     "shortName": "Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:LeasesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.RailVision.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:LeasesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.RailVision.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.RailVision.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.RailVision.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Other Current Assets (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.RailVision.com/role/OtherCurrentAssetsTables",
     "shortName": "Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Fixed Assets, Net (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.RailVision.com/role/FixedAssetsNetTables",
     "shortName": "Fixed Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Other Accounts Payable (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.RailVision.com/role/OtherAccountsPayableTables",
     "shortName": "Other Accounts Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Shareholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.RailVision.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Research and Development, Net (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.RailVision.com/role/ResearchandDevelopmentNetTables",
     "shortName": "Research and Development, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - General and Administrative (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.RailVision.com/role/GeneralandAdministrativeTables",
     "shortName": "General and Administrative (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "ilsPershares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Taxes on Income (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.RailVision.com/role/TaxesonIncomeTables",
     "shortName": "Taxes on Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Transactions and Balances with Related Parties (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables",
     "shortName": "Transactions and Balances with Related Parties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.RailVision.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "rvsn:ComputerSoftwareAndElectronicEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of straight-line method over the estimated useful lives of the assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "rvsn:ComputerSoftwareAndElectronicEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:GovernmentContractReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Other Current Assets (Details) - Schedule of other current assets",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable",
     "shortName": "Other Current Assets (Details) - Schedule of other current assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:GovernmentContractReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Fixed Assets, Net (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.RailVision.com/role/FixedAssetsNetDetails",
     "shortName": "Fixed Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Fixed Assets, Net (Details) - Schedule of fixed assets, net",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable",
     "shortName": "Fixed Assets, Net (Details) - Schedule of fixed assets, net",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherEmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Other Accounts Payable (Details) - Schedule of other accounts payable",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable",
     "shortName": "Other Accounts Payable (Details) - Schedule of other accounts payable",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherEmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c47",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "rvsn:RoyaltyPaymentsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Commitments and Contingencies Liabilities (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails",
     "shortName": "Commitments and Contingencies Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c47",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "rvsn:RoyaltyPaymentsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c56",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Convertible Preferred Shares (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails",
     "shortName": "Convertible Preferred Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c56",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.RailVision.com/role/ConsolidatedIncomeStatement",
     "shortName": "Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c85",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rvsn:GrossProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - Shareholders' Equity (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.RailVision.com/role/ShareholdersEquityDetails",
     "shortName": "Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c85",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rvsn:GrossProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
     "shortName": "Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c10",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c116",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable",
     "shortName": "Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c116",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c119",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostsAndExpensesRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Research and Development, Net (Details) - Schedule of research and development",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable",
     "shortName": "Research and Development, Net (Details) - Schedule of research and development",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c119",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostsAndExpensesRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostsAndExpensesRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - General and Administrative (Details) - Schedule of general and administrative",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
     "shortName": "General and Administrative (Details) - Schedule of general and administrative",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "rvsn:ScheduleOfGeneralAndAdministrativeTableTexBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostsAndExpensesRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Taxes on Income (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.RailVision.com/role/TaxesonIncomeDetails",
     "shortName": "Taxes on Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Taxes on Income (Details) - Schedule of deferred tax assets",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable",
     "shortName": "Taxes on Income (Details) - Schedule of deferred tax assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c125",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Transactions and Balances with Related Parties (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails",
     "shortName": "Transactions and Balances with Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c125",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rvsn:RevenuesFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of transactions",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.RailVision.com/role/ScheduleoftransactionsTable",
     "shortName": "Transactions and Balances with Related Parties (Details) - Schedule of transactions",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "rvsn:RevenuesFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c128",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Transactions and Balances with Related Parties (Details) - Schedule of balances",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.RailVision.com/role/ScheduleofbalancesTable",
     "shortName": "Transactions and Balances with Related Parties (Details) - Schedule of balances",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfClosedBlockAssetsAndLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c128",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Statements of Comprehensive Loss (Parentheticals)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Statements of Comprehensive Loss (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDescription",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Leases (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.RailVision.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable",
     "shortName": "Leases (Details) - Schedule of future lease payments under operating leases",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Leases (Details) - Schedule of weighted average lease term and weighted average discount rate",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable",
     "shortName": "Leases (Details) - Schedule of weighted average lease term and weighted average discount rate",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c2",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.RailVision.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Statements of Convertible Preferred Shares and Changes in Shareholders\u2019 Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.RailVision.com/role/ShareholdersEquityType2or3",
     "shortName": "Statements of Convertible Preferred Shares and Changes in Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.RailVision.com/role/ConsolidatedCashFlow",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - General",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.RailVision.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.RailVision.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_railvisionltd.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 39,
   "tag": {
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r421",
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.RailVision.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rvsn_AggregateOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Ordinary Shares",
        "terseLabel": "Aggregate ordinary shares"
       }
      }
     },
     "localname": "AggregateOrdinaryShares",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_AggregateSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of aggregate ordinary shares.",
        "label": "Aggregate Shares Issued",
        "terseLabel": "Aggregate shares issued"
       }
      }
     },
     "localname": "AggregateSharesIssued",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_AmortizedOver": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortized Over",
        "terseLabel": "Amortized over"
       }
      }
     },
     "localname": "AmortizedOver",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rvsn_ChangeInOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of change in operating lease liability.",
        "label": "Change In Operating Lease Liability",
        "negatedLabel": "Change in operating lease liability"
       }
      }
     },
     "localname": "ChangeInOperatingLeaseLiability",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_CommitmentsandContingenciesLiabilitiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Liabilities (Details) [Line Items]"
       }
      }
     },
     "localname": "CommitmentsandContingenciesLiabilitiesDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_CommitmentsandContingenciesLiabilitiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Liabilities (Details) [Table]"
       }
      }
     },
     "localname": "CommitmentsandContingenciesLiabilitiesDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ComputerSoftwareAndElectronicEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of computer software and electronic equipment.",
        "label": "Computer Software And Electronic Equipment",
        "terseLabel": "Computer software and electronic equipment"
       }
      }
     },
     "localname": "ComputerSoftwareAndElectronicEquipment",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_ConversionOfAConvertibleDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of conversion of a convertible debt.",
        "label": "Conversion Of AConvertible Debt",
        "terseLabel": "Conversion of a convertible debt"
       }
      }
     },
     "localname": "ConversionOfAConvertibleDebt",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_ConversionOfPreferredShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of conversion of preferred shares.",
        "label": "Conversion Of Preferred Shares",
        "terseLabel": "Conversion of preferred shares"
       }
      }
     },
     "localname": "ConversionOfPreferredShares",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_ConvertiblePreferredSharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares Abstract"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ConvertiblePreferredSharesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares (Details) [Line Items]"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ConvertiblePreferredSharesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares (Details) [Table]"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ConvertiblePreferredSharesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares [Abstract]"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredShares"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ConvertiblePreferredSharesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares [Table]"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredShares"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ConvertiblePreferredSharesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Shares Text Block",
        "terseLabel": "CONVERTIBLE PREFERRED SHARES"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesTextBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredShares"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of deferred expenses against additional paid in capital.",
        "label": "Decrease Of Deferred Expenses Against Additional Paid In Capital",
        "terseLabel": "Decrease of deferred expenses against additional paid in capital"
       }
      }
     },
     "localname": "DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_DeferredRevenuesInOtherAccountsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenues In Other Accounts Payable",
        "terseLabel": "Deferred revenues in other accounts payable"
       }
      }
     },
     "localname": "DeferredRevenuesInOtherAccountsPayable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_DeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Abstract",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_DevelopmentAndSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Development And Sales",
        "terseLabel": "Development and sales"
       }
      }
     },
     "localname": "DevelopmentAndSales",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_DisclosureOfGeneralAndAdministrativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of General And Administrative Abstract"
       }
      }
     },
     "localname": "DisclosureOfGeneralAndAdministrativeAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_DisclosureOfGeneralAndAdministrativeTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of General and Administrative.",
        "label": "Disclosure Of General And Administrative Text Block",
        "terseLabel": "GENERAL AND ADMINISTRATIVE"
       }
      }
     },
     "localname": "DisclosureOfGeneralAndAdministrativeTextBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrative"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_DividendYields": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Yields",
        "terseLabel": "Dividend yields"
       }
      }
     },
     "localname": "DividendYields",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees Member",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_ExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePrice",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "rvsn_ExercisePricePerShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Per Shares",
        "terseLabel": "Exercise price per share"
       }
      }
     },
     "localname": "ExercisePricePerShares",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "rvsn_FifthLeaseYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fifth Lease Year Member",
        "terseLabel": "Fifth Lease Year [Member]"
       }
      }
     },
     "localname": "FifthLeaseYearMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_FinancialStatementPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of financial statement.",
        "label": "Financial Statement Policy Text Block",
        "terseLabel": "Financial statement in U.S. dollars"
       }
      }
     },
     "localname": "FinancialStatementPolicyTextBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_FirstTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Two Years Member",
        "terseLabel": "First Two Lease Years [Member]"
       }
      }
     },
     "localname": "FirstTwoYearsMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_FixedAssetsNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FixedAssetsNetLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNet"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_FixedAssetsNetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets, Net [Table]"
       }
      }
     },
     "localname": "FixedAssetsNetTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNet"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_FixedAssetsNetTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets Net Tables Line Items",
        "terseLabel": "Fixed Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FixedAssetsNetTablesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNetTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_FixedAssetsNetTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets, Net (Tables) [Table]"
       }
      }
     },
     "localname": "FixedAssetsNetTablesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNetTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_FixedAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets Policy Text Block",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "FixedAssetsPolicyTextBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_FutureLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Future Lease Payments",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FutureLeasePayments",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_GeneralLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "localname": "GeneralLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/General"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Table]"
       }
      }
     },
     "localname": "GeneralTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/General"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of general and administrative [Abstract]"
       }
      }
     },
     "localname": "GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative (Details) - Schedule of general and administrative [Table]"
       }
      }
     },
     "localname": "GeneralandAdministrativeDetailsScheduleofgeneralandadministrativeTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative [Abstract]"
       }
      }
     },
     "localname": "GeneralandAdministrativeLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative [Table]"
       }
      }
     },
     "localname": "GeneralandAdministrativeTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Generaland Administrative Tables Line Items",
        "terseLabel": "General and Administrative [Abstract]"
       }
      }
     },
     "localname": "GeneralandAdministrativeTablesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrativeTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GeneralandAdministrativeTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative (Tables) [Table]"
       }
      }
     },
     "localname": "GeneralandAdministrativeTablesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrativeTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_GrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross proceeds.",
        "label": "Gross Proceeds",
        "terseLabel": "Gross proceeds (in Dollars)"
       }
      }
     },
     "localname": "GrossProceeds",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_InvestedAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "t is a type of shareholders agreement which serves to regulate the relationships between the founding shareholders who have incorporated or are to incorporate a company and the investor who shall finance their growth.",
        "label": "Invested Agreement",
        "terseLabel": "Invested agreement (in Dollars)"
       }
      }
     },
     "localname": "InvestedAgreement",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_InvestmentAgreementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment agreement description.",
        "label": "Investment Agreement Description",
        "terseLabel": "Investment agreement description"
       }
      }
     },
     "localname": "InvestmentAgreementDescription",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_KnorrBremseRailSystemsSchweizAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Knorr Bremse Rail Systems Schweiz AGMember",
        "terseLabel": "KBCH [Member]",
        "verboseLabel": "Knorr-Bremse Rail Systems Schweiz AG [Member]"
       }
      }
     },
     "localname": "KnorrBremseRailSystemsSchweizAGMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_LaboratoryEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of laboratory equipment.",
        "label": "Laboratory Equipment",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipment",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_LeaseholdImprovements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of leasehold improvements.",
        "label": "Leasehold Improvements",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovements",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Line Items]"
       }
      }
     },
     "localname": "LeasesDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of future lease payments under operating leases [Abstract]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of future lease payments under operating leases [Table]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleoffutureleasepaymentsunderoperatingleasesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average lease term and weighted average discount rate [Abstract]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of weighted average lease term and weighted average discount rate [Table]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofweightedaverageleasetermandweightedaveragediscountrateTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Table]"
       }
      }
     },
     "localname": "LeasesDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases Disclosure Abstract"
       }
      }
     },
     "localname": "LeasesDisclosureAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases Disclosure Text Block",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LeasesDisclosureTextBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_LeasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/Leases"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Table]"
       }
      }
     },
     "localname": "LeasesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/Leases"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases Tables Line Items",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesTablesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_LeasesTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Tables) [Table]"
       }
      }
     },
     "localname": "LeasesTablesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_May112022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "May112022 Member",
        "terseLabel": "May 11 ,2022 [Member]"
       }
      }
     },
     "localname": "May112022Member",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_NetProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds.",
        "label": "Net Proceeds",
        "terseLabel": "Net proceeds (in Dollars)"
       }
      }
     },
     "localname": "NetProceeds",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_November32020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "November32020 Member",
        "terseLabel": "November 3, 2020 [Member]"
       }
      }
     },
     "localname": "November32020Member",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_NumberOfOptionsExercisableAtEndOfPeriodinDollars": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Options Exercisable At End Of Periodin Dollars",
        "terseLabel": "Number of options, Exercisable at end of period"
       }
      }
     },
     "localname": "NumberOfOptionsExercisableAtEndOfPeriodinDollars",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_NumberOfOrdinarySharesAndWarrantsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Ordinary Shares And Warrants Percentage",
        "terseLabel": "Percentage of number of ordinary shares and warrants"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesAndWarrantsPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_ObtainingARightofuseAssetInExchangeForALeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obtaining a right-of-use asset in exchange for a lease liability.",
        "label": "Obtaining ARightofuse Asset In Exchange For ALease Liability",
        "terseLabel": "Obtaining a right-of-use asset in exchange for a lease liability"
       }
      }
     },
     "localname": "ObtainingARightofuseAssetInExchangeForALeaseLiability",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_October2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "October2020 Member",
        "terseLabel": "October 2020 [Member]"
       }
      }
     },
     "localname": "October2020Member",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_OfficeFurnitureAndEquipment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of office furniture and equipment.",
        "label": "Office Furniture And Equipment",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "OfficeFurnitureAndEquipment",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_OptionToPurchaseOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option To Purchase Ordinary Shares",
        "terseLabel": "Option to purchase ordinary shares (in Shares)"
       }
      }
     },
     "localname": "OptionToPurchaseOrdinaryShares",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_OptionsExpire": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Expire",
        "terseLabel": "Options expired"
       }
      }
     },
     "localname": "OptionsExpire",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rvsn_OptionsGrantedDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options Granted Description",
        "terseLabel": "Options granted, description"
       }
      }
     },
     "localname": "OptionsGrantedDescription",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_OrdinarySharesExercisedAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary shares exercised amount.",
        "label": "Ordinary Shares Exercised Amount",
        "terseLabel": "Ordinary shares exercised amount"
       }
      }
     },
     "localname": "OrdinarySharesExercisedAmount",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_OrdinarySharesExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary shares expired.",
        "label": "Ordinary Shares Expired",
        "terseLabel": "Ordinary shares expired"
       }
      }
     },
     "localname": "OrdinarySharesExpired",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_PaymentOfMonthlyRemunerationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Of Monthly Remuneration Amount",
        "terseLabel": "Payment of monthly remuneration amount"
       }
      }
     },
     "localname": "PaymentOfMonthlyRemunerationAmount",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_PaymentOfOperationalFunctionTest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Of Operational Function Test",
        "terseLabel": "Payment of operational function test"
       }
      }
     },
     "localname": "PaymentOfOperationalFunctionTest",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_PaymentOfTotalProceedFromConsiderationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Of Total Proceed From Consideration Percentage",
        "terseLabel": "Payment of total proceeds from consideration, percentage"
       }
      }
     },
     "localname": "PaymentOfTotalProceedFromConsiderationPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_PaymentOfTotalProceedsFromConsiderationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Of Total Proceeds From Consideration Percentage",
        "terseLabel": "Payment of total proceeds from consideration, percentage"
       }
      }
     },
     "localname": "PaymentOfTotalProceedsFromConsiderationPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_PeriodOfFirstCommercialSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Period Of First Commercial Sales",
        "terseLabel": "Period of first commercial sale"
       }
      }
     },
     "localname": "PeriodOfFirstCommercialSales",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rvsn_RevenuesFromRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues From Related Parties",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesFromRelatedParties",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftransactionsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_RiskFreeInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk free interest rate.",
        "label": "Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "RiskFreeInterestRate",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_RoyaltyPaymentsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This percentage for royalty payment.",
        "label": "Royalty Payments Percentage",
        "terseLabel": "Royalty payments, percentage"
       }
      }
     },
     "localname": "RoyaltyPaymentsPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_ScheduleOfBalancesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Balances Abstract"
       }
      }
     },
     "localname": "ScheduleOfBalancesAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Tax Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfFixedAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fixed Assets Net Abstract"
       }
      }
     },
     "localname": "ScheduleOfFixedAssetsNetAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Future Lease Payments Under Operating Leases Abstract"
       }
      }
     },
     "localname": "ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfGeneralAndAdministrativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of General And Administrative Abstract"
       }
      }
     },
     "localname": "ScheduleOfGeneralAndAdministrativeAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfGeneralAndAdministrativeTableTexBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of General And Administrative Table Tex Block",
        "terseLabel": "Schedule of general and administrative"
       }
      }
     },
     "localname": "ScheduleOfGeneralAndAdministrativeTableTexBlock",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/GeneralandAdministrativeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rvsn_ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Option Activity For Options To Employees Officers And Directors Abstract"
       }
      }
     },
     "localname": "ScheduleOfOptionActivityForOptionsToEmployeesOfficersAndDirectorsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfOtherAccountsPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Accounts Payable Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherAccountsPayableAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfOtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Current Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Research And Development Abstract"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Total Share Based Payment Expense Related To Options Granted To Employees Abstract"
       }
      }
     },
     "localname": "ScheduleOfTotalShareBasedPaymentExpenseRelatedToOptionsGrantedToEmployeesAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transactions Abstract"
       }
      }
     },
     "localname": "ScheduleOfTransactionsAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Lease Term And Weighted Average Discount Rate Abstract"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageLeaseTermAndWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.RailVision.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rvsn_September132022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September132022 Member",
        "terseLabel": "September 13,2022 [Member]"
       }
      }
     },
     "localname": "September132022Member",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_SeriesCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series CMember",
        "terseLabel": "Series C [Member]"
       }
      }
     },
     "localname": "SeriesCMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_SeriesDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series DMember",
        "terseLabel": "Series D [Member]"
       }
      }
     },
     "localname": "SeriesDMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_SeriesEMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series EMember",
        "terseLabel": "Series E [Member]"
       }
      }
     },
     "localname": "SeriesEMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_ServiceAgreementWithAConsultantDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service agreement with a consultant description",
        "label": "Service Agreement With AConsultant Description",
        "terseLabel": "Service agreement with a consultant description"
       }
      }
     },
     "localname": "ServiceAgreementWithAConsultantDescription",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Awards Fair Value Assumptions Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardsFairValueAssumptionsExpectedTerm",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "rvsn_SharebasedPaymentExpensesRelatedToNonvestedAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment expenses related to non-vesting condition is any condition that does not determine whether the entity receives the services that entitle the counterparty to receive cash, other assets or equity instruments of the entity under a share-based payment arrangement.",
        "label": "Sharebased Payment Expenses Related To Nonvested Awards",
        "terseLabel": "Share-based payment expenses related to nonvested awards (in Dollars)"
       }
      }
     },
     "localname": "SharebasedPaymentExpensesRelatedToNonvestedAwards",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_ShareholdersEquityDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) - Schedule of option activity for options to employees, officers and directors [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) - Schedule of total share-based payment expense related to options granted to employees [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ShareholdersEquityDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Equity (Details) [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is conversion of convertible debt into ordinary shares upon completion of initial public offering.",
        "label": "Stock Issued During Period Conversion Of Convertible Debt Into Ordinary Shares Upon Completion Of Initial Public Offering",
        "terseLabel": "Conversion of convertible debt into ordinary shares upon completion of initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares conversion of convertible debt into ordinary shares upon completion of initial public offering.",
        "label": "Stock Issued During Period Conversion Of Convertible Debt Into Ordinary Shares Upon Completion Of Initial Public Offering Shares",
        "terseLabel": "Conversion of convertible debt into ordinary shares upon completion of initial public offering (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOfferingShares",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_SubcontractedWorkAndConsulting": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is subcontracted work and consulting.",
        "label": "Subcontracted Work And Consulting",
        "terseLabel": "Subcontracted work and consulting"
       }
      }
     },
     "localname": "SubcontractedWorkAndConsulting",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_TaxesonIncomeDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Line Items]"
       }
      }
     },
     "localname": "TaxesonIncomeDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_TaxesonIncomeDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Table]"
       }
      }
     },
     "localname": "TaxesonIncomeDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_ThirdAndFourthLeaseYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third And Fourth Lease Years Member",
        "terseLabel": "Third and Fourth Lease Years [Member]"
       }
      }
     },
     "localname": "ThirdAndFourthLeaseYearsMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_TotalAmountPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The company amount to be paid.",
        "label": "Total Amount Paid",
        "terseLabel": "Company total amount"
       }
      }
     },
     "localname": "TotalAmountPaid",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rvsn_TransactionsandBalanceswithRelatedPartiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and Balances with Related Parties (Details) [Line Items]"
       }
      }
     },
     "localname": "TransactionsandBalanceswithRelatedPartiesDetailsLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and Balances with Related Parties (Details) - Schedule of balances [Line Items]"
       }
      }
     },
     "localname": "TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesLineItems",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofbalancesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and Balances with Related Parties (Details) - Schedule of balances [Table]"
       }
      }
     },
     "localname": "TransactionsandBalanceswithRelatedPartiesDetailsScheduleofbalancesTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofbalancesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_TransactionsandBalanceswithRelatedPartiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and Balances with Related Parties (Details) [Table]"
       }
      }
     },
     "localname": "TransactionsandBalanceswithRelatedPartiesDetailsTable",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_TwoThousandSeventeenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Seventeen Plan Member",
        "terseLabel": "Two Thousand Seventeen Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandSeventeenPlanMember",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rvsn_UnvestedOptionsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested options percentage.",
        "label": "Unvested Options Percentage",
        "terseLabel": "Unvested options percentage"
       }
      }
     },
     "localname": "UnvestedOptionsPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_WarrantsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants description.",
        "label": "Warrants Description",
        "terseLabel": "Warrants, description"
       }
      }
     },
     "localname": "WarrantsDescription",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "rvsn_WarrantsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Percentage",
        "terseLabel": "Warrants percentage"
       }
      }
     },
     "localname": "WarrantsPercentage",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "rvsn_WarrantsPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Purchase",
        "terseLabel": "Warrants purchase"
       }
      }
     },
     "localname": "WarrantsPurchase",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "rvsn_WeightedAverageExercisePriceExercisableAtEndOfPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Exercisable At End Of Period",
        "terseLabel": "Weighted average exercise price, Exercisable at end of period"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceExercisableAtEndOfPeriod",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "rvsn_WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Exercisable At End Of Periodin Dollars",
        "terseLabel": "Weighted average remaining contractual life, Exercisable at end of period"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeExercisableAtEndOfPeriodinDollars",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "rvsn_WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Outstanding At End Of Period",
        "terseLabel": "Weighted average remaining contractual life, Outstanding at end of period"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLifeOutstandingAtEndOfPeriod",
     "nsuri": "http://www.RailVision.com/20221231",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Chairman [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer [Member]",
        "verboseLabel": "CEO [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails",
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Directors [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r251",
      "r368",
      "r381",
      "r399",
      "r400",
      "r410",
      "r412",
      "r416",
      "r459",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r251",
      "r368",
      "r381",
      "r399",
      "r400",
      "r410",
      "r412",
      "r416",
      "r459",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r250",
      "r251",
      "r278",
      "r279",
      "r280",
      "r344",
      "r368",
      "r381",
      "r399",
      "r400",
      "r410",
      "r412",
      "r416",
      "r455",
      "r459",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r250",
      "r251",
      "r278",
      "r279",
      "r280",
      "r344",
      "r368",
      "r381",
      "r399",
      "r400",
      "r410",
      "r412",
      "r416",
      "r455",
      "r459",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r165",
      "r252",
      "r430",
      "r446"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable",
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r411",
      "r415",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r387",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r411",
      "r415",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r165",
      "r252",
      "r430",
      "r431",
      "r446"
     ],
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable",
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r449",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails",
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "OTHER ACCOUNTS PAYABLE"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/OtherAccountsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableOtherCurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable, Other, Current",
        "terseLabel": "Other accounts payable"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableOtherCurrentAndNoncurrent": {
     "auth_ref": [
      "r98",
      "r105"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred and payable classified as other.",
        "label": "Accounts Payable, Other",
        "totalLabel": "Other accounts payable, total"
       }
      }
     },
     "localname": "AccountsPayableOtherCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r1",
      "r10"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNet": {
     "auth_ref": [
      "r378",
      "r388"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofbalancesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableOtherCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r59",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r414"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r443",
      "r444",
      "r445",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total share-based payment expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r100",
      "r132",
      "r150",
      "r185",
      "r188",
      "r192",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r303",
      "r305",
      "r312",
      "r414",
      "r457",
      "r458",
      "r495"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r127",
      "r138",
      "r150",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r303",
      "r305",
      "r312",
      "r414",
      "r457",
      "r458",
      "r495"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r150",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r303",
      "r305",
      "r312",
      "r457",
      "r458",
      "r495"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.",
        "label": "Benefits, Losses and Expenses",
        "terseLabel": "Operating lease expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r37",
      "r129",
      "r402"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r31",
      "r37",
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r31",
      "r93"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r150",
      "r168",
      "r169",
      "r171",
      "r173",
      "r176",
      "r177",
      "r200",
      "r221",
      "r223",
      "r224",
      "r225",
      "r228",
      "r229",
      "r232",
      "r233",
      "r235",
      "r239",
      "r247",
      "r312",
      "r401",
      "r428",
      "r440",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r62",
      "r215",
      "r216",
      "r389",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES LIABILITIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Aggregate number of shares"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Company at a price per share (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r443",
      "r444",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Ordinary shares, par value (in New Shekels per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r414"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares, NIS 0.01 par value; Authorized 99,900,000 shares; Issued and outstanding: 15,896,040 and 9,157,324 shares as of December 31, 2022 and 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computers and software\t[Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Issued",
        "terseLabel": "Issuance of convertible preferred shares"
       }
      }
     },
     "localname": "ConversionOfStockAmountIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Issuance of preferred A shares"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Issuance of convertible preferred shares (in Shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r2",
      "r3",
      "r66",
      "r67",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Conversion shares"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostMaintenance": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of maintenance incurred and directly related to good produced and service rendered.",
        "label": "Cost, Maintenance",
        "terseLabel": "Rent and office maintenance"
       }
      }
     },
     "localname": "CostMaintenance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r21",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total amount"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r437",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Depreciation expenses"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r22",
      "r150",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r312",
      "r457"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of revenues",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement",
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesRelatedParty": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.",
        "label": "Costs and Expenses, Related Party",
        "terseLabel": "Payroll and related expenses"
       }
      }
     },
     "localname": "CostsAndExpensesRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "terseLabel": "Additional amount (in Dollars)"
       }
      }
     },
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r35",
      "r84",
      "r293",
      "r297",
      "r298",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred expenses"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableOtherCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r83",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Net operating losses (in Dollars)"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Income tax expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r83",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Deferred taxes due to carryforward losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofdeferredtaxassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Deposits": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.",
        "label": "Deposits",
        "terseLabel": "Deposits at the Chamber of Commerce"
       }
      }
     },
     "localname": "Deposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r35",
      "r57"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r35",
      "r184"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockSupplementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r145",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r166",
      "r168",
      "r171",
      "r172",
      "r173",
      "r174",
      "r310",
      "r311",
      "r375",
      "r380",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic and diluted loss per ordinary share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r145",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r168",
      "r171",
      "r172",
      "r173",
      "r174",
      "r310",
      "r311",
      "r375",
      "r380",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Basic and diluted loss per ordinary share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r44",
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Basic and diluted net loss per ordinary share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Share Based Payment Expense [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r65",
      "r124",
      "r141",
      "r142",
      "r143",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r175",
      "r201",
      "r249",
      "r283",
      "r284",
      "r285",
      "r294",
      "r295",
      "r309",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r328",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails",
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExcessStockSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders.",
        "label": "Excess Stock, Shares Issued",
        "terseLabel": "Warrants purchase"
       }
      }
     },
     "localname": "ExcessStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FilmCosts": {
     "auth_ref": [
      "r123",
      "r372",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capitalized film cost for film predominantly monetized on its own and films predominantly monetized with other films and license agreements as group.",
        "label": "Film, Capitalized Cost",
        "terseLabel": "Capital cost"
       }
      }
     },
     "localname": "FilmCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r231",
      "r245",
      "r307",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r409",
      "r450",
      "r451",
      "r452",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r55",
      "r374"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and office equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General and administrative expenses",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement",
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GovernmentContractReceivable": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables that are derived from government contracts.",
        "label": "Government Contract Receivable",
        "terseLabel": "Government institutions"
       }
      }
     },
     "localname": "GovernmentContractReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r20",
      "r150",
      "r185",
      "r187",
      "r191",
      "r193",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r312",
      "r408",
      "r457"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit (loss)"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment": {
     "auth_ref": [
      "r50",
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of average investment of impaired financing receivables for which there is no related allowance for credit losses.",
        "label": "Impaired Financing Receivable, with No Related Allowance, Average Recorded Investment",
        "terseLabel": "R&amp;D consumables"
       }
      }
     },
     "localname": "ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r289",
      "r290",
      "r292",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Increase (decrease) in trade accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "terseLabel": "Increase (decrease) in other accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Decrease (increase) in other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "FIXED ASSETS, NET"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease term, date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvement [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Lessee, Operating Lease, Description",
        "terseLabel": "Lease, description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r150",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r304",
      "r305",
      "r306",
      "r312",
      "r407",
      "r457",
      "r495",
      "r496"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r96",
      "r102",
      "r414",
      "r441",
      "r453",
      "r491"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r128",
      "r150",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r304",
      "r305",
      "r306",
      "r312",
      "r414",
      "r457",
      "r495",
      "r496"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketingExpense": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
        "label": "Marketing Expense",
        "terseLabel": "Marketing and others"
       }
      }
     },
     "localname": "MarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MemberUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest in limited liability company (LLC).",
        "label": "Member Units [Member]",
        "terseLabel": "Balance [Member]"
       }
      }
     },
     "localname": "MemberUnitsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofbalancesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r31",
      "r33",
      "r36"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r19",
      "r36",
      "r99",
      "r106",
      "r126",
      "r139",
      "r140",
      "r143",
      "r150",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r170",
      "r185",
      "r187",
      "r191",
      "r193",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r311",
      "r312",
      "r408",
      "r457"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Loss for the year"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow",
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement",
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Total investment (in Dollars)"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non Cash Activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Financial income (expenses), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r185",
      "r187",
      "r191",
      "r193",
      "r408"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liability balance"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease - right of use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r326",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r325",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofweightedaverageleasetermandweightedaveragediscountrateTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "auth_ref": [
      "r64",
      "r90",
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionMember": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).",
        "label": "Options Held [Member]",
        "terseLabel": "Options to employees [Member]",
        "verboseLabel": "Options Held [Member]"
       }
      }
     },
     "localname": "OptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "GENERAL"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r137",
      "r414"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "verboseLabel": "Other current assets, total"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet",
      "http://www.RailVision.com/role/ScheduleofbalancesTable",
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "OTHER CURRENT ASSETS"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/OtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherDeferredCostsNet": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies.",
        "label": "Other Deferred Costs, Net",
        "terseLabel": "Deferred offering expenses"
       }
      }
     },
     "localname": "OtherDeferredCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableOtherCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other Employee-related Liabilities, Current",
        "terseLabel": "Employees and related expenses"
       }
      }
     },
     "localname": "OtherEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofotheraccountspayableTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r24",
      "r108"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Other Expenses",
        "terseLabel": "Installation and operation",
        "verboseLabel": "Expense (in Dollars)"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense classified as other.",
        "label": "Other General and Administrative Expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftransactionsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesAndDeferredRevenueNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations and noncurrent portion of deferred revenue not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months.",
        "label": "Other Liabilities and Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue in the amount of other accounts payable"
       }
      }
     },
     "localname": "OtherLiabilitiesAndDeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Recorded an expense (in Dollars)"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other research and development expense.",
        "label": "Other Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftotalsharebasedpaymentexpenserelatedtooptionsgrantedtoemployeesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accounts Payable [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Monthly office rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "terseLabel": "Additional payments"
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Accrued post-employment benefit"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PercentageOfWeightedAverageCostInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.",
        "label": "Percentage of Weighted Average Cost Inventory",
        "terseLabel": "Percentage weighted average volatility"
       }
      }
     },
     "localname": "PercentageOfWeightedAverageCostInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Dividend yields"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockDividendsShares": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.",
        "label": "Preferred Stock Dividends, Shares",
        "terseLabel": "Ordinary shares issued"
       }
      }
     },
     "localname": "PreferredStockDividendsShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred A Shares"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred A shares, par value (in New Shekels per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred A shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred A shares, issued",
        "verboseLabel": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred A shares, outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r136",
      "r210",
      "r211",
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofothercurrentassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from a convertible debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Net proceeds, costs and fees (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.",
        "label": "Proceeds from Issuance of Preferred Stock and Preference Stock",
        "terseLabel": "Issuance of preferred A shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "auth_ref": [
      "r29",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Issuance of ordinary shares and warrants, net of issuance expenses"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r29",
      "r80"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional services"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r58",
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r60",
      "r104",
      "r377",
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/FixedAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Public Utility, Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PublicUtilityPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilityPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Public Utility, Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "PublicUtilityPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofstraightlinemethodovertheestimatedusefullivesoftheassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r103",
      "r111",
      "r414"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "States the combined aggregate amount of maturities and sinking fund requirements for a long-term unconditional purchase obligation that has been recognized on the balance sheet.",
        "label": "Recorded Unconditional Purchase Obligation, Amount of Maturities and Sinking Fund Requirements",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r94",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "IPO bonus amount"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r118",
      "r331",
      "r332",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r329",
      "r330",
      "r332",
      "r333",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "TRANSACTIONS AND BALANCES WITH RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Assets Acquired Other than Through Business Combination [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r81",
      "r116",
      "r503"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "negatedLabel": "Research and development expenses, net",
        "terseLabel": "Research and development expense, total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and development expenses, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.",
        "label": "Research and Development Expense, Software (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expenses (in Dollars)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "terseLabel": "RESEARCH AND DEVELOPMENT, NET"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ResearchandDevelopmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r432",
      "r439"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r68",
      "r101",
      "r385",
      "r386",
      "r414"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r124",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r201",
      "r283",
      "r284",
      "r285",
      "r294",
      "r295",
      "r309",
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r144",
      "r150",
      "r182",
      "r183",
      "r186",
      "r189",
      "r190",
      "r194",
      "r195",
      "r197",
      "r200",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r312",
      "r376",
      "r457"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r324",
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Lease liability and right of use asset"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleLeasebackTransactionGrossProceedsFinancingActivities": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow before closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in financing activities.",
        "label": "Sale Leaseback Transaction, Gross Proceeds, Financing Activities",
        "terseLabel": "Gross proceeds (in Dollars)"
       }
      }
     },
     "localname": "SaleLeasebackTransactionGrossProceedsFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (in Dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other accounts payable"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/OtherAccountsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfClosedBlockAssetsAndLiabilities": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of summarized financial data of the closed block, typically including the liabilities of the closed block, assets allocated thereto, and maximum expected future earnings from the operations thereof.",
        "label": "Schedule of Closed Block Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of balances"
       }
      }
     },
     "localname": "ScheduleOfClosedBlockAssetsAndLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of future lease payments under operating leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of other current assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/OtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
        "label": "Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
        "terseLabel": "Schedule of total share-based payment expense related to options granted to employees"
       }
      }
     },
     "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffixedassetsnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation expense and method used, including composite depreciation, and accumulated depreciation.",
        "label": "Public Utility Property, Plant, and Equipment [Table Text Block]",
        "terseLabel": "Schedule of straight-line method over the estimated useful lives of the assets"
       }
      }
     },
     "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/TransactionsandBalanceswithRelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures of the amount of capitalized costs of a research and development nature acquired in a transaction other than a business combination, amount of costs charged to expense during the period, and identification of the income statement caption in which the charge is reflected.",
        "label": "Schedule of Research and Development Assets Acquired Other than Through Business Combination [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature and amounts of capitalized costs of a research and development nature that were acquired in a transaction other than a business combination, the amount of such assets charged to expense during the period, and identification of the income statement caption in which the charges are included.",
        "label": "Schedule of Research and Development Assets Acquired Other than Through Business Combination [Table Text Block]",
        "terseLabel": "Schedule of research and development"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentAssetsAcquiredOtherThanThroughBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ResearchandDevelopmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r75",
      "r77",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of option activity for options to employees, officers and directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of weighted average lease term and weighted average discount rate"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of measurement difference between recognized amounts and resulting measurement differences for securities sold under agreements to repurchase.",
        "label": "Securities Sold under Agreements to Repurchase, Measurement Difference Description",
        "terseLabel": "Agreements executive officers, description"
       }
      }
     },
     "localname": "SecuritiesSoldUnderAgreementsToRepurchaseMeasurementDifferenceDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Total general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of auction market preferred securities that may have different rights to other classifications of auction market preferred securities, for example Series B.",
        "label": "Series A [Member]",
        "terseLabel": "Series A [Member]"
       }
      }
     },
     "localname": "SeriesAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r435",
      "r436",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Preferred A Shares [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of auction market preferred securities that may have different rights to other classifications of auction market preferred securities, for example Series A.",
        "label": "Series B [Member]",
        "terseLabel": "Series B [Member]"
       }
      }
     },
     "localname": "SeriesBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance payment to former Company CEO"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoftransactionsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of options, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "negatedLabel": "Number of options, Exercised",
        "terseLabel": "Granted options shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of options, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted per share (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of options, Outstanding at end of period",
        "periodStartLabel": "Number of options, Outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, Outstanding at end of period",
        "periodStartLabel": "Weighted average exercise price, Outstanding at beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Vested shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r256",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted average remaining contractual life, Outstanding at beginning of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofoptionactivityforoptionstoemployeesofficersanddirectorsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "terseLabel": "Options shares"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options expire term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Share issued price per share (in Dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r43",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r150",
      "r168",
      "r169",
      "r171",
      "r173",
      "r176",
      "r177",
      "r200",
      "r221",
      "r223",
      "r224",
      "r225",
      "r228",
      "r229",
      "r232",
      "r233",
      "r235",
      "r239",
      "r247",
      "r312",
      "r401",
      "r428",
      "r440",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConvertiblePreferredSharesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r17",
      "r65",
      "r124",
      "r141",
      "r142",
      "r143",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r175",
      "r201",
      "r249",
      "r283",
      "r284",
      "r285",
      "r294",
      "r295",
      "r309",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r328",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofbalancesTable",
      "http://www.RailVision.com/role/ShareholdersEquityDetails",
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r175",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r16",
      "r65",
      "r66",
      "r68",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Issuance of convertible preferred shares, net of issuance costs (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r3",
      "r4",
      "r65",
      "r66",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r3",
      "r4",
      "r65",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "(in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r3",
      "r4",
      "r65",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "(in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r3",
      "r4",
      "r65",
      "r68",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of shares as a result of exercise of options (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r17",
      "r65",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of convertible preferred shares, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r17",
      "r65",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of convertible preferred shares into ordinary shares upon completion of initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Issuance of units of ordinary shares and warrants in connection with the initial public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r3",
      "r4",
      "r68",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r65",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of shares as a result of exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionExercisePriceIncrease": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.",
        "label": "Stock Option, Exercise Price, Increase",
        "terseLabel": "Option exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "StockOptionExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r3",
      "r4",
      "r65",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Purchase ordinary shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r52",
      "r414",
      "r441",
      "r453",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r124",
      "r125",
      "r142",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r201",
      "r249",
      "r283",
      "r284",
      "r285",
      "r294",
      "r295",
      "r309",
      "r313",
      "r314",
      "r318",
      "r328",
      "r383",
      "r384",
      "r441",
      "r453",
      "r491"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "totalLabel": "Total shareholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet",
      "http://www.RailVision.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r69",
      "r149",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r246",
      "r249",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r319",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r319",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r319",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r335",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/CommitmentsandContingenciesLiabilitiesDetails",
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r221",
      "r223",
      "r224",
      "r225",
      "r228",
      "r229"
     ],
     "calculation": {
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Preferred A shares, NIS 0.01 par value; Authorized 100,000 shares; Issued and outstanding: No shares as at December 31, 2022 and 51,282 shares as of December 31, 2021;"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TerminationLoans": {
     "auth_ref": [
      "r370"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite liabilities to third parties under a termination loan agreement, whether or not guaranteed in whole or in part by the government.",
        "label": "Termination Loans",
        "terseLabel": "Termination amount (in Dollars)"
       }
      }
     },
     "localname": "TerminationLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r231",
      "r245",
      "r307",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r450",
      "r451",
      "r452",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TravelAndEntertainmentExpense": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses incurred for travel and entertainment during the period.",
        "label": "Travel and Entertainment Expense",
        "terseLabel": "Travel and other expenses",
        "verboseLabel": "Travel expenses"
       }
      }
     },
     "localname": "TravelAndEntertainmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleofgeneralandadministrativeTable",
      "http://www.RailVision.com/role/ScheduleofresearchanddevelopmentTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationImputedInterest": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "If disclosed, the amount of imputed interest necessary to reduce an unconditional purchase obligation to present value on an unrecorded unconditional purchase obligation.",
        "label": "Unrecorded Unconditional Purchase Obligation, Imputed Interest",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationImputedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r178",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates in the preparation of financial statements"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantExercisePriceDecrease": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Decrease",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantExercisePriceDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Exercise price per share (in Dollars per share)"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "KB Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share(*) (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r167",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average number of ordinary shares outstanding used in computing basic and diluted loss per ordinary share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.RailVision.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5,6,7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "805",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505872&loc=d3e30806-158569",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "805",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124502525&loc=d3e31071-158570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "980",
   "URI": "https://asc.fasb.org/extlink&oid=84167750&loc=d3e42232-110370",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "https://asc.fasb.org/subtopic&trid=2197926",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "50",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51831-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "51",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51840-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386837&loc=d3e51843-112757",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154689&loc=d3e54369-107958",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20225997-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55295-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938292&loc=d3e56288-109415",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=126939063&loc=d3e53371-107955",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154689&loc=SL120155198-107958",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r417": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r418": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r419": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r421": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r422": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r423": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r424": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r425": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r426": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r427": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25376-109308",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5258-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "83",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001213900-23-022437-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-022437-xbrl.zip
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M,)8%S%Q0<U8>.X[)>6/XKHS;82=)W)G!)?KA!>&\F.=GN?D>Y+1*$0BF<4$
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MJ=%%]>'YCVHV!W46=%$X@,-?J@*N /UO@%]5<SA,HQ(UJ,/]@T-2 /]Q]LL
MOVP%> A>2%@1U#X_@789GXNT1.Z'ZR.9EP+>(S_+V9RLD!:\-DHJU#*=;\-Q
MGLW *LA55J&A8LY_K5%2TQI6WU!;K35.,9\GH):"THL:Y;P:P:>PS 4J?W /
MP:[R?7$6IED9.FNV>J44:OK#*>CK[O!XS/+E;M'0#7S!QD0DDT2',WY^L/^
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MYH9-9A45&.G"YXVN(?VMD=FV(< D>DR/G\\_;RJXF1[BX>-U#_%20M[&XKN
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MB=OW_J_9K_N36NW:_<4$ '0&%]6+_O10O;[[&(ZWK;QM]9W;5JS(A'!>*$*
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MBVJ(,<H3D^HI,%*TQ[%"& ZA2!&!U1:[K?"R!!'02/F+F,/-A_N'^[A:,IW
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MHB*5B)^49'#<R2#+Z]S6A$X+3/^D!%M:.R</:;?(<S>2-X^7PD=(J'/=[:1
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M-;Z=_!Q):3R;V)QDXF* 5K8OO'UI.,\25'M)(&%FA-4^FQAA_*QV>)(AM*Y
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M6C;1V!-;N?8&O+P9@EZ##&<0HI\=_KY\B>Z;9>6\K*-[]5O-!9+F85V&&(<
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MUD,>WH[= J6\*JFL-,P0RB1+:MDZFH4<D&#IZ6R#;Y^6QHFLAW9$27CC'E,
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MD<UA+6\1U*_D[!;$=:$Y _;_)[_BX"E9$Q];:#*L1FU =Z*\>,.36&UX$8_
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MVA]6<JM5UPCEDK>)$QODT/YO(!AA(.FXOQ<D>^6[MRSW@WL/'HC?73I&32/
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M-GSS9];*GP:#\XK@@R<_/PV;O7?R.)%Y8$HOO!@/U"W WC2F$46P9KFHADL
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MDHY,?Y^6Z\SL9(C)7ZJ?$A9A6<.^=?79N<:E17;WMHMS3ZEGZ7W =F6]5G$
M/M\TI5"<C3C3B?9_B2O2]FX!(W@KPMRCCW0C8D4V0%2M2\*CDK?$RJ/B59*'
MR3R,?1-6(N33L=-;[672_$D.2:.UL:IUL )AI82;P<;8]M7SCWE(ZA I1%//
M9<5IP=2-M)EZ.7MM,X?OCQP.]Q<Z:<Y@+-O@ ?V+@N4GZW P2*]M3!J9<*Q
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M,.+1RWEXFU_.XU-YH#_7H)J_(OKR.T??ICUHHLY]=<10_1Z>2=7FRHR'KQ\
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M@M]2U1?JY6RK#OYNP3IZGZUPSF[+6EU<I3SS'07?QK%3C3<2Z1AY?ZY(!IK
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M$6&BL\L!KV7N:*+!*0ZQ=LT+L 'K.[K?#C0C[::*D]Q+^MF@2"7LQSX[#8H
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MPMV33^+@)M2]CIZ<O_KPM&PAIM_&&\'LR^/55UM/H=,6P!VU?<YN6'UBFID
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M76=M+3DW?DV_*V\V^H 3)IGC0^94/15([(SKPM4E/%;?-4_U/;!XXJ!;AG.
MSIJA;I<M(0WRO=F-W7;"6+&2\=K6TWFG5ZD2[7NM[L;V5.X^E;^'/PE2DF>0
MD@"OLOEC:3GKUS7KOAL)RU\G$I9^O3=7G#0#A.6O$@A+JD>#,4H_?5&0TN0/
MH%K""O[^H'NTCP+4"#K)KY=O6K;_R S&K1QHN<NVK(GT-KZ*'!?G' S&)LT4
ME^$#S\16[4C5'M+"!>71BO>:&AY8T60+1"'[+F<*4*I5)GRWO0/B4DC-\)-H
MZ(^+* _W^OIR#Y$(:3!; *5HD?F0BUZ:-F_3(/XR*HB'7>;)X(M_]H?XU[O^
M[Y@?8[EP)_7#_<[^_KZOR.)(IDHQ C%\E R$:WR);."XOW'0"1Q'/=#HU?QZ
MI'R'RU/9]\G=XL%7V6V&.OIP<LVN5V-.:3\%W+["^2R6#/UQ]NLG_Z3[S#=;
M0@.6C:\E$Z9:827GE" OJ#(W"!#Y#B+$Y:C^][UCRT_#V"M(6ER6K:G?!_]!
M@^[K(%77=$2FBO,38)MIJ(\D.J;^YQ(5-V,W4._EG0_,%ARA5?6HTB[;<U*%
M=NOR;5-& 3'X5Z]_\=X"W )%';Y5[X79;ZOPVD6F?AY[ @@*+K$O0-A5_CZR
MQVC9N$[(9CXZ>\2Z+AX4X#\!+F@_"X><=#W#VBOY^)Z#JO[4*9$4UP_KIMS>
ML8+I7G4#\*-5P/F1SG]F>'7[-D98-\&N*J![!_VY@,_=]7]EH/7%BU3&*SV4
MM8*WSB'.&P^Y.'^#&0=W$#NS<O+ :3OH*P8BKRRH8\L )D4*S&0&_V5$%[-7
MUGV&*E>!3S5UG>5\[/%=.$^_+6)QVGTFCL] YJAIH/5IEY]]M5VC73_MX<4@
M3Y", B*RLUPX?$>VC'O!%3/J.@NPWM$1R]TG\E67),Z+0WSRM.O-(-_2[A0J
MTY'(V=Z?>$NQ["#M7(L);;_4MN+YKVKT^37(_OY?0?;WZI']7U>1_94#1[P(
MV-]W@?UWB\-MO<D4_O3NTV^>1.W]]Q>_MD*T:21VFGF;P1R^LRFPMQG,X>5-
M@;WF80YO-_T^--O^>9MMO\9L^\/]-MO^FQ(?*Y;FE\;UXGUTP&T>T4;>19:Y
M=MQW:S<?O.BPAZW.=K9'[=<>];PWU+4[D4%EC9 [1NIX!M6GK(17-<Y6_H3$
M.+>ZHBG^)Z&9.FA&E9J\$@MVDH;Q()Q$*ON1;+*G3\*G)AT1C2-MNQ"O\BX=
M7_+?2,[4:8DR=%FB<E0JRU5\$Z9)S,7*D4XEU<D@I(T\">FU&J*N4N]O$I*1
M>(4-\_HHEX8SM9H!SCE9Z*15?N1DJ-25U[_DWSSI/^7T4R>UQCI%2C@EDZ3F
M[H$GYVAK,V.EM,%L\V'(=AN%90N]N2Y;;L.25I5J_)H0@@U*[T*1LBZM:2-;
M!.5+UCGNE*9"=</(\ERC4V:R<$MXE8'#< RVR! W=:D-50I<30&\2B8FE>;2
MO;!,1)QA!Y*ZB6N21[8'EP"J2915?L[1X\2)W&J6T=&W4E<I5-@)&SD>;HWM
M>CLN<LE#YBVRB69\35TPY>I+^0Z&>(^Y:Z%&VY#\2TGZY&Y%0'>KK' <9ADC
M5#AII,)OX%:$769+A4W'W-8-LBUKPF6;Q^:;DYWE?82U:J^(D27L8[P)(C&,
MG5BE0=_(!:K;VLYT;].A^<1! /2<5H\6V@5-P=R72F*F1+HF'.ER&T2F!<)X
MI<ORM45O.<6%@HO:EZZ.UQW!9L6:XL1<]7SJ\7OYCE:F8Z\Z=VT$[C:C"B81
M1V#1#8\FT])\X]<$FN?<^CGB-JZ?D /1X*\,8. 'HUQ34^F=4C/!G*HN>]32
M0>/75%$S$:OO@U7-Z+'6 0C99O(FI!Y@<=X!IWJS@J+#5S:JDG7G4P0"SFM
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MRS;O5D,PZ9NSSN!#RTF7K^F26*A7H\RLF4JZ_H73[Y%]SQ*3UQ#X>VB<,;"
MVH)R#P4-:+O<ASE7$6T4F[M<MF&;4U:KI3JSI5(56@W *UVF%N2>Y9OBK>R8
M&]E7I=KW)4YN(S6\ BQ]:O5>3?E)-B>4&.KB8JE\*/7<P' WXE]27S)"-*^@
M&4I;O.OP2@=^^HXXD"'+Q77N-W^)7+/>-5(XO!'-A"81*53M&[;D<;\/7@S7
MT8G^U.I,6W333V'@>%8-L3B8%7E;@2/**KV).=5,I+"!9'=2JJM*AB5JU*6
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M $K#,!QQ@TEP8F[!O:2#N./$\/I3!VV>1\:P R 65!03 T:5=?W?E5_V*M/
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M(.%0Q60HBM68!D B#QPEQG<WM0"9=',]YA(E2ZM<7&8Y2R)1ER&P.S.I:<7
MP >6$Z(?59+\#-PCPR%"O%>G[3GRMX+U*/!U;L-[8NA(D0GY8',5$37#7F4S
M@%.3XJ32 UC4;>[A2^KF --D"5_Q'5EU.\N#7&G\]);)K(K)K+C\\.>$CC+F
M-EJ?F'/,Y<QNW:IVD?6?9F(X%CGL:&C98F3:H(/6OQ6K!5I!Z6AA "'0T78U
MN )&>OOIU'*7LT^G'=9!@F$PR4O.E5J"$"8)VSA7'K0X4D&8A;+W#Z\DWE6D
MI:)%O])\#!;SS*QEM+FUS*9?V,E/.0%CD!OS6 ,OLG+HI2H2_DR3$*/=$291
MJ/ETU[^(_?=!2@*B]Z(#Z.SG'79!,  C:VEF5\(L*X@]!OZGM^>80Y#:30-K
MZ^V_'!5L#.F5"6_TG'!0F@3#$KN;?W3PTI@\P%A.<W')]_$D[9\:T52L'^/7
M[F77?Z/P&#L[T$0E#>)L0L\$QG>A73DBMVG9=.:3*)GR19[9<NOK4>+@&0 L
MFB0!$<P@G*"GR"TD@WO:K$;3PA3ZYA$96IAR[)"U^6B#.D0!NM-[D +($I($
MIT,O\SB30A0/+6 'T!7P'3Z2#;DUS@L2.^_"+^HVS$33UM/42C6_/ K'H4,%
MI:(@Y E](HD  I"*"-9.)SA^,NV+)95!-[?G6;/*X*R\ZU]>L\IA1X?CQ;T'
MDTDD;J&I5D[8[Z,=5+GM,%A']UY)X:390)73-@HMD2%Y27D!G6=&/RAMI7 ,
M%<<U3-C/(Q=I2"P\4Z3Q!>QO$]^!REC-P4C6LX3C]\SQ9WQAITDABL&M%OF<
M6IND0@)]1L*&.RIGAD6G9FPO^2,,3%*4;&44W&:=.<9!$Z"#:X:1OU,>Y_/8
M,R1AK5-'PP[\N!CWZ=X1%>!D^##<P^&3#^.;)&*;-<^A4\,WCWY"-  HJ5]D
M(7%[UGUA:]<-Y)DQ)FEX$PR(O-D6(/K5UDE'*YA*U/T).A*D\*\Z5GG'T<3U
M(NBE[Z'J:C]2_1H2RTD\=_W\-V=T*<Q-/.M#G56?T_560Z'G(LT- ]'&!N::
M$N/1CW!XG[=*GK@.TO',UIS']FYV1%(3GS"(T.P -D,&ACOD"W?3EYAM3A<1
MF/[$]4/:',B#<*!M.RUM((KYQ\$D'-+'=J5&^GBU?%8;D@8_OG8.S R,5C%T
MM I^4LEQZ_<R>C(DFS&V#$>!4D',QNLK%A3ZGR6CZ5@ND@L340B7B!TG&XC1
M:'[X=3F[UJ!HJ.I-!L6Y<\^]C_J>MP9%TR0'*0*94E]\Z']Q[G!J.%!NZ03Q
M_\*+;12OGH?[G-F2V8">]<6R>>$HGX9I_1J'8*R7< ]DGF6.<2":301E'>,D
M=/_9P<)M3M(,'ECVJ\)8X+BH&BG]ZX6S*M'^]4NB:&H\SWK1W'['5<T0:(Q+
M[45B=V)NE$X48EQCE<)W G8\9N4\SLM>AM9_;90Y*RQVBY!V]'*PB%(1-W,@
MP4,6L0+4OUP7H8O>D0^8,O8RRBURA#[I!&_)%&2;./&OF&2Y4Q/1Z$C;)S6_
M\D=A))TIR#)(4B_P!]?<X43?'?/^*S((<Q'+!=OV).43$I52D0A5H6/->WKK
M.+&*"!OQQD")]+U#8,"]J5KU<RZ%)_Z!&DL#;KY"6R+:YH<I#A:RJ.M&N$:7
M8'L)5N5R\CA"EHFY.4^KDA9+*BVL\CA(IY4OI0%DABR^,+M6\FB8I""/(7P.
MU4O ET@G))IO+!N&_4YJ,)(LV)K4@3NM&?LUTQ3F[WH[^N7S/#5SD8R9:RZ4
M]CRQ'<XFE%@?B+$MN>QB,,__\JX;KF^U.)0Z[+A ].46VK&O'6J0-^4DK'/.
M+ #%KO9-,XRA.KY=:T5TD1TP*B)?]I%U )UA5%Y^>*.R"0EMB4BRLRKS' &*
MCQ?8=^74%\AI?:)$'&0;I59N6UN,^!_]B%C@D 4SW0&0#_UC$*:#8@P2H7]Y
MB(&$>(KMC#!C9DN#RK-H:%0,KA\V!6.M\%$@E2=4(N#%G:%]-SE"L#9U [XW
MG8YAFO7EJ6!9IJ).P;^EE0^A8C=AS"9MD_3 .A!Y<P(P9 1&2$\B[FJ=D9_"
M[$OF?X(75(X=5.(JX;Y1PKO:$[E;;&H76>^L6T?G!Z@_X 3D0QY$03AFH?L#
MTS;P JJ^:MCW1(PU="TANW0H'@6%QD1P00Y4B#:2KI;"G@S1?M)2:3!<+8PM
MN\/'<87_F_[ -&!$&L=P*HY%87Z,V<KK&MJ)BB=6^/;:3G-][K^')F(?MHG8
MZTS$/FX3L9=0ZK8PWQ6[IMXA)NBQFJGFL79W0G+LHC3\7?SZ4,7*3%?(KJE5
ML[5F;B*6.OKKG#3I4QS!I#>QTD;_[TA6TL$84MR,B829*VWDQ)+M31^S-.3N
MNP$'W(LT4W/.'=+$((4C&#(Z:I$4.5[0<8>%EN^ _\"JAA,I@"R-H5GVM8L>
M:55P<V52"I"I/(_8%>5Q +#CT[G2K[5LINTDGL%>)Q+--+&!<O.;@!^4I)OV
M0&T[?:^8"YV-$:A7ZA&XS[:?Q :R;.@229K(P3'21'J''1L9'\%$RU0<<B3+
M7C32R</9N@UB-6!9DAZM*\21NKS'#*@?9&$U9F@<;C*Z5XY>OOUDWU>&<J!Z
M8S@8E6!:,BR2_:35:-<_Q9<PUNU/I/IU$.B8YGF6!BJJX!;OUEGNXIH^)#%[
M&.9/-E438OCL"X%K*0K('$"-F?9-#9#E)U\!Y5>'<_JTH"",.3)^E2J)<,S7
M@-VJ,NQRE20($YNPOV3+S]):U_\EN:6?IYV2TNK2$XQ#3IX(]:SK4TA,=$@_
MQ%%[.!\'"GOMI44$,=]QHU=S_D&6R'>MWPT\BQ.--NTF3/-""100EUPE.O4M
M,^EB\.\/D#/-%33:%Q@I^'.<=9D4+[/B]_1V3M^CD<\X6TF\46(]<ZZ1CH:;
M^;FKT4RCI 2.5N37J(WC#"6K-Y4I9TP3<JZH[]:-P(.[MJ7UUS=^3<3RJ[R!
MR44GQB$9;(;.3<-T2SXZK\_]"5&O_9BS^?+@"^[9G+,[3N(])Y6'H[I!!NH:
M:Z=IP;?OWK%:G4EJ=.SY%8TDRS^0[$X PRDX2@<JL(FG'E\=Y\( XZED/R7;
MN?VVR)O_$_CA\!_?]?]W_^ $OJO@IV;:[*^UBG)!/"G6T!5DQ%^::H?6A-^&
M-2'MU)KNIK*$KF(6#L,@%02<[? AN="O][M>SYI\O=[HZV5B1!WO8Q1H)GOV
MWR*<S('U[P0][N(=$_0) 7L@FU$%P_\6I/;5(2M 1T@0T50F[S-3;/1*5E69
MNC0B@Q+"M /1::Q'4AT/COU? JT8? Z'UT'J7^;=CO_)?$@&;!QX1X<G)\<'
MSSJE#<!]^I#<;[E!,A@4DZF$G?X(X<&C#P]..B_V]_T,*R##6ZF<S1()?F+V
M>F*A<6_11_(EQUI)?;A4DUPA]]DC(_Z$#&*I($"^F';+T<Z,2_.ZK*?G:A9H
M^9(](\,RIG3LYM^S-X 10B5=;4SG<4U3Y]#O)!!=A7;MP_FE_^*@L[^_[SVI
M+O+[W@D^?LJ> '$UX(5U ^D\!0-/(7Y//T 5GL %\%MZ&,Y?\!:-0Q'S?M2\
M:>X%/.1)Y^#9\?R0SV3B6\&T=_&N0YZ20ANB>$CJUR7E@%XPF,U6&-/MX8?*
M@A\RIY4:EIDV"&]E2K'-JW-%)%5>O #S;V!%.F2(+L\,0A/BMB@;2W=\=,G^
MO,F2_?SSV7OOZ+3K__KAT]GEQ;O?SM[XEY]/W[[U7U^\?W_VX?-E*]:W84T?
MDMPK75([?)M>-/XV'9.D_WCVZ?3S^8>?_=,/;_RWYQ]./[P^/WWG?SK[[?SL
M=_[PXZ>+RX]GK]=\O[;HVCPT->:H38U99VK,29L:LP.7:MU8INBO>/KA].<S
MJ K:J+OTWIQ?OO[U\O+\X@.S.GK@W;\OR4ZX>/OW?OK#3U[)$%]??'AS_MD\
M2!K(K^\^XSG#02\^;%+_V'*LUPVI&G\/T6"%%/I(E\@/PVQ09)DI'0ET:T"C
MXCM@UJ3[A[;$I+;V'.V:=$HW\D&E]#;^3Q%+U1D'%"J#EO@QF2UE276:<YSD
MRD8PAKZ*,B6N!0X<,"9/7#"8$.JRM(\+,0)G163=)+=<X<J0%,3';H-TN!<E
MR1>&[;%O]V: <XI)$E=L(A>=0C:J&N>T1;PZUUQ*>J2:GI/8!8("87L)C)@-
M1':2@'_:U*9H:B#84#U<>;-I'18+O&2NN,9_/"GG!;PA+NXO8ODSY>1QP;$T
M<PS5#%@(@ <TI%(HL1F=>OXZ8"C-()UZI*4JG?J$'[W5F_E.;^:EW4R#AB'O
MA/WJY+'[;R5!R3QTU[ERV,>2J^<<KO;Q/(Q"P](BEM8O:+LR]-^H 7N2_,,#
M3@GI2?77?N^@Z[\I7VG3K[V'WPWWM0O>>L A;4"KI,KBYBUY?M\+G1N"*#O*
ML([-W3V5C?S$&XD$%3JR,?UN[^V])M,QF=RXMGCX\NPU1GD?L/-.MND)"BOU
M\?(*[#OT <.#%+8Z\NK-E8L;( RJV]8$N;\X/3QQ>N4%%3=XQJ4]#CZ1@6 3
M_(P,]3A?- 91"F@$YHO S3'0>PXR$9<'!WFP9X29U E5\FZ,5[J,B ^*G /X
MC!;GG9Z++.I8H(<]-+-BF6T! 9WYFF:(7/$E6#,T)BZZ:5_1,<W2#,9R)@ Y
M_XJ3--U[E:HQ8'D"Z9RU-XA(M##HI,69=-I3EOAQY?SK,0LYI55WV6/\)H"'
MAC=: HDK6FEGYF J+NQA&J :2M9"O+ 8* ]R, 8$H.%=LUC)J*<R6@TZ:L97
M>_#_^Y,P2C3TA,0H_$^FGX?D/C'3=;CH:7%%^\W\C;.;_DGK1CHP^^\].C>3
M41,[.3NUX]L"R"(EA4#2' [V^7O_-TY8\&U#'-.*4$(-RW"!;6#% %+)"B?\
M!L'I0686(_YIZ#!#.?/XTIQ,Q<3-CN2DQ ^-Z>;(M6 ,:RX>$O1I4UJH\Z.Z
MWFPZ6;6V4.(.V#2F3XUBK(]^]O:D2:$O$),AQ[4BI4N:H;.5P] [8S4*+402
M"V8+T(@MF":QTJ5/$>)(NN&:8)&I02)[^J-!M\HR%"'2IL"O?66 S/@0Y\"Y
MA#U8S,4B<]K$Y(DW5*#QE)/I,IW6+8"P52 9J0-=O'5(X.(C3G))A9D%!BMY
MD62LT^>3O(I,Y>F%D.*7<(TN<&('K&)):DW)C+?9M'E01DQOO\FNR-.N=V'1
MWC^).MG*^;5L-1G$=JN],RUC1&5=O^O"W(6#X]4Z#1N@:JTG]T%;XV4K!*L5
M<*Q4MXNZ31P,;9/^_KQWT--9\ MS(<QHHH5<D7A)-7!Q,!Q+'F\@O2[T@PSY
MBV+U,LL N;CR2RA^KKCB%A/%.A.AFLAW&U_E(DS@DZ8)3FM]X]#$F:6)6.6;
M8@Q+3[#E%O?C%G=><\LT)FE(4PXC3M+/@HCS%;4O1PPX8CA9$L>DW-L?/RD=
M:-DU&91[XCK4Z3Q/&0?=X)\[D-GV]V7-GGG)G1->.^?8;A);&S557>:<$\-N
MYH@QZ1GR':&R(;M>1W>?XX];H1W=<6BR#0,51;K3X3^^V_^._XT$(O/O!R]'
M1W)1K!),,IJ,^>LEV9'#_!JC[/_M.]W1UXQ/MA;;-(;-2#CRN[ENCV1-YFJ/
M,YQ^)%%]FP:3-6Y9/OQI^;OU$+=*.D?VDVBXWNG8_:!=Q:?_^*[WW</FM^ZH
MV[_IZO LQ2W-04?KG)8%'1YT&KS%#9M.>^+K/_&RP_A#^=$]\E96-O$GH50.
M9FC=Q!,A6?7KY9NG"[:VAA!,3UN;[=%=KZ)P!_W>W9IWX\0,K_&"_:S=O,=D
M3^T!?]T!'S3[@!_.C>PH=]#'=^Z#R\[MGJ?R-:]M_/SNN_VDZA(U7W'  ^IN
MDO[HIU?])[W]HT[O\'FG=WS\M$:!%1WXV<G?5DE%;X M, @#Z0Q4+VBU\KW2
M]R[A!K.OK9X0FJIO3HV3.;R8F0.7-*]R$@>'^W=M_N/O0DL ZR2 1;K#X^W"
M7V%GOT,YG^=AZUS!Y;PK;F9+-TJ]CT:RZZ739T?W>.U&UMN>YE]^\\G^\V:<
MYGHUIW4NYF,P39,HJH0,E TFMP2[6H(][NP?O6@&R;;GN9+S/'Y^THSSW#9M
MIPPQ(E,[2;_,H$&UQ+IRW>>X&93:'N8J5)^&Z+';J_E\^I]@/'GY1EC.&"'A
M5N%9/<\Y6>08:IG.]IWFX<$.V%N/H.Q\,M"0@FLEB+4*-7BJ)=*5$^EQJ^?L
MT&F^:(@ V:RBLX%X]N<TN%$13Z1,Z%S@^ED:)]YL5.7NP/JC782'36WU5^7H
MV</"^X^V42T9-9B,#@X6<=QFD-$*=;]6_C=>_M_[S:U"UQYHLW2Z]6MP21Y$
MK8C=/A%[0E33;"';$M)6$-*S3F]A"D0S",FPV!^XZ,H48FU+^=PN%IC^+D7@
M0'\SL!UWUYLR$$H)\U:BH @*"T*Y82SP)?KW// D30"[;2I2!VD1Y@Y._9)"
M5]NN:Q<*#C<-4GO<@M3>MX3^:T!JG[4@M;MQJ59'1HS$\+/ ;C 0PVD%=L-O
M\5F:*Q#=8ZNBI7P-WD*)Q%*#K="!1!PIQN0,(H.LA1XR@M:%+HT%1.E5QY,V
MT=SJ(DF^?%%J@H^=YC(=@'O=N, .I1]_,0),"\FP79 ,]SC)]8$R/+)^_2"@
MAOO!+\@D[K,5#P5J>+3:U\<K<IV;RF8+[A]6;[_A?6M/;.M.K 5#:#!1WLL(
M7=D"6C"$W3_@W0-#:.79VN59DS:F/9+&;<S&,#36&\BIJ0H5)6YY>F +M+!^
MH(7.\Z-%^<T-VH>6!-9) L<+@[XMVD:+MO$@HEUO1G+OL!F)7NUIKN#-1P>+
M+*8M8C6/C+91$_UIJT[7("&/CAM"J^UYKN0\#PX;(DFV3,WY7(T0MZ2Y^FJ9
MMMIT=T[S: ?JVQ\95:,M==\D\VD(O;:GN8K37%@3LD7<Y]XZ3A6X61-1'0CV
MPA'J,:YKCJBW?_>&5@=;TT1@0#]D(@W!''C//8"Y.ZU),&RKA!["-KZJ2NCP
MQ6$S2WK:4U_CJ3\[;N:AKT$FS"[LZ/&J8U?\ZJ\D6YJ%/TR*?J2:1K6+9K9Z
M ZS3.UED4-<<6H-X7TM"#2&AP\[AP2),WB:0T(**V#75T*P]W:;A95FOT>T^
M#;,D]M!@^5KYR$CVS[AAFTE$]@\/.CY2/CLH8%WPD,U6]B5W<(U%7-_N<4D_
M8W2-QW'I_N9)O/ZZN=6OPVS\'1/?JF:D.YJUMRR=L2Y1>:W3F^4WS=BB]G!J
M#Z<M7?FV2U<>9N-OA$3;TI7=/^ =*5UI4B/)3^I&Q46;VOYX><U'"\FZ0;O0
M$L#Z".#Y\V\BK7WM$NYUDN70K-+E+*V-WC08V>_)R<D#A?PZ=VJ1@MZ24*-)
MZ+A!@/!/-Z@AUI@5ZUS:SVF298SL%+9%1*LGX][18^1%S;*\]B3_NN&ZT)FY
M_4K=>G-J[X!G;4EU];)S"41WRW:VZRR7H63OBLKS"!K=SPN1">^#%=&:#DTV
M'1Z2A]7:GRT1U1+10S*QMLH"7: #;MCLU-DQ\17/(R(;M-4=5D[#!_N=9X>/
M4>+9*H)K.<S>B\<H)-]Q3?!MB +/D'3!,!XD8]7A.<5JUAO6BNTM$-N]A2W;
MFU&)TI+15I#1LT5\MAE4M)EZIIK4F_6N](/*_7?SFN"2*3;@OK1%*ZR:'#UK
M3.73?>WMEGX:1#^]WGT%]X;I9[T] +_Q8AF3XK-%]3&[V$3JHD@]DV_EHY63
MK2)3BTK-@C%Z/=%W>>)_?]0[Z.SO[\. B@I<5O_[WL$+?-3QA])8$2.2=36)
M%$JB?%W.-E3C)!;'.WUX&^;77N /:-%DAZ4^)]PK_]=+]M)_3R^^QY#O$GK]
M9Y6._8]AE)!"\?DC#^Q_"A/:ASA/VJZ,ZRI]XT OMR)[XP1ZV_9Q3;_Y=S50
M-2QA>G^6P"%H9@HIL'(R%0L&"[U -U^E^_K]BV?/^9DD]0X.N\=_0T?6 1>]
MZF$X^LF/W&,.!UW_,S,5_8;;('-ZW@5YGH;]0DH6:>R9J1P?GN ]'C&=R3R
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MAF'V\$8-1  15W\!ON9(I/UCD4'TOK@8$U<M,N=-S(?*::0)6;%XY:3H1^&
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M+^3UZ>M=ABJBA^,Z%Q_'A],_7I]J(][<^6/\D@F/L@O+H.A1(E&?.)9/W_>
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M>,[DMUPW<WCKLMSE_Z:65T"[,\X97<U\@!G\>!FG,TS:(>X#W.=T4!1TW*E
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M<+@ID7R/^32CYE<=[1#5S5F=SK"J)((MFJ0\G@P8@)N#8W\#'/L#U,N%>G$
M@.%2O?)'D->^Z&%#Y JY![I-D::%0R(.!*N()#')1>10-S3?#LL[K\08B1QS
M?[@FCOIL+N'S4LBJOG4\<4C]&V31((ON'(YD$'E3Z?DZJ8,OD#/"I7QS'RB4
M=F- DXA3U04OLG#\HQ:$'E*UX3?\EN'-#1,T6ZG(O<X"J^MR(E2//;E6<S*0
MQM$XPFTWY^Q2RC KP-;@"N-.1ENKPJ'1RQ%6>^.^]MR";<F$\VQ*=.8EV56>
MXOU*=CT8)2I95)YMF1<-,X>K3!IJ/";[3O,,T=DXAF9MLB[[J>E$Y4J:U$9
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MTS:<MLT_;3IARG7SZBI S+;DY7F0U3QA9HUF179T_.G$]RX'X)#CM-U^@M/
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M</6 ,6%3NGJ90CL<I<$NE'>["SU\1*2:O +*6M+7A.ZQ[8D04G,5ES-.;5_
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MA^,(GT"#,"VRB<E9;D-MW4=Q7I36,_?>.?PG7XZ3NYS'\B6.:GGVQ$K)[[7
M-F.E<">-3I/SNVTD4#HF:J [EHQB9F<GL!&Y*!0W5>4T3X5G/A>\OG:WZHS
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MNR$2EFM?ZB:!>7?S>'YC@6?J$,(T'#J8ZA8A-G:;P6]4=F*5-":H5$@P*:@
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M)9[$M)0;NAVM4Z%5;#;U*7+Y@<VJ!\8P'[.I7,,T- )#M7"C_%0U.)@21L_
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M*M;NKHLHR%$7I DD2*-C-*-%49EF^-5\7DQ!*C'M)2OG&\-3M:&#NL!5<*?
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M9+L'UK\!2U NN&?F3DTCHN+3_*-F@#@4?D#EA>F18U8K=7H,RH;@IHR,1[]
M#+B;9*3=\DVQ,XT+2).EU*N9KFA).DBR4]\+!S[&;S!72[?G63T+-V$9""#V
MUQFPQ\R O5EGP'XB2<+]V8F6FJ;.M4L/FL&7TQZXYU_ /^\<')Q\/3[O')^'
M1UTA', H5N]@S36P&G-Z3_7(<&702<;1!2CA_R>[!(ON_T3CR3O0?\T&=G3%
M3):DE@Y5DJ''&WX@BG=X5(F(H,;]&\FB2:7OQB5]!5(H#P-AE;=FZ?U2;G?A
MY6^8.HV7Y0VOY)S W \<7F:N.N&,9[&@.?Q(858TBJEBI*36[O07&(U,'VWV
M?7C#OA_5[/O@S^][W*#HY>%VQT9'GL%-827[S4U%1\'\;O[K\WKSM^QFW@H#
ME203[$>>7OS7+]N_T-_P@X'^^][S%DMR@'U")@4,1O_K'?@SP_(2[[+]ZA<T
M6_Y6YOK^X$N4V*A#+Q&;0[^(<5,.S63@G_"GMS[7"G<C_B89O@ME,M:@:NZY
MBP&_U_?$D>':_-<O^V:>M]G!LLS^(^LLHG^B_.SBCOM;/__U-T^(5F=1.^2:
M)WFS@/_D2[6([8=?1#R>#[-8*S+;UL_:&OJZ&C'URV\;7\\.69)GTP*$9;&I
MAWG;&E7>P0U_WO?7=YTB""1X'Q<Y*)$A"J4L_VN87_0WVMN[C?;.FT9[;V]S
M?AE$4KW>?U4KN7_YK4.:AA3E1FNS^M:TH'M5OXFJ5_G/2-2H7+1YY2=O*S\A
M=?S+;ZWV]L*1W/L9JS3X/[,9OEW&I;KC0:"WOJ5+,/GMMV\^##6WNVF-:A:F
M/;\PM]WMD4:R=;]Q/.X1K7U!Y]$/>2T[C_Y:YF3U3WHK^T_W5NY^5A8JU0XF
M:"@C@N_I3NKN1CETN_:]Z]+>[TZ+CL0"A7W70;S0!7@<4?$TY^_V"Y]0&/R1
MP?PLB;!+X8FLC)+;]M#N'SD#\*-PF$W!R?V31V#1C63)=_9OM=IW_XP(6.K)
MM]ISZN</3%[OP%\I)K&.O?S1V,L=<FN5*,P-AQ[NLL#Y">9M].UF&U:P[CT_
MW)J2HR4+NEB^F5$^(-\#FOT!V94(28@+0AY,\FRDJ/0VLM%(KYAD@)PN!.VP
M==(>4Y*P^=35HC;=J09T0A[G>*QW_9+O^O;/W/7:V9W;_6;#U^QS+IJ(RYBJ
MJ"F,GXU&*O=*)-;;^F5OZYV?M*W/HQ]SFYG^'A&8KTZF4QHI^D$E@TF,+  -
M^CL:XO?2<AW_QA-3K.(.7]6VT%]RM=5!1M$K; (^"CM,5%8(<P[28V!76TIP
MKIM&K\J<$ 9<K1 @##"2>&Q%\K[#20::96:2O$QNYY(EW@_Y4&8:G NR.T?P
MJ@P"CW>:I5M^=KD9?IGFQ332Z%""S.* '!3O4!6P;LS61Q0FRJ'AM>-%ECI&
MJ(XG49Q7ZA,&*G"K)C+$F-90QCEK0Y!.M"RQD#$<1.!A9T0Z5DS4 $GUPYLF
MIG/V2 !\D>58,(',AF0#V]1ZY(7"S6^U*#0?T'S'T8Q !+R\##^]]PLB>&X4
MEK,)+8@\H<%/B L-5-#VMSS"KAGN(%SD7 U4?(6#QK<@3"[>SFJ$B-=%\*W@
M9>W"N9<%[B/LBV"$M6Q.N/(R[L=$:XD(7 ?P^X=WIS0>I_N"96;?H &2N^!P
M!Q]OJGQ6 X?[AZ" 2]VK4ZKV#IMA]W^ZG[]P9Y.CTY//U-OD4^_LO'?\(3P[
M[QP?=DX/X:N3TVI]WQH9N!)S>JKR6/KO_D[SS7R;'O[T9Q_(UP_;.?2IY^N"
M=[O-X,O7TX./G;,N=2#J_N,K]A^21D0]^/#]/^D@]\[.OG9/"<_;.3KJ?>IU
MSKN'H?[MZ?H(K\2<5K'"_0^=T(?MHOB(!_"H&< ).OX )^PX/.U^ 'UYVCD^
M%V?O+#SHGI[WCOZ).M1BZ]>';17FA(>M\Q(.VZJTQ]S_@"74IU].3D%YA1].
M?N^>(J]$=WV<5F%."/H_B_)^E*IBZ^1'HF9(@T!4P-<*_-K(-A+@$M!BVB^H
MS*U,9E[W!%LYW##>,-:SP6RPQN2*N(B1R!9=;"Y*+<(IAB@RCI?.F#'U*LJ1
M@SPT);CA!=(HI43J.LF1,9V"*KT4N?)C;N'DU"W &)+8L*>CVTU=EK#/>T%]
MWIF..,ISZF8@O+U"2'$03>(2'/;/4?Y=E4S(GRNWLY*,U>;IY)>?Y)E"::&)
MD+$>EQ:NP07#LU E:D"1(!ZS#B'5SC<P\T6?GJ(&0X=NXL PTWV*KM&%3V(U
MQ5G;^#./$^[-Y-%4_%"[LAZC!>&NKN."^F/ %(:!S]OA39;B:E^;9\UPF(V1
MMWZ@W_.ZZ.>QYG2O&N#7ZQK@QZP!?KNN 5X?TT>>4R\-++,XR_1>D4<JB<,D
MNI96@ZPJF,)HVO^7J!DF== $IX4J45Z7EYH4B5=K;[^UI\/-=3*>&QU%5RH@
M]<6:4!281)FOI".?8:EP=!-8!!%!><O+*+WI(3@QU%3.V*UJ=U74N@+O 8 #
M-Y39W?TF-0"">9CGO<=$*[P B/!HRUZ#F?P# Y^'1#S*R-_NOW[[0$-_Y+'^
M+?[M$,YY'O>GU,L1QXFP."4]29D6E?)R9*%+H^YW*%5^S,BD&,1,$DWT0?S6
M.B!J)F2<:DFQ0*90CE5[).@:8+J+#50:"O&Y?E?LD^BQ1%=1G&BN*'=4Q#.;
M*N[AEDZI4M--F,*"I.3BN/+9$!7I87!U]%"OBJ*!S"T($U,QY:P[AH;I55'3
M7J*O676,0D#B)QJ,YC?R'NW-6R^(-V.XZM9%DFYKD<Y*"JN0YZ;)38C1JOXV
MU&N0[T CD;MP0Y<I^##D==) 3#Y5#>M;='AO$*_VYB1M29A^2UQ"S.-F*3T@
M3FB(-(@%VS.<3J3G+O@\S;"#J(-Z?]>XD?9ML4)FBB?QFDT/I_E=S\/P\['U
M>/R?)+:74R:_Q%&M]\1/5G8KIIC_,<WRZ1BU:I.&^>TR3M3B4(_67[I1;?AO
M^CU#(G4;)%2-*4A1I=P>AEILDN(4-5QM(8O0&!%W5QG]N"BSP7?N3,8:UG9?
MJ/ZX/P-5"[/M$RU\@BJ0W(V=G;#UZ\XK/8[JS[#%:1EQ9$P:;5$S5?LQC8=$
M?SC@^&!#@G".CF]0GU"Z-:I9ZEV;L&UB>'FI)3"J)CQFB:Q4460#Z09)Q'W6
MI/#T53K4-@+&1M!;ATOP6VKG;@*41'JBWPIU"?9N(^^D&9Z@^APST0FS^I'J
M'"X<FV:"80N!&Q#+8W!AKS.D@!EG"(%R'R@CQ*$D*BK*L+UGWH2\8BH0*J1+
M?8&PIQR#R:P&X\K<<(=@>(6X#,60-!8/#4KCM,Q4/V;7B@@5G?WJN<'9?=?"
M=5.UQ83<RL-_P:T03:6WOB"'S9%8\'(G<"_J\5>W!&N5OQ[56N4OLQI=,95_
MG(VE9;T6H!X)LN-B_V$E(>!E3X'ERE.*$?CN,777-J3JACNWHM?G>9ZI31.2
MQK>V7_D!1_,SGINCVST%;@R869A=IQ(RQ90DCXJPX? #< C[W&L5]3TC9=E+
M!X=/O%JX&8]0,]?33#E*2H,05]-9#3,U*>L3=<%N*"@!&LH@8BK?F0R$6/MT
MNK)F31 #G$BWZ!^EOK5H0QJ(UDH;Z@?&"OPFEO9&'# A;YB?2?.?\.O)E2)Z
M?=AB] *(:I_> 'Y#]&FZI((7:M//U,IKN6U?1119QNMJ9NKL'N_#$0[Y*AI@
M+(!]^E_1&N*^!TX, M:(AE%SZXU*X'P<_8C'8"]8Q6VNW:2  "W0C4MO#1%B
MM)#&J\[^,'=L"-\%6:WS+Z:AT?&YVM)1>#+W4AA $H\I%&('2F^)@Q24#E8.
MI)Q+!](MB:FP#2-ODD,BC$U/C:C@,^<PI>>X.$/E]SQUNOQZ"8&[6%A\5AQA
MHF-<7B:A&1X[8TH53CDK<55H-'VL8]"C)@-,%SW(*&K>N1AI)".R1"4S+1;K
M.C\4#89$B$E:;?U0@0',J^E;*KQ,)L)+WZUS 8^:;7EH?5W)!;Q@4\.MJC/&
M!G<\<.V,:BKSW@[97'S=Q"?<,RP*VK5ZZE0 >= #9^2.%,&/*>7 DJ(J)2K-
M:^;OOFF# 2SOJ/FD-)20E7&C(68,)'; &;8AY#O*H-J<ZH Z5I@GRXK8QNJ1
MX5Z:&QTAKXI21<.&OTC9J.9BKFTS;8GHWEQY9NJN!M4]8E=;[X7Y=6QH4\F@
MI^)\,!VCL8?A?+FUGS-1,<V(R]!1XJMT,+-UZ#QD"5/I@=CI29E6AIV44@Y&
M8:,_[['PQ5!=V6!.KC# CR7 WZ4U::;+M1S8%XP%GB@:338ZA[AH%+[Z6SM^
MZU&M@P%+K/563$/WK/;RG9$%ZKE>TT9@??\KR^-RIAT<JT^I_!;3 .DBC0O&
M^WQ/MX9NZL9N@2E496TGFNX,LP,A@W4]--/VWD:TN='>9#TAX",9<J&Q3#8H
MC>'K6D\X(^_-R&(?)%L+=**A%H,\[J.*4^C&\I!EBH=6A9VI- 9CXW.4ZG)T
M:H"C^T^1'=!^]YX6[(L& LNG71DM#<O<LZG;/J'S1BL6:]U<V\;.6TS?;*!6
M6-4E680]9@,"Q$<249P@"K&<'?$06/4^5!<8'.#6?+A=L&-1-DV&7D*<[9/:
MK0-K6O-VT/V.L%/?S/8@E'>C@_)]WP!</%TG2Q"7TM2JB-'1XH2*&Z/Z-SCW
M<! EL"#6&OW/_KNY8;I?O^;-O B_C99(-BWU_67B<X^H>Y'^4VZQ""4&DX=8
M%;^%O9DBS@?=HZWD/W%YPL.H^([),-MD$G?-9[81D;W_[[F*"PX6+.[:B*.I
MY@\7 ^N_^8C\!AAL.KT#9SBUU EHPU;L<>9B/K#VY:WCLBOI5,?+P'"N6"@/
M9YVZ0=,D7#:&<(.J*+"7&4I,P7S 0 J5(/4"H3^J4'T:.][6XW6H")\&RI@)
M=NTB,Q=LQFE!FV4! D7D(%8@@!:!I2DJ:S4GO^M63INC-ZZ>W3SU+>AJ(CI'
MTQSE,R8/;X9--> /-LV'V1PMA!?0P79B#6E5EH-X*0:7:CA-;&J.DH4<Z23(
M#P5:<4:2B].XL44;D<^0*9.0 =:;YU[(9PGKN5:@C=F;=0G#(Y8PO-E>ES#<
M;_>N@[-Z3+MO)C^6U=63(;9WEW6(ZUC .A:P)&/]6_S;F0V7LM<M]%5.*.";
MTHEA]=T-KYIK3=<M6V0:"=44VT@&_6U^86WLBGLM4+,;:XEP(.0IN<^??W9-
MEO*V$,+.'F6N)Y1S0#.RX7D$X"/6W0%1VHWZE:F/WH^0''TCWN3'8J9Z -\4
MQF^7FF5*9!>J--F+*.4 O<8<,KE9>I61:T&ICP))YP:4^FPC3D+P>6+ATW-R
M)]U@G^0#\]"K&3D^<$-'][4?N??*FS#ZC.#PP_++.XKPBA@5IRI*[0.4H&15
M:88OU'Q>-%P\>$W#]@Z62:^3.S^](C+^1$6$]Z PQ ">SU!)Z<5--S&KC:W"
M8X;;V1;.F,B I0%?R$L 4,&XIN';B!)TUB\N[>YE>.;-=7"<%. R#'>WTZY=
M>)SH;<E0?_7&25""^;'R4)(HW7Q'?M]&?"4SUFM6+-@4B_; AFV=5ZC!%#Q%
MG!&L*:D)M'DPN4&])L'-S0=Q@8:0=NT;,LC-.O!O> 6N<V0<5A@VHSMAC1G
M@=\74<)I'1<LH7-,<UNPV,0=R]R)]& :2%QH?"^F^,#*'VZB$\@Q.BJFD4TK
M:]'/LN^T/GRRK]#_L/NL&;Z?\::*BK*Q**CCB0)/J%:1K>"ACS,,DXIL0Q_5
M$0SP&'BY(LU(?GG^+JQ#JMD/&/AA@!Y"?QA*<&+,83D+QK&UH9Q2*Z8Y20W9
M><X=<-D8<#+3O>HS$5063H48%9PN@W'E'6]RAT5VJ?4*Z#'.Y]I,!K!1%Y,B
ML%856H8JQ\:$K*  I9E'A@!B?A5%+"0>S-N!JG,Q$@CL2W R9#KQ?%D9G1W)
M"5IR2#Y[5FCI%Z,HQ,N'.->)5D/RJ>69R$,]/$\^P-=3VO@,%:N_RDAV8O
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M. O\;"_5J?<Y*LA-$4&6-D#=^RMR1ES?RK+T=YETQ025,&F',9)LC/Z7PR$
MF\0,%XIZ2S0DQ"B915Q@^0;9TKZ4M1/.Z*M(V?I_,]62&6CMLTBHS?9@D=G4
MT$#TV1J4;T"$;CQZY;PV6811#-@ZT'TK![KO[EZ1CN(0RCS<IBGV;9R*_1%"
M0!GV_IX@(=VS%V:XHF9HPMO*WU,OD/_41KMKPIL7A=]<G7/-RK35'?'1_Y9G
M*UGL>MU280W\^%+L=TD5PMXR2 >5@O3\/*%*W;Z#-&,Z[B N';?HWBMSGD4I
M72)3OS1M!XT05AHAK"O8;V>C;$3)VD/)R@V7*0:B#.%%M+F="UJ1$FH\RDA]
M<\:,'<+QE"'B68]GF!!>TAY/#GXPS,(/FIKI7U2MR:?*;.'QQ#,N/4"V:)AV
M;36LK0II:$,<D(_Y7RW3MN6E9<XU)UI *:?/$ B[#D,=^Z62VKM4K3!")W='
M!Y<AJK(7FX2;:</'M0&K,LD@ 58K(.IG%-MVCE19>?0H"X]NF7&C"4B[MOUG
MQ@E&6)NIUO29LO%GH+3HYA*C(V3V<\D,&QFKP9PZK\%%,T^R.A;J'<'8F'T.
M#N"*PS]%@02*M@?<M#I%NR#<SCJ];D8C:G/A-MP-W!*2G++"K>7CNZ9B[=K>
M)!]/=#%\90;#(&_D[NILH1F:[6!)OQ?F,_A]]3HHN0(46H]#&<658Q$PC'$$
MAS;RC$%R8FQKYJY4."I\9/U.7TFH$=4>6:5R68DC&\:6$2Q_9*W MJ^"1[NV
MY@AL6;T@MT%K4$I$:6] M6*-#^]K8VHN&&;_9/!A*-W.6;^D(KQ[N)61+0K#
MK7>14/IN?^!6AL$7Q[?6\++O5*Q=V_[S\3R&ER]^)KU&EUT^\NPMQ^L>E3VR
MNI0;Y8U:7BJ34&Y,PXPRC8W*8&^T;57PL(ZKC&!4X+B2>IBVIU6]/);IN)(B
MF5I[2RNGM6MKI)R6S=X26[KNW<<;YJR;7Y*N<Q4%YG8R1F[>46TMLU*C56XW
M A3)J\$/S@JZP5(KBK[U0RHEB^4_I%ZOH.A\T(=42@++?TAGW8)Y4SNOS=L*
M7H<FW#1Y;3LSD!&]^W7BO9.6.7#Q04[[^3S]Y[-W'S^IMC;EH<V:[F)+%9T2
MC9@EFY%VD:(,72ORU<NHXDL%5"SMY>NEZ77M\!IG$DJ%6^3%LJI(&\VSA$8K
M^R96U'5:@QV>EG*J%#3M'.II#7=[6JTTV$J#[=J:* U&&T8H7?_&^;TE0M]E
MDQHS9IPJO73)4%$V_-Y]]_%?9#_$;LL "*Q1"[0,:VJ:\Q71T0[W8I9=F_$>
MF^9BZ5(LUR2K#'KTG\<YBEBT<FAS#2;99='KFR\;."96Y]9^_M'] S%SE8%Z
M2#KF.'I#*/J9H]E:7^?Q#&\7YGJE]\L>=)2S06?0VZX<=#@'/"ATP$IM!WS1
M40;G\/^"GN>#/]]AH?/MU7F^_5%G5#0EH'#_E+VHJ)YW2;DJY2<+3S!*PJZD
MT%&(T;J:\6ZMS8WWVVE2_S82'Z+OQ$Z(N#TW30>[P82XB_CFG?QSH;_7580:
MB$/?'[!$@&.9B$$O3'^554)"D&(<4[;87&=3AUK':+;MJMCV P2DB6FXMI".
M)#:?PS/P MRC+VQBN2CP*/V.C#6EY2.;,6I,(RN7QZ>$L=Y2!+H2MOW:MNII
M2JN>9#!E::1SUC;226ZD,V@;Z32ZD0[<5&]E<?=LI9_.X"#[Z1C$^I CWP%[
M8)8%E)]+,A+JP)?/P%H8];IYB&G=S%O"M3UXWG /GKJYZ^XF*B"87FQ>2[:>
M0*N=?C(/G[4Q0^8!HR:_/'V)XVSC:RO ^+XLRRC26&/TKMA<<>QVLYP23SO'
M@GI6O?LB1ROVQ(\P)II[&S"O#-RK-#735&)'I*/1_Y6H%)-YH!2*XAE5UZ6-
M[5*NT#RWPA#-Y^,(=_2?J%#RF>608;H(HE2#?N5ZY91 +X+9&"9'JXJJ^[$C
M+6@2FUT?+CQ0O3<=U-/7Y=VJ,6?=J]?* 5O A&KE@!O?T6COAO._'5!^?_C<
M6.A5(3RUB-HBZ@%"#Y:H8=3%KQ/K%UC,5%UJ#HIE+4 + G0\G;H+5U<=ZB8[
MUZ::TT*S.'HR;M7DV'DTXP!=\]9M':);E_Z*A3L6 '%F,5%8O ;=TV%LM[=/
MXV_CF\LK>?P@WWZ1/U]=7OW^Z>H>&R/+O:YR45CV]KVQP_1&>44&W.1]+S[Z
M6;GF>TI_U9Q<'GK5;?; SF:P%V>S2>A]6V>7%D5T5BB*J!\;1;06*50F/JBQ
M4#XTI-B82RMP8A"/$XXY_5-8F[A7-:5F4$)R>F-A>P"H<%XBK3K/V??[G>XP
M(=2WL0!]&^>?GE=U41D"))4TZG<&2<EO%8 V0?\Y-"1(Q0&E3)F2/%3@HC-*
M*M1?,4!K45)3"@4UP7>Q<07;0?.M8W9Z EH#EMC"K1I%K85KBX\MW%JXM7![
MTW [  <"/0T"M(EE8$U8**R,6;IFL 0Y[O*W\<W7JP?Y\_?[ZYNOF,34?=]B
M67L[]P!NK537XF,+MQ9N+=P.&FYOW.+&-WP=2D>?AA)KEGYB#7>'4C,6?,C/
M7Y^:MH/)#^OI]&\.S=)MSTJQ.B;QE6K(&(V'PF:?70N.\ Y698H:%SSS"7-8
M;^>A+*@'-H5''8W9J?[LH=+IG6_1;W&P5"<'.F3U32OQ96T2L($J V1'AIAV
MPQ?;]&*TXG<2HF0-2AKB[.<]I5<V*NEP[V164(]:4-<%ZK,6U'6!^KP%=5V@
MOJ@'U(VR*=>@B)"$>S)1L2[H4GW%2BEO'N=\/&HO:S67M==M*%T\/!FWIS3T
M*-X@J'LMJ"M5\?MEHPT35'JON#^;79H+[+"IXN3)>KS2N1A<-%:/WZ/3SGJQ
M^NW%JO)BE6F1MK?WZB#<#)%NH6\9OUN1OFH:/&@H#3Y D;XU6]<&ZM9L71NH
M6[-U65"G)^PI-;<K3NR$NQWPO?WPA_WH:[S5TSP<ZWN;>-?2]/V#V]L1MIL%
MUQ9N+=Q:N+5PVQ.X[=YV6F&V76C7"7U>4ZOV];J%@9ZW$6%>IEVP8V'E,V9R
M_N5L:UBF MFV([8+M#!LL:="["E=J :49]U%8-^9%DXV=AQ+F[C44.?1O#$-
MG-PR=1T>N<8RK,QV:@L+KP?;\I8';[$QA(VC0JDKPV865VRI6[/P*6ONRRAC
M7<;M$KMMUG)L,6_GF)>O(FB]J-8?=KI=I46WO4*W#3ZL[98=+8MO">Z2_J"C
M*%L,9,J(>,4K5AXXSJ6CW'8+G6Z7Q%ULTRM7@+X=CK^N-1ZV1M<]@UOKK&OQ
ML85;"[<6;@<-MS?MK,M0&I-#9+TNIM+6Q6SOXS[ K97C6GQLX=;"K87;0</M
MT&QM64MD'@!6M;FMA0"7:M?OE>E=%2X"23;^\0)ND</SX)5D>SUZ)+<8>M$*
MFF63#ML";K6!NJ8";BVH3_I-+;_U!D'=EM>J#=0UE=?:O;VT9N&:B]&R"O^3
MX0]7IX+S[">SIII-3YA+E%-:2;N]PV7O<%,K>;TAT3=5Z2G6-.$L?\\$^O&6
MTXTK04IFJ:'IO6[GK#=HK'*T1QA@+U4CTVT<?)!Q(OBTT/37]YL <(0]1W#P
M]E"V?"U[557@2[V%ZP7X>I46^3B4H\[*#-LZ7I7>JC+UCO;S4AV:BZ M7K_S
M->X/X#*3Y:;6_'M#.DK6HVAK M8&ZM83LJ<B?LXBV^?#MG1]C=>J]7KMIXS?
MW%MU /Z)]5Q$$G-*U[-/'+>R7-=(391ZDET3I]R2 A$+PAH2X0_PJ+)RF<'6
M'/YU'6[>\D'MX2<?_M9"$-J;W;S#W5K00WNXS3O<K7G#V\.M[7#3"]3TRO2H
M*U"6O]>KL));(A9MK]),BT!;5&CW#7\.S5UU( :;-GOL+<#M[7B;F@77%FXM
MW%JXM7#;$[CMWMO0X%8/RM9$Y;;B9DB''K2M'EKLV0[V-*U>:]OJX<"P,6?;
M&I%P<[Z=5@_#LTY_FRDU+75K%CYE;?5PT;9Z:#&O+.;E:S)2>ZN'B_/=ED)O
MT6V[K1YZS6HMDN!"&0PZ_7[;ZN&-X%P9YVUM*'<.,EW]I&[%9?<+[8(B'3Y*
M(GAA&9U;Z6Z>?*%:3QK,@8]VH].N-4A?BMF\Z6@%\I3INM@"B<'XV5ZJ4^]S
MP26=..:2EN5_X<&'OONAS9QG'*_[=V";@6ULU>0%HR3L2@J=E1BMJQGOUL[1
M^^VTG^!4I*3LZ#NQ$R+BSTW3,4R'>7*A\H?WS3OYYT)_KZL(-6:<?']X]_&>
M+0$CF>'8LFK(*A4X@SEM6W:>X8N_*:>$A-X(?.4284@4/:3VR%:/K,29]=+/
M# @*4H07IK_*Z@Q'8C/8DVRQN<ZF#IP=C!0J_C(Q#=<6)6 D-I_#,_ "$,8O
M;&*YJO4J*WVR=?;D(YLQF9:B7!ZW9U_X[$L<?C_M\/V:/E/3ADNK&738XN+"
M4:O+I67^!-[E('+\K3_,?(%W0^ KFN[7R<='A,MT:BZ6JO$*J$=8#63.8DCJ
M-.#%3Y:J VNT' D AV"<:P; 5H-O;0< B*G&-L!O\K&V==<-IK6)_N/D1/ZB
M,7WV7KY3GT"^>F#_=AD@',@9YQ]DRIN!^>63$_$BB9+\W5!$9/C&*KV8*SO"
M[S:%5KU;V[B!LIJ>:?_A#4\9BEZ9",F[CU].PE#P]O]!?GQ=PM;'ECK1IA_D
M&Q ,.8QN3(3&,/S2+]Y;!"<$\@[V0?/Z)Y-T4A.+J7^>3!A(P;"?)9UY>/A1
MS/!XHN&S":%:!(7C)P_#">$7X%+U1,%;7/57FG,"F/)>U73YGQK6D96_.;-3
MN5:" @MX\&D9,HC+4)7E.[_*,K<Z2ZHQDR]!\'MBQ%KH6Z'N4 SSV0>9JSWR
M$8SCG![7NI>C[Z</IZ#XZ;IJ"=9GNC:L&89A/Z<,R<8SI^\S:<DL\6FF.NIQ
M*J6[=W5V$D;%.#*64? (O8V[/[&UOY!@AL@=C982:L6#Q->NRMHBZ^0.N^)[
M!03*[$:%*6+2TH;C\?Y:.<QH3$1\J,-Z1$/J!M<5^),?#,T6/ 8B5_ TK!H+
M=?WCW>A=RH!Q_&,SXXTG$V-!*%;W(<:S^+Q94[U$8;+P<I, 50XJ^4*X.9"B
M5UG,3PH!_W^4 V[E-O@3K_&IRN:YM6!;J #R<^5**Y]4CD]7V7P2)8^M]R[N
M(H76/(8QT1RFZGRIC5I?T7FJ!MJCZ:!:L\[0"\)P/62LN>2QMWWR>.,N)B!@
M^(5U,T$P![UK[LZ_/WRNG?HW%QHM'AS$9F$=V@PTCE\GUB\PXU1=:@ZRGT/9
M_W@Z=1>N#GKD3(#@,YMK4VVM$M_;!8',2/$5VS^:\?VO67F+ : X-]VP/V&%
M"!<+II]#+37]CIIQ_3-[[Q.* 6]/2$D-<-^1X)2ZIF+L;L>+;M?4KJGF-64E
M:L42>H6A9M ]'?X]+M,CFBDR/!T1'8XFBO!OBW>A\QV!P[^GQM>$GLL>(B->
M.EMY)5,8WWF9Y(JUOF?<-K#:]RPN'!F3S8>CC7$K9>#1<&#7U&.NEZG'W$9.
MM7<'D;7HRF!#T94WN_%-Y>;?[,8W%71^LQO?5#[YS6Y\4S'C'&LK(ZHDY+66
MDT@"OK!))L%(%E,V/3N^^-)=$IM:+'7FB$$T8" 8VK)T)[HVA6]@&)C8@UK:
M*6<]V/SQWZ4$E=3>1&'.^AVV;H<%E_6H6T^"&2F=8?]\(V=-B=9N ""W6",W
M&8PI)8>43!F0&Z63^H&<#N.+0FE^2B]_8ZU4Y%UOJM4YZYYU1F>;4YPW@6;W
M8,V:[:;T\T!U,RJOA-_O)23[9;I=;PER>/>'FS,7=@6^K++%IHKN33S^AIQ^
M!LI?G3"VV6ZT/4L1;IU"ZE:%+XRB^Z%:EFKP"&TX)8/Q _NA.<\\/#]>&NO(
M!J,X;BT2YQT)*-_QW1ANJD/=\+L]W%1*N8!<LOO+7U0X&>073FX!?ZU4@:3?
M.3L_Z_0&2F/Y0 4"R3"W0!(%9$Q/N;T$7TXIQ,MX4K8.OGYG>%:6%^V>6FVJ
M#=Y$%"B& ;GTI*P8D*%@P)LQ#<W8Q&FX.2@SVF^JFM[T:[O) 7%00L8H<K.M
M%]M(NM9A72,4@OX9,/L:$-L+5^:"R'? ZDL?J6_GUQRE[PBC;P5"\T?3[2>#
M7D?I'Y2P<K;#$TDAV'MY!(7,+DT!^<7%YL(F3:>UFWR>342:?<89)5/PP=LP
M\JS9=N!_,OSAZF2F8:(U.#W*NX4WY59L<H@W_59O\FL?E 254"LRS4R3WL$^
M-GJKT3ZD< QS*N*<BW#KN;K0]-?WFRJ 4VV=V!CG)B)093Z>='19YP%E&<#N
M"4SKX]G=Z3?.JD(T\V2"S8#AB5<LEU#Q.2>T:&WXK1EM\OXTEBUGW> F]U#3
MU[^/!N/JN%K.%M_#;F,]!IL?;,IIOIW#K%M+36NNEY&1)75/S]^4<7N]%K?9
MPKQD%]2] T-FNK_)8U(T2[^%["9?3@NX!,!M,LRV@$L W";;W:$!;D-%;Z7>
M?KJ##&$EQ=LLO['#*2,,-N1L*C!69"C;D%:U/:,LF-[8KK<)+IO:!FRM&T"1
M(O\9Q<-<33WV"@"9F4EI1\H!P325S?2+^6X2&C/EZO.E##OG%Z-.=[#9\-J>
M5LQI90Y"[.ZDB]9@<\V$]ECYL3:Y\^.HW^GV^^U19I7;\_6YVU$KGN&@<ZYL
M[J]8M*G37IUG>FQ#HTYSM9]2+T->6H&+&=LK:7^*93>\^THE#9$&]31$JKMS
MQT&=?HGC'U;76TFNH+=2BT9[V,)IM,463KU.=]1M"M69^,RGWAXF;Z.94Y8F
M2Q=MDZ7D)DNCMLE20YLL127CU0M&_ZA$'=4_NMTAPDW]6.%"&MAW2;6?Y2^Z
M^<-N2,^DMB72 ;1$RM;IB ?,9UGZ_O1$4J)2ZE9JP/\W4RV9&3,0\#^S*:/6
M#WVED]&_6%D-^/J!6T%]_2P.R;?330!VJQS4;KM[<$FRPF4="&DC%1PX-NJW
MEG$K:T;A@YUDH3G*0O+<,A>RN638C +4.C*]:([&TM,H&PN[79])J5KZH\'?
M$PX,XV_0G$^*]2MPP01[BI*I6K 26X_W;PEC7L27"=Z[J*/4S:^9FIH&T#)N
MUP( [?4V!SKL-T#+^#X+ /2LN[D04A: 5I6X%VI()/L=B1*HT9C,\ERS)LL\
M ':J@5*$>0_X#=90G"*/<3&=#Y3>. ;S/I5BQU#I?<[7V?O%U)>)(]!L-::R
M>ZKTANA*^(P>PJE&N%HQH"IC<>$]I&3Y#IN;Y%T5K\H(F4%SZR14Q70R0N:B
MX:GAFZYW_8G@U>52OIWDU\KN>UX8*9WN<#^A5"K8+B>4>IW>>=EB;LWA^)?/
MJO'$HG*DS@ :LJZI$TW'MJ#5'NSVE5VJ)<8W=FW<>MOZAKOZYFTJ33(H4C5N
MMRU2BE")<E"Z*'(%=MKBI B-R NC)!VUOSG&M@F"0X-UI'8QC>$E'M.P5ZP/
MMLT<WB#"8QVM)6+/%M.2F78Q32$S*4:JJ442ZI%F\+^.B1)AP7QYZEH6J+6"
M&NVK=GLM-N9M%80/W-TEW]R8]I9%[AAM3MC:$0I6YY')"[LHR/J%=+N]$VRW
MC6B[+$:U!<.8!P;Y:,9"),6QU!F/S7;1'[-47S$^;>_TX>3#'HNMW?&=/>)^
M,QSW>1&RLM,[LEV"L@EL*]!J;,O ZKRXVT.US=GCE?AS2XHL*Y%?^<@.EV22
MR$YJD-EAUM))X&(K*)<%VS:[OMKB1]7):/D/;%B@:,@;/K&ZY<24 ULQ%Y_E
M+QV1J?!;:[%H%[,3BT76>.";+/%:>ZM2P.XPX/G.,E^T&9M]>OT.NPRY2L;^
M%C,0\XO.12.U[TJC1[<*OD&1YNZ[!5_)6-'M@>^LTRO4^:GBX-&6$>W]8G;#
MB/)$':\FK6C&"[/KY5%[?\J-6DS=]M05#>G.M:;/*F\=-]=^@N 3]<?LK8)5
MG21UQ^,Q[4=S//VWJUD,N!KP,>?U3E<-9VS,L'38$A])"4W;'+ET0,IP=6+;
M5LYJFQKQ6S^L,D+B-@Y+Z6W?,%B?=3J5CT2K5J2BR&J!BZP(D?9>CK45G;#=
M4[/V5'_)^61CS X$W=J-,=?>'G.IPQEDB::9$BJPQ!2$70;>WC3@56"'*0:\
M++RV 4RU-<CL[V)JY$!EK#"BRF.;V;VWB]D!.;H.U>]=6FS.+ M$G;&HXELQ
MC*JSCECFE+&9_07NA;?#V_F=MS\JL0ZJ'/\"ZV;2-VE)?-U"QOY:,*TZN\66
MH3C<6RB6,BAL&8J#SD6&^OU-L/>^^^CMG3,H%8%*$V'9QAF;[&TZ>?A,+X,]
M?88MI>9+-QC]L[;0.L=!&]A3.^OZ+TJM?P<<.GJ'V$]F337N*C&7B$%O@DD3
MS;OE^[D26YRE7*7FWJ,ZF'%>:/4:&U+>$'5LHVAL6C/0KJQ7K[L%IJW^4"U+
M-1R[0T6VX"&_%P;[B84AWIKX_"^QWQ1$ZW=&@\;FD&5E$6?=_69Q9\I^L;@L
MM7GWV5>98QMON&]U"X4M0Z$)?K&E,.'+D]=8\^.^,L $#\47;XOQ'HK5;.K.
M:-A<9EBS9RP7Z(:=!HNL=;O%<D%NU\:AUBEV*(O9(?M)R(-%CM3A?(G]V]5>
MX(88HL(0=D2U-&I'B+^O[C2]TT+.96X,F4E^M6JVAN0%_W\5@.?>APS^,#9F
MT2]"3]XQ2S-GJYE]5S]%;UKX@\H\W:L.NZ+>CRG-H3.IB=N$\VX/M+HXE-V=
M:%*&;:=[L;EZ72:(KT6I[M6IEI$$&G>JO4Y_N%D@RW.J3<BV3#0\7&;F)++*
MV^!.V)-F&*C\B):;2SJ%O==7TYO6[PK%TWQLYX,M9C6\$:M#ZBDJ%\T[QE'G
M(H. T!YC^!AW)ABFE''H]#-XO)MB_6HUT[>QF&:*%H-B@@6#GU)%B@RM#@=%
MR!J\),],=Z*SF$Z$)0E=CK&SD+Y>\RC?>6=PD3\';!#;]K&4WG)HN/!F9-(6
M%TKCPMN1;(LA@\<(?Z$^V<G-NOT6W,'K;Z+3=M:^NG&]?-^E.DV\?K_;:M"M
MK,(N13'(N/S4!MW;Z1T<W_"W!GCUM@^NN)[;<3LHVYEZ[Z"RUIN[A4I<#^_M
M067+?;U_G7S\%2$1>2B49N9GF;W[> ,,E)+* D_S^U]_P9=A51.?(&:%]T9U
M+HL*V=AQ=]R&^G;BJ!H9G%6^V!-S?N+:C%?.07<H$X9^:E:MR@E=NE8F+-,3
M./YJIS<&SAS3V-L0TUA\9;5ON9+.7#X^C.]Q&G,.N$#U^*\-S^/SQ;3&6?MU
M#8:;2P.^$9 7;O2U99#W2_9-WX5UE.<^V0C32/[H?F:/\O9M_I;"27JTGQ05
M7]E"W%5U@,I*9/M['O@^V*_ ]]7[L__YD6LW:'Q8V9%GPSV_0:.=W: \;,=O
MZ0679N;Q'"_I2E:?@"W;CHS:%R*1JH,FILUXB.!2<U1]+Z^5M^G;^6>QY2NQ
MXS'?\-C?[QUL]]JXY)M-";,NTBRE6?AZMN?WK5PV=8*!=]6^F]7.^D'V+<'P
M:#=!\_QUXJ\!;0*KEN+J9GU\YLVU%J"WOZ+F:Y@.7G<+OL;2; Y[LNBN6XXD
M7*8B)P6^M1W58538\;36=:\9U+WY_N/D1/ZB,7WV7KY3G]@'&/3?+I9_(.OX
M!_F?JN[BW_+)B7B5T)._'$(OOH@3QUS"PSVT+XEO/*O3"+_;9/MZMP8  \F2
MG@D.<;:O\+*Z,:OJHN'NRTD8#!X /LB/KTO8^M@"G6GZ0;X!&LB!=&,B-,["
M+_WBO45P0C#O8!\TKW\R22<U ?+]Y\F$ <&'_2SIT,/#CV*&QQ-]%^>J"=L]
M$R</PPGA%^!2W5@?6N"OJJS-_O%._:/;'2'HU(^5K(532R ;]ZJFR__42,C^
MYLQ.Y;KIU@V1*<>4OOC4Z,&G1K].K%\^2KBDH^^G#Z?R#%UE%O5*=IY-UU:-
M&4S(?DX97M5G3NQF& LB/LU41SU>WT[HZ.]=G9V$CS^.="3@=L1C%^5KJU4\
M!8FAT6+HBX<2G,NMH>?:(JL_F9VQ #$=%[UNW 4,-5T3$O&S9KAL-@;9\(];
MZTDUM+_(9 \J%<&4/O#*03:@$GV\G?M(%N#89\V>ZJ;M6NP19OBDF],_3Z;=
M/W"&/Y1W,@/Y<(FRAN6R52_XMN==YS/;O&BWCU?(,.6O5S=7]^-O_D6O31+Z
M)7*F,<0O?/CBA%5?1ZCAN'OOB/A6B4\Y@P6R'TF$$J6KF4"$$GTJ@_/ESRSF
MY]Y@^3/IX,,.-:*#<W6AZ:_O-\4Q ,:,$5E.?;?:!KUC*U/>LZ5I4=7B*T R
MY_4]Q]=@!6N*1-D+0_^>#TX':Y&\<53QEY7+(*Y*@ZY-O^IKT]L"8>3_GIX-
M-2,!YFNBT!$J2:B ]KH?+KEB19^4#\?2#Q6ED*EI+=%5C#TY*$KU2;-!,.;E
ML*]M2V6Z#*.-EQ8,K9QWY%Y7&9W*J*N) 64-=#1YQEZ8;E+=_!/0Q8#/.VSZ
M;)BZ^?3J/^D\JPX^SHPG> *GD'"!,X9I29WP&+08='4N)OHKFH$LV-H/]16>
M@7$)->Q76.C"%F_#:(Z)LL@+(\UP^JSJ.LS#2-3RWA;-ULAF9*MSYKR"[#6?
M:U,-5(Q7B20OV+N&_G$&T$>E$\^9179,&OW9!SME40!8W9W!UK0Y5?US9 =T
M'AMW,@4&;*EPQOP9RBE: G6#;U[@Z.!^2CI:&61["8-:[L)[0S["O''SF&"#
M[191[_%^(] ZEFK8"\TAH1'AH<J6^P20!BEN!L<(DI]JH6]\L73AD.4?S]KT
M&0\D#,,)DVU7(T(AH6L9H6F9[M,S'-N+9ID&G0^9LV$^S?"A 0AO+DR$W.E6
MN/)F?-],8YI$9 95$YE^+40F[B+$E,^2O/)9F#NG\N;IA.L&8=2-:L_4?\O"
MABG_KEI_,D<^$K2*_^J1*GP''@!4[2M(@'J]#B^>3"/9KXN)J=L>F;O_Y\.-
M>)&6$?KZ7QWO!U@C7BY 5: N1S:#]8 2)Y]_DH_.CV'!NOGCN$7B.!P;5HW$
M@YTA<5#6!FV.DNU._@=PA-@*O*P!EP!TEBW-_I-G=+C %RP,$<!7HBSQF?-6
MESO+0V_#KM&%86MHT2+>!S"AVG(.O<&HZ!_G?C#N5%O"[[;$&:<#(K*N^R>-
M*Z-)XF9PX1G=?P5H.LGLN!=W.F6V/7=U0'T@V LL+PC@^8O1&I:6.7.G#NSG
M"S W."%\QZ1("%@%L J#X>MXUX6S!;@(,^!KAJ&H"^"&P#3$YGR^;P*'T55@
MMKJ&[ FY"K O0 PG,FM$ @"^#%(MTA;1 =UGWO8IOS/7AN3Y@#J1^6"9H=/C
M)^9SVXZL+DPD1#0H[,EX C1"GL@<C4/?MDV "<I$/S3GF8;6C!G@#NP:I(DG
M9L!*](Z'"_[C$CWN%TK"[?[;U6"%KT!QJ-D0H3^\"*";(?PQB@2IXA0&-^$H
M5I[#F?% $4/^9*]H%K)-PP"93,@ ""7<)D9GZ*IA<#\92 &P#XE*B'HP\PCO
MW'7P5.&*NKIC>[E' G(MS8LC2:.J:=ZP5:K3-=Q/IZLJ;>5*]5<3[R4<,Q!Y
MHR:->C@Z/5LU_#=>=SZK^G:,ZI$(3.+%44:"?-PP'4'QD<)'1 '@5@!?KTFJ
M$Q4A@$!'Q0!W HHQ' FPS*#I-V?7IR#?&J 2<\;W$V53>Y6#AMB^Y*TG=5#.
M(R(O O6'[W"E(<8 JCW "JX%S,@5/9S9!?E!G*8GG]!&8(&^UU6"8S5=X/8
M=5O5N7X;EB(Z@D_Q84,!&Z XVIXZ3%)$RWGB4/^\ZKMU5LO=>G!!=X/Y^/';
M_/3#N"MA5B#>GXGI.F'$#X1S'EX;P6<5#4]/1*>GG$Z'[Y'_*@I&GD&&SXUO
MX$WP:ZYKO.D;::_/I@ZJI8W&H%]0]G0=6YLQ>0D*(K]GO$F<:<&M_<W\ 33
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M-?MV!3U(9./&)&KY(JW@#\A13\\4GXG!.-X-N+_][F-^J$O%ZKOAKA59TM1
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M;<ZVCM#FUNM^X#]*WH_TK?+A^+T_^XHXNQ4][FR078\KJK=M!5G[Y9"UGMC
M:SAQ]PD^R;VN,NKP3GCF8JD:K\3=5XY8)@F2S4 H<$QX0%9]=,%HP:F)$:D<
MAA/F_&#,H!&7JH4J:$?^\:Q-G^4?JBW/70LM#C)P 0HLA#?^2P7X6Z^R<D&A
MA5T>6H@_N#I\VY$HRM!#/AQ7+"M 6@\%3^7O6.!#CGTHNDNJ!.*8YI]P-V%5
M^ES3=: 'EJ."X#-W#;)J!,&0,_8"RAN%V78D /:?#(^S(\\TV[&T"37>Y&4.
M5* SYIQ>LE]M$++L3@BDP96*+  3[;09BZR0+J(M@@=I"/QUP53#IE>8A68?
M"40[A_^,KB]+(XSK $)H!H!/XR>!3^*J=/,)%JQ-^0N 1TOS![/X M.6H1G<
MQ(2[Q(LBX(2B'SRL.M(/!-^$>2/,O/:* )^IQ?A[\U48G&ZO+_?>D(=!.?+0
MKX4\W+F6[:IPNP$GXN^2%*$8^#5'('AH%=$Y_NFZ^0-V^'Y[1W[1RQJ2>L*-
M/\U"A&$Y1!B\20,>(64!&]Y)-JEG+2IYKBXT_?7]IMC%SR[VV"2<1Q)KSN2Y
M92X\%MKO$!<%BNZ HH\/,=72X?P<I'E'ZK&L>J_!YS2M:S"*V/+1!_I^YEH8
MB>]I3M:+;;R_H]%NYU\TRW9$VUK0ZA^ ]]CO/@Y750,1RD]K)J(,NK_'H^8X
M!*S"&T,P,$L^FAS[#TOP,$!.,S0''UFZ$QV6[O<>Q:>GN,OILPJXBT/CMBQ3
MA]W;P#OGFD'"0SPQ.>ZLT0R/G<"OFJ-SVJ)*0%U(YH#Q+?-5U5&X\$;EZ5LA
M ">$]9^%?2>#3*X3 OD]3?AZQY=@WV&C8,-1GX+^R">]D*=D"9?VW4>@4.L5
M-?[N@5Z03_)DGWVP98,Y!'T[B.ZO2)C><](Y*D<ZARWIW O2^9YH9YA@)=.@
M#M&K#11(BE(@.T2"LE$@.42!0/ U'5C(1HHS"E.<;,Y:3N3Y7+?S1YSGSC*G
M(&397P!Z@.DV"-E<X\I&B933%$+$-[(4,_ # E!?"U#?<5#?>N3>MP/<W7J*
METQ:8&A5'<FB#O( N,EK1)^ )['].MF.L<P(LU!! H4$$YQ<G6!;D(]43C?W
M1LLX*T<A1[5H&=^7)C])D#Y$G0 /(\4MEU9N.1JJEA90B@'/0I2/;,:X>_7\
MT]'Y\7$$TZB!,%Q;?K6UX&ZK45S=?(7/MWF%J[C!\-F%FPHWTK_&'2FPNJA+
M^/8G+,]A^NNFQ,=(<;_>;C;;B^GR2T8*)!T4(D.6F5B!\!DVS'XN-8O-#M'
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M/F$C(+C)#6/>7E0=O@>:@"ELGHQ.OTXL$U40C-;0#-N!T;TPY20AWS36E(S
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M KN4GM$9W6B.FA=78J([G"=V7ZX]NP-]7.QN=*KT8]IT![Z;4_DQ)A@ <_D
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M@[,R[ZUGN^3Q6E'SI>2=!\]RF&N6[82/@FXZ!Q:9-1$A80>N[GARRQKS#Y4
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MA>\<S[I_X*-_]$9L>GF:1X='P?VPM69+,E^KY&K!#\W0=]E":0H7_Q'>=HN
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M=*O[I:!K!/]$HVM8WV\\D+DB&PINF Z2TM6V@&F]]B\JO/$.GL>8,WS*\M^
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MM#<QL?^'/93O1:QM"D0\_)X?BO8V.G"'QGXX)JH$O9PY9OD.C<P $"=Y N#
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M64;'CS7Q(TW_U29^W/D?4$L#!!0    ( />!=U:<A4UA0P<  'LX   @
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M\#=,:;9[$/F#Y[]=R_?\_[A??Q?&RGB\3-CGP:NUJUAH=LF'8A!@8C0-P>R
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M?SGP>&,HX*\L#=RFV+0((-7Y0;SM'K]^__9WO'?[\<]GOQR_^G]02P,$%
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M;= :EC$E)LG:746FPD@VK<Z--!R#.O-J>G'$/240_RY9 *LK\'V7?CM1MS1
M]W\95TG\%_R/_%X$6*(-^?3-$L.3I_'*?KSP/AZ/WE!%C3_CI'WG,$B(,V-[
M/<^*BA*NF!ME%\.3?UD:_#V?IRL,ZNVS:NK4VS8JV\A^,:J!^GDP\\^I =Q
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MY^%M2K'3G[97*TW?FH("HOF@XQ%S6[P\>0-KN7_4X1!#O9;@S?J[3*QV>C@
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M+<!V@7]57(I?-!XEX.'!LU^UR2/\5@A.C;4H=MH9,>[_QE00XD2I_-RJ)07
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M-1VXGL=J3(1_U+9[P=SJL[A*6UQ38,G/FA2ADCGS98F57<.CUXT"V(FG0#D
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M4"WUJT)V] ,/;0@WPGLN9(-;7TKS]H<Y7Z(+N$Q>8\%\T^;8+!ZJ'*\"#KJ
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M@%8II9+!SNU=[<&_M7O360NEBS;6<H,+(=?#8CPRWN&?.CDYC9&1#HO;(.A
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M@=-6L-FM:"(VT;01H^9";GW=<&KBPK/X6J>#N_0'(2@QA_AHZ22\<OG) .
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M=I#>C[P!;F(I,:=O>3XN8XGST57D98;=.G8U[2MW"1 <2[S827_Y+CDB/KT
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M]=[DCMP4#&UIG"J 6GI;U\+%(V!@6!"(&J@@%C$Z@+Y*#N/,(9Z8]NU:Y06
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M@:XP;F?E\HE &\%N)7M.>O5HZ%IC?;HU-UV*-1D/+\H;^HM^!I3 VJC$S+^
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MEJ\48#.NN^!69UG&P_S1[5/,NO)M?AQVN7 #M]9L5_TM^[*2_0EE;?TEK\%
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M46]?UE,^'@3[5S$LV=A#(/97[:XB2^@L]K8\*],^C895:!W8LCK,0=R5QX<
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MIURR4;1F7Z7SCIOL-37T!AY8!RC,U#&\@O.L?\'I ?M-#Q?=";!3[]Z:0I!
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MR%YK8HN+O&<^)B);:+=U<^'[RO$"DS6>$5%5'1?F!PMQP*.;?.ZN,NI66->
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MI9TV\5>F T^!]4Q'1/95$4;76^DE_/.0J=]D!GU9%A]1"#P7)6NIX!O$*RS
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M/C\^K8,%?X5V]5QE_9&8UM#7S&(WU5?ZR7<2W7%;?5-()0'@)+#1H C?%W?
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M+42=:YT-6966TZMD&D?5C!VY^LD!B;$=LBZ#-Z_T<$SK5%:5UZ]QVM%[FB1
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M> >(-^\6/VX33[12*8XV6':E5).Q!#-T(-YX)W^I@//_0<&Y4J@%CJ76B'J
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M8-4-C^H12*\7_TO-C/-J#S.B_3AATI/L9Z@,K !L>ES+;+Z!F<FWX@@)1-?
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M/YK$WT#E_K_CBL7OIO\+4$L#!!0    ( />!=U9*^0=N&T   ,9    -
M:6UA9V5?,# R+FIP9YVW9S2<710V?(_1C1IM="$Z44;O!*.74:)&"T800_2(
M%C5Z-X1)C%X2B2X2$KT;HA.]!HD2(<KK>==;_GP_ON_;9ZW[SS[GK'/=>^]K
M[^MFYF89H-+1U-8$0" 08'^[@)MY0!T@)B0D(B0@)B(B(B$A)H70DD/(R"!0
MFCN4M*Q,[&RL3"PL'-PBO!QWA;A86/BD^85$Q6 P&#NOK**,N(*(!$S\OTM
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MM;VS^_OH^.3TS]G?\XO_<($ ,.A_V_\C+NI;7'CX^&!\HO]P@? "_MM C4_
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M Q]/G79GC"5,U:P62';.#%UZ&85N266_<E:Y%>,V7_/E8EYN.2A:T'@IA\-
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MV%:#KF)[0_4KVH%YYGNL!N+*/1]+-XV,%]X\_41!FOPZU'VI/*M8\KX3V_,
M5*FY#6&OTW58EG6B3J?:N>4!'"J)+Y!AW?[>T7CZF8=!T&FY9WC/[/IYZO[B
M=BA_V3.>ZF&5#.=5F?=RR:!K/Y946?(XS>O*@9")NTGWV'^?T&4N1_6XJWM1
MDT'E(&S%;)=&^#P0S5?BVM']YJ.DAC74VD)BAVIV(HF*E&4-5F(#XUF0ZL_K
MDT'H!5>PJQIVG=JR^8^(>&,BFK\X]\ FIX>8%_W>EI69",G6KI25P^*X,O]S
M.=;.=\SI_<7DN&TK:T8D\9H_?\6\-C@RN*NUED4*KX RGYLE!&?/GR+\4_-
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M%<A.?#VV7?+1R);U<W(9M K>F$.JD!]-F:P9I/S(O7]BL:P)Q<G[U-#]"PV
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MD_M6P(01;:3J;?G&1/>W_>6Z9B2HA]8=<!>B#]B_"XZ!CDA]R9U3:-;4U$I
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M>*Q=I-O--;1*>J,N,H??V?7/-1K%X"X?>)XS<@;F;>.;< ,% @N*'^<_>:3
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M0YM:9"R2#'8/L%!O/IB^ON_?$:;<Y44L]LR:]3-;>3*H;H0 JGBLX9QS>Y/
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MY<9SH<12A_IH;FHO)1[0NEHGU[_L'K;B=,N)J$^;1!KA4,"$<ET:^LTP*];
M:EC[%,8UY #I"H7'XTS%=)]_7NT9IKA].JOTJ]!229?>/MMHKJKDZAIT,K9Y
M+W\?'V1!I6L.9*3IU40HMN*J?9+;/>?$$ 3>RO\*:0.6_.Q]A6_X!&[Q[HC>
M6Z_Z4O48[&M*=[KU![,^IJ***]HY HHHH **** $KSGXD^"]7\4WVGS:8;;;
M!$ZOYTA7DD$8P#Z445E4BIQLQIV>AQ:_"+Q5CYCI_P"$Y_\ B:!\(/%&[.;#
M_O\ G_XFBBN;ZG3-/:2%_P"%0^)2,9L/^_Y_^)IX^$?B4#'^@8_Z[G_XFBBG
M]2I>8>TD#?"3Q,%P@T\'_KL?_B:6/X3^*E/S/8D?]=S_ /$T44OJ=,/:R)/^
M%4^)O6Q_[_G_ .)J&Y^$?B>9  =/R.YF/_Q-%%3'!TP]I(?;?"7Q-"A#/8DG
ML)C@?^.U,?A7XEQP;'_O^?\ XFBBK>!I/N'M)$/_  J7Q&GW!89]YV_^)I$^
M$_B;=\XT\CU\\G_V6BBE]1I>8>TD2'X4>)",$6!'O.?_ (FH)?A-XJ^RNB?V
M>[GING('_H-%%$<)30>TD6-.^%'B&RT>.U_T$29+2;9CC).>/EJ<?"[Q#SG[
M%[?OC_\ $T45VI6B<;IQ;NR8?#37L;2E@!Z^<<_^@U$?A?XBW<-98_Z['_XF
MBBB*%[*(I^%_B'^_9?\ ?X__ !-/A^&GB%/O?83CI^]/_P 3111)![*)(_PT
MUQEP3:-DY)\XC'_CM$7PTUM'W,MDP]#,?_B:**7*K![.)<3X?ZPOW4LESZ2'
M_"E_X0#60  +,^I,AY_2BBH]FA^SB#?#_5V7&VT'N'_^M67)\,/$'FL4-EM)
MR,S'_P")HHJHQ2V!TXF-XD^#7B75D@DMCIXFC)!W3D J?^ ^M82_ 3QB!DMI
M9/I]I;_XBBBFTC6&BT%3X"^,@P+?V41G)'VEO_B:67X"^,&<^6NEA3TW73''
M_CE%%3RJYI=CK;X$^-()@^[3!CN+EL_^@U>D^#'C29!'*=)*YSDSL3_Z#114
M2I1;NQJ3+<7P9\0P%?+33@1SGSSQ_P".U')\%O$[SM(6TU@W4-*?_B:**GZK
M"]]1\[)(O@SXBA),2Z<A(Y(G/_Q--D^#?BC.4733GKF=N?\ QVBBCZI"]]1\
M[&#X.>+<@!-,51Z7+?\ Q-3#X/>*<8/]G'_MN?\ XFBBLY8> O:2 _![Q2!P
M;#_P(/\ \36CX9^%GB32O%6FZE=M9&WMIQ(X28DXP>@V\T441H0C+0'-L]OH
MHHKM,S__V5!+ P04    " #W@7=6C!802&!.  #93P  #0   &EM86=E7S P
M-"YJ<&>\N6547$'7-7@)3I! <)<F$"RX0P,)C05W)[B[NP0)P0E.D. 0W-W=
MW;61X.[2P_.^WS?^8V9^3/4ZZZ[J6[?J[#Y5^^Z]&K8 VP#>24.D(  <'!Q@
M\/H!8,O 9P %"0D9"1$%&1D9%14%#1T7 _WM6W0BG/=8N&3$%.1DQ*2DE" 6
M.DIJ)AI24GJ>CTRL;)R<G!1T?$*\[((L')SL_YD$#@45%?TM.B$&!B$[%2D5
M^__K!NL L%& 6[A(>#AJX TV'#PV'*P'H   .$2X_VK _VAP;^ 1$)&045#1
MWKX.J'T'O(&#AW^# (^(B(#P>M?G]3Z @(V(0\4FBO1>\1LRM0,N>T!L-@J-
M6&4GGM+D&8C#T#$0%0V?@)"(F/8#'?U'!DXN;AY>/O[/7\0A$I)2TLHJJFKJ
M&II:1L8FIF;F%I9.SBZN;NX>GD'?@T-"PWZ$Q\7_2DA,2DY)_9.3FY=?4%A4
M7%5=4UM7W]#8U-7=T]O7/S X-#4],SLWO["XM+D%W=[9W?NW?W!^<7EU?7-[
M=__P'UQP #S<_VS_M[BP7W&]04" 1T#^#RZX-V[_&8"-@$C%AH0CJHC\S>$]
M-7L "JY8;'9E)RH-A](9GJ'C)!H^B'.3]OP_T/X+V?\S8('_GY#]K\#^-UQ+
M #H\W&OQX+$!,'#[0/_''^W_E\BO4(H@.8%FY@&.E^Z7TH%37C#@PXLLRYO.
M:Y12S8U[*711TA@4&GL2]T/U#^="->2TTYR0NH;+6A3C5**ZZ$\H<#1\8QYD
MS?/P('*J.[M\65*%3V%/[VO3AI5_IDEJ@P(6)][X88EJ$??LE[A#.Y*(Q>?C
M$4>#H9VLLKT*_40(\'T.48T/Q,#5$.- >8M$^=*3P/GW?K6$6C)D12\KKTEB
M)&<D=IXR[OA0FCP7MX?()S VIP!*N:Z-G?-C"FTH4':U6!M*]$*SYB_ $#9,
MF&#(\@>"F. T"$\$+GPZ'-B=?U(G\.>BP"'SX]C7^CX9)E[SC06;;K'V;@#*
MNQS=UP1O 6HG_O$RT:+ZTJW98RA:X0L#$$7Z5WF)3GS,X2NFKPG:$L^U^@YF
MM,>^J?T6>0_ K24+%HWK6TZ6,R?U^%+I(]^=_+,,.DX5>II<EKUQOC?Z GE;
M7^ T.&HA46A51\YZUJ.N5;YTS)7F\7VN#U$E.(YR,R:@.3W&41;P1!1U8!2%
M'ZJ4^BA.-QQ-DK9@')!Z<:S>ZWEZ@Q7&1>(C6EK[&ZS"G=BDG_B7C*?XSR\:
M)P*U%4** F"^8#%W<K$KB<-C.IAD>X' X;IC0P$)'/RD_6UKV*HD4IBD86K)
MR8Z^,0(R3-FG;NL4&SM7,"4HBE_MY(/.G13[]F,J*BB5M5#'!4U4H/* MXRN
MY^;V!>=\MBPO6U RXT.,ADXOU;U18^>B/;(CDJ, =*T)0XF/4T#WK6QEF[;,
M>T;0MLE)@8 ,W+LE-P[P2#\9NWL69E?XA4 Y_MWKXE8/$>JC>#<)?X72'67?
M$+A_+\SB)47JOA YUKZ=]YQ+V,)@%$G2]DJY'B[*TPZR#;,Q"&<=)8;K!&V\
M6>R@*\K"#.GN<7V(#JN5Q6>T2B[CW([<]E! M'^L2]@#>1=,_;5<6LV/H"1X
MHVG6&#]<7Q_P=I##( Y/(@LASAX@3=UN^60G5-#[":]7:"5)H[J*X<*?\-,I
M+PC Y-O#RX/*8ZQ:.5K4IT+RFWP;\YM'S6@P!@Y$U-7T#B 3\G9]_IQ7XSB+
M!ZFY2Y;=;G8^"&(6!HW^V2ITP%XV0M!$1D*CGL=F^[LURPS*QHD6J;RV^"V-
MH['AGV:KI&<G.U Z(1)D9/"(J@VC]NSV!,N3@$O15V]YI'PFXCW+$X9^SY&2
M",0+4=Y^54ZX_02"-(K?VZ?Z/+;'*7MD'-'2EZ-N/>I-\F&VUBY"D%O)@!&I
M//UDU6/:>\A.0ETZGTUWND.@T!PB=SM>BX3[[?PI7EF*G<,.,J+DR/<LPL>6
MUU*9PT_^*^>;KJ4@.)CCQV_^UI W+<&UVC+U^<:ONF$0-3J=/9!5:@]9.$%)
M]W-/?<S= EV8WLJ_ZFJM&M?*[>#ODMA56,.9/0\W65B*?UHF759]:39:3745
M9#";0:PZ%EL(V)1Q.(\)E<WV-(V=XZ)Z 1[NB0H_C,.W1'\W!.(GM-,B0-?\
MF6>U#P]UV;NL#@>G2,S?#3)%N:N2R2K"@._A"S'"O<67,$!AO_TNU>['E;;\
MNSO'6\G6E.S 8P13<5Z&11+)V]4H@0E$\?.$L(:JP-UAI1J>J;]JI4[F0U5L
MV^B7-1OO0SJA><ZU.[&'OE1GO2\IN>Z[DUS,_#*%.=5SQPT]C?>",T=.Z_>7
MZJ<NS/*RYSP_.--:M?:-&J;G'J435-]^$67XET/!MJ8,[(6\\1?"J?Y;2]#4
MTA[\U[9T:D[D)]/0&SFTH$9,#_@\AS7\N5JL=Q;\B"WU2=B6]E*?;BJ&3E91
M%_YU$Y*D%Q'V$_6:K1\0YV=OPH"PFWG/]!'.4S:;C'>5[/3^PBL!TW3(C5E8
MLN$:>S]H?\Q"7=#_%E %;&-KDM.=T[8'UP05Z2[KC*+$T@B+!=54(R)L1Z#'
MZF0D%>IJ+MY]ZJZ;K\Z>98JXT&F;<X=&X0KK>! 2,?%1;L"OY^F3+UMQZV/4
M#G )_+-3T=>N_=7L0/E]G'SR X 0%!L[HX!<I.9:6J+YKPYR<"$6>Z(QJRK#
M&=6/%IZ3:.@.J'-8>?VU6,?)F3RIA;16MT[G-F.WT&=\"3MH$,L1D+0-I8NJ
M+8""L;#>FU<NYCTNK(G;)^&[?1R,<AY4CGHR"P=2QWNYW?C_:AG/U<^Y3=-(
MD:IS[[C]@8)8A]*-'=(OI^J,$OG(Q274S)>M_)UJ-D@I.H+NYC/,7VCGF+T5
M"^[\^IIT%"UQ4)$RB[5(N^W%GKHINA:.'S 9DD+4%:9K/I&L+EHV- 6I-4=]
MY/H8&I?G:BC!.R;RQ N/"W=0BZN4.Z3%HZ;0*Z6<(=I)$8"@CIAS<'M+SILI
M^C+9GB2?)D$@Q7G.Y/A#<#0X1T!T272<IG"KT>;#J=)D&ZJF%;YG[=:J3Z4*
M@8E+M^XOVYST0*EQ3^"FB3&R:8:+T)=N>7]"5T!+-E?6X<:L;YS+6%PYW=C>
MQXJG2X^V<88KS0:LU-Y:-1='Q],D>\3P!])QOV'0DD4)13CSV$\%KJ3_S^]6
M*XPAB<)>_G  .MWIAFT.7I#:(ONR'_*)*K;'5)\I A?'9H 0FDWIS&4JCR+"
MM8JE4-MH95[CY59?5RO9*1N1+0FZG(0()TQ/BI#:G^'5I.J'U2P/+Y8QUPZN
M;1E@J_0= 4.9-B41>WG\ZYV8J6TI);I6#PEKV06](!E0AH8FWGDWO8[1SG&@
M5^IAE9 X$7D-7 ^X>_-3T#4%)G<Y3ZR?XRV.-+7N@>YM!5EE4^V'L_;?6]K,
M[I;J;+K=-C=2<[0*2=@A:W #M+YVGX]U/UBP"XD##I$;E _R85?0XI'WNK_W
M4K[+) ^_<FL=0#J[V,((>B@//5U6CA^9C)T5^>' <K70V\K[*@WDQ0'WVJ@L
MNM:FU$]$!UJ0/*&5*NXDAWS095=O& H/E2EA_^<(>\:Y&M<V'_+)6M; NZY\
M^R!X7SYH_53Y*_KU'X(L+U2M4[9RV;3M-R93JU^*B.OVD2FXO0PR$%E:-[^5
M'A#+Y9'G.1D56D32)0BBE2;$  >J :3^P@F3K\_C]7=[63@S&TE%:[9I^ZA=
M'CLFH>Q0.%9VTA29$-$)IZN-AWE_I BS.=+37CQV84057-9^M,>#>AN<.:+%
MSA#OTV=AFDF=94\+?G8KDRK16UW3%27E8 K (S&U=RV.<!$":]7__8>LVE[9
M]E.IN;*Q"@=EZ4V>ON]*J!H"Z[T$7KTXX.1@/K'O=BL,FOUDUM(<LO@')]G_
M79>P*THX?QR[/&@#RW+D[(E?/^SI&T_$WV^_Q&] U2$6U.9/T(9J5C7@C+6Q
M_S;4\OA?%J:V\MF/6<.98Q87[=!IK@](5LK$W)W!"#1&#)@KMYV@")713<G0
M\+%FC.,189,F;7GS[*].##CJ?$2$@_\\RJ+"@:V:Z-"Z!^:!J&7-F;&HN/M*
M"UGJ9,7J=#.2NJ"Q%>@\ERD8*7FZQY*+#^MF\X/1SJ>3'[*9GYZ0Y]NYYA1%
M2+WNZ-M2-H<_'6N*_5/J!WW:83&FS\/E>4*(<= -QE6 TVS:C25OS%FQJ!KG
M1.5>&8:W<>E&0I0WBM5244!FXPDVGC&NT=57:VBKJTFQI0GX\P6+^GDNII"D
MPJ.C8UQG]EB].Y&XKS3/4EVRSX==+8Z4%+[!"'G&F-%'16T4%^YGGKMMM^2<
MBX_<K&2F2@)MIA"<ZG+_?)S/J-GR'3>N,(W,ST6S4+W5F^\+!*;*9D,2C[R'
MNJJX<+TZWD*!IV+3UB:SUW!>>:Q6S.)H3!6;8L< .AX#0!EE\1 = ,G;++KR
MBC2\T63)B]).6TS04Z?O_ 7G7YQ5N(&EKV15]<>?;U^0^]*]:;@'RW?-IC5'
MZYZ:%2\AC,EIAC1 K784VZ79RGWT>#9G6:X>>]2Z@]<$ 3,KD(^/<+?VM7".
M8 S!A]Z,@A)+G'59HX:E[$@CR<60MS'M'I5]4AV#'7^7,T-=W=12GR-2$_Y5
MS9E9)05+!Z"/J/XLZI.G+T".JEUZW<AYT4$9RSUJ3==]]7XN/GC9-;\&:%13
M>&R)T'((!<\C;HMCGOBKY%%7[VQEY1YD4(T_V:(JS+6W7")-(8/ ?-8/ZC;B
M@"/V'<C/6OO@UG,WYW6.W,1(FB-%ZL;!H6)_MH!I,KY1C9JS["@8(-4\PT54
MOC.5,#>[+:XVS-(U)G(?M2: Z318EA$.T/_YOX:=Y] Y"?^=DZ+Y:FQO\[$)
M+R6TD*O8<\XN#.(M5(CUX.:WH_PI. 'KAV<&%]Y84?.+F'K_RQK%D^61NE;8
MX_QMYNUS>U^C/KD>5W1(CT(U:%[IK[3"!K3H1<27:P]L:NVSW/[XJ",EH%N]
M(I,J"^&I/($<*HP3!^\]PP"[\Q)62X*)$LGY^J^X9BEI3U8=:P,-D>(KB8_K
M1*F?(XS*\<@V?\HYP3^7:;+=YCK^O 8<):"Z[_YL-\9/;/<8XA$]\DFHN:U]
M/">ONY6CGCW-$9(;#E4 T^BDNA?HQKNNNJD(>,* O,$7KO$%P5&W5AGN"2F$
M>%WY8$'&8O>?2HD"O/&"1,9&85OD>_-+]>%5E7M#.F/_OKLGZ8,O26=@P!F[
M_'E!>=CUB]^61]$-#$AJ!/>U(K:]U2'%FS-0CD[V0(AX=))N1_JD@/U<:KG(
M1_0C]+I$*MXH=L);O5C+:N[]VB'_SZ5^]I3/.LT8K1<<HU[;6CMY0XS=)6('
MW92E'7O7Y6PP(%B@$#,U,A8&^#<49F[L%D1]8L)Z0NV_RN^K$;(DDP:SOB]D
M 1_6^9423(\[3G*5Y;[[L"61ZFOH$)49O:<G#@/0@M3UDO E7I9Y7W[Y=17,
MJY^L:+\0,('SF"&>7?V>+[;/<O*9M-(ZK(N)X^0M!EZ&*:3$3>"GX,6SQ6$^
M2OB%<M^5O?I6#_DGAE.<\M4&^:[S]JZ@L_7>G[>VVF=MG+HW\ M,VHJ1"ZNK
M!!T;N:%VTQ3S4_''/(@_+O.V88#[? P6<+<$;G3C?="' =?_7C4C1W^8KW;S
M>->=7R00K3[#%52@.>C M4S]9SMNM\UM5M"L[""#IKTY5&.&NMX#*S%VI:D0
M/@K@+<NX[?#E;).M][-LT)=H5(8!U:J(=R9;O"$$7^/)QS*?5%FRKMG F]3S
MT>#EU,P7Q,$73BSLP^X7(\^D_W2XJGQ)[WYKP(">LLT+=XH/R-"F&ABPJ;;:
MC==^D]B8KZ$CYT"*TR8E['\>?Y4OFS+DUR55_AX&4+7*P( WKUB(D7]P;?AM
M\Q7Y;>AD0K4?ZKOEWUDX(42MEN<(@>ITN_])*&J&=F90ZC6]_NS/=YR(*5_O
MXO5@0-9N'@P(</2+Y+Q+TNM_"N4"/[V-?[)<=I?0(7,N>96:ML<*]<&UL?-?
M6REN3EY3@@28BGC+E,. ":=7E!VO^RK^!4?6[R7H?Z#:.UNK8(L4_N<T9K->
ML/.5G_Q/N^?0MH^!WUF.2#7!_V'H?S#\[^9)=D[KG%MR@ '6:4\,R-4)J.@1
MN2Z(*"^_3@)'JF$ *D\8\E._RW_E9P'>I#O'>D:N_>]L8W^2:6"50E0EGFJB
M7Q[RG/%-0Y]HR:DI+LG_<Q2884!?])UT"P2\*U0$ S:T84"D:4S[Y=RGQR-E
M^X(7K7X8X!/.@L^YW*L'6G(HM_2[PX<!4#7P)L,YQ>L:@C!@?OKU&<-WZ;[G
M6#1WP7(B?6YHZF^),\\2[V+\1KR47O-/>BU!V%U!#QEF?>'K&J^0(A4O-'(X
MC.F)H$6%<TCO.&R4CMA;'A7P!9CAMSZ4F.TLZ:_I#-MJ/UND# ?Z2 F&GSP-
M'S8(SYH4Z]T*JR]IG,#'1[F_<EK#4TE7CJ%,H%,-E.N?'L[,I_>/U"Z)IE%+
M-J>DBJ=,!/D2.@8Q#E(' >9C!W.7BHSQ?JZ^U3QWLS.M[3 @<SGS\6$=J@J-
M6W(TJ>&K=V6FF!9BZ/H@:VRI.UUV2J)8@^%F/V0J(II0 9%H];3Q*/M-2!Q9
M_NPBO\LX5?S'C/)/.,./_ZDP2=:J:T^<26# PP8,&*KQFO-MA@&4C*</6^M#
M^?IO&2B(KX7-SDM+K-9 E9,YZ>+;VD+=E43;+S3I]*=KC3+12):)=;<\[_F9
M6/LND!!^=_HT1420>Q%?'>MW/JB5>M_64SMP^/\UBBFD1'<N=G3GD/,EWU/\
M%MC.-4V.I7A5YC[[W3!V71E+2<E1 DV0KEC"^APYT'HG\/W8FFO5+:W_ 'S]
MA^]G+_48)3W[5EQ5VS:IBA<Q[, >5?AEP%)S0PM67@@B"Q<>[]N$1AI_5N1I
M4C6[L"?&?(O)+['COO8I<"=2\.6B2W7!7]:;OJEC*>:-E];Q?4)R]]SK$::,
M_EH?JSSJM"O=SIYK-<QZ?=C?ZL.58Z[&CY1&%I+Y+@IW.WY8P,U4:+#\PQV=
M!<Y=J%H<B"%FF0']^CX-/-5:C]>B.%Y%\S;*X4X=SBKWKEVRD@#_4O#6C8Y=
M1-^S-U!>X,?V-E82_)O&:+(GF7/\4"CC,8]L0[VVMD\XW@:Z4\W[\9EYX7:B
M%KU6DTJ[THK7O3:18>P94=_&&TZP;%HEN:/)W9,LI\W@L1?9,CU6!'T'HEC,
MRJS!^[P=@7?$E@%WL@+%VV4\+^_]?"I1P#,'_\+%_F1W3ODXYVD! ^JLP3>6
M\"GDP1]*H-C4 OM>"1*I;R#==NC<Z11I%!_[/0^MS7Y?%9:Q&-GQYN_J,V4+
MGE_$24)KW8N?'.=#UZ8YH:_G)_I0J;Q?U\#GF+CCF:P7ODDHI1R-X;T=%9-D
MQ]48ASKW?%AY?^07GV.TB6>Z;\\,XG?73D]ZY/[/+/(PX+TD7^RQ@/FR'F\[
M.0QHW5Q_W#V$ 95%R/W-=EMG1^O!4S#@G!-Q\O!1_ /C8!)T+NU)"W'C02[T
M0:7D?!T"]A*?09[ZPHGY[UI'/>D.NCE7OJ5/^+EP61YY80GW1\M\9Q#"=L Z
MWSC9/_VH# JPU]>9I)<[\%RN?I0P,=AS6%G_T304!ICF&30)<.1;_MPB$2B\
M5FK2P>_[R#3DQ'B%*;]S[S4[*O9V?P[.R#VQUTS]5XW7;9_P!9:8CU6P?F0;
M+MB36<KOV!_\R"7=3O1$N6K<KE]:^5HDHR8A(,,KG-U'UK[D/*BS=.YBW[>N
M5/E3KQ\2^*E7UV^MWN&9_NWO#.V9*>.'S+%&VKO?&_,P('G%Z/E?NM]1+<,3
MY,S+>?Y88H;UY1?B6%JFEAC< =P38X8^A;M4DWM(_[DC.$^RC?NLVOD<*1,&
M^ 7#.5D-1D:AF_L6,W[0+E3SR.'_BE71ABK?7F-/L+.=/E7^TYN_!V_>^;5D
M=F]?N,C6:K/6I4A_E"_D4"? CRO/!&6TK9?*0&+BM$MB91S,LT<RB!!0EKXF
MJQ,B1)#SGT]EIUQ]HX*</1=1!KP4"=2MGUR=7I5\Y([J4W)I)O)>O?\@FL D
M-7#?<!B=A;M>M5#=&*H5:G6E3/^\WK1Q#6TORC-;F50I>/JS:$&,GV=.]])9
M'0V*++=-@9X51!)(:VJMU@P+,H3HKY0S^*%IE.:$NR34JC1$2G8)?C_C)\?Z
M4":14D:^L2D*A^TTH+CR&&<9L2R[2IB:&7@E!%F$XBMJ2XLN,S'6%-V2H92_
M.T<.M>64N6>V=?LHAQN]I;<@G' 5@#?H+3I9>OT)?467/<#!M,W8;IUL?E]I
M(K5QPY0-ESE@83[WB5<A23$"XT4;=X]T6SVC*1"%:\[=<^K$R+8N-7Q95WAA
MXU)B8*S_)!U]IA5];B]_N;M^! H,;?NM0\H@O[2UAS'^.JS@6LPZT-"M,J]$
M6\^<EYJ::T[//PLOOS257Y9_QNM8P+HZ]'LX:!]KWE2)V,95%&<7"Z?/>O,:
M2!FUGU]?4#%DI\\.=COJXUKC\W[;B#XP0$?[7F5XTT3Y+JEHQQ$]O/C9<OEY
MJ0RBU=+]+Y;KCZV#CEW4265A"^5%6,Y5V<F8L-70DZ;#333V >E97 *%_YOF
MBK,#CX:FQ(GC%Q1MOYS#)/?':0E"L(C\=;DV? SCF.];T9T[[EU#\+Q>XY,_
MWOZKN(L6'74MC1;*9+ZKXYQY,BM;J5U1I*AK"HYO0"9Z9L2K24+3T-5FAP]4
M^PI]VOK[50T&J+<W_DX6 <5YH%U35G:0;\=\-(Q#9EA?C#GJDSC5R.Q/57+E
M4'1<Q&NOS!7\F6;4 ?:;^V/UZ8,'56PW+J4I1ZR6^-&FL,74I#_?<DOL7;B,
MYI$;O@S03>$\X/!4K&QG$+=]5\/1-I11Y:N2:2)_"M[117!;4DSV2&5X1X H
MW@V7?EV*Q=A=)6.*\:L"-2'E=LR>5?(P4XODF[-#_B2X;?UVE'.Q_.D:?#OJ
M*>A+/,D2DSR;PSOP_.@YHW\692ZL8P>*[WF[&;V$_/7]OGAW"KG'#?C!&HR7
MGP:62KHH"U6791&XJ9]&7-08(]JQ_^P5A6C:TV884;GB%"!]Y)4" PSM[H\R
M2RD,_>X/*?:T92Q(>E"2[]=[B0!?RMOBBR_XNC\IOP6,+>ETF))\]!+T^TWQ
M+6T._'A0,\?<395$?KB48U 2<;0W8QAE3^\3#IT$GV9++)2!&UZOVFX/5A:[
M[W:YV2%5!BQL#?#1<\72@:1OBJ6(.G(+?,(=K)S 1TD4E^/7N&^UH^^W9_,L
M,RU]*@L?XBR?;Z*Y@B-+5ZJTJW3V#'-S*_H+C^63)< W5J_C9C+-TOV&Z9Y*
M;+OE&F;*!-,T;H6[[CY%(2LKZ5FXJ1$X:HTU)++#(\9@#XQK\?GOM:2T[\7#
M@'7.D(\"?3#@=K T!STKX)4^VXJJD(-E^%S@BT#*N_"X.7[CW*]?6J"]\Q##
M:IH7-RJ4B_BS.!( TK17H$AV+IF2*+&LG]9]JYF;D.;U/932%[?1'RI)L?K\
M471OJBD%8\01U\N^C+\H*(_+.(FD;?P]9GIG+VFW!-=NA:  5@[QH3!)BJV@
M7VYVHE@)#1_)&*^2)3<.-00TO;5I3Y1%X];>ZN*',0DZSX4_BH&<]X+29B6_
M74 O^+)EE*(MJ!M/209WW'F4A7@@!)<&C#G4C>"P*0]?] :*]5B"Z_&KTK=F
MWUD/]8(V2@C+KDN934SUJ;<^SL/S,6 A7Y8!40YZT1N#4V!""S6T7 YM&?LC
MK%O1COZ]4>,![8QP*"A363((CP8]0CGG>VK@H/7X@T_]LXO^GNZ_,N(YZD_'
MX[DE3X>->))CHN*XRJ#_:6=MS XS+]ZTPH RYJ<2L4*KS OX_^X4FYU599^7
M*P\M>-<,S#-/Y7WKU:RM?Z%F#,3>=17:'X7PF/QT[X*+U2,IDMW3UY=]OM^V
M>W*?;_K:1>)A?!0V>H]VAIKVC+URS6=TESY?A'*1TUTB[*%S>QJLMFYVYY:?
M[O0Q3OFN\=6,';A(M8WFK,NG>ZA="/N&RYJZ4R\?M2%-4O>A5'^^CX !6O*D
M*S[Q'9[;W8%,JQ*S#2^UYBD4')R&S$0 I=#RJ=%+U]730N90"7(8GSZ5^PGA
MI=84T]Q#<0KS!RMW ^S>.L&@BS/13C(IOMP$YQUVR2+ZA-N,;P8Y0DAL_9M2
MAXW8\5%]GE4>UI6%$M\"XCOS[S-\"3PD%"/\4&$ O%H.OW,1FHZ)6W$*"HEK
MND%$['%F7SJ3\_Q/SQ6!=WPH"X/P^2C/%A*K#<4OYXPG$3=14BQ?S M&W-!R
M9C(2O)3393Q ]L?FQQTA0CF!!!$O='3G)?C$?K$>#J[)[LRWA+^CU?ZE7YUF
M=J4A92R,J#TN8+6@9M?0[DJ8<"VQ**;R] E$/"K)4#XJ556/'$G&2#HDW5#.
MWE:ZAZ>@>T6Q%G.,7Q?I$GI72R8O#JATZ%S!7Q?MDD40;;F;_F*O8@.@H 3D
MC)JZNGA=RG><S?Z#*L?J9<PVWC]_ /$,*8K-$7-E/XSRI0Q*P*F@%" &%6UO
M7VFWU&&AZV6LS:;RKV,20MT%7T>AJJ:I^8CMZ1B \.KXM$ZMO;FR^^VK(;8T
M*7(B%GX/*[.G1ZWL4[PC/0T*1LHT+@C846P+<[:YVLB^_6E8@@D!!O$CKG"*
MOR+[S_,/7 GFV!$;:\S[X,8<P6RZ-=7F,27]%F]!L=S;= Y*JQR#@FHF,_:6
MBCWMYGQ?>L+ZX<9U)@K>W9;7!5-@K_2S_"ENU T+&^I.H!+I-9$R\2BT5%@6
MMV,Y3'J+-7S;["?=[F!9O7*?@CGREFW<=[8:*7'-FZ.;R6LZ@5K'"!<R"8FS
MA2"EV#"GQZ&*%2D'$IJU6AYZ1J@3VT2VG/<2=Q!"!M+<X%?2'2W_/LS%V.;C
M:*\P(C-(#S2 R%L_WLYSSZM5"K6\Q__10>5/:>*(VC]57KJ8DKW1/&SE8]Y&
M-BPRC!/Q+8WR&>K/3QRM:[%SKGK$GC_\@^XQ@H^H#^OBK\;$LCQI\>E;3 C-
MAB]23:9RG(V6D/2#6D.#%-Z8LNT%EL-RA*^*]0E)JAL_NMKMJ.6\]<GW4&/1
MB.BO&0DCEA44Q_BU(R&T4 &'YM39&9>6=9\B@AWKP7KA DIBJIF3%O$RQ)\,
MFKC49HSX@$ZT+]:>',]JW&PMB[N7B-=@#PHW _8NJR!$2&CY7MV#D]\WUI*F
MMN;GR)'\FM'JC]S:NI^0:364-YA\9KR##[=_R0PO-$M-&D:HU&\52UCDI."C
MY>2U4G@JWZ[YBN:-W:H3$+"=H"V(]V<=CL^WZDY1A2I/?S)D"%%D)!Q\>;],
M$59D6)O8_Q7[&V$_A0*2-OQ\>.FF2R*W*G;2I>&EOQHE:?P\4M77I7[]@GZK
M+694FA0Q:21XRL[(?F2*:,O!L_PDVJ3(D[8)\!3.;%"F@J:]Z%6OQF2>KH!.
MQDQNY=]MZ8!!2O([:)[S1#$X+#=!9*!&E?G:T2_/!D.33>UW)(<.N/>CJ[LA
M(0QHMP>+6#5R[8'Q=Y;S]B=A@*>ZW036H389EM&@HIMTT&RP)W*@$;NWO-'2
MLH1=1QSR=1G.K)N>6%L98\N=VH6^>W]/?7G]N^72)NBT._R5UF!*Z;BR9'5X
M3:S_1YHW!8H*YOCG,""ORV__#PS@/T1T4H,28/NU@7\[_RDB&GBE6.-@7$41
MQ/^$V:'^!6++?U.MR"R&@9E$,\55;WN"S&("U@]R"UR!Y8P$=^^<@%YVSE[9
MBJD<^02=@QZUW4FBIJL7B=!:(D^;>E\_M+.2"O&,R1E_QJ46\Q>)(!?XU5D%
M7R9$]XLN6Y>W;PTX=E?ZDA\J\"9N>.?V9K2LW\Q+5]>340=R/OU"VQ%F'-]^
MXIM1(3=QSWE:\0MV7>B'S]IZ36GK*N<%VTK&CV?XLASW!#E+U>@%EVK@',Y3
MNN(1USYZ4]B(7@_\K*H$[ZS]YF%__)G#M7]7CF'12]R1><NKJ+W%XUE6 [\^
MGM[JQQ<V/T>6]M^R(P/!O2-H@LM;WZ]T=R%<AB0_!W&_&^)>6X09^FT(%?>V
MYN4U""A@W51(@2.UD7 )=7"\C$H_&WU<_/'))CMC_R>FI+H@EGTKHJR#9\RQ
M1@R!W2_Z \N\T:6_;2K2M.E7D7ZA!UXJ%9HMZ.3>]V/L(Q!6(>#HHZ?_G9']
M*&BED33&'7Y"18R@J9X]!,W$IH/<_?A!Z8!]1VF*XW)T!G-X9>Z[_5-LL3\6
MX9L0)+G2O$&+O&'6> ="K#X >:K.NF8@<0SC7&HW;&:;G%_5#U<6!N"T5WWX
M6L4>EU,5-&9E.K9%4D*X&UR59H]Z@')D:7,2\)-?IV,GHA[IC9QKH;!^^U3L
M2)L&TRB[RTHA#]QAU'7M!R),E3=(A.2UT5;@Q9/4D6]N'!Z67H;Y@[]$:?]P
MZCG;@C[/1+%=%SLNK.(QXY#Y>T99F6Y11]A2(H\B[XDUXF Y'.HBI6PN7H>*
M+=-$0K:>7??R@0/W)P8/K@DY:8%TH;9,CUWZ"TFZRD-=KH* ZY0M'#L9C1E;
M).7Q>;)VXBMM#!+92>@EMD2R\-7%1?\3&&WK^MA5_MT@Z-W(V;[YH]Q8]65$
M_//*S:E\@JW),2V=L6.UQDD+Z\\&$U4PYU! 0K2WP_Q:HK'YDQ#>B#'G*=N]
M.EH>Q"D=LP%OSL_@BXV1Y(XQR(9()[K44,>"0]MBW+C>OCW1/D\A<-7S?.YG
MM96N9KK=$ZA>JI#I*-P[?T#)D9VW)*@'GZ$JA6GM2W*,T26O\CQE;.S\7(7M
MWQ%UI]PH'CHZL@O+OY-2\-8NE*Z#&W,W7Z7H2VC4=E_6-E!R@P<I$4T>NP\/
M=<W\:Z9-O#P</FC3%W^/P!X<IPAV:$*7=2I=*OE:5%M%=$\$'Z#W\T\H 0^'
M!,A1QH$>B9L7>\-YA5>X<1\RUJ-R)VNCKJ"1$^NV'?L=@ESF^7J,]XSIYUWQ
M1_XJR#;VR1C9C;A?#6J9E#6EMHY8('#4+;(:)_@J'\"1^OI8;A.\T<?I$JR@
M"5\&(8ZS]&>6X:HY3D:]_0PY,?]3V1!;IO$[U/)]B)Z E]*^(B0IU?%G2!B)
M*N+ME8"GK\MGO48,$^%W6;0ATD_C,4C@I#VUK:9JGCJYN3\@A1+J.BQK7]4X
M+M/G[:HERT0"&=</F%]E_5L^$AW/YSD_<*!^^J3M>OR'<_SYRJ_406MV+&;?
M#B_;?X20-PI$.T & <H*.N/36OEW3P<NOE2?972JF-;G9VSWK?1+6PT+?Y)]
M?&8GO8I<OJ3TD[ZFT0.?&^J^4-5%@QT7_91DS:UO>'_SVLYDP0 OKG5O_-!G
MDIYYLR#:$4GA%-,R+.E7JQC(<ZL:O:\7?*;H>B>AD@P#AG6_H#^_AP'E"J]Z
M]$\KHG3DJ!I6KQ!%:N#P!,556/LZQ5B3HDY>\^X!Q>W\_;P:0VQZ8#A]OJ2B
M."[PGT#+*[[,TX4!\Q]>5)U5F=5?1-7]K@?;$X!Z7G$=Y5$NK:#4J8ZU@H_G
M.#89!!J/PT[$+YK@J9;;[G<^)?W\Z,@QMI/1F^-79>-;.@V5T]DO5R/K<3#@
M^C#CS@EK29AVWX@(&Q3G*^G7E[9 TW@EH6<U[,N.V! M7O.MT6WXHPZ4%PWY
MLERQG.:NTEZ[Q],;**.I9G)#?]Z# 4<60@%']FQBX=Q]X0*DZ.C3 4O%DN/7
MQ3Q:N>],W#RB,YO27VI5:I_OQA#_"E7>1HHWQV@WS1CY(\;.^%5ARG+/D<EK
M-LIX:40PK$0X'@GY%$X[#Z0>T!O^R# S:#.ZG&]UO25.2 IA&LU/SS!90T[A
MB)*'/C.B)1@A_:DWK<C?J_S!$FJWN?KBLV+!P'(6GI<!Z2\7X3C4:;*<5^>)
MY(@7&KZA"SJQLO51DZGH.W%UY./[9QD=NN6_+"^,]= =5)^N,NGHYKBR]%<%
M1^J$'Z0K1'YR73\$ [RAF0:,5I!D2_Q]1^P8TLC<W2HNH/ZFL.(D2CP&<04M
MAH_HIO29BS)D#,70Y%XYG=OCP,JM<F1D5:)[2F]MV-&6;=< <3D=KE^K-F=?
MG=]0BBB5@_RXVX$FZ%@;P3L+LP&*IZ;I]CM$G,;6[?U<PEH73:+$^N]"^3\9
M!>=_P]!@@*7P]<""E' *W1/#]FG=^XL<1*(!PD/-)F<>@M2:V"]@]UY*T8S2
MB,R!>+'/MD-'!S48'Z^]IB/R_KI?DM"!3X(.O![4W:R+"F1OG.&8%TSP1+MB
M9[#V[J?V/;WYU5(P:CX+((](N)[("M^C!HV*IAA1BT;;79CS;B^[F:I'LM!$
M=\?=&Q!)O>'N7V5RW?9;5^WMH8Y:HXW R!8K%S0JN"J+[N.H2750(Q7GI".K
MT/&[+L%?#1(;*>WR7KZ,[MX?_5K'G5-LK5CX%1!OHGKG,[7ZS$#T*==QI/K-
MMN,0' P /WO&<&( +!I(B@D'\KQ;A8*NI=AF-O[HGG7\5X4\?.Y7_^RNM2M9
MT,HP=P4O++]MIB'M.1EE1,I-Q[$5Z> +VF#$.,3&:V=(VV 0&N8:1*Y:IEDL
M0?G^72T+R(J(,HE"^^Q+QWS_--D(R$UM-BQ%>]DT2F]J^R%*;L3V:_6W5BIP
MO >G4(R5]#FMITY/@SP2X'5&JBA:(]#+"Z3Y4A?CZ?-KN3G7T?\M>?(LG)0G
M 3NZ?:C"+:Z%HZ$W-C/SW&,?+O$DQO@9RB; #!.U+E\#4;]&<'#+^6#H7'07
M";[S"I))J7+A]4H+?4/;&C3@_Y6,B(1>A ]-7G&ZU&+<A7GD7*?OX(L[ ^[&
M.Z'G0R48 (G:)$10->3E+=/RX7^4_-5:U&66O/S+DM/D@ZVNU47I==HXUN)F
M((1/@8B"AL+=$4Q\TH*(&MJEMC%0=1('66LEM*4TNBAGJY_=:!S2Z<)1XKZW
MZ:!;N.(Z%,:)'CHKRVA6Y< _+IDPCN_?T^Z\(J5N++-)/?_T8^KT_/OP\T".
M_C1XKK6JA:"_VF.-?4;.]RC-CQ)1L83-^6:9<\Q]&3YSJO73)JFO>G=#VHN7
MOO1ZC**>[EOKRAG0RW&U;^VA'V:,MC?O)$%+B(<?3__5WYU*MI5CT=L"I%ZU
MRPH&GLRH6MI4M:K=FQ6_:?$7EZ7PRS3&V.<<2XXY8XK"<LC_V7@S9)3" ,JT
M]H?M]:$R52'M%U&>_V8[>U1EN-1@E)*W4W6-W&9IWG))_"%I6+>&;D\#%%/9
M=Z)8OZ&'/R3'8PW72^@+A6ED=]WSC,:QM2F?!KDJS^0PEL::G18-HUA]<S/W
MI1+@%TLZ?9DE:$^CC$59%K+K?A#"KR.VEWK-NE-$FEAE$A_BL/A*/55(/-(C
M<_(8X_!I,-D<=]"'VN^-"%D:2")\<HJ3T J\N& T>:,)9W?R:0T&'*KI_W8K
MK$\B9.M<MRMH/%6T.I'RM=%CY /J1I(HSX;<E0^O"W165W7@:+Q[N+6%)$_E
M:J:@M3]=1]J0-$/Y;DIPQ%QE^(,U9HICW$&Q<XV']"72_6IDK:HCHV($-<*&
M7U]T6FS&I5<FCQ=KTA1&WAR/$90K:Y)3(3%ZT9^'[$1O(^I5GV-$EOY]]ROI
MUAPW1B!\:>TD!,?TK"Z2G#F(2##]PKT$%1>4F2!U.##JE%I7[6#%5:W58@F*
M]J75U]>7]HW\JZ\GS^3V#I+]WO<*>2Z)L7: 'S73VZ:&YVL<P55Q$D;8MH$(
M<-Q)*"1T^7FPD5@6BA%P7.,4QY!^%W9_;LN'&(+\.37V#[YIRN:K'GX^38;"
M9^[K\@0XC[/?EV/.752I"RU<V_7'WZMS6!!DLD510F# ZL<#L6NC>\-6QFX%
MVK;D;'70!83MJ5JUBJ]$1D_9HV';7R#3T^OWD"A50@@W--RPT) H1,Z'[XE!
M3;$BQAT!3LG0D9PS$CK-HE$Q6">E\@DXBO73,6Q\YHIZ>VQ,*%#%%GU>UMPS
MR;7ZW;7UZYRZ5-1V0.Q#^*4/NU^-.*K':D<$*=8F-.M8ZLAYXB"R*L\M;.*8
MQJDJO5R(3;.Z1M:R?P0D[(FIXBMT<%0]C"!#S/0=;GQ(<GF!9WJIRFY;V<Q>
MC@Q3Q(20C*.C5W1"86K8I\Q%3?5YQHAY/G;ZNI2V7J-!4P.:;3LK(?73-<\=
MF8*!D@_^#KE<N@T7CD.&WMJ^I)KO>)Z+"S\K>3ZR[IUK UGGMJHYR+T,+>D6
MP>V:8J[L^3?1Q3\H$T EO5NBIQ4V/R8R,."(BK";SS!B/?%]%!3(NVV,W.:9
M.L%]&X/ IL,BX=M5:9"2A\INW!OE\<\K?%XFF;NXY)UFA1OZAMN+RKV29YSU
MTLH@R$ NE^?KQN6IDH[69TX$]O3W\U/%HLZ Y"3)4.<S%)-WMQQSP1=KBR',
MC*_HSENH&5<@013,]MCB:#7KS.L[FF5Q!@,<E]A@0%0XU(RH)CUVK'N^'6]M
MN3S)!L?/!==7K#ZO,H_'47$0[[(\W/2R1;9(ZM"![B58_XN9W8B7DSZ7I=+]
M4F1/YGILVN6'6B]BR8"HU??*=@^F)?>I-U@8[8O>>)O)GA05'IFWTY7E)"T"
MWGR>W7>YXL].>J6@_+'QS[7C#Z4,R^#PO8<YI86$QFF?PE>3Q+55G&&%>GK6
M0ISM4,CQAD-!<5+C0*"V&1&Y=,0(!I#C'3V7[.GBJ/EA[Z>_RK(5_0?"\C^/
MJM0@7$5Q12IQ7 6X_X2*BR^GU?A__D4M5\4PAWYI!?_'BP(>#SRXYU3[J;D?
M"+>W2C\C7/;O2B!$9*Z][;66VF[C3AL]-SD_K"GVE69LNJ-"XO0QW&M)LLR\
M'?J/TAJI?1ROL7KX7IP;\KMRC)_T55B.!Q52G7U*AJ#/.S8^L8+SY)6V/.EW
M_,L3G^2+5W3=T]1DO/UOXW:2BN['=_3E6KOZ220ENS[:#9BVF40:N7%@9.\:
M40WN_ !-K,;DFFI;>/14"^N7K7O.AE/0!</]+,.+WZ$YNR[(K0STS@I(H_R!
M96?GV4KZ%EU1<J!,"MVG+3/XLQNHJ$HWP!!QG#;*(2A59OPCI;BPGF '86PZ
MP+9>P%=*8@SAE9SC4J.5@A+A'D;2R<_X)[JGV^G$@1COHQ+2_ZS6<GZ?L7-V
M\NSAX6\=B)MC/1<EUZR.>FYM4F-<'B4:B6W"4FI1=R,(ML;]&+CE;JSG&&<<
M<#=+LLJJFQA9R_>585$U'OFZE"^.<L?ND_#D#F?VH&27D:N0E55WUK(4:P_:
M17%PI/$PZV$_#-#+)(\YD^P8!X45[$ BL.?;W$O:%W<EU90F"NF82M$J[?KK
M\S"EY^!%-WZOL>WPHCDUG&49I<?P/CRJV98P+/N+<;;XHYDQKU\4];""Q%@K
MRIX"V6HR]0T8VM3$A[VG[%9_[Y%X <(-A=J1S8RI3=1BL=*Z@0,+P8X0W,IA
M''DR=C#:E3;J\69]")CO+:FQ+4:\3GV(MX -=\K-<C+/D)RRUSOD-KB]\[)T
M\QA"I$$6 L8^$._^/XO!TFB^NG6VAL2IG3"7O7P&/M2(Y P1E'ZC4:>BS4*H
M@=K6#JX! #J,JA4P_[Z2HO0B$I$MAK=" !\?9PE9-Y8M9L>0_R)LV928^($F
M/:Z5MQP40#[VLC52;%>3LD42CDYO%+%MEHVWS_'O_6<'&P>DK/OO.\P]VBJ7
MXY_'? Y_GB.VX/ORM&1\ 58[XB%NY%@0\M_B0LQ&ENRWR5T*7>.XG;1*\ U)
M_GYEE@D'/WL7S%9ZTOW7O:)%&.48$RY B$GHC4O9,F;ISAN^7$F.Y[C1YFF)
M"KXBW!<"4;.Q<Y\+I+65FM06:#1=W\@)";B5-@9)(9A3K_2S:!2"HH)XMQHC
M^7ZNZ#1^#')\=4M+]6+W#6&]EL361LP1;H=+/[R_RA@J3'F(?<1%F3'Y7$Y2
MC$2M6*6VY'\9;)C_@PJG_]9D*2M!X#)C5H&I[(NF'ZN9?_?%PXS +W;>M2$[
M!H4_?&TF>HM73YZ^JIX"A<9\G9W]@T3#++R]QCIX,D8XG2RG+7^?14NX+\0Y
M+:BB<01L'.'&3O4/U:Z__)9M+A17>-$&4-8:R-Q+Z7-[FJE)_BQA'AGXPD]5
M7&V[-B"MIG+3!MVG9PY$79<@/PB^*/VQ6QERBKW#NER+HTVB766" QY[5?96
M_<O%RC!HV/4U&!H4;&DPB$C/G)X9FT>=IQ:F,GK4JSS4>-A?B9+ ;E#6>Y+&
MUM''ZE\YMNRVNY5RDA!SYKUAFY-?B^6BTGM%WK.1H&:=0O([O -?*D0N#2,R
MZNKZZ(L?5D-*P\=+^4F6N/69O,J#&[;PO.6ZYTI!6SZ?S>^5=/T]$0$_Z=&X
M;U(<SH5].C,A'/)1'.E3%2?:$\KD5-/@PX-/SRCJDZJ7)R')YTBI?OO_U9]0
MH=9X]94]KZP'_"=HO[EW;<G((UGQ8',OTE0E_(+R4LDQNK4:NC?BZR-;_EOY
M6/V+XG%[RHM 2L]"^-\]#'C!)R_XAJ! V_IS;(,@=HNIQ^VT?U.#8(U__AI#
M<EW*-0OB@,N8\ 6^0F>.N6?CP%KCC  OR;$'@>C 2>?\UT/U6L]45AD4+YNS
MZ=>%8-2R#!LHW>5#*T77&OLLIQV6UL(R;66X8(PN*BA.ZO143WTFX,"JOD8W
M,3;Z1IQAEA;W[VA5"S-#=9*@LA29RUZ/KLV1F5ABEJ!U;M@8!")D-=*7X]@!
M7X%(B,#"6]I\LVQ"=5/F(-)QJ"R7NS2;"CW[1<69C5OS*;^4O[+'@?1,AL5)
M/:F'XR.ZS?$/\D*_OIR)@HK($YQ_RQ*" 6I+5@TM PI[N^A\?1!A:U*GZY+^
M+N*(:39]*L>#7,PWC3$Y# _?&:1@@!E2::-PP>^CPM[%WG?]6YJ_JIGP.S)X
M/[]P!O6X^77%1/$;P(!(/7DL+?D"[9ZJ/I:"QA#>#QIC\Q (F$?0>36=]"I?
MT\)3]B5V1WO]]\4!*OK[UB+$E!PP%?"[)-UI7.]7ZPET._NI\,_2\7)D&B6:
MU^LV.220[$X>(*N;"PE/K!)G#L/_62Q#K^&[B'^W8A#-1+%AN+#73AJ>^8)=
MHKVJM#:UI/G'K+;>PL^AD29ATO<2_Y\4W3V\F.,)G]*?WW]CX]:H6JS\/B:^
M:?ZA4_ UPD!59>XDAU>1L.L8'IGPP;0^_VRTMC-H*+W+L#)<.XL&(]1T"6TG
MQ-%#B"WJ>EA/I*[>:9D@2OE]E4=LG6J%0XQ7>$DU@73:(DU^R'Y9*?;B.XB'
MLQ+[:,0>9YWKA>[76$K$7($*+-N@S)$Y\>\=O<2,_&Q0>\''EY2R]2[\"FF3
MQE_!5!T1\ O.+V)UBSIGYSAU82=,6U%+G92$2C_K"<>@T><E#$[!'BA";/%3
MV1 <'$RTZZ+;;U$JK#33A7]Y)'!F,E@CXB#-'? E;OGXG09QK/3\&4@?BT!I
M?K/T;SMLND&>J9)YN@7TJ_;B?!B5?T>I.9AR,;G3,<'$&T].MO^<2T8W?I_:
MT)0/S\=&]S4?0]'1CO>BQ1@3SG]7Z]T9*:C1CV)K_GF[;+%W/XE\JO&Q33/?
M$>E  R[6NZ/9M>[HS>*#"\*LYN_=U(4C [R^+59DJ&S(AJ[(I'6B"J6U\#<!
M"5]D?5'523%=T1HV!:(J>0":IZ65$;^@CR6=,^;J(GZI']<<==*?P6B\CDKC
MZEQCVJ% $N<WQI@QD8G?^3U-(GF$':ZSM$0[L'RDDMXH;IP Y/+BG'?.JOT>
M&U296RF&*TS@EA:5F<^0?I99F\GR 9T_B/+)WO(I<=B^>,@ZS.&)#U'J9.7\
MJHAJZJDAIH;[EOUY K%/AM330;K3,25*XWC0V:<81=65B")41\U3>JY>^UYC
M'=B;N7UB%/\;/C3,7-JQ@&(M2?BH)E?R_E<8]=?OCDK*_9O'TORL7#3-BVPX
M@CT963R^/6JM+7&@*0E.)$XSH@1))J'^B3G,%.?C=^0&ZF'8Z5#A9*&VVE([
MVIJ)P28+[+1$]6_]O/<.:^D)*73J>94-YQ@AG33BN]7W<2Q$%06E;JLEX]ZT
M+8=G/:86.2$$)J9\C!-&AZ.>&,[3=[)4E0%0#^]R)$N)Q\G@IP6TLP]\1M?E
M=G>Q/ D;^TG@PP^1?CHP0/IL:M4R%WWFK 2T)GSV7*]D)N*PD(A\CW95:G:[
M-'L5=%?@])"ZX0VJA %=0V=_S<.(='6723-0MY\1/6WV0J^_AUO=,X'>X;-H
M!_G+Z[C\[7$J)T?FG&#KU8Q'4'5$M00F)I&?Y&O6'QZB88 8WFGM1BHU#.BY
ME8,!Y<DPX(I*[U8D^95_4?ZGXY7N/?^VO$EF_* I P.RB)?*_/I.=^Y(=/UD
MB-JOWDL=Z8(C/3,IF9C=F,9:);CJB^Y(U*9M\N,LKO;7%B"VU('_B)CGOMJ8
M*4=@I7C\XQ@UZO4A:QHH;&!BM9KATAXE<\&P4HQ7F_X0JAPXAI(3[D!31XSS
M..,S^X9[S JE[=_-.78TPX[G]:5@Y/'2NH*5F?DB-":'<(4_#I.7)E"HUU7Q
M'94>!"@+A*J?/?&WQ5K@[-ODRY?HMCZ*VT;T8=684FH3H4:\0[:S9<Q.O.@]
MV;[(E(E6PB]C+C-)_8B=Y@EUG47)_2"V;8:<&EZA5)=_;^.AJ'2K5Y"YOG_+
MKK'$>A$G,&\<(F6B F$0L8ZSSS)VM(KFV("28C9P'<D6:7EX(O 'O\384,YL
M\T=(#"]T)N.9(#C^=JJ/UAK0CL:B>-M+E"GQ,O:((%UAHU_[$P9PVCKU/3<[
MQ<FM-N"I;,1Q]!N:,3238F:6R>=[A"S.(/=MG/_UA\;8=T1$]37]J,E\KV5A
MX]I46A/!G*GDI7$2\)LZ!?! PUZ5'$,M\C8KLM#*2"K):[\Q3YS78BSP2<2-
M2%-3'^,.:'3$W=Z+/]7B85_X4OZWKK2@1G[S^W0<RAZ&@)PA:KW!ML$>Z+Q7
M-[;K0#8ON]_\(:2V4$\TWR)>, D']UW6$@I;H$J@[SZ\X(.#JNDY\W8DR?U!
M61S3 $TDMNI\#I"%/E\2J=Z=R'\2*Y0]G3.=T_RCU/;+I&U]])")"7TQZ9L>
M6Q9Y&L'=*NN\J3]G3_L>S_%>A:>-+U/*@MBY/847*7)=&G#3PS3HF)Z3QJ37
M_%\V:P2>7;?.-"S0B3UDAG"+<8A4$DV8A)5KR"$?W_<0]_Y.2-_W(4@4T8 !
ML\WEB;Y*W0B!'!?Q8QQ1C!,VM8P"6#CF26I+&3^00Z&12HNX$+KPS]9#7]M9
MS@2[W/!YMU7)A'U8!&1,4B^_"%-CZZ.<@+ )Q3OCA"+Z25@5A*<@$Q:Y/W[M
M>=78=_>H#X0)SY17HMDD@NR'M%U1*$^(MLT*K-6,DY TB18"1V3(@>U'M&L^
ME]*W<HWLFGZ&+=.6=5+N78ODW!'=/Q-%( @FEP,=5^6?YC;KHW5GU'J*JK2+
MOB!BBD8[+ ?M1RCOB-U4O2B=_ 9%9,%?D*^/7Y5#SA8"25AA@+DSBRB5R$"?
MN,=+:G)-&%PZVCZS8'G\J"';C%NI<=E?=]X?>M97YF%1!"9NCJP ;_\,^=6
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M!0!E*;]^ 9"4>0- RHJ#G.6;+0+-K]$7-!H-XOD_5W,?+"$F'@K.]MI/#O8
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M0*%WEE/^N,7>"?W+>\A[K1>[8F>!X:.SP]Y)F+$*8>6XVIF87#AY=+[8.[W
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M&\EV.&-#-4.^RU97YU]"CZYY=POA3D:6BF9EII(1WY%&?,&2QP%C'X(;%EQ
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MCUXKH>0^]WF+<4B<&9S;0CW_ U!+ P04    " #W@7=6? O6E[P(   150
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MIT9UZ%%HHL!\Q0R$1.>\%/@Z^,,@J=X.' (*SX"P1]X#$V$L"RYBE+QI5N*
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M.DG\U4-!0W8OXMA4;?JSWH',ANLY9 IA!P:G_C._=;ZATMPGA=O2_N(=,!L
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ML@@E<S:[PL4RI5^A%4J729 PQV")$$G#%0,D(VB>11&=@229TU]XVWU=8[\
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M75Z/#-W/1* J!&I&W<D$C4H-#](-;E1 =$K_"6U3]C 8]#*AI%:6M+8C:J.
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MV-J<EIZ=N;_O_1AZ1.VO-DZXVL31_FESL4_\$"8) O+1#\E'-[QAW#N@5FL
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M2 -HW./923:9#[?GSXRU@YT6X54@N%%_;A1[V&D?YEY]]HW-@C +F-5HZLU
MMH.&GZ_7$-=OAK1E[LIYQ7$'V&/@AWL_?%HB*Y:(=]]*6F%C\]%Y\L!QZY[%
MNP@G6X'4>;6:=:7/Z$IW"S6":%X6\@[U:'F:8)'5^;N)$O1C'!_64<QXMNRA
MVZWLOJ:=4=*0"0I41)0WX1,(T"Q!\V4+4JG,\6J#6Q7BZ">>94^?=TZ<'DK5
M\&D[AV2Y+OVN9\%4V=F&-:H 'Z]:[MT2/$;A/FGV^+ 3;J_,ZFI8O1H]M*V[
MS*K$IN-]HX)R]QC1VNHVHI.K('"DYP,Z@#;! 43K-8Z#CZ%U >(PIA+NR4!-
M-R+P!B+%!Y>YAB=-.[C^]\YRT;:;Z=.Q!1Z.T)!A7%^]!9F19&)9AF0P[W#@
MX7?$Y?IC0O-<EX^IXX<X_6?^ZF[P)1>);G7O&]]Y) '_?1^ '2 Q?A?M *Q(
M5$&0CR():S'>!8=R[M&?'+R153],#[)2.4$[TK##59BL1J*TR4T&!V7V'='"
MW,+"Z<J"0RB".+8#J<SR/=:*HN1SJ*H=.>CI'K,7,(1K/TUNR 4J\[OCJ,B>
MY8._CP4AX0+#=0X7]TPB,WGHK.73M95W9<D1XZPK/CAA;+E^'T4>7O(!QL_(
M6DT>HJ#_]@'<C<PW#>"!P@NHB=#5W6JG1WEV54O_"Q'MT.D1NON8]-7#BWT,
M/1@775F2572L>O<!?6[[F/S^RE^O(;H&N0/> OJ#R\H#6E_0<YNPY(OA+&UW
MCYVFV?TTYA7]M2/FO<M7Y8VL5S)K^TDNG,1/ENN9ZV*U@DM#1H'O'NC_KN!K
M>H'F_];W*2ZWJ0WIEP.-(]ID,KYYW"'8<&C0".[.:@RN'/7RI- 6/W2-6:[G
M2>IOD0G:M[%86]SX=;>Z/R\J+B%IAS ?!OP0I!M<N +N'&J>X[^O:3-9W*</
MB175$G:- #;KR@+$P%^W]--UCOY#CKU00W%B)]M7,9[)W0H21VRNF_* )>?C
MUP]? X\^75D-L)5F6!%=*4<)[1N&D^!:/O@_\]_W_K,3X"]HV&-.;D_SC_=2
M</'>[=$DXF7#(18 'J=3UQM28[%/TM[PW^UV*E/A>.6^(DT>S5?\(M>M9-J9
M,+OD]S5]%Y:&C*<-*RG\Q[/2#Y$\[JN'I0515&9X61S5:*.9H'+MOT*/Q@CH
M':S<Z48;DO#AX!ZCKSC@C<RP?%ZV,:!T4 J1U+;%%]L=$C4L7LOXRD]V4>($
MR_5-%#Z1VJX2TM%90VF!8/X U0&3%]Y1+(4U5X"6. WP&DV9M*"WNDA$685I
MTTN[F%V8X*B2T",!H7<1.@5@ZF>Z$]$_VZSOJ!#9;:T4LY.#C>>T<]V8M&A#
M\T[A=A=$M/K'(WT.L%I43)'9U1IV"E31KW?[#,,]Q.'53R%I%S^L$FW?STXD
M7 M4W*AT,@]=+8J)=I_S9;E9#7N305[[Y&9G2]'D"23;BQ#G*2)-.YSJTX%@
M'.7'A##*UT&R_E:A+P+M>7?M--)_Q*.!6B0@86#C4K23>1M2 (THT,2R12C!
MK684'A])3?M.6)Q[$/TFLZ,%JTX"+-T2[R<@A);##!38+%VZO0=[;N[$N&A,
MDC>U&%9KM>UF^A1M@4?P,NI26?.#/?8/(^DBZ3:DE&:UT:+-VX0D<RNI7Q(4
MT3\?%W?+#W"  @['=8V_BQ9;"U)>?J$C_LNF+#1(7_%I5)#0?=?\>QC%\06Z
M;R;PWO&#AT.2HI\?W,T+]/^8O6=QGN."E5O)<*\C*: X4O#WB\L?FV)@W#&K
MQ*'"1RN/^ !W\6<8/T9]<.6,Q18\^93.!G@ZR.:#; $P>__?GVUGY-S]R_\Y
M/06_?/KPT[?_]<L_W=W^]>?PVW?>'V^?GWX^A!^O]B_OW\;OWOY]^J^/JT,2
MO'UV_S@+_I:^21_@W_YX>_[;Z\2]2<_^\_IZ^O#W-\^O%Y<_GSU[#_%_[I_B
M?X???/_IY\>;U=7;O__MD_]I]OMZ=__SCV'TW8>W9^&/V_G;/WY\?757R_TW
M?_,_K&:N_]W\8O_^;_^>/L6;GU?_N'S=??I[>O\<?#I\LWQV7L_>GD4?WJTO
M[Y_"!SC]V^SZMQ?G_.V/WU[^X^'GW?7ZZLY=_.-J<_G/-T^7;__XV\N;?\PO
M/ZQ_<B>/T7<_/?[KVQO_7[N;_=N;\,UT\<?NS>6__O6/_?2?#^MM"!<W;__Y
M>_33I]7O]\GWLZN;Z)MW!V__S]\.]]_\^_=/?_WK?X'+A_O34\WB2##V83*K
MUO\?Y#@4[62A^0T?&EZWD7PHF %:'8/Q$5J*HFSE834N4HRZ;IDMNNR0LE.6
M%COR(I00.@:)!TLN+ I&JRC4#TM]]E\,R/X+Z^R_D&'_Q<C8?]'&_HLN[*=%
MJ<DZEPJV='6&\9C RO9B=EZ.P-1BTO=8$KR!C%;;5[K,E3(3K^PR\4J&B5>C
M8>*5D(E7_3!QKLS$N5TFSF68.!\-$^=")LX[,#'7S)\<7,HM'>0TK:YMXS2M
M0,!U3H!L&-/.MG"<,GE2/DZ;:.F7SGN&\2P(HI2$])#'P4%D@;^/A;<6+C"\
M;%\T_K28 ++&I&.QOEI96"FK)T1=NUG;_C&!O^_QVPQN%3F,;<[<PWCD 0L*
MWG%2C 5D\"@\X4)656QV+J;Z+R!#*IB&3C&K4B2T2%90-HT #;N#+,^.#072
MIC,8:L*0DYL' LN=G=/W1QAXGR5=S_1,\7DN3 K&>'V.Z88#M?UYC;?XGXGA
MLU9$Z,(J9R&EZ.-,XO37*S^&+OJ3O)I$LTHJ$OWKJ!X9"YHZ,IM;<]L:TT&V
M[6\^\3&+.>BH?K)XF<N-#]?SO&+"DA9,Z(W=HM6-!0BT ,)+2<0S0#$%9'.L
M?_Z23,O%I WQWLT3P0DJ 0_K,+V<,P(W/F.:GVGW>T+?.UH#?6%G"N=K<Y;A
M<(T& #RCE(X#>*#USTQ,\&,?)R9NNG$[M]$S6>1<D<6L>69[ 3,@X)7&SD:"
M\Q,.ITUS64#U@L\\_#2_Y _.83+!?%1@<GV.:3NYMC^O-+!S ),).,$#+6MM
M$:4+QK*PTFF_]H" ("M,SA7YRIYI-,&9"0+W82(;"R;G7"Y;>*,0D+_T5L'#
M4^\->/42K3;1/G%P 3KLF8(PQ#DL"MQO6<+T1RX&AU="\"4"^2Q03 -XWAA4
M@!R7"B&1((&B@B"5KN+#KXL;P94J@>[73]'SFVPPO55E_SA>JDI+&3O@CWOR
M(JN3V$$ 6'VI;-(8,[0&NH8'Y"+"#:36A5_@<H-SSMF?N-85N64#<[9Z.S#<
MFS(=-()+FARW\GN:!+;:A4_B)$6*Y&?HQ"J^4-8\LX8\ P)ND1,T$F#=3VM5
MDQGVK7D!Z4NU3MA(:G)[M?%CW!7R&O$BW1!JJ#*^90GC9H 0')X9@">1;"PZ
M32P7-@P!*3X=#8%V(NC<%*[]=6DU)>7 F&A:,EA <!7$NB($(PAE$M&^I!TX
M*&H&B>-R;^D!9[Y'(2ZW&VT=O^_BT.P]>KY$!@RA$ + >TLC8T$Q&/Q"AUM]
M(15RJ9*8R<6T0\WQO#CE"C<1[EDV:HOW;4^(I**Z-<^C4)0:_84,LQN3PN1$
M)1BEB5.75L_Y:C=^"!<X+VPH[A\W&"#\44H("@C:!0$/!62L]9@V/H>84E%%
M4L^O]!Z&,'8"AC+@F :5";U?&5G,;6S+X6DVI/%I6S#_6%0M#OT&*KIO.-E"
MG,]9S+_*)VJ2@VU?9L'%V6.2QHZ;VKO?\>A;YV0?WV&I)N8M9)W-[85+BWDF
MCEW>YL(RI73H"< ]:RT>P&T$9Q4JK>#7O48M6D[ML^7--73 BF"09WGSD[9:
MIY;%! [OFY^X,O<OH_ 9QJF/A.B8&TP2G>6_]K8U3.GR%CBX+=.+6>"8[ITG
M>]L_M24Y5(B(#!7T3@/^RFI:0V:=_MTZ&F+3IDS$HF/?5%!@F(3X-+2-KFGH
MA-[,V_JAC^F#(\24[7S."L9,#"$8+28D]@]79[&TC"VS4LR;NHTI(("F-<);
M6.LZ(5C%I(72"HV&Q#",EK%(3.O-I(406G8,+88IKTC*XTW9)Z4]A;5(F_K
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MS3)%H/<IBG^;D6K)V/R75JI)>0WP@A8AMJA;+&-7DH08-ADO01#C"F@5I4Y
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M_A3A.%\<R")ZH"7+GY+U01D&4 ("/!Y >5P&"""0G  ,"R# @!(T)R"'!V0
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M6#1XWMUT&7M^Z,2'K%EYZ!5].5H3!;,FM/B"GBU2]'!'UN"Q%0DS7]"X::B
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MG$BD!DXL%.QO J%047$RIHJ*$XF*BA.S%17["D4IQ>R4XU$&,I*+&*+2ML=
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MP^70N]:FW%X;QBPMR1="(<L;B3V06*]!Z<,VQL,(8A&WIV9=YF_YCA>[-MY
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M+?22YB753^&#2AS0VJIT2^]/\=)DNU<B6$ I5'SA#62FBKL=X+5VO[U_JR$
MMT4E74.8O%?Q$"/(Q%QFQH!;\1,,P_+B<P_6M1LJ\6,73S-VKTWEV )V\SHO
MLF)[CMUL1UK\;B(T3]A-)\<H=[/3:D>QBJ9^K9)XIQ<'LN)#N]K"6BU8KG5@
M BO\EH+)/$T#T?*0_5"&#!WI B";%UE5O>_+"J0EYY?<)HE =H@:H@V7D5"=
M;##,0M)%@N1BFSJ15R>4-W1$:7Y,[FU@,MKSZ%^,PU/H#!9>3D)NW(Z&Z_&<
M5-Q06:==5Y.4$@%?1\PX^A/X)R%4!](7)SFGSS8980+*F9;L.*OM [E!'DBE
M<L <4A&Q_F[F40FSMM^;W$ERYK/4N5#.N0FDX*G/8'>H+X^5D.K$]_!S,%A=
M=6!=CV7$,S@)L6-F_"23BK(9'!EIII5QQ0;$V2FM9DI2U<9JE;#<@EJG?C-<
MU* "IY=RTBC@>_XD@U:*YDOVXF2]C@/N&C-HG;!^)+;XL6G+32#E'1.94M:S
M;,Y+Y/>D\_7&]B7U+S2+S\49ZVH["Z=3U,+PFSIU(S2:.6&Y"W<H,T(5<1K/
M$)(ZD)T\@N%>!D(_2@+ZE+AIG:'2CL2YZ_R'^)RD]OR%.S3:H"[A&"2%CH O
M)4+VEQU-U R80RVI+YTP[]\D1$CW<(&ZDE]75_O>$\LRJ%!^GQQC>+1JU"V.
M$49;CJ#=[KOCXR'??FM4"3E7Z$K05JR&87J<0*30<A.X)W+#;RZ>Q5I2%0NT
MBL>PO_W1X6__4]8!!V)^O') K'THX:>>"!4A=($!P!F'=,Z0"K5:=1+U>J%*
M)/P\BK>(E)YAY:G%K>5LH3.@8Q&KHQ0T0;N$LM_KBF<7Y<Y=ZUF6.!>-&+1*
M%P/27^M82[;IH./A6AR''1R)ZT/VY RE,8T8M$IH<QBLUHJCL4GI[#AS9&^9
M<VL%0VGTLWLN@U4?RGZR ?S_U<OKH7SGO)XIK)]K5JITZ[.O/$(94+G;<BHV
M?) ,WIZ>3K0TCQ/3,\)/[9R+\@F<^;PA>L<Y=XA4EI80.ZY,OZ@:$B8?,K/S
M(:TJ$JF*2 0(Q%[_>,:<X%Z'S/B\D>J4F$/AL3[Q8IOSNLO$_"!O^[2Y::U<
MD];FN-9Z8\BS.1B%]7)ZEU&S>]91&*,L3.,9I;;6A@LJL--;3Y9G%T&IX5X_
M0>O/:0TCR/K16\-%)JGCZX*#_G"X*7;\QW_Q$ *.;LUD<R;:)R[T/5H][OI"
M2:0\T&@!%K\Y'B\TLQ0H%P]!V$D/TD];UGZ]VU42&? HSD7HQ.O&*Z:;IX=]
M&BX?/_(8B=3UQLSU)G??Y)DZV=W=Y++]JDW(3<;Q "'>*QVCF58L^E94?%M6
M.[[[)IZ78I<K^(<[,<>S6-OF\9 _22/5C02/V=T(-:/R(&-TX['!@,R,R+HA
M5TP/RLRHJ4L)S60&ML>G,98RY&)4VK&^*:2BHFMNUD+Q!.=$,$;:=!>;J8%K
MS0A,#Y&T)E$4D98Z/H4WI$IV+R%?E\0+!>/U>K0% /$@XA22@I,<5% ($$_\
MA#U4V1L'C?X*ON$FRXM194@4TE!V4MZ7?K=%6#B\%&$[$L&"T^R[4[(&@F;;
M160%3%I3A)VU3118CU'%%V0VC4\5F,X>VNJK[EJP!E_OZL?V<)1Q<QI[_ :@
M,+92WG8+4*'ZN:L.FO!3.T,'&0_@4VH2B>7[.>DU<@8V89?-V;A/FE=:%N70
MDA,PA?<[M&8KW>=S:F7'20VV7P'22>6F&, :MZ@;!PR4])N+(1#;I'C&4.HF
MVKVE0.[=-@'E-%2MDF:6#-9K/6<(-?2>.9W>V=711DLC* 7.I+R.RH6GLK!8
MRW=ZV1 B:>TJ0JO/X-5IL^#O^9;G;Z M F3>EU)[<->'0_E=M.!MP(XR&MP4
M;[QN?)!E9H8>H$ WQXI]!^#!+V7K7&\G6O6BN+2EIILL]1:?CVW8T3CWIE"%
M;>@[F.\V;VY70-N(0:NDM^!@O=8MB%!#?PN:. F]X[9%P1^A8+K_5.G/"[.N
MI ]2"%+IO$ C^4.H*@_C\&7 ='V;%_RFX2^>"B>C3 35CT%')GLF2TGPTF-]
M-!'4GQ TTE;(WNP!RN5:7'^.D+B38T2\4U$CX7G6XK*XM 71 2064'YD+]20
MFJ1P47@CAT6+ AR@+-P@42=S<;+O*FUVUT@RH62+7E?6]C4X/%U213H#6 1M
MUA<?S8^I2!EF[W\OR]WW_ !6VYNB$?R$J=05\^&18M/FIA7=)ZW-<4V8,:1M
MH!O%O$3^4+$4%\>LP]"_2:9SC:Q>AU*['\K6]SHHH.>W*D $<N>Z'A8,3%@H
MT$N1P^[@9P"E+;2M3MZ=C. =WZO3WO]Z%@.OYJ,)U46#/$A1!T4&G4L[N="2
M!7V [)_O=%60.R[F$]_VD],2UZN+HL+^]5 ,QF*#P5@W6E)==2KIUL<UCW>T
MV:T G:*JS"LD&P7A\&=V./(^!OBW(G<7BU1%XM0H&M&GK7,B1UJQ(4JZ'"VU
M06D2Z;B$/)EW=#+S^NFIXD]"A%<WN5JFRZ;;-C:2L6J>[A5#5V^;B]PT4F<0
MU,T?65XT'*R'[BS&$O)G>PW3ODNC56-''"6,]H+B!_'ST\RD(=U[M?2\H3@J
MT4MH G^(P6/X5MR*8!?\6AYVWPKQWK6U@>J'\IZ_:IGS#YZ!C ._7^9[H<YR
MP:]1N2!\<\T$#&9@1YBB*[!40\IZ-XOX\+IY6#=1ZK)+9V<7?DK.NA>T!ZEG
M81;G6[ZZD H@GE= AFC>)X0WMN :S;L#)35MA*.7/FQCI_%F7NW.+M3J+)4[
M)PR7 MIH9MG.?KS=E**=Z0+N)I?KG,@C<HL]*HTKT5#^L8VQ$ I77G,G(N Y
MD53,9+W:CTD?F<E,FJ#X!%F]2,VV9TSO7LFS:;I]_T,W?&*X_U,X<XHB[&$U
M9>28*48P/*3@-QW 6.;%97DX9)6[FH>JZR K_9HPLW8H"Q]4?/]ZO'1J]53*
MK2=@'NN6\-WKRPDMF^5]"(PQQ!3U6^'W?O<TK%BVASKQUV6UYWESK%)E-YW
MD>FWOH>QE-^V8Y&.6^B2/S8W15,.O1[?7LL"J%"!KIO]32$N*LC/ XRZ#2A%
M8MS.08+6MW.^$_WW83-\'V UX!$LQ]XD!BMBW9*@HUX4TVB"9EG)_4_$&V +
MJ2D. +%AQ?/<3A-TP]*,:C)ZWW@BL.O9#)@JM/AEV,D*M#M>8Y+B'#$,F>,\
MO!8G4(XG( <I ;&<>!QW)8@X7A Z;1UEF$.&,E>IZP7D"08HLEU#,1P@OK9;
M\XD,HW54<%45\=XCR\Z%)-%!P0)EFC S@&W"Y CJ@);%8@U/9AAZX9_*?\(L
MTD&22O"S'>;B+"9S'R4"VQD/M;1H%]L*4%<V>X/MH+UG]?HIRXNZ6>]:K(XL
MW]T4NA">2PDPXX&XWF)AF"&9'I-U@S(8%3 R]+@)7\&YK+#NX=-X2EV$3R)Y
M0$K/4R$7=5<*@?\]> WKCNR_57OT DV28QV@!_L6(YE _'2&JIW7@7+GK1G^
MIE!B_@@,V_Q=%I$ZQ2]0G^ 80-#432M5HRMYQ!3I-J!O>(*#0&J]O,HJP&2O
M32&SR!O(=.NJN*V8OHQ\EU*24Q0@$=OV**XD1:=S@>NWA1N==1LLV#I/286N
M4.9"\$DC:<?V=![_Z"#U;[;[:BW4HZ:LUDW#A1H%%X@/7__FXOJ>Z2ZLUV<$
MMT\,^>BFH[\K,123&9=:I'(_PFD'_Z[:I021&RW9DH-1DD@+V(!)LXOS0EPX
M?BMQK^O85#QV.:2S"7OI<QJ!([A"!*@,.-I"]17SUV51\,.5N 4/&HG5D^$(
M?5C;B<E>!G8VA0(2(F5\\83)/@TASJI@/S->S3U.$EPXYW(B0M1:>P1D3>G4
MP_16W@E;AD2E^?E!:+W[O2KK^JXJ][G39B>;,-4F\<W96RUV15K$$,G9'13U
MU8\'H=_5N4Z6\M3RU8C;5S]8UR-I>5X?$>-;T$\LJ1:J4]5JR%6;Y%$V'1F0
M'W0>)SCL0<JP3R"2'4FLE4ZYP/P],<RC6H3'TEBG8%XH;'Y:*D%JNUR(&HS[
M<1P@3OV6K@+C,I@&-FYZLT^F_V>PK"X*;GP:I=BN3>$1,31&. $-\Y%-R,M+
M(1I-S\>+X@.QJ;+#L@.$J "*6:_Q"G"QEH%9AI* ORI.6JD-Q/!E&IT$$FEA
M07[LN%8KD\TE^],CQ8U)0(VY;EI)HW_'%7*-L[DMBOBEE$"-?">=0N[XW7:@
M<4G*NE^3LAU-N?=2AMU.I=S6H^?QCOBCBD=C],,NII;3/#=86D!%-"8G,O(H
M,7N#^+\(382&NR]0M^R15[_^\J]?_N7W; R:6MX-\JPA>^'6[>$DCO+Z;_%
MXF"\.M03%WI7,MB3 &J7EU#"I&FJ7(O%I=FD=#62<=T6$6CWF]+XT#?QP<*%
M^"K6)D@%V!LIT,:9/*&OE-LA^=?T5^+\4LR>.'DANZ>/*43>T<MR>P3!]#JO
MM]GAWSRKKL4OSHTQS9EJSZ #DSU2^40=!(P= 5XZ24O[7KWPZ@G0A:KR>_,,
MGVU6A,J=FCY,=6*Z5Z(;,T"+PP?C)IL2U?P(N<,R $IK9&XL<]E4AX>9Q@G#
MQY&E6X^)DSQBC1(JF9>%?-K&,')XN 4T5ZZM+B4\(5Y>@ [L7O>23!=AIVMK
M*W7LGK]"[8?B"7#'W9>ZJ2*N4UW:7DQU2W6S^TC![Q@?V82A"J.X2X/O<)D?
MH/*L.AV])#+7ME@QJQH;0PA!6K;N#;)B>OBDW\M$RK'O:!;SR*(HNY(T+=3;
M",@-4ZFZ7AV2'@J1ET+U\9-D/3$Q'*!4,C;54U;H@FD  5P>\EVFBZG=B<D
M!5AI1;H,479HJS#4$P"Q^_-(0*)N)NEHZ\\%GV@[&^NF6R:4]KDYB/HR/F27
M2.-W0#>#PJ@RP,+UI4,CV'W=++'Q=K!D7&BQ:$IA$?\B2(DSBG<M4\>'C%?N
MMHV/J:.TWMX8[Y*YJ_U/% @;IF5"5<=:M>,5LNBBS"9WY]BB!WB4D9QC&<EI
M#G(XZSB*9MJ+HV]&&]E'XXR*8^MUVC?80T[(B(A23R&!@=ZE4YNN\^KEQJG>
MF_0M:,5N+E,=>&N]8R42(>:T'(FO396!-G.;%_P/WCR7L@;CPS._JIO\!0(
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MC1HR)F?>S/,2*V/VYF#O,CAUMCCBC71@=YDM7,ROJ#*::\4*+EV@5K<1.3A
MWKE# ^;C0[85CC=Q4I%ZAI;8Q?!%'+T,#9]8RFA5!#[#AY7U 5T&KA][2?,$
MFB!;6M+YGHH$$1. 45M=!DP(%.I?2I6$LO3P$THEN>M0,2W(LYU9X-6'I&\;
MW,S.;,(18'?<@F*N9)6C\'H.Z\?C:LGY/\:N1*]V0_Q:F,YI'RX)<1M@$,UI
MPLY+XKQK1)/[.< #$F1J/M)2FURBF(*=PP%H/KTC-HNC-:'X\V'*:=%XC9FE
M"VH?A*:/Y)KDNPS#>!3U9HQL3%%TX6:R=KI)KGD<\2[9/(@;0:E%;D]%LR4$
MH0H !^:?1EJ(13A:ZIN%P!Q0. CBH M":EZ NSC9N87IQ&Y ]2%H'EGCFMO&
MQ=:HN14UJ,I#(&7J6W [63T9M38MMRJ%,G7=&DHR5-^+4%\.*I0TI1/:N Q8
MQV[0#@4Q> W*GJQIX^]13#DUGT,!M[U7]5PAFZR9/."NJDC;(O540%'8H7^?
MZBA *S[YAT4*;RD)PVM*EN#G747*)C=J$JHI@3%@FPU009FW*YZ5VA6?IRT/
MP9U<%R^CAY)2;J\3,85M==L\4YMH:6/$6;6?LQZ5]G&S94+V@::P?6[5ZL!2
MYW185\R#Z"IN+G"P95(VHF/R8MY[$I"R3'HF8#L?P]DL">5U8 6V(U;2(8JT
M3;8R;8O"R@HH</<_U'24UP7EF<X3)\0NL*Z:>5BRM+4 9/8RQZ>LN^LL[>[Z
M/M[<(7J&_3C*>W@6<B<S[_<XC#;P!>:J4MCC695Q'G"-I.9WIY&L:BB*^=)R
M5U57D!F"9F^9<[%HC6L%RG2BJW$^SY=M,WH,?]G!W>QIVU WV04K8+G+N ZR
MXRGB ?7/^_.2$6\*B?!4CD_VY+/6]GID+S6R5Y>160:Z9/^$WJ(T,##MPZ5,
MK5P07E:H^@3VA_KPO2C9Y3^RV9( \0ZQ#UB;"AMY3:-Q76F*->JL&2@(%0XO
M37N'^%JAM1XM8S&5ZJ0NLVTO0,MQ,EL)7#BBUZ*X.OV)5!R)*JT!(-.EO2WW
M^K3HKYO7-/REJ"I[<#/:=:=ZJT^+,EN86#8CVZ RW;^S(O\9V3 QH5,)C3PF
M48TMJKX6F KGB9,83G\05MAEJ+N.?>0%<\\6/%INOO,X!7=1V^1U7W<=$FAM
M$<6$16T.C8:U#=&<CII:PDE05Y#9I"95J3KT]#TUGB[*-M=I.YJT-ODE>*#<
MR6PJ>YU.3?8!9C3"J@E7K#37KLTR,SNU60$,+-Y27OI24<YBRKL8)!,_N>-3
M%/Q#@,$[=,OQ-JQK,;.OK9WBT *>  $:0CI*0Y;0QMQD8 MF!ZW(FDZ+=-EM
MTE]W1#>0\C,=*\/._0Q#HXMXITV.J.0B0Z-),.!I7=;QR.].M4A6'&+AB>,S
M=!==!A&94[9G<.AC.H /6Q+PW(*/HN2#2^:;^&VU^,['[GS)1E+;=K6\&3N>
M--9$"",J".IV]B3M+_W3:5EA)I,=(<KHFC)ZI[QK44Y^-]\FKWR?/R#JXA"\
M?DV>_]-8$KL -GLQO7,--V@270)8L\H- 1GN3KO6K$C!.=XBE_VEAD<$ALDR
MB3.@_B,&=:SAVL]HS9H8M!118:PXXQB(-UC\H2$"R>[0((]'4R@($_3'#$&:
M!; BQZX"K-$;@-V+HD%3Z)3 VM6D&U?0#CI?+X,.5&'S/5" ^X0:9NI[=)_\
M:M2E_,#4#H6*(@AV-7"(IK^VVY]2M=&PYOK*)4KGP<"F1+5:G-]>C%.C-'T=
M-R$SX,VBNL+,70P^=<+UA4_NGPV^'<8V,!FM4/\]MSJK 4Z4K=Z<WC4E.\RP
M/'G\$/(;T_LV*C,WPKOTT00] U,08"K.L4/KE0!)&F*C[U5_.1&NNO7W1\ *
MNMLA>D>&IRT._1O"!;E!;,UUL8]*4BZ(V5FO1<1I7,L1] IZE 15C*1B=F>(
M<72QCN1'B;39Q*?.R56TCS*:IOM-C)/BZLAH/GE]]R2[1B\O/%T[P0H5AE%^
M#URHBJ./ALG\I&Z]]N*G4% (VA^4C9-RD<Y0^O\%4;,;HOH:&HDRGL@9E^"2
M+H.HX:<J&T3E)9"G,>6@S,(0@1>-"[$TW$M/<D+T*+\!485UO+U]+(SB9Z[+
M;RN%U\YCDJ:CC@?=Z$:0J>G=(+0!-",+VS(*:N979!UG[E>9/C4#:$;6L.L7
MSWD8R_19MN[+(#K@BD&U32Z@\B^#'0I-IGN[!'@:Z=Y.B,&JXI3Z6#F/V39H
MYOX98XJ8Z,QTH\=KWV&12^#QL[VMAK:[$HS-.@3U65/J@R6!,V2<J-=/&/,/
M3V.1:$04ZKT"6.5G;Z"96R2Z!'@:BT0GQ$8+()FD+D)>>,&&S0N ^!OS\V6Y
MM1]S8>D/$'^ GO\$>L%0$\+HN9#Z9"KW4%2#W_1[ZP>I*Q?3-%I&E=,D8X<!
M^J\A:?+0KRC8&#>P^OF93B+ *[S[TI69C@3-#NF30RF+9:&#PAYFAM=^G1[^
M "A@FT>],:&Q6/!I; @:$05\7$FIAQB3D_^/;U!WCL\WL3=LUT*QFU51LM"C
M_(/"7Z;5X]7DZ/E#5BG,_I&<E-XP],Z72P2^F1A9>,LV(F.K=L#UD+(ECV['
M4S++:=SL&L/$AEPS:6F*.;KE@%\F&&P[7XJ#*EY6@+E=HAH^D<!EHAVR?8&W
M7^B3NQ>Z,FG"?&WR*!)H#KBJ,BANGM_Q;NU<MAO^I!19QB%*BD N@WQ9O"!T
MIE!4IT;9^*Y8=@)P?2N":*I8MMC0X)":$V]ZU?6]X226BO8ZX3!4!5.4:=:9
MDA3048V E9.L&Q+ 8A4I1>6;B?GR+&.:/04=SE;,)X11RZLF0DI4)FYRD512
MKCJ,H+TP1[S@^18%B+(!#'AG*"W82FXQ^]C5> FJG9%D-CX;=,,CA2TSH/2!
M]/E.]O55\WN#W2ROBF\(FJO^[]4QGSUE6&&>"AQ]R$VV41C<5>TYER$#5)EO
M<[IR OPYP>)P/9L#DQQH[G&:+S-_Y_C[#4-XAD/7)V%,T8*YBQ,?_M 97#RS
M=E";M,6-%;PJ("\RC_D\+EX%>(E=7IA5<Q7/%-./%BXL^QUZ%QZZ9IX@4]-1
MM]A:(HLD:.7&B#.GX=:+XG7BNCNYC;=;O_$1;ZA[QD(\E>MAZMAH6[0Z.)E-
M)4BIM;0V=8%GZVRYP _(2T?S'D6J"\M;0KQ[[/MLE;YDX@4KOG]/J1[@UC1E
MY'C+9VS*"(GO<)J^DSTW+-.0V^ZT?6MZM5*R%3X/&Q4!^GSZB&AT6%5]K+!;
M)-6T1+NV="TB(AP-;69Z9F;Y6IX ;K"O>8T=;E6O&"K7ZZ;?A\PW,)(T=GQ=
M.Y0N3LKA506&G#939'8VQ")L_;-&50K#A4,"NB^U+U+%&FJFC=TV<+/!:;<0
M)^ /KO!=&PKXGJTP8,6=3H'XK$)<>_@FQWM  8T('UU34I*YV<> %&RA_'RI
M'-# A^7CMO+,SRJKQ\N*Y\)-M)KG7>?I<"<9V3U(.TGQO5 ?#<FD8#LYN2V2
M"!U#JZ*X/1R.T#MT!+)MF! (M0V3D$E 'J -GCS-2XW\!#(=OTE,QAY3M3^;
ME@RDU)!<,2*K=S9_3R)=(5@/LX'/U]0(ZP^WQ/F:+3H5T7%WO_M6/.V-JFX8
M00;BFFUSSM .^23I2)$EIY7,,*<X*U'4-)EZF*E/IIQPD6J0].J,F<INR3*Z
M9R:G?W*IRV'VW$?,"HK3;0#B=B89L@H--O-FW@8'F$,3X1V2/18Z0#)?9C1G
M59I2VQHI@K(;G+912Q>SM5" DD=N;]-/Q=31AXIU%.K%VO0$5CPV?DE4M^EU
MC=WLR9"()N7V.7(4S1:R]4_0I !:#B,[%XZ%\X!"$J2=JQ6W/.G'C)+VE',7
MIR'=K*M$]1V+=K R?;POH,9*S](.V*P]%5U0)PC9D'G'%.8G3KBW<%%XCZ/U
M#?)Y?[QKAV8G-LK[@3V=QR([;?N:'G;*,Z>-\AA;&7'.IN>5J+K+&Q@)9*V=
M:\GM2X6)E'[7M]JT!"JM'\M&^RDA\;U&\>\ECTW23^6V$=5O#(5<?;KB5E]"
MTLX#CP9C.(S,Z$%&50%R87W[UT;MJ3%@[QBIM<<2\5V(_HP9T?-=TH%#/:-?
MH:3K1**-C?+[JA6"VDX>6OF8;LO4H[C2,4,[6+;.@/I-EY/'Y%^/ZG/!XMM4
M)TZ(P_FR0CA#1-?<$&1J.M"6NTTEBJ39/K@?^ 7\\S#"&[8?@&XD5B%NM-FQ
MG/*JL!CJ"5*_RMHY$5OO>_11L6-F":!AJB?(OL0Q[?I5;4:HU7N*\33\5*74
M[!-$$:P/B(JF+QQ,/SI^C-ZQ70';#!S,4:^VQ?E.OXF% I90S]$HWK53<[^M
MGT]?15UC'_ 6"$#D<KG9,K-)6O-1MB??DM#QY\LK$JRN\$Y(7\./6U1$L,D1
MJV%L]C40%(1I5Y#D_MDU8:-#$<Z<BN\$F;S IB#,UO!N7T[_XF .: ,.$GC=
MH!T*8L1?2UX%2=LPO5._GY\=,;4$?@/Z8P.X^^9'R-.G)Y(+XR[#@SDE?5-<
M18+I+_"#\%5O@#W\>9<KQ%8?E.;D]<[U+DXVK>:=B WH10TQO9MK<+..D%JF
MLPA'JQ9K(0C!FDZK*/G<H;QE,G^<(7$W>J=M'S=[?',O;KE601Y<FDHON^2P
M.U2^VV'Q(<RMNT9>[/-G].([1O)#E+0/;WV45=N9I;(<-BV+ ]"VM(5D0[^R
M_5S[V@^O8A0M8.F?<[V,+>V6)P.MK54%#4V\U%>R+ZR'GD3)8_O7,))<#>BK
M5Z5@]/0;LK4>8"'E%)KKU8LJ>RP!K!9 *;T]=@PH&.Q-0I.UZ5IYQ72\>&X*
MO?8*J\Z7V'+O$&:(-(0;*:93$,6NYGO#4+?SCF.]M\NP[=03:?&RMX3FHX7B
MT^'9@\*/(\U"98$L:PH#H %3#]:U;!:;!S*R^<A+8C3V'V(X"J##E<I.I+O0
MT#CJ:309.MA$"XLD%)^YS,"8OA.[63 L%VM*XM7Z) Y9;!Z&S(#N<)!H3?\\
M!1?4<"@FWZ=(I]*LW2MUME:1S](]H99&$IDW$3KRSJ:;JEPV3I26D;592Z<C
MR!O.DVF=TY*C$[84(]FZ@]]M;>R314WB9>2R-,V<#DG.8*Y*:;"L77E*S9"&
MY0@L[XETT'G^^"]CD$4C@8&\G)P4AN- R49*REC;F8T3;K!4W-=]V7V6BMN$
M9AXC34-!]J9+ZU4Z+LEC#+O,#3"*4^9CD)=(U>0VM%E#'U^3V=AA)M"+*&34
M.GK#+67'.KF^6VK=MXK;7U7&<GO=YB]-S _)=ER@3;F,=N5JZ\VE;4,ZS*=?
MQ!'3SCNVR=K$FQL.EW_M/"9O,UT0.M\BOO,*5H4QZ%_]A\AD)&?1.6&;/?\@
MW $#\@&F\PGAU9JM?;,=$W:%WL>;.T2S,\:Q3$5&!E/1HH)U2$$+V)-F[(*)
M;,!DR1<'/F3V+=J@:$T\PM\ 6B.4]=[QXA M8]_'.Q22)?N%<Z@3EC^2*YR(
M9XRY8MXEC.<[?OB!\J8_WH>$,;_G'LZ7[!=9H"83D@"R4ZX7%+O24 ]SAA=U
M27 >4" @QJ8EG!IID.7#AO$]$;S9EPHK94P,L/NJF)V$-/KMQ@E6:/: A;3/
M/BAHGOW70>ME6B:WGPK3FJNL @;<09&D+MXAOK!!:2.C9FJ=;[2P$MKY< OQ
MFY(=9V$C&'IE>H;V4)WP548,6ELD![WS  M]B=XDH2^/&*ZSGFU.4SG24(>L
MGM00L]3Y<HE==!'3 /-M9E$NH8"UZWL;=->XS>H$Q51]:_6M."Z5C]R(D@"[
M<DH3)&7ZT&2 !D7!,I%:8Q\1RG_^**>UIN^,E@D/T$\C!F +AG0*G=<Z7VZV
ME.R2N\@2*?3:E]./\9L5T@P#6,-4<PDCPFM4W?3*>#D5I)8'JE]!5\SP=!!2
MS+B^Y:FP@*ONE 0)I1OD(KS3D*OI9&5JX9!14C%.Z\;-](66,[0E(:XZI>'M
M,'*RMFGK@ =P/EM:,XG<>8G4*0F3B\7 :FKF86*54=57"TK0VT/9294RW%?&
M95W/3E" EAB\]4P/-YO4V8L<7,R@UNX ;1WL94)EHX+.X3?RL$F)+2A!]4H?
MX$[K5[[UZ+"'F:'\VB ?VP$=6.-U=;TF8]"IRQ(#VX*:)HS4NZ*S</:.&&S2
MN-]\+7G/E737%63W8F7O+Q0J84H-7!1W72U$ "JA1STK%V:K7LX[_M&XV&FX
MP3G=;8$M+2*G=K[="_?)XX)]+GKZ#:'@ D?3;QM*3F>A?E%%0,=_;K57/"[<
M&=DX.!A+WP6.IIL5B4\"L=9@!2S+A_<J*LN/,?;DQ4^3)=34QL7X^8^:;EI!
M,]J&3Z\*FU5GF^;:- ;Q.)^*SHHGP&SIY_\*M:BO@Y'1\R0U-7;!!GB@I*32
MQG,N+3KMXF2X,D)-K9W0P;ZR]U0"ORO@TA[0L.\M)>%H$7[*;*K+4FU'*Z3=
M#$"SSS'/7#?>Q,G5TC/$V+LX093]VT?92TRS#:$1_IS\O'4PP(8 )M9$766G
MQ<#IQ/0)9ZMH\ >=G:PFNQ51\QR@!Z!&"VN<K&?OMM!!6KHA6B5I7NT#/*"\
MIHW4T$/_\\W6)X\(99?ZQSFMZF<ZD5./'@76SCT$T(1\-T=EC1WE3'+JQY$2
M>NT_BX18TX94?F3OE^K19 L3TY?Y9+78AA7@TJ4R&8OBEXY9 ^\]"5Q=<U.,
MK8U351#0 <D;$CG^)*J!D^;E3M:)>DEH^H,P(BA;A$*2W/Z@O!68AUGPSDPQ
M'!S7;(L-L).^#6D')Y*O?>$\8\O[[>9L54.?@=P4HJ/ZBP9G*&*:"(&@%P)
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M8X2XW*?RAE+>_?\R2/OV9;T9F0<4+G(2)&6O 8ABE>MR<&Y&Q:M<8'^3O <
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MF/(!7>#0=7Q^:GH>>&?=3\_UZZ*5J*D]M*QNVE$QDR@^.-#"<_1I6Y)"BT*
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M)8)617]E*'+E .0H!IS7[ITSH(9J1&V;3G54\G-=DVF)8KP#J*T&LI8L65W
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M:7-I;VYL=&0N:'1M4$L! A0#%     @ ]X%W5O#)=C0L!P  XSD  "
M         ( !BP # &8R,&8R,#(R97@Q,BTQ7W)A:6QV:7-I;VYL=&0N:'1M
M4$L! A0#%     @ ]X%W5IR%36%#!P  >S@  "               ( !]0<#
M &8R,&8R,#(R97@Q,BTR7W)A:6QV:7-I;VYL=&0N:'1M4$L! A0#%     @
M]X%W5GUGE"YB P  TQ0  "               ( !=@\# &8R,&8R,#(R97@Q
M,RTQ7W)A:6QV:7-I;VYL=&0N:'1M4$L! A0#%     @ ]X%W5KA'^?)L P
MXQ0  "               ( !%A,# &8R,&8R,#(R97@Q,RTR7W)A:6QV:7-I
M;VYL=&0N:'1M4$L! A0#%     @ ]X%W5GA"FVOB'0  %M   !\
M     ( !P!8# &8R,&8R,#(R97@R+3%?<F%I;'9I<VEO;FQT9"YH=&U02P$"
M% ,4    " #W@7=6$0,KJ?M)  !J\0$ 'P              @ '?- , 9C(P
M9C(P,C)E>#0M-%]R86EL=FES:6]N;'1D+FAT;5!+ 0(4 Q0    ( />!=U:
M)&=IO X  &H/   +              "  1=_ P!F:6Y?,# Q+FIP9U!+ 0(4
M Q0    ( />!=U88"AH0Y%<  /):   +              "  ?R- P!F:6Y?
M,# R+FIP9U!+ 0(4 Q0    ( />!=U;O\U!RB5@  +I;   -
M  "  0GF P!I;6%G95\P,#$N:G!G4$L! A0#%     @ ]X%W5DKY!VX;0
MQD    T              ( !O3X$ &EM86=E7S P,BYJ<&=02P$"% ,4
M" #W@7=67J-;3SY$  "'10  #0              @ $#?P0 :6UA9V5?,# S
M+FIP9U!+ 0(4 Q0    ( />!=U:,%A!(8$X  -E/   -              "
M 6S#! !I;6%G95\P,#0N:G!G4$L! A0#%     @ ]X%W5KO8< -7%0  B?T
M !$              ( !]Q$% ')V<VXM,C R,C$R,S$N>'-D4$L! A0#%
M  @ ]X%W5GP+UI>\"   $54  !4              ( !?2<% ')V<VXM,C R
M,C$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( />!=U;S7<FHSSL  +N2 P 5
M          "  6PP!0!R=G-N+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4
M" #W@7=6U9M&L.B6  "=: < %0              @ %N; 4 <G9S;BTR,#(R
M,3(S,5]L86(N>&UL4$L! A0#%     @ ]X%W5J>\INZ%/   $,D# !4
M         ( !B0,& ')V<VXM,C R,C$R,S%?<')E+GAM;%!+!08     $@ 2
+ ,,$  !!0 8    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
